0001558370-24-010167.txt : 20240725 0001558370-24-010167.hdr.sgml : 20240725 20240725153350 ACCESSION NUMBER: 0001558370-24-010167 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 135 CONFORMED PERIOD OF REPORT: 20230304 FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RITE AID CORP CENTRAL INDEX KEY: 0000084129 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 231614034 STATE OF INCORPORATION: DE FISCAL YEAR END: 0302 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-05742 FILM NUMBER: 241141715 BUSINESS ADDRESS: STREET 1: 1200 INTREPID AVENUE, 2ND FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19112 BUSINESS PHONE: 7177612633 MAIL ADDRESS: STREET 1: PO BOX 3165 CITY: HARRISBURG STATE: PA ZIP: 17105 FORMER COMPANY: FORMER CONFORMED NAME: RACK RITE DISTRIBUTORS DATE OF NAME CHANGE: 19680510 FORMER COMPANY: FORMER CONFORMED NAME: LEHRMAN LOUIS & CO DATE OF NAME CHANGE: 19680510 10-K/A 1 rad-20230304x10ka.htm 10-K/A
91610000.1800000841292023FYtruehttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrentRite Aid Corporation ("Rite Aid," the "Company," "we," "us," and "our") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment" or "Form 10-K/A") to our Annual Report on Form 10-K for the fiscal year ended March 4, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on May 1, 2023 (the "Original Form 10-K") to make certain changes, as described below. Subsequent to the issuance of the Company's consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement related to the Company's historical accounting for closed store liabilities in accordance with changes in ASC 420, Exit or Disposal Cost Obligations. Based on their evaluation, management concluded the misstatement is not material to the Company's previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the "previously issued financial statements"). However, due to the discovery of this error, we reevaluated the effectiveness of our internal control over financial reporting ("ICFR") as of March 4, 2023 and identified a material weakness in our ICFR. For a more detailed description of this material weakness, refer to Part II, Item 9A,"Controls and Procedures." This Amendment therefore amends our assessment of our ICFR and our disclosure controls and procedures to indicate that they were not effective as of March 4, 2023 because of this material weakness. Our independent registered public accounting firm, Deloitte & Touche LLP, has also amended its opinion on our ICFR as of March 4, 2023. In conjunction with filing this Amendment, we determined it was appropriate to revise the consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes thereto to reflect the impact of the immaterial misstatement in the periods impacted. For additional information and a more detailed discussion, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements. Item 1A, "Risk Factors," of Part I of the Original Form 10-K, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Continuing Operations;" Item 8, "Financial Statements and Supplementary Data," and Item 9A, "Controls and Procedures," of Part II of the Original Form 10-K are hereby deleted in their entireties and replaced with Item 1A, Item 7, Item 8, and Item 9A included herein, Item 15, "Exhibits and Financial Statement Schedule," of Part IV of the Original Form 10-K also has been amended to include a new consent of Deloitte & Touche LLP and, as required by Rule 12b-15 under the Securities Act of 1934, as amended, to provide new currently dated certifications by our Chief Executive Officer and Chief Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The new consent is attached to this Amendment as Exhibit 23 and the new certifications are attached to this Amendment as Exhibits 31.1, 31.2 and 32. The other Items of the Original Form 10-K have not been amended and, accordingly, have not been repeated in this Amendment. The only changes to the Original Form 10-K are related to the matters described above. Except as described above, this Amendment does not amend, update, or change any other item or disclosure in the Original Form 10-K and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Original Form 10-K was filed, and the Company has not undertaken herein to amend, update, or change any information contained in the Original Form 10-K to give effect to any event following the date of filing of the Original Form 10-K, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and any subsequent filing with the SEC.5575200056629000719188000522372000993810007191880005223720009022000013.159.661.860.1813.159.661.68http://www.riteaid.com/20230304#GainLossOnAcquisitionOfBusiness13.159.661.8613.159.661.68http://www.riteaid.com/20230304#LeaseTerminationAndLongLivedAssetImpairmentChargeshttp://www.riteaid.com/20230304#LeaseTerminationAndLongLivedAssetImpairmentChargesP3YP90DP5YP22Yhttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent0.000.00P0Y0000084129us-gaap:AllowanceForCreditLossMember2022-02-272023-03-040000084129us-gaap:AllowanceForCreditLossMember2021-02-282022-02-260000084129us-gaap:AllowanceForCreditLossMember2020-03-012021-02-270000084129us-gaap:AllowanceForCreditLossMember2023-03-040000084129us-gaap:AllowanceForCreditLossMember2022-02-260000084129us-gaap:AllowanceForCreditLossMember2021-02-270000084129us-gaap:AllowanceForCreditLossMember2020-02-2900000841292022-11-272023-03-0400000841292021-11-282022-02-2600000841292020-11-292021-02-270000084129us-gaap:RetainedEarningsMember2023-03-040000084129us-gaap:AdditionalPaidInCapitalMember2023-03-040000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-040000084129us-gaap:RetainedEarningsMember2022-02-260000084129us-gaap:AdditionalPaidInCapitalMember2022-02-260000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-260000084129us-gaap:RetainedEarningsMember2021-02-270000084129us-gaap:AdditionalPaidInCapitalMember2021-02-270000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-270000084129us-gaap:RetainedEarningsMember2020-02-290000084129us-gaap:AdditionalPaidInCapitalMember2020-02-290000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-02-290000084129rad:EnvisionInsuranceCompanyMember2022-12-310000084129us-gaap:CommonStockMember2023-03-040000084129us-gaap:CommonStockMember2022-02-260000084129us-gaap:CommonStockMember2021-02-270000084129us-gaap:CommonStockMember2020-02-2900000841292022-07-310000084129rad:AmendedAndRestated2020OmnibusEquityPlanMember2021-07-310000084129rad:OmnibusEquityPlan2020Member2020-07-310000084129srt:MaximumMemberus-gaap:EmployeeStockOptionMemberrad:OmnibusEquityPlan2014Member2014-06-300000084129rad:OmnibusEquityPlan2014Member2014-06-300000084129rad:OmnibusEquityPlan2012Member2012-06-300000084129rad:OmnibusEquityPlan2010Member2010-06-300000084129us-gaap:RestrictedStockMember2022-02-260000084129us-gaap:RestrictedStockMember2021-02-270000084129us-gaap:RestrictedStockMember2020-02-290000084129us-gaap:RestrictedStockMember2021-02-282022-02-260000084129us-gaap:RestrictedStockMember2020-03-012021-02-270000084129rad:RetailPharmacyMember2020-03-012021-02-270000084129rad:PharmacySalesMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:PharmacySalesMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:FrontEndSalesMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:FrontEndSalesMember2022-02-272023-03-040000084129rad:PharmacySalesMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129rad:FrontEndSalesMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129rad:PharmacySalesMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129rad:FrontEndSalesMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129rad:PharmacyServicesMember2020-03-012021-02-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2023-03-040000084129rad:FacilityAndEquipmentLeaseExitChargesMember2023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-05-280000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-05-280000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-05-280000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-02-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-02-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-02-260000084129rad:FacilityAndEquipmentLeaseExitChargesMember2022-02-260000084129rad:FacilityAndEquipmentLeaseExitChargesMember2021-02-270000084129rad:FacilityAndEquipmentLeaseExitChargesMember2020-02-290000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-02-272023-03-040000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2021-02-282022-02-260000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:RetentionMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:RetentionMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:OperatingSegmentsMemberrad:SkuOptimizationMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:OperatingSegmentsMemberrad:SkuOptimizationMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:CostOfSalesMemberrad:SkuOptimizationMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OtherRestructuringMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:RetentionMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2020-03-012021-02-270000084129us-gaap:IntersegmentEliminationMemberrad:SkuOptimizationMember2020-03-012021-02-270000084129us-gaap:CostOfSalesMemberrad:SkuOptimizationMember2020-03-012021-02-270000084129us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-03-012021-02-270000084129us-gaap:CostOfSalesMember2020-03-012021-02-270000084129rad:SkuOptimizationMember2020-03-012021-02-270000084129us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-03-040000084129us-gaap:LeaseholdImprovementsMember2023-03-040000084129us-gaap:LandMember2023-03-040000084129us-gaap:EquipmentMember2023-03-040000084129us-gaap:ConstructionInProgressMember2023-03-040000084129us-gaap:BuildingMember2023-03-040000084129us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-02-260000084129us-gaap:LeaseholdImprovementsMember2022-02-260000084129us-gaap:LandMember2022-02-260000084129us-gaap:EquipmentMember2022-02-260000084129us-gaap:ConstructionInProgressMember2022-02-260000084129us-gaap:BuildingMember2022-02-260000084129rad:FinanceLeasedAssetsMember2023-03-040000084129rad:FinanceLeasedAssetsMember2022-02-260000084129us-gaap:SoftwareDevelopmentMember2022-02-272023-03-040000084129us-gaap:SoftwareDevelopmentMember2021-02-282022-02-260000084129us-gaap:SoftwareDevelopmentMember2020-03-012021-02-270000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2018-03-012018-03-310000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-272023-03-040000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-282022-02-260000084129us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-012021-02-270000084129us-gaap:InternalRevenueServiceIRSMember2023-03-040000084129rad:RetailStoreMember2023-03-040000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2018-03-310000084129rad:BlueCrossBlueShieldLitigationMember2023-03-040000084129rad:RetailSitesInActiveStatusMember2023-03-040000084129us-gaap:RetainedEarningsMember2022-02-272023-03-040000084129us-gaap:RetainedEarningsMember2021-02-282022-02-260000084129us-gaap:RetainedEarningsMember2020-03-012021-02-270000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2022-02-272023-03-040000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2022-02-272023-03-040000084129rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember2022-02-272023-03-040000084129rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember2022-02-272023-03-040000084129rad:SEIUHealthCareEmployeesPensionFund1199Member2022-02-272023-03-040000084129rad:IndividuallyInsignificantMultiemployerPlanMember2022-02-272023-03-040000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2021-02-282022-02-260000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2021-02-282022-02-260000084129rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember2021-02-282022-02-260000084129rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember2021-02-282022-02-260000084129rad:SEIUHealthCareEmployeesPensionFund1199Member2021-02-282022-02-260000084129rad:IndividuallyInsignificantMultiemployerPlanMember2021-02-282022-02-260000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2020-03-012021-02-270000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2020-03-012021-02-270000084129rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember2020-03-012021-02-270000084129rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember2020-03-012021-02-270000084129rad:SEIUHealthCareEmployeesPensionFund1199Member2020-03-012021-02-270000084129rad:IndividuallyInsignificantMultiemployerPlanMember2020-03-012021-02-270000084129rad:RiteAidSubsidiariesMember2023-03-040000084129rad:WalgreensBootsAllianceWbaMemberrad:WalgreensMember2017-09-180000084129rad:BlueCrossBlueShieldLitigationMember2022-02-272023-03-040000084129us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-040000084129us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-040000084129us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-02-260000084129us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-02-260000084129us-gaap:SubordinatedDebtMember2023-03-040000084129rad:UnsecuredUnguaranteedDebtMember2023-03-040000084129rad:SeniorSecuredDebtMember2023-03-040000084129us-gaap:SubordinatedDebtMember2022-02-260000084129rad:UnsecuredUnguaranteedDebtMember2022-02-260000084129rad:SeniorSecuredDebtMember2022-02-260000084129rad:NewYorkEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember2022-12-012022-12-310000084129rad:CaliforniaEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember2022-08-012022-08-310000084129rad:CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember2022-08-012022-08-310000084129rad:HumanaLitigationMember2022-04-222022-04-220000084129srt:MinimumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-12-012022-12-010000084129srt:MaximumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-12-012022-12-010000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-12-010000084129rad:FiloTermLoanDueAugust2026Member2022-12-010000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2021-08-200000084129rad:FiloTermLoanDueAugust2026Member2021-08-200000084129rad:SeniorSecuredRevolvingCreditFacilityDueJanuary2020Member2018-12-200000084129rad:SeniorSecuredRevolvingCreditFacilityDueDecember2023Member2018-12-200000084129srt:MinimumMemberus-gaap:EquipmentMember2023-03-040000084129srt:MaximumMemberus-gaap:EquipmentMember2023-03-040000084129srt:MinimumMemberus-gaap:BuildingMember2023-03-040000084129srt:MaximumMemberus-gaap:BuildingMember2023-03-040000084129us-gaap:TrademarksMember2020-03-012021-02-2700000841292020-03-012020-05-300000084129rad:PharmacyServicesMember2022-11-272023-03-040000084129rad:PharmacyServicesMember2022-05-292022-08-270000084129rad:RetailPharmacyMember2022-02-272023-03-040000084129rad:RetailPharmacyMember2021-02-282022-02-260000084129rad:PharmacyServicesMember2021-02-282022-02-260000084129rad:RetailPharmacyMember2023-03-040000084129rad:RetailPharmacyMember2022-02-260000084129rad:RetailPharmacyMember2021-02-270000084129rad:PharmacyServicesMember2021-02-270000084129rad:SeniorNotes7.5PercentMember2022-12-092022-12-090000084129rad:SeniorSecuredCreditFacilityMember2022-12-012022-12-0100000841292022-06-132022-06-130000084129rad:SeniorSecuredCreditFacilityMember2022-02-272023-03-040000084129rad:February2023ReceivablePurchaseAgreementMember2022-11-272023-03-040000084129rad:MostCurrentReceivablePurchaseAgreementMember2022-02-272023-03-040000084129rad:January2022ReceivablePurchaseAgreementMember2021-11-282022-02-2600000841292021-05-302021-08-280000084129rad:October2022ReceivablePurchaseAgreementMember2022-08-282022-11-260000084129us-gaap:TrademarksMember2023-03-040000084129us-gaap:LicensingAgreementsMemberrad:PharmacyServicesMember2023-03-040000084129rad:EnvisionInsuranceCompanyMemberus-gaap:LicensingAgreementsMember2022-02-260000084129rad:EnvisionInsuranceCompanyMemberus-gaap:LicensingAgreementsMember2022-02-250000084129us-gaap:TrademarksMember2023-03-040000084129us-gaap:NoncompeteAgreementsMember2023-03-040000084129us-gaap:LicensingAgreementsMember2023-03-040000084129us-gaap:CustomerRelationshipsMember2023-03-040000084129us-gaap:ComputerSoftwareIntangibleAssetMember2023-03-040000084129rad:PrescriptionFilesMember2023-03-040000084129us-gaap:TrademarksMember2022-02-260000084129us-gaap:NoncompeteAgreementsMember2022-02-260000084129us-gaap:LicensingAgreementsMember2022-02-260000084129us-gaap:CustomerRelationshipsMember2022-02-260000084129us-gaap:ComputerSoftwareIntangibleAssetMember2022-02-260000084129rad:PrescriptionFilesMember2022-02-260000084129rad:SeniorNotes6.125Percent2023DueMember2020-07-102020-07-100000084129rad:SeniorNotes6.125Percent2023DueMember2020-06-252020-06-250000084129rad:SeniorNotes6.125Percent2023DueMember2020-06-202020-06-200000084129us-gaap:EmployeeStockOptionMember2021-02-282022-02-260000084129us-gaap:EmployeeStockOptionMember2020-03-012021-02-270000084129us-gaap:RestrictedStockMember2022-02-272023-03-040000084129us-gaap:EmployeeStockOptionMember2022-02-272023-03-040000084129us-gaap:RestrictedStockMember2023-03-040000084129us-gaap:EmployeeStockOptionMember2023-03-040000084129rad:SeniorNotes6.125Percent2023DueMember2020-07-242020-07-240000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2021-02-282021-05-290000084129us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2022-02-272023-03-040000084129us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2021-02-282022-02-260000084129us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2020-03-012021-02-270000084129us-gaap:DefinedBenefitPlanEquitySecuritiesMember2023-03-040000084129us-gaap:FixedIncomeSecuritiesMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesMember2022-02-260000084129rad:DefinedBenefitPlanOtherInvestmentMember2022-02-260000084129us-gaap:FixedIncomeSecuritiesMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-03-040000084129rad:DefinedBenefitPlanOtherInvestmentMember2023-03-040000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:SmallMidCapMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129rad:AgtHighYieldBondMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:FairValueMeasurementsRecurringMember2023-03-040000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:SmallMidCapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AgtHighYieldBondMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FixedIncomeFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:TwentyPlusYearTreasuryStripsMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:SmallMidCapMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermUsGovernmentBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:LongTermCreditBondIndexMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonMultiAssetCreditMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonHighYieldPlusBondMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonGlobalRealEstateMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AonCoreRealEstateFunMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129rad:AgtHighYieldBondMemberus-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:FairValueMeasurementsRecurringMember2022-02-260000084129us-gaap:PensionPlansDefinedBenefitMember2021-02-270000084129us-gaap:PensionPlansDefinedBenefitMember2022-02-260000084129us-gaap:InternalRevenueServiceIRSMemberrad:TaxPeriodBetweenFiscal2032And2037Member2023-03-040000084129us-gaap:InternalRevenueServiceIRSMemberrad:TaxPeriodBetweenFiscal2029And2031Member2023-03-040000084129us-gaap:StateAndLocalJurisdictionMember2023-03-040000084129rad:SeniorNotes6.125Percent2023DueMember2023-03-040000084129rad:SeniorNotes7.5PercentMember2022-12-090000084129rad:SeniorNotes7.5PercentMember2022-11-300000084129rad:SeniorNotes7.5PercentMember2022-11-030000084129rad:SeniorNotes7.5PercentMember2022-06-290000084129rad:Notes7.7PercentDueFeb2027Member2022-06-290000084129rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member2022-06-290000084129rad:SeniorSecuredNotes8.0PercentMember2022-06-130000084129rad:SeniorNotes7.70PercentMember2022-06-130000084129rad:SeniorNotes7.5PercentMember2022-06-130000084129rad:SeniorNotes6.875PercentMember2022-06-130000084129rad:SeniorNotes6.125Percent2023DueMember2021-05-280000084129rad:SeniorNotes6.125Percent2023DueMember2020-07-2400000841292020-07-100000084129rad:SeniorSecuredNotes8.0PercentMember2020-07-090000084129rad:SeniorNotes6.125Percent2023DueMember2020-06-250000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2023-03-040000084129rad:SeniorSecuredNotes8.0PercentMember2023-03-040000084129rad:SeniorNotes7.5PercentMember2023-03-040000084129rad:Notes7.7PercentDueFeb2027Member2023-03-040000084129rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member2023-03-040000084129rad:FiloTermLoanDueAugust2026Member2023-03-040000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-02-260000084129rad:SeniorSecuredNotes8.0PercentMember2022-02-260000084129rad:SeniorNotes7.5PercentMember2022-02-260000084129rad:Notes7.7PercentDueFeb2027Member2022-02-260000084129rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member2022-02-260000084129rad:FiloTermLoanDueAugust2026Member2022-02-260000084129rad:SeniorSecuredNotes8.0PercentMember2020-07-240000084129rad:SeniorSecuredNotes8.0PercentMember2020-06-250000084129rad:SeniorSecuredTermLoanDueDecember2023Member2018-12-200000084129us-gaap:FairValueInputsLevel1Member2023-03-040000084129us-gaap:FairValueInputsLevel1Member2022-02-260000084129rad:FiloTermLoanDueAugust2026Memberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-12-012022-12-010000084129rad:FiloTermLoanDueAugust2026Memberus-gaap:BaseRateMember2022-12-012022-12-010000084129srt:MinimumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Memberus-gaap:BaseRateMember2021-08-202021-08-200000084129srt:MinimumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Memberrad:LondonInterbankOfferedRateMember2021-08-202021-08-200000084129srt:MaximumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Memberus-gaap:BaseRateMember2021-08-202021-08-200000084129srt:MaximumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Memberrad:LondonInterbankOfferedRateMember2021-08-202021-08-200000084129rad:FiloTermLoanDueAugust2026Memberus-gaap:BaseRateMember2021-08-202021-08-200000084129rad:FiloTermLoanDueAugust2026Memberrad:LondonInterbankOfferedRateMember2021-08-202021-08-200000084129rad:MedicarePartDMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:MedicarePartDMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129rad:MedicarePartDMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129rad:RiteAidRewardsProgramMemberrad:RetailPharmacyMember2023-03-040000084129rad:RiteAidRewardsProgramMemberrad:RetailPharmacyMember2022-02-260000084129rad:CaremarkMemberrad:LargestThirdPartyPayorsMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2022-02-272023-03-040000084129rad:TopFiveThirdPartyPayorsMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2022-02-272023-03-040000084129rad:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:PreviouslyDisclosedClientLossMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:PrescriptionDrugsMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:OverTheCounterMedicationsAndPersonalCareMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:MedicarePartDMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:MedicarePartDMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2022-02-272023-03-040000084129rad:MedicaidAgenciesAndRelatedManagedCareMedicaidPayorsMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2022-02-272023-03-040000084129rad:McKessonCorporationMemberrad:PharmacySalesMemberus-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2022-02-272023-03-040000084129rad:LargestMedicaidAgenciesMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2022-02-272023-03-040000084129rad:LargestCustomerMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129rad:HealthAndBeautyAidsMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:GeneralMerchandiseAndOtherMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129rad:CaremarkMemberrad:LargestThirdPartyPayorsMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2021-02-282022-02-260000084129rad:PrescriptionDrugsMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129rad:MedicarePartDMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129rad:LargestCustomerMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129rad:CaremarkMemberrad:LargestThirdPartyPayorsMemberrad:PharmacySalesMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMember2020-03-012021-02-270000084129rad:PrescriptionDrugsMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:ProductConcentrationRiskMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129rad:MedicarePartDMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129rad:LargestCustomerMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberrad:PharmacyServicesMember2020-03-012021-02-2700000841292020-02-290000084129rad:BartellDrugCompanyMemberus-gaap:TrademarksMember2020-12-180000084129rad:BartellDrugCompanyMemberrad:PrescriptionFilesMember2020-12-180000084129rad:BartellDrugCompanyMember2020-12-182021-02-270000084129rad:BartellDrugCompanyMember2020-12-182020-12-180000084129rad:BartellDrugCompanyMember2022-02-272023-03-040000084129rad:BartellDrugCompanyMember2020-03-012021-02-270000084129us-gaap:OperatingSegmentsMemberrad:RetailPharmacyMember2023-03-040000084129us-gaap:OperatingSegmentsMemberrad:PharmacyServicesMember2023-03-040000084129us-gaap:OperatingSegmentsMemberrad:RetailPharmacyMember2022-02-260000084129us-gaap:OperatingSegmentsMemberrad:PharmacyServicesMember2022-02-260000084129us-gaap:RestrictedStockMember2022-02-272023-03-040000084129us-gaap:EmployeeStockOptionMember2022-02-272023-03-040000084129us-gaap:RestrictedStockMember2021-02-282022-02-260000084129us-gaap:EmployeeStockOptionMember2021-02-282022-02-260000084129us-gaap:RestrictedStockMember2020-03-012021-02-270000084129us-gaap:EmployeeStockOptionMember2020-03-012021-02-270000084129rad:ManufacturersRebatesReceivablesMemberrad:PharmacyServicesMember2021-11-282022-02-260000084129rad:ManufacturersRebatesReceivablesMemberrad:PharmacyServicesMember2023-03-040000084129rad:ManufacturersRebatesReceivablesMemberrad:PharmacyServicesMember2022-02-260000084129us-gaap:PerformanceSharesMember2022-02-272023-03-040000084129us-gaap:PerformanceSharesMember2021-02-282022-02-260000084129us-gaap:PerformanceSharesMember2020-03-012021-02-270000084129us-gaap:CommonStockMember2022-02-272023-03-040000084129us-gaap:AdditionalPaidInCapitalMember2022-02-272023-03-040000084129us-gaap:CommonStockMember2021-02-282022-02-260000084129us-gaap:AdditionalPaidInCapitalMember2021-02-282022-02-260000084129us-gaap:CommonStockMember2020-03-012021-02-270000084129us-gaap:AdditionalPaidInCapitalMember2020-03-012021-02-270000084129srt:MinimumMemberus-gaap:CustomerRelationshipsMember2022-02-272023-03-040000084129srt:MaximumMemberus-gaap:CustomerRelationshipsMember2022-02-272023-03-040000084129rad:PrescriptionFilesMember2022-02-272023-03-040000084129rad:BartellDrugCompanyMemberrad:PrescriptionFilesMember2020-12-182020-12-180000084129us-gaap:IntersegmentEliminationMember2023-03-040000084129rad:October2022ReceivablePurchaseAgreementMember2023-03-040000084129rad:February2023ReceivablePurchaseAgreementMember2023-03-040000084129rad:EnvisionInsuranceCompanyMember2023-03-040000084129us-gaap:IntersegmentEliminationMember2022-02-260000084129rad:EnvisionInsuranceCompanyMember2022-02-260000084129rad:RiteAidRewardsProgramMemberrad:RetailPharmacyMember2022-02-272022-02-270000084129rad:RetailStoreMember2022-02-272023-03-040000084129rad:DistributionCenterMember2022-02-272023-03-040000084129srt:MinimumMember2020-03-012021-02-270000084129srt:MaximumMember2020-03-012021-02-270000084129rad:PharmacyServicesMember2022-02-272023-03-040000084129rad:PharmacyServicesMember2023-03-040000084129rad:PharmacyServicesMember2022-02-260000084129rad:RetailSitesNewRelocatedAndRemodeledMembersrt:MinimumMember2022-02-272023-03-040000084129rad:WellnessPlusProgramMember2020-12-202020-12-200000084129rad:FacilityAndEquipmentLeaseExitChargesMember2022-02-272023-03-040000084129rad:FacilityAndEquipmentLeaseExitChargesMember2021-02-282022-02-260000084129rad:FacilityAndEquipmentLeaseExitChargesMember2020-03-012021-02-270000084129rad:RetailSitesInClosedStatusMember2022-02-272023-03-040000084129rad:RetailSitesInActiveStatusMember2022-02-272023-03-040000084129rad:RetailSitesInClosedStatusMember2021-02-282022-02-260000084129rad:RetailSitesInActiveStatusMember2021-02-282022-02-260000084129rad:RetailSitesInClosedStatusMember2020-03-012021-02-270000084129rad:RetailSitesInActiveStatusMember2020-03-012021-02-270000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2023-03-040000084129us-gaap:DiscontinuedOperationsHeldforsaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2017-09-180000084129us-gaap:DiscontinuedOperationsHeldforsaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2017-06-280000084129rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember2021-01-012021-01-010000084129rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember2020-01-012020-12-310000084129rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember2020-01-012020-01-010000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2022-02-062022-02-060000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2022-02-012022-02-010000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2021-10-012021-10-010000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2021-02-072021-02-070000084129rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember2020-10-012020-10-010000084129rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember2020-02-022020-02-020000084129rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember2014-09-012014-09-010000084129rad:SEIUHealthCareEmployeesPensionFund1199Member2021-10-012021-10-010000084129rad:SEIUHealthCareEmployeesPensionFund1199Member2018-09-302018-09-300000084129srt:MaximumMember2022-02-272023-03-040000084129srt:MinimumMember2022-02-272023-03-040000084129rad:RiteAidRewardsProgramMemberrad:RetailPharmacyMember2022-02-270000084129rad:BartellDrugCompanyMember2021-02-282022-02-260000084129srt:MinimumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-02-272023-03-040000084129srt:MaximumMemberrad:FiloTermLoanDueAugust2026Member2022-02-272023-03-040000084129srt:MaximumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-02-272023-03-040000084129srt:ScenarioPreviouslyReportedMember2022-02-272023-03-040000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2022-02-272023-03-040000084129srt:ScenarioPreviouslyReportedMember2021-02-282022-02-260000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-02-282022-02-260000084129srt:ScenarioPreviouslyReportedMember2020-03-012021-02-270000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-03-012021-02-270000084129rad:RetailSitesInClosedOrApprovedForClosureStatusMember2022-02-272023-03-040000084129rad:RetailSitesInClosedOrApprovedForClosureStatusMember2021-02-282022-02-260000084129rad:RetailSitesInClosedOrApprovedForClosureStatusMember2020-03-012021-02-270000084129srt:MinimumMemberus-gaap:StateAndLocalJurisdictionMember2022-02-272023-03-040000084129srt:MaximumMemberus-gaap:StateAndLocalJurisdictionMember2022-02-272023-03-040000084129rad:SeniorSecuredCreditFacilityMember2021-08-202021-08-200000084129rad:SeniorNotes6.125Percent2023DueMember2021-05-282021-05-280000084129srt:MinimumMemberrad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2023-03-040000084129srt:ScenarioPreviouslyReportedMember2023-03-040000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-03-040000084129srt:ScenarioPreviouslyReportedMember2022-02-260000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2022-02-260000084129srt:ScenarioPreviouslyReportedMember2021-02-270000084129srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-02-2700000841292021-02-270000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2022-02-272023-03-040000084129us-gaap:PensionPlansDefinedBenefitMember2023-03-040000084129us-gaap:PensionPlansDefinedBenefitMember2022-02-272023-03-040000084129us-gaap:PensionPlansDefinedBenefitMember2021-02-282022-02-260000084129us-gaap:PensionPlansDefinedBenefitMember2020-03-012021-02-270000084129rad:SeniorNotes7.5PercentMember2022-06-132022-06-130000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-12-012022-12-010000084129rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member2022-02-272023-03-040000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2021-02-282022-02-260000084129us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberrad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember2020-03-012021-02-270000084129rad:RetailSitesPreviouslyImpairedMember2022-02-272023-03-040000084129rad:RetailSitesNewRelocatedAndRemodeledMember2022-02-272023-03-040000084129rad:OtherRetailSitesMember2022-02-272023-03-040000084129rad:RetailSitesPreviouslyImpairedMember2021-02-282022-02-260000084129rad:RetailSitesNewRelocatedAndRemodeledMember2021-02-282022-02-260000084129rad:OtherRetailSitesMember2021-02-282022-02-260000084129rad:RetailSitesPreviouslyImpairedMember2020-03-012021-02-270000084129rad:RetailSitesNewRelocatedAndRemodeledMember2020-03-012021-02-270000084129rad:OtherRetailSitesMember2020-03-012021-02-270000084129rad:BartellDrugCompanyMember2020-12-180000084129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2023-03-040000084129us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-02-260000084129us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-02-260000084129us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-02-260000084129us-gaap:OperatingSegmentsMemberrad:RetailPharmacyMember2022-02-272023-03-040000084129us-gaap:OperatingSegmentsMemberrad:PharmacyServicesMember2022-02-272023-03-040000084129us-gaap:IntersegmentEliminationMember2022-02-272023-03-040000084129us-gaap:OperatingSegmentsMemberrad:RetailPharmacyMember2021-02-282022-02-260000084129us-gaap:OperatingSegmentsMemberrad:PharmacyServicesMember2021-02-282022-02-260000084129us-gaap:IntersegmentEliminationMember2021-02-282022-02-2600000841292021-02-282022-02-260000084129us-gaap:OperatingSegmentsMemberrad:RetailPharmacyMember2020-03-012021-02-270000084129us-gaap:OperatingSegmentsMemberrad:PharmacyServicesMember2020-03-012021-02-270000084129us-gaap:IntersegmentEliminationMember2020-03-012021-02-2700000841292020-03-012021-02-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-11-272023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-11-272023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-11-272023-03-040000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-08-282022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-08-282022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-08-282022-11-260000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-05-292022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-05-292022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-05-292022-08-270000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:OtherRestructuringMember2022-02-272022-05-280000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberus-gaap:EmployeeSeveranceMember2022-02-272022-05-280000084129rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMemberrad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember2022-02-272022-05-2800000841292023-03-0400000841292022-02-260000084129rad:February2023ReceivablePurchaseAgreementMember2023-02-032023-02-030000084129rad:October2022ReceivablePurchaseAgreementMember2022-10-132022-10-130000084129rad:January2022ReceivablePurchaseAgreementMember2022-01-242022-01-240000084129rad:August2021ReceivablePurchaseAgreementMember2021-08-122021-08-120000084129rad:February2021ReceivablePurchaseAgreementMember2021-02-182021-02-180000084129rad:November2020ReceivablePurchaseAgreementMember2020-11-122020-11-1200000841292022-08-2700000841292024-07-2200000841292022-02-272023-03-04iso4217:USDxbrli:sharesrad:lawsuitrad:segmentrad:statexbrli:sharesiso4217:USDxbrli:purerad:storerad:Pointiso4217:USDutr:Hrad:itemrad:Centerrad:location

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For The Fiscal Year Ended March 4, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For The Transition Period From To

Commission File Number 1-5742

RITE AID CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

    

23-1614034
(I.R.S. Employer
Identification No.)

PO Box 3165, HarrisburgPennsylvania
(Address of principal executive offices)

17105
(Zip Code)

Registrant’s telephone number, including area code: (717761-2633

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report):

30 Hunter Lane, Camp Hill, Pennsylvania 17011

Securities registered pursuant to Section 12(b) of the Act: None (*)

(*)On October 17, 2023, Rite Aid Corporation’s common stock, which previously traded on the New York Stock Exchange under the symbol RAD, began trading exclusively on the over-the-counter market under the symbol RADCQ. On October 31, 2023, the New York Stock Exchange filed a Form 25-NSE with the U.S. Securities and Exchange Commission and Rite Aid Corporation’s common stock was subsequently delisted from the New York Stock Exchange. On January 29, 2024, Rite Aid Corporation’s common stock was deregistered under Section 12(b) of the Securities Exchange Act of 1934, as amended.

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No 

Indicate by check mark if the registrant is not required to file reports pursuant to section 13 or section 15(d) of the Exchange Act. Yes  No 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “Large Accelerated Filer,” “Accelerated Filer,” “Smaller Reporting Company,” and “Emerging Growth Company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer 

Accelerated Filer 

Non-Accelerated Filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). 

The aggregate market value of the voting and non-voting common stock of the registrant held by non-affiliates of the registrant based on the closing price at which such stock was sold on the New York Stock Exchange on August 27, 2022 was approximately $447,694,555. For purposes of this calculation, only executive officers and directors are deemed to be affiliates of the registrant.

As of July 22, 2024 the registrant had outstanding 55,974,015 shares of common stock, par value $1.00 per share.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the registrant’s definitive proxy statement pursuant to Regulation 14A of the Securities Exchange Act of 1934 or an amendment to this Annual Report on Form 10-K, to be filed with the Securities and Exchange Commission, are incorporated by reference into Part III of this Annual Report on Form 10-K.

EXPLANATORY NOTE

Rite Aid Corporation (“Rite Aid,” the “Company,” “we,” “us,” and “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment" or “Form 10-K/A”) to our Annual Report on Form 10-K for the fiscal year ended March 4, 2023, which was filed with the Securities and Exchange Commission (the “SEC”) on May 1, 2023 (the “Original Form 10-K”) to make certain changes, as described below.

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement related to the Company’s historical accounting for closed store liabilities in accordance with changes in ASC 420, Exit or Disposal Cost Obligations. Based on their evaluation, management concluded the misstatement is not material to the Company’s previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the “previously issued financial statements”).

However, due to the discovery of this error, we reevaluated the effectiveness of our internal control over financial reporting (“ICFR”) as of March 4, 2023 and identified a material weakness in our ICFR. For a more detailed description of this material weakness, refer to Part II, Item 9A,“Controls and Procedures.” This Amendment therefore amends our assessment of our ICFR and our disclosure controls and procedures to indicate that they were not effective as of March 4, 2023 because of this material weakness. Our independent registered public accounting firm, Deloitte & Touche LLP, has also amended its opinion on our ICFR as of March 4, 2023.

In conjunction with filing this Amendment, we determined it was appropriate to revise the consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes thereto to reflect the impact of the immaterial misstatement in the periods impacted. For additional information and a more detailed discussion, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements.

Item 1A, “Risk Factors,” of Part I of the Original Form 10-K, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations;” Item 8, “Financial Statements and Supplementary Data,” and Item 9A, “Controls and Procedures,” of Part II of the Original Form 10-K are hereby deleted in their entireties and replaced with Item 1A, Item 7, Item 8, and Item 9A included herein, Item 15, “Exhibits and Financial Statement Schedule,” of Part IV of the Original Form 10-K also has been amended to include, as required by Rule 12b-15 under the Securities Act of 1934, as amended, to provide new currently dated certifications by our Chief Executive Officer and Chief Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The new certifications are attached to this Amendment as Exhibits 31.1, 31.2 and 32. The other Items of the Original Form 10-K have not been amended and, accordingly, have not been repeated in this Amendment.

The only changes to the Original Form 10-K are related to the matters described above. Except as described above, this Amendment does not amend, update, or change any other item or disclosure in the Original Form 10-K and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Original Form 10-K was filed, and the Company has not undertaken herein to amend, update, or change any information contained in the Original Form 10-K to give effect to any event following the date of filing of the Original Form 10-K, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and any subsequent filing with the SEC.

2

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report, as well as our other public filings or public statements, include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by terms and phrases such as “anticipate,” “believe,” “intend,” “estimate,” “expect,” “continue,” “should,” “could,” “may,” “plan,” “project,” “predict,” “will” and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies.

Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:

the impact of widespread health developments, such as the global coronavirus (“COVID-19”) pandemic, the changing consumer behavior and preferences (including preferred shopping locations, vaccine hesitancy and the emergence of new variants), and the impact of those factors on the broader economy, financial and labor markets, wages, availability and access to credit and capital, our front-end and pharmacy operations and services, supply chain challenges including shipping delays, container and trucker shortages, port congestion and other logistics problems, our associates and executive and administrative personnel, our third-party service providers (including suppliers, vendors and business partners), and customers. In addition, continued shortages of pharmacists, pharmacy technicians and other employee turnover in the markets in which we operate, may inhibit our ability to maintain store hours at preferred levels. Any of these developments could result in a material adverse effect on our business, financial conditions and results of operations;
our ability to successfully implement our strategy, attract and retain a sufficient number of our target consumers, integrate operations such as Elixir, our pharmacy benefit management (“PBM”) operations, and any acquisitions, implement and integrate information technology and digital services, obtain permits required for store remodels, and improve the operating performance of our stores and PBM operations;

our high level of indebtedness, the ability to refinance such indebtedness on acceptable terms (including the impact of rising interest rates, market volatility, and continuing actions by the United States Federal Reserve), and our ability to satisfy our obligations and the other covenants contained in our credit and debt agreements;

the nature, cost, impact and outcome of pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions, including those related to opioids, “usual and customary” pricing, government payer programs, business practices, or other matters;
general competitive, economic, industry, market, political (including healthcare reform) and regulatory conditions, including continued impacts of inflation or other pricing environment factors on our costs, liquidity and our ability to pass on price increases to our customers, including as a result of inflationary and deflationary pressures, a decline in consumer spending or deterioration in consumer financial position, whether due to inflation or other factors, as well as other factors specific to the markets in which we operate;

the severity and resulting impact of the cough, cold and flu season;

the impact on retail pharmacy business as PBM payors seek to reduce payments to retail pharmacies and incent or mandate movement away from retail pharmacies to PBM mail order pharmacies;

our ability to achieve the benefits of our efforts to reduce the purchasing cost of our generic drugs;

the risk that changes in federal or state laws or regulations, including to those relating to labor or wages, the Health Care Education Affordability Reconciliation Act, the repeal of all or part of the Patient Protection and the Affordable Care Act (or “ACA”), and decisions of agencies and courts including the United States

4

Supreme Court regarding those and other matters relevant to Rite Aid Corporation or its operations, and any regulations enacted thereunder may occur;

the impact of the loss of one or more major third-party payor contracts and the risk that providers and state contract changes may occur;

the risk that we may need to take further impairment charges if our future results do not meet our expectations;

our ability to sell our Centers of Medicare and Medicaid Services (“CMS”) receivables, in whole or in part, and on reasonably available terms, which could negatively impact our liquidity and leverage ratio if we do not consummate a sale;

our ability to grow prescription count, realize front-end sales growth, and improve and grow the operations of our PBM;

our ability to achieve cost savings and the other benefits of our organizational restructuring within our anticipated timeframe, if at all;

decisions to close additional stores and distribution centers or undertake additional refinancing activities, which could result in further charges;

our ability to manage expenses, our liquidity and our investments in working capital;

the continued impact of gross margin pressure in the PBM industry due to continued consolidation and client demand for lower prices while providing enhanced service offerings;

risks related to breaches of our (or our vendors’) information or payment systems or unauthorized access to confidential or personal information of our associates or customers;

our ability to maintain our current pharmacy services business and obtain new pharmacy services business and clients, including maintaining renewals of expiring contracts, avoiding contract termination rights that may permit certain of our clients to terminate their contracts prior to their expiration, early price renegotiations prior to contract expirations, the risk that we cannot meet client guarantees and the impact of pricing decisions on our ability to retain our customer base;

our chief executive officer search process, and our ability to manage the transition to a new chief executive

officer and other management;

our ability to manage our Medicare Part D plan medical loss ratio (“MLR”) and meet the financial obligations of the plan;

the risk that we could experience deterioration in our current Star rating with the CMS or incur CMS penalties and/or sanctions;

our ability to achieve the benefits of our efforts of our performance acceleration program;

the expiration or termination of our Medicare or Medicaid managed care contracts by federal or state governments;

changes in future exchange or interest rates or credit ratings, changes in tax laws, regulations, rates and policies; and

5

other risks and uncertainties described from time to time in our filings with the U.S. Securities and Exchange Commission (the “SEC”).

We undertake no obligation to update or revise the forward-looking statements included in this report, whether as a result of new information, future events or otherwise, after the date of this report. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences are discussed in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Overview and Factors Affecting our Future Prospects” included in this Annual Report on Form 10-K/A. Additionally, the continued impact of COVID-19 could heighten many of the risk factors described herein.

PART I

Item 1A.   Risk Factors

Factors Affecting our Future Prospects

Set forth below is a description of certain risk factors which we believe may be relevant to an understanding of us and our business. Security holders are cautioned that these and other factors may affect future performance and cause actual results to differ from those which may be anticipated, and such differences may be material. Additionally, the continuing impact of COVID-19 could further exacerbate many of the risks described below or described elsewhere herein. See the section entitled “Cautionary Statement Regarding Forward-Looking Statements.”

Summary

The following is a summary of the principal risks we face:

Risks Related to our Financial Condition

Widespread health developments, including the lingering global COVID-19 pandemic and the end of the associated public health emergency and other pandemic-related measures, could materially and adversely affect our business, financial condition and results of operations.
We are highly leveraged. Our substantial indebtedness and limited cash flow could adversely affect our ability to service debt or obtain additional financing if necessary. Additionally, the capital markets have experienced a high degree of volatility, which could make it difficult to obtain new financing or refinancing existing indebtedness.
Borrowings under our senior secured credit facilities are based upon variable rates of interest.
The covenants in the instruments that govern our current indebtedness may limit our operating and financial flexibility.
We have identified a material weakness in our internal control over financial reporting and determined that our internal control over financial reporting and our disclosure controls and procedures were not effective as of March 4, 2023. Failure to remediate the material weakness or any other material weaknesses that we identify in the future could result in material misstatements in our financial statements or cause us to fail to meet our periodic reporting obligations.

Risks Related to our Operations

We need to improve our operations in order to improve our financial condition, but our operations will not improve if we cannot effectively implement our business strategy or if our strategy is negatively affected by worsening economic conditions.

6

We purchase all of our brand and generic drugs from a single wholesaler. A disruption in this relationship may have a negative effect on us.
Inflation could adversely impact our financial condition and results of operations.
We recently implemented a performance acceleration program, which we cannot guarantee will achieve its intended result.
Our ability to attract and motivate talented employees is uncertain and poses financial risks.
Failure or significant disruption to our information technology systems/infrastructure or a cyber-security breach could adversely affect our operations.
We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and potentially disrupt our business.
Our operating results are affected by the health of the economy in general and in the communities we serve.
Any failure to protect the security of personal information about our customers and associates could result in significant business liability and reputational harm.
Any inability to keep existing store locations or open new locations in desirable places may have a negative impact on our operations.
A variety of business continuity hazards and risks could materially and adversely affect our and our vendors’ business operations and our quarterly results may fluctuate significantly.
Negative public perception of the industries in which we operate, or of our industries’ or our practices, can adversely affect our businesses, operating results, cash flows and prospects.
We may be unable to achieve our environmental, social and governance goals.

Risks Related to the Retail Pharmacy and PBM Industries in which we Operate

The markets in which we operate are very competitive and further increases in competition could adversely affect us.
New and emerging payment models for health care services reimbursement may hinder our retail pharmacies’ and PBMs’ ability to compete, and negatively impact our revenue.
A change in our pharmacy and payor mix could adversely affect our profit margins.
A sudden and material decrease in the number of Medicaid enrollees due to the “Medicaid Cliff” could have a sudden destabilizing impact on retail pharmacy revenue.
Consolidation in the healthcare industry could adversely affect our business, financial condition and results of operations.
There are risks related to the availability, pricing, and safety profiles of the pharmacy drugs and products we purchase and sell.
Changes in third-party reimbursement levels for prescription drugs and changes in industry pricing benchmarks could reduce our margins and have a material adverse effect on our business.

7

A substantial portion of our pharmacy revenue is currently generated from a limited number of third-party payors, and, if there is a loss of, or significant change to prescription drug reimbursement rates by, a major third-party payor, our revenue will decrease and our business and prospects could be adversely impacted.
A substantial portion of our Pharmacy Services Segment revenue is currently generated from a limited number of customers, and, if there is a loss of a major customer, our revenue will decrease and our business and prospects could be adversely impacted.
We are, and in the future may become, involved in legal proceedings that may adversely affect our financial position and our pursuit of refinancing opportunities, as well as our reputation and brand.
We are subject to governmental regulations, procedures and requirements; our non-compliance or a significant legislative, regulatory, or public policy change could adversely affect our business, the results of our operations or our financial condition.
Government audits, investigations, and reviews could lead to liability and operational changes.
If our compliance or other systems and processes fail or are deemed inadequate, we may become subject to regulatory actions and/or litigation.
Certain risks are inherent in providing pharmacy services; our insurance may not be adequate to cover any claims against us.
We may be subject to significant liability should the consumption of any of our products cause injury, illness or death.
Risks of declining gross margins in the PBM industry could adversely impact our profitability, and could result in further impairment charges.
The possibility of PBM client loss and/or the failure to win new PBM business could impact our ability to secure new business.
Regulatory or business changes relating to our participation in Medicare Part D, the medical loss ratio for our Medicare Part D eligible members, or our failure to otherwise execute on our strategies related to Medicare Part D, may adversely impact our business and our financial results.
Failure to timely identify or effectively respond to changing consumer preferences and spending patterns, an inability to expand the products being purchased by our clients and customers, or the failure or inability to obtain or offer particular categories of products could negatively affect our relationship with our clients and customers and the demand for our products and services.
The impact of extreme events, natural disasters, and climate change could create unpredictability for our business operations.
The seasonal nature of our business causes fluctuations in operations.
Changes in laws governing labor, employers, and union organizing may increase our labor costs.

8

Risks Related to our Financial Condition

Widespread health developments, including the lingering global COVID-19 pandemic and the end of the associated public health emergency and other pandemic-related measures, could materially and adversely affect our business, financial condition and results of operations.

We continue to closely monitor lingering impacts relating to the COVID-19 pandemic. The approaching end of the public health emergency and the expiration of certain measures related to local, national and international responses to the pandemic could have uncertain impacts on the services that we offer to patients and our revenue stream and/or reimbursement.

The continuing nature and scope of COVID-19’s impacts to our business and operations, as well as the impact of the end of the public health emergency and other pandemic-related measures, will depend on a series of evolving factors and developments that are difficult to assess, predict, or control, which include, but are not limited to, the following:

additional outbreaks or spikes in the number of COVID-19 cases, future mutations or related variants of the virus, and the continuing efficacy and availability of vaccines;

the extent and duration of the effect on consumer confidence, economic well-being, spending, and drug utilization, customer demand, consumer behavior, buying patterns and shopping behaviors, including spending on discretionary categories, which often include higher margin products, and increased utilization of online sales channels after the COVID-19 pandemic;

the possible expiration, termination or reduction of governmental, business, or other measures implemented in response to the COVID-19 pandemic;

continuing impacts on our distribution channels and supply chain;

volatility or disruptions in the credit and financial markets;

increased cyber-security risks, including as a result of our associates, and employees of our business partners, vendors, suppliers and other third parties with which we do business, working remotely;

additional increased costs associated with operating during the COVID-19 pandemic;

evolving macroeconomic factors, including general economic uncertainty, product costs, unemployment rates, and recessionary and inflationary pressures;

economic activity as the COVID-19 pandemic subsides, which may vary materially over time and among the different regions and markets we serve;

the long-term impact of the COVID-19 pandemic on the global economy, trade relations, consumer behavior, our industry, our business operations, and the political environment; and

relaxation or lifting of government mandates and restrictions related to COVID-19, such as the mask mandate.

The above factors and risks, among others, are difficult to predict and could result in material adverse impacts to our business, operations, cash flows, and financial condition. In addition, it is difficult to predict the potentially adverse impacts that COVID-19 and the end of the public health emergency could continue to have on our customers, suppliers, vendors, and other business partners, which, in turn could materially and adversely impact our business. Additionally, the impact of COVID-19 and the end of the public health emergency could further exacerbate the impact of the other risk factors contained herein and in the other reports the Company files with the SEC.

9

We are highly leveraged. Our substantial indebtedness and limited cash flow could adversely affect our ability to service debt or obtain additional financing if necessary. Additionally, the capital markets have experienced a high degree of volatility, which could make it difficult to obtain new financing or refinancing existing indebtedness.

We had, as of March 4, 2023, approximately $2.9 billion of outstanding indebtedness and stockholders’ deficit of $594.2 million. We also had additional borrowing capacity under our $2.85 billion senior secured asset-based revolving credit facility (the “Existing Senior Secured Revolving Credit Facility” or “revolver”) of $1,404.0 million, net of outstanding letters of credit of approximately $208.7 million.

Our high level of indebtedness and limited cash flow will continue to restrict our operations. Among other things, our indebtedness will:

limit our flexibility in planning for, or reacting to, changes in the markets in which we compete;
place us at a competitive disadvantage relative to our competitors with less indebtedness;
limit our ability to reinvest in our business;
render us more vulnerable to general adverse economic, regulatory and industry conditions; and
require us to dedicate a substantial portion of our cash flow to service our debt.

Our ability to meet our cash requirements, including our debt service obligations, is dependent upon our ability to maintain and improve our operating performance, which is subject to general economic and competitive conditions and to financial, business and other factors, many of which are beyond our control, such as perceived reputation and ongoing litigation. In particular, in fiscal 2023, we were named as a defendant in numerous lawsuits relating to the distribution and dispensing of prescription opioids. Costs incurred in litigation can be substantial, regardless of the outcome, and could harm our reputation, even if we are successful. Although we believe we have adequate sources of liquidity to meet our anticipated requirements for working capital, debt service and capital expenditures through at least the next twelve months, the costs associated with these legal proceedings are impossible to estimate with certainty, could exceed any applicable insurance coverage, and could significantly impact such liquidity. See “Risks Related to the Retail Pharmacy and PBM Industries in which we Operate —We are, and in the future may become, involved in legal proceedings that may adversely affect our financial position and our pursuit of refinancing opportunities” and “Risks Related to our Operations— Negative public perception of the industries in which we operate, or of our industries’ or our practices, can adversely affect our businesses, our operating results, cash flows and prospects.”

If our operating results, cash flow or capital resources prove inadequate, or if interest rates rise significantly, we could face liquidity constraints. Additionally, we improved our leverage and liquidity position this past year by selling our rights in our calendar 2022 Medicare Part D final reconciliation payment. There can be no assurance that we will enter into a similar transaction for our calendar 2023 payment, or that if we do so, that the terms of such transaction will differ, and such differences could be material. If we are unable to service our debt or experience a significant reduction in our liquidity, we could be forced to reduce or delay planned capital expenditures and other initiatives, sell assets, restructure or refinance our debt, raise additional capital through short-term loans, selling or licensing intellectual property or seek additional equity capital, or need to change certain elements of our strategy, and we may be unable to take any of these actions on satisfactory terms or in a timely manner. Any of these actions may not be sufficient to allow us to service our debt obligations or may have an adverse impact on our business. Our existing debt agreements limit our ability to take certain of these actions. Our failure to generate sufficient operating cash flow to pay our debts or refinance our indebtedness could have a material adverse effect on us.

We are currently exploring several refinancing opportunities and will continue to explore various options in the pursuit thereof. However, many of our existing debt agreements contain provisions that could require us to obtain unanimous consent for specified amendments or changes, including those needed for certain refinancings, or to waive an event of default if we are unable to service our debt. A default on any of our debt obligations could trigger certain acceleration clauses, causing those and our other debt obligations to become due and payable. Upon an acceleration of

10

any of our debt, we may not be able to make payments under our other debt agreements. While we continue to work through a number of refinancing alternatives to address our upcoming debt maturities, which are no earlier than July 2025, we make no assurance regarding the likelihood or exact timing of any refinancing or the terms thereof. See “The covenants in the instruments that govern our current indebtedness may limit our operating and financial flexibility.” Our failure to generate sufficient operating cash flow to pay our debts or refinance our indebtedness could have a material adverse effect on us.

Borrowings under our senior secured credit facilities are based upon variable rates of interest.

The ICE Benchmark Administration, the administrator for LIBOR, ceased the publication of one-week and two-month USD LIBOR after December 2021 and intends to cease publishing all remaining USD LIBOR tenors in mid-2023. The Alternative Reference Rates Committee, a group of market participants convened by the U.S. Federal Reserve Board and the Federal Reserve Bank of New York, has recommended the Secured Overnight Financing Rate (“SOFR”), a rate calculated based on repurchase agreements backed by treasury securities, as its recommended alternative benchmark rate to replace USD LIBOR. Any new benchmark rate will likely not replicate LIBOR exactly, which could impact our contracts that terminate after mid-2023.

As a result of the cessation of LIBOR, we have amended certain of our credit agreements and facilities to replace LIBOR with SOFR as the applicable reference rate. In particular, borrowings under our senior secured credit agreement, dated as of December 20, 2018 (as amended by the First Amendment to Credit Agreement, dated as of January 6, 2020, as further amended by the Second Amendment to Credit Agreement, dated as of August 20, 2021, and as further amended by the Third Amendment to Credit Agreement, dated as of December 1, 2022, the “Credit Agreement”), consisting of a $2,850.0 million senior secured asset-based revolving credit facility (“Existing Senior Secured Revolving Credit Facility” or “revolver”) and a $400.0 million “first-in, last out” senior secured term loan facility (“Existing Senior Secured Term Loan”) (collectively, the “Existing Facilities”) bear interest at a rate that varies depending on SOFR. If SOFR rises (including as a result of recent actions by the U.S. Federal Reserve), the interest rates on borrowings under our Existing Facilities will increase. Therefore an increase in SOFR would increase our interest payment obligations under those borrowings and have a negative effect on our cash flow and financial condition.

There is uncertainty about how applicable law and the courts will address the replacement of LIBOR with alternative rates on variable rate retail loan contracts. In addition, changes to benchmark rates may have an uncertain impact on our cost of funds and our access to the capital markets, which could impact our results of operations and cash flows. Uncertainty as to the nature of such potential changes may also adversely affect the trading market for our securities, and at this time, it is not possible to predict how markets will respond to SOFR or other alternative reference rates. In addition, there are differences between how LIBOR and SOFR are calculated, which could result in increased borrowing costs. We cannot predict to what extent the withdrawal and replacement of LIBOR will impact us. However, the implementation of alternative underlying floating-rate indices and reference rates may have an adverse impact on our business, results of operations or financial condition.

The covenants in the instruments that govern our current indebtedness may limit our operating and financial flexibility.

The covenants in the instruments that govern our current indebtedness limit our ability to:

incur debt and liens;
pay dividends;
make redemptions and repurchases of capital stock;
make loans and investments;
prepay, redeem or repurchase debt;

11

engage in acquisitions, consolidations, asset dispositions, sale-leaseback transactions and affiliate transactions;
change our business;
amend some of our debt and other material agreements;
issue and sell capital stock of subsidiaries;
restrict distributions from subsidiaries; and
grant negative pledges to other creditors.

The Existing Credit Agreement has a financial covenant that requires us to maintain a minimum fixed charge coverage ratio of 1.00 to 1.00 (i) on any date on which availability under the Existing Senior Secured Revolving Credit Facility is less than $206.0 million or (ii) on the third consecutive business day on which availability under the Existing Senior Secured Revolving Credit Facility is less than $257.5 million and, in each case, ending on and excluding the first day thereafter, if any, which is the 30th consecutive calendar day on which availability under the revolver is equal to or greater than $257.5 million. As of March 4, 2023, the availability under the Existing Senior Secured Revolving Credit Facility was at a level that did not trigger the Existing Credit Agreement’s financial covenant. The Existing Credit Agreement also limits our ability to maintain cash, without repaying a portion of our outstanding borrowings under the revolver, above a specified amount. For additional details, see the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Future Liquidity”.

The breach of certain covenants in our debt instruments could result in a default under our debt agreements, which could trigger certain acceleration clauses, causing those and other obligations to become due and payable. Upon an acceleration of any of our debt, we may not be able to make payments under our other outstanding debt agreements. If we are unable to make payments under our debt obligations, lenders of our secured debt obligations may be able to foreclose on the collateral that secures such debt and our assets may be insufficient to satisfy such secured debt and, to the extent of any remaining assets, any unsecured debt.

We have identified a material weakness in our internal control over financial reporting and determined that our internal control over financial reporting and our disclosure controls and procedures were not effective as of March 4, 2023. Failure to remediate the material weakness or any other material weaknesses that we identify in the future could result in material misstatements in our financial statements or cause us to fail to meet our periodic reporting obligations.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management is required to report on, and our independent registered public accounting firm is required to attest to, the effectiveness of our internal control over financial reporting. The rules governing the standards that must be met for management to determine the adequacy of our internal control over financial reporting are complex and require significant documentation and testing if a deficiency is identified. Annually, we perform activities that include reviewing, documenting, and testing our internal control over financial reporting. If we fail to maintain the adequacy of our internal control over financial reporting, we will not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002. Any failure to achieve and maintain an effective internal control environment could result in materially misstated consolidated financial statements and a failure to meet our reporting obligations.

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement related to the Company’s historical accounting for closed store liabilities in accordance with changes in ASC 420, Exit or Disposal Cost Obligations. Based on their evaluation, management concluded the misstatement is not material to the Company’s previously issued

12

consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended.

Due to the discovery of this error, we reevaluated the effectiveness of our disclosure controls and procedures and internal control over financial reporting and identified a material weakness in our internal control over financial reporting, and as a result, determined that our disclosure controls and procedures and internal control over financial reporting are not effective. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. For further discussion of the material weakness, see Part II, Item 9A, “Controls and Procedures.” In conjunction with filing this Amendment, we determined to revise our consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes hereto to reflect the impact of the error in the periods impacted. For additional information and a detailed discussion of the revision, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements.

Management is actively engaged in the planning for, and implementation of, remediation efforts to address our material weakness. However, we may not be successful in promptly remediating the material weaknesses identified by management or be able to identify and remediate additional control deficiencies, including material weaknesses, in the future. Our management may also be unable to conclude in future periods that our disclosure controls and procedures are effective due to the effects of various factors, which may, in part, include unremediated material weaknesses in internal control over financial reporting. Any failure to establish and maintain effective disclosure controls and procedures and internal control over financial reporting, including due to a failure to remediate the material weakness or the discovery or occurrence of any additional material weaknesses in our internal control over financial reporting in the future, could adversely affect our ability to prepare financial statements within required time periods and record, process and report financial information accurately, which could result in material misstatements in our financial statements and cause us to fail to meet our reporting and financial obligations, negatively impact the price of our common stock, limit our liquidity and access to capital markets, adversely affect our business, harm our reputation or subject us to litigation or investigations requiring management resources and payment of legal and other expenses.

In addition, our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.

13

Risks Related to our Operations

We need to improve our operations in order to improve our financial condition, but our operations will not improve if we cannot effectively implement our business strategy or if our strategy is negatively affected by worsening economic conditions.

We have not achieved the sales productivity level of our major competitors. Improving our retail sales, prescription volumes and profitability and membership at our PBM are essential to enable us to cover our fixed staffing costs and to improve profitability and generate operating cash flow. If we are not successful in implementing our strategies, including our efforts to increase sales and further reduce costs, or if our strategies are not effective, we may not be able to improve our operations. Furthermore, any adverse change or weakness in general economic conditions or major industries can adversely affect drug benefit plans and reduce our pharmacy sales. Adverse changes in general economic conditions, including, but not limited to, increased costs including higher wages, those resulting from supply chain disruptions, high energy costs, increasing production costs, and record inflation, has affected and could continue to affect consumer buying practices. These factors may consequently reduce our sales of front-end products, and cause a decrease in our profitability. Failure to improve operations or weakness in major industries or general economic conditions would adversely affect our results of operations, financial condition and cash flows and our ability to make principal or interest payments on our debt.

We purchase all of our brand and generic drugs from a single wholesaler. A disruption in this relationship may have a negative effect on us.

We purchase all of our brand drugs and, with limited exceptions, all of our generic drugs from a single wholesaler, McKesson. Given that McKesson acts as a wholesaler for drugs purchased from manufacturers worldwide, any disruption in the supply of a given drug, including disruptions related to a pandemic or to extreme weather or natural disasters, supply shortages of key ingredients, or regulatory actions by domestic or foreign governmental agencies, or specific actions taken by drug manufacturers, could adversely impact McKesson’s ability to fulfill our demands, which could adversely affect us. Pharmacy sales represented approximately 71.2% of our total drugstore sales during fiscal 2023. While we believe that alternative sources of supply for most generic and brand name pharmaceuticals are available, a significant disruption in our relationship with McKesson could result in disruptions to our business until we execute a replacement wholesaler agreement or develop and implement self-distribution processes. We believe we could obtain qualified alternative sources, including through self-distribution, for substantially all of the prescription drugs we sell on an acceptable basis, and accordingly that the impact of any disruption would be temporary. On February 28, 2019, we and McKesson entered into a contract that will continue our pharmaceutical sourcing and distribution partnership for an additional ten years. Under the terms, McKesson will continue providing us with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029. Material changes in our agreement with McKesson could result in disruptions in our business until we execute a replacement wholesaler agreement or develop and implement self-distribution processes.

14

Inflation could adversely impact our financial condition and results of operations.

Inflation in the United States began to rise significantly in the second half of the calendar year of 2021 and continued to rise through the middle of 2022; the inflation rate remains high. This is primarily believed to be the result of the economic impacts from the COVID-19 pandemic, including the global supply chain disruptions, strong economic recovery and associated widespread demand for goods, and government stimulus packages, among other factors. For instance, global supply chain disruptions have resulted in shortages in materials and services. Such shortages have resulted in inflationary cost increases for labor, materials, and services, and could continue to cause costs to increase as well as scarcity of certain products. We are experiencing inflationary pressures in many areas of our business, including with respect to employee wages and the cost of prescription drugs, although, to date, we have been able to slightly offset such pressures through price increases and other measures. We cannot, however, predict any future trends in the rate of inflation or associated increases in our operating costs and how that may impact our business. To the extent we are unable to recover higher operating costs resulting from inflation or otherwise mitigate the impact of such costs on our business, our revenues and gross margins could decrease, and our financial condition and results of operations could be adversely affected. Acts by the U.S. Federal Reserve, or other governmental entities, intended to address inflation may also have a negative impact on us, such as increased borrowing costs.

We recently implemented a performance acceleration program, which we cannot guarantee will achieve its intended result.

In December 2022, we announced the implementation of a performance acceleration program designed to increase our strategic focus and operational efficiency. The program is intended to reallocate resources toward our strategic priorities and faster growth, drive efficiencies in our operations and reduce structural costs. For example, we are aiming to rebuild our indirect buying process and renegotiate vendor contracts, reduce our lease burden through lease renegotiations, and decrease prescription brand inventory by implementing new controls and deploying “just in time” ordering models. The successful implementation of the program may present organizational challenges and result in short term charges and other costs. As a result, we may not be able to fully realize all of the anticipated benefits from the program, and even if we do not realize its intended benefits, the program is accompanied by significant consulting and other costs. Events and circumstances, such as financial or strategic difficulties, delays and unexpected costs may occur that could result in our not realizing all of the anticipated benefits or our not realizing such benefits on our expected timetable. If we are unable to fully realize the anticipated savings from the performance acceleration program, our ability to fund other initiatives and enhance profitability may be adversely affected. Any failure to implement the performance acceleration program in accordance with our expectations could adversely affect our business, results of operations, cash flows and financial condition.

Our ability to attract and motivate talented employees is uncertain and poses financial risks.

We regularly compete with similar companies for talented employees and our success depends in part on attracting, retaining, and/or replacing key personnel with equally qualified employees. The unusually difficult challenge to find and retain talented employees and to reduce turnover, including, but not limited to, pharmacists and pharmacy technicians, in recent months and years continues due to macroeconomic conditions, societal issues, and other factors. In addition, job market dynamics have been impacted by the “great resignation,” with a significant number of people leaving the workforce, and future challenges related to workplace practices could lead to attrition and difficulty attracting high-quality employees. These factors may require our retail pharmacies to increase compensation to both hire and retain employees. We may also lose employees due to illness or other sudden occurrences, which makes succession planning difficult.

Loss and/or transition of Company personnel, including senior executives, creates uncertainty as there is no guarantee that new personnel or leadership will adequately perform or smoothly transition into their new roles. Moreover, our investors, business partners, and employees prefer stability and any high level of employee turnover could undermine stakeholder support. Ultimately, the unpredictability regarding employee continuity and potential disruption stemming from employee losses pose a threat to our overall financial condition and operations. We are actively searching for a new chief executive officer and need to fill other senior positions. We cannot assure you when we will fill such positions, the success of the integration of such personnel and whether such hires will result in changes to our strategy or result in the need to fill other positions.

15

Failure or significant disruption to our information technology systems/infrastructure or a cyber-security breach could adversely affect our operations.

Technology and computer systems are critical to many aspects of our pharmacy business, including, but not limited to, the drug supply chain, our dispensing of drugs, and our reimbursement. For instance, we rely extensively on computer systems used by Rite Aid, Elixir Insurance, Bartell, and Health Dialog, to manage our ordering, pricing, point-of-sale, inventory replenishment and other processes. Our computer systems are at risk for failures, security breaches, and natural disasters, and they have been subject to attack by perpetrators of random or targeted malicious technology-related events, such as cyberattacks, ransomware, computer malware, worms, bot attacks or other destructive or disruptive software and attempts to misappropriate customer information, including credit card information. These sorts of attacks could subject our systems to damage or interruption from power outages, computer and telecommunications failures, computer malware, cyber-security breaches, vandalism, coordinated cyber-security attacks, severe weather conditions, catastrophic events and human error. Our disaster recovery planning considers many possible scenarios but cannot account for all eventualities. Collectively, we are building a security-aware culture across the organization by providing role-based security training, developing security champions across Technology and business areas, and partnering with industry experts. Our information security program is designed to protect confidential information, networks and systems against attacks through a multi-layered approach to address information security threats and vulnerabilities. However, a compromise of our information security controls or of those businesses with whom we interact, which results in confidential information being accessed, obtained, damaged or used by unauthorized or improper persons, could harm our reputation and expose us to regulatory actions and claims from customers and clients, financial institutions, payment card associations and other persons, any of which could adversely affect our business, financial position and results of operations. Moreover, a data security breach could require that we expend significant resources related to our information systems and infrastructure, and could distract management and other key personnel from performing their primary operational duties. We could also be adversely impacted by any significant disruptions in, or security breaches of, the systems and technology of third-party suppliers or processors we interact with, including key payors and vendors with whom we share information. If our systems are damaged, fail to function properly or otherwise become unavailable, we may incur substantial costs to repair or replace them, and may experience loss of critical data and interruptions or delays in our ability to perform critical functions, which could adversely affect our business and results of operations. Any compromise or breach of our data security, whether external or internal, or misuse of customer, associate, supplier, or our data could also result in a violation of applicable privacy, information security, and other laws, significant legal and financial exposure, fines or lawsuits, damage to our reputation, loss or misuse of the information and a loss of confidence in our security measures, which could harm our business. Although we maintain cyber-security insurance, we cannot know that the coverage limits under our insurance program will be adequate to protect us against future claims.

To effectively compete with our competitors and continue business partner relations, we must and are investing in and updating our technology and computer systems. In addition, as the regulatory environment related to information security, data collection and use, and privacy becomes increasingly rigorous, with new and constantly changing requirements applicable to our business, compliance with those requirements could also result in additional costs. While we seek to ensure that our security operations are current and that our technology can properly interface with our business partners, there are risks that our technology investments will not be successful, will not provide a return on investment, and/or may fail or never be deployed. Oftentimes, we are implementing multiple updates or technology changes at the same time. We are currently in the process of changing our omni-channel distribution and there can be no assurance that we will be able to implement this technology on its intended timeline or that it will achieve its intended benefits.

We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and potentially disrupt our business.

We accept payments using a variety of methods, including cash, checks, credit and debit cards, gift cards and mobile payment technology, and we may accept new forms of payment over time. Acceptance of these payment options subjects us to rules, regulations, contractual obligations and compliance requirements including payment network rules and operating guidelines, data security standards and certification requirements, and rules governing electronic funds transfers. These requirements may change over time or be reinterpreted, making compliance more difficult or costly. For certain payment methods, including credit and debit cards, we pay interchange and other fees, which may increase over time and raise our operating costs. We rely on third parties to provide payment processing services, including the

16

processing of credit cards, debit cards, and other forms of electronic payment. If these companies become unable to provide these services to us, or if their systems are compromised, it could potentially disrupt our business. The payment methods that we offer also subject us to potential fraud and theft by criminals, who are becoming increasingly more sophisticated, seeking to obtain unauthorized access to or exploit weaknesses that may exist in the payment systems. If we fail to comply with applicable rules or requirements for the payment methods we accept, or if payment-related data is compromised due to a breach or misuse of data, we may be liable for costs incurred by payment card issuing banks and other third parties or subject to fines and higher transaction fees, or our ability to accept or facilitate certain types of payments may be impaired. In addition, our customers could lose confidence in certain payment types, which may result in a shift to other payment types or potential changes to our payment systems that may result in higher costs. As a result, our business and operating results could be adversely affected.

Our operating results are affected by the health of the economy in general and in the communities we serve.

The United States financial markets have been experiencing, and may continue to experience, volatility and disruptions, including diminished liquidity and credit availability, inflation, declines in consumer confidence and economic growth and increases in unemployment rates, all of which have resulted in uncertainty about economic stability. Our business is affected by economic instability and declines in consumer confidence in general and in the communities we serve, and various other economic factors, including inflation and changes in consumer purchasing power, preferences and/or spending patterns. An unfavorable, uncertain or volatile economic environment, as we have experienced as a result of inflation, rising interest rates, supply chain disruptions and COVID-19, has caused and could cause a decline in drug utilization, a dampening demand for PBM services and retail products, and an increase in theft or other crime that could impact our retail locations. For example, in fiscal 2023, retail theft was significantly higher than predicted. Such theft has had a negative impact on our retail profit and continued high or unpredictable retail theft rates could continue to negatively impact our results of operations. In addition, adverse changes in the U.S. economy, consumer confidence and economic conditions could have an adverse effect on our results of operations.

Any failure to protect the security of personal information about our customers and associates, could result in significant business liability and reputational harm.

In the ordinary course of business, we collect, process and store certain personal information that our customers provide to purchase products or services, enroll in promotional programs, register on our website, or otherwise communicate and interact with us, including in connection with our administration of COVID-19 vaccines. We may collect, maintain, and store information about our associates in the normal course of business and contract with third-party business associates and vendors to accomplish these tasks. We may share information about such persons with vendors that assist with certain aspects of our business. Despite instituted safeguards for the protection of such information, security could be compromised and confidential customer or business information misappropriated, for which we have paid related penalties in the past. Data breaches or violations of data protection laws may result in liability for the Company, even if caused, in whole or in part, by a business associate, vendor, or other third-party. The unlawful handling or disclosure of sensitive personal information could also pose a serious risk to our customers’ trust in the Company, including the unlawful handling or disclosure due to security breaches of the systems and technology of third-party suppliers or processors that we interact with, including key payors and vendors with whom we share information including PHI, PII, and personal credit card information. We are constantly working to enhance our defenses against Ransomware attacks, but there is always a risk of controls being defeated which could result in loss of customer or business information that could disrupt our operations, damage our reputation, and expose us to claims from customers, financial institutions, payment card companies and other persons, or result in governmental investigation and enforcement, sanctions, fines, and/or penalties, any of which could have an adverse effect on our business, financial condition and results of operations. Compliance with more rigorous privacy and information security laws and standards, including, without limitation, the 2010 FTC Consent Order to which we are subject regarding the protection of personal information, may result in significant expense due to increased investment in technology, the ongoing development and implementation of new operational and control processes, and other security protocols or efforts. Our brand, reputation, and customer loyalty may be negatively impacted, and we may become subject to enforcement actions, fines, penalties, and additional obligations under new or extended consent orders, in the event of any personal information-related privacy or security issues or the breach or violation of the FTC Consent Order. The occurrence or scope of any future data privacy or security failures are unpredictable, and it may prove difficult or impossible to fully mitigate or remediate

17

their negative consequences. If we fail to comply or are alleged to have failed to comply with applicable data protection and privacy and security laws and regulations, we could be subject to government regulatory investigations and enforcement actions, as well as private individual or class action lawsuits.

Any inability to keep existing store locations or open new locations in desirable places may have a negative impact on our operations.

We compete with other retailers and businesses to identify and develop desirable locations for retail store operations. Our ability to find suitable locations and our store construction, renovation, and operating costs can vary based on the specific state and locality and applicable zoning, environmental, and real estate laws. Additionally, construction delays, adverse modifications in lease terms, and changes in community demographics can negatively impact our store operations and revenues, and in some instances may cause us to close or relocate stores, or result in an impairment charge. The recent increase in costs, including as a result of inflation, associated with hiring and maintaining our retail pharmacy workforce may also negatively impact the profitability of some of our store locations to the extent that we may be forced to close some locations. These factors and charges may vary over time, which may make it more difficult to compare our operating results from period to period.

A variety of business continuity hazards and risks could materially and adversely affect our and our vendors’ business operations and our quarterly results may fluctuate significantly.

A variety of potential hazards, risks, and factors could adversely impact our and our vendors’ operations and performance, including, but not limited to, health epidemics or pandemics like COVID-19, supply chain disruptions and delays, energy shortages and inflationary energy costs, extreme weather, whether as a result of climate change or otherwise, natural disasters, acts of war, terrorism or violence, extended protests or periods of civil unrest, labor disputes, quality control issues, infrastructure failures, trade sanctions, inflation, changing market conditions, the introduction of new prescriptions drugs, the seasonal nature of our business, and changes in payor reimbursement rates and terms. These and other factors could lead to disruptions in and interfere with domestic and global supply chains, revenue flows, reimbursements, and our ability to source products and find qualified vendors to access appropriate products in a timely and efficient manner. We could also be liable for any resulting personal injury or property damage arising from these risks to the extent our existing insurance coverage is insufficient or unavailable to cover associated losses. Due to these often unavoidable risks, some of which are beyond our management and control, our businesses, operating results, cash flows, and financial condition could be adversely affected.

Historically, our operating results have varied on a quarterly basis, and one or more of the above or other factors or risks could cause our results to fluctuate significantly. Accordingly, quarter-to-quarter comparisons of our operating results are not necessarily meaningful and a single quarter’s results may not provide reliable insight into our anticipated future performance.

Negative public perception of the industries in which we operate, or of our industries’ or our practices, can adversely affect our businesses, operating results, cash flows and prospects.

Our brand and reputation are two of our most important assets, and the industries in which we operate have been and are negatively perceived by the public from time to time. Negative publicity may come as a result of adverse media and/or social media coverage, litigation against us and other industry participants, the ongoing public debates over drug pricing, PBMs, government involvement in drug pricing and purchasing, changes to the ACA, governmental hearings and/or investigations, including in connection with the distribution and dispensing of prescription opioids, actual or perceived shortfalls regarding our industries’ or our own products and/or business practices (including PBM operations, drug pricing and insurance coverage determinations) and social media and other media relations activities. Negative publicity also may come from a failure to meet customer expectations for consistent, high quality and accessible care. This risk may increase as we continue to offer products and services that make greater use of data and as our business model becomes more focused on delivering health care to consumers.

In addition, by working with the U.S. government in the distribution and administration of the COVID-19 vaccine, we may be subject to negative publicity related to the government’s actions in response to COVID-19 that are outside of our ability to control.

18

Furthermore, the use of social media platforms, including blogs, social media websites and other forms of internet-based communication, which allow individuals access to a broad audience of consumers and other interested persons, has become commonplace. Negative commentary regarding us or the brands that we sell or our personnel may be posted on social media platforms or similar devices at any time and may harm our reputation or business. Consumers value readily available information concerning retailers and their goods and services and often act on such information without further investigation and without regard to its accuracy. The harm may be immediate without affording us an opportunity for redress or correction. In addition, social media platforms provide users with access to such a broad audience that collective action against our website and marketplace stores, such as boycotts, can be more easily organized. If such actions were organized, we could suffer reputational damage as well as physical damage to our stores and merchandise. Moreover, short sellers and others, some of whom post anonymously on social media, may be positioned to profit if our stock declines and their activities can negatively affect our stock price.

We also use social media platforms as marketing tools or as channels to disseminate information. For example, the Company and certain of its executive officers maintain Facebook, Instagram, Twitter, LinkedIn, and other social media accounts, where marketing and other information relevant to customers and investors is disseminated. As laws and regulations rapidly evolve to govern the use of these platforms and devices, the failure by us, our employees or third parties acting at our direction to abide by applicable laws and regulations in the use of these platforms and devices could adversely impact our business, financial condition and results of operations or subject us to fines or other penalties.

Negative public perception and/or publicity of our industries in general, or of us or our key suppliers and vendors in particular, can further increase our costs of doing business and adversely affect our operating results and our stock price by:

adversely affecting our brand and reputation;

adversely affecting our ability to market and sell our products and/or services and/or retain our existing customers and members;

requiring us to change our products and/or services;

reducing or restricting the revenue we can receive for our products and/or services; and/or

increasing or significantly changing the regulatory and legislative requirements with which we must comply.

We may be unable to achieve our environmental, social and governance goals.

We are dedicated to corporate social responsibility and sustainability and we established certain goals as part of our ESG strategy. We face pressure from our colleagues, customers, and stockholders to meet our goals and to make significant advancements in environmental, social and governance matters. Achievement of our goals is subject to risks and uncertainties, many of which are outside of our control, and it is possible that we may fail to achieve these goals or that our colleagues, customers, or stockholders may not be satisfied with the goals we set or our efforts to achieve them. These risks and uncertainties include, but are not limited to: our ability to set and execute on our operational strategies and achieve our goals within the currently projected costs and the expected timeframes; the availability and cost of technological advancements, renewable energy and other materials necessary to meet our goals and expectations; compliance with, and changes or additions to, global and regional regulations, taxes, charges, mandates or requirements relating to climate-related goals; labor-related regulations and requirements that restrict or prohibit our ability to impose requirements on third-party contractors; the actions of competitors and competitive pressures; an acquisition of or merger with another company that has not adopted similar goals or whose progress towards reaching its goals is not as advanced as ours; and the pace of regional and global recovery from the COVID-19 pandemic. A failure to meet our goals could adversely affect public perception of our business, employee morale or customer or stockholder support.

19

Further, an increasing percentage of colleagues, customers, and stockholders considers sustainability factors in making employment, consumer health care and investment decisions. If we are unable to meet our goals, we may lose colleagues, have difficulty recruiting new colleagues, and be unable to attract investors, customers, or partners, our stock price may be negatively impacted, our reputation may be negatively affected, and it may be more difficult for us to compete effectively, all of which would have an adverse effect on our business, operating results, and financial condition.

Risks Related to the Retail Pharmacy and PBM Industries in which we Operate

The markets in which we operate are very competitive and further increases in competition could adversely affect us.

In the retail pharmacy business, we face intense competition with local, regional and national companies, including other drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, dollar stores and internet pharmacies. Many of our competitors are larger, better capitalized, have access to greater financial and other resources, are diversified through other industries and have an international presence. Additionally, some of our competitors are vertically integrated, allowing them to leverage healthcare, health plan, and PBM operations together with their retail pharmacy footprint. Increasingly, these competitors are expanding in our existing markets. Greater competition exerts pressure on our pricing and promotional models and may force us to modify or reduce our prices. The ability of our stores to achieve profitability depends on their ability to achieve a critical mass of loyal, repeat customers.

Competition from grocers and online retailers has significantly increased during the past few years. Some of our competitors have or may merge with or acquire pharmacies, pharmaceutical services companies, PBMs, health insurance companies, specialty or mail order facilities and/or enter into strategic partnership alliances with Group Purchasing Organizations or wholesalers, which may further increase competition. We may not be able to effectively compete against them because our existing or potential competitors have financial and other resources that are superior to ours.

In the PBM business, we also face competition from other PBMs, including large, national PBMs, PBMs owned by national health plans and middle-market stand-alone PBMs. Certain of these competitors entered into the PBM industry before us, and there is no assurance that we will successfully compete with entities with more established PBM businesses and scale. Further, we may be at a competitive disadvantage because we are more highly leveraged than our competitors.

We cannot assure you that we will be able to continue to effectively compete in our markets or increase our sales volume in response to further increased competition.

Our market dynamics are subject to fluctuation due to consumer behavior and technology changes, among other factors. We must adjust our operations and business model to meet these evolving market demands. If we fail to make proper adjustments to meet changing market conditions, we may lose customers, which would have a negative impact on our revenue.

Increasingly, a greater volume or proportion of dispensed prescriptions involve specialty drugs, which are often furnished through limited distribution channels. Because these channels are restricted, there is substantial competition among our competitors to be included in these networks. Furthermore, participation in these networks is challenging, as the higher costs and complexities of specialty drugs may be difficult to manage. If we are unable to effectively compete for specialty drug business and access this market, we face potential harm to our business operations and adverse impacts to our financial condition. 

20

New and emerging payment models for health care services reimbursement may hinder our retail pharmacies’ and PBMs’ ability to compete, and negatively impact our revenue.

Government and commercial payors are increasingly exploring alternatives to fee-for-service payment models. Such alternatives include risk sharing, value-based payment and bundled payment systems for health care services. Our retail pharmacies do not operate as part of integrated health care delivery models and, unlike some of our competitors, we have not invested in health care delivery models which integrate different health care services, such as pharmacy and primary care services. Additionally, our retail pharmacies are not active participants in any risk assumption payment models. Moreover, it is operationally difficult to apply value-based payment to prescription drug benefit services. To the extent that payors increasingly embrace these new payment delivery models and systems and our retail competitors are able to adapt to such changes, our retail pharmacies risk being excluded from such networks and the corresponding loss of reimbursement. Even though the COVID-19 pandemic and resulting government waivers have allowed pharmacists to embrace an expanded scope of services, the end of the COVID-19 pandemic could result in a rollback of those waivers and our pharmacists may no longer be authorized to offer such services as part of the various novel delivery and payment models.

With regard to our PBM business, given the major challenges involved in creating complex delivery networks to implement integrated delivery of health care services and/or nontraditional payment systems, our PBM business risks an inability to develop robust pharmacy networks capable of providing the level and scope of services necessary to sustain such models. Our PBM business may face a competitive disadvantage. Furthermore, our competitors with strong regional networks may threaten our ability to compete in certain regions. Ultimately, if we cannot develop thriving networks as part of new and emerging payment and delivery models our bottom line will suffer.

A change in our pharmacy and payor mix could adversely affect our profit margins.

Our Retail Pharmacy Segment is subject to changes in pharmacy and payor mix, including shifts in pharmacy prescription volume toward programs offering less favorable reimbursement terms, which could adversely affect the results of our operations. For instance, we anticipate that a growing number of prescription drug sales will involve government subsidized drug benefit programs, 90-day fill programs, and specialty drug sales, under which our business may receive lower margins. As our government-funded businesses grow, our exposure to changes in law and policy under those programs will increase. Also, the government could reduce funding for health care or other programs or cancel, decline to renew, or modify our contracts, which could adversely impact our business, operating results, and cash flows. Moreover, many Medicare Part D plans and commercial payors are adopting preferred pharmacy networks, in which participating pharmacies must accept lower reimbursement in exchange for access to the payors’ patient population. We could incur negative financial impacts should the terms and conditions of such preferred networks become less favorable or if we are unable to offset lower reimbursement with additional prescription volume, other business, or improved efficiencies. We could also be negatively impacted by changes in the relative distribution of drugs dispensed at our pharmacies between brands and generics or if we experience an increase in the amounts we pay to procure pharmaceutical products.

21

A sudden and material decrease in the number of Medicaid enrollees due to the “Medicaid Cliff” could have a sudden destabilizing impact on retail pharmacy revenue.

During the COVID-19 related federal public health emergency, the federal government provided supplemental Medicaid funding to states as long as states agreed to provide for continuous Medicaid coverage for current enrollees. This continuous enrollment has ended as of March 31, 2023. States will once again be required to remove Medicaid ineligible individuals from the Medicaid rolls. Anywhere from 5 to 15 million Americans could lose coverage as a result. Each state will manage the unwinding differently so the impact will be different from state to state. These changes could have a sudden and material negative impact on the Company’s overall retail pharmacy revenue received from Medicaid and Medicaid MCOs.

Consolidation in the healthcare industry could adversely affect our business, financial condition and results of operations.

Many organizations in the healthcare industry, including PBMs and Part D plans, have consolidated to create larger healthcare enterprises with greater market power, which has contributed to continued pricing pressures and has weakened our retail pharmacies’ ability to obtain advantageous pharmacy network contracting terms. The effects of organizational consolidation are exacerbated by the growing market share of specialty pharmacies, compared to retail pharmacies, for limited-distribution high-cost therapies for rare diseases. Within the Part D plan market, approximately one-third of our PBM business is Part D business and it will be more difficult for our PBM to compete in and obtain competitive reimbursement terms in the consolidated Part D plan marketplace. Our PBM business also faces increased competitive threats from the consolidation among middle-market PBMs.

If this consolidation trend continues, it could give the resulting enterprises even greater bargaining power, which may lead to further pressure on the prices for our products and services and/or reduce our access to customers. If these pressures result in reductions in our prices and/or reduce our access to customers, our business will become less profitable unless we are able to achieve corresponding reductions in costs or develop profitable new revenue streams. We expect that market demand, government regulation, third-party reimbursement policies, government contracting requirements, and societal pressures will continue to cause the healthcare industry to evolve, potentially resulting in further business consolidations and alliances among the industry participants we engage with, which may adversely impact our business, financial condition and results of operations. In addition, our new strategy also includes selective acquisition opportunities and we cannot assure you that we will be able to consummate any such transactions on commercially reasonable terms, if at all.

There are risks related to the availability, pricing, and safety profiles of the pharmacy drugs and products we purchase and sell.

The continued conversion of various prescription drugs, including potential conversions of a number of popular medications, to over-the-counter medications may reduce our pharmacy sales and customers may seek to purchase such medications at non-pharmacy stores. Also, if the rate at which new prescription drugs become available slows or if new prescription drugs that are introduced into the market fail to achieve popularity, our pharmacy sales may be adversely affected. The withdrawal of certain drugs from the market, including COVID-19 vaccines, increased safety risk profiles or regulatory restrictions, concerns about the safety or effectiveness of certain drugs, or negative publicity surrounding certain categories of drugs may also have a negative effect on our pharmacy sales or may cause shifts in our pharmacy or front-end product mix. Additionally, as we offer new products and services, our litigation and regulatory risk profile may change and increase our exposure to new risks that we have not previously encountered or addressed.

The availability of brand versus generic drugs and changes in those markets may also negatively impact our financial condition. Brand name drugs may become subject to inflation. Moreover, as generic drug utilization has increased, and due to consolidation within the generic drug manufacturing industry, our pharmacy business has experienced decreasing profit margins on generic drug sales. Generic drug profit margins also suffer as a result of downward pricing pressure from discount card vendors, cash pay pharmacies and other competitors, which are growing as a share of the prescription drug marketplace. If our businesses are unable to accommodate shrinking profit margins and decreased sales on certain prescription drug products, our costs, revenue and overall profits could be adversely and materially impacted. 

22

Changes in third-party reimbursement levels for prescription drugs and changes in industry pricing benchmarks could reduce our margins and have a material adverse effect on our business.

Sales of prescription drugs reimbursed by third-party payors, including the Medicare Part D plans and state sponsored Medicaid and related managed care Medicaid plans, represented substantially all of our pharmacy sales in our Retail Pharmacy Segment in fiscal 2023.

The continued efforts of Congress and Federal agencies, health maintenance organizations, managed care organizations, PBM companies, other State and local government entities, and other third-party payors to reduce prescription drug costs and pharmacy reimbursement rates, as well as litigation relating to how drugs are priced, may impact our profitability. Consolidation within the Part D plan marketplace and fewer Part D plans may increase plans’ reimbursement leverage over our retail pharmacies. Additionally, on April 29, 2022, CMS issued a final rule that requires Part D plans to reflect all pharmacy price concessions (also known as “Direct and Indirect Remuneration” or “pharmacy DIR”) in a pharmacy’s negotiated price at the point of sale starting for contract year 2024. With respect to retail pharmacies, the final rule could result in unpredictable results, including changes to reimbursement terms in contracts with Part D payors for contract year 2024 as well as temporary cash flow issues in the first few months of implementation of the final rule. Our PBM business could also experience challenges related to utilizing pharmacy price concessions in Part D bids and subsequent contracts.

The competitive success of our pharmacy business is largely dependent on our ability to establish and maintain contractual relationships with PBMs and other payors on acceptable terms as they may adopt narrow or restricted retail or specialty pharmacy networks. Some of these entities may offer pricing terms that we may not be willing to accept or otherwise restrict or exclude our participation in their networks of pharmacy providers. Any significant loss of third-party business could have a material adverse effect on our business and results of operations. Decreased reimbursement payments to retail and mail order pharmacies for brand and generic drugs has caused a reduction in our profit. Historically, the effect of this trend has been mitigated by our efforts to negotiate reduced acquisition costs of generic pharmaceuticals with manufacturers. Additionally, it has resulted in us providing contractual financial performance guarantees to certain of our PBM clients with respect to minimum drug price discounts for our retail pharmacy network and mail order pharmacy. Any inability to achieve guaranteed minimum drug price discounts provided to our PBM clients could have an adverse effect on our results of operations.

In addition, it is possible that the pharmaceutical industry or regulators may evaluate and/or develop an alternative pricing reference to replace Average Wholesale Price (“AWP”), which is the pricing reference used for many of our PBM client contracts, pharmaceutical manufacturer rebate agreements, retail pharmacy network contracts, specialty payor agreements and other contracts with third-party payors in connection with the reimbursement of drug payments. Future changes to the use of AWP or to other published pricing benchmarks used to establish pharmaceutical pricing, including changes in the basis for calculating reimbursement by federal and state health programs and/or other payors, could impact the reimbursement we receive from Medicare programs and Medicaid health plans, the reimbursement we receive from PBM clients and other payors and/or our ability to negotiate rebates with pharmaceutical manufacturers, acquisition discounts with wholesalers and retail discounts with network pharmacies. Likewise, Congress or the federal agencies could take actions that reduce or eliminate drug rebates obtained through negotiation with pharmaceutical manufacturers. The effect of these possible changes on our business cannot be predicted at this time.

During the past several years, the United States health care industry has been subject to an increase in governmental regulation, licensing and audits at both the federal and state levels. Efforts to control health care costs, including prescription drug costs, are continuing at the federal and state government levels. Changing political, economic and regulatory influences may significantly affect health care financing and reimbursement practices. A change in the composition of pharmacy prescription volume toward programs offering lower reimbursement rates could negatively impact our profitability. Additionally, significant changes in legislation, regulation and government policy could significantly impact our business and the health care and retail industries. While it is not possible to predict whether and when any such changes will occur or what form any such changes may take, legislative proposals have been made that could have a material adverse effect on our business include, but are not limited to, revisions to certain ACA provisions and other significant changes to health care system legislation as well as changes with respect to tax and trade policies, tariffs and other government regulations affecting trade between the United States and other countries.

23

Significant changes to Medicaid funding or even significant destabilization of the Health Insurance Marketplaces could impact the number of Americans with health insurance and, consequently, prescription drug coverage. We cannot predict the effect, if any, that such legislative or regulatory changes may have on our retail pharmacy and pharmacy services operations.

A substantial portion of our pharmacy revenue is currently generated from a limited number of third-party payors, and, if there is a loss of, or significant change to prescription drug reimbursement rates by, a major third-party payor, our revenue will decrease and our business and prospects could be adversely impacted.

A substantial portion of our pharmacy revenue is currently generated from a limited number of third-party payors. While we are not limited in the number of third-party payors with which we can do business and results may vary over time, our top five third-party payors accounted for 83.4%, 77.4% and 77.9% of our pharmacy revenue during fiscal 2023, 2022 and 2021, respectively. The largest third-party payor, CVS/Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. We expect that a limited number of third-party payors will continue to account for a significant percentage of our pharmacy revenue, and the loss of all or a portion of, or a significant change to customer access or prescription drug reimbursement rates by, a major third-party payor could decrease our revenue and harm our business. Revenue could further be impacted through changes in third-party payor behavior responding to the implementation of CMS’ final rule on the assessment of pharmacy price concessions, specifically through the Part D bid process and subsequent contracts.

In 2020, CMS adopted the Transparency in Coverage Final Rule, which requires non-grandfathered group health plans and health insurance issuers offering non-grandfathered coverage in the group and individual markets to disclose on a public website certain price information, including negotiated rates and historical net prices for covered prescription drugs. Enforcement began on July 1, 2022. CMS’ enforcement of the rule could inhibit the ability of pharmacy stakeholders, including our PBM and retail pharmacy business segments, respectively, from negotiating favorable reimbursement contracts for our Company.

A substantial portion of our Pharmacy Services Segment revenue is currently generated from a limited number of customers, and, if there is a loss of a major customer, our revenue will decrease and our business and prospects could be adversely impacted.

A substantial portion of our Pharmacy Services Segment revenue is currently generated from a limited number of customers. While we are not limited in the number of customers with which we can do business and results may vary over time, our top five customers accounted for 65.9%, which includes 6.9% related to a client which termed on January 1, 2023, 60.7% and 59.7% of our Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. We expect that a limited number of customers will continue to account for a significant percentage of our Pharmacy Services Segment revenue, and the loss of all or a portion of a major customer could decrease our revenue and harm our business.

We are, and in the future may become, involved in legal proceedings that may adversely affect our financial position and our pursuit of refinancing opportunities, as well as our reputation and brand.

We operate in a highly regulated and litigious environment. We and/or one or more of our subsidiaries are regularly involved in a variety of legal proceedings arising in the ordinary course of our business, including arbitration, litigation (and related settlement discussions), and other claims, and are subject to regulatory proceedings including audits, inspections, inquiries, investigations, and similar actions by health care, insurance, pharmacy, tax and other governmental authorities. Legal proceedings, in general, and securities, derivative action and class action and multi-district litigation, in particular, can be expensive and disruptive, and may exceed any applicable insurance coverage. Additionally, defending against these lawsuits and proceedings may involve significant expense and diversion of management’s attention and resources. Some of these suits may purport or may be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years.

24

For example, we, along with certain of our chain pharmacy competitors, have been named as a defendant in numerous lawsuits relating to the distribution and dispensing of prescription opioids, including in the consolidated federal multi-district litigation entitled In re National Prescription Opiate Litigation (MDL No. 2804), currently pending in the United States District Court for the Northern District of Ohio. Similar cases that name us as a defendant also have been filed in numerous state court proceedings by any array of plaintiffs, including state Attorneys General, counties, cities, municipalities, Native American tribes, hospitals, third-party payors, and individuals. A qui tam complaint has also been filed in the federal District Court for the Northern District of Ohio in which qui tam relators and the United States DOJ allege violations of the federal False Claims Act and Controlled Substances Act related to the dispensing of controlled substances, primarily opioids and seek damages under the False Claims Act, civil penalties under the Controlled Substances Act, damages in connection with alleged payment by mistake (on behalf of Federal Healthcare Programs), and damages in connection with alleged unjust enrichment. The Company has also received subpoenas, civil investigative demands, and other requests relating to opioid matters from the DOJ and several state Attorneys General. Certain “usual and customary” actions are pending (or may be brought) against the Company which seek large and/or indeterminate damages. Generally, these matters allege that the Company’s retail stores overcharged for prescription drugs by not submitting the price available to members of the Rite Aid’s Rx Savings Program as the pharmacy’s usual and customary price, and related theories. These claims typically are alleged to arise under the Company’s agreements with insurers, as tort claims, or under the False Claims Act and similar theories for governmental programs, but may be alleged to arise otherwise. Also, the Company is defending putative stockholder class actions which name the Company and certain former and current executives individually as defendants.

We cannot predict with certainty the outcomes of these and other legal proceedings and other contingencies, and the costs incurred in litigation can be substantial, regardless of the outcome. Proceedings that we believe are insignificant may develop into material proceedings and subject us to unforeseen outcomes or expenses. Additionally, the actions of certain participants in our industry may encourage legal proceedings against us or cause us to reconsider our litigation strategies. As a result, we could from time to time incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments could harm our reputation and have a material adverse effect on our results of operations, financial condition and business practices. Moreover, negative postings or comments on social media or networking websites about us or these legal proceedings and the on-demand news cycle, even if inaccurate or malicious, have in the past, and could in the future, generate adverse publicity that could damage our reputation. See “Risks Related to our Operations—Negative public perception of the industries in which we operate, or of our industries’ or our practices, can adversely affect our businesses, operating results, cash flows and prospects.”

Furthermore, the uncertainty relating to any legal proceedings may also impair our ability to raise capital or the cost of such capital, as well as our credit ratings. Significant liabilities resulting from legal proceedings could force us to implement further cost reduction and other cash-focused measures to manage liquidity any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.

We are subject to governmental regulations, procedures and requirements; our non-compliance or a significant legislative, regulatory, or public policy change could adversely affect our business, the results of our operations or our financial condition.

Our business is subject to numerous federal, state and local laws and regulations. Changes in these laws, regulations, or in related public policy may require extensive system and operating changes that may be difficult to implement, increase our operating costs and require significant capital expenditures. Untimely compliance or non-compliance with applicable regulations could result in the imposition of civil and criminal penalties that could adversely affect the continued operation of our business, including: (i) suspension of payments from government programs; (ii) loss of required government certifications; (iii) loss of authorizations or changes in requirements for participating in, or exclusion from government reimbursement programs, such as the Medicare and Medicaid programs; (iv) loss of licenses; or (v) significant fines or monetary penalties. The regulations to which we are subject include, but are not limited to, federal, state and local regulations of pharmacies; dispensing and sale of controlled substances and products containing pseudoephedrine, among others; applicable Medicare and Medicaid Regulations; HIPAA; regulations relating to the protection of the environment and health and safety matters, including those governing exposure to and the management and disposal of hazardous substances; regulations enforced by the U.S. Federal Trade Commission, the CPSC, the HHS and the DEA as well as state regulatory authorities, governing the sale, advertisement and promotion of

25

products we sell; anti-kickback laws; false claims laws and federal and state laws governing the practice of the profession of pharmacy and medicine. For example, in the U.S., the DEA, FDA and various other regulatory authorities regulate the distribution and dispensing of pharmaceuticals, controlled substances and listed chemicals. We are required to hold valid DEA and state-level licenses, meet various security and operating standards and comply with the federal and various state-controlled substance acts and related regulations governing the sale, dispensing, disposal, holding and distribution of controlled substances and listed chemicals. Regulatory authorities have broad enforcement powers, including the ability to seize or recall products and impose significant criminal, civil and administrative sanctions for violations of these laws and regulations. We are also governed by federal and state laws of general applicability, including laws regulating matters of wage and hour laws, working conditions, health and safety and equal employment opportunity.

Our dealings with customers face scrutiny from the federal and state government agencies, including the Federal Trade Commission, which are charged with enforcing consumer protection laws and deterring alleged unfair or deceptive trade practices. Under these laws, regulated entities may be subject to legal action and government investigations in regard to a wide array of customer-facing matters, including product pricing and expiration, disability access, and member loyalty and other financial incentive programs. A failure to keep our customers adequately informed of our practices could result in government investigations or regulatory action which may result in potential fines and penalties.

Government audits, investigations, and reviews could lead to liability and operational changes.

Our pharmacy, PBM, and PDP businesses are subject to periodic audits, investigations, and reviews from state and federal regulators and agencies. Health care laws and regulations, particularly within the pharmacy sector, are complex and subject to frequent change. Moreover, federal and state regulators are highly focused on and engage in vigorous enforcement efforts with regard to fraud, waste and abuse within the health care and pharmacy industry. Accordingly, we invest significant resources in our compliance efforts and must constantly re-evaluate our efforts, as the laws, regulations, and enforcement trends may change.

Because our business is subject to varied audits, investigations, and reviews, we face risks including financial penalties, civil and/or criminal liability, suspension or exclusion from government programs, and possible licensure sanction. For example, because our PDP is governed by CMS’ audit authority, it could be subject to financial recoupment, penalties, beneficiary enrollment restrictions, and other forms of sanction. In addition, our PBM’s operations could be indirectly and adversely impacted if any of its Medicare plan clients are subjected to adverse government audits or enforcement actions. The outcome of any given audit, investigation, and/or review could require significant changes to our business practices, revenue flow, and overall financial condition, with a resulting adverse impact on the Company as a whole.

If our compliance or other systems and processes fail or are deemed inadequate, we may become subject to regulatory actions and/or litigation.

In addition to Rite Aid being subject to extensive and complex regulations, many contracts that Elixir Insurance has with its customers impose compliance obligations on it. These compliance obligations frequently are reviewed and audited by Elixir Insurance’s customers and regulators. More generally, if the Company’s systems and processes designed to maintain compliance with applicable legal and contractual requirements, and to prevent and detect instances of, or the potential for, noncompliance fail or are deemed inadequate, we may be subject to regulatory actions, litigation and other proceedings which may result in damages, fines, suspension or loss of licensure, suspension or exclusion from participation in government programs and/or other penalties, any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.

Certain risks are inherent in providing pharmacy services; our insurance may not be adequate to cover any claims against us.

Pharmacies are exposed to risks inherent in the packaging and distribution of pharmaceuticals and other healthcare products, such as with respect to improper filling of prescriptions, labeling of prescriptions, adequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs. In addition, federal and state laws that require our pharmacists to offer counseling, without additional charge, to customers about medication, dosage, delivery

26

systems, common side effects and other information the pharmacists deem significant can impact our business. Our pharmacists may also have a duty to warn customers regarding any potential negative effects of a prescription drug if the warning could reduce or negate these effects. Although we maintain professional liability and errors and omissions liability insurance, from time to time, claims result in the payment of significant amounts, some portions of which are not funded by insurance. We cannot assure you that the coverage limits under our insurance programs will be adequate to protect us against future claims, or that we will be able to maintain this insurance on acceptable terms in the future. Our results of operations, financial condition or cash flows may be adversely affected if in the future our insurance coverage proves to be inadequate or unavailable or there is an increase in liability for which we self-insure or we suffer reputational harm as a result of an error or omission.

We may be subject to significant liability should the consumption of any of our products cause injury, illness or death.

Products that we sell could become subject to contamination, product tampering, mislabeling or other damage requiring us to recall our products. We could be adversely impacted by the supply of defective or expired products, including the infiltration of counterfeit products into the supply chain, errors in re-labeling of products, product tampering, product recall and contamination or product mishandling issues. The federal Drug Supply Chain Security Act (“DSCSA”), which has the purpose of preventing counterfeit drugs from entering the United States supply chain, is scheduled to be fully implemented in November of 2023. There is uncertainty regarding whether the drug supply chain is fully ready for the transition to a track and trace model based on the electronic interoperable exchange of data at the product level. Moreover, with final implementation of the DSCSA, there is a potential for increased FDA DSCSA enforcement, which could increase pharmacy costs to comply with the DSCSA and pharmacy costs for identifying and investigating potentially counterfeit drugs.

In addition, errors in the dispensing and packaging of pharmaceuticals could lead to serious injury or death. Product liability claims may be asserted against us with respect to any of the products or pharmaceuticals we sell and we may be obligated to recall our products. Moreover, while we have insurance to cover potential product liability and some claims may be subject to indemnification from other parties, we cannot guarantee that our insurance limits and/or indemnification will be adequate to cover any and all product related claims. We also may not be able to maintain this insurance on acceptable terms in the future. A product liability judgment against the Company or a product recall could have a material, adverse effect on our business, reputation, financial condition or results of operations. Further, certain products dispensed or administered at our stores could be subject to liability protections under the current PREP Act declaration issued for the COVID-19 pandemic, though those liability protections are set to expire in the near future. Even with the protections currently in effect, we may be subject to state tort claims based on recent litigation on the scope of preemption under the PREP Act.

Risks of declining gross margins in the PBM industry could adversely impact our profitability, and could result in further impairment charges.

The PBM industry has been experiencing margin pressure as a result of competitive pressures and increased client demands for lower prices, performance guarantees, enhanced service offerings and higher rebate yields. With respect to rebate yields, we maintain contractual relationships with brand name pharmaceutical manufacturers that provide for rebates on drugs dispensed by pharmacies in our retail network and by our mail order pharmacy (all or a portion of which may be passed on to clients). Manufacturer rebates often depend on a PBM’s ability to meet contractual market share or other requirements, including in some cases the placement of a manufacturer’s products on the PBM’s formularies. If we lose our relationship with one or more pharmaceutical manufacturers, or if the rebates provided by pharmaceutical manufacturers decline, our business and financial results could be adversely affected. Further, changes in existing federal or state laws or regulations or the adoption of new laws or regulations relating to patent term extensions, rebate arrangements with pharmaceutical manufacturers, or to formulary management or other PBM services could also reduce or eliminate the manufacturer rebates we receive. We also have performance guarantees with select customers for rebates, and if our rebate aggregation contracts change or we are unable to meet our obligations due to mix of brand drugs, our financial performance for this business could be impacted.

We also maintain contractual relationships with participating pharmacies that provide for discounts on retail transactions for generic drugs and brand drugs dispensed by pharmacies in our retail network. If we lose our relationship

27

with one or more of the larger pharmacies in our network, or if the retail discounts provided by network pharmacies decline, our business and financial results could be adversely affected. In addition, changes in federal or state laws or regulations or the adoption of new laws or regulations relating to claims processing and billing, including our ability to collect network administration and technology fees, could adversely impact our profitability.

Legislation exists under Medicare Part D and in the majority of states that affect the ability of our PBM business (and its health plan clients) to limit access to pharmacy provider networks or remove pharmacy network providers. For instance, “any willing provider” laws may mandate that our PBM or its health plan clients admit nonparticipating pharmacies that are willing and able to satisfy the applicable terms and conditions for network participation. Medicare Part D and many states have implemented laws or rules that limit the ability of PBMs and health plans to impose formulary conditions or restrictions, such as co-payment differentials, and drug tiering designs, which may be used to manage drug benefits and promote cost-efficient utilization. Together, these laws could affect the ability of our PBM to effectively manage costs for its health plan clients. Additionally, many states now have legislation impacting the ability of our PBM to conduct audits of claims submitted by network pharmacies. These laws could hinder our PBM’s ability to recover overpayments identified through audits and negatively affect our PBM’s services and its ability to achieve enhanced economic outcomes for its health plan clients.

The possibility of PBM client loss and/or the failure to win new PBM business could impact our ability to secure new business.

Our PBM business generates net revenues primarily by contracting with clients to provide prescription drugs and related health care services to plan members. PBM client contracts often have terms of approximately three years in duration, so approximately one third of a PBM’s client base typically is subject to renewal each year. In some cases, however, PBM clients may negotiate a shorter or longer contract term or may require early or periodic renegotiation of pricing prior to expiration of a contract. In addition, the reputational impact of a service-related incident could negatively affect our ability to grow and retain our client base. Further, the PBM industry has been impacted by consolidation activity that may continue in the future. In the event one or more of our PBM clients is acquired by an entity that obtains PBM services from a competitor, we may be unable to retain all or a portion of our clients’ business. Due to the competitive nature of the business, we continually face challenges in competing for new PBM business and retaining or renewing our existing PBM business. There can be no assurance that we will be able to win new business or secure renewal business on terms as favorable to us as the present terms. These circumstances, either individually or in the aggregate, could result in an adverse effect on our business and financial results.

Regulatory or business changes relating to our participation in Medicare Part D, the medical loss ratio for our Medicare Part D eligible members, or our failure to otherwise execute on our strategies related to Medicare Part D, may adversely impact our business and our financial results.

One of our subsidiaries, Elixir Insurance is an insurer domiciled in Ohio (with Ohio as its primary insurance regulator) and licensed in all 50 states, and is approved to function as a PDP plan sponsor for purposes of individual insurance products offered to Medicare-eligible beneficiaries and for purposes of making employer/union-only group waiver plans available for eligible clients. We also provide other products and services in support of our clients’ Medicare Part D plans or the Federal Retiree Drug Subsidy program. We are working to minimize the working capital tied to the business by reducing and/or selling the receivables as we did for calendar 2022, however there are no assurances that we can reduce or sell the receivable for calendar 2023. There are many uncertainties about the financial and regulatory risks of participating in the Medicare Part D program and we can give no assurance that these risks will not materially adversely impact our business and financial results in future periods.

28

Elixir Insurance is subject to various contractual and regulatory compliance requirements associated with participating in Medicare Part D. Elixir Insurance is subject to certain aspects of state laws regulating the business of insurance in all jurisdictions in which Elixir Insurance offers its PDP plans. As a PDP sponsor, Elixir Insurance is required to comply with Federal Medicare Part D laws and regulations applicable to PDP sponsors. Additionally, the receipt of Federal funds made available through the Part D program by us, our affiliates, or clients is subject to compliance with the Part D regulations and established laws and regulations governing the Federal government’s payment for healthcare goods and services, including the Anti-Kickback Statute and the False Claims Act. Similar to our requirements with other clients, our policies and practices associated with operating our PDP are subject to audit. If material contractual or regulatory noncompliance was to be identified, monetary penalties and/or applicable sanctions, including suspension of enrollment and marketing or debarment from participation in Medicare programs, could be imposed. Further, the adoption or promulgation of new or more complex Medicare Part D regulatory requirements, including those governing pharmacy networks, benefit designs, and product pricing, could require us to incur significant costs which could adversely impact our business and our financial results. Similar negative impacts could result from potential Part D reimbursement reductions, adverse CMS audits, government enforcement actions, or decreases in star ratings. Further, Elixir Insurance’s level of margin is limited by minimum MLR requirements imposed by the ACA. Medicare PDPs are subject to minimum MLR audits and Elixir Insurance could be required to pay MLR rebates for failure to meet minimum MLRs in a given year and repeated MLR failures could lead to CMS termination.

In addition, due to the availability of Medicare Part D, some of our employer clients may decide to stop providing pharmacy benefit coverage to retirees, instead allowing the retirees to choose their own Part D plans, which could cause a reduction in demand for our Medicare Part D group insurance products. Extensive competition among Medicare Part D plans could also result in the loss of Medicare Part D members by our managed care customers, which would also result in a decline in our membership base. For example, if we were to receive a lower Star rating from CMS, fewer customers may select our plans, which could have an adverse effect on our financial results. Like many aspects of our business, the administration of the Medicare Part D program is complex. Any failure to execute the provisions of the Medicare Part D program may have an adverse effect on our financial position, results of operations or cash flows.

Failure to timely identify or effectively respond to changing consumer preferences and spending patterns, an inability to expand the products being purchased by our clients and customers, or the failure or inability to obtain or offer particular categories of products could negatively affect our relationship with our clients and customers and the demand for our products and services.

The success of our business depends in part on customer loyalty, superior customer service and our ability to persuade customers to purchase products in additional categories and our private label brands. Failure to timely identify or effectively respond to changing consumer preferences and spending patterns, an inability to expand the products being purchased by our clients and customers, or the failure or inability to obtain or offer particular categories of products could negatively affect our relationship with our clients and customers and the demand for our products and services.

We offer our customers private label brand products that are available exclusively at our stores and through our online retail site. The sale of private label products subjects us to unique risks including potential product liability risks and mandatory or voluntary product recalls, our ability to successfully protect our intellectual property rights and the rights of applicable third parties, and other risks generally encountered by entities that source, market and sell private-label products. Any failure to adequately address some or all of these risks could have an adverse effect on our business, results of operations and financial condition. Additionally, an increase in the sales of our private label brands may negatively affect our sales of national-branded products which consequently, could adversely impact certain of our supplier relationships. Our ability to locate qualified, economically stable suppliers who satisfy our requirements, and to acquire sufficient products in a timely and effective manner, is critical to ensuring, among other things, that customer confidence is not diminished. Any failure to develop sourcing relationships with a broad and deep supplier base could adversely affect our financial performance and erode customer loyalty.

Moreover, customer expectations and new technology advances from our competitors have required that our business evolve to enable us to interface with our retail customers not only face-to-face in our stores but also online and via mobile and social media. Our customers utilize computers, tablets, mobile phones and other electronic devices to shop in our stores and online, as well as provide public reactions concerning each facet of our operation. If we fail to

29

keep pace with dynamic customer expectations and new technology developments, our ability to compete and maintain customer loyalty could be adversely affected.

Finally, EI’s specialty pharmacy business focuses on complex and high-cost medications that serve a relatively limited universe of patients. As a result, the future growth of our specialty pharmacy business is dependent largely upon expanding our base of drugs or penetration in certain treatment categories. Any contraction of our base of patients or reduction in demand for the prescriptions we currently dispense could have an adverse effect on our business, financial condition and results of operations.

The impact of extreme events, natural disasters, and climate change could create unpredictability for our business operations.

Extreme weather, natural disasters, and pandemics, such as COVID-19, can have severe negative ramifications for the pharmacy industry, including interfering with revenue flows, reimbursement, and the drug supply chain. More broadly, long-term climate change has unknown and potentially negative impacts on our industry. These sorts of extreme events can lead to unknown cost increases for our business to supply health care services and therefore pose a risk to our business and operating results.

The seasonal nature of our business causes fluctuations in operations.

Our first and fourth fiscal quarter operation results generally fluctuate during the holidays, and cough, cold, and flu season, during which time we typically experience a larger proportion of retail sales and earnings as compared to other fiscal quarters. We increase our merchandise and inventory levels in anticipation of the holiday season, and there is a risk that unpredictable events, such as inclement weather, could impact retail sales and earnings during this time. Furthermore, the unpredictable timing and severity of the cough, cold, and flu season may impact our first and fourth fiscal quarter operation results, including in regard to prescription and non-prescription drug sales.

Changes in laws governing labor, employers, and union organizing may increase our labor costs.

The Company’s business costs are directly impacted by legal and regulatory mandates governing employers and unionizing activities. Federal and state labor laws are subject to ongoing legislative changes, and any new or more stringent mandates imposed on employers, such as minimum wage increases or additional paid leave requirements, will increase our costs as an employer. Our employee-related operating costs could also increase in response to any union organizing activities among our employees. Overall, these potential labor, wage and union-related changes could increase our operating costs and thereby negatively impact our financial condition.

30

PART II

Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations

The Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations set forth below gives effect to the revision of our previously issued consolidated financial statements for each of the three fiscal years ended March 4, 2023 to correct an error in the periods impacted. For additional information and a detailed discussion of the revision and recast, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements included in Item 8.

Overview

We are a healthcare company with a retail footprint, providing our customers and communities with a high level of care and service through various programs we offer through our two reportable business segments, our Retail Pharmacy Segment and our Pharmacy Services Segment. We accomplish our goal of delivering comprehensive care to our customers through our retail drugstores and our PBM, Elixir. We also offer fully integrated mail-order and specialty pharmacy services through Elixir Pharmacy. Additionally, through Elixir Insurance (“EI”), Elixir also serves seniors enrolled in Medicare Part D. When combined with our retail platform, this comprehensive suite of services allows us to provide value and choice to customers, patients and payors and allows us to compete in today’s evolving healthcare marketplace.

Retail Pharmacy Segment

Our Retail Pharmacy Segment sells brand and generic prescription drugs and provides various other pharmacy services, as well as an assortment of front-end products including health and beauty aids, personal care products, seasonal merchandise, and a large private brand product line. Our Retail Pharmacy Segment generates the majority of its revenue through the sale of prescription drugs and front-end products at our over 2,300 retail pharmacy locations across 17 states and through our ecommerce platform available at www.riteaid.com. We replenish our retail stores through a combination of direct store delivery of pharmaceutical products facilitated through our pharmaceutical Purchasing and Delivery Agreement with McKesson, and the majority of our front-end products through our network of distribution centers.

Pharmacy Services Segment

Our Pharmacy Services Segment provides a fully integrated suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. Elixir provides services to various clients across its different lines of business, including major health plans, commercial employers, labor groups and state and local governments, representing over 1.4 million covered lives, including approximately 0.3 million covered lives through our Medicare Part D insurance offerings. Elixir continues to focus its efforts and offerings to its target market of small to mid-market employers, labor unions and regional health plans, including provider-led health plans and government sponsored Medicaid and Medicare plans.

Restructuring

Beginning in fiscal 2019, we initiated a series of restructuring plans designed to reorganize our executive management team, reduce managerial layers, and consolidate roles. In March 2020, we announced the details of our strategy, which includes building tools to work with regional health plans to improve patient health outcomes, rationalizing SKU’s in our front-end offering to free up working capital and update our merchandise assortment, assessing our pricing and promotional strategy, rebranding its retail pharmacy and pharmacy services business, launching our Store of the Future format and further reducing SG&A and headcount, including integrating certain back office functions in the Pharmacy Services Segment both within the segment and across the enterprise. Other strategic initiatives include the expansion of our digital business, replacing and updating our financial systems to improve

31

efficiency, and movement to a common client platform at Elixir. In April 2022, we announced further strategic initiatives to reduce costs through the closure of unprofitable stores, reduce corporate administration expenses, improve efficiencies in worked payroll and other store labor costs, engage in a comprehensive review of purchasing and other business processes in both the Retail Pharmacy and Pharmacy Services Segments in order to identify areas of opportunity, as well as expense reductions at the Pharmacy Services Segment. In December 2022, we announced a new multi-year performance acceleration program, which allows us to fast-track initiatives that will improve sales, script volume and operating margins, and free up cash. We are partnering with a leading consulting firm that has worked with several Fortune 150 firms to execute the turnaround model. This program has given us visibility to the profitability opportunities we can drive over the next three years by focusing on improvements and growth in our core businesses. These and future restructuring activities are expected to provide future growth and expense efficiency benefits. There can be no assurance that our current and future restructuring charges will achieve the cost savings and remerchandising benefits in the amounts or time anticipated.

Asset Sale to WBA

As previously disclosed, on September 18, 2017, we entered into the Amended and Restated Asset Purchase Agreement (the “Amended and Restated Asset Purchase Agreement”) with WBA and Walgreen Co., an Illinois corporation and wholly-owned direct subsidiary of WBA as buyer, which, based on its magnitude and because we exited certain markets, we applied discontinued operations treatment as required by Generally Accepted Accounting Principles (“GAAP”).

During the thirteen-week period ended May 30, 2020, we completed the final asset transfer under the Amended and Restated Asset Purchase Agreement, resulting in net income from discontinued operations, net of tax of $9.1 million. On October 17, 2020, we and WBA mutually agreed to terminate the services under the Transition Services Agreement (“TSA”).

Impact of COVID-19

In March 2020, the outbreak of COVID-19 caused by a novel strain of the coronavirus was recognized as a pandemic by the World Health Organization. The COVID-19 pandemic has severely impacted the economies of the United States and other countries around the world.

The COVID-19 pandemic had a significant impact on our operating results for the fiscal years ended March 4, 2023 and February 26, 2022 and will continue to have an impact on several factors underlying our operating results and liquidity in fiscal 2024. Those factors include the number of individuals that receive a COVID-19 vaccine or booster; demand for COVID-19 testing; the timing and extent to which elective procedures return to pre-pandemic levels; the demand for flu and other immunizations and the length and severity of the upcoming cough, cold and flu season.

Overview of Financial Results from Continuing Operations

The following information summarizes our financial results from continuing operations for fiscal 2023 compared to fiscal 2022. For discussion of our financial results from continuing operations for fiscal 2022 to fiscal 2021, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations” included in our Annual Report on Form 10-K for the fiscal year ended February 26, 2022, which we filed with the SEC on April 25, 2022.

Net Loss: Our net loss from continuing operations for fiscal 2023 was $719.2 million or $13.15 per basic and diluted share compared to net loss from continuing operations for fiscal 2022 of $522.4 million or $9.66 per basic and diluted share. The increase in net loss was due primarily to increased goodwill and intangible asset impairment charges for the impairment of goodwill related to the Pharmacy Services Segment, a decrease in Adjusted EBITDA, higher restructuring-related charges, higher interest expense, and increased facility exit and impairment charges. These items were partially offset by a gain on the repurchase of certain bonds at a discount and a gain on sale of assets resulting from sale-leasebacks and script file sales from store closures.

32

Adjusted EBITDA: Our Adjusted EBITDA from continuing operations for fiscal 2023 was $429.2 million or 1.8 percent of revenues, compared to $505.9 million or 2.1 percent of revenues for fiscal 2022. The decrease in Adjusted EBITDA from continuing operations was due primarily to a decrease of $104.6 million in the Retail Pharmacy Segment partially offset by an increase of $27.8 million in the Pharmacy Services Segment. The decrease in the Retail Pharmacy Segment Adjusted EBITDA was due to decreased gross profit, partially offset by a decrease in SG&A expenses of $164.5 million. Gross profit was negatively impacted by the decline in COVID vaccinations and testing, partially offset by the increase in prescriptions sold. SG&A expenses benefitted from lower payroll, occupancy, and other operating costs due to store closures and cost control initiatives, partially offset by the extra week in fiscal 2023. The increase in the Pharmacy Services Segment Adjusted EBITDA resulted from improved procurement economics and reductions in SG&A expense. Please see the sections entitled “Segment Analysis” and Adjusted EBITDA, Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” below for additional details.

Consolidated Results of Operations—Continuing Operations

Revenue and Other Operating Data

Year Ended

 

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

Revenues(a)

$

24,091,899

$

24,568,255

$

24,043,240

Revenue (decline) growth

 

(1.9)

%  

 

2.2

%  

 

9.6

%

Net loss

$

(719,188)

$

(522,372)

$

(99,381)

Net loss per diluted share

$

(13.15)

$

(9.66)

$

(1.86)

Adjusted EBITDA(b)

$

429,180

$

505,905

$

437,665

Adjusted Net Loss(b)

$

(143,744)

$

(95,322)

$

(8,510)

Adjusted Net Loss per Diluted Share(b)

$

(2.63)

$

(1.76)

$

(0.16)

(a)Revenues for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 exclude $215,467, $249,686 and $292,157, respectively, of inter-segment activity that is eliminated in consolidation.
(b)See “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.

Revenues

Fiscal 2023 compared to Fiscal 2022: The 1.9% decrease in revenues was due primarily to a $800.8 million decrease in Pharmacy Services Segment revenues, partially offset by a $290.3 million increase in Retail Pharmacy Segment revenues. Same store sales trends for fiscal 2023 and fiscal 2022 are described in the “Segment Analysis” section below.

Please see the section entitled “Segment Analysis” below for additional details regarding revenues.

33

Costs and Expenses

Year Ended

 

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

Cost of revenues(a)

$

19,287,959

$

19,461,760

$

19,338,918

Gross profit

 

4,803,940

 

5,106,495

 

4,704,322

Gross margin

 

19.9

%  

 

20.8

%  

 

19.6

%

Selling, general and administrative expenses

$

4,902,087

$

5,033,876

$

4,657,185

Selling, general and administrative expenses as a percentage of revenues

 

20.3

%  

 

20.5

%  

 

19.4

%

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

Interest expense

 

224,399

 

191,601

 

201,388

(Gain) loss on debt modifications and retirements, net

 

(80,142)

 

3,235

 

(5,274)

(Gain) loss on sale of assets, net

 

(68,586)

 

5,505

 

(69,300)

Loss (gain) on Bartell acquisition

 

 

5,346

 

(47,705)

(a)Cost of revenues for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 exclude $215,467, $249,686 and $292,157, respectively, of inter-segment activity that is eliminated in consolidation.

Gross Profit and Cost of Revenues

Gross profit decreased by $302.6 million in fiscal 2023 compared to fiscal 2022. Gross profit for fiscal 2023 includes a decrease of $327.2 million in our Retail Pharmacy Segment and an increase in gross profit of $24.7 million relating to our Pharmacy Services Segment. Gross margin was 19.9% for fiscal 2023 compared to 20.8% in fiscal 2022. Please see the section entitled “Segment Analysis” for a more detailed description of gross profit and gross margin results by segment.

Selling, General and Administrative Expenses

SG&A decreased by $131.8 million in fiscal 2023 compared to fiscal 2022. The decrease in SG&A includes a decrease of $112.6 million relating to our Retail Pharmacy Segment and a decrease of $19.2 million relating to our Pharmacy Services Segment. Please see the section entitled “Segment Analysis” below for additional details regarding SG&A.

Facility Exit and Impairment Charges

Impairment Charges:

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that an asset group has a carrying value that may not be recoverable. The individual operating store is the lowest level for which cash flows are identifiable. As such, we evaluate individual stores for recoverability of assets. To determine if a store needs to be tested for recoverability, we consider items such as decreases in market prices, changes in the manner in which the store is being used or physical condition, changes in legal factors or business climate, an accumulation of losses significantly in excess of budget, a current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection of continuing losses, or an expectation that the store will be closed or sold.

34

We monitor new and recently relocated stores against operational projections and other strategic factors such as regional economics, new competitive entries and other local market considerations to determine if an impairment evaluation is required. For other stores, we perform a recoverability analysis if they have experienced current-period and historical cash flow losses.

In performing the recoverability test, we compare the expected future cash flows of a store to the carrying amount of its assets. Significant judgment is used to estimate future cash flows. Major assumptions that contribute to our future cash flow projections include expected sales, gross profit and distribution expenses; expected costs such as payroll, occupancy costs and advertising expenses; and estimates for other significant selling, and general and administrative expenses. Additionally, we take into consideration that certain operating stores are executing specific improvement plans which are monitored quarterly to recoup recent capital investments, such as an acquisition of an independent pharmacy, which we have made to respond to specific competitive or local market conditions, or have specific programs tailored towards a specific geography or market.

We recorded impairment charges of $137.1 million in fiscal 2023, $150.8 million in fiscal 2022 and $46.3 million in fiscal 2021. We recorded impairment charges of $59.6 million in the fourth quarter of fiscal 2023, $99.4 million in the fourth quarter of fiscal 2022 and $31.1 million in the fourth quarter of fiscal 2021. Our methodology for recording impairment charges has been consistently applied in the periods presented.

As of March 4, 2023, approximately $717.2 million of our long-lived assets, including intangible assets, were associated with 2,309 active operating stores. Additionally, we have approximately $2.3 billion of operating lease right-of-use assets associated with the active stores.

If an operating store’s estimated future undiscounted cash flows are not sufficient to cover its carrying value, its carrying value is reduced to fair value based on its estimated future discounted cash flows. The discount rate is commensurate with the risks associated with the recovery of a similar asset. Operating lease right-of-use assets are included within the stores’ asset groups. We obtain fair values of these right-of-use assets based on real estate market data.

An impairment charge is recorded in the period that the store does not meet its original return on investment and/or has an operating loss for the last two years and its projected cash flows do not exceed its current asset carrying value. The amount of the impairment charge is the entire difference between the current carrying asset value and the estimated fair value of the assets using discounted future cash flows.

We recorded impairment charges for active stores of $13.6 million in fiscal 2023, $56.2 million in fiscal 2022 and $29.8 million in fiscal 2021.

We review key performance results for active stores on a quarterly basis and approve certain stores for closure. Impairment for closed stores, if any (many stores are closed on lease expiration), is recorded in the quarter the closure decision is approved. Closure decisions are made on an individual store or regional basis considering all of the macroeconomic, industry and other factors, in addition to the operating store’s individual operating results. We recorded impairment charges for closed facilities of $123.5 million in fiscal 2023, $94.6 million in fiscal 2022 and $16.5 million in fiscal 2021.

35

The following table summarizes the impairment charges and number of locations, segregated by closed facilities and active stores that have been recorded in fiscal 2023, 2022 and 2021:

March 4, 2023

February 26, 2022

February 27, 2021

(in thousands, except number of stores)

    

Number

    

Charge

    

Number

    

Charge

    

Number

    

Charge

Active stores:

Stores previously impaired(1)

 

44

$

4,866

 

118

$

12,339

 

174

$

21,372

New, relocated and remodeled stores(2)

 

8

 

4,640

 

1

 

538

 

2

 

1,519

Remaining stores not meeting the recoverability test(3)

 

12

 

4,038

 

88

 

43,305

 

19

 

6,854

Total impairment charges—active stores

 

64

 

13,544

 

207

 

56,182

 

195

 

29,745

Total impairment charges—closed facilities

 

194

 

123,531

 

147

 

94,606

 

33

 

16,542

Total impairment charges—all locations

 

258

$

137,075

 

354

$

150,788

 

228

$

46,287

(1)These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, we will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. Our fiscal 2023 impairment charge includes $3,087 of impairment relating to our right-of-use (“ROU”) and $1,779 of capital additions. Our fiscal 2022 impairment charge includes $5,434 of impairment relating to our ROU and $6,905 of capital additions. Our fiscal 2021 impairment charge includes $15,459 of impairment relating to our ROU and $5,913 of capital additions.
(2)These charges are related to new stores (open at least three years) and relocated stores (relocated in the last two years) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met our original return on investment projections and have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. Our fiscal 2023 impairment charge includes $1,765 of impairment relating to our ROU and $2,875 of capital additions. Our fiscal 2022 impairment charge includes $0 of impairment relating to our ROU and $538 of capital additions. Our fiscal 2021 impairment charge includes $347 of impairment relating to our ROU and $1,172 of capital additions.
(3)These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. Our fiscal 2023 impairment charge includes $1,765 of impairment relating to our ROU and $2,273 of capital additions. Our fiscal 2022 impairment charge includes $26,130 of impairment relating to our ROU and $17,175 of capital additions. Our fiscal 2021 impairment charge includes $3,177 of impairment relating to our ROU and $3,677 of capital additions.

The primary drivers of our impairment charges are each store’s current and historical operating performance and the assumptions that we make about each store’s operating performance in future periods. Projected cash flows are updated based on the next year’s operating budget which includes the qualitative factors noted above. We are unable to predict with any degree of certainty which individual stores will fall short or exceed future operating plans. Accordingly, we are unable to describe future trends that would affect our impairment charges, including the likely stores and their related asset values that may fail their recoverability test in future periods.

To the extent that actual future cash flows may differ from our projections materially, certain stores that are either not impaired or partially impaired in the current period may be further impaired in future periods. A 50 and 100 basis point decrease in our future sales assumptions as of March 4, 2023 would have resulted in 8 and 17, respectively, additional stores being subjected to our impairment analysis.

Facility Exit Charges: We calculate our liability for facility exit or disposal cost obligations to include long-term contract termination costs and costs related to the disposal of long-lived assets. We assess stores and distribution centers for potential closure and relocation. Decisions to close or relocate stores or distribution centers in future periods would result in inventory liquidation charges, as well as impairment of assets at these locations.

36

In fiscal 2023, 2022 and 2021, we recorded facility exit charges of $43.6 million, $13.3 million, and $11.4 million, respectively.

Goodwill and intangible asset impairment charges

In connection with the restructuring initiatives previously announced on March 16, 2020, we rebranded our EnvisionRxOptions and MedTrak subsidiaries to its new brand name, Elixir. These trademarks qualify as Level 3 within the fair value hierarchy. Upon the implementation of the rebranding initiatives during the first quarter of fiscal 2021, we have determined that the carrying value exceeded the fair value and consequently we incurred an impairment charge of $29.9 million for these trademarks, which is included within goodwill and intangible asset impairment charges within the condensed consolidated statement of operations.

In the fourth quarter of fiscal 2021, we completed a quantitative goodwill impairment assessment and determined after evaluating the results, events and circumstances, that sufficient evidence existed to assert that it is more likely than not that the fair values of the reporting units exceeded their carrying values. Therefore, no goodwill impairment charge was recorded for the fiscal year ended February 27, 2021.

In the fourth quarter of fiscal 2022, we completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to a decrease in Adjusted EBITDA that was driven by commercial and Medicare Part D business compression due to industry consolidation, an increase in the medical loss ratio at Elixir Insurance, and a decision to exit our rebate aggregation business. This resulted in goodwill impairment charges of $229.0 million for the fiscal year ended February 26, 2022.

In the second quarter of fiscal 2023, we completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to an update to our preliminary fiscal 2024 and beyond forecasted revenue driven by current updates in the estimate of lives for calendar year 2023 based on the latest estimates of existing client retention for 2023, the latest selling season and EI bid results and other business factors which only became evident during the second quarter. This resulted in goodwill impairment charges of $252.2 million in the second quarter of fiscal 2023.

In the fourth quarter of fiscal 2023, we completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to downward macroeconomic pressure during the fourth quarter of fiscal 2023 which manifested in increased interest rates, increased cost of borrowing and a decrease of industry multiples. The market factors that drove the goodwill impairment charges of $119.0 million in the fourth quarter of fiscal 2023 were not known in prior quarters.

Interest Expense

In fiscal 2023, 2022 and 2021, interest expense was $224.4 million, $191.6 million and $201.4 million, respectively.

The annual weighted average interest rates on our indebtedness in fiscal 2023, 2022 and 2021 were 7.2%, 5.6% and 5.4%, respectively.

Income Taxes–Continuing Operations

Income tax benefit of $6.5 million, $3.8 million and $20.2 million, has been recorded for fiscal 2023, 2022 and 2021, respectively. Net loss for fiscal 2023 included a provision for income tax based on an overall tax rate of 0.9%,

37

which was net of adjustments to maintain a full valuation allowance for federal deferred tax assets as well as the majority of our state deferred tax assets. These assets may not be realized based on our most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of our net deferred tax assets.

Net loss for fiscal 2022 included a provision for income tax based on an overall tax rate of 0.7%, which was net of adjustments to maintain a full valuation allowance for federal deferred tax assets as well as the majority of our state deferred tax assets. These assets may not be realized based on our most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of our net deferred tax assets.

ASC 740, “Income Taxes” requires a company to evaluate its deferred tax assets on a regular basis to determine if a valuation allowance against the net deferred tax assets is required. We take into account all available positive and negative evidence with regard to the recognition of a deferred tax asset including our past earnings history, expected future earnings, the character and jurisdiction of such earnings, unsettled circumstances that, if unfavorably resolved, would adversely affect recognition of a deferred tax asset, carryback and carryforward periods and tax planning strategies that could potentially enhance the likelihood of realization of a deferred tax asset. The ultimate realization of deferred tax assets is dependent upon the existence of sufficient taxable income generated in the carryforward periods. Accordingly, changes in the valuation allowance from period to period are included in the tax provision in the period of change.

We maintained a valuation allowance of $1,636.5 million, $1,818.1 million and $1,657.2 million against remaining net deferred tax assets at fiscal year-end 2023, 2022 and 2021, respectively.

Our ability to utilize the losses and credits to offset future taxable income may be deferred or limited significantly if we were to experience an “ownership change” as defined in section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). In general, an ownership change will occur if there is a cumulative change in ownership of our stock by “5-percent shareholders” (as defined in the Code) that exceeds 50 percentage points over a rolling three-year period. We determined that no ownership change has occurred for purposes of Section 382 for the period ended March 4, 2023. It is important to note, that the limitation that would be created upon an ownership change would only apply to income earned after the event that caused the ownership change.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe that this legislation will have a material impact on our financial statements.

Dilutive Equity Issuances

On March 4, 2023, 56.6 million shares of common stock, which includes unvested restricted shares, were outstanding and an additional 0.5 million shares of common stock were issuable related to outstanding stock options.

38

On March 4, 2023, our 0.5 million shares of potentially issuable common stock consisted of the following (shares in thousands):

    

Outstanding

Stock

Strike price

Options(a)

$0.00 - $19.99

503

$20.00 to $39.99

 

$40.00 to $59.99

 

13

$60.00 to $79.99

 

$80.00 to $99.99

 

$100.00 to $119.99

 

$120.00 to $139.99

 

$140.00 to $159.99

 

8

$160.00 and over

 

8

Total issuable shares

 

532

(a)The exercise of these options would provide cash of $6.8 million.

Segment Analysis

We evaluate the Retail Pharmacy and Pharmacy Services Segments’ performance based on revenue, gross profit, and Adjusted EBITDA. The following is a reconciliation of our segments to the consolidated financial statements:

    

Retail

    

Pharmacy

    

Intersegment

    

Pharmacy

Services

Eliminations(1)

Consolidated

March 4, 2023:

Revenues

$

17,785,067

$

6,522,299

$

(215,467)

$

24,091,899

Gross Profit

 

4,394,850

 

409,090

 

 

4,803,940

Adjusted EBITDA(*)

 

288,077

 

141,103

 

 

429,180

February 26, 2022:

Revenues

$

17,494,816

$

7,323,125

$

(249,686)

$

24,568,255

Gross Profit

 

4,722,075

 

384,420

 

 

5,106,495

Adjusted EBITDA(*)

 

392,633

 

113,272

 

 

505,905

February 27, 2021:

 

  

 

  

 

  

 

  

Revenues

$

16,365,260

$

7,970,137

$

(292,157)

$

24,043,240

Gross Profit

 

4,255,791

 

448,531

 

 

4,704,322

Adjusted EBITDA(*)

 

279,896

 

157,769

 

 

437,665

(1)Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.

(*)

See the section entitled “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” below for additional details.

39

Retail Pharmacy Segment Results of Continuing Operations

Revenues and Other Operating Data

Year Ended

 

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

(Dollars in thousands)

 

Revenues

$

17,785,067

$

17,494,816

$

16,365,260

Revenue growth

 

1.7

%  

 

6.9

%  

 

4.8

%

Same store sales growth

 

6.9

%  

 

4.5

%  

 

3.5

%

Pharmacy sales growth

 

3.5

%  

 

12.0

%  

 

4.8

%

Same store prescription count growth, adjusted to 30-day equivalents

 

3.5

%  

 

8.7

%  

 

1.3

%

Same store pharmacy sales growth

 

9.1

%  

 

7.9

%  

 

3.2

%

Pharmacy sales as a % of total retail sales

 

71.2

%  

 

70.0

%  

 

66.7

%

Front-end sales (decline) growth

 

(2.7)

%  

 

(1.3)

%  

 

3.3

%

Same store front-end sales growth (decline)

 

1.1

%  

 

(3.3)

%  

 

3.1

%

Front-end sales as a % of total retail sales

 

28.8

%  

 

30.0

%  

 

33.3

%

Adjusted EBITDA(*)

$

288,077

$

392,633

$

279,896

Store data:

 

  

 

  

 

  

Total stores (beginning of period)

 

2,450

 

2,510

 

2,461

New stores

 

3

 

2

 

Store acquisitions

 

 

1

 

67

Closed stores

 

(144)

 

(63)

 

(18)

Total stores (end of period)

 

2,309

 

2,450

 

2,510

Relocated stores

 

2

 

 

3

Remodeled and expanded stores

 

22

 

9

 

7

(*)

See the section entitled “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” below for additional details.

Revenues

Fiscal 2023 compared to Fiscal 2022: The 1.7% increase in revenue was due primarily to an extra week in the fourth quarter of fiscal 2023 and an increase in both acute and maintenance prescriptions, partially offset by a reduction in COVID-19 vaccine and testing revenue as well as store closures. Same store sales trends for fiscal 2023 and fiscal 2022 are described in the following paragraphs. We include in same store sales all stores that have been open at least one year except stores in liquidation, which are not included. Relocation stores are not included in same store sales until they have been open for one year.

Pharmacy same store sales increased 9.1%. Pharmacy same store sales were positively impacted by an increase of 3.5% in same store prescription count, adjusted to 30-day equivalents, compared to the prior year driven primarily by an increase in same store prescriptions, excluding COVID immunizations and tests, of 6.9%, with same store maintenance prescriptions increasing 5.9% and other same store acute prescriptions increasing 10.1%.

Front-end same store sales increased 1.1%. Front-end same stores sales, excluding cigarettes and tobacco products, increased 1.6% driven by increases in health and consumable products, partially offset by decreases in alcohol sales.

40

Costs and Expenses

Year Ended

 

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

(Dollars in thousands)

 

Cost of revenues

$

13,390,217

    

$

12,772,741

    

$

12,109,469

Gross profit

 

4,394,850

 

4,722,075

 

4,255,791

Gross margin

 

24.7

%  

 

27.0

%  

 

26.0

%

FIFO gross profit(*)

 

4,447,878

 

4,723,389

 

4,204,099

FIFO gross margin(*)

 

25.0

%  

 

27.0

%  

 

25.7

%

Selling, general and administrative expenses

$

4,544,217

$

4,656,776

$

4,299,152

Selling, general and administrative expenses as a percentage of revenues

 

25.6

%  

 

26.6

%  

 

26.3

%

(*)

See the section entitled “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” below for additional details.

Gross Profit and Cost of Revenues

Gross profit decreased by $327.2 million in fiscal 2023 compared to fiscal 2022. The decrease in gross profit was driven by the decline in COVID vaccinations and testing, partially offset by the increase in prescriptions sold.

Overall gross margin was 24.7% for fiscal 2023 compared to 27.0% in fiscal 2022. The decline in gross margin as a percentage of revenues is due primarily to the reductions in COVID vaccinations and testing.

We use the LIFO method of inventory valuation, which is determined annually when inflation rates and inventory levels are finalized. Therefore, LIFO costs for interim period financial statements are estimated. The LIFO charge for fiscal 2023 was $53.0 million compared to a LIFO charge of $1.3 million in fiscal 2022. The LIFO charge for fiscal 2023 is due to higher front-end inflation in the current year.

Selling, General and Administrative Expenses

SG&A decreased $112.6 million due primarily to lower payroll, occupancy, and other operating costs due to store closures and cost control initiatives, partially offset by an extra week. SG&A as a percentage of revenue was 25.6% in fiscal 2023 compared to 26.6% in fiscal 2022. The decrease is due primarily to the items noted above.

Pharmacy Services Segment Results of Operations

Revenues and Other Operating Data

Year Ended

 

    

March 4,

    

February 26,

    

February 27,

 

2023

2022

2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

(Dollars in thousands)

 

Revenues

$

6,522,299

$

7,323,125

$

7,970,137

Revenue (decline) growth

 

(10.9)

%  

 

(8.1)

%  

 

21.5

%  

Adjusted EBITDA(*)

$

141,103

$

113,272

$

157,769

(*)

See the section entitled “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” below for additional details.

41

Revenues

Pharmacy Services Segment revenues decreased $800.8 million in fiscal 2023 compared to fiscal 2022. Approximately $198.0 million of the decline was primarily the result of a decrease in Elixir Individual Part D Insurance membership due to a change in the Company’s pricing structure and approximately $166.0 million of the decline was due to a loss of a large commercial client. The remaining decline was driven by the loss of revenue from smaller commercial clients, partially offset by increased utilization and higher cost drugs.

The Inflation Reduction Act of 2022 contains several provisions affecting Medicare, which will take effect over various periods of time from 2023 to 2029. Based on our current analysis of the provisions, we do not believe that this legislation will have a material impact on our financial statements.

Costs and Expenses

Year Ended

 

    

March 4,

    

February 26,

    

February 27,

 

2023

2022

2021

 

(53 Weeks)

(52 Weeks)

(52 Weeks)

 

(Dollars in thousands)

 

Cost of revenues

$

6,113,209

$

6,938,705

$

7,521,606

Gross profit

 

409,090

 

384,420

 

448,531

Gross margin

 

6.3

%  

 

5.2

%  

 

5.6

%

Selling, general and administrative expenses

$

357,870

$

377,100

$

358,033

Selling, general and administrative expenses as a percentage of revenues

 

5.5

%  

 

5.1

%  

 

4.5

%

Gross Profit and Cost of Revenues

Gross profit increased by $24.7 million in fiscal 2023 compared to fiscal 2022. The increase in gross profit was due primarily to improved procurement economics, partially offset by the decline in revenues as mentioned above.

Gross margin was 6.3% in fiscal 2023 compared to 5.2% in fiscal 2022. The increase in gross margin is due primarily to improved procurement economics and change in client mix.

Selling, General and Administrative Expenses

Pharmacy Services Segment selling, general and administrative expenses decreased $19.2 million in fiscal 2023 compared to fiscal 2022. SG&A expenses as a percentage of revenues was 5.5% in fiscal 2023 compared to 5.1% in fiscal 2022. The decrease in SG&A is due primarily to further consolidation of administrative functions. The increase in SG&A as a percentage of revenues is due primarily to the loss of sales volume.

Liquidity and Capital Resources

General

We have two primary sources of liquidity: (i) cash provided by operating activities and (ii) borrowings under our Existing Facilities. Our principal uses of cash are to provide working capital for operations, to service our obligations to pay interest and principal on debt and to fund capital expenditures. Total liquidity as of March 4, 2023 was $1,484.8 million, which consisted of revolver borrowing capacity of $1,404.0 million and invested cash of $80.8 million.

Credit Facilities

On December 20, 2018, we entered into a senior secured credit agreement (as amended by the First Amendment to Credit Agreement, dated as of January 6, 2020, the “Prior Credit Agreement”; and the Credit Agreement, as further amended by the Second Amendment (as defined below), the “Prior Amended Credit Agreement”), which provided for

42

facilities consisting of a $2.7 billion senior secured asset-based revolving credit facility and a $450.0 million “first-in, last out” senior secured term loan facility, the proceeds of which were used in December 2018 to refinance our prior $2.7 billion existing credit agreement.

On August 20, 2021, we entered into the Second Amendment to Credit Agreement (the “Second Amendment”), which, among other things, amended the Prior Credit Agreement to provide for a $2.8 billion senior secured asset-based revolving credit facility (the “Prior Senior Secured Revolving Credit Facility”) and a $350.0 million “first-in, last-out” senior secured term loan facility (“Prior Senior Secured Term Loan” and together with the Prior Senior Secured Revolving Credit Facility, collectively, the “Prior Amended Facilities”). The Prior Amended Facilities extended our debt maturity profile and provided additional liquidity. Borrowings under the Prior Senior Secured Revolving Credit Facility bore interest at a rate per annum equal to, at our option, (x) a base rate (determined in a customary manner) plus a margin of between 0.25% to 0.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of between 1.25% and 1.75%, in each case based upon the Average ABL Availability (as defined in the Prior Amended Credit Agreement).  Borrowings under the Prior Senior Secured Term Loan bore interest at a rate per annum equal to, at our option, (x) a base rate (determined in a customary manner) plus a margin of 1.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of 2.75%.

On December 1, 2022, we entered into the Third Amendment to Credit Agreement (the “Third Amendment”), which, among other things, amended the Prior Amended Credit Agreement (the Prior Amended Credit Agreement, as modified by the Third Amendment, the “Existing Credit Agreement”) to provide for a $2.85 billion senior secured asset-based revolving credit facility (the “Existing Senior Secured Revolving Credit Facility”) and a $400.0 million “first-in, last-out” senior secured term loan facility (the “Existing Senior Secured Term Loan” and, together with the Existing Senior Secured Revolving Credit Facility, collectively, the “Existing Facilities”), replaced the LIBOR rate with a Term SOFR-based rate as the applicable benchmark for the Existing Facilities, included COVID-19 vaccines in the borrowing base under the Existing Senior Secured Revolving Credit Facility, subject to limitations and conditions as specified in the Existing Credit Agreement, and increased the interest rate applicable to loans under the Existing Senior Secured Term Loan to (x) a base rate (determined in a customary manner) plus a margin of 2.00% or (y) an adjusted Term SOFR-based rate (determined in a customary manner) plus a margin of 3.00%.

We are required to pay fees between 0.250% and 0.375% per annum on the daily unused amount of the commitments under the Existing Senior Secured Revolving Credit Facility, depending on Average ABL Availability (as defined in the Existing Credit Agreement). The Existing Facilities are scheduled to mature on August 20, 2026 (subject to a springing maturity if certain of our existing secured notes are not refinanced or repaid prior to the date that is 91 days prior to the stated maturity thereof).

Our borrowing capacity under the Existing Senior Secured Revolving Credit Facility is based upon a specified borrowing base consisting of accounts receivable, inventory and prescription files. As of March 4, 2023, we had approximately $1,600.0 million of borrowings outstanding under the Existing Facilities and had letters of credit outstanding under the Existing Senior Secured Revolving Credit Facility in a face amount of approximately $208.7 million, which resulted in remaining borrowing capacity under the Existing Senior Secured Revolving Credit Facility of $1,404.0 million. If at any time the total credit exposure outstanding under the Existing Senior Secured Revolving Credit Facility exceeds the borrowing base, we will be required to repay amounts outstanding to eliminate such shortfall.

The Existing Credit Agreement restricts us and all of our subsidiaries, including the subsidiaries that guarantee our obligations under the Existing Facilities, the secured guaranteed notes and unsecured notes (collectively, the “Subsidiary Guarantors”) from accumulating cash on hand in excess of $200.0 million at any time when revolving loans are outstanding (not including cash located in store and lockbox deposit accounts and cash necessary to cover our current liabilities). The Existing Credit Agreement also states that if at any time (other than following the exercise of remedies or acceleration of any senior obligations or second priority debt and receipt of a triggering notice by the senior collateral agent from a representative of the senior obligations or the second priority debt) either (i) an event of default exists under the Existing Facilities or (ii) availability under the Existing Senior Secured Revolving Credit Facility is less than or equal to $283.3 million for three consecutive business days or less than or equal to $206.0 million on any day (a “cash sweep period”), the funds in our deposit accounts will be swept to a concentration account with the senior collateral

43

agent and will be applied first to repay outstanding revolving loans under the Existing Facilities, and then held as collateral for the senior obligations until such cash sweep period is rescinded pursuant to the terms of the Existing Facilities.

Our obligations under the Existing Facilities and the Subsidiary Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on all of the Subsidiary Guarantors’ cash and cash equivalents, accounts receivable, inventory, prescription files (including eligible script lists), intellectual property (prior to the repayment of the Existing Senior Secured Term Loan) and certain other assets arising therefrom or related thereto (including substantially all of their deposit accounts, collectively, the “ABL priority collateral”) and (ii) a second-priority lien on all of the Subsidiary Guarantors’ equipment, fixtures, investment property (other than equity interests in subsidiaries), intellectual property (following the repayment of the Existing Senior Secured Term Loan) and all other assets that do not constitute ABL priority collateral, in each case, subject to customary exceptions and limitations.

The Existing Credit Agreement allows us to have outstanding, at any time, up to an aggregate principal amount of $1.5 billion in secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock in addition to borrowings under the Existing Facilities and existing indebtedness; provided that not in excess of $750.0 million of such secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock shall mature or require scheduled payments of principal prior to 90 days after the latest maturity date of any Term Loan or Other Revolving Commitment (each as defined in the Existing Credit Agreement) (excluding bridge facilities allowing extensions on customary terms to at least the date that is 90 days after such date). Subject to the limitations described in the immediately preceding sentence, the Existing Credit Agreement additionally allows us to issue or incur an unlimited amount of unsecured debt and disqualified preferred stock so long as a Financial Covenant Effectiveness Period (as defined in the Existing Credit Agreement) is not in effect; provided, however, that certain of our other outstanding indebtedness limits the amount of unsecured debt that can be incurred if certain interest coverage levels are not met at the time of incurrence or other exemptions are not available. The Existing Credit Agreement also contains certain restrictions on the amount of secured first priority debt we are able to incur. The Existing Credit Agreement also allows for the voluntary repurchase of any debt or other convertible debt, so long as the Existing Facilities are not in default and we maintain availability under the Existing Senior Secured Revolving Credit Facility of more than $375.95 million.

The Existing Credit Agreement has a financial covenant that requires us to maintain a minimum fixed charge coverage ratio of 1.00 to 1.00 (i) on any date on which availability under the Existing Senior Secured Revolving Credit Facility is less than $206.0 million or (ii) on the third consecutive business day on which availability under the Existing Senior Secured Revolving Credit Facility is less than $257.5 million and, in each case, ending on and excluding the first day thereafter, if any, which is the 30th consecutive calendar day on which availability under the revolver is equal to or greater than $257.5 million. As of March 4, 2023, the availability under the Existing Senior Secured Revolving Credit Facility was at a level that did not trigger the Existing Credit Agreement’s financial covenant. The Existing Credit Agreement also contains covenants which place restrictions on the incurrence of debt, the payments of dividends, the making of investments, sale of assets, mergers and acquisitions and the granting of liens.

The Existing Credit Agreement provides for customary events of default including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if we fail to make any required payment on debt having a principal amount in excess of $50.0 million or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity or require the repayment, repurchase, redemption or defeasance of such debt.

The indentures that govern our secured notes contain restrictions on the amount of additional secured and unsecured debt that we may incur. As of March 4, 2023, we had the ability to issue additional secured and unsecured debt under the indentures governing our secured notes, including the ability to draw the full amount of our Existing Senior Secured Revolving Credit Facility and enter into certain sale and leaseback transactions. We also have certain limitations in our unguaranteed unsecured notes on the amount of secured debt that we may incur. We have additional debt incurrence capacity under such indentures.

44

Fiscal 2021, 2022 and 2023 Transactions

On June 25, 2020, we commenced an offer to exchange (the “June 25, 2020 Exchange Offer”) up to $750.0 million aggregate principal amount of the outstanding 6.125% Senior Notes due 2023 (the “6.125% Notes”) for a combination of $600.0 million newly issued 8.0% Senior Secured Notes due 2026 (the “8.0% Notes”) and $145.5 million cash. On July 10, 2020, we increased the maximum amount of 6.125% Notes that may be accepted for exchange from $750.0 million to $1,125.0 million and, on July 24, 2020, we announced that we accepted for payment $1,062.7 million aggregate principal amount of the 6.125% Notes in exchange for $849.9 million aggregate principal amount of newly issued 8.0% Notes and $206.4 million in cash. In connection therewith, we recorded a gain on debt modification of $5.3 million which is included in the results of operations and cash flows of continuing operations. The 8.0% Notes are secured on an equal and ratable basis by the same assets that secure the 7.500% Notes. The 8.0% Notes are guaranteed on a senior secured basis by the same subsidiaries that guarantee the 7.500% Notes. In conjunction with the June 25, 2020 Exchange Offer, we also commenced a solicitation of consents from the holders of outstanding 6.125% Notes to certain proposed amendments to the indenture governing the 6.125% Notes. On July 9, 2020, following the receipt of the requisite number of consents, we entered into a supplemental indenture, which modified certain limitations in the debt covenant to allow for the creation of the 8.0% Notes.

On April 28, 2021, we issued a notice of redemption for all of the 6.125% Notes that were outstanding on May 28, 2021, pursuant to the terms of the indenture of the 6.125% Notes. On May 28, 2021, we redeemed 100% of the remaining outstanding 6.125% Notes at par. In connection therewith, we recorded a loss on debt retirement of $0.4 million which included unamortized debt issuance costs. The debt repayment and related loss on debt retirement is included in the results of operations and cash flows.

On August 20, 2021, we entered into the Second Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Prior Senior Secured Revolving Credit Facility from $2.7 billion to $2.8 billion and decrease the aggregate principal amount of loans outstanding under the Prior Senior Secured Term Loan from $450.0 million to $350.0 million. In connection therewith, we recorded a loss on debt modification and retirement of $2.8 million which included unamortized debt issuance costs. The debt repayment and related loss on debt modification and retirement is included in the results of operations and cash flows.

On June 13, 2022, we commenced a series of cash tender offers to purchase up to $150.0 million aggregate principal amount of our 7.500% Senior Secured Notes due 2025 (the “7.500% Notes”), 8.0% Notes, 7.70% Notes due 2027 (the “7.70% Notes”) and 6.875% Notes due 2028 (the “6.875% Notes”), subject to prioritized acceptance levels, a subcap of $100.0 million with respect to the 7.500% Notes and proration. On June 29, 2022, pursuant to an early settlement, we purchased an aggregate principal amount of $114.9 million of our 7.500% Notes, $51.7 million aggregate principal amount of our 7.70% Notes and $27.0 million aggregate principal amount of our 6.875% Notes. In connection therewith, we recorded a gain on debt retirement of $41.3 million, which included unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On November 3, 2022, we announced the commencement of a cash tender offer to purchase up to $200.0 million aggregate purchase price (not including any accrued and unpaid interest) of our 7.500% Notes, subject to proration. On November 30, 2022, pursuant to an early settlement, we purchased an aggregate principal amount of $160.5 million of our 7.500% Notes and on December 9, 2022, pursuant to the final settlement, we purchased an additional aggregate principal amount of $4.6 million of our 7.500% Notes. In connection therewith, we recorded a gain on debt retirement of $38.9 million, which includes unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On December 1, 2022, we entered into the Third Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Existing Senior Secured Revolving Credit Facility from $2.8 billion to $2.85 billion and increase the aggregate principal amount of loans outstanding under the Existing Senior Secured Term Loan from $350.0 million to $400.0 million. As a result of the Third Amendment, we have increased our liquidity by $100.0 million. In connection therewith, we recorded a loss on debt modification and retirement of $0.1 million, which includes unamortized debt issuance costs. The related loss on debt modification and retirement is included in the results of operations and cash flows.

45

Guarantor Summarized Financial Information

Certain of our subsidiaries, which are listed on Exhibit 22 to this Annual Report on Form 10-K, have guaranteed our obligations under the 7.500% Notes and the 8.00% Notes (collectively, the "Guaranteed Notes"). As discussed in Note 16 to the consolidated financial statements, the Guaranteed Notes were issued by us, as the parent company, and are guaranteed by substantially all of the parent company’s consolidated subsidiaries (the “guarantors” or “Subsidiary Guarantors”) except for EI (the “non-guarantor”). The parent company and guarantors are referred to as the “obligor group.” The Subsidiary Guarantors fully and unconditionally and jointly and severally guarantee the Guaranteed Notes. The 7.500% Notes, the 8.00% Notes and the obligations under the related guarantees are secured by (i) a first-priority lien on all of the Subsidiary Guarantors’ equipment, fixtures, investment property (other than equity interests in subsidiaries), intellectual property (following the repayment of the Existing Senior Secured Term Loan) and other collateral to the extent it does not constitute ABL priority collateral (as defined below), and (ii) a second-priority lien on all of the Subsidiary Guarantors’ cash and cash equivalents, accounts receivables, payment intangibles, inventory, prescription files (including eligible script lists) and, intellectual property (prior to the repayment of the Existing Senior Secured Term Loan) (collectively, the “ABL priority collateral”), which, in each case, also secure the Existing Facilities.

Under certain circumstances, subsidiaries may be released from their guarantees without consent of the note holders. Our subsidiaries conduct substantially all of our operations and have significant liabilities, including trade payables. If the subsidiary guarantees are invalid or unenforceable or are limited by fraudulent conveyance or other laws, the registered debt will be structurally subordinated to the substantial liabilities of our subsidiaries.

Condensed Combined Financial Information

The following tables include summarized financial information of the obligor group. Investments in and the equity in the earnings of EI, which is not a member of the obligor group, have been excluded. The summarized financial information of the obligor group is presented on a combined basis with intercompany balances and transactions between entities in the obligor group eliminated. The obligor group’s amounts due to/from and transactions with EI have been presented in separate line items, if material.

March 4,

    

February 26,

In millions

2023

2022

Due from EI

$

18.0

$

26.5

Other current assets

3,184.5

3,314.9

Total current assets

$

3,202.5

$

3,341.4

Operating lease right-of-use assets

$

2,497.2

$

2,813.5

Goodwill

507.9

879.1

Other noncurrent assets

1,256.0

1,428.8

Total noncurrent assets

$

4,261.1

$

5,121.4

Due to EI

$

$

Other current liabilities

 

2,657.5

 

2,887.0

Total current liabilities

$

2,657.5

$

2,887.0

Long-term debt less current maturities

$

2,925.3

$

2,733.0

Long-term operating lease liabilities

2,372.9

2,597.1

Other noncurrent liabilities

102.2

129.9

Total noncurrent liabilities

$

5,400.4

$

5,460.0

46

    

Year Ended

    

March 4, 2023

In millions

(53 Weeks)

Revenues(a)

$

23,569.5

Cost of revenues(b)

 

18,765.6

Gross profit

 

4,803.9

Net loss from continuing operations

 

(696.3)

Net income from discontinued operations

 

Net loss

$

(696.3)

Net loss attributable to Rite Aid

$

(719.2)

(a)Includes $6.6 million of revenues generated from the non-guarantor for the fifty-three week period ended March 4, 2023.
(b)Includes $6.4 million of cost of revenues incurred in transactions with the non-guarantor for the fifty-three week period ended March 4, 2023.

Off-Balance Sheet Arrangements

As of March 4, 2023, we had no material off balance sheet arrangements.

Contractual Obligations and Commitments

The following table details the maturities of our indebtedness and lease financing obligations as of March 4, 2023, as well as other contractual cash obligations and commitments.

Payment due by period

    

Less Than 1 Year

    

1 to 3 Years

    

3 to 5 Years

    

After 5 Years

    

Total

(Dollars in thousands)

Contractual Cash Obligations

Long-term debt(1)

$

212,664

$

627,099

$

2,730,152

$

2,187

$

3,572,102

Lease financing obligations(2)

 

3,188

 

10,153

 

3,067

 

10,923

 

27,331

Operating leases

 

677,631

 

1,101,245

 

778,445

 

1,148,719

 

3,706,040

Open purchase orders

 

305,531

 

 

 

 

305,531

Other, primarily self-insurance and retirement plan obligations(3)

 

56,628

 

43,299

 

9,653

 

30,803

 

140,383

Minimum purchase commitments(4)

 

68,537

 

202,195

 

20,486

 

 

291,218

Total contractual cash obligations

$

1,324,179

$

1,983,991

$

3,541,803

$

1,192,632

$

8,042,605

Payment due by period

    

Less Than 1 Year

    

1 to 3 Years

    

3 to 5 Years

    

After 5 Years

    

Total

Commitments

 

  

 

  

 

  

 

  

 

  

Lease guarantees(5)

$

674

$

494

$

247

$

456

$

1,871

Lease guarantees(6)

 

162,041

 

258,591

 

170,799

 

146,490

 

737,921

Outstanding letters of credit

 

208,698

 

 

 

 

208,698

Total contractual cash obligations and commitments

$

1,695,592

$

2,243,076

$

3,712,849

$

1,339,578

$

8,991,095

(1)Includes principal and interest payments for all outstanding debt instruments. Interest was calculated on variable rate instruments using rates as of March 4, 2023.
(2)Represents the minimum lease payments on non-cancelable leases, including interest, net of sublease income on a continuing operations basis as the minimum lease payments on non-cancelable leases, including interest, net of sublease income have been assumed by WBA as part of the Sale.

47

(3)Includes the undiscounted payments for self-insured medical coverage, actuarially determined undiscounted payments for self-insured workers’ compensation and general liability, and actuarially determined obligations for defined benefit pension and nonqualified executive retirement plans.
(4)Represents commitments to purchase products and licensing fees from certain vendors.
(5)Represents lease guarantee obligations for 3 former stores related to certain business dispositions. The respective purchasers assume the obligations and are, therefore, primarily liable for these obligations.
(6)Represents lease guarantee obligations for 676 former stores related to the Asset Sale. WBA assumed the obligations and are, therefore, primarily liable for these obligations.

Obligations for income tax uncertainties pursuant to ASC 740, “Income Taxes” of approximately $1.5 million are not included in the table above as we are uncertain as to if or when such amounts may be settled.

Net Cash (Used In) Provided By Operating, Investing and Financing Activities from Continuing Operations

Cash flow used in operating activities was $52.4 million in fiscal 2023. Operating cash flow was impacted by lower payroll, benefit and other operating expense related accruals, the timing of warehouse payables and the timing of payments to Elixir’s pharmacy network. These amounts were partially offset by lower manufacturer rebates receivables and lower third-party receivables.

Cash flow provided by operating activities was $379.3 million in fiscal 2022. Operating cash flow was positively impacted by the timing of warehouse payables, the timing of payments to Elixir’s pharmacy network, increased payroll, litigation and other operating expense related accruals and a reduction of manufacturer rebates receivables. These amounts were partially offset by increases in pharmacy inventory and the payment of $51.0 million of employer payroll taxes that were previously deferred under the CARES Act.

Cash used in investing activities was $104.8 million in fiscal 2023. Cash used in investing activities includes purchases of property, plant and equipment of $215.3 million and prescription file buys of $32.4 million, partially offset by proceeds from sale-leaseback transactions and proceeds from the sale of assets and investments.

Cash used in investing activities was $134.1 million in fiscal 2022. Cash used in investing activities includes purchases of property, plant and equipment of $194.1 million and prescription file buys of $26.6 million, partially offset by proceeds from sale-leaseback transactions, insurance proceeds and proceeds from the sale of assets and investments.

Cash provided by financing activities was $274.6 million in fiscal 2023. Cash provided by financing activities reflects incremental borrowings on the Existing Senior Secured Revolving Credit Facility and Existing Senior Secured Term Loan, partially offset by the repayment of a portion of the 7.5% Notes, 7.7% Notes, and 6.875% Notes.

Cash used in financing activities was $366.4 million in fiscal 2022. Cash used by financing activities reflects the repayment of our 6.125% Notes and the amendment and extension of our Prior Senior Secured Revolving Credit Facility and Prior Senior Secured Term Loan.

48

Capital Expenditures

During the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 capital expenditures were as follows:

Year Ended

    

March 4,

    

February 26,

    

February 27,

2023

2022

2021

(53 weeks)

(52 weeks)

(52 weeks)

(Dollars in thousands)

New store construction, store relocation and store remodel projects

$

44,338

$

79,903

$

97,662

Technology enhancements, improvements to distribution centers and other corporate requirements

 

170,947

 

114,187

 

97,479

Purchase of prescription files from other retail pharmacies

 

32,400

 

26,623

 

29,800

Total capital expenditures

$

247,685

$

220,713

$

224,941

Future Liquidity

We are highly leveraged. Our high level of indebtedness could: (i) limit our ability to obtain additional financing; (ii) limit our flexibility in planning for, or reacting to, changes in our business and the industry; (iii) place us at a competitive disadvantage relative to our competitors with less debt; (iv) render us more vulnerable to general adverse economic and industry conditions, including those resulting from COVID-19; a decline in the overall economy, and the current rising interest rate environment, and (v) require us to dedicate a substantial portion of our cash flow to service our debt. Additionally, we currently expect continued pressure on consumer spending and supply chain challenges. Based upon our current levels of operations, we believe that cash flow from operations together with available borrowings under the revolver and other sources of liquidity will be adequate to meet our requirements for working capital, debt service, capital expenditures and other strategic investments at least for the next twelve months. Based on our liquidity position, which we expect to remain strong, we do not expect to be subject to the minimum fixed charge covenant in the Amended Facilities in the next twelve months. We will continue to assess our liquidity position and potential sources of supplemental liquidity in light of our operating performance, and other relevant circumstances, and we may evaluate alternative sources of liquidity (particularly in light of the current market volatility), including further opportunities related to any receivable due to us from CMS, sale and leaseback transactions, and other transactions to optimize our asset base. From time to time, we may seek additional deleveraging or refinancing transactions, including entering into transactions to exchange debt for shares of common stock or other debt securities (including additional secured debt), issuance of equity (including preferred stock and convertible securities), repurchase or redemption of outstanding indebtedness, including our recent cash tender offers whereby we purchased an aggregate principal amount of $193.6 million of certain of our outstanding series of senior notes as announced on June 13, 2022 and an aggregate principal amount of $165.1 million of our outstanding 7.500% Senior Secured Notes due 2025 as announced on November 3, 2022, or seek to refinance our outstanding debt or may otherwise seek transactions to reduce interest expense and extend debt maturities. We may also look to make additional investments in our business to further our strategic objectives, including targeted acquisitions, the performance acceleration program, technology investments or other transactions to optimize our asset base. Any of these transactions could impact our financial results, including additional changes or realization of cancellation of indebtedness-income. As a result of the current market volatility and rising interest rate environment, we cannot assure you whether any of such transactions will be consummated, whether we will achieve the benefits of any such transaction, or whether our cost of capital will increase, any of which could have an impact on our future liquidity.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to inventory shrink, goodwill impairment, impairment of long-lived assets, revenue recognition, vendor discounts and purchase discounts,

49

self-insurance liabilities, lease termination charges, income taxes and litigation. Additionally, we have critical accounting policies regarding revenue recognition and vendor allowances and purchase discounts for our Pharmacy Services Segment. We base our estimates on historical experience, current and anticipated business conditions, the condition of the financial markets and various other assumptions that are believed to be reasonable under existing conditions. Variability reflected in the sensitivity analyses presented below is based on our recent historical experience. Actual results may differ materially from these estimates and sensitivity analyses.

The following critical accounting policies require the use of significant judgments and estimates by management:

Inventory shrink: The carrying value of our inventory is reduced by a reserve for estimated shrink losses that occur between physical inventory dates. When estimating these losses, we consider historical loss results at specific locations. Shrink expense is recognized by applying the estimated shrink rate to sales since the last physical inventory. Although possible, we do not expect a significant change to our shrink rate in future periods. A 10 basis point difference in our estimated shrink rate for the year ended March 4, 2023, would have affected pre-tax income by approximately $12.7 million.

Goodwill Impairment: Our policy is to perform an impairment test of goodwill at least annually, and more frequently if events or circumstances occurred that would indicate a reduced fair value in our reporting units could exist. In our quantitative impairment test, fair value estimates are calculated using an average of the income and market approaches. The income approach is based on the present value of future cash flows of each reporting unit, while the market approach is based on certain multiples of selected guideline public companies or selected guideline transactions. The approaches incorporate a number of market participant assumptions including future growth rates, discount rates, income tax rates and market activity in assessing fair value and are reporting unit specific. If the carrying amount exceeds the reporting unit’s fair value, we recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. In addition, we consider the income tax effect of any tax deductible goodwill when measuring a goodwill impairment loss. Our Pharmacy Services reporting unit has goodwill of $464.4 million as of March 4, 2023 and the fair value of the reporting unit is equal to the carrying value. The goodwill related to our Pharmacy Services Segment is at risk of future impairment if the fair value of this segment, and its associated assets, decrease in value due to further declines in its operating results or an inability to execute management’s business strategies. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from our estimates. If our ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, we may have to record impairment charges in future periods.

Impairment of long-lived assets: We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that an asset group has a carrying value that may not be recoverable. The individual operating store is the lowest level for which cash flows are identifiable. As such, we evaluate individual stores for recoverability. To determine if a store needs to be tested for recoverability, we consider items such as decreases in market prices, changes in the manner in which the store is being used or physical condition, changes in legal factors or business climate, an accumulation of losses significantly in excess of budget, a current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection of continuing losses, or an expectation that the store will be closed or sold.

We monitor new and recently relocated stores against operational projections and other strategic factors such as regional economics, new competitive entries and other local market considerations to determine if an impairment evaluation is required. For other stores, we perform a recoverability analysis if they have experienced current-period and historical cash flow losses.

In performing the recoverability test, we compare the expected future cash flows of a store to the carrying amount of its assets. Significant judgment is used to estimate future cash flows. Major assumptions that contribute to our future cash flow projections include: expected sales and gross profit, pharmacy reimbursement rates, expected costs such as payroll, and estimates for other significant selling, general and administrative expenses.

50

If an operating store’s estimated future undiscounted cash flows are not sufficient to cover its carrying value, its carrying value is reduced to fair value which is its estimated future discounted cash flows. The discount rate is commensurate with the risks associated with the recovery of a similar asset. Beginning in fiscal year 2020, operating lease right-of-use assets are included within the stores’ asset groups. We obtain fair values of these right-of-use assets based on real estate market data.

We assess stores and distribution centers for potential closure. Impairment charges for closed stores, if any, are evaluated and recorded in the quarter the closure decision is approved.

We also evaluate assets to be disposed of on a quarterly basis to determine if an additional impairment charge is required. Fair value estimates are provided by independent brokers who operate in the local markets where the assets are located.

If our actual future cash flows differ from our projections materially, certain stores that are either not impaired or partially impaired in the current period may be further impaired in future periods. A 50 and 100 basis point decrease in our future sales assumptions as of March 4, 2023 would have resulted in 8 and 17, respectively, additional stores being subjected to our impairment analysis.

Revenue recognition for our loyalty program: We offered a chain-wide customer loyalty program, “wellness+ Rewards”. Members participating in our wellness+ Rewards loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, we granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.

A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.

Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue.

Self-insurance liabilities: We expense claims for self-insured workers’ compensation and general liability insurance coverage as incurred including an estimate for claims incurred but not paid. The expense for self-insured workers’ compensation and general liability claims incurred but not paid is determined using several factors, including historical claims experience and development, severity of claims, medical costs and the time needed to settle claims. We discount the estimated expense for workers’ compensation to present value as the time period from incurrence of the claim to final settlement can be several years. We base our estimates for such timing on previous settlement activity. The discount rate is based on the current market rates for Treasury bills that approximate the average time to settle the workers’ compensation claims. These assumptions are updated on an annual basis. A 25 basis point difference in the discount rate for the year ended March 4, 2023, would have affected pre-tax income by approximately $0.8 million.

51

Income taxes: We currently have net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate significant deferred tax assets. Realization is dependent on generating sufficient taxable income prior to the expiration of the loss carryforwards.

Our ability to utilize the losses and credits to offset future taxable income may be deferred or limited significantly if we were to experience an “ownership change” as defined in section 382 of the Code. In general, an ownership change will occur if there is a cumulative change in ownership of our stock by “5-percent shareholders” (as defined in the Code) that exceeds 50 percentage points over a rolling three-year period. We determined that no ownership change has occurred for purposes of Section 382 for the period ended March 4, 2023. It is important to note that the limitation that would be created upon an ownership change would only apply to income earned after the event that caused the ownership change.

We regularly review the deferred tax assets for recoverability considering the relative impact of negative and positive evidence including our historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. The weight given to the potential effect of the negative and positive evidence is commensurate with the extent to which it can be objectively verified. In evaluating the objective evidence that historical results provide, we consider three years of cumulative pre-tax book income (loss).

We establish a valuation allowance against deferred tax assets when we determine that it is more likely than not that some portion of our deferred tax assets will not be realized. Valuation allowances are based on evidence of our ability to generate sufficient taxable income by jurisdiction. On a quarterly basis, management evaluates the likelihood that we will realize the deferred tax assets and adjusts the valuation allowances, if appropriate. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would impact the provision for income taxes.

We recognize tax liabilities in accordance with ASC 740, “Income Taxes” and we adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the tax liabilities.

Litigation reserves: We are involved in litigation on an ongoing basis. We accrue our best estimate of the probable loss related to legal claims. Such estimates are based upon a combination of litigation and settlement strategies. These estimates are updated as the facts and circumstances of the cases develop and/or change. To the extent additional information arises or our strategies change, it is possible that our best estimate of the probable liability may also change. Changes to these reserves during the last three fiscal years were not material.

Revenue recognition for our Pharmacy Services segment:

The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and (ii) under retail pharmacy network contracts, where it is the principal, at contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, other sponsors of health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member copayments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:

Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services

52

Segment’s online claims processing system. At this point, we have performed across all of our performance obligations;
Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments, and;
Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member based fee, or a claims volume based fee.

In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.

Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.

For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized.

We deduct the manufacturers’ rebates that are earned by our clients based on their members’ utilization of brand-name formulary drugs from our revenues that are generated from prescription drugs sold by third-party pharmacies. For the majority of our clients, we pass these rebates to clients at point-of-sale based on actual claims data and our estimates of the manufacturers’ rebates earned by our clients. We base our estimates on the best available data and recent history for the various factors that can affect the amount of rebates earned by the client. We also deduct pricing guarantees and guarantees regarding the level of service we will provide to the client or member as well as other payments made to our clients from our revenues. Because the inputs to most of these estimates are not subject to a high degree of subjectivity or volatility, the effect of adjustments between estimated and actual amounts has not been material to our results of operations, financial condition or cash flows.

We participate in the federal government’s Medicare Part D program as a PDP through our EI subsidiary. Our net revenues include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS. The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, but is subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially deferred as accrued expenses and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.

We have recorded estimates of various assets and liabilities arising from our participation in the Medicare Part D program based on information in our claims management and enrollment systems. Significant estimates arising from our participation in the Medicare Part D program include: (i) estimates of low-income cost subsidy, reinsurance amounts and coverage gap discount amounts ultimately payable to or receivable from CMS based on a detailed claims reconciliation, (ii) an estimate of amounts receivable from CMS under a risk-sharing feature of the Medicare Part D program design, referred to as the risk corridor (iii) estimates for claims that have been reported and are in the process of

53

being paid or contested and (iv) our estimate of claims that have been incurred but have not yet been reported. Actual amounts of Medicare Part D-related assets and liabilities could differ significantly from amounts recorded. Historically, the effect of these adjustments has not been material to our results of operations, financial position or cash flows.

Vendor allowances and purchase discounts for our Pharmacy Services Segment: Our Pharmacy Services Segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized based on estimates when prescriptions are dispensed and are generally calculated and billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the results of operations, financial condition or cash flows. We account for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. During the thirteen-week period ended February 26, 2022, we reassessed our historical policy for estimating our allowance for manufacturer rebate receivables at our Pharmacy Services Segment and concluded that, due to changes in our business practices and other conditions, certain amounts within the outstanding receivable had an increased risk of uncollectability. As a result, we increased our allowance for manufacturer rebate receivables by $15.1 million, which was recorded as an increase to cost of revenues in the thirteen-week period ended February 26, 2022. This change in estimate is a non-recurring item that is excluded from Adjusted EBITDA (see “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non GAAP Measures” for details). The Pharmacy Services Segment also receives additional discounts under its wholesaler contract. In addition, the Pharmacy Services Segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.

Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures

In addition to net income (loss) determined in accordance with GAAP, we use certain non-GAAP measures, such as “Adjusted EBITDA”, in assessing our operating performance. We believe the non-GAAP measures serve as an appropriate measure in evaluating the performance of our business. We define Adjusted EBITDA as net income (loss) excluding the impact of income taxes, interest expense, depreciation and amortization, LIFO adjustments (which removes the entire impact of LIFO, and effectively reflects the results as if we were on a FIFO inventory basis), charges or credits for facility exit and impairment, goodwill and intangible asset impairment charges, inventory write-downs related to store closings, gains or losses on debt modifications and retirements, and other items (including stock-based compensation expense, merger and acquisition-related costs, non-recurring litigation and other contractual settlements, severance, restructuring-related costs, costs related to facility closures, gain or loss on sale of assets, the gain or loss on Bartell acquisition, and the change in estimate related to manufacturer rebate receivables). We reference this particular non-GAAP financial measure frequently in our decision-making because it provides supplemental information that facilitates internal comparisons to the historical periods and external comparisons to competitors. In addition, incentive compensation is primarily based on Adjusted EBITDA and we base certain of our forward-looking estimates on Adjusted EBITDA to facilitate quantification of planned business activities and enhance subsequent follow-up with comparisons of actual to planned Adjusted EBITDA.

We present these non-GAAP financial measures in order to provide transparency to our investors because they are measures that management uses to assess both management performance and the financial performance of our operations and to allocate resources. In addition, management believes that these measures may assist investors with understanding and evaluating our initiatives to drive improved financial performance and enables investors to supplementally compare our operating performance with the operating performance of our competitors including with those of our competitors having different capital structures. While we have excluded certain of these items from historical non-GAAP financial measures, there is no guarantee that the items excluded from non-GAAP financial measures will not continue into future periods. For instance, we expect to continue to experience charges for facility exit and impairment charges and inventory write-downs related to store closures as we continue to complete a multi-year

54

strategic initiative designed to improve overall performance. We also expect to continue to experience and report restructuring-related charges associated with continued execution of our strategic initiatives.

Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share or other non-GAAP measures should not be considered in isolation from, and are not intended to represent an alternative measure of, operating results or of cash flows from operating activities, as determined in accordance with GAAP. Our definition of these non-GAAP measures may not be comparable to similarly titled measurements reported by other companies, including companies in our industry.

The following is a reconciliation of our net loss to Adjusted EBITDA for fiscal 2023, 2022 and 2021:

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

(53 weeks)

(52 weeks)

(52 weeks)

(Dollars in thousands)

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Interest expense

 

224,399

 

191,601

 

201,388

Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Depreciation and amortization

 

276,583

 

295,686

 

327,124

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

(Gain) loss on debt modifications and retirements, net

 

(80,142)

 

3,235

 

(5,274)

Merger and Acquisition‑related costs

 

 

12,797

 

10,549

Stock-based compensation expense

 

11,537

 

13,050

 

13,003

Restructuring-related costs

 

108,626

 

35,121

 

84,552

Inventory write-downs related to store closings

 

14,270

 

5,298

 

3,709

Litigation and other contractual settlements

 

53,882

 

50,212

 

(Gain) loss on sale of assets, net

 

(68,586)

 

5,505

 

(69,300)

Loss (gain) on Bartell acquisition

 

 

5,346

 

(47,705)

Change in estimate related to manufacturer rebate receivables

15,068

Other

 

9,401

 

4,740

 

3,283

Adjusted EBITDA

$

429,180

$

505,905

$

437,665

55

The following is a reconciliation of our net loss from continuing operations to Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Diluted Share for fiscal 2023, 2022 and 2021. Adjusted Net Income (Loss) is defined as net income (loss) excluding the impact of amortization expense, merger and acquisition-related costs, non-recurring litigation and other contractual settlements, gains or losses on debt modifications and retirements, LIFO adjustments (which removes the entire impact of LIFO, and effectively reflects the results as if we were on a FIFO inventory basis), goodwill and intangible asset impairment charges, restructuring-related costs, the gain or loss on Bartell acquisition, and the change in estimate related to manufacturer rebate receivables. We calculate Adjusted Net Income (Loss) per Diluted Share using our above-referenced definition of Adjusted Net Income (Loss). We believe Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Diluted Share are useful indicators of our operating performance over multiple periods. Adjusted Net Income (Loss) per Diluted Share is calculated using our above-referenced definition of Adjusted Net Income (Loss):

    

March 4, 2023

    

February 26, 2022

    

February 27, 2021

(53 weeks)

(52 weeks)

(52 weeks)

(Dollars in thousands)

Net loss

$

(719,188)

    

$

(522,372)

    

$

(99,381)

Add back - Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Loss before income taxes

 

(725,655)

 

(526,152)

 

(119,538)

Adjustments:

 

  

 

  

 

  

Amortization expense

 

74,024

 

78,047

 

89,020

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

(Gain) loss on debt modifications and retirements, net

 

(80,142)

 

3,235

 

(5,274)

Merger and Acquisition‑related costs

 

 

12,797

 

10,549

Restructuring-related costs

 

108,626

 

35,121

 

84,552

Loss (gain) on Bartell acquisition

 

 

5,346

 

(47,705)

Change in estimate related to manufacturer rebate receivables

15,068

Litigation and other contractual settlements

 

53,882

 

50,212

 

Adjusted loss before income taxes

 

(145,037)

 

(96,012)

 

(10,236)

Adjusted income tax benefit (a)

 

(1,293)

 

(690)

 

(1,726)

Adjusted net loss

 

(143,744)

$

(95,322)

$

(8,510)

Net loss per diluted share

$

(13.15)

$

(9.66)

$

(1.86)

Adjusted net loss per diluted share

$

(2.63)

$

(1.76)

$

(0.16)

(a)The fiscal year 2023, 2022 and 2021 adjustments to the income tax provision include adjustments to the GAAP basis tax provision commensurate with non-GAAP adjustments and certain discrete tax items, when applicable, was used for the fifty-three weeks ended March 4, 2023 and the fifty-two weeks ended February 26, 2022 and February 27, 2021, respectively.

In addition to Adjusted EBITDA, Adjusted Net (Loss) Income and Adjusted Net (Loss) Income per Diluted Share, we occasionally refer to several other Non-GAAP measures, on a less frequent basis, in order to describe certain components of our business and how we utilize them to describe our results. These measures include but are not limited to Adjusted EBITDA Gross Margin and Gross Profit (gross margin/gross profit excluding non-Adjusted EBITDA items), Adjusted EBITDA SG&A (SG&A expenses excluding non-Adjusted EBITDA items), FIFO Gross Margin and FIFO Gross Profit (gross margin/gross profit before LIFO charges), and Free Cash Flow (Adjusted EBITDA less cash paid for interest, rent on closed stores, capital expenditures, restructuring-related costs and the change in working capital).

56

Item 8.   Financial Statements and Supplementary Data

Our consolidated financial statements and notes thereto are included elsewhere in this report and are incorporated by reference herein. See Item 15 of Part IV.

Item 9A.   Controls and Procedures

(a)    Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any control or procedure, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

At the time that the Original Form 10-K was filed on May 1, 2023, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures and concluded that they were effective to accomplish their objectives at a reasonable assurance level. Subsequent to that evaluation, our management, including our Chief Executive Officer and our Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of March 4, 2023, due to the material weakness in internal control over financial reporting described below.

(b)    Internal Control Over Financial Reporting

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a - 15(f) and 15d - 15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of March 4, 2023 based on the framework in “Internal Control—Integrated Framework” (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Based on management’s assessment, at the time the Original Form 10-K was filed, management concluded that the Company’s internal control over financial reporting was effective as of March 4, 2023. Subsequent to that assessment, management identified the material weakness in internal control as described below. Consequently, management concluded that the Company did not maintain effective internal control over financial reporting as of March 4, 2023.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

During the fourth quarter of fiscal year 2024, an error was identified with respect to our accounting for closed store liabilities. We did not appropriately conclude on the treatment of executory costs associated with store closures within our Closed Store Exit Costs and Associated Accounting For Closed and Liquidating Stores accounting policy. The inappropriate conclusions within this accounting policy led to the misstatement further detailed within Note 25 to the Consolidated Financial Statements included herein.

The misstatement was the result of deficiencies in direct and indirect controls that, in the aggregate, constitute a material weakness as we did not effectively design and operate controls pertaining to the initial adoption, or annual recertification, of our accounting policies.

57

The effectiveness of our internal control over financial reporting as of March 4, 2023 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in its report, which is included herein.

Remediation Plan

As part of our commitment to strengthening our internal control over financial reporting, we are implementing remedial actions under the oversight of the Audit Committee of our Board of Directors to address these deficiencies, including:

Enhancing the design of our controls over the adoption of accounting policies to ensure they are in compliance with the relevant GAAP.
Enhancing the design of our annual accounting policy recertification control to include as part of the review process, the verification that accounting policies are in compliance with the relevant GAAP.

We will continue to monitor the design and effectiveness of these and other processes, procedures, and controls and make any further change management determines appropriate. The material weakness cannot be considered remediated until applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. Accordingly, we will continue to monitor and evaluate the effectiveness of our internal control over financial reporting.

(c)    Changes in Internal Control Over Financial Reporting

Other than the material weakness described above, there have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a - 15(f) and 15d - 15(f) under the Exchange Act) during our fourth fiscal quarter ended March 4, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

58

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of Rite Aid Corporation

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Rite Aid Corporation and subsidiaries (the “Company”) as of March 4, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, because of the effect of the material weakness identified below on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of March 4, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

In our report dated May 1, 2023, we expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting. As described below, a material weakness was subsequently identified in internal control over financial reporting. Accordingly, management has revised its assessment about the effectiveness of the Company’s internal control over financial reporting and our present opinion on the effectiveness of the Company’s internal control over financial reporting as of May 1, 2023, as expressed herein, is different from that expressed in our previous report.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended March 4, 2023, of the Company and our report dated May 1, 2023 (July 25, 2024, as to Note 25 to the consolidated financial statements), expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting (as revised). Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

59

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Material Weakness

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Management identified a deficiency in internal control over financial reporting that resulted in a material weakness. The Company did not appropriately conclude on the treatment of executory costs associated with store closures within its Closed Store Exit Costs and Associated Accounting For Closed and Liquidating Stores accounting policy. The misstatement was the result of deficiencies in direct and indirect controls that, in the aggregate, constitute a material weakness as the Company did not effectively design and operate controls pertaining to the initial adoption, or annual recertification, of our accounting policies.

This material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the consolidated financial statements as of and for the year ended March 4, 2023 of the Company, and this report does not affect our report on such financial statements.

/s/ Deloitte & Touche LLP

Philadelphia, Pennsylvania  

May 1, 2023 (July 25, 2024, as to the material weakness)

60

PART IV

Item 15.   Exhibits and Financial Statement Schedule

(a)The consolidated financial statements of the Company and report of the independent registered public accounting firm identified in the following index are included in this report from the individual pages filed as a part of this report:

1.           Financial Statements

The following financial statements, report of the independent registered public accounting firm and supplementary data are included herein:

Report of Independent Registered Public Accounting Firm (PCAOB ID 34)

68

Consolidated Balance Sheets as of March 4, 2023 and February 26, 2022

70

Consolidated Statements of Operations for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021

71

Consolidated Statements of Comprehensive Loss for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021

72

Consolidated Statements of Stockholders’ (Deficit) Equity for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021

73

Consolidated Statements of Cash Flows for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021

74

Notes to Consolidated Financial Statements

75

2.           Financial Statement Schedule

Schedule II—Valuation and Qualifying Accounts

All other schedules are omitted because they are not applicable, not required or the required information is included in the consolidated financial statements or notes thereto.

3.           Exhibits

Exhibit
Numbers

    

Description

   

Incorporation By Reference To

2.1

Amended and Restated Asset Purchase Agreement, dated September 18, 2017, among Rite Aid Corporation, Walgreens Boots Alliance, Inc. and Walgreen Co.*

Exhibit 2.1 to Form 8-K, filed on September 19, 2017

2.2

Receivable Purchase Agreement, dated as of October 13, 2022, by and between Elixir Insurance Company and Part D Receivable Trust 2020-1 (Series F)

Exhibit 2.1 Filed to Form 8-K, filed on October 14, 2022

2.3

Indemnity Agreement, dated as of October 13, 2022 by and between Rite Aid Corporation and Part D Receivable Trust 2020-1 (Series F)

Exhibit 2.2 Filed to Form 8-K, filed on October 14, 2022

2.4

Receivable Purchase Agreement, dated as of February 3, 2023, by and between Elixir Insurance Company and Part D Receivable Trust 2020-1 (Series G)

Exhibit 2.1 Filed to Form 8-K, filed on February 3, 2023

2.5

Indemnity Agreement, dated as of February 3, 2023, by and between Rite Aid Corporation and Part D Receivable Trust 2020-1 (Series G)

Exhibit 2.2 to Form 8-K, filed on February 3, 2023

3.1

Amended and Restated Certificate of Incorporation

Exhibit 3.1 to Form 10-K, filed on April 23, 2014

3.2

Certificate of Amendment to the Amended and Restated Certificate of Incorporation

Exhibit 3.1 to Form 8-K, filed on April 18, 2019

61

Exhibit
Numbers

    

Description

   

Incorporation By Reference To

3.3

Amended and Restated By-Laws

Exhibit 3.1 to Form 8-K, filed on April 17, 2020

4.1

Indenture, dated as of August 1, 1993, between Rite Aid Corporation, as issuer, and Morgan Guaranty Trust Company of New York, as trustee, related to the Company’s 7.70% Notes due 2027

Exhibit 4A to Registration Statement on Form S-3, File No. 033-63794, filed on June 3, 1993

4.2

Supplemental Indenture, dated as of February 3, 2000, between Rite Aid Corporation and U.S. Bank Trust National Association (as successor trustee to Morgan Guaranty Trust Company of New York) to the Indenture dated as of August 1, 1993, between Rite Aid Corporation and Morgan Guaranty Trust Company of New York, relating to the Company’s 7.70% Notes due 2027

Exhibit 4.1 to Form 8-K filed on February 7, 2000

4.3

Indenture, dated as of December 21, 1998, between Rite Aid Corporation, as issuer, and Harris Trust and Savings Bank, as trustee, related to the Company’s 6.875% Notes due 2028

Exhibit 4.1 to Registration Statement on Form S-4, File No. 333-74751, filed on March 19, 1999

4.4

Supplemental Indenture, dated as of February 3, 2000, between Rite Aid Corporation and Harris Trust and Savings Bank to the Indenture, dated December 21, 1998, between Rite Aid Corporation and Harris Trust and Savings Bank, related to the Company’s 6.875% Notes due 2028

Exhibit 4.4 to Form 8-K, filed on February 7, 2000

4.5

Indenture, dated as of February 5, 2020, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., related to the Company’s 7.500% Senior Secured Notes due 2025

Exhibit 4.1 to Form 8-K filed on February 5, 2020

4.6

Description of the Company’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934

Exhibit 4.9 to Form 10-K filed on April 27, 2020

4.7

Indenture, dated as of July 27, 2020, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., related to the Company’s 8.000% Senior Secured Notes due 2026

Exhibit 4.1 to Form 8-K filed on July 27, 2020

4.8

Supplemental Indenture, dated as of August 27, 2021, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of February 5, 2020, related to the Company’s 7.500% Senior Secured Notes due 2025

Exhibit 4.12 to Form 10-Q filed on October 5, 2021

4.9

Supplemental Indenture, dated as of August 27, 2021, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of July 27, 2020, related to the Company’s 8.000% Senior Secured Notes due 2026

Exhibit 4.13 to Form 10-Q filed on October 5, 2021

4.10

Supplemental Indenture, dated as of March 31, 2022, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of February 5, 2020, related to the Company's 7.500% Senior Secured Notes due 2025

Exhibit 4.10 to Form 10-Q, filed on July 6, 2022

4.11

Supplemental Indenture, dated as of March 31, 2022, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of July 27, 2020, related to the Company’s 8.000% Senior Secured Notes due 2026

Exhibit 4.11 to Form 10-Q, filed on July 6, 2022

62

Exhibit
Numbers

    

Description

   

Incorporation By Reference To

4.12

Supplemental Indenture, dated as of September 19, 2022, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of February 5, 2020, related to the Company's 7.500% Senior Secured Notes due 2025

Exhibit 4.12 to Form 10-Q, filed on January 4, 2023

4.13

Supplemental Indenture, dated as of September 19, 2022, among Rite Aid Corporation, the subsidiary guarantors named therein and The Bank of New York Mellon Trust Company, N.A., to the Indenture, dated as of July 27, 2020, related to the Company’s 8.000% Senior Secured Notes due 2026

Exhibit 4.13 to Form 10-Q, filed on January 4, 2023

10.1

2010 Omnibus Equity Plan

Exhibit 10.1 to Form 8-K, filed on June 25, 2010

10.2

Amendment No. 1, dated September 21, 2010, to the 2010 Omnibus Equity Plan

Exhibit 10.7 to Form 10-Q, filed on October 7, 2010

10.3

Amendment No. 2, dated January 16, 2013, to the 2010 Omnibus Equity Plan

Exhibit 10.8 to Form 10-K, filed on April 23, 2013

10.4

2012 Omnibus Equity Plan

Exhibit 10.1 to Form 8-K, filed on June 25, 2012

10.5

Amendment No. 1, dated January 16, 2013, to the 2012 Omnibus Equity Plan

Exhibit 10.10 to Form 10-K, filed on April 23, 2013

10.6

2014 Omnibus Equity Plan

Exhibit 10.1 to Form 8-K, filed on June 23, 2014

10.7

Form of Award Agreement

Exhibit 10.2 to Form 8-K, filed on May 15, 2012

10.8

Executive Incentive Plan for Officers of Rite Aid Corporation

Exhibit 10.1 to Form 8-K, filed on February 24, 2012

10.9

Employment Agreement by and between Rite Aid Corporation and Jocelyn Konrad dated as of August 18, 2015

Exhibit 10.1 to Form 10-Q, filed on January 6, 2016

10.10

Credit Agreement, dated as of December 20, 2018, among Rite Aid Corporation, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent and collateral agent.

Exhibit 10.1 to Form 8-K, filed on December 20, 2018

10.11

First Amendment to Credit Agreement, dated as of January 6, 2020, among Rite Aid Corporation, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent.

Exhibit 10.1 to Form 8-K, filed on January 7, 2020

10.12

Second Amendment to Credit Agreement, dated as of August 20, 2021, among Rite Aid Corporation, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent

Exhibit 9.01 to Form 8-K, filed on August 23, 2021

10.13

Third Amendment to Credit Agreement, dated as of December 1, 2022, among Rite Aid Corporation, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent

Exhibit 9.01 to Form 8-K/A, filed on December 6, 2022

10.14

Amended and Restated Collateral Trust and Intercreditor Agreement, including the related definitions annex, dated as of June 5, 2009, among Rite Aid Corporation, each subsidiary named therein or which becomes a party thereto, Wilmington Trust Company, as collateral trustee, Citicorp North America, Inc., as senior collateral processing agent, The Bank of New York Trust Company, N.A., as trustee under the 2017 7.5% Note Indenture (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee under the 2016 10.375% Note Indenture (as defined therein), and each other Second Priority Representative and Senior Representative which becomes a party thereto

Exhibit 10.3 to Form 8-K, filed on June 11, 2009

63

Exhibit
Numbers

    

Description

   

Incorporation By Reference To

10.15

Amendment to Employment Agreement by and between Rite Aid Corporation and Jocelyn Z. Konrad, dated as of March 12, 2019

Exhibit 10.32 to Form 10-Q, filed on July 11, 2019

10.16

Amendment to Employment Agreement by and between Rite Aid Corporation and Matthew C. Schroeder, dated as of March 12, 2019

Exhibit 10.33 to Form 10-Q, filed on July 11, 2019

10.17

Amendment to Employment Agreement by and between Rite Aid Corporation and Brian Hoover, dated as of March 12, 2019

Exhibit 10.34 to Form 10-Q, filed on July 11, 2019

10.18

Amendment to Employment Agreement by and between Rite Aid Corporation and Brian Hoover, dated as of December 5, 2017

Exhibit 10.35 to Form 10-Q, filed on July 11, 2019

10.19

Amendment to Employment Agreement by and between Rite Aid Corporation and Brian Hoover, dated as of August 10, 2016

Exhibit 10.36 to Form 10-Q, filed on July 11, 2019

10.20

Employment Agreement by and between Rite Aid Corporation and Brian Hoover, dated as of January 1, 2001

Exhibit 10.37 to Form 10-Q, filed on July 11, 2019

10.21

Eleventh Amendment to Supply Agreement by and between Rite Aid Corporation and McKesson Corporation, dated as of February 28, 2019*

Exhibit 10.38 to Form 10-Q, filed on July 11, 2019

10.22

Employment Agreement by and between Rite Aid Corporation and Heyward Donigan, dated August 8, 2019*

Exhibit 10.1 to Form 8-K, filed on August 12, 2019

10.23

Employment Inducement Award Agreement by and between Rite Aid Corporation and Heyward Donigan, dated August 12, 2019

Exhibit 10.2 to Form 8-K, filed on August 12, 2019

10.24

Employment Agreement dated October 2, 2019 by and between Rite Aid Corporation and James Peters

Exhibit 10.1 to Form 8-K, filed on October 2, 2019

10.25

Employment Agreement by and between Rite Aid Corporation and Jessica Kazmaier, dated as of March 12, 2019

Exhibit 10.43 to Form 10-K filed on April 27, 2020

10.26

Amendment to Employment Agreement by and between Jessica Kazmaier, dated November 6, 2019

Exhibit 10.44 to Form 10-K filed on April 27, 2020

10.27

Employment Agreement by and between Justin Mennen, dated as of December 7, 2018

Exhibit 10.45 to Form 10-K filed on April 27, 2020

10.28

Amendment to Employment Agreement by and between Justin Mennen, dated November 6, 2019

Exhibit 10.46 to Form 10-K filed on April 27, 2020

10.29

Employment Agreement by and between Rite Aid Corporation and Andre Persaud, dated as of January 28, 2020

Exhibit 10.47 to Form 10-K filed on April 27, 2020

10.30

Employment Agreement by and between Rite Aid Corporation and Paul D. Gilbert, as of July 29, 2020

Exhibit 10.46 to Form 10-Q filed on October 6, 2020

10.31

Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Plan, as amended

Appendix B-1 to Schedule 14A (Definitive Proxy Statement) filed on June 10, 2022

10.32

Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Plan

Appendix B-1 to Schedule 14A (Definitive Proxy Statement) filed on May 20, 2021

10.33

Form Award Agreement (Executive) under the Rite Aid Corporation 2020 Omnibus Equity Plan

Exhibit 10.2 to Form 8-K filed on July 8, 2020

10.34

Form Award Agreement (Non-employee Director) under the Rite Aid Corporation 2020 Omnibus Equity Plan

Exhibit 10.3 to Form 8-K filed on July 8, 2020

10.35

Separation Agreement by and between Rite Aid Corporation and Jocelyn Konrad, dated as of March 7, 2022

Exhibit 10.35 to Form 10-Q, filed on July 6, 2022

10.36

Separation Agreement by and between Rite Aid Corporation and James Peters, as of March 7, 2022

Exhibit 10.36 to Form 10-Q, filed on July 6, 2022

10.37

Offer Letter, by and between Rite Aid Corporation and Steven K. Bixler dated September 11, 2022

Exhibit 10.1 to Form 8-K, filed on September 12, 2022

10.38

Separation Agreement by and between Rite Aid Corporation and Heyward Donigan dated January 7, 2023

Exhibit 10.1 to Form 8-K filed on January 9, 2023

64

Exhibit
Numbers

    

Description

   

Incorporation By Reference To

10.39

Offer Letter by and between Rite Aid Corporation and Elizabeth “Busy” Burr dated January 7, 2023

Exhibit 10.2 to Form 8-K filed on January 9, 2023

21

Subsidiaries of the Registrant

Exhibit 21 to the Form 10-K filed on May 1, 2023

22

List of Subsidiary Guarantors

Exhibit 22 to the Form 10-K filed on May 1, 2023

23

Consent of Independent Registered Public Accounting Firm

Exhibit 23 to the Form 10-K filed on May 1, 2023

31.1

Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended

Filed herewith

31.2

Certification of CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended

Filed herewith

32

Certification of CEO and CFO pursuant to 18 United States Code, Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002

Filed herewith

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Filed herewith

101.SCH

XBRL Taxonomy Extension Schema Document.

Filed herewith

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

Filed herewith

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

Filed herewith

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

Filed herewith

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

Filed herewith

104

Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Filed herewith

*

Portions of this exhibit have been omitted pursuant to Item 601(b)(2)(ii) or 601(b)(10)(iv) of Regulation S-K, as applicable.

Compensatory plan or arrangement

In reviewing the agreements included as exhibits to this Annual Report on Form 10-K please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Rite Aid Corporation, its subsidiaries or the other parties to the agreements. The agreements may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:

should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;

65

may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Rite Aid Corporation may be found elsewhere in this report and the Company’s other public filings, which are available without charge through the SEC’s website at http://www.sec.gov.

66

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

RITE AID CORPORATION

By:

/s/ JEFFREY S. STEIN

Jeffrey S. Stein

Chief Executive Officer and Chief Restructuring Officer

Dated:

July 25, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in their respective capacities on July 25, 2024.

Signature

Title

/s/ JEFFREY S. STEIN

     Chief Executive Officer and Chief Restructuring Officer (principal executive officer)

Jeffrey S. Stein

/s/ MATTHEW C. SCHROEDER

     Executive Vice President and Chief Financial Officer (principal financial officer)

Matthew C. Schroeder

/s/ STEVEN BIXLER

     Senior Vice President and Chief Accounting Officer (principal accounting officer)

Steven Bixler

67

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of Rite Aid Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Rite Aid Corporation and subsidiaries (the "Company") as of March 4, 2023 and February 26, 2022, the related consolidated statements of operations, comprehensive loss, stockholders' (deficit) equity, and cash flows, for each of the three years in the period ended March 4, 2023, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 4, 2023 and February 26, 2022, and the results of its operations and its cash flows for each of the three years in the period ended March 4, 2023, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of March 4, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated May 1, 2023, (July 25, 2024 as to the effects of the material weakness described therein), expressed an adverse opinion on the Company's internal control over financial reporting because of the material weakness.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

68

Goodwill – Pharmacy Services Reporting Unit — Refer to Note 14 to the financial statements

Critical Audit Matter Description

The Company’s evaluation of goodwill for impairment involves the comparison of the fair value of each reporting unit to the carrying value of each reporting unit. The Company uses either a qualitative assessment approach or a quantitative assessment approach. For the quantitative approach, the Company estimates fair value using an average based on an income approach and a market approach. The income approach is based on the present value of future cash flows of the reporting unit, while the market approach is based on certain multiples of selected guideline public companies or selected guideline transactions. The approaches incorporate a number of market participant assumptions including future growth rates, discount rates, income tax rates, and market activity. Changes in these assumptions could have a significant impact on either the fair value, the amount of any goodwill impairment charge, or both. The goodwill balance was $508 million as of March 4, 2023 of which $464 million is allocated to the Pharmacy Services reporting unit. During the current year, the Company recorded a partial impairment charge of $371 million for the Pharmacy Services reporting unit, with $252 million occurring as part of an interim assessment during the thirteen week period ended August 27, 2022, and $119 million occurring as part of the annual assessment during the fourteen week period ended March 4, 2023 for the Pharmacy Services reporting unit.

Given the significant estimates and assumptions by management to estimate the fair value of the Pharmacy Services reporting unit, including future growth rates, discount rates, and market activity, our audit procedures included a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures included the following, among others:

We tested the effectiveness of controls over management’s goodwill impairment evaluation, including those over the determination of the fair value of the Pharmacy Services reporting unit, such as controls related to management’s selection of future growth rates, discount rate, and market multiples. 
We evaluated management’s ability to accurately forecast future revenues and EBITDA margins by comparing actual results to management’s historical forecasts.
We evaluated the reasonableness of management’s future growth rates by comparing the forecasts of revenues and EBITDA to:
oHistorical revenues and EBITDA margins.
oInternal communications to management and the Board of Directors.
oForecasted information included in Company press releases as well as in analyst and industry reports for the Company and certain of its peer companies.

With the assistance of our fair value specialists, we evaluated the reasonableness of the (1) valuation methodology, (2) discount rate, and (3) market activity by:
oTesting the source information underlying the determination of the discount rate and market multiples and the mathematical accuracy of the calculations.
oDeveloping a range of independent estimates and comparing those to the discount rate and market multiples selected by management.

/s/ Deloitte & Touche LLP

Philadelphia, Pennsylvania

May 1, 2023 (July 25, 2024, as to Note 25 to the financial statements)

We have served as the Company's auditor since 1999.

69

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

March 4,

February 26,

    

2023

    

2022

ASSETS

Current assets:

Cash and cash equivalents

$

157,151

$

39,721

Accounts receivable, net

 

1,149,958

 

1,343,496

Inventories, net

 

1,900,744

 

1,959,389

Prepaid expenses and other current assets

 

93,194

 

106,749

Total current assets

 

3,301,047

 

3,449,355

Property, plant and equipment, net

 

907,771

 

989,167

Operating lease right-of-use assets

2,497,206

2,813,535

Goodwill

507,936

879,136

Other intangibles, net

 

250,112

 

291,196

Deferred tax assets

12,368

20,071

Other assets

 

50,922

 

86,543

Total assets

$

7,527,362

$

8,529,003

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY

Current liabilities:

Current maturities of long-term debt and lease financing obligations

$

6,332

$

5,544

Accounts payable

 

1,494,611

 

1,571,261

Accrued salaries, wages and other current liabilities

 

709,891

 

776,559

Current portion of operating lease liabilities

502,403

575,651

Total current liabilities

 

2,713,237

 

2,929,015

Long-term debt, less current maturities

 

2,925,258

 

2,732,986

Long-term operating lease liabilities

2,372,943

2,597,090

Lease financing obligations, less current maturities

 

12,580

 

14,830

Other noncurrent liabilities

 

97,577

 

139,254

Total liabilities

 

8,121,595

 

8,413,175

Commitments and contingencies

 

 

Stockholders’ (deficit) equity:

Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 56,629 and 55,752

 

56,629

 

55,752

Additional paid-in capital

 

5,917,964

 

5,910,299

Accumulated deficit

 

(6,553,974)

 

(5,834,786)

Accumulated other comprehensive loss

 

(14,852)

 

(15,437)

Total stockholders’ (deficit) equity

 

(594,233)

 

115,828

Total liabilities and stockholders’ (deficit) equity

$

7,527,362

$

8,529,003

The accompanying notes are an integral part of these consolidated financial statements.

70

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Revenues

$

24,091,899

$

24,568,255

$

24,043,240

Costs and expenses:

Cost of revenues

 

19,287,959

 

19,461,760

 

19,338,918

Selling, general and administrative expenses

 

4,902,087

 

5,033,876

 

4,657,185

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

371,200

229,000

29,852

Interest expense

 

224,399

 

191,601

 

201,388

(Gain) loss on debt modifications and retirements, net

 

(80,142)

 

3,235

 

(5,274)

(Gain) loss on sale of assets, net

 

(68,586)

 

5,505

 

(69,300)

Loss (gain) on Bartell acquisition

 

 

5,346

 

(47,705)

 

24,817,554

 

25,094,407

 

24,162,778

Loss from continuing operations before income taxes

 

(725,655)

 

(526,152)

 

(119,538)

Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Net loss from continuing operations

(719,188)

(522,372)

(99,381)

Net income from discontinued operations, net of tax

9,161

Net loss

$

(719,188)

$

(522,372)

$

(90,220)

Computation of loss attributable to common stockholders:

Loss from continuing operations attributable to common stockholders—basic and diluted

$

(719,188)

$

(522,372)

$

(99,381)

Income from discontinued operations attributable to common stockholders—basic and diluted

9,161

Net loss attributable to common stockholders—basic and diluted

$

(719,188)

$

(522,372)

$

(90,220)

Basic and diluted loss per share:

Continuing operations

$

(13.15)

$

(9.66)

$

(1.86)

Discontinued operations

$

$

$

0.18

Net basic and diluted loss per share

$

(13.15)

$

(9.66)

$

(1.68)

The accompanying notes are an integral part of these consolidated financial statements.

71

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In thousands)

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Net loss

$

(719,188)

$

(522,372)

$

(90,220)

Other comprehensive income:

Defined benefit pension plans:

Amortization of net actuarial losses included in net periodic pension cost, net of $0, $0 and $0 income tax expense

 

585

 

8,590

 

24,382

Change in fair value of interest rate cap

27

462

Total other comprehensive income

 

585

 

8,617

 

24,844

Comprehensive loss

$

(718,603)

$

(513,755)

$

(65,376)

The accompanying notes are an integral part of these consolidated financial statements.

72

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Accumulated

Additional

Other

Common Stock

Paid-In

Accumulated

Comprehensive

    

Shares

    

Amount

    

Capital

    

Deficit

    

Loss

    

Total

BALANCE FEBRUARY 29, 2020

 

54,716

$

54,716

$

5,890,903

$

(5,222,194)

$

(48,898)

$

674,527

Net loss

 

(90,220)

(90,220)

Other comprehensive loss:

Changes in Defined Benefit Plans, net of $0 tax expense

24,382

24,382

Change in fair value of interest rate cap

462

462

Comprehensive loss

(65,376)

Exchange of restricted shares for taxes

(189)

(189)

(2,897)

(3,086)

Issuance of restricted stock

780

780

(780)

Cancellation of restricted stock

(166)

(166)

166

Amortization of restricted stock balance

9,126

9,126

Stock-based compensation expense

599

599

Stock options exercised

2

2

51

53

BALANCE FEBRUARY 27, 2021

 

55,143

$

55,143

$

5,897,168

$

(5,312,414)

$

(24,054)

$

615,843

Net loss

 

(522,372)

(522,372)

Other comprehensive loss:

Changes in Defined Benefit Plans, net of $0 tax expense

8,590

8,590

Change in fair value of interest rate cap

27

27

Comprehensive loss

(513,755)

Exchange of restricted shares for taxes

(177)

(177)

(2,411)

(2,588)

Issuance of restricted stock

973

973

(973)

Cancellation of restricted stock

(187)

(187)

187

Amortization of restricted stock balance

10,308

10,308

Stock-based compensation expense

600

600

Amortization of performance-based incentive plans

5,420

5,420

BALANCE FEBRUARY 26, 2022

 

55,752

$

55,752

$

5,910,299

$

(5,834,786)

$

(15,437)

$

115,828

Net loss

 

(719,188)

(719,188)

Other comprehensive loss:

Changes in Defined Benefit Plans, net of $0 tax expense

585

585

Comprehensive loss

(718,603)

Exchange of restricted shares for taxes

(415)

(415)

(2,247)

(2,662)

Issuance of restricted stock

1,662

1,662

(1,662)

Cancellation of restricted stock

(370)

(370)

370

Amortization of restricted stock balance

13,897

13,897

Stock-based compensation expense

720

720

Amortization of performance-based incentive plans

(3,413)

(3,413)

BALANCE MARCH 4, 2023

 

56,629

$

56,629

$

5,917,964

$

(6,553,974)

$

(14,852)

$

(594,233)

The accompanying notes are an integral part of these consolidated financial statements.

73

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Operating activities:

    

Net loss

$

(719,188)

$

(522,372)

$

(90,220)

Net income from discontinued operations, net of tax

9,161

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Adjustments to reconcile to net cash (used in) provided by operating activities of continuing operations:

Depreciation and amortization

 

276,583

 

295,686

 

327,124

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

371,200

229,000

29,852

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

(Gain) loss on sale of assets, net

 

(68,586)

 

5,505

 

(69,300)

Change in allowances for uncollectible accounts receivable

15,267

22,011

Loss (gain) on Bartell acquisition

 

 

5,346

 

(47,705)

Stock-based compensation expense

 

11,537

 

13,050

 

13,003

(Gain) loss on debt modifications and retirements, net

 

(80,142)

 

3,235

 

(5,274)

Changes in deferred taxes

7,703

(6,709)

(10,633)

Changes in operating assets and liabilities:

Accounts receivable

 

151,610

 

54,086

 

(182,404)

Inventories

 

5,158

 

(97,112)

 

177,263

Accounts payable

 

(96,570)

 

139,228

 

(35,372)

Operating lease right-of-use assets and operating lease liabilities

(86,133)

(29,375)

(28,044)

Other assets

 

36,478

 

33,737

 

80,975

Other liabilities

(111,021)

68,558

(50,947)

Net cash (used in) provided by operating activities of continuing operations:

 

(52,439)

 

379,272

 

105,179

Investing activities:

Payments for property, plant and equipment

 

(215,285)

 

(194,090)

 

(195,141)

Intangible assets acquired

(32,400)

(26,623)

(29,800)

Acquisition of business, net of cash acquired

(86,230)

Proceeds from insured loss

10,436

12,500

Proceeds from dispositions of assets and investments

69,582

18,706

11,444

Proceeds from sale-leaseback transactions

 

73,344

 

57,498

 

177,892

Net cash used in investing activities of continuing operations:

 

(104,759)

 

(134,073)

 

(109,335)

Financing activities:

Proceeds from issuance of long-term debt

 

50,000

 

350,000

 

849,918

Net proceeds from (payments to) revolver

 

491,000

 

(141,000)

 

200,000

Principal payments on long-term debt

 

(277,941)

 

(545,036)

 

(1,058,537)

Change in zero balance cash accounts

 

18,289

 

(8,285)

 

(36,463)

Net proceeds from issuance of common stock

 

 

 

53

Financing fees paid for early debt redemption

 

(1,733)

 

(833)

 

(2,399)

Payments for taxes related to net share settlement of equity awards

(2,662)

(2,588)

(3,086)

Deferred financing costs paid

 

(2,325)

 

(18,638)

 

(14,729)

Net cash provided by (used in) financing activities of continuing operations:

 

274,628

 

(366,380)

 

(65,243)

Cash flows from discontinued operations:

Operating activities of discontinued operations

(82,189)

Investing activities of discontinued operations

94,310

Financing activities of discontinued operations

Net cash provided by discontinued operations

12,121

Increase (decrease) in cash and cash equivalents

 

117,430

 

(121,181)

 

(57,278)

Cash and cash equivalents, beginning of period

 

39,721

 

160,902

 

218,180

Cash and cash equivalents, end of period

$

157,151

$

39,721

$

160,902

The accompanying notes are an integral part of these consolidated financial statements.

74

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

1. Summary of Significant Accounting Policies

Description of Business

The Company is a Delaware corporation and through its 100% owned subsidiaries, operates a pharmacy retail healthcare company in the United States of America. The Company operates through its two reportable segments: the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy Segment operates one of the largest retail drugstore chains in the United States, with 2,309 stores in operation as of March 4, 2023. The Retail Pharmacy Segment’s drugstores’ primary business is the sale of brand and generic prescription drugs. The Retail Pharmacy Segment also sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment provides a fully integrated suite of pharmacy benefit management (“PBM”) offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs, through Elixir Pharmacy and Laker Software. Elixir also offers a national Medicare Part D prescription drug plan through Elixir Insurance (“EI”). See Note 21 for additional details on the Company’s reportable segments.

The discussion and presentation of the operating and financial results of our business segments have been impacted by the following event.

Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement (the "Amended and Restated Asset Purchase Agreement"), dated as of September 18, 2017, by and among Rite Aid, WBA and Walgreen Co., an Illinois corporation and 100% owned subsidiary of WBA ("Buyer"), Buyer agreed to purchase from Rite Aid 1,932 stores (the "Acquired Stores"), three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of approximately $4,375,000, on a cash free, debt free basis (the "Asset Sale" or the "Sale"). As of March 4, 2023, the Company has sold all 1,932 Acquired Stores, three distribution centers and related assets to WBA in exchange for proceeds of $4,375,000, which were used to repay outstanding debt. Based on its magnitude and because the Company has exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Asset Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). See additional information as provided in Note 4 Asset Sale to WBA.

75

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Revenues for the Company are as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Retail Pharmacy Segment:

Pharmacy sales

    

$

12,582,593

    

$

12,152,491

    

$

10,915,442

Front-end sales

 

5,078,820

 

5,218,182

 

5,322,943

Other revenue

 

123,654

 

124,143

 

126,875

Total Retail Pharmacy Segment

17,785,067

17,494,816

16,365,260

Pharmacy Services Segment revenue

6,522,299

7,323,125

7,970,137

Intersegment elimination

(215,467)

(249,686)

(292,157)

Total revenue

$

24,091,899

$

24,568,255

$

24,043,240

Sales of prescription drugs for our Retail Pharmacy Segment represented approximately 71.2%, 70.0% and 66.7% of the Company’s total drugstore sales in fiscal years 2023, 2022 and 2021, respectively. The Retail Pharmacy Segment’s principal classes of products in fiscal 2023 were the following:

Percentage

 

Product Class

    

of Sales

Prescription drugs

 

71.2

%

Over-the-counter medications and personal care

 

10.9

%

Health and beauty aids

 

4.3

%

General merchandise and other

 

13.6

%

Fiscal Year

The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year ended March 4, 2023 included 53 weeks. The fiscal years ended February 26, 2022 and February 27, 2021 included 52 weeks.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its 100% owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and highly liquid investments, which are readily convertible to known amounts of cash and which have original maturities of three months or less when purchased.

Allowance for Uncollectible Receivables

In our Retail Pharmacy Segment, substantially all prescription sales are made to customers who are covered by third-party payors, such as insurance companies, government agencies and employers. The Company recognizes receivables that represent the amount owed to the Company for sales made to customers or employees of those payors that have not yet been paid. In our Pharmacy Services Segment, receivables are recorded for claims for prescriptions

76

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

issued for customers, customer administrative fees, amounts due from the Centers for Medicare and Medicaid Services (“CMS”) for Medicare Part D, and amounts due from certain drug manufacturers or rebate aggregators for rebates. The Company maintains a reserve for the expected credit losses associated with these receivables. This reserve is calculated based upon historical collection activity adjusted for current conditions.

Inventories

Inventories are stated at the lower of cost or market. Inventory balances include the capitalization of certain costs related to purchasing, freight and handling costs associated with placing inventory in its location and condition for sale. The Company uses the last-in, first-out (“LIFO”) cost flow assumption for substantially all of its inventories. The Company calculates its inflation index based on internal product mix and utilizes the link-chain LIFO method.

Impairment of Long-Lived Assets

Asset impairments are recorded when the carrying value of assets are not recoverable. For purposes of recognizing and measuring impairment of long-lived assets, the Company categorizes assets of operating stores as “Assets to Be Held and Used” and “Assets to Be Disposed Of.” The Company evaluates assets at the store level because this is the lowest level of identifiable cash flows ascertainable to evaluate impairment. Assets being tested for recoverability at the store level include tangible long-lived assets, right-of-use assets for leased stores, and identifiable, finite-lived intangibles that arose in purchase business combinations. Corporate assets to be held and used are evaluated for impairment based on excess cash flows from the stores that support those assets.

The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset.

Property, Plant and Equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation and amortization. The Company provides for depreciation using the straight-line method over the following useful lives: buildings—30 to 45 years; equipment—3 to 15 years.

Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the term of the lease. When determining the amortization period of a leasehold improvement, the Company considers whether discretionary exercise of a lease renewal option is reasonably assured. If it is determined that the exercise of such option is reasonably assured, the Company will amortize the leasehold improvement asset over the minimum lease term, plus the option period. This determination depends on the remaining life of the minimum lease term and any economic penalties that would be incurred if the lease option is not exercised.

Capitalized lease assets are recorded at the lesser of the present value of minimum lease payments or fair market value and amortized over the estimated useful life of the related property or term of the lease.

77

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The Company capitalizes direct internal and external development costs associated with internal-use software. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. For fiscal years 2023, 2022 and 2021, the Company capitalized costs of approximately $5,099, $13,388 and $12,669, respectively.

Goodwill

The Company recognizes goodwill as the excess of the purchase price over the fair value of the assets acquired and liabilities assumed during business combinations. The Company accounts for goodwill under ASC Topic 350, “Intangibles—Goodwill and Other”, which does not permit amortization, but instead requires the Company to perform an annual impairment review, or more frequently if events or circumstances indicate that impairment may be more likely. See Note 14 for additional information on goodwill.

Intangible Assets

The Company has certain finite-lived intangible assets that are amortized over their useful lives. Prescription files acquired in business combinations are amortized over an estimated useful life of 10 years on an accelerated basis, which approximates the anticipated prescription file retention and related cash flows. Purchased prescription files acquired in other than business combinations are amortized over their estimated useful lives of five years on a straight-line basis. The value of finite-lived trade names are amortized over 10 years on a straight-line basis. The value of customer relationships, acquired in connection with the Company’s acquisition of Elixir, are amortized over a period between 10 and 20 years on a descending percentage method which matches the pattern of expected discounted cash flows. The Pharmacy Services Segment’s contract with CMS for Part D, which is required in order to act as a national provider of the Part D benefit, is amortized over 12 years on a straight line basis, of which four years remain.

Indefinite lived assets

The Company has a single indefinite-lived intangible asset consisting of a trade name. Intangible assets that are determined to have an indefinite life are not amortized, but are required to be evaluated at least annually for impairment. If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-lived intangible asset is impaired by the amount of the excess.

Deferred Financing Costs

Costs incurred to issue debt are deferred and amortized as a component of interest expense over the terms of the related debt agreements. Amortization expense of deferred financing costs was $9,993, $10,927 and $11,201 for fiscal 2023, 2022 and 2021, respectively.

Revenue Recognition

Retail Pharmacy Segment

For front-end sales, the Retail Pharmacy Segment recognizes revenues upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation at the point of sale for front-end transactions. The Retail Pharmacy Segment front-end revenue is measured based on the amount of fixed consideration that it expects to

78

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

receive, net of an allowance for estimated future returns. Return activity is immaterial to revenues and results of operations in all periods presented.

For pharmacy sales, the Retail Pharmacy Segment recognizes revenue upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation, upon pickup by the customer, which is when the customer takes title to the product. Each prescription claim represents an individual arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims. The Company's revenue is measured based on the amount of fixed consideration that we expect to receive, reduced by refunds owed to the third-party payor for pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not highly subjective or volatile. The effect of adjustments between estimated and actual amounts has not been material to the Company's results of operations or financial position. Prescriptions are generally not returnable.

The Retail Pharmacy Segment offered a chain-wide loyalty card program titled wellness+. Individual customers were able to become members of the wellness+ program. Members participating in the wellness+ loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, the Company granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.

A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.

Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue. For the fifty-three week period ended March 4, 2023, the Company recognized additional contract deferrals of $2,030 as a reduction of revenues. The Retail Pharmacy Segment had accrued contract liabilities of $2,030 and $0 as of March 4, 2023 and February 26, 2022, respectively.

Pharmacy Services Segment

The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and; (ii) under retail pharmacy network contracts where it is the principal at the contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of

79

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member co-payments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:

Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services Segment’s online claims processing system. At this point the Company has performed all of its performance obligations.
Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments.
Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member-based fee, or a claims volume-based fee.

In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.

Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.

For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized, except the administrative fee.

Drug Discounts—The Pharmacy Services Segment deducts from its revenues that are generated from prescription drugs sold by third-party pharmacies any rebates, inclusive of discounts and fees, earned by its clients based on utilization levels and other factors as negotiated with the prescription drug manufacturers, rebate aggregators or suppliers. Rebates are paid to clients in accordance with the terms of client contracts.

80

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Medicare Part D—The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a Medicare Part D Prescription Drug Plan (“PDP”). Please refer to Note 10, Medicare Part D.

Disaggregation of Revenue

The following tables disaggregate the Company’s revenue by major source in each segment for the fiscal year ended March 4, 2023:

March 4,

    

2023

In thousands

(53 Weeks)

    

Retail Pharmacy Segment:

  

 

Pharmacy sales

$

12,582,593

Front-end sales

 

5,078,820

Other revenue

 

123,654

Total Retail Pharmacy Segment

17,785,067

Pharmacy Services Segment

 

6,522,299

Intersegment elimination

 

(215,467)

Total revenue

$

24,091,899

See Note 21 for additional information about the revenues of the Company’s business segments.

Cost of Revenues

Retail Pharmacy Segment

Cost of revenues for the Retail Pharmacy Segment includes the following: the cost of inventory sold during the period, including related vendor rebates and allowances, LIFO credit or charges, costs incurred to return merchandise to vendors, inventory shrink, purchasing costs and warehousing costs, which include inbound freight costs from the vendor, distribution payroll and benefit costs, distribution center occupancy costs and depreciation expense and delivery expenses to the stores.

Pharmacy Services Segment

The Pharmacy Services Segment’s cost of revenues includes the cost of prescription drugs sold during the reporting period indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The cost of prescription drugs sold component of cost of revenues includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients’ benefit plans from the Pharmacy Services Segment’s mail service dispensing pharmacy, net of any volume-related or other discounts (see the section entitled “Vendor Rebates and Allowances and Purchase Discounts” below) and (ii) the cost of prescription drugs sold through the Pharmacy Services Segment’s retail pharmacy network under contracts where it is the principal, net of any volume-related or other discounts.

See Note 21 for additional information about the cost of revenues of the Company’s business segments.

81

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Vendor Rebates and Allowances and Purchase Discounts

Retail Pharmacy Segment

The Retail Pharmacy Segment’s rebates and allowances received from vendors relate to either buying and merchandising or promoting the product. Buying and merchandising related rebates and allowances are recorded as a reduction of cost of revenue as product is sold. Buying and merchandising rebates and allowances include all types of vendor programs such as cash discounts from timely payment of invoices, purchase discounts or rebates, volume purchase allowances, price reduction allowances and slotting allowances. Certain product promotion related rebates and allowances, primarily related to advertising, are recorded as a reduction in selling, general and administrative expenses when the advertising commitment has been satisfied.

Pharmacy Services Segment

The Pharmacy Services Segment receives purchase discounts on products purchased. The Pharmacy Services Segment’s contractual arrangements with vendors, including manufacturers and rebate aggregators, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized when prescriptions are dispensed and are generally billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Pharmacy Services Segment’s results of operations. The Pharmacy Services Segment accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services Segment also receives additional discounts under its wholesaler and rebate aggregator contracts and fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.

Rebates payable to clients for the Pharmacy Services Segment

The Pharmacy Services Segment has contractual arrangements with clients, including health plans, commercial employers, labor groups, and state and local governments, which entitles such clients to a portion of certain rebates received by the Pharmacy Services Segment. Estimated rebates payable to clients are recognized when prescriptions are dispensed and are generally paid to clients up to eight months in arrears.  Historically, the effect of adjustments resulting from the reconciliation of estimated rebates payable to clients recognized and the amount actually paid has not been material to the Pharmacy Services Segment’s results of operations.  The Pharmacy Services Segment accounts for the effect of any such difference as a change in accounting estimate in the period the reconciliation is completed.  Estimated rebates payable to clients are recorded as a reduction of revenues.

Leases

The Company determines if an arrangement contains a lease at the inception of a contract. Operating lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized at the commencement date based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company’s leases is not readily

82

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest that we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses quoted interest rates obtained from financial institutions in an input to derive its incremental borrowing rate as the discount rate for the lease. The ROU asset is equal to the operating lease liability plus lease payments made before commencement, less lease incentives received from the landlord.

The Company’s real estate leases typically contain options that permit lease extensions for additional periods of up to five years each. For real estate leases, generally, the renewal periods are not included within the lease term and the associated payments are not included in the measurement of the ROU asset and operating lease liability as the options to extend are not considered reasonably certain to occur at lease commencement. The Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and will include all reasonably certain options in the measurement of its lease term. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the operating lease right-of-use asset and the operating lease liability until the renewals are i) evaluated and ii) determined to be exercised. The Company has an insignificant amount of non-real estate leases however, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. The Company rarely executes leases less than 12 months.

For real estate leases, the Company accounts for lease components and non-lease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the operating lease right-of-use assets and operating lease liabilities.

The Company records rent expense on operating leases on a straight-line basis over the reasonably certain lease term. The Company begins to record rent expense at the time that the Company has the right to use the property.

Selling, General and Administrative Expenses

Selling, general and administrative expenses include store and corporate administrative payroll and benefit costs, occupancy costs which include retail store and corporate rent costs, facility and leasehold improvement depreciation and utility costs, advertising, repair and maintenance, insurance, equipment depreciation and professional fees.

Repairs and Maintenance

Routine repairs and maintenance are charged to operations as incurred. Improvements and major repairs, which extend the useful life of an asset, are capitalized and depreciated.

Advertising

Advertising costs, net of specific vendor advertising allowances, are expensed in the period the advertisement first takes place. Advertising expenses, net of vendor advertising allowances, for fiscal 2023, 2022 and 2021 were $133,379, $146,085 and $122,725, respectively.

83

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Insurance

The Company is self-insured for certain general liability and workers’ compensation claims. For claims that are self-insured, stop-loss insurance coverage is maintained for workers’ compensation occurrences exceeding $1,000 and general liability occurrences exceeding $3,000. The Company utilizes actuarial studies as the basis for developing reported claims and estimating claims incurred but not reported relating to the Company’s self-insurance. Workers’ compensation claims are discounted to present value using a risk-free interest rate.

The Company is also self-insured for certain employee health and welfare plans. We record the related self-insurance liabilities based on claims incurred and an estimate of claims incurred but not yet reported.

Benefit Plan Accruals

The Company has several defined benefit plans, under which participants earn a retirement benefit based upon a formula set forth in the plan. The Company records expense related to these plans using actuarially determined amounts that are calculated under the provisions of ASC 715, “Compensation—Retirement Benefits.” Key assumptions used in the actuarial valuations include the discount rate, the expected rate of return on plan assets and the rate of increase in future compensation levels.

Stock-Based Compensation

The Company has several stock award plans, which are described in detail in Note 18. The Company accounts for stock-based compensation under ASC 718, “Compensation—Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.

Store Pre-opening Expenses

Costs incurred prior to the opening of a new or relocated store, associated with a remodeled store or related to the opening of a distribution facility are charged to operations as incurred.

Litigation Reserves

The Company is involved in litigation on an ongoing basis. The Company accrues its best estimate of the probable loss related to legal claims. Such estimates are developed in consultation with in-house counsel, and are based upon a combination of litigation and settlement strategies.

Income Taxes

Deferred income taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities. Deferred income tax expense (benefit) represents the change during the reporting period in the deferred tax assets and deferred tax liabilities, net of the effect of acquisitions and dispositions. Deferred tax assets include tax loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.

84

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The Company has net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate a significant deferred tax asset. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies.

The Company recognizes tax liabilities in accordance with ASC 740, “Income Taxes” and the Company adjusts these liabilities with changes in judgment as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the tax liabilities.

Sales Tax Collected

Sales taxes collected from customers and remitted to various governmental agencies are presented on a net basis (excluded from revenues) in the Company’s statement of operations.

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Significant Concentrations

Retail Pharmacy Segment

The Company’s pharmacy sales were primarily to customers covered by health plan contracts, which typically contract with a third-party payor that agrees to pay for all or a portion of a customer’s eligible prescription purchases. During fiscal 2023, the top five third-party payors accounted for approximately 83.4% of the Company’s pharmacy sales. The largest third-party payor, Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. Third-party payors are entities such as an insurance company, governmental agency, health maintenance organization or other managed care provider, and typically represent several health care contracts and customers.

During fiscal 2023, state sponsored Medicaid agencies and related managed care Medicaid payors accounted for approximately 19.9% of the Company’s pharmacy sales, the largest of which was approximately 6.6% of the Company’s pharmacy sales. During fiscal 2023, approximately 38.8% of the Company’s pharmacy sales were to customers covered by Medicare Part D. Any significant loss of third-party payor business could have a material adverse effect on the Company’s business and results of operations.

During fiscal 2023, the Company purchased brand and generic pharmaceuticals, which amounted to approximately 98% of the dollar volume of its prescription drugs from McKesson Corporation (“McKesson”) under its expanded agreement executed on February 17, 2014 and amended in fiscal 2019 for its pharmaceutical purchasing and distribution whereby McKesson assumed responsibility for purchasing essentially all of the brand and generic medications the Company dispenses as well as providing a new direct store delivery model to all of the Company’s stores. If the Company’s relationship with McKesson was disrupted, it could temporarily have difficulty filling

85

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

prescriptions for brand-named and generic drugs until it executed a replacement wholesaler agreement or developed and implemented self-distribution processes.

Pharmacy Services Segment

The Company’s Pharmacy Services Segment revenue is currently generated from a limited number of customers. During fiscal 2023, its top five customers accounted for 65.9% of its Pharmacy Services Segment revenue, which includes 6.9% related to a client which termed on January 1, 2023. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. Pharmacy Services Segment customers are entities such as employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of health benefit plans, and individuals throughout the United States.

The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a PDP. During fiscal 2023, fiscal 2022 and fiscal 2021, net revenues of $529,025 (2.2% of consolidated revenues), $589,620 (2.4% of consolidated revenues) and $630,104 (2.6% of consolidated revenues), respectively, include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS.

Derivatives

The Company may enter into interest rate swap agreements to hedge the exposure to increasing rates with respect to its variable rate debt, when the Company deems it prudent to do so. Upon inception of interest rate swap or cap agreements, or modifications thereto, the Company performs a comprehensive review of the interest rate swap agreements based on the criteria as provided by ASC 815, “Derivatives and Hedging.”

Recently Adopted Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another rate affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of Interbank Offered Rates (“IBORs”) and, particularly, the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to the above ASU to clarify certain optional expedients and exceptions in Topic 848. The Company adopted ASU 2020-04 effective December 1, 2022 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation, the recognition of deferred tax liabilities and the methodology for calculating income taxes in the interim period. The amendments also improve consistent application of and simplify

86

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020 (fiscal 2022). The Company adopted ASU 2019-12 effective February 28, 2021 and the adoption of this standard did not have a material impact on the Company’s financial position.

In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement benefits (Topic 715-20). This ASU amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. This ASU is effective for fiscal years ending after December 15, 2020 and must be applied on a retrospective basis. The Company adopted ASU 2018-14 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which is intended to provide entities with additional guidance to determine which software implementation costs to capitalize and which costs to expense. The ASU will allow entities to capitalize costs for implementation activities during the application development stage. ASU No. 2018-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2019 (fiscal 2021). Early adoption of ASU 2018-15 is permitted. The Company adopted ASU 2018-15 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model), that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity will recognize, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses. ASU 2016-13 impacts non-banks as most non-banks have financial instruments or other assets (e.g., trade, contract and lease receivables, financial guarantees, loans and loan commitments and held-to-maturity debt securities). The Company adopted ASU 2016-13 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

2. Acquisition

On December 18, 2020, pursuant to that certain stock purchase agreement, dated as of October 7, 2020, by and between the Company and Bartell Drug Company (“Bartell”), the Company acquired Bartell (the “Acquisition”), a Washington corporation, for approximately $89,724 in cash, subject to certain customary post-closing working capital adjustments. The Company financed the Acquisition with borrowings under its senior secured credit facilities together with cash on hand.  Bartell operated 67 retail drugstores and one distribution center in the greater Seattle Washington area.  Bartell operates as a 100 percent owned subsidiary of the Company within its Retail Pharmacy Segment.

The Company’s consolidated financial statements for fiscal 2023 and 2022 include Bartell’s results of operations. The Company’s consolidated financial statements for fiscal 2021 include Bartell’s results of operations from the Acquisition date of December 18, 2020 through February 27, 2021, including revenues of $101,083. The Company’s consolidated financial statements at February 26, 2022 reflect the final purchase accounting adjustments in accordance with ASC 805 “Business Combinations,” whereby the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values on the Acquisition date.

87

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following allocation of the purchase price and the estimated transaction costs is final:

Final purchase price

Cash consideration

$

89,724

Total

 

89,724

Final purchase price allocation

Cash and cash equivalents

$

3,494

Accounts receivable

 

23,860

Inventories

67,745

Prepaid expenses and other current assets

1,857

Total current assets

96,956

Property and equipment

28,229

Operating lease right-of-use assets

143,651

Intangible assets(1)

68,700

Other assets

1,805

Total assets acquired

339,341

Accounts payable

24,166

Accrued salaries, wages and other current liabilities

20,335

Current portion of operating lease liabilities

24,617

Total current liabilities

69,118

Long-term operating lease liabilities

124,023

Other long-term liabilities

166

Total liabilities assumed

193,307

Deferred tax liabilities recorded on purchase

13,951

Net assets acquired

132,083

Bargain purchase gain

(42,359)

Total purchase price

$

89,724

(1)            Intangible assets are recorded at estimated fair value, as determined by management based on available information which includes a final valuation prepared by an independent third-party. The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty and the multi-period excess earnings methods. The major assumptions used in arriving at the estimated identifiable intangible asset values included management’s final estimates of future cash flows, discounted at an appropriate rate of return which are based on the weighted average cost of capital for both the Company and other market participants, projected customer attrition rates, as well as applicable royalty rates for comparable assets. The useful lives for intangible assets were determined based upon the remaining useful economic lives of the intangible assets that are expected to contribute directly or indirectly to future cash flows. The estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation include:

88

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Estimated Fair Value

Estimated Useful Life
(In Years)

Prescription files

$

54,300

10

Tradename

 

14,400

Indefinite

Total

$

68,700

During fiscal 2021, the Company recorded a gain on Bartell acquisition of $47,705 primarily due to fair value adjustments related to prescription files and the tradename compared to book values. During fiscal 2022, in connection with determining its final purchase price allocation, the Company recorded a loss on Bartell acquisition of $5,346 primarily due to contract termination charges, inventory valuation adjustments and changes in deferred income taxes, resulting in a net bargain purchase gain of $42,359. The Company believes that the bargain purchase gain was primarily the result of the decision by the Bartell stockholders to sell their interests as Bartell had been experiencing increasing borrowings under its credit agreements to meet its operating needs and increasing net losses. The agreed upon purchase price reflected the fact the seller would have needed to incur further significant debt to cover the operating costs of Bartell, which would have required amendments to its credit arrangements. With the Company’s existing infrastructure, scale and expertise, the Company believe that it has access to the necessary synergies to allow necessary operational improvements to be implemented more efficiently than the seller.

During fiscal 2023, fiscal 2022 and fiscal 2021, acquisition costs of $0, $12,797 and $10,549, respectively, were expensed as incurred. The following unaudited pro forma combined financial data gives effect to the Acquisition as if it had occurred as of March 1, 2019.

 

The unaudited combined pro forma results do not include any incremental cost savings that may result from the integration. The adjustments are based on information available to the Company at this time. Accordingly, the adjustments are subject to change and the impact of such changes may be material.

The unaudited combined pro forma information is for informational purposes only.  The pro forma information is not necessarily indicative of what the combined company’s results actually would have been had the Acquisition been completed as of the beginning of the periods as indicated.  In addition, the unaudited pro forma information does not purport to project the future results of the combined company.

March 4,

February 26,

February 27,

2023

2022

2021

    

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Pro forma

Pro forma

Pro forma

Net revenues as reported

$

24,091,899

$

24,568,255

$

24,043,240

Supplemental Pro forma revenues

$

24,091,899

$

24,568,255

$

24,468,777

Net loss as reported

$

(719,188)

$

(522,372)

$

(90,220)

Supplemental Pro forma net loss

$

(719,188)

$

(522,372)

$

(116,040)

3. Restructuring

Beginning in fiscal 2019, the Company initiated a series of restructuring plans designed to reorganize its executive management team, reduce managerial layers, and consolidate roles. In March 2020, the Company announced

89

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

the details of its strategy, which includes building tools to work with regional health plans to improve patient health outcomes, rationalizing SKU’s in its front-end offering to free up working capital and update its merchandise assortment, assessing its pricing and promotional strategy, rebranding its retail pharmacy and pharmacy services business, launching its Store of the Future format and further reducing SG&A and headcount, including integrating certain back office functions in the Pharmacy Services Segment both within the segment and across the enterprise. Other strategic initiatives include the expansion of the Company’s digital business, replacing and updating the Company’s financial systems to improve efficiency, and movement to a common client platform at Elixir. In April 2022, the Company announced further strategic initiatives to reduce costs through the closure of unprofitable stores, reduce corporate administration expenses, improve efficiencies in worked payroll and other store labor costs, engage in a comprehensive review of purchasing and other business processes in both the Retail Pharmacy and Pharmacy Services Segments in order to identify areas of opportunity, as well as expense reductions at the Pharmacy Services Segment. In December 2022, the Company announced a new multi-year performance acceleration program, which allows it to fast-track initiatives that will improve sales, script volume and operating margins, and free up cash. The Company is partnering with a leading consulting firm that has worked with several Fortune 150 firms to execute the turnaround model. This program has given the Company visibility to the profitability opportunities it can drive over the next three years by focusing on improvements and growth in its core businesses. These and future restructuring activities are expected to provide future growth and expense efficiency benefits. There can be no assurance that the Company’s current and future restructuring charges will achieve the cost savings and remerchandising benefits in the amounts or time anticipated.

For the year ended March 4, 2023, the Company incurred total restructuring-related costs of $108,626, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

15,342

 

$

4,088

 

$

19,430

Professional and other fees relating to restructuring activities(c)

 

71,142

 

18,054

 

89,196

Total restructuring-related costs

 

$

86,484

 

$

22,142

 

$

108,626

For the year ended February 26, 2022, the Company incurred total restructuring-related costs of $35,121, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

$

 

$

2,502

 

$

2,502

Professional and other fees relating to restructuring activities(c)

 

12,237

 

20,382

 

32,619

Total restructuring-related costs

$

12,237

 

$

22,884

 

$

35,121

90

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

For the year ended February 27, 2021, the Company incurred total restructuring-related costs of $84,552, of which $63,613 is included as a component of SG&A and $20,939 is included as a component of cost of revenues. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

13,443

 

$

4,353

 

$

17,796

Non-executive retention costs associated with the March 2019 reorganization(b)

 

1,136

 

(124)

 

1,012

Professional and other fees relating to restructuring activities(c)

 

40,053

 

4,752

 

44,805

SKU optimization charges(d)

20,939

20,939

Total restructuring-related costs

 

$

75,571

 

$

8,981

 

$

84,552

In addition, during the fiscal year ended February 27, 2021, the Company incurred intangible asset impairment charges of $29,852 in connection with its rebranding initiatives as described in Note 14, Goodwill and Other Intangibles.

A summary of activity for the year ended March 4, 2023 in the restructuring-related liabilities associated with the programs noted above, which is included in accrued salaries, wages and other current liabilities, is as follows:

Severance and related

Professional and

    

costs (a)

    

other fees (c)

    

Total

Balance as of February 26, 2022

$

4,257

 

$

4,463

 

$

8,720

Additions charged to expense 

 

11,904

10,742

 

22,646

Cash payments

 

(5,231)

(11,727)

 

(16,958)

Balance as of May 28, 2022

$

10,930

 

$

3,478

 

$

14,408

Additions charged to expense 

 

913

11,892

12,805

Cash payments

 

(2,782)

(10,066)

(12,848)

Balance as of August 27, 2022

$

9,061

$

5,304

$

14,365

Additions charged to expense 

4,800

21,700

26,500

Cash payments

(4,452)

(18,297)

(22,749)

Balance as of November 26, 2022

$

9,409

$

8,707

$

18,116

Additions charged to expense 

1,813

44,862

46,675

Cash payments

(3,564)

(11,415)

(14,979)

Balance as of March 4, 2023

 

$

7,658

 

$

42,154

 

$

49,812

(a)– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.
(b)– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.
(c)– Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.
(d)– Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.

91

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

4. Asset Sale to WBA

On September 18, 2017, the Company entered into the Amended and Restated Asset Purchase Agreement with WBA and Buyer, which amended and restated in its entirety the previously disclosed Asset Purchase Agreement, dated as of June 28, 2017, by and among the Company, WBA and Buyer. Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement, Buyer purchased from the Company 1,932 Acquired Stores, three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of $4,375,000, on a cash-free, debt-free basis (the “Asset Sale” or “Sale”). The Company completed the store transfer process in March of 2018, which resulted in the transfer of all 1,932 stores and related assets to WBA, and received cash proceeds of $4,156,686.

During the first quarter of fiscal 2021, the Company completed the sale of the final distribution center and related assets to WBA for proceeds of $94,289. The impact of the sale of the distribution center and related assets resulted in a pre-tax gain of $12,690, which was included in the results of operations and cash flows of discontinued operations during fiscal 2021. The transfer of the final distribution center and related assets constitutes the final closing under the Amended and Restated Asset Purchase Agreement.

The Company had agreed to provide transition services to Buyer for up to three years after the initial closing of the Sale. Under the terms of the TSA, the Company provided various services on behalf of WBA, including, but not limited to, the purchase and distribution of inventory and virtually all selling, general and administrative activities. The term of the TSA had been extended to October 17, 2020, unless earlier terminated. In connection with these services, the Company purchased the related inventory and incurred cash payments for the selling, general and administrative activities, which, the Company billed on a cash neutral basis to WBA in accordance with terms as outlined in the TSA. There were no billings for these items during the fifty-three week period ended March 4, 2023 and fifty-two week period ended February 26, 2022. The Company charged WBA TSA fees of $0, $0 and $1,467 during the fifty-three week period ended March 4, 2023, and fifty-two week periods ended February 26, 2022 and February 27, 2021, respectively, which are reflected as a reduction to selling, general and administrative expenses. On October 17, 2020, the Company and WBA mutually agreed to terminate the services under the TSA.

Based on its magnitude and because the Company exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). In accordance with ASC 205-20, the Company reclassified the financial results of the Disposal Group in its consolidated statements of operations and consolidated statements of cash flows for fiscal 2021. The Company also revised its discussion and presentation of operating and financial results to be reflective of its continuing operations as required by ASC 205-20.

As of March 4, 2023 and February 26, 2022, there were no assets and liabilities classified as held for sale relating to the Asset Sale to WBA.

92

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The operating results of the discontinued operations that are reflected on the consolidated statements of operations within net income from discontinued operations are as follows:

    

March 4,

    

February 26,

    

February 27,

2023

2022

2021

(53 weeks)

(52 weeks)

(52 weeks)

Revenues

$

$

$

174

Costs and expenses:

 

 

 

Cost of revenues(a)

 

 

 

8

Selling, general and administrative expenses(a)

 

 

 

871

Interest expense(b)

 

 

 

Gain on sale of assets, net

 

 

 

(14,149)

 

 

 

(13,270)

Income from discontinued operations before income taxes

 

 

 

13,444

Income tax expense

 

 

 

4,283

Net income from discontinued operations, net of tax

$

$

$

9,161

(a)Cost of revenues and selling, general and administrative expenses for the discontinued operations excludes corporate overhead. These charges are reflected in continuing operations.
(b)In accordance with ASC 205-20, the operating results for the fifty-two week period ended February 27, 2021, for the discontinued operations include interest expense relating to the outstanding indebtedness repaid with the estimated excess proceeds from the Sale.

The operating results reflected above do not fully represent the Disposal Group’s historical operating results, as the results reported within net income from discontinued operations only include expenses that are directly attributable to the Disposal Group.

93

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

5. Loss Per Share

Basic loss per share is computed by dividing loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company subject to anti-dilution limitations.

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Basic and diluted loss per share:

    

    

    

    

    

    

Numerator:

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Net income from discontinued operations

9,161

Loss attributable to common stockholders — basic and diluted

$

(719,188)

$

(522,372)

$

(90,220)

Denominator:

Basic and diluted weighted average shares

 

54,680

 

54,055

 

53,653

Basic and diluted loss per share:

Continuing operations

$

(13.15)

$

(9.66)

$

(1.86)

Discontinued operations

0.18

Net basic and diluted loss per share

$

(13.15)

$

(9.66)

$

(1.68)

Due to their anti-dilutive effect, 532, 701 and 780 potential common shares related to stock options have been excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021, respectively. Also, excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021 are restricted shares of 1,476, 1,533 and 1,293, respectively, which are included in shares outstanding.

6. Facility Exit and Impairment Charges

Impairment Charges

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that an asset group has a carrying value that may not be recoverable. The individual operating store is the lowest level for which cash flows are identifiable. As such, the Company evaluates individual stores for recoverability of assets. To determine if a store needs to be tested for recoverability, the Company considers items such as decreases in market prices, changes in the manner in which the store is being used or physical condition, changes in legal factors or business climate, an accumulation of losses significantly in excess of budget, a current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection of continuing losses, or an expectation that the store will be closed or sold.

The Company monitors new and recently relocated stores against operational projections and other strategic factors such as regional economics, new competitive entries and other local market considerations to determine if an impairment evaluation is required. For other stores, it performs a recoverability analysis if it has experienced current-period and historical cash flow losses.

94

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

In performing the recoverability test, the Company compares the expected future cash flows of a store to the carrying amount of its assets. Significant judgment is used to estimate future cash flows. Major assumptions that contribute to its future cash flow projections include expected sales, gross profit and distribution expenses; expected costs such as payroll, occupancy costs and advertising expenses; and estimates for other significant selling, general and administrative expenses. Many long-term macroeconomic and industry factors are considered, both quantitatively and qualitatively, in the future cash flow assumptions. In addition to current and expected economic conditions such as inflation, interest and unemployment rates that affect customer shopping patterns, the Company considers that it operates in a highly competitive industry which includes the actions of other national and regional drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, dollar stores and internet pharmacies. Additionally, the Company takes into consideration that certain operating stores are executing specific improvement plans which are monitored quarterly to recoup recent capital investments, such as an acquisition of an independent pharmacy, which it has made to respond to specific competitive or local market conditions, or have specific programs tailored towards a specific geography or market.

The Company recorded impairment charges of $137,075 in fiscal 2023, $150,788 in fiscal 2022 and $46,287 in fiscal 2021. The Company recorded impairment charges of $59,573 in the fourth quarter of fiscal 2023, $99,416 in the fourth quarter of fiscal 2022 and $31,057 in the fourth quarter of fiscal 2021. The Company’s methodology for recording impairment charges has been consistently applied in the periods presented.

As of March 4, 2023, $717.2 million of the Company’s long-lived assets, including intangible assets, were associated with 2,309 active operating stores. Additionally, we have approximately $2.3 billion of operating lease right-of-use assets associated with the active stores.

If an operating store’s estimated future undiscounted cash flows are not sufficient to cover its carrying value, its carrying value is reduced to fair value. Fair value is its estimated future discounted cash flows. The discount rate is commensurate with the risks associated with the recovery of a similar asset. Operating lease right-of-use assets are included within the stores’ asset groups. The Company obtains fair values of these right-of-use assets based on real estate market data.

An impairment charge is recorded in the period that the store does not meet its original return on investment and/or has an operating loss for the last two years and its projected cash flows do not exceed its current asset carrying value. The amount of the impairment charge is the entire difference between the current asset carrying value and its fair value which is the estimated future discounted cash flows.

The Company recorded impairment charges for active stores of $13,544 in fiscal 2023, $56,182 in fiscal 2022 and $29,745 in fiscal 2021.

The Company reviews key performance results for active stores on a quarterly basis and approves certain stores for closure. Impairment for closed stores, if any (many stores are closed on lease expiration), are recorded in the quarter the closure decision is approved. Closure decisions are made on an individual store or regional basis considering all of the macroeconomic, industry and other factors, in addition to the active store’s individual operating results. The Company recorded impairment charges for closed facilities of $123,531 in fiscal 2023, $94,606 in fiscal 2022 and $16,542 in fiscal 2021.

95

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following table summarizes the impairment charges and number of locations, segregated by closed facilities and active stores that have been recorded in fiscal 2023, 2022 and 2021:

March 4, 2023

February 26, 2022

February 27, 2021

(in thousands, except number of stores)

Number

    

Charge

    

Number

    

Charge

    

Number

    

Charge

Active stores:

Stores previously impaired(1)

44

$

4,866

118

$

12,339

174

$

21,372

New, relocated and remodeled stores(2)

8

 

4,640

1

 

538

2

 

1,519

Remaining stores not meeting the recoverability test(3)

12

 

4,038

88

 

43,305

19

 

6,854

Total impairment charges—active stores

64

 

13,544

207

 

56,182

195

 

29,745

Total impairment charges—closed facilities

194

123,531

147

94,606

33

16,542

Total impairment charges—all locations

258

$

137,075

354

$

150,788

228

$

46,287

(1)These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, the Company will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. The fiscal 2023 impairment charge includes $3,087 of impairment relating to the ROU and $1,779 of capital additions. The fiscal 2022 impairment charge includes $5,434 of impairment relating to the ROU and $6,905 of capital additions. The fiscal 2021 impairment charge includes $15,459 of impairment relating to the ROU and $5,913 of capital additions.
(2)These charges are related to new stores (open at least three years) and relocated stores (relocated in the last two years) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met their original return on investment projections and have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,875 of capital additions. The fiscal 2022 impairment charge includes $0 of impairment relating to the ROU and $538 of capital additions. The fiscal 2021 impairment charge includes $347 of impairment relating to the ROU and $1,172 of capital additions.
(3)These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,273 of capital additions. The fiscal 2022 impairment charge includes $26,130 of impairment relating to the ROU and $17,175 of capital additions. The fiscal 2021 impairment charge includes $3,177 of impairment relating to the ROU and $3,677 of capital additions.

96

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The primary drivers of its impairment charges are each store’s current and historical operating performance and the assumptions that the Company makes about each store’s operating performance in future periods. Projected cash flows are updated based on the next year’s operating budget which includes the qualitative factors noted above. The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:

Level 1—Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2—Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.
Level 3—Inputs to the valuation methodology are unobservable inputs based upon management’s best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.

Long-lived non-financial assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using Level 2 and Level 3 inputs as defined in the fair value hierarchy. The fair value of long-lived assets using Level 2 inputs is determined by evaluating the current economic conditions in the geographic area for similar use assets. The fair value of long-lived assets using Level 3 inputs is determined by estimating the amount and timing of net future cash flows (which are unobservable inputs) and discounting them using a risk-adjusted rate of interest (which is Level 1). The Company estimates future cash flows based on its experience and knowledge of the market in which the store is located. Significant increases or decreases in actual cash flows may result in valuation changes.

The table below sets forth by level within the fair value hierarchy the long-lived assets, which include right-of-use assets, as of the impairment measurement date for which an impairment assessment was performed and total losses as of March 4, 2023 and February 26, 2022:

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

March 4, 2023

Long-lived assets held for use

$

$

22,959

$

42,717

$

65,676

$

(132,243)

Long-lived assets held for sale

$

$

5,115

$

$

5,115

$

(4,832)

Total

$

$

28,074

$

42,717

$

70,791

$

(137,075)

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

February 26, 2022

Long-lived assets held for use

$

$

240,176

$

23,594

$

263,770

$

(150,064)

Long-lived assets held for sale

$

$

2,371

$

$

2,371

$

(724)

Total

$

$

242,547

$

23,594

$

266,141

$

(150,788)

97

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The above assets reflected in the caption ‘Long-lived assets held for sale’ have not been reclassified to assets held for sale due to their immateriality.

Lease Termination and Facility Exit Charges

The Company assesses stores and distribution centers for potential closure or relocation. Decisions to close or relocate stores or distribution centers in future periods would result in inventory liquidation charges, as well as impairment of assets at these locations. When a store or distribution center is closed, the Company records executory costs for leases, as well as other store or distribution center closing and liquidation costs, when incurred.

In fiscal 2023, 2022 and 2021, the Company recorded facility exit charges of $43,562, $13,296 and $11,427, respectively.

The Company calculates the liability for facility exit or disposal cost obligations to include long-term contract termination costs and costs related to the disposal of long-lived assets.

The following table reflects the accrued facility exit charges:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Balance—beginning of period

$

1,892

$

2,754

$

2,253

Provision for facility exit charges

 

461

 

162

793

Changes in assumptions and other adjustments

Interest accretion

 

 

 

Cash payments

 

(125)

 

(1,024)

 

(292)

Balance—end of period

$

2,228

$

1,892

$

2,754

The Company’s revenues and income before income taxes for fiscal 2023, 2022 and 2021 included results from stores that have been closed or are approved for closure as of March 4, 2023. The revenue, operating expenses and income before income taxes of these stores for the periods are presented as follows:

Year Ended

March 4,

February 26,

February 27,

    

2023

    

2022

    

2021

Revenues

$

178,030

$

586,056

$

639,471

Operating expenses

 

192,357

 

640,996

 

699,662

Gain from sale of assets

 

(46,125)

 

(13,670)

 

(7,954)

Other expenses

 

25,396

52,999

13,057

Income (loss) before income taxes

 

6,402

 

(94,269)

 

(65,294)

Included in these stores’ income (loss) before income taxes are:

Depreciation and amortization

 

934

 

3,499

 

4,535

Inventory liquidation charges

 

(6,369)

 

(1,646)

 

(1,528)

98

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The above results are not necessarily indicative of the impact that these closures will have on revenues and operating results of the Company in the future, as the Company often transfers the business of a closed store to another Company store, thereby retaining a portion of these revenues and operating expenses.

7. Fair Value Measurements

The Company utilizes the three-level valuation hierarchy as described in Note 6 for the recognition and disclosure of fair value measurements.

As of March 4, 2023 and February 26, 2022, the Company did not have any financial assets measured on a recurring basis. Please see Note 6 and Note 14 for fair value measurements of non-financial assets measured on a non-recurring basis.

Other Financial Instruments

Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets. The Company believes the carrying value of these investments approximates their fair value.

The fair value for Secured Overnight Financing Rate (“SOFR”) based borrowings as of March 4, 2023 and LIBOR-based borrowings as of February 26, 2022 under the Company’s senior secured credit facility is estimated based on the quoted market price of the financial instrument which is considered Level 1 of the fair value hierarchy. The fair values of substantially all of the Company’s other long-term indebtedness are estimated based on quoted market prices of the financial instruments which are considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,925,258 and $2,368,328, respectively, as of March 4, 2023. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,732,986 and $2,661,122 respectively, as of February 26, 2022.

99

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

8. Income Taxes

The provision for income tax benefit from continuing operations was as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Current tax:

Federal

$

(6)

$

(6)

$

(6,758)

State

 

9,082

 

7,454

 

4,145

 

9,076

 

7,448

 

(2,613)

Deferred tax and other:

Federal

 

 

(1,301)

 

(12,649)

State

 

(15,543)

 

(9,927)

 

(4,895)

 

(15,543)

 

(11,228)

 

(17,544)

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

A reconciliation of the expected statutory federal tax and the total income tax benefit from continuing operations was as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Federal statutory rate

$

(152,388)

$

(110,492)

$

(25,103)

Nondeductible expenses

 

556

398

588

State income taxes, net

 

271,306

(45,388)

10,042

Bargain purchase gain

1,123

(10,018)

Decrease of previously recorded liabilities

 

(18,689)

(3,798)

(2,273)

Nondeductible compensation

 

2,045

1,551

3,764

Qualified fringe disallowance

342

224

313

Nondeductible excise tax

 

1,296

Stock based compensation

2,213

198

2,806

Valuation allowance

 

(112,037)

152,785

(2,222)

Other

185

(381)

650

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

Net loss for fiscal 2023 from continuing operations included an income tax benefit of $6,467. The state income tax expense reflected in the table above primarily resulted from the re-measurement of state deferred tax assets due to a reduced statutory Pennsylvania corporate net income tax rate. This state tax expense was offset by a corresponding income tax benefit of $256,411 to reduce the valuation allowance as a result of the reduced tax rate. Overall, an income tax benefit of $112,037 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.

100

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Net loss for fiscal 2022 from continuing operations included an income tax benefit of $3,780, of which $152,785 of income tax expense was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.

Net loss for fiscal 2021 from continuing operations included income tax benefit of $20,157, of which $2,222 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets. Additionally, the overall tax rate includes a permanent tax benefit related to the Company’s bargain purchase gain on the Bartell acquisition resulting in an impact of 8.4%.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on its financial statements.

The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Deferred tax assets:

Accounts receivable

$

26,769

$

22,958

Accrued expenses

 

143,207

 

95,421

Pension, retirement and other benefits

 

40,100

 

67,686

Long-lived assets

 

364,618

 

299,507

Operating lease liabilities

781,721

883,713

Credits

 

21,955

 

22,917

Net operating losses

 

1,200,516

 

1,487,639

Other

 

271

 

225

Total gross deferred tax assets

 

2,579,157

 

2,880,066

Valuation allowance

 

(1,636,461)

 

(1,818,069)

Total deferred tax assets

 

942,696

 

1,061,997

Deferred tax liabilities:

Outside basis difference

5,622

5,682

Inventory

 

244,554

 

251,221

Operating lease right-of-use assets

680,152

785,023

Total gross deferred tax liabilities

 

930,328

 

1,041,926

Net deferred tax assets

$

12,368

$

20,071

101

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

A reconciliation of the beginning and ending amount of unrecognized tax benefits from continuing operations was as follows:

    

2023

    

2022

    

2021

Unrecognized tax benefits

$

103,629

$

184,414

$

198,325

Increases to prior year tax positions

 

1

 

24

 

42

Decreases to tax positions in prior periods

 

(29,432)

 

(294)

 

(807)

Increases to current year tax positions

 

 

 

Settlements

 

 

 

Divestitures

Lapse of statute of limitations

 

(27,113)

 

(80,515)

 

(13,146)

Unrecognized tax benefits balance

$

47,085

$

103,629

$

184,414

The amount of the above unrecognized tax benefits as of March 4, 2023, February 26, 2022 and February 27, 2021 which would impact the Company’s effective tax rate, if recognized, was $1,498, $18,737 and $20,923, respectively. Additionally, any impact on the effective rate may be mitigated by the valuation allowance that is remaining against the Company’s net deferred tax assets.

The Company believes that it is reasonably possible that a decrease of up to $4,001 in unrecognized tax benefits related to state exposures may be necessary in the next twelve months, however, management does not expect the change to have a significant impact on the results of operations or the financial position of the Company.

The Company recognizes interest and penalties related to tax contingencies as income tax expense. The Company recognized an expense/(benefit) for interest and penalties in connection with tax matters of $(6,006), $(183) and $(123) for fiscal years 2023, 2022 and 2021, respectively. As of March 4, 2023 and February 26, 2022 the total amount of accrued income tax-related interest and penalties was $490 and $6,496, respectively.

The Company files U.S. federal income tax returns as well as income tax returns in those states where it does business. The consolidated federal income tax returns are closed for examination through fiscal year 2019. However, any net operating losses that were generated in these prior closed years may be subject to examination by the IRS upon utilization. Tax examinations by various state taxing authorities could generally be conducted for a period of three to five years after filing of the respective return.

Net Operating Losses and Tax Credits

As of March 4, 2023, the Company had federal net operating loss carryforwards of approximately $2,133,742. Of these, $884,668 will expire, if not utilized, between fiscal 2029 and 2031. An additional $193,961 will expire, if not utilized, between fiscal 2032 and 2038.

As of March 4, 2023, the Company had state net operating loss carryforwards of approximately $12,279,752, the majority of which will expire ratably through fiscal 2032; the net tax effect of these carryforwards is $754,483 and are reflected in the table above.

As of March 4, 2023, the Company had federal business tax credit carryforwards of $11,363, the majority of which will expire between 2024 and 2029.

102

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Valuation Allowances

The valuation allowances as of March 4, 2023 and February 26, 2022 apply to the net deferred tax assets of the Company. The Company maintained a valuation allowance of $1,636,461 and $1,818,069 as of March 4, 2023 and February 26, 2022, respectively. A valuation allowance has been recorded for fiscal 2023 and fiscal 2022 to reduce certain federal and state net deferred tax assets that may not be realized based on all available evidence that currently does not support the realization of these assets.

9. Accounts Receivable

The Company maintains an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable. The allowance for uncollectible accounts as of March 4, 2023 and February 26, 2022 was $53,453 and $28,069, respectively. The Company’s accounts receivable are due primarily from third-party payors (e.g., PBM companies, insurance companies or governmental agencies) and are recorded net of any allowances provided for under the respective plans. Since payments due from third-party payors are sensitive to payment criteria changes and legislative actions, the allowance is reviewed continually and adjusted for accounts deemed uncollectible by management.

10. Medicare Part D

The Company offers Medicare Part D benefits through EI, which has contracted with CMS to be a PDP and, pursuant to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, must be a risk-bearing entity regulated under state insurance laws or similar statutes.

EI is a licensed domestic insurance company under the applicable laws and regulations. Pursuant to these laws and regulations, EI must file quarterly and annual reports with the National Association of Insurance Commissioners (“NAIC”) and certain state regulators, must maintain certain minimum amounts of capital and surplus under formulas established by certain states and must, in certain circumstances, request and receive the approval of certain state regulators before making dividend payments or other capital distributions to the Company. The Company does not believe these limitations on dividends and distributions materially impact its financial position. EI is subject to minimum capital and surplus requirements in certain states. The minimum amount of capital and surplus required to satisfy regulatory requirements in these states is $10,693 as of December 31, 2022. EI was in excess of the minimum required amounts in these states as of March 4, 2023.

The Company has recorded estimates of various assets and liabilities arising from its participation in the Medicare Part D program based on information in its claims management and enrollment systems. Significant estimates arising from its participation in this program include: (i) estimates of low-income cost subsidies, reinsurance amounts, and coverage gap discount amounts ultimately payable to CMS based on a detailed claims reconciliation that will occur in the following year; (ii) an estimate of amounts receivable from CMS under a risk-sharing feature of the Medicare Part D program design, referred to as the risk corridor and; (iii) estimates for claims that have been reported and are in the process of being paid or contested and for our estimate of claims that have been incurred but have not yet been reported.

On November 12, 2020, the Company entered into a receivable purchase agreement (the “November 2020 Receivable Purchase Agreement”) with Bank of America, N.A. (the “Purchaser”).

103

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Pursuant to the terms and conditions set forth in the November 2020 Receivable Purchase Agreement, the Company sold $464,019, a portion of its calendar 2020 CMS receivable, for $444,812, of which $412,795 was received on November 12, 2020 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $19,207, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 28, 2020.

On November 12, 2020, concurrent with the November 2020 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “November 2020 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the November 2020 Indemnity Agreement. Based on its evaluation of the November 2020 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the November 2020 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the November 2020 Indemnity Agreement.

On February 18, 2021, the Company entered into a receivable purchase agreement (the “February 2021 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the February 2021 Receivable Purchase Agreement, the Company sold $300,015, the remaining portion of its calendar 2020 CMS receivable, for $290,613, of which $269,912 was received on February 18, 2021 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $9,403, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 27, 2021.

On February 18, 2021, concurrent with the February 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2021 Indemnity Agreement. Based on its evaluation of the February 2021 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2021 Indemnity Agreement.

On August 12, 2021, the Company entered into a receivable purchase agreement (the “August 2021 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the August 2021 Receivable Purchase Agreement, the Company sold $271,829, a portion of its calendar 2021 CMS receivable, for $258,116, of which $239,360 was received on August 12, 2021 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,713, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended August 28, 2021.

On August 12, 2021, concurrent with the August 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “August 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the August 2021 Indemnity Agreement. Based on its evaluation of the August 2021 Indemnity Agreement, the Company has determined that it is highly unlikely

104

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

that the events covered under the August 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the August 2021 Indemnity Agreement.

On January 24, 2022, the Company entered into a receivable purchase agreement (the “January 2022 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the January 2022 Receivable Purchase Agreement, the Company sold $400,680, a portion of its calendar 2021 CMS receivable, for $387,035, of which $359,388 was received on January 24, 2022 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,645, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 26, 2022.

On January 24, 2022, concurrent with the January 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “January 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the January 2022 Indemnity Agreement. Based on its evaluation of the January 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the January 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the January 2022 Indemnity Agreement.

On October 13, 2022, the Company entered into a receivable purchase agreement (the “October 2022 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the October 2022 Receivable Purchase Agreement, the Company sold $195,487, a portion of its calendar 2022 CMS receivable, for $180,405, of which $166,917 was received on October 13, 2022. The remaining $13,488, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $15,082, which was included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 26, 2022.

On October 13, 2022, concurrent with the October 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “October 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse, and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the October 2022 Indemnity Agreement. Based on its evaluation of the October 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the October 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the October 2022 Indemnity Agreement.

During the thirteen-week period ended November 26, 2022, the Company incurred additional fees of $1,937, which were included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable.

On February 3, 2023, the Company entered into a receivable purchase agreement (the “February 2023 Receivable Purchase Agreement”) with Purchaser.

105

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Pursuant to the terms and conditions set forth in the February 2023 Receivable Purchase Agreement, the Company sold $278,390, a portion of its calendar 2022 CMS receivable, for $261,771, of which $242,562 was received on February 3, 2023. The remaining $19,209, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $16,619, which is included as a component of (gain) loss on sale of assets, net during the fourteen-week period ended March 4, 2023.

On February 3, 2023, concurrent with the February 2023 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2023 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2023 Indemnity Agreement. Based on its evaluation of the February 2023 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2023 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2023 Indemnity Agreement.

During the fourteen-week period ended March 4, 2023, the company incurred additional fees of $2,573, which are included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable.

As of March 4, 2023 and February 26, 2022, accounts receivable, net included $22,362 and $34,898 due from the Purchaser, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance for the respective calendar years from CMS.

As of March 4, 2023 and February 26, 2022, accounts receivable, net included $45,201 and $63,203 of amounts due from CMS.

The Inflation Reduction Act of 2022 contains several provisions affecting Medicare, which will take effect over various periods of time from 2023 to 2029. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on the financial statements.

11. Manufacturer Rebates Receivables

The Pharmacy Services Segment has manufacturer rebates receivables of $357,699 and $535,620 included in Accounts receivable, net of an allowance for uncollectible rebates of $8,680 and $18,796, as of March 4, 2023 and February 26, 2022, respectively.

During the thirteen-week period ended February 26, 2022, the Company reassessed its historical policy for estimating its allowance for manufacturer rebate receivables and concluded that, due to changes in its business practices and other market conditions, certain amounts within the outstanding receivable had an increased risk of uncollectability. As a result, the Company increased its allowance for manufacturer rebate receivables by $15,068, which was recorded as an increase to costs of revenue during the thirteen-week period ended February 26, 2022. The Company determined that this change in estimate is a non-recurring item that should be added back to Adjusted EBITDA (see “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non GAAP Measures” for details).

106

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

12. Inventory

As of March 4, 2023 and February 26, 2022, inventories were $539,932 and $487,173, respectively, lower than the amounts that would have been reported using the first-in, first-out (“FIFO”) cost flow assumption. The Company calculates its FIFO inventory valuation using the retail method for store inventories and the cost method for distribution facility inventories. The Company recorded a LIFO charge of $53,028 and $1,314, for fiscal year 2023 and 2022, respectively, and a LIFO credit of $51,692 for fiscal year 2021. During fiscal 2023, 2022 and 2021, a reduction in non-pharmacy inventories resulted in the liquidation of applicable LIFO inventory quantities carried at lower costs in prior years. This LIFO liquidation resulted in a $31,857, $13,090 and $26,861 cost of revenues decrease, with a corresponding reduction to the adjustment to LIFO for fiscal 2023, fiscal 2022 and fiscal 2021, respectively.

13. Property, Plant and Equipment

Following is a summary of property, plant and equipment, including capital lease assets, as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Land

$

69,588

$

83,485

Buildings

 

208,681

 

314,143

Leasehold improvements

 

1,568,983

 

1,566,082

Equipment

 

1,855,083

 

1,794,937

Software

89,597

92,139

Construction in progress

 

109,690

 

97,715

 

3,901,622

 

3,948,501

Accumulated depreciation

 

(2,993,851)

 

(2,959,334)

Property, plant and equipment, net

$

907,771

$

989,167

Depreciation expense, which included the depreciation of assets recorded under capital leases, was $202,559, $217,639 and $238,104 in fiscal 2023, 2022 and 2021, respectively.

Included in property, plant and equipment was the carrying amount, which approximates fair value, of assets to be disposed of totaling $3,972 and $1,463 as of March 4, 2023 and February 26, 2022, respectively.

14. Goodwill and Other Intangibles

Goodwill and indefinite-lived assets, such as certain trademarks acquired in connection with acquisition transactions, are not amortized, but are instead evaluated for impairment on an annual basis at the end of the fiscal year, or more frequently if events or circumstances indicate it may be more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, the Company performs a quantitative goodwill impairment test. The fair value estimates used in the quantitative impairment test are calculated using an average of the income and market approaches. The income approach is based on the present value of future cash flows of each reporting unit, while the market approach is based on certain multiples of selected guideline public companies or selected guideline transactions. The approaches, which qualify as Level 3 within the fair value hierarchy, incorporate a number of market participant assumptions including future growth rates, discount rates, income tax rates and market activity in assessing fair value and are reporting unit specific. If the carrying amount exceeds the reporting unit’s fair value, the

107

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. In addition, the Company considers the income tax effect of any tax deductible goodwill when measuring a goodwill impairment loss.

In the fourth quarter of fiscal 2021, the Company completed a quantitative goodwill impairment assessment and determined after evaluating the results, events and circumstances, that sufficient evidence existed to assert that it is more likely than not that the fair values of the reporting units exceeded their carrying values. Therefore, no goodwill impairment charge was recorded for the fiscal year ended February 27, 2021.

In the fourth quarter of fiscal 2022, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to a decrease in Adjusted EBITDA that was driven by commercial and Medicare Part D business compression due to industry consolidation, an increase in the medical loss ratio at Elixir Insurance, and a decision to exit our rebate aggregation business. This resulted in goodwill impairment charges of $229,000 for the fiscal year ended February 26, 2022.

In the second quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to an update to the Company’s preliminary fiscal 2024 and beyond forecasted revenue driven by current updates in the estimate of lives for calendar year 2023 based on the latest estimates of existing client retention for 2023, the latest selling season and EI bid results and other business factors which only became evident during the second quarter. This resulted in goodwill impairment charges of $252,200 in the second quarter of fiscal 2023.

In the fourth quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to downward macroeconomic pressure during the fourth quarter of fiscal 2023 which manifested in increased interest rates, increased cost of borrowing and a decrease of industry multiples. The market factors that drove the goodwill impairment charges of $119,000 in the fourth quarter of fiscal 2023 were not known in prior quarters.

The goodwill related to the Pharmacy Services Segment is at risk of future impairment if the fair value of this segment, and its associated assets, decrease in value due to further declines in its operating results or an inability to execute management’s business strategies. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company's estimates. If the Company's ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record impairment charges in future periods.

As of March 4, 2023 and February 26, 2022, the accumulated impairment losses for the Pharmacy Services Segment was $1,174,912 and $803,712, respectively.

108

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Below is a summary of the changes in the carrying amount of goodwill by segment for the fiscal years ended March 4, 2023 and February 26, 2022:

    

Retail

    

Pharmacy

    

Pharmacy

Services

Total

Balance, February 27, 2021

 

$

43,492

$

1,064,644

$

1,108,136

Goodwill impairment

(229,000)

(229,000)

Balance, February 26, 2022

43,492

835,644

879,136

Goodwill impairment

(371,200)

(371,200)

Balance, March 4, 2023

$

43,492

$

464,444

$

507,936

The Company’s intangible assets are primarily finite-lived and amortized over their useful lives. Following is a summary of the Company’s finite-lived and indefinite-lived intangible assets as of March 4, 2023 and February 26, 2022.

March 4, 2023

February 26, 2022

Remaining

Remaining

Weighted

Weighted

Gross

Average

Gross

Average

Carrying

Accumulated

Amortization

Carrying

Accumulated

Amortization

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

$

201,919

$

(182,957)

$

18,962

3

years

$

197,651

$

(178,958)

$

18,693

3

years

Prescription files

 

1,029,665

(928,478)

101,187

 

5

years

 

1,030,169

 

(918,773)

111,396

 

6

years

Customer relationships(a)

388,000

(306,139)

81,861

9

years

388,000

(286,090)

101,910

10

years

CMS license

57,500

(23,798)

33,702

4

years

57,500

(15,372)

42,128

5

years

Claims adjudication and other developed software

58,985

(58,985)

0

years

58,985

(56,316)

2,669

1

years

Total finite

$

1,736,069

$

(1,500,357)

235,712

$

1,732,305

$

(1,455,509)

$

276,796

Trademarks

14,400

14,400

Indefinite

14,400

14,400

Indefinite

Total

$

1,750,469

$

(1,500,357)

$

250,112

$

1,746,705

$

(1,455,509)

$

291,196

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.

The Company is continuing to reposition its approach to the Elixir Insurance Part D business including an expectation of a purposeful shrinkage of the business. As a result, at the end of fiscal 2022, the Company adjusted the remaining amortization period of the CMS License to five years. Prior to such adjustment, the remaining life was nineteen years.

In connection with the restructuring initiatives previously announced on March 16, 2020, the Company rebranded its EnvisionRxOptions and MedTrak subsidiaries to its new brand name, Elixir. These trademarks qualify as Level 3 within the fair value hierarchy. Upon the implementation of the rebranding initiatives during the first quarter of fiscal 2021, the Company has determined that the carrying value exceeded the fair value and consequently the Company incurred an impairment charge of $29,852 for these trademarks, which is included within intangible asset impairment charges within the consolidated statement of operations.

Amortization expense for these intangible assets and liabilities was $74,024, $78,047 and $89,020 for fiscal 2023, 2022 and 2021, respectively. The anticipated annual amortization expense for these intangible assets and liabilities is 2024—$61,343; 2025—$50,209; 2026—$39,771; 2027—$32,779 and 2028—$25,299.

109

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

15. Accrued Salaries, Wages and Other Current Liabilities

Accrued salaries, wages and other current liabilities consisted of the following as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Accrued wages, benefits and other personnel costs

$

190,664

$

291,004

Accrued interest

 

18,630

 

18,286

Accrued sales and other taxes payable

 

86,920

 

75,068

Accrued store expense

 

71,398

 

70,537

Accrued litigation, legal and professional fees

41,205

43,200

Accrued self-insurance

25,760

28,402

Other

 

275,314

 

250,062

$

709,891

$

776,559

110

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

16. Indebtedness and Credit Agreement

Following is a summary of indebtedness and lease financing obligations as of March 4, 2023 and February 26, 2022:

March 4,

February 26,

    

2023

    

2022

Secured Debt:

Senior secured revolving credit facility due August 2026 ($1,200,000 and $709,000 face value less unamortized debt issuance costs of $16,117 and $18,010)

1,183,883

690,990

FILO Term Loan due August 2026 ($400,000 and $350,000 face value less unamortized debt issuance costs of $2,090 and $2,344)

397,910

347,656

 

1,581,793

 

1,038,646

Second Lien Secured Debt:

7.5% senior secured notes due July 2025 ($320,002 and $600,000 face value less unamortized debt issuance costs of $2,529 and $6,824)

 

317,473

 

593,176

8.0% senior secured notes due November 2026 ($849,918 face value less unamortized debt issuance costs of $11,259 and $14,397)

838,659

835,521

1,156,132

1,428,697

Unguaranteed Unsecured Debt:

7.7% notes due February 2027 ($185,691 and $237,386 face value less unamortized debt issuance costs of $398 and $642)

 

185,293

 

236,744

6.875% fixed-rate senior notes due December 2028 ($2,046 and $29,001 face value less unamortized debt issuance costs of $6 and $102)

 

2,040

 

28,899

 

187,333

 

265,643

Lease financing obligations

 

18,912

 

20,374

Total debt

 

2,944,170

 

2,753,360

Current maturities of long-term debt and lease financing obligations

 

(6,332)

 

(5,544)

Long-term debt and lease financing obligations, less current maturities

$

2,937,838

$

2,747,816

Credit Facilities

On December 20, 2018, the Company entered into a senior secured credit agreement (as amended by the First Amendment to Credit Agreement, dated as of January 6, 2020, the “Prior Credit Agreement”; and the Credit Agreement, as further amended by the Second Amendment (as defined below), the “Prior Amended Credit Agreement”), which provided for facilities consisting of a $2,700,000 senior secured asset-based revolving credit facility and a $450,000 “first-in, last-out” senior secured term loan facility, the proceeds of which were used in December 2018 to refinance its prior $2,700,000 existing credit agreement.

111

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

On August 20, 2021, the Company entered into the Second Amendment to Credit Agreement (the “Second Amendment”), which, among other things, amended the Prior Credit Agreement to provide for a $2,800,000 senior secured asset-based revolving credit facility (the “Prior Senior Secured Revolving Credit Facility”) and a $350,000 “first-in, last-out” senior secured term loan facility (“Prior Senior Secured Term Loan” and together with the Prior Senior Secured Revolving Credit Facility, collectively, the “Prior Amended Facilities”). The Prior Amended Facilities extended the Company’s debt maturity profile and provided additional liquidity. Borrowings under the Prior Senior Secured Revolving Credit Facility bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of between 0.25% to 0.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of between 1.25% and 1.75%, in each case based upon the Average ABL Availability (as defined in the Prior Amended Credit Agreement). Borrowings under the Prior Senior Secured Term Loan bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of 1.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of 2.75%.

On December 1, 2022, the Company entered into the Third Amendment to Credit Agreement (the “Third Amendment”), which, among other things, amended the Prior Amended Credit Agreement (the Prior Amended Credit Agreement, as modified by the Third Amendment, the “Existing Credit Agreement”) to provide for a $2,850,000 senior secured asset-based revolving credit facility (the “Existing Senior Secured Revolving Credit Facility”) and a $400,000 “first-in, last-out” senior secured term loan facility (the “Existing Senior Secured Term Loan” and, together with the Existing Senior Secured Revolving Credit Facility, collectively, the “Existing Facilities”), replaced the LIBOR rate with a Term SOFR-based rate as the applicable benchmark for the Existing Facilities, included COVID-19 vaccines in the borrowing base under the Existing Senior Secured Revolving Credit Facility, subject to limitations and conditions as specified in the Existing Credit Agreement, and increased the interest rate applicable to loans under the Existing Senior Secured Term Loan to (x) a base rate (determined in a customary manner) plus a margin of 2.00% or (y) an adjusted Term SOFR-based rate (determined in a customary manner) plus a margin of 3.00%.

The Company is required to pay fees between 0.250% and 0.375% per annum on the daily unused amount of the commitments under the Existing Senior Secured Revolving Credit Facility, depending on Average ABL Availability (as defined in the Existing Credit Agreement). The Existing Facilities are scheduled to mature on August 20, 2026 (subject to a springing maturity if certain of the Company’s existing secured notes are not refinanced or repaid prior to the date that is 91 days prior to the stated maturity thereof).

The Company’s borrowing capacity under the Existing Senior Secured Revolving Credit Facility is based upon a specified borrowing base consisting of accounts receivable, inventory and prescription files. As of March 4, 2023, the Company had approximately $1,600,000 of borrowings outstanding under the Existing Facilities and had letters of credit outstanding under the Existing Senior Secured Revolving Credit Facility in a face amount of approximately $208,698, which resulted in remaining borrowing capacity under the Existing Senior Secured Revolving Credit Facility of $1,403,996. If at any time the total credit exposure outstanding under the Existing Senior Secured Revolving Credit Facility exceeds the borrowing base, the Company will be required to repay amounts outstanding to eliminate such shortfall.

The Existing Credit Agreement restricts the Company and all of its subsidiaries including the subsidiaries that guarantee its obligations under the Existing Facilities, the secured guaranteed notes and unsecured guaranteed notes (collectively, the “Subsidiary Guarantors”) from accumulating cash on hand in excess of $200,000 at any time when revolving loans are outstanding (not including cash located in store and lockbox deposit accounts and cash necessary to cover current liabilities). The Existing Credit Agreement also states that if at any time (other than following the exercise of remedies or acceleration of any senior obligations or second priority debt and receipt of a triggering notice by the

112

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

senior collateral agent from a representative of the senior obligations or the second priority debt) either (i) an event of default exists under the Existing Facilities or (ii) availability under the Existing Senior Secured Revolving Credit Facility is less than or equal to $283,250 for three consecutive business days or less than or equal to $206,000 on any day (a “cash sweep period”), the funds in the Company’s deposit accounts will be swept to a concentration account with the senior collateral agent and will be applied first to repay outstanding revolving loans under the Existing Facilities, and then held as collateral for the senior obligations until such cash sweep period is rescinded pursuant to the terms of the Existing Facilities.

The Company’s obligations under the Existing Facilities and the Subsidiary Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on all of the Subsidiary Guarantors’ cash and cash equivalents, accounts receivable, inventory, prescription files (including eligible script lists), intellectual property (prior to the repayment of the Existing Senior Secured Term Loan) and certain other assets arising therefrom or related thereto (including substantially all of their deposit accounts, collectively, the “ABL priority collateral”) and (ii) a second-priority lien on all of the Subsidiary Guarantors’ equipment, fixtures, investment property (other than equity interests in subsidiaries), intellectual property (following the repayment of the Existing Senior Secured Term Loan) and all other assets that do not constitute ABL priority collateral, in each case, subject to customary exceptions and limitations.

The Existing Credit Agreement allows the Company to have outstanding, at any time, up to an aggregate principal amount of $1,500,000 in secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock in addition to borrowings under the Existing Facilities and existing indebtedness, provided that not in excess of $750,000 of such secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock shall mature or require scheduled payments of principal prior to 90 days after the latest maturity date of any Term Loan or Other Revolving Commitment (each as defined in the Existing Credit Agreement) (excluding bridge facilities allowing extensions on customary terms to at least the date that is 90 days after such date). Subject to the limitations described in the immediately preceding sentence, the Existing Credit Agreement additionally allows the Company to issue or incur an unlimited amount of unsecured debt and disqualified preferred stock so long as a Financial Covenant Effectiveness Period (as defined in the Existing Credit Agreement) is not in effect; provided, however, that certain of the Company’s other outstanding indebtedness limits the amount of unsecured debt that can be incurred if certain interest coverage levels are not met at the time of incurrence or other exemptions are not available. The Existing Credit Agreement also contains certain restrictions on the amount of secured first priority debt the Company is able to incur. The Existing Credit Agreement also allows for the voluntary repurchase of any debt or other convertible debt, so long as the Existing Facilities are not in default and the Company maintains availability under its revolver of more than $375,950.

The Existing Credit Agreement has a financial covenant that requires the Company to maintain a minimum fixed charge coverage ratio of 1.00 to 1.00 (i) on any date on which availability under the Existing Senior Secured Revolving Credit Facility is less than $206,000 or (ii) on the third consecutive business day on which availability under the Existing Senior Secured Revolving Credit Facility is less than $257,500 and, in each case, ending on and excluding the first day thereafter, if any, which is the 30th consecutive calendar day on which availability under the revolver is equal to or greater than $257,500. As of March 4, 2023, the availability under the Existing Senior Secured Revolving Credit Facility was at a level that did not trigger the Existing Credit Agreement’s financial covenant. The Existing Credit Agreement also contains covenants which place restrictions on the incurrence of debt, the payments of dividends, the making of investments, sale of assets, mergers and acquisitions and the granting of liens.

The Existing Credit Agreement provides for customary events of default including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if the Company fails to make any

113

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

required payment on debt having a principal amount in excess of $50,000 or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity or require the repayment, repurchase, redemption or defeasance of such debt.

Fiscal 2021, 2022 and 2023 Transactions

On June 25, 2020, the Company commenced an offer to exchange (the “June 25, 2020 Exchange Offer”) up to $750,000 aggregate principal amount of the outstanding 6.125% Senior Notes due 2023 (the “6.125% Notes”) for a combination of $600,000 newly issued 8.0% Senior Secured Notes due 2026 (the “8.0% Notes”) and $145,500 cash. On July 10, 2020, the Company increased the maximum amount of 6.125% Notes that may be accepted for exchange from $750,000 to $1,125,000 and, on July 24, 2020, the Company announced that it accepted for payment $1,062,682 aggregate principal amount of the 6.125% Notes in exchange for $849,918 aggregate principal amount of newly issued 8.0% Notes and $206,373 in cash. In connection therewith, the Company recorded a gain on debt modification of $5,274 which is included in the results of operations and cash flows of continuing operations. The 8.0% Notes are secured on an equal and ratable basis by the same assets that secure the 7.500% Notes. The 8.0% Notes are guaranteed on a senior secured basis by the same subsidiaries that guarantee the 7.500% Notes. In conjunction with the June 25, 2020 Exchange Offer, the Company also commenced a solicitation of consents from the holders of outstanding 6.125% Notes to certain proposed amendments to the indenture governing the 6.125% Notes. On July 9, 2020, following the receipt of the requisite number of consents, the Company entered into a supplemental indenture, which modified certain limitations in the debt covenant to allow for the creation of the 8.0% Notes.

On April 28, 2021, the Company issued a notice of redemption for all of the 6.125% Notes that were outstanding on May 28, 2021, pursuant to the terms of the indenture of the 6.125% Notes. On May 28, 2021, the Company redeemed 100% of the remaining outstanding 6.125% Notes at par. In connection therewith, the Company recorded a loss on debt retirement of $396 which included unamortized debt issuance costs. The debt repayment and related loss on debt retirement is included in the results of operations and cash flows.

On August 20, 2021, the Company entered into the Second Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Prior Senior Secured Revolving Credit Facility from $2,700,000 to $2,800,000 and decrease the aggregate principal amount of loans outstanding under the Prior Senior Secured Term Loan from $450,000 to $350,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $2,839 which included unamortized debt issuance costs. The debt repayment and related loss on debt modification and retirement is included in the results of operations and cash flows.

On June 13, 2022, the Company commenced a series of cash tender offers to purchase up to $150,000 aggregate principal amount of the Company’s 7.500% Senior Secured Notes due 2025 (the “7.500% Notes”), 8.0% Notes), 7.70% Notes due 2027 (the “7.70% Notes”) and 6.875% Notes due 2028 (the “6.875% Notes”), subject to prioritized acceptance levels, a subcap of $100,000 with respect to the 7.500% Notes and proration. On June 29, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $114,942 of its 7.500% Notes, $51,695 aggregate principal amount of its 7.70% Notes and $26,955 aggregate principal amount of its 6.875% Notes. In connection therewith, the Company recorded a gain on debt retirement of $41,312, which included unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On November 3, 2022, the Company announced the commencement of a cash tender offer to purchase up to $200,000 aggregate purchase price (not including any accrued and unpaid interest) of the Company’s 7.500% Notes,

114

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

subject to proration. On November 30, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $160,497 of its 7.500% Notes and on December 9, 2022, pursuant to the final settlement, the Company purchased an additional aggregate principal amount of $4,559 of its 7.500% Notes. In connection therewith, the Company recorded a gain on debt retirement of $38,978, which includes unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On December 1, 2022, the Company entered into the Third Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Existing Senior Secured Revolving Credit Facility from $2,800,000 to $2,850,000 and increase the aggregate principal amount of loans outstanding under the Existing Senior Secured Term Loan from $350,000 to $400,000. As a result of the Third Amendment, the Company has increased its liquidity by $100,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $148, which includes unamortized debt issuance costs. The related loss on debt modification and retirement is included in the results of operations and cash flows.

Interest Rates and Maturities

The annual weighted average interest rate on the Company’s indebtedness was 7.2%, 5.6% and 5.4% for fiscal 2023, 2022 and 2021, respectively.

The aggregate annual principal payments of long-term debt for the five succeeding fiscal years are as follows: 2024—$0; 2025—$0; 2026—$320,002; 2027—$2,635,609 and $2,046 in 2028 and thereafter.

17. Leases

The Company leases most of its retail stores and certain distribution facilities under noncancellable operating and finance leases, most of which have initial lease terms ranging from 5 to 22 years. The Company also leases certain of its equipment and other assets under noncancellable operating leases with initial terms ranging from 3 to 10 years. In addition to minimum rental payments, certain store leases require additional payments based on sales volume, as well as reimbursements for taxes, maintenance and insurance. Most leases contain renewal options, certain of which involve rent increases.

The following table is a summary of the Company’s components of net lease cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Year Ended

March 4, 2023

    

February 26, 2022

    

February 27, 2021

Operating lease cost

 

$

641,394

$

669,421

$

651,261

Financing lease cost:

Amortization of right-of-use asset

 

3,471

3,638

4,359

Interest on long-term finance lease liabilities

 

1,968

2,167

2,505

Total finance lease costs

 

$

5,439

$

5,805

$

6,864

Short-term lease costs

 

3,126

3,180

3,214

Variable lease costs

 

178,263

175,697

172,088

Less: sublease income

 

(12,871)

(13,510)

(14,886)

Net lease cost

 

$

815,351

$

840,593

$

818,541

115

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Supplemental cash flow information related to leases for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Year Ended

    

March 4, 2023

    

February 26, 2022

 

February 27, 2021

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows paid for operating leases

 

$

706,506

 

$

703,326

 

$

683,226

Operating cash flows paid for interest portion of finance leases

 

1,968

 

2,167

 

2,505

Financing cash flows paid for principal portion of finance leases

 

4,019

 

4,117

 

4,744

Right-of-use assets obtained in exchange for lease obligations:

Operating leases

 

264,507

 

350,132

 

513,215

Finance leases

 

 

 

Supplemental balance sheet information related to leases as of March 4, 2023 and February 26, 2022 (in thousands, except lease term and discount rate):

March 4,

 

February 26,

 

    

2023

 

2022

 

Operating leases:

Operating lease right-of-use asset

 

$

2,497,206

$

2,813,535

Short-term operating lease liabilities

 

$

502,403

$

575,651

Long-term operating lease liabilities

 

2,372,943

 

2,597,090

Total operating lease liabilities

 

$

2,875,346

$

3,172,741

Finance leases:

Property, plant and equipment, net

 

$

13,576

$

13,950

Current maturities of long-term debt and lease financing obligations

 

$

6,332

$

5,544

Lease financing obligations, less current maturities

 

12,580

 

14,830

Total finance lease liabilities

 

$

18,912

$

20,374

Weighted average remaining lease term

Operating leases

 

7.5

 

7.7

Finance leases

 

8.0

 

8.7

Weighted average discount rate

Operating leases

 

6.5

%

 

6.0

%

Finance leases

 

9.0

%

 

10.0

%

As a result of the Sale to WBA and the related Amended and Restated Asset Purchase Agreement, the Company has lease guarantee obligations related to 676 former stores. The Company is only obligated to pay for the lease guarantees in the event that WBA fails to perform under the lease agreements, as WBA is the primary obligor.

116

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following table summarizes the maturity of lease liabilities under finance and operating leases as of March 4, 2023:

March 4, 2023

Finance

Operating

Fiscal year

    

Leases

    

 Leases(1)

    

Total

2024

 

$

3,188

 

$

677,631

 

$

680,819

2025

 

7,732

 

593,857

 

601,589

2026

 

2,421

 

507,388

 

509,809

2027

 

1,567

 

426,503

 

428,070

2028

 

1,500

 

351,942

 

353,442

Thereafter

 

10,923

 

1,148,719

 

1,159,642

Total lease payments

 

27,331

 

3,706,040

 

3,733,371

Less: imputed interest

 

(8,419)

 

(830,694)

 

(839,113)

Total lease liabilities

 

$

18,912

 

$

2,875,346

 

$

2,894,258

(1)Future operating lease payments have not been reduced by minimum sublease rentals of $24.0 million due in the future under noncancelable leases.

Sale-Leaseback Transactions:

During the year ended March 4, 2023, the Company sold twelve owned and operated properties, including the Pontiac, MI and Liverpool, NY distribution centers and ten retail stores to independent third parties. Net proceeds from the sales were $73,344. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years for the retail stores and over a minimum lease term of three years for the distribution centers. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $38,214 which is included in the (gain) loss on sale of assets, net for fifty-three weeks ended March 4, 2023.

During the year ended February 26, 2022, the Company sold twenty owned and operating properties to independent third parties. Net proceeds from the sale were $57,498. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $8,600 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 26, 2022.

During the year ended February 27, 2021, the Company sold eleven owned and operating properties, including the Company’s Perryman, MD, Woodland, CA, and Lancaster, CA distribution centers, the Company’s Ice Cream Plant and seven retail stores to independent third parties. Net proceeds from the sales were $177,892. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over minimum lease terms between 15 and 20 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $93,841 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 27, 2021.

The Company has additional capacity under its outstanding debt agreements to enter into additional sale-leaseback transactions.

117

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

18. Stock Option and Stock Award Plans

The Company recognizes share-based compensation expense in accordance with ASC 718, “Compensation—Stock Compensation.” Expense is recognized over the requisite service period of the award, net of an estimate for the impact of forfeitures. Operating results for fiscal 2023, 2022 and 2021 include $11,537, $13,050 and $13,003 of compensation costs related to the Company’s stock-based compensation arrangements.

In June 2010, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2010 Omnibus Equity Plan. Under the plan, 1,750 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2010 Omnibus Equity Plan became effective on June 23, 2010.

In June 2012, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2012 Omnibus Equity Plan. Under the plan, 1,425 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2012 Omnibus Equity Plan became effective on June 21, 2012.

In June 2014, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2014 Omnibus Equity Plan. Under the plan, 2,900 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan and the Rite Aid Corporation 2012 Omnibus Equity Plan as of the effective date of the 2014 Plan (provided that no more than 1,250 shares may be granted as incentive stock options) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2014 Omnibus Equity Plan became effective on June 19, 2014.

In July 2020, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,350 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan, the Rite Aid Corporation 2012 Omnibus Equity Plan and the Rite Aid Corporation 2014 Omnibus Equity Plan (collectively, the “Prior Plans”) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2020 Omnibus Equity Plan became effective on July 8, 2020. Upon the adoption date, shares of common stock may no longer be issued pursuant to the Prior Plans.

In July 2021, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 4,562 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 7, 2021.

In July 2022, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,250 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 27, 2022.

118

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

All of the plans provide for the Board of Directors (or at its election, the Compensation Committee) to determine both when and in what manner options may be exercised; however, it may not be more than 10 years from the date of grant. All of the plans provide that stock options may be granted at prices that are not less than the fair market value of a share of common stock on the date of grant. The aggregate number of remaining shares authorized for issuance for all plans is 3,628 as of March 4, 2023.

Stock Options

The Company determines the fair value of stock options issued on the date of grant using the Black-Scholes-Merton option-pricing model. The Company did not grant any options in fiscal 2023, 2022 and 2021

The weighted average fair value of options granted during fiscal 2023, 2022 and 2021 was $0.00. Following is a summary of stock option transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

    

    

Weighted

    

Weighted

    

Average

Average

Exercise

Remaining

Aggregate

Price

Contractual

Intrinsic

Shares

Per Share

Term

Value

Outstanding as of February 29, 2020

 

1,295

$

30.29

Granted

 

 

N/A

Exercised

 

(2)

 

25.08

Canceled

 

(513)

 

48.16

Outstanding as of February 27, 2021

 

780

$

18.56

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(79)

 

45.78

Outstanding as of February 26, 2022

 

701

$

15.50

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(169)

 

23.85

Outstanding as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Vested or expected to vest as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Exercisable as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

As of March 4, 2023, there was $0 of total unrecognized pre-tax compensation costs related to unvested stock options, net of forfeitures. These costs are expected to be recognized over a weighted average period of zero years.

Cash received from stock option exercises for fiscal 2023, 2022 and 2021 was $0, $0 and $53, respectively. The income tax benefit from stock options for fiscal 2023, 2022 and 2021 was $0, $0 and $1, respectively. The total intrinsic value of stock options exercised for fiscal 2023, 2022 and 2021 was $0, $0 and $10, respectively.

Typically, stock options granted vest, and are subsequently exercisable in equal annual installments over a four-year period for employees.

119

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Restricted Stock

The Company provides restricted stock grants to associates under plans approved by the stockholders. Shares awarded under the plans typically vest in equal annual installments over a three-year period. Unvested shares are forfeited upon termination of employment. Following is a summary of restricted stock transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

    

    

Weighted

Average

Grant Date

Shares

Fair Value

Balance as of February 29, 2020

 

1,253

$

10.32

Granted

 

780

 

17.79

Vested

 

(574)

 

13.37

Canceled

 

(166)

 

12.23

Balance as of February 27, 2021

 

1,293

$

13.23

Granted

 

973

 

15.00

Vested

 

(546)

 

12.25

Canceled

 

(187)

 

15.51

Balance as of February 26, 2022

 

1,533

$

14.42

Granted

 

1,662

 

6.50

Vested

 

(1,349)

 

12.40

Canceled

 

(370)

 

10.83

Balance as of March 4, 2023

 

1,476

$

8.25

As of March 4, 2023, there was $9,719 of total unrecognized pre-tax compensation costs related to unvested restricted stock grants, net of forfeitures. These costs are expected to be recognized over a weighted average period of 1.7 years.

The total fair value of restricted stock vested during fiscal years 2023, 2022 and 2021 was $16,746, $6,677 and $7,670, respectively.

Performance Based Incentive Plan

The Company provides certain of its associates with performance based incentive awards under its equity incentive plans, pursuant to which the associates will receive a certain number of shares of the Company’s common stock based on the Company meeting certain financial and performance goals. If such goals are not met, no stock-based compensation expense is recognized and any recognized stock-based compensation expense is reversed. The Company recorded a benefit of $3,080 and expense of $2,143 and $3,278 related to these performance based incentive awards under the Company’s equity incentive plans for fiscal 2023, 2022 and 2021, respectively, which is recorded as a component of stock-based compensation expense.

120

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

19. Retirement Plans

Defined Contribution Plans

The Company and its subsidiaries sponsor several retirement plans that are primarily 401(k) defined contribution plans covering nonunion associates and certain union associates. The Company does not contribute to all of the plans. In accordance with those plan provisions, the Company matches 100% of a participant’s pre-tax payroll contributions, up to a maximum of 3% of such participant’s pre-tax annual compensation. Thereafter, the Company will match 50% of the participant’s additional pre-tax payroll contributions, up to a maximum of 2% of such participant’s additional pre-tax annual compensation. Total expense recognized for the above plans was $44,504 in fiscal 2023, $41,528 in fiscal 2022 and $36,270 in fiscal 2021.

The Company sponsored a Supplemental Executive Retirement Plan (“SERP”) for its officers, based on an account-based plan design, that was subject to a five-year graduated vesting schedule. On February 25, 2019, the SERP was terminated and additional allocations were discontinued and all prior benefits under the program became fully vested. During fiscal 2020, participant benefits under this program were paid in full. No expense was recognized for the SERP in fiscal 2023, 2022 or 2021.

Defined Benefit Plans

The Company and its subsidiaries also sponsor a qualified defined benefit pension plan that requires benefits to be paid to eligible associates based upon years of service and, in some cases, eligible compensation. The Company’s funding policy for The Rite Aid Pension Plan (the “Defined Benefit Pension Plan”) is to contribute the minimum amount required by the Employee Retirement Income Security Act of 1974. However, the Company may, at its sole discretion, contribute additional funds to the plan. The Company made contributions of $0 in fiscal 2023, $1,700 in fiscal 2022 and $6,305 in fiscal 2021.

Net periodic pension expense and other changes recognized in other comprehensive income for the defined benefit pension plans included the following components:

Defined Benefit Pension Plan

    

2023

    

2022

    

2021

Service cost

$

336

$

425

$

486

Interest cost

 

5,036

 

4,861

 

4,753

Expected return on plan assets

 

(4,998)

 

(5,194)

 

(4,614)

Amortization of unrecognized net loss

 

 

344

 

3,749

Net periodic pension expense

$

374

$

436

$

4,374

Other changes recognized in other comprehensive loss:

Unrecognized net gain arising during period

$

(585)

$

(8,246)

$

(20,633)

Amortization of unrecognized net (loss) gain

 

 

(344)

 

(3,749)

Net amount recognized in other comprehensive loss

 

(585)

 

(8,590)

 

(24,382)

Net amount recognized in pension expense and other comprehensive loss

$

(211)

$

(8,154)

$

(20,008)

121

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The table below sets forth reconciliation from the beginning of the year for both the benefit obligation and plan assets of the Company’s defined benefit plans, as well as the funded status and amounts recognized in the Company’s balance sheet as of March 4, 2023 and February 26, 2022:

Defined Benefit

Pension Plan

    

2023

    

2022

Change in benefit obligations:

    

    

Benefit obligation at end of prior year

$

160,133

$

168,872

Service cost

 

336

 

425

Interest cost

 

5,036

 

4,861

Distributions

 

(8,328)

 

(8,582)

Actuarial gain

 

(26,014)

 

(5,443)

Benefit obligation at end of year

$

131,163

$

160,133

Change in plan assets:

Fair value of plan assets at beginning of year

$

149,527

$

148,412

Employer contributions

 

 

1,700

Actual return on plan assets

 

(20,430)

 

7,997

Distributions (including expenses paid by the plan)

 

(8,328)

 

(8,582)

Fair value of plan assets at end of year

$

120,769

$

149,527

Funded status

$

(10,394)

$

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in consolidated balance sheets consisted of:

Accrued pension liability

 

(10,394)

 

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in accumulated other comprehensive loss consist of:

Net actuarial loss

$

11,202

$

(11,787)

Amount recognized

$

11,202

$

(11,787)

The decrease in the benefit obligation during the year ended March 4, 2023, was driven by the increase in discount rate from 3.25% as of February 26, 2022 to 5.00% as of March 4, 2023.

The decrease in the benefit obligation during the year ended February 26, 2022, was driven by the increase in discount rate from 3.00% as of February 27, 2021 to 3.25% as of February 26, 2022. The pension plan also benefitted from favorable return on assets and favorable experience from updated census data.

The estimated net actuarial loss and prior service cost amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense in fiscal 2024 are $0 and $0, respectively.

The accumulated benefit obligation for the defined benefit pension plan was $131,163 and $160,133 as of March 4, 2023 and February 26, 2022, respectively.

122

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The accumulated benefit obligation and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows:

Defined Benefit

Pension Plan

2023

    

2022

Accumulated Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

The projected benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows:

Defined Benefit

Pension Plan

2023

    

2022

Projected Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

The significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation as of March 4, 2023, February 26, 2022 and February 27, 2021 were as follows:

Defined Benefit

Pension Plan

    

2023

    

2022

    

2021

Discount rate

    

5.00

%  

3.25

%  

3.00

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

6.50

%  

5.00

%  

5.50

%

Weighted average assumptions used to determine net cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 were:

Defined Benefit

Pension Plan

    

2023

2022

2021

Discount rate

3.25

%   

3.00

%   

2.75

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

5.00

%  

5.50

%  

6.00

%

To develop the expected long-term rate of return on assets assumption, the Company considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio. This resulted in the selection of the 5.00% long-term rate of return on plan assets assumption for fiscal 2023, 5.50% for 2022 and 6.00% for 2021.

123

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The Company’s pension plan asset allocations as of March 4, 2023 and February 26, 2022 by asset category were as follows:

    

March 4,

    

February 26,

 

2023

2022

 

Equity securities

 

30

%  

30

%

Fixed income securities

 

59

%  

57

%

Other

11

%  

13

%

Total

 

100

%  

100

%

The investment objectives of the Defined Benefit Pension Plan, the only defined benefit plan with assets, are to:

Achieve a rate of return on investments that exceeds inflation over a full market cycle and is consistent with actuarial assumptions;
Balance the correlation between assets and liabilities by diversifying the portfolio among various asset classes to address return risk and interest rate risk;
Balance the allocation of assets between the investment managers to minimize concentration risk;
Maintain liquidity in the portfolio sufficient to meet plan obligations as they come due; and
Control administrative and management costs.

The asset allocation established for the pension investment program reflects the risk tolerance of the Company, as determined by:

the current and anticipated financial strength of the Company;
the funded status of the plan; and
plan liabilities.

Investments in both the equity and fixed income markets will be maintained, recognizing that historical results indicate that equities (primarily common stocks) have higher expected returns than fixed income investments. It is also recognized that the correlation between assets and liabilities must be balanced to address higher volatility of equity investments (return risk) and interest rate risk.

124

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following targets are to be applied to the allocation of plan assets.

    

Target

 

Category

Allocation

    

Equity securities

 

30

%

Fixed income securities

 

62

%

Other

8

%

Total

 

100

%

The Company expects to contribute $0 to the Defined Benefit Pension Plan during fiscal 2024.

Short-Term Investments

Short-term investments, which is a short-term investment fund, and is considered cash and cash equivalents, is classified within Level 2 of the valuation hierarchy due to the lack of an active market for trading.

Common and Collective Trusts

Common collective trust funds are stated at fair value as determined by the issuer of the common collective trust funds based on the net asset value (“NAV”) of the underlying investments in accordance with ASC 820. There are generally no restrictions on redemptions from these funds and no unfunded commitments to invest. In accordance with ASC subtopic 820-10, certain investments that were measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. The underlying investments mainly consist of equity and fixed income securities funds that are valued based on the daily closing price as reported by the fund.

The proceeding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement as of March 4, 2023.

125

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following table sets forth by level within the fair value hierarchy a summary of the plan’s investments measured at fair value on a recurring basis as of March 4, 2023 and February 26, 2022:

Fair Value Measurements as of March 4, 2023

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

13,901

Large Cap

 

 

 

 

18,556

Small-Mid Cap

 

 

 

 

3,309

Fixed Income

Aon High Yield Plus Bond

72

Aon Multi-Asset Credit

4,775

Long-Term Credit Bond Index

 

 

 

 

41,360

Long-Term U.S. Government Bonds

1,588

20+ Year Treasury STRIPS

12,821

Intermediate Fixed Income

9,781

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

11

Aon Core Real Estate Fund

13,479

Short-Term Investments

 

 

1,111

 

 

1,111

Total

$

$

1,111

$

$

120,764

126

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Fair Value Measurements as of February 26, 2022

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

17,783

Large Cap

 

 

 

 

23,027

Small-Mid Cap

 

 

 

 

4,213

Fixed Income

Aon High Yield Plus Bond

75

Aon Multi-Asset Credit

7,386

Long-Term Credit Bond Index

 

 

 

 

47,976

Long-Term U.S. Government Bonds

19,763

20+ Year Treasury STRIPS

483

Intermediate Fixed Income

8,554

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

13

Aon Core Real Estate Fund

18,720

Short-Term Investments

 

 

1,532

 

 

1,532

Total

$

$

1,532

$

$

149,525

Following are the future benefit payments expected to be paid for the Defined Benefit Pension Plan during the years indicated:

Defined Benefit

Fiscal Year

    

Pension Plan

2024

$

9,497

2025

 

9,379

2026

 

9,373

2027

 

9,410

2028

 

9,252

2029 - 2033

 

44,769

Total

$

91,680

20. Multiemployer Plans that Provide Pension Benefits

The Company contributes to a number of multiemployer defined benefit pension plans under the terms of collective-bargaining agreements that cover certain of its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer plans. Assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers. If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers. Additionally, if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability.

127

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The Company’s participation in these plans for the annual period ended March 4, 2023 is outlined in the table below. The “EIN/Pension Plan Number” column provides the Employer Identification Number (EIN) and the three-digit plan number, if applicable. The most recent Pension Protection Act zone status available for fiscal 2023 and fiscal 2022 is for the plan year-ends as indicated below. The zone status is based on information that the Company received from the plan and is certified by the plan’s actuary. Among other factors, plans in the red zone are generally less than 65% funded, plans in the yellow zone are less than 80% funded, and plans in the green zone are at least 80% funded. The “FIP/RP Status Pending/Implemented” column indicates plans for which a financial improvement plan (“FIP”) or a rehabilitation plan (“RP”) is either pending or has been implemented. In addition to regular plan contributions, the Company may be subject to a surcharge if the plan is in the red zone. The “Surcharge Imposed” column indicates whether a surcharge has been imposed on contributions to the plan. The last two columns list the expiration date(s) of the collective-bargaining agreement(s) to which the plans are subject and any minimum funding requirements. There have been no significant changes that affect the comparability of total employer contributions of fiscal years 2023, 2022 and 2021.

Expiration

FIP/ RP

Date of

Pension Protection 

Status

Collective-

Minimum

EIN/Pension

Act Zone Status

Pending/

Contributions of the Company

Surcharge

Bargaining

Funding

Pension

    

Plan Number

    

2023

    

2022

    

Implemented

    

2023

    

2022

    

2021

    

Imposed

    

Agreement

    

Requirements

1199 SEIU Health Care Employees Pension Fund

13-3604862-001

Green—
12/31/2021

Green—
12/31/2020

No

$

7,493

$

9,242

$

9,613

No

4/18/2025

Contribution rate of 11.3% of gross wages per associate beginning 10/01/2021. Contribution rate of 12.6% of gross wages per associate beginning 09/30/2018.

 

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

51-6029925-001

 

Green—
12/31/2022

 

Red—
12/31/2021

 

No

 

8,131

 

8,989

 

8,239

 

No

 

7/20/2024

 

Beginning 01/01/2021, contributions of $1.844 per hour worked for pharmacists and $0.836 per hour worked for non-pharmacists. From 01/01/2020 through 12/31/2020 contributions of $1.758 per hour worked for pharmacists and $0.797 per hour worked for non-pharmacists.

 

 

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

94-2518312-001

 

Green—
12/31/2022

 

Green—
12/31/2021

 

No

 

2,605

 

3,224

 

2,319

 

No

 

7/13/2022

 

Effective 01/01/2020, contribution rate of $0.855 per hour worked for clerks and $1.239 per hour works for pharmacists. Effective 09/01/2014, contribution rate frozen at $0.55 per hour worked for associates.

 

 

United Food and Commercial Workers Union-Employer Pension Fund

 

34-6665155-001

 

Red—
9/30/2022

 

Red—
9/30/2021

 

Implemented

 

954

 

802

 

809

 

No

 

7/07/2024

 

Effective 02/06/2022, contribution rate of $2.57 per hour worked.
Effective 02/07/2021 contribution rate of $2.43 per hour worked.
Effective 02/02/2020 contribution rate of $2.30 per hour worked.

 

 

United Food and Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

 

51-6031766-001

 

Green—
9/30/2022

 

Green—
9/30/2021

 

No

 

434

 

370

 

399

 

No

 

7/07/2024

 

Effective 10/01/2022 contribution rate of $2.33 per hour worked.
Effective 10/01/2021 contribution rate of $2.24 per hour worked.
Effective 10/01/2020 contribution rate of $2.15 per hour worked.

 

 

Other Funds

 

2,046

 

1,887

 

1,573

$

21,663

$

24,514

$

22,952

128

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The Company was listed in these plans’ Forms 5500 as providing more than 5% of the total contributions for the following plans and plan years:

    

Year Contributions to Plan 

Exceeded More Than 5 % of

Total Contributions (as of

Pension Fund

 the Plan’s Year-End)

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

12/31/2021 and 12/31/2020

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

12/31/2021 and 12/31/2020

United Food & Commercial Workers Union - Employer Pension Fund

 

9/30/2021 and 9/30/2020

United Food & Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

9/30/2021 and 9/30/2020

At the date the Company’s financial statements were issued, certain Forms 5500 were not available.

During fiscal 2023, 2022 and 2021, the Company did not withdraw from any plans or incur any additional withdrawal liabilities.

21. Segment Reporting

The Company has two reportable segments, Retail Pharmacy Segment and Pharmacy Services Segment.

The Retail Pharmacy Segment’s primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy Segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment offers a full range of PBM services including plan design and administration, formulary management and claims processing. Additionally, the Pharmacy Services Segment offers specialty and mail order services, and drug benefits to eligible beneficiaries under the federal government’s Medicare Part D program.

The Company’s chief operating decision makers are its Chief Executive Officer, Chief Financial Officer, and several other members of the Executive Leadership Team (collectively the “CODM”). The CODM has ultimate responsibility for enterprise decisions. The CODM determines, in particular, resource allocation for, and monitors performance of, the consolidated enterprise, the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy and Pharmacy Services Segment managers have responsibility for operating decisions, allocating resources and assessing performance within their respective segments. The CODM relies on internal management reporting that analyzes enterprise results on certain key performance indicators, namely, revenues, gross profit and Adjusted EBITDA.

129

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following is balance sheet information for the Company’s reportable segments:

    

Retail

    

Pharmacy

    

    

Pharmacy

Services

Eliminations(1)

Consolidated

March 4, 2023:

Total Assets

$

5,487,845

$

2,049,107

$

(9,590)

$

7,527,362

Goodwill

 

43,492

464,444

 

 

507,936

February 26, 2022:

Total Assets

$

6,068,594

$

2,482,232

$

(21,823)

$

8,529,003

Goodwill

 

43,492

835,644

 

 

879,136

(1)As of March 4, 2023 and February 26, 2022, intersegment eliminations include intersegment accounts receivable of $9,590 and $21,823, respectively, that represent amounts owed from the Pharmacy Services Segment to the Retail Pharmacy Segment that are created when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products.

130

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following table is a reconciliation of the Company’s business segments to the consolidated financial statements for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Retail

Pharmacy

Intersegment

    

Pharmacy

    

Services

    

Eliminations(1)

    

Consolidated

March 4, 2023:

Revenues

$

17,785,067

$

6,522,299

$

(215,467)

$

24,091,899

Gross Profit

 

4,394,850

 

409,090

 

 

4,803,940

Adjusted EBITDA(2)

 

288,077

 

141,103

 

 

429,180

Depreciation and amortization

229,380

47,203

276,583

LIFO charge

53,028

53,028

Stock-based compensation expense

10,604

933

11,537

Additions to property and equipment and intangible assets

226,563

21,122

247,685

February 26, 2022:

Revenues

$

17,494,816

$

7,323,125

$

(249,686)

$

24,568,255

Gross Profit

 

4,722,075

384,420

 

5,106,495

Adjusted EBITDA(2)

 

392,633

113,272

 

505,905

Depreciation and amortization

244,122

51,564

295,686

LIFO charge

1,314

1,314

Stock-based compensation expense

12,282

768

13,050

Additions to property and equipment and intangible assets

202,386

18,327

220,713

February 27, 2021:

 

 

Revenues

$

16,365,260

$

7,970,137

$

(292,157)

$

24,043,240

Gross Profit

 

4,255,791

448,531

 

4,704,322

Adjusted EBITDA(2)

 

279,896

157,769

 

437,665

Depreciation and amortization

269,985

57,139

327,124

LIFO credit

(51,692)

(51,692)

Stock-based compensation expense

11,594

1,409

13,003

Restructuring-related costs–SKU optimization charges

20,939

20,939

Additions to property and equipment and intangible assets

204,290

20,651

224,941

(1)Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.
(2)See the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.

131

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following is a reconciliation of net loss to Adjusted EBITDA for fiscal 2023, 2022 and 2021:

    

March 4,

February 26,

February 27,

2023

    

2022

    

2021

(53 weeks)

(52 weeks)

(52 weeks)

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Interest expense

 

224,399

 

191,601

 

201,388

Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Depreciation and amortization

276,583

295,686

327,124

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

(Gain) loss on debt modifications and retirements, net

(80,142)

3,235

(5,274)

Merger and Acquisition-related costs

 

 

12,797

 

10,549

Stock-based compensation expense

11,537

13,050

13,003

Restructuring-related costs

108,626

35,121

84,552

Inventory write-downs related to store closings

14,270

5,298

3,709

Litigation and other contractual settlements

53,882

50,212

(Gain) loss on sale of assets, net

(68,586)

5,505

(69,300)

Loss (gain) on Bartell acquisition

5,346

(47,705)

Change in estimate related to manufacturer rebate receivables

15,068

Other

 

9,401

 

4,740

 

3,283

Adjusted EBITDA from continuing operations

$

429,180

$

505,905

$

437,665

22. Commitments, Contingencies and Guarantees

Legal Matters and Regulatory Proceedings

The Company is regularly involved in a variety of legal matters including arbitration, litigation (and related settlement discussions), audits by counter parties under our contracts, and other claims, and is subject to regulatory proceedings including audits, inspections, inquiries, investigations, and similar actions by health care, insurance, pharmacy, tax and other governmental authorities arising in the ordinary course of its business, including, without limitation, the matters described below. Substantial damages are sought from the Company in virtually all of these matters, even if a specific amount is not specified. The Company records accruals for outstanding legal matters and applicable regulatory proceedings when it believes it is probable that a loss has been incurred, and the amount can be reasonably estimated. The Company evaluates on a quarterly basis, developments in legal matters and regulatory proceedings that could affect the amount of any existing accrual or that warrant an accrual. If a loss contingency is not both probable and estimable, the Company typically does not establish an accrued liability. Unless specifically noted otherwise, with respect to the litigation and other legal proceedings described below, the Company is unable to estimate the amount or range of reasonably possible loss due to the inherent difficulty of predicting the outcome of and uncertainties at the current stage of such litigation and legal proceedings.

None of the Company’s accruals for outstanding legal matters or regulatory proceedings are currently material, individually or in the aggregate, to the Company’s consolidated financial position. However, during the course of any proceeding, developments may result in the creation or an increase of an accrual that could be material. Additionally,

132

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

unfavorable or unexpected outcomes in outstanding legal matters or regulatory proceedings could exceed any accrual and impact the Company’s financial position. Further, even if the Company is successful in its legal proceedings, the Company may incur significant costs and expenses defending itself or others that it is required to indemnify, and such costs and expenses may not be subject to or may exceed reimbursement pursuant to any applicable insurance. Such proceedings may also require significant attention of management.

The Company’s contingencies are subject to significant uncertainties, many of which are beyond the Company’s control, including, among other factors: (i) the stage of any proceeding and delays in scheduling; (ii) whether class or collective action status is sought and the likelihood of a class being certified; (iii) the outcome of pending or potential appeals, motions and settlement discussions; (iv) the range and magnitude of potential damages, fines or penalties, which are often unspecified or indeterminate; (v) the impact of discovery on the matter; (vi) whether novel or unsettled legal theories are at issue or advanced; (vii) whether there are significant factual issues to be resolved including findings made by juries; (viii) the exercise of discretion in enforcement actions including in the case of certain government agency investigations, whether a qui tam lawsuit (“whistleblower” action) has been filed and whether the government agency makes a decision to intervene in the lawsuit following investigation; (ix) changes in priorities following any change in political administration at the state or federal level; and/or (x) the impact, results and settlements of similar claims made against competitors and other industry participants. Additionally, the Company may determine that a settlement is in its best interest, even if it believes that it has meritorious defenses and has not previously accrued for the matter.

Employment Litigation.

The Company is currently a defendant in several lawsuits filed in courts in California that contain allegations regarding violations of the California Business and Professions Code, various California employment laws and regulations, industry wage orders, wage-and-hour laws, rules and regulations pertaining primarily to failure to pay overtime, failure to pay premiums for missed meals and rest periods, failure to provide accurate wage statements, and failure to reimburse business expenses (collectively, the “California Cases”).

Some of the California Cases purport or may be determined to be class actions or representative actions under the California Private Attorneys General Act and seek substantial damages and penalties. In August 2022, the Company agreed to settle a putative class action regarding reimbursement for cell phone and mileage expenses for shift supervisors and managers/assistant managers for $1.29 million, and a putative wage and hour class action brought on behalf of drivers and other ice cream plant associates for $0.8 million. These settlements are subject to court approval.

The Company has also reached an agreement in principle to resolve a putative employment collective and class action filed in federal court in New York, which raises similar allegations in addition to others about the payment frequency for certain employees (the “New York Case”). In December 2022, the parties reached an agreement in principle to resolve the individual plaintiff’s claims as well as those of the class, resulting in the federal court issuing an order of judgment and a new matter filed in New York state court, which the parties have agreed to resolve for $6.45 million. The parties continue to work on a definitive settlement agreement, which will be subject to court approval and the Company expects that it will have the right terminate the agreement if certain participation thresholds are not met.

The Company has aggressively defended itself and challenged the merits of these employment lawsuits and, where applicable, allegations that the lawsuits should be certified as class or representative actions.

133

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Usual and Customary Litigation.

The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company’s retail stores overcharged for prescription drugs by not submitting the price available to members of the Rite Aid’s Rx Savings Program as the pharmacy’s usual and customary price, and related theories. The Company is defending itself against these claims.

The Company is a defendant in a putative consumer class action lawsuit in the United States District Court for the Southern District of California captioned Byron Stafford v. Rite Aid Corp. A separate lawsuit, Robert Josten v. Rite Aid Corp., was consolidated with this lawsuit for pre-trial purposes. The lawsuit contains allegations that (i) the Company was obligated to charge the plaintiffs’ insurance companies its usual and customary prices for their prescription drugs; and (ii) the Company failed to do so because the prices it reported were not equal to or adjusted to account for the prices that Rite Aid offered to uninsured and underinsured customers through its Rx Savings Program. The Company is defending itself in a second putative class action lawsuit against similar pricing allegations filed in the United States District Court for the Eastern District of Pennsylvania.

On February 6, 2019, Humana, Inc., filed a claim pursuant to a binding arbitration provision of the parties’ agreement alleging that the Company improperly submitted various usual and customary overcharges by failing to report its Rx Savings Program prices as its usual and customary prices to Humana. An arbitration hearing was held in this matter in November 2021.  

On April 22, 2022, the arbitrator issued an Opinion and Final Award against the Company for breach of contract awarding Humana $122.6 million, which includes $40.7 million in prejudgment interest (the “Arbitration Award”). The Company continues to believe that the Arbitration Award contains a number of significant factual and legal errors. On June 20, 2022, the Company both opposed Humana’s effort to confirm the Arbitration Award and petitioned the United States District Court for Western District of Kentucky for vacatur of the Arbitration Award, as is its right under the Federal Arbitration Act (“FAA”). As such, the Company has determined that it is not probable that a loss has occurred.

The FAA, as interpreted and applied by federal courts, permits vacatur when, among other things, an arbitrator’s decision: (1) is irreconcilable with the terms of a contract between the parties; (2) rests on a plain legal error that manifests disregard for the law; or (3) incorporates a refusal to consider pertinent, material evidence. Similarly, the FAA, as interpreted and applied by federal courts, permits modification of an arbitrator’s decision to correct an evident material miscalculation of figures. Although the Company cannot make any assurances of success in its efforts, it is the Company’s view that the errors in the Arbitration Award support both vacatur and modification under the FAA, the effect of either of which could be to set aside the Arbitration Award or reduce or eliminate the damages provided for in the Arbitration Award.

Argument on Humana’s petition to confirm the Arbitration Award and Rite Aid’s motion for vacatur of the Arbitration Award is scheduled for May 10, 2023. Depending on the court’s determination, it is possible that one or both parties may appeal the decision, or seek other remedies.

The Company is a defendant in two consolidated lawsuits pending in the United States District Court for the District of Minnesota filed in 2020 by various Blue Cross/Blue Shield plans that operate in eight different states (North Carolina, North Dakota, Alabama, Utah, Minnesota, Oregon, Washington and New Jersey) alleging that the Company improperly submitted various usual and customary overcharges to several Pharmacy Benefit Managers, all but one of

134

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

which are not owned by plaintiffs, with which Rite Aid and the insurers had independent contracts. The Company is also defending a lawsuit filed in Delaware state court in 2019 by multiple Centene entities alleging that the Company overcharged for prescriptions by improperly reporting usual and customary prices. The Delaware lawsuit is scheduled to start trial in May 2023. The Company is defending a similar lawsuit filed in 2022 by WellCare in Florida state court.

Drug Utilization Review and Code 1 Litigation

In June 2012, qui tam plaintiff, Loyd F. Schmuckley (“Relator”) filed a complaint under seal against the Company alleging that it failed to comply with certain requirements of California’s Medicaid program between 2007 and 2014. In June 2013, the Company was served with a Civil Investigative Demand (“CID”) by the United States Attorney’s Office for the Eastern District of California regarding (1) the Company’s Drug Utilization Review and prescription dispensing protocol; and (2) the dispensing of drugs designated as “Code 1” by the State of California. Specifically, the Relator alleged that the Company did not perform special verification and documentation for certain medications known as “Code 1” drugs. While the complaint remained under seal, the United States Department of Justice conducted an extensive investigation and ultimately declined to intervene. Although numerous states declined to intervene, in September 2017, the State of California’s Department of Justice’s Bureau of Medical Fraud and Elder Abuse filed a complaint in intervention. The Company filed a motion to dismiss Relator’s and the State of California’s respective complaints in January 2018, and the hearing was held on March 23, 2018. On September 5, 2018, the court issued an order denying the motion to dismiss. Substantial damages are sought from the Company in this matter. No trial date has been set and as discovery continues, the parties have participated in and are expected to continue to participate in a mediation process, although there is no expected date or terms for any potential resolution of this matter.

Controlled Substances Litigation, Audits and Investigations

The Company, along with various other defendants, is named in multiple opioid-related lawsuits filed by counties, cities, municipalities, Native American tribes, hospitals, third-party payers, and others across the United States. In December 2017, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) consolidated and transferred more than a thousand federal opioid-related lawsuits that name the Company as a defendant to the multi-district litigation (“MDL”) pending in the United States District Court for the Northern District of Ohio under In re National Prescription Opiate Litigation (Case No. 17-MD-2804). A significant number of similar cases that are not part of the MDL and name the Company as a defendant are also pending in state courts. On June 1, 2022, the JPML ordered that newly filed cases will no longer be transferred to the MDL. The plaintiffs in these opioid-related lawsuits generally allege claims that include, without limitation, public nuisance and negligence theories of liability resulting from the impacts of widespread opioid abuse against defendants along the pharmaceutical supply chain, including manufacturers, wholesale distributors, and retail pharmacies. At this stage of the proceedings, the Company is not able to predict the outcome of the opioid-related lawsuits in which it remains a defendant or estimate a potential range of loss regarding the lawsuits, and is defending itself against all relevant claims. From time to time, some of these cases may be settled, dismissed or otherwise terminated, and additional such cases may be filed.

The Company also has received warrants, subpoenas, CIDs, and other requests for documents and information from, and is being investigated by, the federal and state governments regarding opioids and other controlled substances. The Company has been cooperating with and responding to these investigatory inquiries.

As previously disclosed, on December 13, 2022, a qui tam complaint filed by three former Rite Aid pharmacy personnel (Andrew White, Mark Rosenberg, and Ann Wegelin) (collectively, “qui tam Relators”) was unsealed by the

135

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

federal District Court for the Northern District of Ohio in an order that also directed the United States Department of Justice to file within 90 days a complaint intervening or partially intervening in the Second Amended Complaint (the “Complaint”). On February 23, 2023, the following states, which were listed in the Complaint, declined to intervene: Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Nevada, New Hampshire, New Jersey, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington and the District of Columbia. On February 23, 2023, California stated its intention to make an intervention decision on or before May 2, 2023. On March 13, 2023, the United States Department of Justice filed its complaint in the federal District Court for the Northern District of Ohio against Rite Aid (“DOJ’s Complaint”) alleging violations of the federal False Claims Act and Controlled Substances Act related to the dispensing of controlled substances, primarily opioids. DOJ’s Complaint seeks damages under the False Claims Act, civil penalties under the Controlled Substances Act, damages in connection with alleged payment by mistake (on behalf of Federal Healthcare Programs), and damages in connection with alleged unjust enrichment.

In April 2019, the Company initiated a coverage action styled Rite Aid Corporation et al. v. ACE American Ins. Co. et al. Through this action, the Company is seeking the recovery of defense costs and settlement and/or judgment costs that may be paid for the opioid-related lawsuits. The action seeks declaratory relief with respect to the obligations of the insurers under the policies at issue in the action and asserts claims for breach of contract and statutory remedies against one of these insurers. Although the trial court determined on the Company’s motion for partial summary judgment that this insurer was obligated to reimburse the Company for its defense costs, on January 10, 2022, the Delaware Supreme Court reversed the trial court’s order and ruled that the insurer had no duty to defend the first MDL suits set for trial based on the specific allegations at issue in those cases. The matter has been remanded to the lower court for further proceedings.

Miscellaneous Litigation and Investigations.

Following the Company’s response to a 2020 CID from the Federal Trade Commission (“FTC”) with respect to consumer protection laws, the Company is seeking to negotiate a resolution with the FTC. The allegations relate to certain business practices that the Company has not engaged in for nearly three years, and the Company currently believes that any resolution will not likely require a monetary payment. Discussions are ongoing with the FTC and the timing and substance of any settlement cannot be determined at this time. During the course of the Company’s discussions with the FTC in connection with its response to that CID, the FTC also requested certain information from the Company related to compliance with the Company’s 2010 FTC Consent Order. The Company cooperated with the FTC's request, however, the FTC Staff informed the Company that it would recommend that the FTC file a complaint against the Company for violation of the Consent Order, including a monetary payment and other relief, unless the Company informs FTC Staff that it is willing to discuss a resolution. The Company is evaluating the matter, including potential resolution, although no assurance can be given that the matter will be resolved to the parties’ mutual satisfaction, or that the resolution will not include a monetary payment, and that the payment will not be material. It is also possible that discussions relating to the 2010 FTC Consent Order could affect the resolution of the 2020 CID.

The Company has received CIDs from the Department of Justice related to the Medicare Part D plan sponsored by a subsidiary of the Company. The Company is also defending a lawsuit asserting numerous claims based on allegations surrounding the Company’s use of a certain font including in the Company’s rebranded logo. The Company is defending a putative class action it has removed to federal court in California regarding alleged privacy breaches.

The Company is defending a putative shareholder class action currently captioned Page v. Rite Aid Corporation et al., filed in the United States District Court for the Eastern District of Pennsylvania. The matter names Rite Aid

136

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

Corporation and certain executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to alleged misstatements and omissions concerning the growth of Elixir’s PBM services businesses. The matter remains in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit. The Company is also defending a putative shareholder class action currently captioned Holland v. Rite Aid Corporation et al., filed in the United States District Court for the Northern District of Ohio. The matter names Rite Aid Corporation and certain former and current executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to the DOJ’s Complaint and alleged misstatements and omissions concerning the Company’s risk for regulatory action and litigation related to controlled substances practices.  This matter is also in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit.

23. Supplementary Cash Flow Data

March 4,

February 26,

February 27,

2023

    

2022

    

2021

Cash paid for interest (a)

$

212,355

$

180,583

$

181,634

Cash (refunds) payments for income taxes, net(a)

$

(5,309)

$

6,233

$

7,535

Equipment financed under capital leases

$

3,334

$

1,698

$

1,849

Accrued capital expenditures

$

18,711

$

45,465

$

19,904

Gross borrowings from revolver(a)

$

3,510,000

$

5,131,000

$

7,912,000

Gross repayments to revolver(a)

$

3,019,000

$

5,272,000

$

7,712,000

(a)–Amounts are presented on a total company basis.

Significant components of cash used in Other Liabilities of $111,021 for the fifty-three week period ended March 4, 2023 includes cash used from changes in accrued wages, benefits and other personnel costs of $100,340 and provided from changes in accrued store expenses of $11,426.

24. Financial Instruments

The carrying amounts and fair values of financial instruments as of March 4, 2023 and February 26, 2022 are listed as follows:

2023

2022

    

Carrying

    

Fair

    

Carrying

    

Fair

Amount

Value

Amount

Value

Variable rate indebtedness

$

1,581,793

$

1,600,000

$

1,038,646

$

1,059,000

Fixed rate indebtedness

$

1,343,465

$

768,328

$

1,694,340

$

1,602,122

Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets.

137

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

The following methods and assumptions were used in estimating fair value disclosures for financial instruments:

Borrowings under credit facilities:

The carrying amounts for SOFR-based and LIBOR-based borrowings under the credit facilities are estimated based on the quoted market price of the financial instruments. The LIBOR-based borrowings under the credit facilities transitioned to Term SOFR on December 1, 2022.

Long-term indebtedness:

The fair values of long-term indebtedness are estimated based on the quoted market prices of the financial instruments. If quoted market prices were not available, the Company estimated the fair value based on the quoted market price of a financial instrument with similar characteristics.

25. Revision of Previously Issued Consolidated Financial Statements

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement in accordance with the U.S. SEC Staff’s Accounting Bulletin Nos. 99, Materiality (“SAB 99”) and 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”). The misstatement pertains to the Company’s historical accounting for closed store liabilities. Based on their evaluation, management concluded the misstatement is not material to the Company’s previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the “previously issued financial statements”). However, as prescribed by SAB 108, in conjunction with the re-issuance of the Company’s previously issued financial statements, the misstatement has been corrected as an immaterial revision of the accompanying consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes hereto. A summary of the nature of the misstatement and its impact on the Company’s previously issued financial statements is summarized as follows.

The Company adopted ASC 842, Leases, (“ASC 842”) on the first day of fiscal year 2020 under the alternative transition method as permissible under ASC 842. As part of this adoption, the Company elected the practical expedients, as permitted under the transition guidance, which included, among other things, the ability to carry forward existing lease classifications. Based on this election, the Company appropriately eliminated the majority of its closed store and lease exit liabilities as of the date of adoption, which had been accrued in accordance with ASC 420, Exit or Disposal Cost Obligations, (“ASC 420”). Moreover, due to the Company’s practical expedients election, variable costs, consisting primarily of real estate taxes and common area maintenance expenses, associated with store closures that occur subsequent to the adoption of ASC 842 may no longer be accrued under ASC 420, but rather recognized as expense as they are incurred.

Due to an oversight in their evaluation of an amendment to ASC 420 as a result of the adoption of ASC 842, management determined that the Company incorrectly continued to accrue estimated costs associated with store closures as a liability subsequent to the date of adoption, rather than recognize the costs as they are incurred. The impact of the misstatement resulted in an overstatement of these costs, which have historically been classified within Facility exit and impairment charges in the Company’s Consolidated Statements of Operations, and an overstatement of store closure liabilities, which have historically been classified within Accrued salaries, wages and other current liabilities (current

138

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

portion) and Other noncurrent liabilities (long-term portion) in the Company’s Consolidated Balance Sheets. The misstatement had no impact on the Company’s previously issued consolidated financial statements as of and for the fiscal year ended February 29, 2020 and each of the interim and year-to-date periods then ended.

A summary of revisions to the Company’s previously reported financial statements is presented below.

As of and for the fiscal year ended March 4, 2023

    

Previously 

    

    

As

(In 000’s, except per share amounts )

Reported

Adjustment

 Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

724,529

$

(14,638)

$

709,891

Total current liabilities

 

2,727,875

 

(14,638)

 

2,713,237

Other noncurrent liabilities

 

130,482

 

(32,905)

 

97,577

Total liabilities

 

8,169,138

 

(47,543)

 

8,121,595

Accumulated deficit

 

(6,601,517)

 

(47,543)

 

(6,553,974)

Total stockholders’ (deficit) equity

 

(641,776)

 

(47,543)

 

(594,233)

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

211,385

$

(30,748)

$

180,637

Loss from continuing operations before income taxes

 

(756,403)

 

30,748

 

(725,655)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Net loss

 

(749,936)

 

30,748

 

(719,188)

Comprehensive loss

 

(749,351)

 

30,748

 

(718,603)

Basic and diluted loss per share from continuing operations

 

(13.71)

 

0.56

 

(13.15)

Net basic and diluted loss per share

 

(13.71)

 

0.56

 

(13.15)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(749,936)

$

30,748

$

(719,188)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Facility exit and impairment charges

 

211,385

 

(30,748)

 

180,637

139

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

As of and for the fiscal year ended February 26, 2022

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

780,632

$

(4,073)

$

776,559

Total current liabilities

 

2,933,088

 

(4,073)

 

2,929,015

Other noncurrent liabilities

 

151,976

 

(12,722)

 

139,254

Total liabilities

 

8,429,970

 

(16,795)

 

8,413,175

Accumulated deficit

 

(5,851,581)

 

16,795

 

(5,834,786)

Total stockholders’ (deficit) equity

 

99,033

 

16,795

 

115,828

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

180,190

$

(16,106)

$

164,084

Loss from continuing operations before income taxes

 

(542,258)

 

16,106

 

(526,152)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Net loss

 

(538,478)

 

16,106

 

(522,372)

Comprehensive loss

 

(529,861)

 

16,106

 

(513,755)

Basic and diluted loss per share from continuing operations

 

(9.96)

 

0.30

 

(9.66)

Net basic and diluted loss per share

 

(9.96)

 

0.30

 

(9.66)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(538,478)

$

16,106

$

(522,372)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Facility exit and impairment charges

 

180,190

 

(16,106)

 

164,084

140

Table of Contents

RITE AID CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(In thousands, except per share amounts)

As of and for the fiscal year ended February 27, 2021

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

642,364

$

854

$

643,218

Total current liabilities

 

2,602,946

 

854

 

2,603,800

Other noncurrent liabilities

 

208,213

 

(1,543)

 

206,670

Total liabilities

 

8,720,250

 

(689)

 

8,719,561

Accumulated deficit

 

(5,313,103)

 

689

 

(5,312,414)

Total stockholders’ (deficit) equity

 

615,154

 

689

 

615,843

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

58,403

$

(689)

$

57,714

Loss from continuing operations before income taxes

 

(120,227)

 

689

 

(119,538)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Net loss

 

(90,909)

 

689

 

(90,220)

Comprehensive loss

 

(66,065)

 

689

 

(65,376)

Basic and diluted loss per share from continuing operations

 

(1.87)

 

0.01

 

(1.86)

Net basic and diluted loss per share

 

(1.69)

 

0.01

 

(1.68)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(90,909)

$

689

$

(90,220)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Facility exit and impairment charges

 

58,403

 

(689)

 

57,714

141

RITE AID CORPORATION AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(dollars in thousands)

    

    

Additions

    

    

Balance at

Charged to

Balance at

Allowances deducted from accounts receivable for estimated

Beginning

Costs and

End of

uncollectible amounts:

of Period

Expenses

Deductions

Period

Year ended March 4, 2023

$

46,865

$

63,373

$

48,105

$

62,133

Year ended February 26, 2022

$

24,854

$

106,113

$

84,102

$

46,865

Year ended February 27, 2021

$

12,849

$

43,855

$

31,850

$

24,854

142

EX-31.1 2 rad-20230304xex31d1.htm EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Jeffrey S. Stein, Chief Executive Officer and Chief Restructuring Officer, certify that:

1.

I have reviewed this annual report on Form 10-K/A of Rite Aid Corporation (the “Registrant”);

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.

The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“the Exchange Act”)) and internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) for the Registrant and have:

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.

The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 25, 2024

By:

/s/ JEFFREY S. STEIN

Jeffrey S. Stein

Chief Executive Officer and Chief Restructuring Officer


EX-31.2 3 rad-20230304xex31d2.htm EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Matthew C. Schroeder, Executive Vice President and Chief Financial Officer, certify that:

1.

I have reviewed this annual report on Form 10-K/A of Rite Aid Corporation (the “Registrant”);

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.

The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“the Exchange Act”)) and internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) for the Registrant and have:

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.

The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 25, 2024

By:

/s/ MATTHEW C. SCHROEDER

Matthew C. Schroeder

Executive Vice President and Chief Financial Officer


EX-32 4 rad-20230304xex32.htm EX-32

Exhibit 32

Certification of CEO and CFO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-K/A of Rite Aid Corporation (the “Company”) for the annual period ended March 4, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Jeffrey S. Stein, as Chief Executive Officer and Chief Restructuring Officer of the Company, and Matthew C. Schroeder, as Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JEFFREY S. STEIN

Name:

Jeffrey S. Stein

Title:

Chief Executive Officer and Chief Restructuring Officer

Date:

July 25, 2024

/s/ MATTHEW C. SCHROEDER

Name:

Matthew C. Schroeder

Title:

Executive Vice President and Chief Financial Officer

Date:

July 25, 2024


EX-101.SCH 5 rad-20230304.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS - Cal 2 link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Acquisition - Purchase price allocation (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Asset Sale to WBA - Operating results of discontinued operations (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Facility Exit and Impairment Charges - Fair value (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Income Taxes - Rate reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details) (Calc 2) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 41403 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 41701 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 41703 - Disclosure - Leases - Supplemental BS Information (Details) link:presentationLink link:calculationLink link:definitionLink 41704 - Disclosure - Leases - Maturity of lease liabilities under finance and operating leases (Details) link:presentationLink link:calculationLink link:definitionLink 41902 - Disclosure - Retirement Plans - Net periodic cost (Details) link:presentationLink link:calculationLink link:definitionLink 41903 - Disclosure - Retirement Plans - Benefit obligation and funded status (Details) link:presentationLink link:calculationLink link:definitionLink 41908 - Disclosure - Retirement Plans - Future Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 42103 - Disclosure - Segment Reporting - Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Asset Sale to WBA link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Facility Exit and Impairment Charges link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Medicare Part D link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Indebtedness and Credit Agreement link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - Stock Option and Stock Award Plans link:presentationLink link:calculationLink link:definitionLink 11901 - Disclosure - Retirement Plans link:presentationLink link:calculationLink link:definitionLink 12001 - Disclosure - Multiemployer Plans that Provide Pension Benefits link:presentationLink link:calculationLink link:definitionLink 12101 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 12201 - Disclosure - Commitments, Contingencies and Guarantees link:presentationLink link:calculationLink link:definitionLink 12301 - Disclosure - Supplementary Cash Flow Data link:presentationLink link:calculationLink link:definitionLink 12401 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 12601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30103 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Asset Sale to WBA (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Facility Exit and Impairment Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 31503 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 31603 - Disclosure - Indebtedness and Credit Agreement (Tables) link:presentationLink link:calculationLink link:definitionLink 31703 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 31803 - Disclosure - Stock Option and Stock Award Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 31903 - Disclosure - Retirement Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 32003 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 32103 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 32303 - Disclosure - Supplementary Cash Flow Data (Tables) link:presentationLink link:calculationLink link:definitionLink 32403 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Summary of Significant Accounting Policies - Sales (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Summary of Significant Accounting Policies - FY thru Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 40104 - Disclosure - Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details) link:presentationLink link:calculationLink link:definitionLink 40105 - Disclosure - Summary of Significant Accounting Policies - Significant Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Acquisition - Intangible assets acquired (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Acquisition - Acquisition costs (Details) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - Acquisition - Proforma information (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Restructuring (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Asset Sale to WBA (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Facility Exit and Impairment Charges (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Facility Exit and Impairment Charges - Results from closed stores (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40804 - Disclosure - Income Taxes - Unrecognized Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 40805 - Disclosure - Income Taxes - Tax Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 40806 - Disclosure - Income Taxes - Net Operating Losses and Tax Credits (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Medicare Part D (Details) link:presentationLink link:calculationLink link:definitionLink 41004 - Disclosure - Indebtedness - DIP Term Loan Credit Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Manufacturer Rebates Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 41404 - Disclosure - Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details) link:presentationLink link:calculationLink link:definitionLink 41602 - Disclosure - Indebtedness and Credit Agreement - Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 41603 - Disclosure - Indebtedness and Credit Agreement - Transactions and Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 41705 - Disclosure - Leases - Sale Leaseback (Details) link:presentationLink link:calculationLink link:definitionLink 41801 - Disclosure - Stock Option and Stock Awards Plans (Details) link:presentationLink link:calculationLink link:definitionLink 41802 - Disclosure - Stock Option and Stock Award Plans - Options (Details) link:presentationLink link:calculationLink link:definitionLink 41803 - Disclosure - Stock Option and Stock Award Plans - Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 41901 - Disclosure - Retirement Plans (Details) link:presentationLink link:calculationLink link:definitionLink 41904 - Disclosure - Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details) link:presentationLink link:calculationLink link:definitionLink 41905 - Disclosure - Retirement Plans - Projected benefit obligation and fair value of plan assets (Details) link:presentationLink link:calculationLink link:definitionLink 41906 - Disclosure - Retirement Plans - Assumptions and assets (Details) link:presentationLink link:calculationLink link:definitionLink 41907 - Disclosure - Retirement Plans - Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 42001 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 42101 - Disclosure - Segment Reporting - Balance Sheet information (Details) link:presentationLink link:calculationLink link:definitionLink 42102 - Disclosure - Segment Reporting - Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 42201 - Disclosure - Commitments, Contingencies and Guarantees (Details) link:presentationLink link:calculationLink link:definitionLink 42301 - Disclosure - Supplementary Cash Flow Data (Details) link:presentationLink link:calculationLink link:definitionLink 42401 - Disclosure - Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 42501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 42601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Manufacturer Rebates Receivables link:presentationLink link:calculationLink link:definitionLink 12501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 32503 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Tables) link:presentationLink link:calculationLink link:definitionLink 41702 - Disclosure - Leases - Supplemental cash flow information related to leases (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 rad-20230304_cal.xml EX-101.CAL EX-101.DEF 7 rad-20230304_def.xml EX-101.DEF EX-101.LAB 8 rad-20230304_lab.xml EX-101.LAB EX-101.PRE 9 rad-20230304_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document and Entity Information - USD ($)
12 Months Ended
Mar. 04, 2023
Jul. 22, 2024
Aug. 27, 2022
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Mar. 04, 2023    
Document Transition Report false    
Entity File Number 1-5742    
Entity Registrant Name RITE AID CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 23-1614034    
Entity Address, Address Line One PO Box 3165    
Entity Address, City or Town Harrisburg    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 17105    
City Area Code 717    
Local Phone Number 761-2633    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status No    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
ICFR Auditor Attestation Flag true    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Document Financial Statement Error Correction [Flag] false    
Entity Public Float     $ 447,694,555
Entity Common Stock, Shares Outstanding   55,974,015  
Auditor Name Deloitte & Touche LLP    
Auditor Firm ID 34    
Auditor Location Philadelphia, Pennsylvania    
Entity Central Index Key 0000084129    
Current Fiscal Year End Date --03-04    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag true    
Amendment Description Rite Aid Corporation ("Rite Aid," the "Company," "we," "us," and "our") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment" or "Form 10-K/A") to our Annual Report on Form 10-K for the fiscal year ended March 4, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on May 1, 2023 (the "Original Form 10-K") to make certain changes, as described below. Subsequent to the issuance of the Company's consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement related to the Company's historical accounting for closed store liabilities in accordance with changes in ASC 420, Exit or Disposal Cost Obligations. Based on their evaluation, management concluded the misstatement is not material to the Company's previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the "previously issued financial statements"). However, due to the discovery of this error, we reevaluated the effectiveness of our internal control over financial reporting ("ICFR") as of March 4, 2023 and identified a material weakness in our ICFR. For a more detailed description of this material weakness, refer to Part II, Item 9A,"Controls and Procedures." This Amendment therefore amends our assessment of our ICFR and our disclosure controls and procedures to indicate that they were not effective as of March 4, 2023 because of this material weakness. Our independent registered public accounting firm, Deloitte & Touche LLP, has also amended its opinion on our ICFR as of March 4, 2023. In conjunction with filing this Amendment, we determined it was appropriate to revise the consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes thereto to reflect the impact of the immaterial misstatement in the periods impacted. For additional information and a more detailed discussion, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements. Item 1A, "Risk Factors," of Part I of the Original Form 10-K, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Continuing Operations;" Item 8, "Financial Statements and Supplementary Data," and Item 9A, "Controls and Procedures," of Part II of the Original Form 10-K are hereby deleted in their entireties and replaced with Item 1A, Item 7, Item 8, and Item 9A included herein, Item 15, "Exhibits and Financial Statement Schedule," of Part IV of the Original Form 10-K also has been amended to include a new consent of Deloitte & Touche LLP and, as required by Rule 12b-15 under the Securities Act of 1934, as amended, to provide new currently dated certifications by our Chief Executive Officer and Chief Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The new consent is attached to this Amendment as Exhibit 23 and the new certifications are attached to this Amendment as Exhibits 31.1, 31.2 and 32. The other Items of the Original Form 10-K have not been amended and, accordingly, have not been repeated in this Amendment. The only changes to the Original Form 10-K are related to the matters described above. Except as described above, this Amendment does not amend, update, or change any other item or disclosure in the Original Form 10-K and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Original Form 10-K was filed, and the Company has not undertaken herein to amend, update, or change any information contained in the Original Form 10-K to give effect to any event following the date of filing of the Original Form 10-K, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and any subsequent filing with the SEC.    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Current assets:    
Cash and cash equivalents $ 157,151 $ 39,721
Accounts receivable, net 1,149,958 1,343,496
Inventories, net 1,900,744 1,959,389
Prepaid expenses and other current assets 93,194 106,749
Total current assets 3,301,047 3,449,355
Property, plant and equipment, net 907,771 989,167
Operating lease right-of-use assets 2,497,206 2,813,535
Goodwill 507,936 879,136
Other intangibles, net 250,112 291,196
Deferred tax assets 12,368 20,071
Other assets 50,922 86,543
Total assets 7,527,362 8,529,003
Current liabilities:    
Current maturities of long-term debt and lease financing obligations 6,332 5,544
Accounts payable 1,494,611 1,571,261
Accrued salaries, wages and other current liabilities 709,891 776,559
Current portion of operating lease liabilities 502,403 575,651
Total current liabilities 2,713,237 2,929,015
Long-term debt, less current maturities 2,925,258 2,732,986
Long-term operating lease liabilities 2,372,943 2,597,090
Lease financing obligations, less current maturities 12,580 14,830
Other noncurrent liabilities 97,577 139,254
Total liabilities 8,121,595 8,413,175
Commitments and contingencies
Stockholders' (deficit) equity:    
Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 56,629 and 55,752 56,629 55,752
Additional paid-in capital 5,917,964 5,910,299
Accumulated deficit (6,553,974) (5,834,786)
Accumulated other comprehensive loss (14,852) (15,437)
Total stockholders' (deficit) equity (594,233) 115,828
Total liabilities and stockholders' (deficit) equity $ 7,527,362 $ 8,529,003
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
shares in Thousands
Mar. 04, 2023
Feb. 26, 2022
CONSOLIDATED BALANCE SHEETS    
Common stock, par value (in dollars per share) $ 1 $ 1
Common stock, shares authorized 75,000 75,000
Common stock, shares issued 56,629 55,752
Common stock, shares outstanding 56,629 55,752
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS      
Revenues $ 24,091,899 $ 24,568,255 $ 24,043,240
Costs and expenses:      
Cost of revenues 19,287,959 19,461,760 19,338,918
Selling, general and administrative expenses 4,902,087 5,033,876 4,657,185
Facility exit and impairment charges 180,637 164,084 57,714
Goodwill and intangible asset impairment charges 371,200 229,000 29,852
Interest expense 224,399 191,601 201,388
(Gain) loss on debt modifications and retirements, net (80,142) 3,235 (5,274)
(Gain) loss on sale of assets, net (68,586) 5,505 (69,300)
Loss (gain) on Bartell acquisition 5,346 (47,705)
Total costs and expenses 24,817,554 25,094,407 24,162,778
Loss before income taxes (725,655) (526,152) (119,538)
Income tax benefit (6,467) (3,780) (20,157)
Net loss from continuing operations (719,188) (522,372) (99,381)
Net income from discontinued operations, net of tax     9,161
Net loss (719,188) (522,372) (90,220)
Computation of loss attributable to common stockholders:      
Loss from continuing operations attributable to common stockholders - basic (719,188) (522,372) (99,381)
Loss from continuing operations attributable to common stockholders - diluted (719,188) (522,372) (99,381)
Income from discontinued operations attributable to common stockholders-basic 9,161
Income from discontinued operations attributable to common stockholders-diluted     9,161
Net loss attributable to common stockholders - basic (719,188) (522,372) (90,220)
Net loss attributable to common stockholders - diluted $ (719,188) $ (522,372) $ (90,220)
Basic loss per share:      
Continuing operations $ (13.15) $ (9.66) $ (1.86)
Discontinued operations 0.18
Net basic loss per share (13.15) (9.66) (1.68)
Diluted loss per share:      
Continuing operations (13.15) (9.66) (1.86)
Discontinued operations     0.18
Net diluted loss per share $ (13.15) $ (9.66) $ (1.68)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS      
Net loss $ (719,188) $ (522,372) $ (90,220)
Defined benefit pension plans:      
Amortization of net actuarial losses included in net periodic pension cost, net of $0, $0 and $0 income tax expense 585 8,590 24,382
Change in fair value of interest rate cap   27 462
Total other comprehensive income 585 8,617 24,844
Comprehensive loss $ (718,603) $ (513,755) $ (65,376)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS      
Amortization of net actuarial losses included in net periodic pension cost, net of income tax expense $ 0 $ 0 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
BALANCE - beginning of period at Feb. 29, 2020 $ 54,716 $ 5,890,903 $ (5,222,194) $ (48,898) $ 674,527
BALANCE (in shares) at Feb. 29, 2020 54,716        
Increase (Decrease) in Stockholders' Deficit          
Net loss     (90,220)   (90,220)
Comprehensive loss         (65,376)
Changes in Defined Benefit Plans, net of $0 tax expense       24,382 24,382
Change in fair value of interest rate cap       462 462
Issuance of restricted stock $ 780 (780)      
Issuance of restricted stock (in shares) 780        
Exchange of restricted shares for taxes $ (189) (2,897)     (3,086)
Exchange of restricted shares for taxes (in shares) (189)        
Cancellation of restricted stock $ (166) 166      
Cancellation of restricted stock (in shares) (166)        
Amortization of restricted stock balance   9,126     9,126
Stock-based compensation expense   599     599
Stock options exercised $ 2 51     $ 53
Stock options exercised (in shares) 2       2
BALANCE - end of period at Feb. 27, 2021 $ 55,143 5,897,168 (5,312,414) (24,054) $ 615,843
BALANCE (in shares) at Feb. 27, 2021 55,143        
Increase (Decrease) in Stockholders' Deficit          
Net loss     (522,372)   (522,372)
Comprehensive loss         (513,755)
Changes in Defined Benefit Plans, net of $0 tax expense       8,590 8,590
Change in fair value of interest rate cap       27 27
Issuance of restricted stock $ 973 (973)      
Issuance of restricted stock (in shares) 973        
Exchange of restricted shares for taxes $ (177) (2,411)     (2,588)
Exchange of restricted shares for taxes (in shares) (177)        
Cancellation of restricted stock $ (187) 187      
Cancellation of restricted stock (in shares) (187)        
Amortization of restricted stock balance   10,308     10,308
Stock-based compensation expense   600     600
Amortization of performance-based incentive plans   5,420     $ 5,420
Stock options exercised (in shares)        
BALANCE - end of period at Feb. 26, 2022 $ 55,752 5,910,299 (5,834,786) (15,437) $ 115,828
BALANCE (in shares) at Feb. 26, 2022 55,752        
Increase (Decrease) in Stockholders' Deficit          
Net loss     (719,188)   (719,188)
Comprehensive loss         (718,603)
Changes in Defined Benefit Plans, net of $0 tax expense       585 585
Issuance of restricted stock $ 1,662 (1,662)      
Issuance of restricted stock (in shares) 1,662        
Exchange of restricted shares for taxes $ (415) (2,247)     (2,662)
Exchange of restricted shares for taxes (in shares) (415)        
Cancellation of restricted stock $ (370) 370      
Cancellation of restricted stock (in shares) (370)        
Amortization of restricted stock balance   13,897     13,897
Stock-based compensation expense   720     720
Amortization of performance-based incentive plans   (3,413)     $ (3,413)
Stock options exercised (in shares)        
BALANCE - end of period at Mar. 04, 2023 $ 56,629 $ 5,917,964 $ (6,553,974) $ (14,852) $ (594,233)
BALANCE (in shares) at Mar. 04, 2023 56,629        
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY      
Changes in defined benefit plans, tax expense $ 0 $ 0 $ 0
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Operating activities:      
Net loss $ (719,188) $ (522,372) $ (90,220)
Net income from discontinued operations, net of tax     9,161
Net loss from continuing operations (719,188) (522,372) (99,381)
Adjustments to reconcile to net cash (used in) provided by operating activities of continuing operations:      
Depreciation and amortization 276,583 295,686 327,124
Facility exit and impairment charges 180,637 164,084 57,714
Goodwill and intangible asset impairment charges 371,200 229,000 29,852
LIFO charge (credit) 53,028 1,314 (51,692)
(Gain) loss on sale of assets, net (68,586) 5,505 (69,300)
Change in allowances for uncollectible accounts receivable 15,267 22,011  
Loss (gain) on Bartell acquisition 5,346 (47,705)
Stock-based compensation expense 11,537 13,050 13,003
(Gain) loss on debt modifications and retirements, net (80,142) 3,235 (5,274)
Changes in deferred taxes 7,703 (6,709) (10,633)
Changes in operating assets and liabilities:      
Accounts receivable 151,610 54,086 (182,404)
Inventories 5,158 (97,112) 177,263
Accounts payable (96,570) 139,228 (35,372)
Operating lease right-of-use assets and operating lease liabilities (86,133) (29,375) (28,044)
Other assets 36,478 33,737 80,975
Other liabilities (111,021) 68,558 (50,947)
Net cash (used in) provided by operating activities of continuing operations: (52,439) 379,272 105,179
Investing activities:      
Payments for property, plant and equipment (215,285) (194,090) (195,141)
Intangible assets acquired (32,400) (26,623) (29,800)
Acquisition of business, net of cash acquired     (86,230)
Proceeds from insured loss   10,436 12,500
Proceeds from dispositions of assets and investments 69,582 18,706 11,444
Proceeds from sale-leaseback transactions 73,344 57,498 177,892
Net cash used in investing activities of continuing operations: (104,759) (134,073) (109,335)
Financing activities:      
Proceeds from issuance of long-term debt 50,000 350,000 849,918
Net proceeds from (payments to) revolver 491,000 (141,000) 200,000
Principal payments on long-term debt (277,941) (545,036) (1,058,537)
Change in zero balance cash accounts 18,289 (8,285) (36,463)
Net proceeds from issuance of common stock     53
Financing fees paid for early debt redemption (1,733) (833) (2,399)
Payments for taxes related to net share settlement of equity awards (2,662) (2,588) (3,086)
Deferred financing costs paid (2,325) (18,638) (14,729)
Net cash provided by (used in) financing activities of continuing operations: 274,628 (366,380) (65,243)
Cash flows from discontinued operations:      
Operating activities of discontinued operations 0 0 (82,189)
Investing activities of discontinued operations 0 0 94,310
Financing activities of discontinued operations 0 0 0
Net cash provided by discontinued operations 0 0 12,121
Increase (decrease) in cash and cash equivalents 117,430 (121,181) (57,278)
Cash and cash equivalents, beginning of period 39,721 160,902 218,180
Cash and cash equivalents, end of period $ 157,151 $ 39,721 $ 160,902
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies
12 Months Ended
Mar. 04, 2023
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

1. Summary of Significant Accounting Policies

Description of Business

The Company is a Delaware corporation and through its 100% owned subsidiaries, operates a pharmacy retail healthcare company in the United States of America. The Company operates through its two reportable segments: the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy Segment operates one of the largest retail drugstore chains in the United States, with 2,309 stores in operation as of March 4, 2023. The Retail Pharmacy Segment’s drugstores’ primary business is the sale of brand and generic prescription drugs. The Retail Pharmacy Segment also sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment provides a fully integrated suite of pharmacy benefit management (“PBM”) offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs, through Elixir Pharmacy and Laker Software. Elixir also offers a national Medicare Part D prescription drug plan through Elixir Insurance (“EI”). See Note 21 for additional details on the Company’s reportable segments.

The discussion and presentation of the operating and financial results of our business segments have been impacted by the following event.

Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement (the "Amended and Restated Asset Purchase Agreement"), dated as of September 18, 2017, by and among Rite Aid, WBA and Walgreen Co., an Illinois corporation and 100% owned subsidiary of WBA ("Buyer"), Buyer agreed to purchase from Rite Aid 1,932 stores (the "Acquired Stores"), three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of approximately $4,375,000, on a cash free, debt free basis (the "Asset Sale" or the "Sale"). As of March 4, 2023, the Company has sold all 1,932 Acquired Stores, three distribution centers and related assets to WBA in exchange for proceeds of $4,375,000, which were used to repay outstanding debt. Based on its magnitude and because the Company has exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Asset Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). See additional information as provided in Note 4 Asset Sale to WBA.

Revenues for the Company are as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Retail Pharmacy Segment:

Pharmacy sales

    

$

12,582,593

    

$

12,152,491

    

$

10,915,442

Front-end sales

 

5,078,820

 

5,218,182

 

5,322,943

Other revenue

 

123,654

 

124,143

 

126,875

Total Retail Pharmacy Segment

17,785,067

17,494,816

16,365,260

Pharmacy Services Segment revenue

6,522,299

7,323,125

7,970,137

Intersegment elimination

(215,467)

(249,686)

(292,157)

Total revenue

$

24,091,899

$

24,568,255

$

24,043,240

Sales of prescription drugs for our Retail Pharmacy Segment represented approximately 71.2%, 70.0% and 66.7% of the Company’s total drugstore sales in fiscal years 2023, 2022 and 2021, respectively. The Retail Pharmacy Segment’s principal classes of products in fiscal 2023 were the following:

Percentage

 

Product Class

    

of Sales

Prescription drugs

 

71.2

%

Over-the-counter medications and personal care

 

10.9

%

Health and beauty aids

 

4.3

%

General merchandise and other

 

13.6

%

Fiscal Year

The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year ended March 4, 2023 included 53 weeks. The fiscal years ended February 26, 2022 and February 27, 2021 included 52 weeks.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its 100% owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and highly liquid investments, which are readily convertible to known amounts of cash and which have original maturities of three months or less when purchased.

Allowance for Uncollectible Receivables

In our Retail Pharmacy Segment, substantially all prescription sales are made to customers who are covered by third-party payors, such as insurance companies, government agencies and employers. The Company recognizes receivables that represent the amount owed to the Company for sales made to customers or employees of those payors that have not yet been paid. In our Pharmacy Services Segment, receivables are recorded for claims for prescriptions

issued for customers, customer administrative fees, amounts due from the Centers for Medicare and Medicaid Services (“CMS”) for Medicare Part D, and amounts due from certain drug manufacturers or rebate aggregators for rebates. The Company maintains a reserve for the expected credit losses associated with these receivables. This reserve is calculated based upon historical collection activity adjusted for current conditions.

Inventories

Inventories are stated at the lower of cost or market. Inventory balances include the capitalization of certain costs related to purchasing, freight and handling costs associated with placing inventory in its location and condition for sale. The Company uses the last-in, first-out (“LIFO”) cost flow assumption for substantially all of its inventories. The Company calculates its inflation index based on internal product mix and utilizes the link-chain LIFO method.

Impairment of Long-Lived Assets

Asset impairments are recorded when the carrying value of assets are not recoverable. For purposes of recognizing and measuring impairment of long-lived assets, the Company categorizes assets of operating stores as “Assets to Be Held and Used” and “Assets to Be Disposed Of.” The Company evaluates assets at the store level because this is the lowest level of identifiable cash flows ascertainable to evaluate impairment. Assets being tested for recoverability at the store level include tangible long-lived assets, right-of-use assets for leased stores, and identifiable, finite-lived intangibles that arose in purchase business combinations. Corporate assets to be held and used are evaluated for impairment based on excess cash flows from the stores that support those assets.

The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset.

Property, Plant and Equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation and amortization. The Company provides for depreciation using the straight-line method over the following useful lives: buildings—30 to 45 years; equipment—3 to 15 years.

Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the term of the lease. When determining the amortization period of a leasehold improvement, the Company considers whether discretionary exercise of a lease renewal option is reasonably assured. If it is determined that the exercise of such option is reasonably assured, the Company will amortize the leasehold improvement asset over the minimum lease term, plus the option period. This determination depends on the remaining life of the minimum lease term and any economic penalties that would be incurred if the lease option is not exercised.

Capitalized lease assets are recorded at the lesser of the present value of minimum lease payments or fair market value and amortized over the estimated useful life of the related property or term of the lease.

The Company capitalizes direct internal and external development costs associated with internal-use software. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. For fiscal years 2023, 2022 and 2021, the Company capitalized costs of approximately $5,099, $13,388 and $12,669, respectively.

Goodwill

The Company recognizes goodwill as the excess of the purchase price over the fair value of the assets acquired and liabilities assumed during business combinations. The Company accounts for goodwill under ASC Topic 350, “Intangibles—Goodwill and Other”, which does not permit amortization, but instead requires the Company to perform an annual impairment review, or more frequently if events or circumstances indicate that impairment may be more likely. See Note 14 for additional information on goodwill.

Intangible Assets

The Company has certain finite-lived intangible assets that are amortized over their useful lives. Prescription files acquired in business combinations are amortized over an estimated useful life of 10 years on an accelerated basis, which approximates the anticipated prescription file retention and related cash flows. Purchased prescription files acquired in other than business combinations are amortized over their estimated useful lives of five years on a straight-line basis. The value of finite-lived trade names are amortized over 10 years on a straight-line basis. The value of customer relationships, acquired in connection with the Company’s acquisition of Elixir, are amortized over a period between 10 and 20 years on a descending percentage method which matches the pattern of expected discounted cash flows. The Pharmacy Services Segment’s contract with CMS for Part D, which is required in order to act as a national provider of the Part D benefit, is amortized over 12 years on a straight line basis, of which four years remain.

Indefinite lived assets

The Company has a single indefinite-lived intangible asset consisting of a trade name. Intangible assets that are determined to have an indefinite life are not amortized, but are required to be evaluated at least annually for impairment. If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-lived intangible asset is impaired by the amount of the excess.

Deferred Financing Costs

Costs incurred to issue debt are deferred and amortized as a component of interest expense over the terms of the related debt agreements. Amortization expense of deferred financing costs was $9,993, $10,927 and $11,201 for fiscal 2023, 2022 and 2021, respectively.

Revenue Recognition

Retail Pharmacy Segment

For front-end sales, the Retail Pharmacy Segment recognizes revenues upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation at the point of sale for front-end transactions. The Retail Pharmacy Segment front-end revenue is measured based on the amount of fixed consideration that it expects to

receive, net of an allowance for estimated future returns. Return activity is immaterial to revenues and results of operations in all periods presented.

For pharmacy sales, the Retail Pharmacy Segment recognizes revenue upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation, upon pickup by the customer, which is when the customer takes title to the product. Each prescription claim represents an individual arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims. The Company's revenue is measured based on the amount of fixed consideration that we expect to receive, reduced by refunds owed to the third-party payor for pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not highly subjective or volatile. The effect of adjustments between estimated and actual amounts has not been material to the Company's results of operations or financial position. Prescriptions are generally not returnable.

The Retail Pharmacy Segment offered a chain-wide loyalty card program titled wellness+. Individual customers were able to become members of the wellness+ program. Members participating in the wellness+ loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, the Company granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.

A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.

Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue. For the fifty-three week period ended March 4, 2023, the Company recognized additional contract deferrals of $2,030 as a reduction of revenues. The Retail Pharmacy Segment had accrued contract liabilities of $2,030 and $0 as of March 4, 2023 and February 26, 2022, respectively.

Pharmacy Services Segment

The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and; (ii) under retail pharmacy network contracts where it is the principal at the contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of

health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member co-payments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:

Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services Segment’s online claims processing system. At this point the Company has performed all of its performance obligations.
Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments.
Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member-based fee, or a claims volume-based fee.

In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.

Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.

For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized, except the administrative fee.

Drug Discounts—The Pharmacy Services Segment deducts from its revenues that are generated from prescription drugs sold by third-party pharmacies any rebates, inclusive of discounts and fees, earned by its clients based on utilization levels and other factors as negotiated with the prescription drug manufacturers, rebate aggregators or suppliers. Rebates are paid to clients in accordance with the terms of client contracts.

Medicare Part D—The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a Medicare Part D Prescription Drug Plan (“PDP”). Please refer to Note 10, Medicare Part D.

Disaggregation of Revenue

The following tables disaggregate the Company’s revenue by major source in each segment for the fiscal year ended March 4, 2023:

March 4,

    

2023

In thousands

(53 Weeks)

    

Retail Pharmacy Segment:

  

 

Pharmacy sales

$

12,582,593

Front-end sales

 

5,078,820

Other revenue

 

123,654

Total Retail Pharmacy Segment

17,785,067

Pharmacy Services Segment

 

6,522,299

Intersegment elimination

 

(215,467)

Total revenue

$

24,091,899

See Note 21 for additional information about the revenues of the Company’s business segments.

Cost of Revenues

Retail Pharmacy Segment

Cost of revenues for the Retail Pharmacy Segment includes the following: the cost of inventory sold during the period, including related vendor rebates and allowances, LIFO credit or charges, costs incurred to return merchandise to vendors, inventory shrink, purchasing costs and warehousing costs, which include inbound freight costs from the vendor, distribution payroll and benefit costs, distribution center occupancy costs and depreciation expense and delivery expenses to the stores.

Pharmacy Services Segment

The Pharmacy Services Segment’s cost of revenues includes the cost of prescription drugs sold during the reporting period indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The cost of prescription drugs sold component of cost of revenues includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients’ benefit plans from the Pharmacy Services Segment’s mail service dispensing pharmacy, net of any volume-related or other discounts (see the section entitled “Vendor Rebates and Allowances and Purchase Discounts” below) and (ii) the cost of prescription drugs sold through the Pharmacy Services Segment’s retail pharmacy network under contracts where it is the principal, net of any volume-related or other discounts.

See Note 21 for additional information about the cost of revenues of the Company’s business segments.

Vendor Rebates and Allowances and Purchase Discounts

Retail Pharmacy Segment

The Retail Pharmacy Segment’s rebates and allowances received from vendors relate to either buying and merchandising or promoting the product. Buying and merchandising related rebates and allowances are recorded as a reduction of cost of revenue as product is sold. Buying and merchandising rebates and allowances include all types of vendor programs such as cash discounts from timely payment of invoices, purchase discounts or rebates, volume purchase allowances, price reduction allowances and slotting allowances. Certain product promotion related rebates and allowances, primarily related to advertising, are recorded as a reduction in selling, general and administrative expenses when the advertising commitment has been satisfied.

Pharmacy Services Segment

The Pharmacy Services Segment receives purchase discounts on products purchased. The Pharmacy Services Segment’s contractual arrangements with vendors, including manufacturers and rebate aggregators, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized when prescriptions are dispensed and are generally billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Pharmacy Services Segment’s results of operations. The Pharmacy Services Segment accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services Segment also receives additional discounts under its wholesaler and rebate aggregator contracts and fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.

Rebates payable to clients for the Pharmacy Services Segment

The Pharmacy Services Segment has contractual arrangements with clients, including health plans, commercial employers, labor groups, and state and local governments, which entitles such clients to a portion of certain rebates received by the Pharmacy Services Segment. Estimated rebates payable to clients are recognized when prescriptions are dispensed and are generally paid to clients up to eight months in arrears.  Historically, the effect of adjustments resulting from the reconciliation of estimated rebates payable to clients recognized and the amount actually paid has not been material to the Pharmacy Services Segment’s results of operations.  The Pharmacy Services Segment accounts for the effect of any such difference as a change in accounting estimate in the period the reconciliation is completed.  Estimated rebates payable to clients are recorded as a reduction of revenues.

Leases

The Company determines if an arrangement contains a lease at the inception of a contract. Operating lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized at the commencement date based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company’s leases is not readily

determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest that we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses quoted interest rates obtained from financial institutions in an input to derive its incremental borrowing rate as the discount rate for the lease. The ROU asset is equal to the operating lease liability plus lease payments made before commencement, less lease incentives received from the landlord.

The Company’s real estate leases typically contain options that permit lease extensions for additional periods of up to five years each. For real estate leases, generally, the renewal periods are not included within the lease term and the associated payments are not included in the measurement of the ROU asset and operating lease liability as the options to extend are not considered reasonably certain to occur at lease commencement. The Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and will include all reasonably certain options in the measurement of its lease term. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the operating lease right-of-use asset and the operating lease liability until the renewals are i) evaluated and ii) determined to be exercised. The Company has an insignificant amount of non-real estate leases however, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. The Company rarely executes leases less than 12 months.

For real estate leases, the Company accounts for lease components and non-lease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the operating lease right-of-use assets and operating lease liabilities.

The Company records rent expense on operating leases on a straight-line basis over the reasonably certain lease term. The Company begins to record rent expense at the time that the Company has the right to use the property.

Selling, General and Administrative Expenses

Selling, general and administrative expenses include store and corporate administrative payroll and benefit costs, occupancy costs which include retail store and corporate rent costs, facility and leasehold improvement depreciation and utility costs, advertising, repair and maintenance, insurance, equipment depreciation and professional fees.

Repairs and Maintenance

Routine repairs and maintenance are charged to operations as incurred. Improvements and major repairs, which extend the useful life of an asset, are capitalized and depreciated.

Advertising

Advertising costs, net of specific vendor advertising allowances, are expensed in the period the advertisement first takes place. Advertising expenses, net of vendor advertising allowances, for fiscal 2023, 2022 and 2021 were $133,379, $146,085 and $122,725, respectively.

Insurance

The Company is self-insured for certain general liability and workers’ compensation claims. For claims that are self-insured, stop-loss insurance coverage is maintained for workers’ compensation occurrences exceeding $1,000 and general liability occurrences exceeding $3,000. The Company utilizes actuarial studies as the basis for developing reported claims and estimating claims incurred but not reported relating to the Company’s self-insurance. Workers’ compensation claims are discounted to present value using a risk-free interest rate.

The Company is also self-insured for certain employee health and welfare plans. We record the related self-insurance liabilities based on claims incurred and an estimate of claims incurred but not yet reported.

Benefit Plan Accruals

The Company has several defined benefit plans, under which participants earn a retirement benefit based upon a formula set forth in the plan. The Company records expense related to these plans using actuarially determined amounts that are calculated under the provisions of ASC 715, “Compensation—Retirement Benefits.” Key assumptions used in the actuarial valuations include the discount rate, the expected rate of return on plan assets and the rate of increase in future compensation levels.

Stock-Based Compensation

The Company has several stock award plans, which are described in detail in Note 18. The Company accounts for stock-based compensation under ASC 718, “Compensation—Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.

Store Pre-opening Expenses

Costs incurred prior to the opening of a new or relocated store, associated with a remodeled store or related to the opening of a distribution facility are charged to operations as incurred.

Litigation Reserves

The Company is involved in litigation on an ongoing basis. The Company accrues its best estimate of the probable loss related to legal claims. Such estimates are developed in consultation with in-house counsel, and are based upon a combination of litigation and settlement strategies.

Income Taxes

Deferred income taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities. Deferred income tax expense (benefit) represents the change during the reporting period in the deferred tax assets and deferred tax liabilities, net of the effect of acquisitions and dispositions. Deferred tax assets include tax loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.

The Company has net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate a significant deferred tax asset. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies.

The Company recognizes tax liabilities in accordance with ASC 740, “Income Taxes” and the Company adjusts these liabilities with changes in judgment as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the tax liabilities.

Sales Tax Collected

Sales taxes collected from customers and remitted to various governmental agencies are presented on a net basis (excluded from revenues) in the Company’s statement of operations.

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Significant Concentrations

Retail Pharmacy Segment

The Company’s pharmacy sales were primarily to customers covered by health plan contracts, which typically contract with a third-party payor that agrees to pay for all or a portion of a customer’s eligible prescription purchases. During fiscal 2023, the top five third-party payors accounted for approximately 83.4% of the Company’s pharmacy sales. The largest third-party payor, Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. Third-party payors are entities such as an insurance company, governmental agency, health maintenance organization or other managed care provider, and typically represent several health care contracts and customers.

During fiscal 2023, state sponsored Medicaid agencies and related managed care Medicaid payors accounted for approximately 19.9% of the Company’s pharmacy sales, the largest of which was approximately 6.6% of the Company’s pharmacy sales. During fiscal 2023, approximately 38.8% of the Company’s pharmacy sales were to customers covered by Medicare Part D. Any significant loss of third-party payor business could have a material adverse effect on the Company’s business and results of operations.

During fiscal 2023, the Company purchased brand and generic pharmaceuticals, which amounted to approximately 98% of the dollar volume of its prescription drugs from McKesson Corporation (“McKesson”) under its expanded agreement executed on February 17, 2014 and amended in fiscal 2019 for its pharmaceutical purchasing and distribution whereby McKesson assumed responsibility for purchasing essentially all of the brand and generic medications the Company dispenses as well as providing a new direct store delivery model to all of the Company’s stores. If the Company’s relationship with McKesson was disrupted, it could temporarily have difficulty filling

prescriptions for brand-named and generic drugs until it executed a replacement wholesaler agreement or developed and implemented self-distribution processes.

Pharmacy Services Segment

The Company’s Pharmacy Services Segment revenue is currently generated from a limited number of customers. During fiscal 2023, its top five customers accounted for 65.9% of its Pharmacy Services Segment revenue, which includes 6.9% related to a client which termed on January 1, 2023. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. Pharmacy Services Segment customers are entities such as employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of health benefit plans, and individuals throughout the United States.

The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a PDP. During fiscal 2023, fiscal 2022 and fiscal 2021, net revenues of $529,025 (2.2% of consolidated revenues), $589,620 (2.4% of consolidated revenues) and $630,104 (2.6% of consolidated revenues), respectively, include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS.

Derivatives

The Company may enter into interest rate swap agreements to hedge the exposure to increasing rates with respect to its variable rate debt, when the Company deems it prudent to do so. Upon inception of interest rate swap or cap agreements, or modifications thereto, the Company performs a comprehensive review of the interest rate swap agreements based on the criteria as provided by ASC 815, “Derivatives and Hedging.”

Recently Adopted Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another rate affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of Interbank Offered Rates (“IBORs”) and, particularly, the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to the above ASU to clarify certain optional expedients and exceptions in Topic 848. The Company adopted ASU 2020-04 effective December 1, 2022 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation, the recognition of deferred tax liabilities and the methodology for calculating income taxes in the interim period. The amendments also improve consistent application of and simplify

GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020 (fiscal 2022). The Company adopted ASU 2019-12 effective February 28, 2021 and the adoption of this standard did not have a material impact on the Company’s financial position.

In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement benefits (Topic 715-20). This ASU amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. This ASU is effective for fiscal years ending after December 15, 2020 and must be applied on a retrospective basis. The Company adopted ASU 2018-14 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which is intended to provide entities with additional guidance to determine which software implementation costs to capitalize and which costs to expense. The ASU will allow entities to capitalize costs for implementation activities during the application development stage. ASU No. 2018-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2019 (fiscal 2021). Early adoption of ASU 2018-15 is permitted. The Company adopted ASU 2018-15 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model), that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity will recognize, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses. ASU 2016-13 impacts non-banks as most non-banks have financial instruments or other assets (e.g., trade, contract and lease receivables, financial guarantees, loans and loan commitments and held-to-maturity debt securities). The Company adopted ASU 2016-13 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition
12 Months Ended
Mar. 04, 2023
Acquisition  
Acquisition

2. Acquisition

On December 18, 2020, pursuant to that certain stock purchase agreement, dated as of October 7, 2020, by and between the Company and Bartell Drug Company (“Bartell”), the Company acquired Bartell (the “Acquisition”), a Washington corporation, for approximately $89,724 in cash, subject to certain customary post-closing working capital adjustments. The Company financed the Acquisition with borrowings under its senior secured credit facilities together with cash on hand.  Bartell operated 67 retail drugstores and one distribution center in the greater Seattle Washington area.  Bartell operates as a 100 percent owned subsidiary of the Company within its Retail Pharmacy Segment.

The Company’s consolidated financial statements for fiscal 2023 and 2022 include Bartell’s results of operations. The Company’s consolidated financial statements for fiscal 2021 include Bartell’s results of operations from the Acquisition date of December 18, 2020 through February 27, 2021, including revenues of $101,083. The Company’s consolidated financial statements at February 26, 2022 reflect the final purchase accounting adjustments in accordance with ASC 805 “Business Combinations,” whereby the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values on the Acquisition date.

The following allocation of the purchase price and the estimated transaction costs is final:

Final purchase price

Cash consideration

$

89,724

Total

 

89,724

Final purchase price allocation

Cash and cash equivalents

$

3,494

Accounts receivable

 

23,860

Inventories

67,745

Prepaid expenses and other current assets

1,857

Total current assets

96,956

Property and equipment

28,229

Operating lease right-of-use assets

143,651

Intangible assets(1)

68,700

Other assets

1,805

Total assets acquired

339,341

Accounts payable

24,166

Accrued salaries, wages and other current liabilities

20,335

Current portion of operating lease liabilities

24,617

Total current liabilities

69,118

Long-term operating lease liabilities

124,023

Other long-term liabilities

166

Total liabilities assumed

193,307

Deferred tax liabilities recorded on purchase

13,951

Net assets acquired

132,083

Bargain purchase gain

(42,359)

Total purchase price

$

89,724

(1)            Intangible assets are recorded at estimated fair value, as determined by management based on available information which includes a final valuation prepared by an independent third-party. The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty and the multi-period excess earnings methods. The major assumptions used in arriving at the estimated identifiable intangible asset values included management’s final estimates of future cash flows, discounted at an appropriate rate of return which are based on the weighted average cost of capital for both the Company and other market participants, projected customer attrition rates, as well as applicable royalty rates for comparable assets. The useful lives for intangible assets were determined based upon the remaining useful economic lives of the intangible assets that are expected to contribute directly or indirectly to future cash flows. The estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation include:

Estimated Fair Value

Estimated Useful Life
(In Years)

Prescription files

$

54,300

10

Tradename

 

14,400

Indefinite

Total

$

68,700

During fiscal 2021, the Company recorded a gain on Bartell acquisition of $47,705 primarily due to fair value adjustments related to prescription files and the tradename compared to book values. During fiscal 2022, in connection with determining its final purchase price allocation, the Company recorded a loss on Bartell acquisition of $5,346 primarily due to contract termination charges, inventory valuation adjustments and changes in deferred income taxes, resulting in a net bargain purchase gain of $42,359. The Company believes that the bargain purchase gain was primarily the result of the decision by the Bartell stockholders to sell their interests as Bartell had been experiencing increasing borrowings under its credit agreements to meet its operating needs and increasing net losses. The agreed upon purchase price reflected the fact the seller would have needed to incur further significant debt to cover the operating costs of Bartell, which would have required amendments to its credit arrangements. With the Company’s existing infrastructure, scale and expertise, the Company believe that it has access to the necessary synergies to allow necessary operational improvements to be implemented more efficiently than the seller.

During fiscal 2023, fiscal 2022 and fiscal 2021, acquisition costs of $0, $12,797 and $10,549, respectively, were expensed as incurred. The following unaudited pro forma combined financial data gives effect to the Acquisition as if it had occurred as of March 1, 2019.

 

The unaudited combined pro forma results do not include any incremental cost savings that may result from the integration. The adjustments are based on information available to the Company at this time. Accordingly, the adjustments are subject to change and the impact of such changes may be material.

The unaudited combined pro forma information is for informational purposes only.  The pro forma information is not necessarily indicative of what the combined company’s results actually would have been had the Acquisition been completed as of the beginning of the periods as indicated.  In addition, the unaudited pro forma information does not purport to project the future results of the combined company.

March 4,

February 26,

February 27,

2023

2022

2021

    

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Pro forma

Pro forma

Pro forma

Net revenues as reported

$

24,091,899

$

24,568,255

$

24,043,240

Supplemental Pro forma revenues

$

24,091,899

$

24,568,255

$

24,468,777

Net loss as reported

$

(719,188)

$

(522,372)

$

(90,220)

Supplemental Pro forma net loss

$

(719,188)

$

(522,372)

$

(116,040)

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.2
Restructuring
12 Months Ended
Mar. 04, 2023
Restructuring  
Restructuring

3. Restructuring

Beginning in fiscal 2019, the Company initiated a series of restructuring plans designed to reorganize its executive management team, reduce managerial layers, and consolidate roles. In March 2020, the Company announced

the details of its strategy, which includes building tools to work with regional health plans to improve patient health outcomes, rationalizing SKU’s in its front-end offering to free up working capital and update its merchandise assortment, assessing its pricing and promotional strategy, rebranding its retail pharmacy and pharmacy services business, launching its Store of the Future format and further reducing SG&A and headcount, including integrating certain back office functions in the Pharmacy Services Segment both within the segment and across the enterprise. Other strategic initiatives include the expansion of the Company’s digital business, replacing and updating the Company’s financial systems to improve efficiency, and movement to a common client platform at Elixir. In April 2022, the Company announced further strategic initiatives to reduce costs through the closure of unprofitable stores, reduce corporate administration expenses, improve efficiencies in worked payroll and other store labor costs, engage in a comprehensive review of purchasing and other business processes in both the Retail Pharmacy and Pharmacy Services Segments in order to identify areas of opportunity, as well as expense reductions at the Pharmacy Services Segment. In December 2022, the Company announced a new multi-year performance acceleration program, which allows it to fast-track initiatives that will improve sales, script volume and operating margins, and free up cash. The Company is partnering with a leading consulting firm that has worked with several Fortune 150 firms to execute the turnaround model. This program has given the Company visibility to the profitability opportunities it can drive over the next three years by focusing on improvements and growth in its core businesses. These and future restructuring activities are expected to provide future growth and expense efficiency benefits. There can be no assurance that the Company’s current and future restructuring charges will achieve the cost savings and remerchandising benefits in the amounts or time anticipated.

For the year ended March 4, 2023, the Company incurred total restructuring-related costs of $108,626, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

15,342

 

$

4,088

 

$

19,430

Professional and other fees relating to restructuring activities(c)

 

71,142

 

18,054

 

89,196

Total restructuring-related costs

 

$

86,484

 

$

22,142

 

$

108,626

For the year ended February 26, 2022, the Company incurred total restructuring-related costs of $35,121, which are included as a component of SG&A. These costs are as follows:

Retail Pharmacy

Pharmacy

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

$

 

$

2,502

 

$

2,502

Professional and other fees relating to restructuring activities(c)

 

12,237

 

20,382

 

32,619

Total restructuring-related costs

$

12,237

 

$

22,884

 

$

35,121

For the year ended February 27, 2021, the Company incurred total restructuring-related costs of $84,552, of which $63,613 is included as a component of SG&A and $20,939 is included as a component of cost of revenues. These costs are as follows:

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

13,443

 

$

4,353

 

$

17,796

Non-executive retention costs associated with the March 2019 reorganization(b)

 

1,136

 

(124)

 

1,012

Professional and other fees relating to restructuring activities(c)

 

40,053

 

4,752

 

44,805

SKU optimization charges(d)

20,939

20,939

Total restructuring-related costs

 

$

75,571

 

$

8,981

 

$

84,552

In addition, during the fiscal year ended February 27, 2021, the Company incurred intangible asset impairment charges of $29,852 in connection with its rebranding initiatives as described in Note 14, Goodwill and Other Intangibles.

A summary of activity for the year ended March 4, 2023 in the restructuring-related liabilities associated with the programs noted above, which is included in accrued salaries, wages and other current liabilities, is as follows:

Severance and related

Professional and

    

costs (a)

    

other fees (c)

    

Total

Balance as of February 26, 2022

$

4,257

 

$

4,463

 

$

8,720

Additions charged to expense 

 

11,904

10,742

 

22,646

Cash payments

 

(5,231)

(11,727)

 

(16,958)

Balance as of May 28, 2022

$

10,930

 

$

3,478

 

$

14,408

Additions charged to expense 

 

913

11,892

12,805

Cash payments

 

(2,782)

(10,066)

(12,848)

Balance as of August 27, 2022

$

9,061

$

5,304

$

14,365

Additions charged to expense 

4,800

21,700

26,500

Cash payments

(4,452)

(18,297)

(22,749)

Balance as of November 26, 2022

$

9,409

$

8,707

$

18,116

Additions charged to expense 

1,813

44,862

46,675

Cash payments

(3,564)

(11,415)

(14,979)

Balance as of March 4, 2023

 

$

7,658

 

$

42,154

 

$

49,812

(a)– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.
(b)– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.
(c)– Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.
(d)– Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.2
Asset Sale to WBA
12 Months Ended
Mar. 04, 2023
Asset Sale to WBA  
Asset Sale to WBA

4. Asset Sale to WBA

On September 18, 2017, the Company entered into the Amended and Restated Asset Purchase Agreement with WBA and Buyer, which amended and restated in its entirety the previously disclosed Asset Purchase Agreement, dated as of June 28, 2017, by and among the Company, WBA and Buyer. Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement, Buyer purchased from the Company 1,932 Acquired Stores, three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of $4,375,000, on a cash-free, debt-free basis (the “Asset Sale” or “Sale”). The Company completed the store transfer process in March of 2018, which resulted in the transfer of all 1,932 stores and related assets to WBA, and received cash proceeds of $4,156,686.

During the first quarter of fiscal 2021, the Company completed the sale of the final distribution center and related assets to WBA for proceeds of $94,289. The impact of the sale of the distribution center and related assets resulted in a pre-tax gain of $12,690, which was included in the results of operations and cash flows of discontinued operations during fiscal 2021. The transfer of the final distribution center and related assets constitutes the final closing under the Amended and Restated Asset Purchase Agreement.

The Company had agreed to provide transition services to Buyer for up to three years after the initial closing of the Sale. Under the terms of the TSA, the Company provided various services on behalf of WBA, including, but not limited to, the purchase and distribution of inventory and virtually all selling, general and administrative activities. The term of the TSA had been extended to October 17, 2020, unless earlier terminated. In connection with these services, the Company purchased the related inventory and incurred cash payments for the selling, general and administrative activities, which, the Company billed on a cash neutral basis to WBA in accordance with terms as outlined in the TSA. There were no billings for these items during the fifty-three week period ended March 4, 2023 and fifty-two week period ended February 26, 2022. The Company charged WBA TSA fees of $0, $0 and $1,467 during the fifty-three week period ended March 4, 2023, and fifty-two week periods ended February 26, 2022 and February 27, 2021, respectively, which are reflected as a reduction to selling, general and administrative expenses. On October 17, 2020, the Company and WBA mutually agreed to terminate the services under the TSA.

Based on its magnitude and because the Company exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). In accordance with ASC 205-20, the Company reclassified the financial results of the Disposal Group in its consolidated statements of operations and consolidated statements of cash flows for fiscal 2021. The Company also revised its discussion and presentation of operating and financial results to be reflective of its continuing operations as required by ASC 205-20.

As of March 4, 2023 and February 26, 2022, there were no assets and liabilities classified as held for sale relating to the Asset Sale to WBA.

The operating results of the discontinued operations that are reflected on the consolidated statements of operations within net income from discontinued operations are as follows:

    

March 4,

    

February 26,

    

February 27,

2023

2022

2021

(53 weeks)

(52 weeks)

(52 weeks)

Revenues

$

$

$

174

Costs and expenses:

 

 

 

Cost of revenues(a)

 

 

 

8

Selling, general and administrative expenses(a)

 

 

 

871

Interest expense(b)

 

 

 

Gain on sale of assets, net

 

 

 

(14,149)

 

 

 

(13,270)

Income from discontinued operations before income taxes

 

 

 

13,444

Income tax expense

 

 

 

4,283

Net income from discontinued operations, net of tax

$

$

$

9,161

(a)Cost of revenues and selling, general and administrative expenses for the discontinued operations excludes corporate overhead. These charges are reflected in continuing operations.
(b)In accordance with ASC 205-20, the operating results for the fifty-two week period ended February 27, 2021, for the discontinued operations include interest expense relating to the outstanding indebtedness repaid with the estimated excess proceeds from the Sale.

The operating results reflected above do not fully represent the Disposal Group’s historical operating results, as the results reported within net income from discontinued operations only include expenses that are directly attributable to the Disposal Group.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.2
Loss Per Share
12 Months Ended
Mar. 04, 2023
Loss Per Share  
Loss Per Share

5. Loss Per Share

Basic loss per share is computed by dividing loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company subject to anti-dilution limitations.

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Basic and diluted loss per share:

    

    

    

    

    

    

Numerator:

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Net income from discontinued operations

9,161

Loss attributable to common stockholders — basic and diluted

$

(719,188)

$

(522,372)

$

(90,220)

Denominator:

Basic and diluted weighted average shares

 

54,680

 

54,055

 

53,653

Basic and diluted loss per share:

Continuing operations

$

(13.15)

$

(9.66)

$

(1.86)

Discontinued operations

0.18

Net basic and diluted loss per share

$

(13.15)

$

(9.66)

$

(1.68)

Due to their anti-dilutive effect, 532, 701 and 780 potential common shares related to stock options have been excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021, respectively. Also, excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021 are restricted shares of 1,476, 1,533 and 1,293, respectively, which are included in shares outstanding.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges
12 Months Ended
Mar. 04, 2023
Facility Exit and Impairment Charges  
Facility Exit and Impairment Charges

6. Facility Exit and Impairment Charges

Impairment Charges

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that an asset group has a carrying value that may not be recoverable. The individual operating store is the lowest level for which cash flows are identifiable. As such, the Company evaluates individual stores for recoverability of assets. To determine if a store needs to be tested for recoverability, the Company considers items such as decreases in market prices, changes in the manner in which the store is being used or physical condition, changes in legal factors or business climate, an accumulation of losses significantly in excess of budget, a current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection of continuing losses, or an expectation that the store will be closed or sold.

The Company monitors new and recently relocated stores against operational projections and other strategic factors such as regional economics, new competitive entries and other local market considerations to determine if an impairment evaluation is required. For other stores, it performs a recoverability analysis if it has experienced current-period and historical cash flow losses.

In performing the recoverability test, the Company compares the expected future cash flows of a store to the carrying amount of its assets. Significant judgment is used to estimate future cash flows. Major assumptions that contribute to its future cash flow projections include expected sales, gross profit and distribution expenses; expected costs such as payroll, occupancy costs and advertising expenses; and estimates for other significant selling, general and administrative expenses. Many long-term macroeconomic and industry factors are considered, both quantitatively and qualitatively, in the future cash flow assumptions. In addition to current and expected economic conditions such as inflation, interest and unemployment rates that affect customer shopping patterns, the Company considers that it operates in a highly competitive industry which includes the actions of other national and regional drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, dollar stores and internet pharmacies. Additionally, the Company takes into consideration that certain operating stores are executing specific improvement plans which are monitored quarterly to recoup recent capital investments, such as an acquisition of an independent pharmacy, which it has made to respond to specific competitive or local market conditions, or have specific programs tailored towards a specific geography or market.

The Company recorded impairment charges of $137,075 in fiscal 2023, $150,788 in fiscal 2022 and $46,287 in fiscal 2021. The Company recorded impairment charges of $59,573 in the fourth quarter of fiscal 2023, $99,416 in the fourth quarter of fiscal 2022 and $31,057 in the fourth quarter of fiscal 2021. The Company’s methodology for recording impairment charges has been consistently applied in the periods presented.

As of March 4, 2023, $717.2 million of the Company’s long-lived assets, including intangible assets, were associated with 2,309 active operating stores. Additionally, we have approximately $2.3 billion of operating lease right-of-use assets associated with the active stores.

If an operating store’s estimated future undiscounted cash flows are not sufficient to cover its carrying value, its carrying value is reduced to fair value. Fair value is its estimated future discounted cash flows. The discount rate is commensurate with the risks associated with the recovery of a similar asset. Operating lease right-of-use assets are included within the stores’ asset groups. The Company obtains fair values of these right-of-use assets based on real estate market data.

An impairment charge is recorded in the period that the store does not meet its original return on investment and/or has an operating loss for the last two years and its projected cash flows do not exceed its current asset carrying value. The amount of the impairment charge is the entire difference between the current asset carrying value and its fair value which is the estimated future discounted cash flows.

The Company recorded impairment charges for active stores of $13,544 in fiscal 2023, $56,182 in fiscal 2022 and $29,745 in fiscal 2021.

The Company reviews key performance results for active stores on a quarterly basis and approves certain stores for closure. Impairment for closed stores, if any (many stores are closed on lease expiration), are recorded in the quarter the closure decision is approved. Closure decisions are made on an individual store or regional basis considering all of the macroeconomic, industry and other factors, in addition to the active store’s individual operating results. The Company recorded impairment charges for closed facilities of $123,531 in fiscal 2023, $94,606 in fiscal 2022 and $16,542 in fiscal 2021.

The following table summarizes the impairment charges and number of locations, segregated by closed facilities and active stores that have been recorded in fiscal 2023, 2022 and 2021:

March 4, 2023

February 26, 2022

February 27, 2021

(in thousands, except number of stores)

Number

    

Charge

    

Number

    

Charge

    

Number

    

Charge

Active stores:

Stores previously impaired(1)

44

$

4,866

118

$

12,339

174

$

21,372

New, relocated and remodeled stores(2)

8

 

4,640

1

 

538

2

 

1,519

Remaining stores not meeting the recoverability test(3)

12

 

4,038

88

 

43,305

19

 

6,854

Total impairment charges—active stores

64

 

13,544

207

 

56,182

195

 

29,745

Total impairment charges—closed facilities

194

123,531

147

94,606

33

16,542

Total impairment charges—all locations

258

$

137,075

354

$

150,788

228

$

46,287

(1)These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, the Company will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. The fiscal 2023 impairment charge includes $3,087 of impairment relating to the ROU and $1,779 of capital additions. The fiscal 2022 impairment charge includes $5,434 of impairment relating to the ROU and $6,905 of capital additions. The fiscal 2021 impairment charge includes $15,459 of impairment relating to the ROU and $5,913 of capital additions.
(2)These charges are related to new stores (open at least three years) and relocated stores (relocated in the last two years) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met their original return on investment projections and have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,875 of capital additions. The fiscal 2022 impairment charge includes $0 of impairment relating to the ROU and $538 of capital additions. The fiscal 2021 impairment charge includes $347 of impairment relating to the ROU and $1,172 of capital additions.
(3)These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,273 of capital additions. The fiscal 2022 impairment charge includes $26,130 of impairment relating to the ROU and $17,175 of capital additions. The fiscal 2021 impairment charge includes $3,177 of impairment relating to the ROU and $3,677 of capital additions.

The primary drivers of its impairment charges are each store’s current and historical operating performance and the assumptions that the Company makes about each store’s operating performance in future periods. Projected cash flows are updated based on the next year’s operating budget which includes the qualitative factors noted above. The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:

Level 1—Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2—Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.
Level 3—Inputs to the valuation methodology are unobservable inputs based upon management’s best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.

Long-lived non-financial assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using Level 2 and Level 3 inputs as defined in the fair value hierarchy. The fair value of long-lived assets using Level 2 inputs is determined by evaluating the current economic conditions in the geographic area for similar use assets. The fair value of long-lived assets using Level 3 inputs is determined by estimating the amount and timing of net future cash flows (which are unobservable inputs) and discounting them using a risk-adjusted rate of interest (which is Level 1). The Company estimates future cash flows based on its experience and knowledge of the market in which the store is located. Significant increases or decreases in actual cash flows may result in valuation changes.

The table below sets forth by level within the fair value hierarchy the long-lived assets, which include right-of-use assets, as of the impairment measurement date for which an impairment assessment was performed and total losses as of March 4, 2023 and February 26, 2022:

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

March 4, 2023

Long-lived assets held for use

$

$

22,959

$

42,717

$

65,676

$

(132,243)

Long-lived assets held for sale

$

$

5,115

$

$

5,115

$

(4,832)

Total

$

$

28,074

$

42,717

$

70,791

$

(137,075)

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

February 26, 2022

Long-lived assets held for use

$

$

240,176

$

23,594

$

263,770

$

(150,064)

Long-lived assets held for sale

$

$

2,371

$

$

2,371

$

(724)

Total

$

$

242,547

$

23,594

$

266,141

$

(150,788)

The above assets reflected in the caption ‘Long-lived assets held for sale’ have not been reclassified to assets held for sale due to their immateriality.

Lease Termination and Facility Exit Charges

The Company assesses stores and distribution centers for potential closure or relocation. Decisions to close or relocate stores or distribution centers in future periods would result in inventory liquidation charges, as well as impairment of assets at these locations. When a store or distribution center is closed, the Company records executory costs for leases, as well as other store or distribution center closing and liquidation costs, when incurred.

In fiscal 2023, 2022 and 2021, the Company recorded facility exit charges of $43,562, $13,296 and $11,427, respectively.

The Company calculates the liability for facility exit or disposal cost obligations to include long-term contract termination costs and costs related to the disposal of long-lived assets.

The following table reflects the accrued facility exit charges:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Balance—beginning of period

$

1,892

$

2,754

$

2,253

Provision for facility exit charges

 

461

 

162

793

Changes in assumptions and other adjustments

Interest accretion

 

 

 

Cash payments

 

(125)

 

(1,024)

 

(292)

Balance—end of period

$

2,228

$

1,892

$

2,754

The Company’s revenues and income before income taxes for fiscal 2023, 2022 and 2021 included results from stores that have been closed or are approved for closure as of March 4, 2023. The revenue, operating expenses and income before income taxes of these stores for the periods are presented as follows:

Year Ended

March 4,

February 26,

February 27,

    

2023

    

2022

    

2021

Revenues

$

178,030

$

586,056

$

639,471

Operating expenses

 

192,357

 

640,996

 

699,662

Gain from sale of assets

 

(46,125)

 

(13,670)

 

(7,954)

Other expenses

 

25,396

52,999

13,057

Income (loss) before income taxes

 

6,402

 

(94,269)

 

(65,294)

Included in these stores’ income (loss) before income taxes are:

Depreciation and amortization

 

934

 

3,499

 

4,535

Inventory liquidation charges

 

(6,369)

 

(1,646)

 

(1,528)

The above results are not necessarily indicative of the impact that these closures will have on revenues and operating results of the Company in the future, as the Company often transfers the business of a closed store to another Company store, thereby retaining a portion of these revenues and operating expenses.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements
12 Months Ended
Mar. 04, 2023
Fair Value Measurements  
Fair Value Measurements

7. Fair Value Measurements

The Company utilizes the three-level valuation hierarchy as described in Note 6 for the recognition and disclosure of fair value measurements.

As of March 4, 2023 and February 26, 2022, the Company did not have any financial assets measured on a recurring basis. Please see Note 6 and Note 14 for fair value measurements of non-financial assets measured on a non-recurring basis.

Other Financial Instruments

Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets. The Company believes the carrying value of these investments approximates their fair value.

The fair value for Secured Overnight Financing Rate (“SOFR”) based borrowings as of March 4, 2023 and LIBOR-based borrowings as of February 26, 2022 under the Company’s senior secured credit facility is estimated based on the quoted market price of the financial instrument which is considered Level 1 of the fair value hierarchy. The fair values of substantially all of the Company’s other long-term indebtedness are estimated based on quoted market prices of the financial instruments which are considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,925,258 and $2,368,328, respectively, as of March 4, 2023. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,732,986 and $2,661,122 respectively, as of February 26, 2022.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes
12 Months Ended
Mar. 04, 2023
Income Taxes  
Income Taxes

8. Income Taxes

The provision for income tax benefit from continuing operations was as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Current tax:

Federal

$

(6)

$

(6)

$

(6,758)

State

 

9,082

 

7,454

 

4,145

 

9,076

 

7,448

 

(2,613)

Deferred tax and other:

Federal

 

 

(1,301)

 

(12,649)

State

 

(15,543)

 

(9,927)

 

(4,895)

 

(15,543)

 

(11,228)

 

(17,544)

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

A reconciliation of the expected statutory federal tax and the total income tax benefit from continuing operations was as follows:

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Federal statutory rate

$

(152,388)

$

(110,492)

$

(25,103)

Nondeductible expenses

 

556

398

588

State income taxes, net

 

271,306

(45,388)

10,042

Bargain purchase gain

1,123

(10,018)

Decrease of previously recorded liabilities

 

(18,689)

(3,798)

(2,273)

Nondeductible compensation

 

2,045

1,551

3,764

Qualified fringe disallowance

342

224

313

Nondeductible excise tax

 

1,296

Stock based compensation

2,213

198

2,806

Valuation allowance

 

(112,037)

152,785

(2,222)

Other

185

(381)

650

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

Net loss for fiscal 2023 from continuing operations included an income tax benefit of $6,467. The state income tax expense reflected in the table above primarily resulted from the re-measurement of state deferred tax assets due to a reduced statutory Pennsylvania corporate net income tax rate. This state tax expense was offset by a corresponding income tax benefit of $256,411 to reduce the valuation allowance as a result of the reduced tax rate. Overall, an income tax benefit of $112,037 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.

Net loss for fiscal 2022 from continuing operations included an income tax benefit of $3,780, of which $152,785 of income tax expense was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.

Net loss for fiscal 2021 from continuing operations included income tax benefit of $20,157, of which $2,222 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets. Additionally, the overall tax rate includes a permanent tax benefit related to the Company’s bargain purchase gain on the Bartell acquisition resulting in an impact of 8.4%.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on its financial statements.

The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Deferred tax assets:

Accounts receivable

$

26,769

$

22,958

Accrued expenses

 

143,207

 

95,421

Pension, retirement and other benefits

 

40,100

 

67,686

Long-lived assets

 

364,618

 

299,507

Operating lease liabilities

781,721

883,713

Credits

 

21,955

 

22,917

Net operating losses

 

1,200,516

 

1,487,639

Other

 

271

 

225

Total gross deferred tax assets

 

2,579,157

 

2,880,066

Valuation allowance

 

(1,636,461)

 

(1,818,069)

Total deferred tax assets

 

942,696

 

1,061,997

Deferred tax liabilities:

Outside basis difference

5,622

5,682

Inventory

 

244,554

 

251,221

Operating lease right-of-use assets

680,152

785,023

Total gross deferred tax liabilities

 

930,328

 

1,041,926

Net deferred tax assets

$

12,368

$

20,071

A reconciliation of the beginning and ending amount of unrecognized tax benefits from continuing operations was as follows:

    

2023

    

2022

    

2021

Unrecognized tax benefits

$

103,629

$

184,414

$

198,325

Increases to prior year tax positions

 

1

 

24

 

42

Decreases to tax positions in prior periods

 

(29,432)

 

(294)

 

(807)

Increases to current year tax positions

 

 

 

Settlements

 

 

 

Divestitures

Lapse of statute of limitations

 

(27,113)

 

(80,515)

 

(13,146)

Unrecognized tax benefits balance

$

47,085

$

103,629

$

184,414

The amount of the above unrecognized tax benefits as of March 4, 2023, February 26, 2022 and February 27, 2021 which would impact the Company’s effective tax rate, if recognized, was $1,498, $18,737 and $20,923, respectively. Additionally, any impact on the effective rate may be mitigated by the valuation allowance that is remaining against the Company’s net deferred tax assets.

The Company believes that it is reasonably possible that a decrease of up to $4,001 in unrecognized tax benefits related to state exposures may be necessary in the next twelve months, however, management does not expect the change to have a significant impact on the results of operations or the financial position of the Company.

The Company recognizes interest and penalties related to tax contingencies as income tax expense. The Company recognized an expense/(benefit) for interest and penalties in connection with tax matters of $(6,006), $(183) and $(123) for fiscal years 2023, 2022 and 2021, respectively. As of March 4, 2023 and February 26, 2022 the total amount of accrued income tax-related interest and penalties was $490 and $6,496, respectively.

The Company files U.S. federal income tax returns as well as income tax returns in those states where it does business. The consolidated federal income tax returns are closed for examination through fiscal year 2019. However, any net operating losses that were generated in these prior closed years may be subject to examination by the IRS upon utilization. Tax examinations by various state taxing authorities could generally be conducted for a period of three to five years after filing of the respective return.

Net Operating Losses and Tax Credits

As of March 4, 2023, the Company had federal net operating loss carryforwards of approximately $2,133,742. Of these, $884,668 will expire, if not utilized, between fiscal 2029 and 2031. An additional $193,961 will expire, if not utilized, between fiscal 2032 and 2038.

As of March 4, 2023, the Company had state net operating loss carryforwards of approximately $12,279,752, the majority of which will expire ratably through fiscal 2032; the net tax effect of these carryforwards is $754,483 and are reflected in the table above.

As of March 4, 2023, the Company had federal business tax credit carryforwards of $11,363, the majority of which will expire between 2024 and 2029.

Valuation Allowances

The valuation allowances as of March 4, 2023 and February 26, 2022 apply to the net deferred tax assets of the Company. The Company maintained a valuation allowance of $1,636,461 and $1,818,069 as of March 4, 2023 and February 26, 2022, respectively. A valuation allowance has been recorded for fiscal 2023 and fiscal 2022 to reduce certain federal and state net deferred tax assets that may not be realized based on all available evidence that currently does not support the realization of these assets.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.2
Accounts Receivable
12 Months Ended
Mar. 04, 2023
Accounts Receivable  
Accounts Receivable

9. Accounts Receivable

The Company maintains an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable. The allowance for uncollectible accounts as of March 4, 2023 and February 26, 2022 was $53,453 and $28,069, respectively. The Company’s accounts receivable are due primarily from third-party payors (e.g., PBM companies, insurance companies or governmental agencies) and are recorded net of any allowances provided for under the respective plans. Since payments due from third-party payors are sensitive to payment criteria changes and legislative actions, the allowance is reviewed continually and adjusted for accounts deemed uncollectible by management.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Medicare Part D
12 Months Ended
Mar. 04, 2023
Medicare Part D  
Medicare Part D

10. Medicare Part D

The Company offers Medicare Part D benefits through EI, which has contracted with CMS to be a PDP and, pursuant to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, must be a risk-bearing entity regulated under state insurance laws or similar statutes.

EI is a licensed domestic insurance company under the applicable laws and regulations. Pursuant to these laws and regulations, EI must file quarterly and annual reports with the National Association of Insurance Commissioners (“NAIC”) and certain state regulators, must maintain certain minimum amounts of capital and surplus under formulas established by certain states and must, in certain circumstances, request and receive the approval of certain state regulators before making dividend payments or other capital distributions to the Company. The Company does not believe these limitations on dividends and distributions materially impact its financial position. EI is subject to minimum capital and surplus requirements in certain states. The minimum amount of capital and surplus required to satisfy regulatory requirements in these states is $10,693 as of December 31, 2022. EI was in excess of the minimum required amounts in these states as of March 4, 2023.

The Company has recorded estimates of various assets and liabilities arising from its participation in the Medicare Part D program based on information in its claims management and enrollment systems. Significant estimates arising from its participation in this program include: (i) estimates of low-income cost subsidies, reinsurance amounts, and coverage gap discount amounts ultimately payable to CMS based on a detailed claims reconciliation that will occur in the following year; (ii) an estimate of amounts receivable from CMS under a risk-sharing feature of the Medicare Part D program design, referred to as the risk corridor and; (iii) estimates for claims that have been reported and are in the process of being paid or contested and for our estimate of claims that have been incurred but have not yet been reported.

On November 12, 2020, the Company entered into a receivable purchase agreement (the “November 2020 Receivable Purchase Agreement”) with Bank of America, N.A. (the “Purchaser”).

Pursuant to the terms and conditions set forth in the November 2020 Receivable Purchase Agreement, the Company sold $464,019, a portion of its calendar 2020 CMS receivable, for $444,812, of which $412,795 was received on November 12, 2020 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $19,207, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 28, 2020.

On November 12, 2020, concurrent with the November 2020 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “November 2020 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the November 2020 Indemnity Agreement. Based on its evaluation of the November 2020 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the November 2020 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the November 2020 Indemnity Agreement.

On February 18, 2021, the Company entered into a receivable purchase agreement (the “February 2021 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the February 2021 Receivable Purchase Agreement, the Company sold $300,015, the remaining portion of its calendar 2020 CMS receivable, for $290,613, of which $269,912 was received on February 18, 2021 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $9,403, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 27, 2021.

On February 18, 2021, concurrent with the February 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2021 Indemnity Agreement. Based on its evaluation of the February 2021 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2021 Indemnity Agreement.

On August 12, 2021, the Company entered into a receivable purchase agreement (the “August 2021 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the August 2021 Receivable Purchase Agreement, the Company sold $271,829, a portion of its calendar 2021 CMS receivable, for $258,116, of which $239,360 was received on August 12, 2021 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,713, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended August 28, 2021.

On August 12, 2021, concurrent with the August 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “August 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the August 2021 Indemnity Agreement. Based on its evaluation of the August 2021 Indemnity Agreement, the Company has determined that it is highly unlikely

that the events covered under the August 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the August 2021 Indemnity Agreement.

On January 24, 2022, the Company entered into a receivable purchase agreement (the “January 2022 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the January 2022 Receivable Purchase Agreement, the Company sold $400,680, a portion of its calendar 2021 CMS receivable, for $387,035, of which $359,388 was received on January 24, 2022 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,645, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 26, 2022.

On January 24, 2022, concurrent with the January 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “January 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the January 2022 Indemnity Agreement. Based on its evaluation of the January 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the January 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the January 2022 Indemnity Agreement.

On October 13, 2022, the Company entered into a receivable purchase agreement (the “October 2022 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the October 2022 Receivable Purchase Agreement, the Company sold $195,487, a portion of its calendar 2022 CMS receivable, for $180,405, of which $166,917 was received on October 13, 2022. The remaining $13,488, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $15,082, which was included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 26, 2022.

On October 13, 2022, concurrent with the October 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “October 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse, and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the October 2022 Indemnity Agreement. Based on its evaluation of the October 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the October 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the October 2022 Indemnity Agreement.

During the thirteen-week period ended November 26, 2022, the Company incurred additional fees of $1,937, which were included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable.

On February 3, 2023, the Company entered into a receivable purchase agreement (the “February 2023 Receivable Purchase Agreement”) with Purchaser.

Pursuant to the terms and conditions set forth in the February 2023 Receivable Purchase Agreement, the Company sold $278,390, a portion of its calendar 2022 CMS receivable, for $261,771, of which $242,562 was received on February 3, 2023. The remaining $19,209, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $16,619, which is included as a component of (gain) loss on sale of assets, net during the fourteen-week period ended March 4, 2023.

On February 3, 2023, concurrent with the February 2023 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2023 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2023 Indemnity Agreement. Based on its evaluation of the February 2023 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2023 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2023 Indemnity Agreement.

During the fourteen-week period ended March 4, 2023, the company incurred additional fees of $2,573, which are included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable.

As of March 4, 2023 and February 26, 2022, accounts receivable, net included $22,362 and $34,898 due from the Purchaser, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance for the respective calendar years from CMS.

As of March 4, 2023 and February 26, 2022, accounts receivable, net included $45,201 and $63,203 of amounts due from CMS.

The Inflation Reduction Act of 2022 contains several provisions affecting Medicare, which will take effect over various periods of time from 2023 to 2029. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on the financial statements.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.2
Manufacturer Rebates Receivables
12 Months Ended
Mar. 04, 2023
Manufacturer Rebates Receivables  
Manufacturer Rebates Receivables

11. Manufacturer Rebates Receivables

The Pharmacy Services Segment has manufacturer rebates receivables of $357,699 and $535,620 included in Accounts receivable, net of an allowance for uncollectible rebates of $8,680 and $18,796, as of March 4, 2023 and February 26, 2022, respectively.

During the thirteen-week period ended February 26, 2022, the Company reassessed its historical policy for estimating its allowance for manufacturer rebate receivables and concluded that, due to changes in its business practices and other market conditions, certain amounts within the outstanding receivable had an increased risk of uncollectability. As a result, the Company increased its allowance for manufacturer rebate receivables by $15,068, which was recorded as an increase to costs of revenue during the thirteen-week period ended February 26, 2022. The Company determined that this change in estimate is a non-recurring item that should be added back to Adjusted EBITDA (see “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non GAAP Measures” for details).

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Inventory
12 Months Ended
Mar. 04, 2023
Inventory  
Inventory

12. Inventory

As of March 4, 2023 and February 26, 2022, inventories were $539,932 and $487,173, respectively, lower than the amounts that would have been reported using the first-in, first-out (“FIFO”) cost flow assumption. The Company calculates its FIFO inventory valuation using the retail method for store inventories and the cost method for distribution facility inventories. The Company recorded a LIFO charge of $53,028 and $1,314, for fiscal year 2023 and 2022, respectively, and a LIFO credit of $51,692 for fiscal year 2021. During fiscal 2023, 2022 and 2021, a reduction in non-pharmacy inventories resulted in the liquidation of applicable LIFO inventory quantities carried at lower costs in prior years. This LIFO liquidation resulted in a $31,857, $13,090 and $26,861 cost of revenues decrease, with a corresponding reduction to the adjustment to LIFO for fiscal 2023, fiscal 2022 and fiscal 2021, respectively.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Property, Plant and Equipment
12 Months Ended
Mar. 04, 2023
Property, Plant and Equipment  
Property, Plant and Equipment

13. Property, Plant and Equipment

Following is a summary of property, plant and equipment, including capital lease assets, as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Land

$

69,588

$

83,485

Buildings

 

208,681

 

314,143

Leasehold improvements

 

1,568,983

 

1,566,082

Equipment

 

1,855,083

 

1,794,937

Software

89,597

92,139

Construction in progress

 

109,690

 

97,715

 

3,901,622

 

3,948,501

Accumulated depreciation

 

(2,993,851)

 

(2,959,334)

Property, plant and equipment, net

$

907,771

$

989,167

Depreciation expense, which included the depreciation of assets recorded under capital leases, was $202,559, $217,639 and $238,104 in fiscal 2023, 2022 and 2021, respectively.

Included in property, plant and equipment was the carrying amount, which approximates fair value, of assets to be disposed of totaling $3,972 and $1,463 as of March 4, 2023 and February 26, 2022, respectively.

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets
12 Months Ended
Mar. 04, 2023
Goodwill and Other Intangible Assets  
Goodwill and Other Intangible Assets

14. Goodwill and Other Intangibles

Goodwill and indefinite-lived assets, such as certain trademarks acquired in connection with acquisition transactions, are not amortized, but are instead evaluated for impairment on an annual basis at the end of the fiscal year, or more frequently if events or circumstances indicate it may be more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, the Company performs a quantitative goodwill impairment test. The fair value estimates used in the quantitative impairment test are calculated using an average of the income and market approaches. The income approach is based on the present value of future cash flows of each reporting unit, while the market approach is based on certain multiples of selected guideline public companies or selected guideline transactions. The approaches, which qualify as Level 3 within the fair value hierarchy, incorporate a number of market participant assumptions including future growth rates, discount rates, income tax rates and market activity in assessing fair value and are reporting unit specific. If the carrying amount exceeds the reporting unit’s fair value, the

Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. In addition, the Company considers the income tax effect of any tax deductible goodwill when measuring a goodwill impairment loss.

In the fourth quarter of fiscal 2021, the Company completed a quantitative goodwill impairment assessment and determined after evaluating the results, events and circumstances, that sufficient evidence existed to assert that it is more likely than not that the fair values of the reporting units exceeded their carrying values. Therefore, no goodwill impairment charge was recorded for the fiscal year ended February 27, 2021.

In the fourth quarter of fiscal 2022, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to a decrease in Adjusted EBITDA that was driven by commercial and Medicare Part D business compression due to industry consolidation, an increase in the medical loss ratio at Elixir Insurance, and a decision to exit our rebate aggregation business. This resulted in goodwill impairment charges of $229,000 for the fiscal year ended February 26, 2022.

In the second quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to an update to the Company’s preliminary fiscal 2024 and beyond forecasted revenue driven by current updates in the estimate of lives for calendar year 2023 based on the latest estimates of existing client retention for 2023, the latest selling season and EI bid results and other business factors which only became evident during the second quarter. This resulted in goodwill impairment charges of $252,200 in the second quarter of fiscal 2023.

In the fourth quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to downward macroeconomic pressure during the fourth quarter of fiscal 2023 which manifested in increased interest rates, increased cost of borrowing and a decrease of industry multiples. The market factors that drove the goodwill impairment charges of $119,000 in the fourth quarter of fiscal 2023 were not known in prior quarters.

The goodwill related to the Pharmacy Services Segment is at risk of future impairment if the fair value of this segment, and its associated assets, decrease in value due to further declines in its operating results or an inability to execute management’s business strategies. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company's estimates. If the Company's ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record impairment charges in future periods.

As of March 4, 2023 and February 26, 2022, the accumulated impairment losses for the Pharmacy Services Segment was $1,174,912 and $803,712, respectively.

Below is a summary of the changes in the carrying amount of goodwill by segment for the fiscal years ended March 4, 2023 and February 26, 2022:

    

Retail

    

Pharmacy

    

Pharmacy

Services

Total

Balance, February 27, 2021

 

$

43,492

$

1,064,644

$

1,108,136

Goodwill impairment

(229,000)

(229,000)

Balance, February 26, 2022

43,492

835,644

879,136

Goodwill impairment

(371,200)

(371,200)

Balance, March 4, 2023

$

43,492

$

464,444

$

507,936

The Company’s intangible assets are primarily finite-lived and amortized over their useful lives. Following is a summary of the Company’s finite-lived and indefinite-lived intangible assets as of March 4, 2023 and February 26, 2022.

March 4, 2023

February 26, 2022

Remaining

Remaining

Weighted

Weighted

Gross

Average

Gross

Average

Carrying

Accumulated

Amortization

Carrying

Accumulated

Amortization

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

$

201,919

$

(182,957)

$

18,962

3

years

$

197,651

$

(178,958)

$

18,693

3

years

Prescription files

 

1,029,665

(928,478)

101,187

 

5

years

 

1,030,169

 

(918,773)

111,396

 

6

years

Customer relationships(a)

388,000

(306,139)

81,861

9

years

388,000

(286,090)

101,910

10

years

CMS license

57,500

(23,798)

33,702

4

years

57,500

(15,372)

42,128

5

years

Claims adjudication and other developed software

58,985

(58,985)

0

years

58,985

(56,316)

2,669

1

years

Total finite

$

1,736,069

$

(1,500,357)

235,712

$

1,732,305

$

(1,455,509)

$

276,796

Trademarks

14,400

14,400

Indefinite

14,400

14,400

Indefinite

Total

$

1,750,469

$

(1,500,357)

$

250,112

$

1,746,705

$

(1,455,509)

$

291,196

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.

The Company is continuing to reposition its approach to the Elixir Insurance Part D business including an expectation of a purposeful shrinkage of the business. As a result, at the end of fiscal 2022, the Company adjusted the remaining amortization period of the CMS License to five years. Prior to such adjustment, the remaining life was nineteen years.

In connection with the restructuring initiatives previously announced on March 16, 2020, the Company rebranded its EnvisionRxOptions and MedTrak subsidiaries to its new brand name, Elixir. These trademarks qualify as Level 3 within the fair value hierarchy. Upon the implementation of the rebranding initiatives during the first quarter of fiscal 2021, the Company has determined that the carrying value exceeded the fair value and consequently the Company incurred an impairment charge of $29,852 for these trademarks, which is included within intangible asset impairment charges within the consolidated statement of operations.

Amortization expense for these intangible assets and liabilities was $74,024, $78,047 and $89,020 for fiscal 2023, 2022 and 2021, respectively. The anticipated annual amortization expense for these intangible assets and liabilities is 2024—$61,343; 2025—$50,209; 2026—$39,771; 2027—$32,779 and 2028—$25,299.

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.2
Accrued Salaries, Wages and Other Current Liabilities
12 Months Ended
Mar. 04, 2023
Accrued Salaries, Wages and Other Current Liabilities  
Accrued Salaries, Wages and Other Current Liabilities

15. Accrued Salaries, Wages and Other Current Liabilities

Accrued salaries, wages and other current liabilities consisted of the following as of March 4, 2023 and February 26, 2022:

    

2023

    

2022

Accrued wages, benefits and other personnel costs

$

190,664

$

291,004

Accrued interest

 

18,630

 

18,286

Accrued sales and other taxes payable

 

86,920

 

75,068

Accrued store expense

 

71,398

 

70,537

Accrued litigation, legal and professional fees

41,205

43,200

Accrued self-insurance

25,760

28,402

Other

 

275,314

 

250,062

$

709,891

$

776,559

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.2
Indebtedness and Credit Agreement
12 Months Ended
Mar. 04, 2023
Indebtedness and Credit Agreement  
Indebtedness and Credit Agreement

16. Indebtedness and Credit Agreement

Following is a summary of indebtedness and lease financing obligations as of March 4, 2023 and February 26, 2022:

March 4,

February 26,

    

2023

    

2022

Secured Debt:

Senior secured revolving credit facility due August 2026 ($1,200,000 and $709,000 face value less unamortized debt issuance costs of $16,117 and $18,010)

1,183,883

690,990

FILO Term Loan due August 2026 ($400,000 and $350,000 face value less unamortized debt issuance costs of $2,090 and $2,344)

397,910

347,656

 

1,581,793

 

1,038,646

Second Lien Secured Debt:

7.5% senior secured notes due July 2025 ($320,002 and $600,000 face value less unamortized debt issuance costs of $2,529 and $6,824)

 

317,473

 

593,176

8.0% senior secured notes due November 2026 ($849,918 face value less unamortized debt issuance costs of $11,259 and $14,397)

838,659

835,521

1,156,132

1,428,697

Unguaranteed Unsecured Debt:

7.7% notes due February 2027 ($185,691 and $237,386 face value less unamortized debt issuance costs of $398 and $642)

 

185,293

 

236,744

6.875% fixed-rate senior notes due December 2028 ($2,046 and $29,001 face value less unamortized debt issuance costs of $6 and $102)

 

2,040

 

28,899

 

187,333

 

265,643

Lease financing obligations

 

18,912

 

20,374

Total debt

 

2,944,170

 

2,753,360

Current maturities of long-term debt and lease financing obligations

 

(6,332)

 

(5,544)

Long-term debt and lease financing obligations, less current maturities

$

2,937,838

$

2,747,816

Credit Facilities

On December 20, 2018, the Company entered into a senior secured credit agreement (as amended by the First Amendment to Credit Agreement, dated as of January 6, 2020, the “Prior Credit Agreement”; and the Credit Agreement, as further amended by the Second Amendment (as defined below), the “Prior Amended Credit Agreement”), which provided for facilities consisting of a $2,700,000 senior secured asset-based revolving credit facility and a $450,000 “first-in, last-out” senior secured term loan facility, the proceeds of which were used in December 2018 to refinance its prior $2,700,000 existing credit agreement.

On August 20, 2021, the Company entered into the Second Amendment to Credit Agreement (the “Second Amendment”), which, among other things, amended the Prior Credit Agreement to provide for a $2,800,000 senior secured asset-based revolving credit facility (the “Prior Senior Secured Revolving Credit Facility”) and a $350,000 “first-in, last-out” senior secured term loan facility (“Prior Senior Secured Term Loan” and together with the Prior Senior Secured Revolving Credit Facility, collectively, the “Prior Amended Facilities”). The Prior Amended Facilities extended the Company’s debt maturity profile and provided additional liquidity. Borrowings under the Prior Senior Secured Revolving Credit Facility bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of between 0.25% to 0.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of between 1.25% and 1.75%, in each case based upon the Average ABL Availability (as defined in the Prior Amended Credit Agreement). Borrowings under the Prior Senior Secured Term Loan bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of 1.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of 2.75%.

On December 1, 2022, the Company entered into the Third Amendment to Credit Agreement (the “Third Amendment”), which, among other things, amended the Prior Amended Credit Agreement (the Prior Amended Credit Agreement, as modified by the Third Amendment, the “Existing Credit Agreement”) to provide for a $2,850,000 senior secured asset-based revolving credit facility (the “Existing Senior Secured Revolving Credit Facility”) and a $400,000 “first-in, last-out” senior secured term loan facility (the “Existing Senior Secured Term Loan” and, together with the Existing Senior Secured Revolving Credit Facility, collectively, the “Existing Facilities”), replaced the LIBOR rate with a Term SOFR-based rate as the applicable benchmark for the Existing Facilities, included COVID-19 vaccines in the borrowing base under the Existing Senior Secured Revolving Credit Facility, subject to limitations and conditions as specified in the Existing Credit Agreement, and increased the interest rate applicable to loans under the Existing Senior Secured Term Loan to (x) a base rate (determined in a customary manner) plus a margin of 2.00% or (y) an adjusted Term SOFR-based rate (determined in a customary manner) plus a margin of 3.00%.

The Company is required to pay fees between 0.250% and 0.375% per annum on the daily unused amount of the commitments under the Existing Senior Secured Revolving Credit Facility, depending on Average ABL Availability (as defined in the Existing Credit Agreement). The Existing Facilities are scheduled to mature on August 20, 2026 (subject to a springing maturity if certain of the Company’s existing secured notes are not refinanced or repaid prior to the date that is 91 days prior to the stated maturity thereof).

The Company’s borrowing capacity under the Existing Senior Secured Revolving Credit Facility is based upon a specified borrowing base consisting of accounts receivable, inventory and prescription files. As of March 4, 2023, the Company had approximately $1,600,000 of borrowings outstanding under the Existing Facilities and had letters of credit outstanding under the Existing Senior Secured Revolving Credit Facility in a face amount of approximately $208,698, which resulted in remaining borrowing capacity under the Existing Senior Secured Revolving Credit Facility of $1,403,996. If at any time the total credit exposure outstanding under the Existing Senior Secured Revolving Credit Facility exceeds the borrowing base, the Company will be required to repay amounts outstanding to eliminate such shortfall.

The Existing Credit Agreement restricts the Company and all of its subsidiaries including the subsidiaries that guarantee its obligations under the Existing Facilities, the secured guaranteed notes and unsecured guaranteed notes (collectively, the “Subsidiary Guarantors”) from accumulating cash on hand in excess of $200,000 at any time when revolving loans are outstanding (not including cash located in store and lockbox deposit accounts and cash necessary to cover current liabilities). The Existing Credit Agreement also states that if at any time (other than following the exercise of remedies or acceleration of any senior obligations or second priority debt and receipt of a triggering notice by the

senior collateral agent from a representative of the senior obligations or the second priority debt) either (i) an event of default exists under the Existing Facilities or (ii) availability under the Existing Senior Secured Revolving Credit Facility is less than or equal to $283,250 for three consecutive business days or less than or equal to $206,000 on any day (a “cash sweep period”), the funds in the Company’s deposit accounts will be swept to a concentration account with the senior collateral agent and will be applied first to repay outstanding revolving loans under the Existing Facilities, and then held as collateral for the senior obligations until such cash sweep period is rescinded pursuant to the terms of the Existing Facilities.

The Company’s obligations under the Existing Facilities and the Subsidiary Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on all of the Subsidiary Guarantors’ cash and cash equivalents, accounts receivable, inventory, prescription files (including eligible script lists), intellectual property (prior to the repayment of the Existing Senior Secured Term Loan) and certain other assets arising therefrom or related thereto (including substantially all of their deposit accounts, collectively, the “ABL priority collateral”) and (ii) a second-priority lien on all of the Subsidiary Guarantors’ equipment, fixtures, investment property (other than equity interests in subsidiaries), intellectual property (following the repayment of the Existing Senior Secured Term Loan) and all other assets that do not constitute ABL priority collateral, in each case, subject to customary exceptions and limitations.

The Existing Credit Agreement allows the Company to have outstanding, at any time, up to an aggregate principal amount of $1,500,000 in secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock in addition to borrowings under the Existing Facilities and existing indebtedness, provided that not in excess of $750,000 of such secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock shall mature or require scheduled payments of principal prior to 90 days after the latest maturity date of any Term Loan or Other Revolving Commitment (each as defined in the Existing Credit Agreement) (excluding bridge facilities allowing extensions on customary terms to at least the date that is 90 days after such date). Subject to the limitations described in the immediately preceding sentence, the Existing Credit Agreement additionally allows the Company to issue or incur an unlimited amount of unsecured debt and disqualified preferred stock so long as a Financial Covenant Effectiveness Period (as defined in the Existing Credit Agreement) is not in effect; provided, however, that certain of the Company’s other outstanding indebtedness limits the amount of unsecured debt that can be incurred if certain interest coverage levels are not met at the time of incurrence or other exemptions are not available. The Existing Credit Agreement also contains certain restrictions on the amount of secured first priority debt the Company is able to incur. The Existing Credit Agreement also allows for the voluntary repurchase of any debt or other convertible debt, so long as the Existing Facilities are not in default and the Company maintains availability under its revolver of more than $375,950.

The Existing Credit Agreement has a financial covenant that requires the Company to maintain a minimum fixed charge coverage ratio of 1.00 to 1.00 (i) on any date on which availability under the Existing Senior Secured Revolving Credit Facility is less than $206,000 or (ii) on the third consecutive business day on which availability under the Existing Senior Secured Revolving Credit Facility is less than $257,500 and, in each case, ending on and excluding the first day thereafter, if any, which is the 30th consecutive calendar day on which availability under the revolver is equal to or greater than $257,500. As of March 4, 2023, the availability under the Existing Senior Secured Revolving Credit Facility was at a level that did not trigger the Existing Credit Agreement’s financial covenant. The Existing Credit Agreement also contains covenants which place restrictions on the incurrence of debt, the payments of dividends, the making of investments, sale of assets, mergers and acquisitions and the granting of liens.

The Existing Credit Agreement provides for customary events of default including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if the Company fails to make any

required payment on debt having a principal amount in excess of $50,000 or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity or require the repayment, repurchase, redemption or defeasance of such debt.

Fiscal 2021, 2022 and 2023 Transactions

On June 25, 2020, the Company commenced an offer to exchange (the “June 25, 2020 Exchange Offer”) up to $750,000 aggregate principal amount of the outstanding 6.125% Senior Notes due 2023 (the “6.125% Notes”) for a combination of $600,000 newly issued 8.0% Senior Secured Notes due 2026 (the “8.0% Notes”) and $145,500 cash. On July 10, 2020, the Company increased the maximum amount of 6.125% Notes that may be accepted for exchange from $750,000 to $1,125,000 and, on July 24, 2020, the Company announced that it accepted for payment $1,062,682 aggregate principal amount of the 6.125% Notes in exchange for $849,918 aggregate principal amount of newly issued 8.0% Notes and $206,373 in cash. In connection therewith, the Company recorded a gain on debt modification of $5,274 which is included in the results of operations and cash flows of continuing operations. The 8.0% Notes are secured on an equal and ratable basis by the same assets that secure the 7.500% Notes. The 8.0% Notes are guaranteed on a senior secured basis by the same subsidiaries that guarantee the 7.500% Notes. In conjunction with the June 25, 2020 Exchange Offer, the Company also commenced a solicitation of consents from the holders of outstanding 6.125% Notes to certain proposed amendments to the indenture governing the 6.125% Notes. On July 9, 2020, following the receipt of the requisite number of consents, the Company entered into a supplemental indenture, which modified certain limitations in the debt covenant to allow for the creation of the 8.0% Notes.

On April 28, 2021, the Company issued a notice of redemption for all of the 6.125% Notes that were outstanding on May 28, 2021, pursuant to the terms of the indenture of the 6.125% Notes. On May 28, 2021, the Company redeemed 100% of the remaining outstanding 6.125% Notes at par. In connection therewith, the Company recorded a loss on debt retirement of $396 which included unamortized debt issuance costs. The debt repayment and related loss on debt retirement is included in the results of operations and cash flows.

On August 20, 2021, the Company entered into the Second Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Prior Senior Secured Revolving Credit Facility from $2,700,000 to $2,800,000 and decrease the aggregate principal amount of loans outstanding under the Prior Senior Secured Term Loan from $450,000 to $350,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $2,839 which included unamortized debt issuance costs. The debt repayment and related loss on debt modification and retirement is included in the results of operations and cash flows.

On June 13, 2022, the Company commenced a series of cash tender offers to purchase up to $150,000 aggregate principal amount of the Company’s 7.500% Senior Secured Notes due 2025 (the “7.500% Notes”), 8.0% Notes), 7.70% Notes due 2027 (the “7.70% Notes”) and 6.875% Notes due 2028 (the “6.875% Notes”), subject to prioritized acceptance levels, a subcap of $100,000 with respect to the 7.500% Notes and proration. On June 29, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $114,942 of its 7.500% Notes, $51,695 aggregate principal amount of its 7.70% Notes and $26,955 aggregate principal amount of its 6.875% Notes. In connection therewith, the Company recorded a gain on debt retirement of $41,312, which included unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On November 3, 2022, the Company announced the commencement of a cash tender offer to purchase up to $200,000 aggregate purchase price (not including any accrued and unpaid interest) of the Company’s 7.500% Notes,

subject to proration. On November 30, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $160,497 of its 7.500% Notes and on December 9, 2022, pursuant to the final settlement, the Company purchased an additional aggregate principal amount of $4,559 of its 7.500% Notes. In connection therewith, the Company recorded a gain on debt retirement of $38,978, which includes unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.

On December 1, 2022, the Company entered into the Third Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Existing Senior Secured Revolving Credit Facility from $2,800,000 to $2,850,000 and increase the aggregate principal amount of loans outstanding under the Existing Senior Secured Term Loan from $350,000 to $400,000. As a result of the Third Amendment, the Company has increased its liquidity by $100,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $148, which includes unamortized debt issuance costs. The related loss on debt modification and retirement is included in the results of operations and cash flows.

Interest Rates and Maturities

The annual weighted average interest rate on the Company’s indebtedness was 7.2%, 5.6% and 5.4% for fiscal 2023, 2022 and 2021, respectively.

The aggregate annual principal payments of long-term debt for the five succeeding fiscal years are as follows: 2024—$0; 2025—$0; 2026—$320,002; 2027—$2,635,609 and $2,046 in 2028 and thereafter.

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.2
Leases
12 Months Ended
Mar. 04, 2023
Leases  
Leases

17. Leases

The Company leases most of its retail stores and certain distribution facilities under noncancellable operating and finance leases, most of which have initial lease terms ranging from 5 to 22 years. The Company also leases certain of its equipment and other assets under noncancellable operating leases with initial terms ranging from 3 to 10 years. In addition to minimum rental payments, certain store leases require additional payments based on sales volume, as well as reimbursements for taxes, maintenance and insurance. Most leases contain renewal options, certain of which involve rent increases.

The following table is a summary of the Company’s components of net lease cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Year Ended

March 4, 2023

    

February 26, 2022

    

February 27, 2021

Operating lease cost

 

$

641,394

$

669,421

$

651,261

Financing lease cost:

Amortization of right-of-use asset

 

3,471

3,638

4,359

Interest on long-term finance lease liabilities

 

1,968

2,167

2,505

Total finance lease costs

 

$

5,439

$

5,805

$

6,864

Short-term lease costs

 

3,126

3,180

3,214

Variable lease costs

 

178,263

175,697

172,088

Less: sublease income

 

(12,871)

(13,510)

(14,886)

Net lease cost

 

$

815,351

$

840,593

$

818,541

Supplemental cash flow information related to leases for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Year Ended

    

March 4, 2023

    

February 26, 2022

 

February 27, 2021

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows paid for operating leases

 

$

706,506

 

$

703,326

 

$

683,226

Operating cash flows paid for interest portion of finance leases

 

1,968

 

2,167

 

2,505

Financing cash flows paid for principal portion of finance leases

 

4,019

 

4,117

 

4,744

Right-of-use assets obtained in exchange for lease obligations:

Operating leases

 

264,507

 

350,132

 

513,215

Finance leases

 

 

 

Supplemental balance sheet information related to leases as of March 4, 2023 and February 26, 2022 (in thousands, except lease term and discount rate):

March 4,

 

February 26,

 

    

2023

 

2022

 

Operating leases:

Operating lease right-of-use asset

 

$

2,497,206

$

2,813,535

Short-term operating lease liabilities

 

$

502,403

$

575,651

Long-term operating lease liabilities

 

2,372,943

 

2,597,090

Total operating lease liabilities

 

$

2,875,346

$

3,172,741

Finance leases:

Property, plant and equipment, net

 

$

13,576

$

13,950

Current maturities of long-term debt and lease financing obligations

 

$

6,332

$

5,544

Lease financing obligations, less current maturities

 

12,580

 

14,830

Total finance lease liabilities

 

$

18,912

$

20,374

Weighted average remaining lease term

Operating leases

 

7.5

 

7.7

Finance leases

 

8.0

 

8.7

Weighted average discount rate

Operating leases

 

6.5

%

 

6.0

%

Finance leases

 

9.0

%

 

10.0

%

As a result of the Sale to WBA and the related Amended and Restated Asset Purchase Agreement, the Company has lease guarantee obligations related to 676 former stores. The Company is only obligated to pay for the lease guarantees in the event that WBA fails to perform under the lease agreements, as WBA is the primary obligor.

The following table summarizes the maturity of lease liabilities under finance and operating leases as of March 4, 2023:

March 4, 2023

Finance

Operating

Fiscal year

    

Leases

    

 Leases(1)

    

Total

2024

 

$

3,188

 

$

677,631

 

$

680,819

2025

 

7,732

 

593,857

 

601,589

2026

 

2,421

 

507,388

 

509,809

2027

 

1,567

 

426,503

 

428,070

2028

 

1,500

 

351,942

 

353,442

Thereafter

 

10,923

 

1,148,719

 

1,159,642

Total lease payments

 

27,331

 

3,706,040

 

3,733,371

Less: imputed interest

 

(8,419)

 

(830,694)

 

(839,113)

Total lease liabilities

 

$

18,912

 

$

2,875,346

 

$

2,894,258

(1)Future operating lease payments have not been reduced by minimum sublease rentals of $24.0 million due in the future under noncancelable leases.

Sale-Leaseback Transactions:

During the year ended March 4, 2023, the Company sold twelve owned and operated properties, including the Pontiac, MI and Liverpool, NY distribution centers and ten retail stores to independent third parties. Net proceeds from the sales were $73,344. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years for the retail stores and over a minimum lease term of three years for the distribution centers. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $38,214 which is included in the (gain) loss on sale of assets, net for fifty-three weeks ended March 4, 2023.

During the year ended February 26, 2022, the Company sold twenty owned and operating properties to independent third parties. Net proceeds from the sale were $57,498. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $8,600 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 26, 2022.

During the year ended February 27, 2021, the Company sold eleven owned and operating properties, including the Company’s Perryman, MD, Woodland, CA, and Lancaster, CA distribution centers, the Company’s Ice Cream Plant and seven retail stores to independent third parties. Net proceeds from the sales were $177,892. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over minimum lease terms between 15 and 20 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $93,841 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 27, 2021.

The Company has additional capacity under its outstanding debt agreements to enter into additional sale-leaseback transactions.

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.2
Stock Option and Stock Award Plans
12 Months Ended
Mar. 04, 2023
Stock Options and Stock Awards  
Stock Options and Stock Awards

18. Stock Option and Stock Award Plans

The Company recognizes share-based compensation expense in accordance with ASC 718, “Compensation—Stock Compensation.” Expense is recognized over the requisite service period of the award, net of an estimate for the impact of forfeitures. Operating results for fiscal 2023, 2022 and 2021 include $11,537, $13,050 and $13,003 of compensation costs related to the Company’s stock-based compensation arrangements.

In June 2010, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2010 Omnibus Equity Plan. Under the plan, 1,750 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2010 Omnibus Equity Plan became effective on June 23, 2010.

In June 2012, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2012 Omnibus Equity Plan. Under the plan, 1,425 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2012 Omnibus Equity Plan became effective on June 21, 2012.

In June 2014, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2014 Omnibus Equity Plan. Under the plan, 2,900 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan and the Rite Aid Corporation 2012 Omnibus Equity Plan as of the effective date of the 2014 Plan (provided that no more than 1,250 shares may be granted as incentive stock options) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2014 Omnibus Equity Plan became effective on June 19, 2014.

In July 2020, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,350 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan, the Rite Aid Corporation 2012 Omnibus Equity Plan and the Rite Aid Corporation 2014 Omnibus Equity Plan (collectively, the “Prior Plans”) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2020 Omnibus Equity Plan became effective on July 8, 2020. Upon the adoption date, shares of common stock may no longer be issued pursuant to the Prior Plans.

In July 2021, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 4,562 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 7, 2021.

In July 2022, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,250 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 27, 2022.

All of the plans provide for the Board of Directors (or at its election, the Compensation Committee) to determine both when and in what manner options may be exercised; however, it may not be more than 10 years from the date of grant. All of the plans provide that stock options may be granted at prices that are not less than the fair market value of a share of common stock on the date of grant. The aggregate number of remaining shares authorized for issuance for all plans is 3,628 as of March 4, 2023.

Stock Options

The Company determines the fair value of stock options issued on the date of grant using the Black-Scholes-Merton option-pricing model. The Company did not grant any options in fiscal 2023, 2022 and 2021

The weighted average fair value of options granted during fiscal 2023, 2022 and 2021 was $0.00. Following is a summary of stock option transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

    

    

Weighted

    

Weighted

    

Average

Average

Exercise

Remaining

Aggregate

Price

Contractual

Intrinsic

Shares

Per Share

Term

Value

Outstanding as of February 29, 2020

 

1,295

$

30.29

Granted

 

 

N/A

Exercised

 

(2)

 

25.08

Canceled

 

(513)

 

48.16

Outstanding as of February 27, 2021

 

780

$

18.56

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(79)

 

45.78

Outstanding as of February 26, 2022

 

701

$

15.50

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(169)

 

23.85

Outstanding as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Vested or expected to vest as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Exercisable as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

As of March 4, 2023, there was $0 of total unrecognized pre-tax compensation costs related to unvested stock options, net of forfeitures. These costs are expected to be recognized over a weighted average period of zero years.

Cash received from stock option exercises for fiscal 2023, 2022 and 2021 was $0, $0 and $53, respectively. The income tax benefit from stock options for fiscal 2023, 2022 and 2021 was $0, $0 and $1, respectively. The total intrinsic value of stock options exercised for fiscal 2023, 2022 and 2021 was $0, $0 and $10, respectively.

Typically, stock options granted vest, and are subsequently exercisable in equal annual installments over a four-year period for employees.

Restricted Stock

The Company provides restricted stock grants to associates under plans approved by the stockholders. Shares awarded under the plans typically vest in equal annual installments over a three-year period. Unvested shares are forfeited upon termination of employment. Following is a summary of restricted stock transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

    

    

Weighted

Average

Grant Date

Shares

Fair Value

Balance as of February 29, 2020

 

1,253

$

10.32

Granted

 

780

 

17.79

Vested

 

(574)

 

13.37

Canceled

 

(166)

 

12.23

Balance as of February 27, 2021

 

1,293

$

13.23

Granted

 

973

 

15.00

Vested

 

(546)

 

12.25

Canceled

 

(187)

 

15.51

Balance as of February 26, 2022

 

1,533

$

14.42

Granted

 

1,662

 

6.50

Vested

 

(1,349)

 

12.40

Canceled

 

(370)

 

10.83

Balance as of March 4, 2023

 

1,476

$

8.25

As of March 4, 2023, there was $9,719 of total unrecognized pre-tax compensation costs related to unvested restricted stock grants, net of forfeitures. These costs are expected to be recognized over a weighted average period of 1.7 years.

The total fair value of restricted stock vested during fiscal years 2023, 2022 and 2021 was $16,746, $6,677 and $7,670, respectively.

Performance Based Incentive Plan

The Company provides certain of its associates with performance based incentive awards under its equity incentive plans, pursuant to which the associates will receive a certain number of shares of the Company’s common stock based on the Company meeting certain financial and performance goals. If such goals are not met, no stock-based compensation expense is recognized and any recognized stock-based compensation expense is reversed. The Company recorded a benefit of $3,080 and expense of $2,143 and $3,278 related to these performance based incentive awards under the Company’s equity incentive plans for fiscal 2023, 2022 and 2021, respectively, which is recorded as a component of stock-based compensation expense.

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans
12 Months Ended
Mar. 04, 2023
Retirement Plans  
Retirement Plans

19. Retirement Plans

Defined Contribution Plans

The Company and its subsidiaries sponsor several retirement plans that are primarily 401(k) defined contribution plans covering nonunion associates and certain union associates. The Company does not contribute to all of the plans. In accordance with those plan provisions, the Company matches 100% of a participant’s pre-tax payroll contributions, up to a maximum of 3% of such participant’s pre-tax annual compensation. Thereafter, the Company will match 50% of the participant’s additional pre-tax payroll contributions, up to a maximum of 2% of such participant’s additional pre-tax annual compensation. Total expense recognized for the above plans was $44,504 in fiscal 2023, $41,528 in fiscal 2022 and $36,270 in fiscal 2021.

The Company sponsored a Supplemental Executive Retirement Plan (“SERP”) for its officers, based on an account-based plan design, that was subject to a five-year graduated vesting schedule. On February 25, 2019, the SERP was terminated and additional allocations were discontinued and all prior benefits under the program became fully vested. During fiscal 2020, participant benefits under this program were paid in full. No expense was recognized for the SERP in fiscal 2023, 2022 or 2021.

Defined Benefit Plans

The Company and its subsidiaries also sponsor a qualified defined benefit pension plan that requires benefits to be paid to eligible associates based upon years of service and, in some cases, eligible compensation. The Company’s funding policy for The Rite Aid Pension Plan (the “Defined Benefit Pension Plan”) is to contribute the minimum amount required by the Employee Retirement Income Security Act of 1974. However, the Company may, at its sole discretion, contribute additional funds to the plan. The Company made contributions of $0 in fiscal 2023, $1,700 in fiscal 2022 and $6,305 in fiscal 2021.

Net periodic pension expense and other changes recognized in other comprehensive income for the defined benefit pension plans included the following components:

Defined Benefit Pension Plan

    

2023

    

2022

    

2021

Service cost

$

336

$

425

$

486

Interest cost

 

5,036

 

4,861

 

4,753

Expected return on plan assets

 

(4,998)

 

(5,194)

 

(4,614)

Amortization of unrecognized net loss

 

 

344

 

3,749

Net periodic pension expense

$

374

$

436

$

4,374

Other changes recognized in other comprehensive loss:

Unrecognized net gain arising during period

$

(585)

$

(8,246)

$

(20,633)

Amortization of unrecognized net (loss) gain

 

 

(344)

 

(3,749)

Net amount recognized in other comprehensive loss

 

(585)

 

(8,590)

 

(24,382)

Net amount recognized in pension expense and other comprehensive loss

$

(211)

$

(8,154)

$

(20,008)

The table below sets forth reconciliation from the beginning of the year for both the benefit obligation and plan assets of the Company’s defined benefit plans, as well as the funded status and amounts recognized in the Company’s balance sheet as of March 4, 2023 and February 26, 2022:

Defined Benefit

Pension Plan

    

2023

    

2022

Change in benefit obligations:

    

    

Benefit obligation at end of prior year

$

160,133

$

168,872

Service cost

 

336

 

425

Interest cost

 

5,036

 

4,861

Distributions

 

(8,328)

 

(8,582)

Actuarial gain

 

(26,014)

 

(5,443)

Benefit obligation at end of year

$

131,163

$

160,133

Change in plan assets:

Fair value of plan assets at beginning of year

$

149,527

$

148,412

Employer contributions

 

 

1,700

Actual return on plan assets

 

(20,430)

 

7,997

Distributions (including expenses paid by the plan)

 

(8,328)

 

(8,582)

Fair value of plan assets at end of year

$

120,769

$

149,527

Funded status

$

(10,394)

$

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in consolidated balance sheets consisted of:

Accrued pension liability

 

(10,394)

 

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in accumulated other comprehensive loss consist of:

Net actuarial loss

$

11,202

$

(11,787)

Amount recognized

$

11,202

$

(11,787)

The decrease in the benefit obligation during the year ended March 4, 2023, was driven by the increase in discount rate from 3.25% as of February 26, 2022 to 5.00% as of March 4, 2023.

The decrease in the benefit obligation during the year ended February 26, 2022, was driven by the increase in discount rate from 3.00% as of February 27, 2021 to 3.25% as of February 26, 2022. The pension plan also benefitted from favorable return on assets and favorable experience from updated census data.

The estimated net actuarial loss and prior service cost amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense in fiscal 2024 are $0 and $0, respectively.

The accumulated benefit obligation for the defined benefit pension plan was $131,163 and $160,133 as of March 4, 2023 and February 26, 2022, respectively.

The accumulated benefit obligation and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows:

Defined Benefit

Pension Plan

2023

    

2022

Accumulated Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

The projected benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows:

Defined Benefit

Pension Plan

2023

    

2022

Projected Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

The significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation as of March 4, 2023, February 26, 2022 and February 27, 2021 were as follows:

Defined Benefit

Pension Plan

    

2023

    

2022

    

2021

Discount rate

    

5.00

%  

3.25

%  

3.00

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

6.50

%  

5.00

%  

5.50

%

Weighted average assumptions used to determine net cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 were:

Defined Benefit

Pension Plan

    

2023

2022

2021

Discount rate

3.25

%   

3.00

%   

2.75

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

5.00

%  

5.50

%  

6.00

%

To develop the expected long-term rate of return on assets assumption, the Company considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio. This resulted in the selection of the 5.00% long-term rate of return on plan assets assumption for fiscal 2023, 5.50% for 2022 and 6.00% for 2021.

The Company’s pension plan asset allocations as of March 4, 2023 and February 26, 2022 by asset category were as follows:

    

March 4,

    

February 26,

 

2023

2022

 

Equity securities

 

30

%  

30

%

Fixed income securities

 

59

%  

57

%

Other

11

%  

13

%

Total

 

100

%  

100

%

The investment objectives of the Defined Benefit Pension Plan, the only defined benefit plan with assets, are to:

Achieve a rate of return on investments that exceeds inflation over a full market cycle and is consistent with actuarial assumptions;
Balance the correlation between assets and liabilities by diversifying the portfolio among various asset classes to address return risk and interest rate risk;
Balance the allocation of assets between the investment managers to minimize concentration risk;
Maintain liquidity in the portfolio sufficient to meet plan obligations as they come due; and
Control administrative and management costs.

The asset allocation established for the pension investment program reflects the risk tolerance of the Company, as determined by:

the current and anticipated financial strength of the Company;
the funded status of the plan; and
plan liabilities.

Investments in both the equity and fixed income markets will be maintained, recognizing that historical results indicate that equities (primarily common stocks) have higher expected returns than fixed income investments. It is also recognized that the correlation between assets and liabilities must be balanced to address higher volatility of equity investments (return risk) and interest rate risk.

The following targets are to be applied to the allocation of plan assets.

    

Target

 

Category

Allocation

    

Equity securities

 

30

%

Fixed income securities

 

62

%

Other

8

%

Total

 

100

%

The Company expects to contribute $0 to the Defined Benefit Pension Plan during fiscal 2024.

Short-Term Investments

Short-term investments, which is a short-term investment fund, and is considered cash and cash equivalents, is classified within Level 2 of the valuation hierarchy due to the lack of an active market for trading.

Common and Collective Trusts

Common collective trust funds are stated at fair value as determined by the issuer of the common collective trust funds based on the net asset value (“NAV”) of the underlying investments in accordance with ASC 820. There are generally no restrictions on redemptions from these funds and no unfunded commitments to invest. In accordance with ASC subtopic 820-10, certain investments that were measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. The underlying investments mainly consist of equity and fixed income securities funds that are valued based on the daily closing price as reported by the fund.

The proceeding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement as of March 4, 2023.

The following table sets forth by level within the fair value hierarchy a summary of the plan’s investments measured at fair value on a recurring basis as of March 4, 2023 and February 26, 2022:

Fair Value Measurements as of March 4, 2023

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

13,901

Large Cap

 

 

 

 

18,556

Small-Mid Cap

 

 

 

 

3,309

Fixed Income

Aon High Yield Plus Bond

72

Aon Multi-Asset Credit

4,775

Long-Term Credit Bond Index

 

 

 

 

41,360

Long-Term U.S. Government Bonds

1,588

20+ Year Treasury STRIPS

12,821

Intermediate Fixed Income

9,781

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

11

Aon Core Real Estate Fund

13,479

Short-Term Investments

 

 

1,111

 

 

1,111

Total

$

$

1,111

$

$

120,764

Fair Value Measurements as of February 26, 2022

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

17,783

Large Cap

 

 

 

 

23,027

Small-Mid Cap

 

 

 

 

4,213

Fixed Income

Aon High Yield Plus Bond

75

Aon Multi-Asset Credit

7,386

Long-Term Credit Bond Index

 

 

 

 

47,976

Long-Term U.S. Government Bonds

19,763

20+ Year Treasury STRIPS

483

Intermediate Fixed Income

8,554

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

13

Aon Core Real Estate Fund

18,720

Short-Term Investments

 

 

1,532

 

 

1,532

Total

$

$

1,532

$

$

149,525

Following are the future benefit payments expected to be paid for the Defined Benefit Pension Plan during the years indicated:

Defined Benefit

Fiscal Year

    

Pension Plan

2024

$

9,497

2025

 

9,379

2026

 

9,373

2027

 

9,410

2028

 

9,252

2029 - 2033

 

44,769

Total

$

91,680

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.2
Multiemployer Plans that Provide Pension Benefits
12 Months Ended
Mar. 04, 2023
Multiemployer Plans that Provide Pension Benefits  
Multiemployer Plans that Provide Pension Benefits

20. Multiemployer Plans that Provide Pension Benefits

The Company contributes to a number of multiemployer defined benefit pension plans under the terms of collective-bargaining agreements that cover certain of its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer plans. Assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers. If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers. Additionally, if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability.

The Company’s participation in these plans for the annual period ended March 4, 2023 is outlined in the table below. The “EIN/Pension Plan Number” column provides the Employer Identification Number (EIN) and the three-digit plan number, if applicable. The most recent Pension Protection Act zone status available for fiscal 2023 and fiscal 2022 is for the plan year-ends as indicated below. The zone status is based on information that the Company received from the plan and is certified by the plan’s actuary. Among other factors, plans in the red zone are generally less than 65% funded, plans in the yellow zone are less than 80% funded, and plans in the green zone are at least 80% funded. The “FIP/RP Status Pending/Implemented” column indicates plans for which a financial improvement plan (“FIP”) or a rehabilitation plan (“RP”) is either pending or has been implemented. In addition to regular plan contributions, the Company may be subject to a surcharge if the plan is in the red zone. The “Surcharge Imposed” column indicates whether a surcharge has been imposed on contributions to the plan. The last two columns list the expiration date(s) of the collective-bargaining agreement(s) to which the plans are subject and any minimum funding requirements. There have been no significant changes that affect the comparability of total employer contributions of fiscal years 2023, 2022 and 2021.

Expiration

FIP/ RP

Date of

Pension Protection 

Status

Collective-

Minimum

EIN/Pension

Act Zone Status

Pending/

Contributions of the Company

Surcharge

Bargaining

Funding

Pension

    

Plan Number

    

2023

    

2022

    

Implemented

    

2023

    

2022

    

2021

    

Imposed

    

Agreement

    

Requirements

1199 SEIU Health Care Employees Pension Fund

13-3604862-001

Green—
12/31/2021

Green—
12/31/2020

No

$

7,493

$

9,242

$

9,613

No

4/18/2025

Contribution rate of 11.3% of gross wages per associate beginning 10/01/2021. Contribution rate of 12.6% of gross wages per associate beginning 09/30/2018.

 

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

51-6029925-001

 

Green—
12/31/2022

 

Red—
12/31/2021

 

No

 

8,131

 

8,989

 

8,239

 

No

 

7/20/2024

 

Beginning 01/01/2021, contributions of $1.844 per hour worked for pharmacists and $0.836 per hour worked for non-pharmacists. From 01/01/2020 through 12/31/2020 contributions of $1.758 per hour worked for pharmacists and $0.797 per hour worked for non-pharmacists.

 

 

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

94-2518312-001

 

Green—
12/31/2022

 

Green—
12/31/2021

 

No

 

2,605

 

3,224

 

2,319

 

No

 

7/13/2022

 

Effective 01/01/2020, contribution rate of $0.855 per hour worked for clerks and $1.239 per hour works for pharmacists. Effective 09/01/2014, contribution rate frozen at $0.55 per hour worked for associates.

 

 

United Food and Commercial Workers Union-Employer Pension Fund

 

34-6665155-001

 

Red—
9/30/2022

 

Red—
9/30/2021

 

Implemented

 

954

 

802

 

809

 

No

 

7/07/2024

 

Effective 02/06/2022, contribution rate of $2.57 per hour worked.
Effective 02/07/2021 contribution rate of $2.43 per hour worked.
Effective 02/02/2020 contribution rate of $2.30 per hour worked.

 

 

United Food and Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

 

51-6031766-001

 

Green—
9/30/2022

 

Green—
9/30/2021

 

No

 

434

 

370

 

399

 

No

 

7/07/2024

 

Effective 10/01/2022 contribution rate of $2.33 per hour worked.
Effective 10/01/2021 contribution rate of $2.24 per hour worked.
Effective 10/01/2020 contribution rate of $2.15 per hour worked.

 

 

Other Funds

 

2,046

 

1,887

 

1,573

$

21,663

$

24,514

$

22,952

The Company was listed in these plans’ Forms 5500 as providing more than 5% of the total contributions for the following plans and plan years:

    

Year Contributions to Plan 

Exceeded More Than 5 % of

Total Contributions (as of

Pension Fund

 the Plan’s Year-End)

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

12/31/2021 and 12/31/2020

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

12/31/2021 and 12/31/2020

United Food & Commercial Workers Union - Employer Pension Fund

 

9/30/2021 and 9/30/2020

United Food & Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

9/30/2021 and 9/30/2020

At the date the Company’s financial statements were issued, certain Forms 5500 were not available.

During fiscal 2023, 2022 and 2021, the Company did not withdraw from any plans or incur any additional withdrawal liabilities.

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Reporting
12 Months Ended
Mar. 04, 2023
Segment Reporting  
Segment Reporting

21. Segment Reporting

The Company has two reportable segments, Retail Pharmacy Segment and Pharmacy Services Segment.

The Retail Pharmacy Segment’s primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy Segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment offers a full range of PBM services including plan design and administration, formulary management and claims processing. Additionally, the Pharmacy Services Segment offers specialty and mail order services, and drug benefits to eligible beneficiaries under the federal government’s Medicare Part D program.

The Company’s chief operating decision makers are its Chief Executive Officer, Chief Financial Officer, and several other members of the Executive Leadership Team (collectively the “CODM”). The CODM has ultimate responsibility for enterprise decisions. The CODM determines, in particular, resource allocation for, and monitors performance of, the consolidated enterprise, the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy and Pharmacy Services Segment managers have responsibility for operating decisions, allocating resources and assessing performance within their respective segments. The CODM relies on internal management reporting that analyzes enterprise results on certain key performance indicators, namely, revenues, gross profit and Adjusted EBITDA.

The following is balance sheet information for the Company’s reportable segments:

    

Retail

    

Pharmacy

    

    

Pharmacy

Services

Eliminations(1)

Consolidated

March 4, 2023:

Total Assets

$

5,487,845

$

2,049,107

$

(9,590)

$

7,527,362

Goodwill

 

43,492

464,444

 

 

507,936

February 26, 2022:

Total Assets

$

6,068,594

$

2,482,232

$

(21,823)

$

8,529,003

Goodwill

 

43,492

835,644

 

 

879,136

(1)As of March 4, 2023 and February 26, 2022, intersegment eliminations include intersegment accounts receivable of $9,590 and $21,823, respectively, that represent amounts owed from the Pharmacy Services Segment to the Retail Pharmacy Segment that are created when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products.

The following table is a reconciliation of the Company’s business segments to the consolidated financial statements for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:

Retail

Pharmacy

Intersegment

    

Pharmacy

    

Services

    

Eliminations(1)

    

Consolidated

March 4, 2023:

Revenues

$

17,785,067

$

6,522,299

$

(215,467)

$

24,091,899

Gross Profit

 

4,394,850

 

409,090

 

 

4,803,940

Adjusted EBITDA(2)

 

288,077

 

141,103

 

 

429,180

Depreciation and amortization

229,380

47,203

276,583

LIFO charge

53,028

53,028

Stock-based compensation expense

10,604

933

11,537

Additions to property and equipment and intangible assets

226,563

21,122

247,685

February 26, 2022:

Revenues

$

17,494,816

$

7,323,125

$

(249,686)

$

24,568,255

Gross Profit

 

4,722,075

384,420

 

5,106,495

Adjusted EBITDA(2)

 

392,633

113,272

 

505,905

Depreciation and amortization

244,122

51,564

295,686

LIFO charge

1,314

1,314

Stock-based compensation expense

12,282

768

13,050

Additions to property and equipment and intangible assets

202,386

18,327

220,713

February 27, 2021:

 

 

Revenues

$

16,365,260

$

7,970,137

$

(292,157)

$

24,043,240

Gross Profit

 

4,255,791

448,531

 

4,704,322

Adjusted EBITDA(2)

 

279,896

157,769

 

437,665

Depreciation and amortization

269,985

57,139

327,124

LIFO credit

(51,692)

(51,692)

Stock-based compensation expense

11,594

1,409

13,003

Restructuring-related costs–SKU optimization charges

20,939

20,939

Additions to property and equipment and intangible assets

204,290

20,651

224,941

(1)Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.
(2)See the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.

The following is a reconciliation of net loss to Adjusted EBITDA for fiscal 2023, 2022 and 2021:

    

March 4,

February 26,

February 27,

2023

    

2022

    

2021

(53 weeks)

(52 weeks)

(52 weeks)

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Interest expense

 

224,399

 

191,601

 

201,388

Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Depreciation and amortization

276,583

295,686

327,124

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

(Gain) loss on debt modifications and retirements, net

(80,142)

3,235

(5,274)

Merger and Acquisition-related costs

 

 

12,797

 

10,549

Stock-based compensation expense

11,537

13,050

13,003

Restructuring-related costs

108,626

35,121

84,552

Inventory write-downs related to store closings

14,270

5,298

3,709

Litigation and other contractual settlements

53,882

50,212

(Gain) loss on sale of assets, net

(68,586)

5,505

(69,300)

Loss (gain) on Bartell acquisition

5,346

(47,705)

Change in estimate related to manufacturer rebate receivables

15,068

Other

 

9,401

 

4,740

 

3,283

Adjusted EBITDA from continuing operations

$

429,180

$

505,905

$

437,665

XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments, Contingencies and Guarantees
12 Months Ended
Mar. 04, 2023
Commitments, Contingencies and Guarantees  
Commitments, Contingencies and Guarantees

22. Commitments, Contingencies and Guarantees

Legal Matters and Regulatory Proceedings

The Company is regularly involved in a variety of legal matters including arbitration, litigation (and related settlement discussions), audits by counter parties under our contracts, and other claims, and is subject to regulatory proceedings including audits, inspections, inquiries, investigations, and similar actions by health care, insurance, pharmacy, tax and other governmental authorities arising in the ordinary course of its business, including, without limitation, the matters described below. Substantial damages are sought from the Company in virtually all of these matters, even if a specific amount is not specified. The Company records accruals for outstanding legal matters and applicable regulatory proceedings when it believes it is probable that a loss has been incurred, and the amount can be reasonably estimated. The Company evaluates on a quarterly basis, developments in legal matters and regulatory proceedings that could affect the amount of any existing accrual or that warrant an accrual. If a loss contingency is not both probable and estimable, the Company typically does not establish an accrued liability. Unless specifically noted otherwise, with respect to the litigation and other legal proceedings described below, the Company is unable to estimate the amount or range of reasonably possible loss due to the inherent difficulty of predicting the outcome of and uncertainties at the current stage of such litigation and legal proceedings.

None of the Company’s accruals for outstanding legal matters or regulatory proceedings are currently material, individually or in the aggregate, to the Company’s consolidated financial position. However, during the course of any proceeding, developments may result in the creation or an increase of an accrual that could be material. Additionally,

unfavorable or unexpected outcomes in outstanding legal matters or regulatory proceedings could exceed any accrual and impact the Company’s financial position. Further, even if the Company is successful in its legal proceedings, the Company may incur significant costs and expenses defending itself or others that it is required to indemnify, and such costs and expenses may not be subject to or may exceed reimbursement pursuant to any applicable insurance. Such proceedings may also require significant attention of management.

The Company’s contingencies are subject to significant uncertainties, many of which are beyond the Company’s control, including, among other factors: (i) the stage of any proceeding and delays in scheduling; (ii) whether class or collective action status is sought and the likelihood of a class being certified; (iii) the outcome of pending or potential appeals, motions and settlement discussions; (iv) the range and magnitude of potential damages, fines or penalties, which are often unspecified or indeterminate; (v) the impact of discovery on the matter; (vi) whether novel or unsettled legal theories are at issue or advanced; (vii) whether there are significant factual issues to be resolved including findings made by juries; (viii) the exercise of discretion in enforcement actions including in the case of certain government agency investigations, whether a qui tam lawsuit (“whistleblower” action) has been filed and whether the government agency makes a decision to intervene in the lawsuit following investigation; (ix) changes in priorities following any change in political administration at the state or federal level; and/or (x) the impact, results and settlements of similar claims made against competitors and other industry participants. Additionally, the Company may determine that a settlement is in its best interest, even if it believes that it has meritorious defenses and has not previously accrued for the matter.

Employment Litigation.

The Company is currently a defendant in several lawsuits filed in courts in California that contain allegations regarding violations of the California Business and Professions Code, various California employment laws and regulations, industry wage orders, wage-and-hour laws, rules and regulations pertaining primarily to failure to pay overtime, failure to pay premiums for missed meals and rest periods, failure to provide accurate wage statements, and failure to reimburse business expenses (collectively, the “California Cases”).

Some of the California Cases purport or may be determined to be class actions or representative actions under the California Private Attorneys General Act and seek substantial damages and penalties. In August 2022, the Company agreed to settle a putative class action regarding reimbursement for cell phone and mileage expenses for shift supervisors and managers/assistant managers for $1.29 million, and a putative wage and hour class action brought on behalf of drivers and other ice cream plant associates for $0.8 million. These settlements are subject to court approval.

The Company has also reached an agreement in principle to resolve a putative employment collective and class action filed in federal court in New York, which raises similar allegations in addition to others about the payment frequency for certain employees (the “New York Case”). In December 2022, the parties reached an agreement in principle to resolve the individual plaintiff’s claims as well as those of the class, resulting in the federal court issuing an order of judgment and a new matter filed in New York state court, which the parties have agreed to resolve for $6.45 million. The parties continue to work on a definitive settlement agreement, which will be subject to court approval and the Company expects that it will have the right terminate the agreement if certain participation thresholds are not met.

The Company has aggressively defended itself and challenged the merits of these employment lawsuits and, where applicable, allegations that the lawsuits should be certified as class or representative actions.

Usual and Customary Litigation.

The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company’s retail stores overcharged for prescription drugs by not submitting the price available to members of the Rite Aid’s Rx Savings Program as the pharmacy’s usual and customary price, and related theories. The Company is defending itself against these claims.

The Company is a defendant in a putative consumer class action lawsuit in the United States District Court for the Southern District of California captioned Byron Stafford v. Rite Aid Corp. A separate lawsuit, Robert Josten v. Rite Aid Corp., was consolidated with this lawsuit for pre-trial purposes. The lawsuit contains allegations that (i) the Company was obligated to charge the plaintiffs’ insurance companies its usual and customary prices for their prescription drugs; and (ii) the Company failed to do so because the prices it reported were not equal to or adjusted to account for the prices that Rite Aid offered to uninsured and underinsured customers through its Rx Savings Program. The Company is defending itself in a second putative class action lawsuit against similar pricing allegations filed in the United States District Court for the Eastern District of Pennsylvania.

On February 6, 2019, Humana, Inc., filed a claim pursuant to a binding arbitration provision of the parties’ agreement alleging that the Company improperly submitted various usual and customary overcharges by failing to report its Rx Savings Program prices as its usual and customary prices to Humana. An arbitration hearing was held in this matter in November 2021.  

On April 22, 2022, the arbitrator issued an Opinion and Final Award against the Company for breach of contract awarding Humana $122.6 million, which includes $40.7 million in prejudgment interest (the “Arbitration Award”). The Company continues to believe that the Arbitration Award contains a number of significant factual and legal errors. On June 20, 2022, the Company both opposed Humana’s effort to confirm the Arbitration Award and petitioned the United States District Court for Western District of Kentucky for vacatur of the Arbitration Award, as is its right under the Federal Arbitration Act (“FAA”). As such, the Company has determined that it is not probable that a loss has occurred.

The FAA, as interpreted and applied by federal courts, permits vacatur when, among other things, an arbitrator’s decision: (1) is irreconcilable with the terms of a contract between the parties; (2) rests on a plain legal error that manifests disregard for the law; or (3) incorporates a refusal to consider pertinent, material evidence. Similarly, the FAA, as interpreted and applied by federal courts, permits modification of an arbitrator’s decision to correct an evident material miscalculation of figures. Although the Company cannot make any assurances of success in its efforts, it is the Company’s view that the errors in the Arbitration Award support both vacatur and modification under the FAA, the effect of either of which could be to set aside the Arbitration Award or reduce or eliminate the damages provided for in the Arbitration Award.

Argument on Humana’s petition to confirm the Arbitration Award and Rite Aid’s motion for vacatur of the Arbitration Award is scheduled for May 10, 2023. Depending on the court’s determination, it is possible that one or both parties may appeal the decision, or seek other remedies.

The Company is a defendant in two consolidated lawsuits pending in the United States District Court for the District of Minnesota filed in 2020 by various Blue Cross/Blue Shield plans that operate in eight different states (North Carolina, North Dakota, Alabama, Utah, Minnesota, Oregon, Washington and New Jersey) alleging that the Company improperly submitted various usual and customary overcharges to several Pharmacy Benefit Managers, all but one of

which are not owned by plaintiffs, with which Rite Aid and the insurers had independent contracts. The Company is also defending a lawsuit filed in Delaware state court in 2019 by multiple Centene entities alleging that the Company overcharged for prescriptions by improperly reporting usual and customary prices. The Delaware lawsuit is scheduled to start trial in May 2023. The Company is defending a similar lawsuit filed in 2022 by WellCare in Florida state court.

Drug Utilization Review and Code 1 Litigation

In June 2012, qui tam plaintiff, Loyd F. Schmuckley (“Relator”) filed a complaint under seal against the Company alleging that it failed to comply with certain requirements of California’s Medicaid program between 2007 and 2014. In June 2013, the Company was served with a Civil Investigative Demand (“CID”) by the United States Attorney’s Office for the Eastern District of California regarding (1) the Company’s Drug Utilization Review and prescription dispensing protocol; and (2) the dispensing of drugs designated as “Code 1” by the State of California. Specifically, the Relator alleged that the Company did not perform special verification and documentation for certain medications known as “Code 1” drugs. While the complaint remained under seal, the United States Department of Justice conducted an extensive investigation and ultimately declined to intervene. Although numerous states declined to intervene, in September 2017, the State of California’s Department of Justice’s Bureau of Medical Fraud and Elder Abuse filed a complaint in intervention. The Company filed a motion to dismiss Relator’s and the State of California’s respective complaints in January 2018, and the hearing was held on March 23, 2018. On September 5, 2018, the court issued an order denying the motion to dismiss. Substantial damages are sought from the Company in this matter. No trial date has been set and as discovery continues, the parties have participated in and are expected to continue to participate in a mediation process, although there is no expected date or terms for any potential resolution of this matter.

Controlled Substances Litigation, Audits and Investigations

The Company, along with various other defendants, is named in multiple opioid-related lawsuits filed by counties, cities, municipalities, Native American tribes, hospitals, third-party payers, and others across the United States. In December 2017, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) consolidated and transferred more than a thousand federal opioid-related lawsuits that name the Company as a defendant to the multi-district litigation (“MDL”) pending in the United States District Court for the Northern District of Ohio under In re National Prescription Opiate Litigation (Case No. 17-MD-2804). A significant number of similar cases that are not part of the MDL and name the Company as a defendant are also pending in state courts. On June 1, 2022, the JPML ordered that newly filed cases will no longer be transferred to the MDL. The plaintiffs in these opioid-related lawsuits generally allege claims that include, without limitation, public nuisance and negligence theories of liability resulting from the impacts of widespread opioid abuse against defendants along the pharmaceutical supply chain, including manufacturers, wholesale distributors, and retail pharmacies. At this stage of the proceedings, the Company is not able to predict the outcome of the opioid-related lawsuits in which it remains a defendant or estimate a potential range of loss regarding the lawsuits, and is defending itself against all relevant claims. From time to time, some of these cases may be settled, dismissed or otherwise terminated, and additional such cases may be filed.

The Company also has received warrants, subpoenas, CIDs, and other requests for documents and information from, and is being investigated by, the federal and state governments regarding opioids and other controlled substances. The Company has been cooperating with and responding to these investigatory inquiries.

As previously disclosed, on December 13, 2022, a qui tam complaint filed by three former Rite Aid pharmacy personnel (Andrew White, Mark Rosenberg, and Ann Wegelin) (collectively, “qui tam Relators”) was unsealed by the

federal District Court for the Northern District of Ohio in an order that also directed the United States Department of Justice to file within 90 days a complaint intervening or partially intervening in the Second Amended Complaint (the “Complaint”). On February 23, 2023, the following states, which were listed in the Complaint, declined to intervene: Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Nevada, New Hampshire, New Jersey, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington and the District of Columbia. On February 23, 2023, California stated its intention to make an intervention decision on or before May 2, 2023. On March 13, 2023, the United States Department of Justice filed its complaint in the federal District Court for the Northern District of Ohio against Rite Aid (“DOJ’s Complaint”) alleging violations of the federal False Claims Act and Controlled Substances Act related to the dispensing of controlled substances, primarily opioids. DOJ’s Complaint seeks damages under the False Claims Act, civil penalties under the Controlled Substances Act, damages in connection with alleged payment by mistake (on behalf of Federal Healthcare Programs), and damages in connection with alleged unjust enrichment.

In April 2019, the Company initiated a coverage action styled Rite Aid Corporation et al. v. ACE American Ins. Co. et al. Through this action, the Company is seeking the recovery of defense costs and settlement and/or judgment costs that may be paid for the opioid-related lawsuits. The action seeks declaratory relief with respect to the obligations of the insurers under the policies at issue in the action and asserts claims for breach of contract and statutory remedies against one of these insurers. Although the trial court determined on the Company’s motion for partial summary judgment that this insurer was obligated to reimburse the Company for its defense costs, on January 10, 2022, the Delaware Supreme Court reversed the trial court’s order and ruled that the insurer had no duty to defend the first MDL suits set for trial based on the specific allegations at issue in those cases. The matter has been remanded to the lower court for further proceedings.

Miscellaneous Litigation and Investigations.

Following the Company’s response to a 2020 CID from the Federal Trade Commission (“FTC”) with respect to consumer protection laws, the Company is seeking to negotiate a resolution with the FTC. The allegations relate to certain business practices that the Company has not engaged in for nearly three years, and the Company currently believes that any resolution will not likely require a monetary payment. Discussions are ongoing with the FTC and the timing and substance of any settlement cannot be determined at this time. During the course of the Company’s discussions with the FTC in connection with its response to that CID, the FTC also requested certain information from the Company related to compliance with the Company’s 2010 FTC Consent Order. The Company cooperated with the FTC's request, however, the FTC Staff informed the Company that it would recommend that the FTC file a complaint against the Company for violation of the Consent Order, including a monetary payment and other relief, unless the Company informs FTC Staff that it is willing to discuss a resolution. The Company is evaluating the matter, including potential resolution, although no assurance can be given that the matter will be resolved to the parties’ mutual satisfaction, or that the resolution will not include a monetary payment, and that the payment will not be material. It is also possible that discussions relating to the 2010 FTC Consent Order could affect the resolution of the 2020 CID.

The Company has received CIDs from the Department of Justice related to the Medicare Part D plan sponsored by a subsidiary of the Company. The Company is also defending a lawsuit asserting numerous claims based on allegations surrounding the Company’s use of a certain font including in the Company’s rebranded logo. The Company is defending a putative class action it has removed to federal court in California regarding alleged privacy breaches.

The Company is defending a putative shareholder class action currently captioned Page v. Rite Aid Corporation et al., filed in the United States District Court for the Eastern District of Pennsylvania. The matter names Rite Aid

Corporation and certain executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to alleged misstatements and omissions concerning the growth of Elixir’s PBM services businesses. The matter remains in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit. The Company is also defending a putative shareholder class action currently captioned Holland v. Rite Aid Corporation et al., filed in the United States District Court for the Northern District of Ohio. The matter names Rite Aid Corporation and certain former and current executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to the DOJ’s Complaint and alleged misstatements and omissions concerning the Company’s risk for regulatory action and litigation related to controlled substances practices.  This matter is also in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit.

XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.2
Supplementary Cash Flow Data
12 Months Ended
Mar. 04, 2023
Supplementary Cash Flow Data  
Supplementary Cash Flow Data

23. Supplementary Cash Flow Data

March 4,

February 26,

February 27,

2023

    

2022

    

2021

Cash paid for interest (a)

$

212,355

$

180,583

$

181,634

Cash (refunds) payments for income taxes, net(a)

$

(5,309)

$

6,233

$

7,535

Equipment financed under capital leases

$

3,334

$

1,698

$

1,849

Accrued capital expenditures

$

18,711

$

45,465

$

19,904

Gross borrowings from revolver(a)

$

3,510,000

$

5,131,000

$

7,912,000

Gross repayments to revolver(a)

$

3,019,000

$

5,272,000

$

7,712,000

(a)–Amounts are presented on a total company basis.

Significant components of cash used in Other Liabilities of $111,021 for the fifty-three week period ended March 4, 2023 includes cash used from changes in accrued wages, benefits and other personnel costs of $100,340 and provided from changes in accrued store expenses of $11,426.

XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.2
Financial Instruments
12 Months Ended
Mar. 04, 2023
Financial Instruments  
Financial Instruments

24. Financial Instruments

The carrying amounts and fair values of financial instruments as of March 4, 2023 and February 26, 2022 are listed as follows:

2023

2022

    

Carrying

    

Fair

    

Carrying

    

Fair

Amount

Value

Amount

Value

Variable rate indebtedness

$

1,581,793

$

1,600,000

$

1,038,646

$

1,059,000

Fixed rate indebtedness

$

1,343,465

$

768,328

$

1,694,340

$

1,602,122

Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets.

The following methods and assumptions were used in estimating fair value disclosures for financial instruments:

Borrowings under credit facilities:

The carrying amounts for SOFR-based and LIBOR-based borrowings under the credit facilities are estimated based on the quoted market price of the financial instruments. The LIBOR-based borrowings under the credit facilities transitioned to Term SOFR on December 1, 2022.

Long-term indebtedness:

The fair values of long-term indebtedness are estimated based on the quoted market prices of the financial instruments. If quoted market prices were not available, the Company estimated the fair value based on the quoted market price of a financial instrument with similar characteristics.

XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.2
Revision of Previously Issued Consolidated Financial Statements
12 Months Ended
Mar. 04, 2023
Revision of Previously Issued Consolidated Financial Statements  
Revision of Previously Issued Consolidated Financial Statements

25. Revision of Previously Issued Consolidated Financial Statements

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement in accordance with the U.S. SEC Staff’s Accounting Bulletin Nos. 99, Materiality (“SAB 99”) and 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”). The misstatement pertains to the Company’s historical accounting for closed store liabilities. Based on their evaluation, management concluded the misstatement is not material to the Company’s previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the “previously issued financial statements”). However, as prescribed by SAB 108, in conjunction with the re-issuance of the Company’s previously issued financial statements, the misstatement has been corrected as an immaterial revision of the accompanying consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes hereto. A summary of the nature of the misstatement and its impact on the Company’s previously issued financial statements is summarized as follows.

The Company adopted ASC 842, Leases, (“ASC 842”) on the first day of fiscal year 2020 under the alternative transition method as permissible under ASC 842. As part of this adoption, the Company elected the practical expedients, as permitted under the transition guidance, which included, among other things, the ability to carry forward existing lease classifications. Based on this election, the Company appropriately eliminated the majority of its closed store and lease exit liabilities as of the date of adoption, which had been accrued in accordance with ASC 420, Exit or Disposal Cost Obligations, (“ASC 420”). Moreover, due to the Company’s practical expedients election, variable costs, consisting primarily of real estate taxes and common area maintenance expenses, associated with store closures that occur subsequent to the adoption of ASC 842 may no longer be accrued under ASC 420, but rather recognized as expense as they are incurred.

Due to an oversight in their evaluation of an amendment to ASC 420 as a result of the adoption of ASC 842, management determined that the Company incorrectly continued to accrue estimated costs associated with store closures as a liability subsequent to the date of adoption, rather than recognize the costs as they are incurred. The impact of the misstatement resulted in an overstatement of these costs, which have historically been classified within Facility exit and impairment charges in the Company’s Consolidated Statements of Operations, and an overstatement of store closure liabilities, which have historically been classified within Accrued salaries, wages and other current liabilities (current

portion) and Other noncurrent liabilities (long-term portion) in the Company’s Consolidated Balance Sheets. The misstatement had no impact on the Company’s previously issued consolidated financial statements as of and for the fiscal year ended February 29, 2020 and each of the interim and year-to-date periods then ended.

A summary of revisions to the Company’s previously reported financial statements is presented below.

As of and for the fiscal year ended March 4, 2023

    

Previously 

    

    

As

(In 000’s, except per share amounts )

Reported

Adjustment

 Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

724,529

$

(14,638)

$

709,891

Total current liabilities

 

2,727,875

 

(14,638)

 

2,713,237

Other noncurrent liabilities

 

130,482

 

(32,905)

 

97,577

Total liabilities

 

8,169,138

 

(47,543)

 

8,121,595

Accumulated deficit

 

(6,601,517)

 

(47,543)

 

(6,553,974)

Total stockholders’ (deficit) equity

 

(641,776)

 

(47,543)

 

(594,233)

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

211,385

$

(30,748)

$

180,637

Loss from continuing operations before income taxes

 

(756,403)

 

30,748

 

(725,655)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Net loss

 

(749,936)

 

30,748

 

(719,188)

Comprehensive loss

 

(749,351)

 

30,748

 

(718,603)

Basic and diluted loss per share from continuing operations

 

(13.71)

 

0.56

 

(13.15)

Net basic and diluted loss per share

 

(13.71)

 

0.56

 

(13.15)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(749,936)

$

30,748

$

(719,188)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Facility exit and impairment charges

 

211,385

 

(30,748)

 

180,637

As of and for the fiscal year ended February 26, 2022

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

780,632

$

(4,073)

$

776,559

Total current liabilities

 

2,933,088

 

(4,073)

 

2,929,015

Other noncurrent liabilities

 

151,976

 

(12,722)

 

139,254

Total liabilities

 

8,429,970

 

(16,795)

 

8,413,175

Accumulated deficit

 

(5,851,581)

 

16,795

 

(5,834,786)

Total stockholders’ (deficit) equity

 

99,033

 

16,795

 

115,828

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

180,190

$

(16,106)

$

164,084

Loss from continuing operations before income taxes

 

(542,258)

 

16,106

 

(526,152)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Net loss

 

(538,478)

 

16,106

 

(522,372)

Comprehensive loss

 

(529,861)

 

16,106

 

(513,755)

Basic and diluted loss per share from continuing operations

 

(9.96)

 

0.30

 

(9.66)

Net basic and diluted loss per share

 

(9.96)

 

0.30

 

(9.66)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(538,478)

$

16,106

$

(522,372)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Facility exit and impairment charges

 

180,190

 

(16,106)

 

164,084

As of and for the fiscal year ended February 27, 2021

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

642,364

$

854

$

643,218

Total current liabilities

 

2,602,946

 

854

 

2,603,800

Other noncurrent liabilities

 

208,213

 

(1,543)

 

206,670

Total liabilities

 

8,720,250

 

(689)

 

8,719,561

Accumulated deficit

 

(5,313,103)

 

689

 

(5,312,414)

Total stockholders’ (deficit) equity

 

615,154

 

689

 

615,843

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

58,403

$

(689)

$

57,714

Loss from continuing operations before income taxes

 

(120,227)

 

689

 

(119,538)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Net loss

 

(90,909)

 

689

 

(90,220)

Comprehensive loss

 

(66,065)

 

689

 

(65,376)

Basic and diluted loss per share from continuing operations

 

(1.87)

 

0.01

 

(1.86)

Net basic and diluted loss per share

 

(1.69)

 

0.01

 

(1.68)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(90,909)

$

689

$

(90,220)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Facility exit and impairment charges

 

58,403

 

(689)

 

57,714

XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.2
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS
12 Months Ended
Mar. 04, 2023
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS  
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021

(dollars in thousands)

    

    

Additions

    

    

Balance at

Charged to

Balance at

Allowances deducted from accounts receivable for estimated

Beginning

Costs and

End of

uncollectible amounts:

of Period

Expenses

Deductions

Period

Year ended March 4, 2023

$

46,865

$

63,373

$

48,105

$

62,133

Year ended February 26, 2022

$

24,854

$

106,113

$

84,102

$

46,865

Year ended February 27, 2021

$

12,849

$

43,855

$

31,850

$

24,854

XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Mar. 04, 2023
Summary of Significant Accounting Policies  
Comparability

Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement (the "Amended and Restated Asset Purchase Agreement"), dated as of September 18, 2017, by and among Rite Aid, WBA and Walgreen Co., an Illinois corporation and 100% owned subsidiary of WBA ("Buyer"), Buyer agreed to purchase from Rite Aid 1,932 stores (the "Acquired Stores"), three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of approximately $4,375,000, on a cash free, debt free basis (the "Asset Sale" or the "Sale"). As of March 4, 2023, the Company has sold all 1,932 Acquired Stores, three distribution centers and related assets to WBA in exchange for proceeds of $4,375,000, which were used to repay outstanding debt. Based on its magnitude and because the Company has exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Asset Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). See additional information as provided in Note 4 Asset Sale to WBA.

Fiscal Year

Fiscal Year

The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year ended March 4, 2023 included 53 weeks. The fiscal years ended February 26, 2022 and February 27, 2021 included 52 weeks.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its 100% owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and highly liquid investments, which are readily convertible to known amounts of cash and which have original maturities of three months or less when purchased.

Allowance for Uncollectible Receivables

Allowance for Uncollectible Receivables

In our Retail Pharmacy Segment, substantially all prescription sales are made to customers who are covered by third-party payors, such as insurance companies, government agencies and employers. The Company recognizes receivables that represent the amount owed to the Company for sales made to customers or employees of those payors that have not yet been paid. In our Pharmacy Services Segment, receivables are recorded for claims for prescriptions

issued for customers, customer administrative fees, amounts due from the Centers for Medicare and Medicaid Services (“CMS”) for Medicare Part D, and amounts due from certain drug manufacturers or rebate aggregators for rebates. The Company maintains a reserve for the expected credit losses associated with these receivables. This reserve is calculated based upon historical collection activity adjusted for current conditions.

Inventories

Inventories

Inventories are stated at the lower of cost or market. Inventory balances include the capitalization of certain costs related to purchasing, freight and handling costs associated with placing inventory in its location and condition for sale. The Company uses the last-in, first-out (“LIFO”) cost flow assumption for substantially all of its inventories. The Company calculates its inflation index based on internal product mix and utilizes the link-chain LIFO method.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Asset impairments are recorded when the carrying value of assets are not recoverable. For purposes of recognizing and measuring impairment of long-lived assets, the Company categorizes assets of operating stores as “Assets to Be Held and Used” and “Assets to Be Disposed Of.” The Company evaluates assets at the store level because this is the lowest level of identifiable cash flows ascertainable to evaluate impairment. Assets being tested for recoverability at the store level include tangible long-lived assets, right-of-use assets for leased stores, and identifiable, finite-lived intangibles that arose in purchase business combinations. Corporate assets to be held and used are evaluated for impairment based on excess cash flows from the stores that support those assets.

The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation and amortization. The Company provides for depreciation using the straight-line method over the following useful lives: buildings—30 to 45 years; equipment—3 to 15 years.

Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the term of the lease. When determining the amortization period of a leasehold improvement, the Company considers whether discretionary exercise of a lease renewal option is reasonably assured. If it is determined that the exercise of such option is reasonably assured, the Company will amortize the leasehold improvement asset over the minimum lease term, plus the option period. This determination depends on the remaining life of the minimum lease term and any economic penalties that would be incurred if the lease option is not exercised.

Capitalized lease assets are recorded at the lesser of the present value of minimum lease payments or fair market value and amortized over the estimated useful life of the related property or term of the lease.

The Company capitalizes direct internal and external development costs associated with internal-use software. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. For fiscal years 2023, 2022 and 2021, the Company capitalized costs of approximately $5,099, $13,388 and $12,669, respectively.

Goodwill

Goodwill

The Company recognizes goodwill as the excess of the purchase price over the fair value of the assets acquired and liabilities assumed during business combinations. The Company accounts for goodwill under ASC Topic 350, “Intangibles—Goodwill and Other”, which does not permit amortization, but instead requires the Company to perform an annual impairment review, or more frequently if events or circumstances indicate that impairment may be more likely. See Note 14 for additional information on goodwill.

Intangible Assets

Intangible Assets

The Company has certain finite-lived intangible assets that are amortized over their useful lives. Prescription files acquired in business combinations are amortized over an estimated useful life of 10 years on an accelerated basis, which approximates the anticipated prescription file retention and related cash flows. Purchased prescription files acquired in other than business combinations are amortized over their estimated useful lives of five years on a straight-line basis. The value of finite-lived trade names are amortized over 10 years on a straight-line basis. The value of customer relationships, acquired in connection with the Company’s acquisition of Elixir, are amortized over a period between 10 and 20 years on a descending percentage method which matches the pattern of expected discounted cash flows. The Pharmacy Services Segment’s contract with CMS for Part D, which is required in order to act as a national provider of the Part D benefit, is amortized over 12 years on a straight line basis, of which four years remain.

Indefinite lived assets

Indefinite lived assets

The Company has a single indefinite-lived intangible asset consisting of a trade name. Intangible assets that are determined to have an indefinite life are not amortized, but are required to be evaluated at least annually for impairment. If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-lived intangible asset is impaired by the amount of the excess.

Deferred Financing Costs

Deferred Financing Costs

Costs incurred to issue debt are deferred and amortized as a component of interest expense over the terms of the related debt agreements. Amortization expense of deferred financing costs was $9,993, $10,927 and $11,201 for fiscal 2023, 2022 and 2021, respectively.

Revenue Recognition

Revenue Recognition

Retail Pharmacy Segment

For front-end sales, the Retail Pharmacy Segment recognizes revenues upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation at the point of sale for front-end transactions. The Retail Pharmacy Segment front-end revenue is measured based on the amount of fixed consideration that it expects to

receive, net of an allowance for estimated future returns. Return activity is immaterial to revenues and results of operations in all periods presented.

For pharmacy sales, the Retail Pharmacy Segment recognizes revenue upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation, upon pickup by the customer, which is when the customer takes title to the product. Each prescription claim represents an individual arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims. The Company's revenue is measured based on the amount of fixed consideration that we expect to receive, reduced by refunds owed to the third-party payor for pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not highly subjective or volatile. The effect of adjustments between estimated and actual amounts has not been material to the Company's results of operations or financial position. Prescriptions are generally not returnable.

The Retail Pharmacy Segment offered a chain-wide loyalty card program titled wellness+. Individual customers were able to become members of the wellness+ program. Members participating in the wellness+ loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, the Company granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.

A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.

Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue. For the fifty-three week period ended March 4, 2023, the Company recognized additional contract deferrals of $2,030 as a reduction of revenues. The Retail Pharmacy Segment had accrued contract liabilities of $2,030 and $0 as of March 4, 2023 and February 26, 2022, respectively.

Pharmacy Services Segment

The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and; (ii) under retail pharmacy network contracts where it is the principal at the contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of

health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member co-payments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:

Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services Segment’s online claims processing system. At this point the Company has performed all of its performance obligations.
Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments.
Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member-based fee, or a claims volume-based fee.

In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.

Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.

For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized, except the administrative fee.

Drug Discounts—The Pharmacy Services Segment deducts from its revenues that are generated from prescription drugs sold by third-party pharmacies any rebates, inclusive of discounts and fees, earned by its clients based on utilization levels and other factors as negotiated with the prescription drug manufacturers, rebate aggregators or suppliers. Rebates are paid to clients in accordance with the terms of client contracts.

Medicare Part D—The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a Medicare Part D Prescription Drug Plan (“PDP”). Please refer to Note 10, Medicare Part D.

Disaggregation of Revenue

The following tables disaggregate the Company’s revenue by major source in each segment for the fiscal year ended March 4, 2023:

March 4,

    

2023

In thousands

(53 Weeks)

    

Retail Pharmacy Segment:

  

 

Pharmacy sales

$

12,582,593

Front-end sales

 

5,078,820

Other revenue

 

123,654

Total Retail Pharmacy Segment

17,785,067

Pharmacy Services Segment

 

6,522,299

Intersegment elimination

 

(215,467)

Total revenue

$

24,091,899

See Note 21 for additional information about the revenues of the Company’s business segments.

Cost of Revenues

Cost of Revenues

Retail Pharmacy Segment

Cost of revenues for the Retail Pharmacy Segment includes the following: the cost of inventory sold during the period, including related vendor rebates and allowances, LIFO credit or charges, costs incurred to return merchandise to vendors, inventory shrink, purchasing costs and warehousing costs, which include inbound freight costs from the vendor, distribution payroll and benefit costs, distribution center occupancy costs and depreciation expense and delivery expenses to the stores.

Pharmacy Services Segment

The Pharmacy Services Segment’s cost of revenues includes the cost of prescription drugs sold during the reporting period indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The cost of prescription drugs sold component of cost of revenues includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients’ benefit plans from the Pharmacy Services Segment’s mail service dispensing pharmacy, net of any volume-related or other discounts (see the section entitled “Vendor Rebates and Allowances and Purchase Discounts” below) and (ii) the cost of prescription drugs sold through the Pharmacy Services Segment’s retail pharmacy network under contracts where it is the principal, net of any volume-related or other discounts.

See Note 21 for additional information about the cost of revenues of the Company’s business segments.

Vendor Rebates and Allowances and Purchase Discounts

Retail Pharmacy Segment

The Retail Pharmacy Segment’s rebates and allowances received from vendors relate to either buying and merchandising or promoting the product. Buying and merchandising related rebates and allowances are recorded as a reduction of cost of revenue as product is sold. Buying and merchandising rebates and allowances include all types of vendor programs such as cash discounts from timely payment of invoices, purchase discounts or rebates, volume purchase allowances, price reduction allowances and slotting allowances. Certain product promotion related rebates and allowances, primarily related to advertising, are recorded as a reduction in selling, general and administrative expenses when the advertising commitment has been satisfied.

Pharmacy Services Segment

The Pharmacy Services Segment receives purchase discounts on products purchased. The Pharmacy Services Segment’s contractual arrangements with vendors, including manufacturers and rebate aggregators, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized when prescriptions are dispensed and are generally billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Pharmacy Services Segment’s results of operations. The Pharmacy Services Segment accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services Segment also receives additional discounts under its wholesaler and rebate aggregator contracts and fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.

Rebates payable to clients for the Pharmacy Services Segment

The Pharmacy Services Segment has contractual arrangements with clients, including health plans, commercial employers, labor groups, and state and local governments, which entitles such clients to a portion of certain rebates received by the Pharmacy Services Segment. Estimated rebates payable to clients are recognized when prescriptions are dispensed and are generally paid to clients up to eight months in arrears.  Historically, the effect of adjustments resulting from the reconciliation of estimated rebates payable to clients recognized and the amount actually paid has not been material to the Pharmacy Services Segment’s results of operations.  The Pharmacy Services Segment accounts for the effect of any such difference as a change in accounting estimate in the period the reconciliation is completed.  Estimated rebates payable to clients are recorded as a reduction of revenues.

Leases

Leases

The Company determines if an arrangement contains a lease at the inception of a contract. Operating lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized at the commencement date based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company’s leases is not readily

determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest that we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses quoted interest rates obtained from financial institutions in an input to derive its incremental borrowing rate as the discount rate for the lease. The ROU asset is equal to the operating lease liability plus lease payments made before commencement, less lease incentives received from the landlord.

The Company’s real estate leases typically contain options that permit lease extensions for additional periods of up to five years each. For real estate leases, generally, the renewal periods are not included within the lease term and the associated payments are not included in the measurement of the ROU asset and operating lease liability as the options to extend are not considered reasonably certain to occur at lease commencement. The Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and will include all reasonably certain options in the measurement of its lease term. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the operating lease right-of-use asset and the operating lease liability until the renewals are i) evaluated and ii) determined to be exercised. The Company has an insignificant amount of non-real estate leases however, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. The Company rarely executes leases less than 12 months.

For real estate leases, the Company accounts for lease components and non-lease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the operating lease right-of-use assets and operating lease liabilities.

The Company records rent expense on operating leases on a straight-line basis over the reasonably certain lease term. The Company begins to record rent expense at the time that the Company has the right to use the property.

Selling, General and Administrative Expenses

Selling, General and Administrative Expenses

Selling, general and administrative expenses include store and corporate administrative payroll and benefit costs, occupancy costs which include retail store and corporate rent costs, facility and leasehold improvement depreciation and utility costs, advertising, repair and maintenance, insurance, equipment depreciation and professional fees.

Repairs and Maintenance

Repairs and Maintenance

Routine repairs and maintenance are charged to operations as incurred. Improvements and major repairs, which extend the useful life of an asset, are capitalized and depreciated.

Advertising

Advertising

Advertising costs, net of specific vendor advertising allowances, are expensed in the period the advertisement first takes place. Advertising expenses, net of vendor advertising allowances, for fiscal 2023, 2022 and 2021 were $133,379, $146,085 and $122,725, respectively.

Insurance

Insurance

The Company is self-insured for certain general liability and workers’ compensation claims. For claims that are self-insured, stop-loss insurance coverage is maintained for workers’ compensation occurrences exceeding $1,000 and general liability occurrences exceeding $3,000. The Company utilizes actuarial studies as the basis for developing reported claims and estimating claims incurred but not reported relating to the Company’s self-insurance. Workers’ compensation claims are discounted to present value using a risk-free interest rate.

The Company is also self-insured for certain employee health and welfare plans. We record the related self-insurance liabilities based on claims incurred and an estimate of claims incurred but not yet reported.

Benefit Plan Accruals

Benefit Plan Accruals

The Company has several defined benefit plans, under which participants earn a retirement benefit based upon a formula set forth in the plan. The Company records expense related to these plans using actuarially determined amounts that are calculated under the provisions of ASC 715, “Compensation—Retirement Benefits.” Key assumptions used in the actuarial valuations include the discount rate, the expected rate of return on plan assets and the rate of increase in future compensation levels.

Stock-Based Compensation

Stock-Based Compensation

The Company has several stock award plans, which are described in detail in Note 18. The Company accounts for stock-based compensation under ASC 718, “Compensation—Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.

Store Pre-opening Expenses

Store Pre-opening Expenses

Costs incurred prior to the opening of a new or relocated store, associated with a remodeled store or related to the opening of a distribution facility are charged to operations as incurred.

Litigation Reserves

Litigation Reserves

The Company is involved in litigation on an ongoing basis. The Company accrues its best estimate of the probable loss related to legal claims. Such estimates are developed in consultation with in-house counsel, and are based upon a combination of litigation and settlement strategies.

Income Taxes

Income Taxes

Deferred income taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities. Deferred income tax expense (benefit) represents the change during the reporting period in the deferred tax assets and deferred tax liabilities, net of the effect of acquisitions and dispositions. Deferred tax assets include tax loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.

The Company has net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate a significant deferred tax asset. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies.

The Company recognizes tax liabilities in accordance with ASC 740, “Income Taxes” and the Company adjusts these liabilities with changes in judgment as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the tax liabilities.

Sales Tax Collected

Sales Tax Collected

Sales taxes collected from customers and remitted to various governmental agencies are presented on a net basis (excluded from revenues) in the Company’s statement of operations.

Use of Estimates

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Significant Concentrations

Significant Concentrations

Retail Pharmacy Segment

The Company’s pharmacy sales were primarily to customers covered by health plan contracts, which typically contract with a third-party payor that agrees to pay for all or a portion of a customer’s eligible prescription purchases. During fiscal 2023, the top five third-party payors accounted for approximately 83.4% of the Company’s pharmacy sales. The largest third-party payor, Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. Third-party payors are entities such as an insurance company, governmental agency, health maintenance organization or other managed care provider, and typically represent several health care contracts and customers.

During fiscal 2023, state sponsored Medicaid agencies and related managed care Medicaid payors accounted for approximately 19.9% of the Company’s pharmacy sales, the largest of which was approximately 6.6% of the Company’s pharmacy sales. During fiscal 2023, approximately 38.8% of the Company’s pharmacy sales were to customers covered by Medicare Part D. Any significant loss of third-party payor business could have a material adverse effect on the Company’s business and results of operations.

During fiscal 2023, the Company purchased brand and generic pharmaceuticals, which amounted to approximately 98% of the dollar volume of its prescription drugs from McKesson Corporation (“McKesson”) under its expanded agreement executed on February 17, 2014 and amended in fiscal 2019 for its pharmaceutical purchasing and distribution whereby McKesson assumed responsibility for purchasing essentially all of the brand and generic medications the Company dispenses as well as providing a new direct store delivery model to all of the Company’s stores. If the Company’s relationship with McKesson was disrupted, it could temporarily have difficulty filling

prescriptions for brand-named and generic drugs until it executed a replacement wholesaler agreement or developed and implemented self-distribution processes.

Pharmacy Services Segment

The Company’s Pharmacy Services Segment revenue is currently generated from a limited number of customers. During fiscal 2023, its top five customers accounted for 65.9% of its Pharmacy Services Segment revenue, which includes 6.9% related to a client which termed on January 1, 2023. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. Pharmacy Services Segment customers are entities such as employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of health benefit plans, and individuals throughout the United States.

The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a PDP. During fiscal 2023, fiscal 2022 and fiscal 2021, net revenues of $529,025 (2.2% of consolidated revenues), $589,620 (2.4% of consolidated revenues) and $630,104 (2.6% of consolidated revenues), respectively, include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS.

Derivatives

Derivatives

The Company may enter into interest rate swap agreements to hedge the exposure to increasing rates with respect to its variable rate debt, when the Company deems it prudent to do so. Upon inception of interest rate swap or cap agreements, or modifications thereto, the Company performs a comprehensive review of the interest rate swap agreements based on the criteria as provided by ASC 815, “Derivatives and Hedging.”

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another rate affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of Interbank Offered Rates (“IBORs”) and, particularly, the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to the above ASU to clarify certain optional expedients and exceptions in Topic 848. The Company adopted ASU 2020-04 effective December 1, 2022 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation, the recognition of deferred tax liabilities and the methodology for calculating income taxes in the interim period. The amendments also improve consistent application of and simplify

GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020 (fiscal 2022). The Company adopted ASU 2019-12 effective February 28, 2021 and the adoption of this standard did not have a material impact on the Company’s financial position.

In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement benefits (Topic 715-20). This ASU amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. This ASU is effective for fiscal years ending after December 15, 2020 and must be applied on a retrospective basis. The Company adopted ASU 2018-14 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which is intended to provide entities with additional guidance to determine which software implementation costs to capitalize and which costs to expense. The ASU will allow entities to capitalize costs for implementation activities during the application development stage. ASU No. 2018-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2019 (fiscal 2021). Early adoption of ASU 2018-15 is permitted. The Company adopted ASU 2018-15 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model), that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity will recognize, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses. ASU 2016-13 impacts non-banks as most non-banks have financial instruments or other assets (e.g., trade, contract and lease receivables, financial guarantees, loans and loan commitments and held-to-maturity debt securities). The Company adopted ASU 2016-13 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.

XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 04, 2023
Summary of Significant Accounting Policies  
Schedule of revenues

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Retail Pharmacy Segment:

Pharmacy sales

    

$

12,582,593

    

$

12,152,491

    

$

10,915,442

Front-end sales

 

5,078,820

 

5,218,182

 

5,322,943

Other revenue

 

123,654

 

124,143

 

126,875

Total Retail Pharmacy Segment

17,785,067

17,494,816

16,365,260

Pharmacy Services Segment revenue

6,522,299

7,323,125

7,970,137

Intersegment elimination

(215,467)

(249,686)

(292,157)

Total revenue

$

24,091,899

$

24,568,255

$

24,043,240

Schedule of principal classes of products

Percentage

 

Product Class

    

of Sales

Prescription drugs

 

71.2

%

Over-the-counter medications and personal care

 

10.9

%

Health and beauty aids

 

4.3

%

General merchandise and other

 

13.6

%

Schedule of disaggregation of revenue

March 4,

    

2023

In thousands

(53 Weeks)

    

Retail Pharmacy Segment:

  

 

Pharmacy sales

$

12,582,593

Front-end sales

 

5,078,820

Other revenue

 

123,654

Total Retail Pharmacy Segment

17,785,067

Pharmacy Services Segment

 

6,522,299

Intersegment elimination

 

(215,467)

Total revenue

$

24,091,899

XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition (Tables)
12 Months Ended
Mar. 04, 2023
Acquisition  
Schedule of purchase price allocation

Final purchase price

Cash consideration

$

89,724

Total

 

89,724

Final purchase price allocation

Cash and cash equivalents

$

3,494

Accounts receivable

 

23,860

Inventories

67,745

Prepaid expenses and other current assets

1,857

Total current assets

96,956

Property and equipment

28,229

Operating lease right-of-use assets

143,651

Intangible assets(1)

68,700

Other assets

1,805

Total assets acquired

339,341

Accounts payable

24,166

Accrued salaries, wages and other current liabilities

20,335

Current portion of operating lease liabilities

24,617

Total current liabilities

69,118

Long-term operating lease liabilities

124,023

Other long-term liabilities

166

Total liabilities assumed

193,307

Deferred tax liabilities recorded on purchase

13,951

Net assets acquired

132,083

Bargain purchase gain

(42,359)

Total purchase price

$

89,724

(1)            Intangible assets are recorded at estimated fair value, as determined by management based on available information which includes a final valuation prepared by an independent third-party. The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty and the multi-period excess earnings methods. The major assumptions used in arriving at the estimated identifiable intangible asset values included management’s final estimates of future cash flows, discounted at an appropriate rate of return which are based on the weighted average cost of capital for both the Company and other market participants, projected customer attrition rates, as well as applicable royalty rates for comparable assets. The useful lives for intangible assets were determined based upon the remaining useful economic lives of the intangible assets that are expected to contribute directly or indirectly to future cash flows. The estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation include:

Schedule of estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation

Estimated Fair Value

Estimated Useful Life
(In Years)

Prescription files

$

54,300

10

Tradename

 

14,400

Indefinite

Total

$

68,700

Schedule of unaudited pro forma combined financial data

March 4,

February 26,

February 27,

2023

2022

2021

    

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Pro forma

Pro forma

Pro forma

Net revenues as reported

$

24,091,899

$

24,568,255

$

24,043,240

Supplemental Pro forma revenues

$

24,091,899

$

24,568,255

$

24,468,777

Net loss as reported

$

(719,188)

$

(522,372)

$

(90,220)

Supplemental Pro forma net loss

$

(719,188)

$

(522,372)

$

(116,040)

XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Restructuring (Tables)
12 Months Ended
Mar. 04, 2023
Restructuring  
Schedule of restructuring-related costs

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

15,342

 

$

4,088

 

$

19,430

Professional and other fees relating to restructuring activities(c)

 

71,142

 

18,054

 

89,196

Total restructuring-related costs

 

$

86,484

 

$

22,142

 

$

108,626

Retail Pharmacy

Pharmacy

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

$

 

$

2,502

 

$

2,502

Professional and other fees relating to restructuring activities(c)

 

12,237

 

20,382

 

32,619

Total restructuring-related costs

$

12,237

 

$

22,884

 

$

35,121

Retail Pharmacy

Pharmacy

    

 Segment

    

Services Segment

    

Total

Restructuring-related costs

Severance and related costs associated with ongoing reorganization efforts(a)

 

$

13,443

 

$

4,353

 

$

17,796

Non-executive retention costs associated with the March 2019 reorganization(b)

 

1,136

 

(124)

 

1,012

Professional and other fees relating to restructuring activities(c)

 

40,053

 

4,752

 

44,805

SKU optimization charges(d)

20,939

20,939

Total restructuring-related costs

 

$

75,571

 

$

8,981

 

$

84,552

Schedule of restructuring-related liabilities

Severance and related

Professional and

    

costs (a)

    

other fees (c)

    

Total

Balance as of February 26, 2022

$

4,257

 

$

4,463

 

$

8,720

Additions charged to expense 

 

11,904

10,742

 

22,646

Cash payments

 

(5,231)

(11,727)

 

(16,958)

Balance as of May 28, 2022

$

10,930

 

$

3,478

 

$

14,408

Additions charged to expense 

 

913

11,892

12,805

Cash payments

 

(2,782)

(10,066)

(12,848)

Balance as of August 27, 2022

$

9,061

$

5,304

$

14,365

Additions charged to expense 

4,800

21,700

26,500

Cash payments

(4,452)

(18,297)

(22,749)

Balance as of November 26, 2022

$

9,409

$

8,707

$

18,116

Additions charged to expense 

1,813

44,862

46,675

Cash payments

(3,564)

(11,415)

(14,979)

Balance as of March 4, 2023

 

$

7,658

 

$

42,154

 

$

49,812

(a)– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.
(b)– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.
(c)– Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.
(d)– Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.2
Asset Sale to WBA (Tables)
12 Months Ended
Mar. 04, 2023
Asset Sale to WBA  
Schedule of assets and operating results of discontinued operations

The operating results of the discontinued operations that are reflected on the consolidated statements of operations within net income from discontinued operations are as follows:

    

March 4,

    

February 26,

    

February 27,

2023

2022

2021

(53 weeks)

(52 weeks)

(52 weeks)

Revenues

$

$

$

174

Costs and expenses:

 

 

 

Cost of revenues(a)

 

 

 

8

Selling, general and administrative expenses(a)

 

 

 

871

Interest expense(b)

 

 

 

Gain on sale of assets, net

 

 

 

(14,149)

 

 

 

(13,270)

Income from discontinued operations before income taxes

 

 

 

13,444

Income tax expense

 

 

 

4,283

Net income from discontinued operations, net of tax

$

$

$

9,161

(a)Cost of revenues and selling, general and administrative expenses for the discontinued operations excludes corporate overhead. These charges are reflected in continuing operations.
(b)In accordance with ASC 205-20, the operating results for the fifty-two week period ended February 27, 2021, for the discontinued operations include interest expense relating to the outstanding indebtedness repaid with the estimated excess proceeds from the Sale.
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2
Loss Per Share (Tables)
12 Months Ended
Mar. 04, 2023
Loss Per Share  
Schedule of calculation of basic and diluted loss per share

March 4,

February 26,

February 27,

2023

2022

2021

(53 Weeks)

(52 Weeks)

(52 Weeks)

Basic and diluted loss per share:

    

    

    

    

    

    

Numerator:

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Net income from discontinued operations

9,161

Loss attributable to common stockholders — basic and diluted

$

(719,188)

$

(522,372)

$

(90,220)

Denominator:

Basic and diluted weighted average shares

 

54,680

 

54,055

 

53,653

Basic and diluted loss per share:

Continuing operations

$

(13.15)

$

(9.66)

$

(1.86)

Discontinued operations

0.18

Net basic and diluted loss per share

$

(13.15)

$

(9.66)

$

(1.68)

XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges (Tables)
12 Months Ended
Mar. 04, 2023
Facility Exit and Impairment Charges  
Schedule of amounts relating to facility exit and impairment charges

March 4, 2023

February 26, 2022

February 27, 2021

(in thousands, except number of stores)

Number

    

Charge

    

Number

    

Charge

    

Number

    

Charge

Active stores:

Stores previously impaired(1)

44

$

4,866

118

$

12,339

174

$

21,372

New, relocated and remodeled stores(2)

8

 

4,640

1

 

538

2

 

1,519

Remaining stores not meeting the recoverability test(3)

12

 

4,038

88

 

43,305

19

 

6,854

Total impairment charges—active stores

64

 

13,544

207

 

56,182

195

 

29,745

Total impairment charges—closed facilities

194

123,531

147

94,606

33

16,542

Total impairment charges—all locations

258

$

137,075

354

$

150,788

228

$

46,287

(1)These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, the Company will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. The fiscal 2023 impairment charge includes $3,087 of impairment relating to the ROU and $1,779 of capital additions. The fiscal 2022 impairment charge includes $5,434 of impairment relating to the ROU and $6,905 of capital additions. The fiscal 2021 impairment charge includes $15,459 of impairment relating to the ROU and $5,913 of capital additions.
(2)These charges are related to new stores (open at least three years) and relocated stores (relocated in the last two years) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met their original return on investment projections and have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,875 of capital additions. The fiscal 2022 impairment charge includes $0 of impairment relating to the ROU and $538 of capital additions. The fiscal 2021 impairment charge includes $347 of impairment relating to the ROU and $1,172 of capital additions.
(3)These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least two years. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes $1,765 of impairment relating to the ROU and $2,273 of capital additions. The fiscal 2022 impairment charge includes $26,130 of impairment relating to the ROU and $17,175 of capital additions. The fiscal 2021 impairment charge includes $3,177 of impairment relating to the ROU and $3,677 of capital additions.
Schedule of fair value of long-lived assets measured on non-recurring basis

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

March 4, 2023

Long-lived assets held for use

$

$

22,959

$

42,717

$

65,676

$

(132,243)

Long-lived assets held for sale

$

$

5,115

$

$

5,115

$

(4,832)

Total

$

$

28,074

$

42,717

$

70,791

$

(137,075)

Fair Values

Total

as of

Charges

    

Level 1

    

Level 2

    

Level 3

    

Impairment Date

    

February 26, 2022

Long-lived assets held for use

$

$

240,176

$

23,594

$

263,770

$

(150,064)

Long-lived assets held for sale

$

$

2,371

$

$

2,371

$

(724)

Total

$

$

242,547

$

23,594

$

266,141

$

(150,788)

Schedule of accrued facility exit charges

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Balance—beginning of period

$

1,892

$

2,754

$

2,253

Provision for facility exit charges

 

461

 

162

793

Changes in assumptions and other adjustments

Interest accretion

 

 

 

Cash payments

 

(125)

 

(1,024)

 

(292)

Balance—end of period

$

2,228

$

1,892

$

2,754

Schedule of revenue, operating expenses, and income before income taxes of stores

Year Ended

March 4,

February 26,

February 27,

    

2023

    

2022

    

2021

Revenues

$

178,030

$

586,056

$

639,471

Operating expenses

 

192,357

 

640,996

 

699,662

Gain from sale of assets

 

(46,125)

 

(13,670)

 

(7,954)

Other expenses

 

25,396

52,999

13,057

Income (loss) before income taxes

 

6,402

 

(94,269)

 

(65,294)

Included in these stores’ income (loss) before income taxes are:

Depreciation and amortization

 

934

 

3,499

 

4,535

Inventory liquidation charges

 

(6,369)

 

(1,646)

 

(1,528)

XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Tables)
12 Months Ended
Mar. 04, 2023
Income Taxes  
Schedule of provision for income tax expense (benefit) from continuing operations

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Current tax:

Federal

$

(6)

$

(6)

$

(6,758)

State

 

9,082

 

7,454

 

4,145

 

9,076

 

7,448

 

(2,613)

Deferred tax and other:

Federal

 

 

(1,301)

 

(12,649)

State

 

(15,543)

 

(9,927)

 

(4,895)

 

(15,543)

 

(11,228)

 

(17,544)

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

Schedule of reconciliation of the expected statutory federal tax and the total income tax expense (benefit) from continuing operations

Year Ended

March 4,

February 26,

February 27,

2023

2022

2021

    

(53 Weeks)

    

(52 Weeks)

    

(52 Weeks)

Federal statutory rate

$

(152,388)

$

(110,492)

$

(25,103)

Nondeductible expenses

 

556

398

588

State income taxes, net

 

271,306

(45,388)

10,042

Bargain purchase gain

1,123

(10,018)

Decrease of previously recorded liabilities

 

(18,689)

(3,798)

(2,273)

Nondeductible compensation

 

2,045

1,551

3,764

Qualified fringe disallowance

342

224

313

Nondeductible excise tax

 

1,296

Stock based compensation

2,213

198

2,806

Valuation allowance

 

(112,037)

152,785

(2,222)

Other

185

(381)

650

Total income tax benefit

$

(6,467)

$

(3,780)

$

(20,157)

Schedule of significant components of deferred tax assets and liabilities

    

2023

    

2022

Deferred tax assets:

Accounts receivable

$

26,769

$

22,958

Accrued expenses

 

143,207

 

95,421

Pension, retirement and other benefits

 

40,100

 

67,686

Long-lived assets

 

364,618

 

299,507

Operating lease liabilities

781,721

883,713

Credits

 

21,955

 

22,917

Net operating losses

 

1,200,516

 

1,487,639

Other

 

271

 

225

Total gross deferred tax assets

 

2,579,157

 

2,880,066

Valuation allowance

 

(1,636,461)

 

(1,818,069)

Total deferred tax assets

 

942,696

 

1,061,997

Deferred tax liabilities:

Outside basis difference

5,622

5,682

Inventory

 

244,554

 

251,221

Operating lease right-of-use assets

680,152

785,023

Total gross deferred tax liabilities

 

930,328

 

1,041,926

Net deferred tax assets

$

12,368

$

20,071

Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits from continuing operations

    

2023

    

2022

    

2021

Unrecognized tax benefits

$

103,629

$

184,414

$

198,325

Increases to prior year tax positions

 

1

 

24

 

42

Decreases to tax positions in prior periods

 

(29,432)

 

(294)

 

(807)

Increases to current year tax positions

 

 

 

Settlements

 

 

 

Divestitures

Lapse of statute of limitations

 

(27,113)

 

(80,515)

 

(13,146)

Unrecognized tax benefits balance

$

47,085

$

103,629

$

184,414

XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.2
Property, Plant and Equipment (Tables)
12 Months Ended
Mar. 04, 2023
Property, Plant and Equipment  
Schedule of property, plant and equipment, including capital lease assets

    

2023

    

2022

Land

$

69,588

$

83,485

Buildings

 

208,681

 

314,143

Leasehold improvements

 

1,568,983

 

1,566,082

Equipment

 

1,855,083

 

1,794,937

Software

89,597

92,139

Construction in progress

 

109,690

 

97,715

 

3,901,622

 

3,948,501

Accumulated depreciation

 

(2,993,851)

 

(2,959,334)

Property, plant and equipment, net

$

907,771

$

989,167

XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Mar. 04, 2023
Goodwill and Other Intangible Assets  
Summary of the changes in the carrying amount of goodwill

    

Retail

    

Pharmacy

    

Pharmacy

Services

Total

Balance, February 27, 2021

 

$

43,492

$

1,064,644

$

1,108,136

Goodwill impairment

(229,000)

(229,000)

Balance, February 26, 2022

43,492

835,644

879,136

Goodwill impairment

(371,200)

(371,200)

Balance, March 4, 2023

$

43,492

$

464,444

$

507,936

Schedule of indefinite-lived intangible assets

March 4, 2023

February 26, 2022

Remaining

Remaining

Weighted

Weighted

Gross

Average

Gross

Average

Carrying

Accumulated

Amortization

Carrying

Accumulated

Amortization

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

$

201,919

$

(182,957)

$

18,962

3

years

$

197,651

$

(178,958)

$

18,693

3

years

Prescription files

 

1,029,665

(928,478)

101,187

 

5

years

 

1,030,169

 

(918,773)

111,396

 

6

years

Customer relationships(a)

388,000

(306,139)

81,861

9

years

388,000

(286,090)

101,910

10

years

CMS license

57,500

(23,798)

33,702

4

years

57,500

(15,372)

42,128

5

years

Claims adjudication and other developed software

58,985

(58,985)

0

years

58,985

(56,316)

2,669

1

years

Total finite

$

1,736,069

$

(1,500,357)

235,712

$

1,732,305

$

(1,455,509)

$

276,796

Trademarks

14,400

14,400

Indefinite

14,400

14,400

Indefinite

Total

$

1,750,469

$

(1,500,357)

$

250,112

$

1,746,705

$

(1,455,509)

$

291,196

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.
Schedule of finite-lived intangible assets

March 4, 2023

February 26, 2022

Remaining

Remaining

Weighted

Weighted

Gross

Average

Gross

Average

Carrying

Accumulated

Amortization

Carrying

Accumulated

Amortization

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

$

201,919

$

(182,957)

$

18,962

3

years

$

197,651

$

(178,958)

$

18,693

3

years

Prescription files

 

1,029,665

(928,478)

101,187

 

5

years

 

1,030,169

 

(918,773)

111,396

 

6

years

Customer relationships(a)

388,000

(306,139)

81,861

9

years

388,000

(286,090)

101,910

10

years

CMS license

57,500

(23,798)

33,702

4

years

57,500

(15,372)

42,128

5

years

Claims adjudication and other developed software

58,985

(58,985)

0

years

58,985

(56,316)

2,669

1

years

Total finite

$

1,736,069

$

(1,500,357)

235,712

$

1,732,305

$

(1,455,509)

$

276,796

Trademarks

14,400

14,400

Indefinite

14,400

14,400

Indefinite

Total

$

1,750,469

$

(1,500,357)

$

250,112

$

1,746,705

$

(1,455,509)

$

291,196

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.2
Accrued Salaries, Wages and Other Current Liabilities (Tables)
12 Months Ended
Mar. 04, 2023
Accrued Salaries, Wages and Other Current Liabilities  
Schedule of accrued salaries, wages and other current liabilities

    

2023

    

2022

Accrued wages, benefits and other personnel costs

$

190,664

$

291,004

Accrued interest

 

18,630

 

18,286

Accrued sales and other taxes payable

 

86,920

 

75,068

Accrued store expense

 

71,398

 

70,537

Accrued litigation, legal and professional fees

41,205

43,200

Accrued self-insurance

25,760

28,402

Other

 

275,314

 

250,062

$

709,891

$

776,559

XML 57 R47.htm IDEA: XBRL DOCUMENT v3.24.2
Indebtedness and Credit Agreement (Tables)
12 Months Ended
Mar. 04, 2023
Indebtedness and Credit Agreement  
Summary of indebtedness and lease financing obligations

March 4,

February 26,

    

2023

    

2022

Secured Debt:

Senior secured revolving credit facility due August 2026 ($1,200,000 and $709,000 face value less unamortized debt issuance costs of $16,117 and $18,010)

1,183,883

690,990

FILO Term Loan due August 2026 ($400,000 and $350,000 face value less unamortized debt issuance costs of $2,090 and $2,344)

397,910

347,656

 

1,581,793

 

1,038,646

Second Lien Secured Debt:

7.5% senior secured notes due July 2025 ($320,002 and $600,000 face value less unamortized debt issuance costs of $2,529 and $6,824)

 

317,473

 

593,176

8.0% senior secured notes due November 2026 ($849,918 face value less unamortized debt issuance costs of $11,259 and $14,397)

838,659

835,521

1,156,132

1,428,697

Unguaranteed Unsecured Debt:

7.7% notes due February 2027 ($185,691 and $237,386 face value less unamortized debt issuance costs of $398 and $642)

 

185,293

 

236,744

6.875% fixed-rate senior notes due December 2028 ($2,046 and $29,001 face value less unamortized debt issuance costs of $6 and $102)

 

2,040

 

28,899

 

187,333

 

265,643

Lease financing obligations

 

18,912

 

20,374

Total debt

 

2,944,170

 

2,753,360

Current maturities of long-term debt and lease financing obligations

 

(6,332)

 

(5,544)

Long-term debt and lease financing obligations, less current maturities

$

2,937,838

$

2,747,816

XML 58 R48.htm IDEA: XBRL DOCUMENT v3.24.2
Leases (Tables)
12 Months Ended
Mar. 04, 2023
Leases  
Schedule of components of net lease cost

Year Ended

March 4, 2023

    

February 26, 2022

    

February 27, 2021

Operating lease cost

 

$

641,394

$

669,421

$

651,261

Financing lease cost:

Amortization of right-of-use asset

 

3,471

3,638

4,359

Interest on long-term finance lease liabilities

 

1,968

2,167

2,505

Total finance lease costs

 

$

5,439

$

5,805

$

6,864

Short-term lease costs

 

3,126

3,180

3,214

Variable lease costs

 

178,263

175,697

172,088

Less: sublease income

 

(12,871)

(13,510)

(14,886)

Net lease cost

 

$

815,351

$

840,593

$

818,541

Schedule of supplemental cash flow information related to leases

Year Ended

    

March 4, 2023

    

February 26, 2022

 

February 27, 2021

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows paid for operating leases

 

$

706,506

 

$

703,326

 

$

683,226

Operating cash flows paid for interest portion of finance leases

 

1,968

 

2,167

 

2,505

Financing cash flows paid for principal portion of finance leases

 

4,019

 

4,117

 

4,744

Right-of-use assets obtained in exchange for lease obligations:

Operating leases

 

264,507

 

350,132

 

513,215

Finance leases

 

 

 

Schedule of supplemental balance sheet information related to leases

March 4,

 

February 26,

 

    

2023

 

2022

 

Operating leases:

Operating lease right-of-use asset

 

$

2,497,206

$

2,813,535

Short-term operating lease liabilities

 

$

502,403

$

575,651

Long-term operating lease liabilities

 

2,372,943

 

2,597,090

Total operating lease liabilities

 

$

2,875,346

$

3,172,741

Finance leases:

Property, plant and equipment, net

 

$

13,576

$

13,950

Current maturities of long-term debt and lease financing obligations

 

$

6,332

$

5,544

Lease financing obligations, less current maturities

 

12,580

 

14,830

Total finance lease liabilities

 

$

18,912

$

20,374

Weighted average remaining lease term

Operating leases

 

7.5

 

7.7

Finance leases

 

8.0

 

8.7

Weighted average discount rate

Operating leases

 

6.5

%

 

6.0

%

Finance leases

 

9.0

%

 

10.0

%

Schedule of minimum lease payments, financing leases

March 4, 2023

Finance

Operating

Fiscal year

    

Leases

    

 Leases(1)

    

Total

2024

 

$

3,188

 

$

677,631

 

$

680,819

2025

 

7,732

 

593,857

 

601,589

2026

 

2,421

 

507,388

 

509,809

2027

 

1,567

 

426,503

 

428,070

2028

 

1,500

 

351,942

 

353,442

Thereafter

 

10,923

 

1,148,719

 

1,159,642

Total lease payments

 

27,331

 

3,706,040

 

3,733,371

Less: imputed interest

 

(8,419)

 

(830,694)

 

(839,113)

Total lease liabilities

 

$

18,912

 

$

2,875,346

 

$

2,894,258

Schedule of minimum lease payments, operating leases

March 4, 2023

Finance

Operating

Fiscal year

    

Leases

    

 Leases(1)

    

Total

2024

 

$

3,188

 

$

677,631

 

$

680,819

2025

 

7,732

 

593,857

 

601,589

2026

 

2,421

 

507,388

 

509,809

2027

 

1,567

 

426,503

 

428,070

2028

 

1,500

 

351,942

 

353,442

Thereafter

 

10,923

 

1,148,719

 

1,159,642

Total lease payments

 

27,331

 

3,706,040

 

3,733,371

Less: imputed interest

 

(8,419)

 

(830,694)

 

(839,113)

Total lease liabilities

 

$

18,912

 

$

2,875,346

 

$

2,894,258

(1)Future operating lease payments have not been reduced by minimum sublease rentals of $24.0 million due in the future under noncancelable leases.
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.24.2
Stock Option and Stock Award Plans (Tables)
12 Months Ended
Mar. 04, 2023
Stock Options and Stock Awards  
Schedule of stock option transactions

    

    

Weighted

    

Weighted

    

Average

Average

Exercise

Remaining

Aggregate

Price

Contractual

Intrinsic

Shares

Per Share

Term

Value

Outstanding as of February 29, 2020

 

1,295

$

30.29

Granted

 

 

N/A

Exercised

 

(2)

 

25.08

Canceled

 

(513)

 

48.16

Outstanding as of February 27, 2021

 

780

$

18.56

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(79)

 

45.78

Outstanding as of February 26, 2022

 

701

$

15.50

Granted

 

 

N/A

Exercised

 

 

N/A

Canceled

 

(169)

 

23.85

Outstanding as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Vested or expected to vest as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Exercisable as of March 4, 2023

 

532

$

12.85

 

0.15

$

0.00

Schedule of restricted stock transactions

    

    

Weighted

Average

Grant Date

Shares

Fair Value

Balance as of February 29, 2020

 

1,253

$

10.32

Granted

 

780

 

17.79

Vested

 

(574)

 

13.37

Canceled

 

(166)

 

12.23

Balance as of February 27, 2021

 

1,293

$

13.23

Granted

 

973

 

15.00

Vested

 

(546)

 

12.25

Canceled

 

(187)

 

15.51

Balance as of February 26, 2022

 

1,533

$

14.42

Granted

 

1,662

 

6.50

Vested

 

(1,349)

 

12.40

Canceled

 

(370)

 

10.83

Balance as of March 4, 2023

 

1,476

$

8.25

XML 60 R50.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans (Tables)
12 Months Ended
Mar. 04, 2023
Retirement Plans  
Summary of net periodic pension expense for the defined benefit plans

Defined Benefit Pension Plan

    

2023

    

2022

    

2021

Service cost

$

336

$

425

$

486

Interest cost

 

5,036

 

4,861

 

4,753

Expected return on plan assets

 

(4,998)

 

(5,194)

 

(4,614)

Amortization of unrecognized net loss

 

 

344

 

3,749

Net periodic pension expense

$

374

$

436

$

4,374

Other changes recognized in other comprehensive loss:

Unrecognized net gain arising during period

$

(585)

$

(8,246)

$

(20,633)

Amortization of unrecognized net (loss) gain

 

 

(344)

 

(3,749)

Net amount recognized in other comprehensive loss

 

(585)

 

(8,590)

 

(24,382)

Net amount recognized in pension expense and other comprehensive loss

$

(211)

$

(8,154)

$

(20,008)

Schedule of reconciliation for both benefit obligation and plan assets of defined benefit plans, as well as funded status and amounts recognized in balance sheet

Defined Benefit

Pension Plan

    

2023

    

2022

Change in benefit obligations:

    

    

Benefit obligation at end of prior year

$

160,133

$

168,872

Service cost

 

336

 

425

Interest cost

 

5,036

 

4,861

Distributions

 

(8,328)

 

(8,582)

Actuarial gain

 

(26,014)

 

(5,443)

Benefit obligation at end of year

$

131,163

$

160,133

Change in plan assets:

Fair value of plan assets at beginning of year

$

149,527

$

148,412

Employer contributions

 

 

1,700

Actual return on plan assets

 

(20,430)

 

7,997

Distributions (including expenses paid by the plan)

 

(8,328)

 

(8,582)

Fair value of plan assets at end of year

$

120,769

$

149,527

Funded status

$

(10,394)

$

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in consolidated balance sheets consisted of:

Accrued pension liability

 

(10,394)

 

(10,606)

Net amount recognized

$

(10,394)

$

(10,606)

Amounts recognized in accumulated other comprehensive loss consist of:

Net actuarial loss

$

11,202

$

(11,787)

Amount recognized

$

11,202

$

(11,787)

Schedule of accumulated benefit obligation and fair value of plan assets

Defined Benefit

Pension Plan

2023

    

2022

Accumulated Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

Schedule of projected benefit obligation and fair value of plan assets

Defined Benefit

Pension Plan

2023

    

2022

Projected Benefit Obligations

$

131,163

$

160,133

Fair Value of Plan Assets

$

120,769

$

149,527

Schedules of assumptions used for benefit obligation and cost

Defined Benefit

Pension Plan

    

2023

    

2022

    

2021

Discount rate

    

5.00

%  

3.25

%  

3.00

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

6.50

%  

5.00

%  

5.50

%

Defined Benefit

Pension Plan

    

2023

2022

2021

Discount rate

3.25

%   

3.00

%   

2.75

%

Rate of increase in future compensation levels

 

N/A

N/A

N/A

Expected long-term rate of return on plan assets

 

5.00

%  

5.50

%  

6.00

%

Schedule of pension plan asset allocation percentages

    

March 4,

    

February 26,

 

2023

2022

 

Equity securities

 

30

%  

30

%

Fixed income securities

 

59

%  

57

%

Other

11

%  

13

%

Total

 

100

%  

100

%

Schedule of target allocation of plan assets

    

Target

 

Category

Allocation

    

Equity securities

 

30

%

Fixed income securities

 

62

%

Other

8

%

Total

 

100

%

Summary of the plan's investments measured at fair value on a recurring basis

Fair Value Measurements as of March 4, 2023

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

13,901

Large Cap

 

 

 

 

18,556

Small-Mid Cap

 

 

 

 

3,309

Fixed Income

Aon High Yield Plus Bond

72

Aon Multi-Asset Credit

4,775

Long-Term Credit Bond Index

 

 

 

 

41,360

Long-Term U.S. Government Bonds

1,588

20+ Year Treasury STRIPS

12,821

Intermediate Fixed Income

9,781

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

11

Aon Core Real Estate Fund

13,479

Short-Term Investments

 

 

1,111

 

 

1,111

Total

$

$

1,111

$

$

120,764

Fair Value Measurements as of February 26, 2022

Quoted Prices in

Active Markets

Significant

Significant

for Identical

Observable

Unobservable

    

Assets (Level 1)

    

Inputs (Level 2)

    

Inputs (Level 3)

    

Total

Equity Securities

International equity

$

$

$

$

17,783

Large Cap

 

 

 

 

23,027

Small-Mid Cap

 

 

 

 

4,213

Fixed Income

Aon High Yield Plus Bond

75

Aon Multi-Asset Credit

7,386

Long-Term Credit Bond Index

 

 

 

 

47,976

Long-Term U.S. Government Bonds

19,763

20+ Year Treasury STRIPS

483

Intermediate Fixed Income

8,554

AGT High Yield Bond

Other types of investments

Aon Global Real Estate

13

Aon Core Real Estate Fund

18,720

Short-Term Investments

 

 

1,532

 

 

1,532

Total

$

$

1,532

$

$

149,525

Schedule of future benefit payments expected to be paid

Defined Benefit

Fiscal Year

    

Pension Plan

2024

$

9,497

2025

 

9,379

2026

 

9,373

2027

 

9,410

2028

 

9,252

2029 - 2033

 

44,769

Total

$

91,680

XML 61 R51.htm IDEA: XBRL DOCUMENT v3.24.2
Multiemployer Plans that Provide Pension Benefits (Tables)
12 Months Ended
Mar. 04, 2023
Multiemployer Plans that Provide Pension Benefits  
Schedule of multiemployer defined benefit pension plans

Expiration

FIP/ RP

Date of

Pension Protection 

Status

Collective-

Minimum

EIN/Pension

Act Zone Status

Pending/

Contributions of the Company

Surcharge

Bargaining

Funding

Pension

    

Plan Number

    

2023

    

2022

    

Implemented

    

2023

    

2022

    

2021

    

Imposed

    

Agreement

    

Requirements

1199 SEIU Health Care Employees Pension Fund

13-3604862-001

Green—
12/31/2021

Green—
12/31/2020

No

$

7,493

$

9,242

$

9,613

No

4/18/2025

Contribution rate of 11.3% of gross wages per associate beginning 10/01/2021. Contribution rate of 12.6% of gross wages per associate beginning 09/30/2018.

 

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

51-6029925-001

 

Green—
12/31/2022

 

Red—
12/31/2021

 

No

 

8,131

 

8,989

 

8,239

 

No

 

7/20/2024

 

Beginning 01/01/2021, contributions of $1.844 per hour worked for pharmacists and $0.836 per hour worked for non-pharmacists. From 01/01/2020 through 12/31/2020 contributions of $1.758 per hour worked for pharmacists and $0.797 per hour worked for non-pharmacists.

 

 

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

94-2518312-001

 

Green—
12/31/2022

 

Green—
12/31/2021

 

No

 

2,605

 

3,224

 

2,319

 

No

 

7/13/2022

 

Effective 01/01/2020, contribution rate of $0.855 per hour worked for clerks and $1.239 per hour works for pharmacists. Effective 09/01/2014, contribution rate frozen at $0.55 per hour worked for associates.

 

 

United Food and Commercial Workers Union-Employer Pension Fund

 

34-6665155-001

 

Red—
9/30/2022

 

Red—
9/30/2021

 

Implemented

 

954

 

802

 

809

 

No

 

7/07/2024

 

Effective 02/06/2022, contribution rate of $2.57 per hour worked.
Effective 02/07/2021 contribution rate of $2.43 per hour worked.
Effective 02/02/2020 contribution rate of $2.30 per hour worked.

 

 

United Food and Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

 

51-6031766-001

 

Green—
9/30/2022

 

Green—
9/30/2021

 

No

 

434

 

370

 

399

 

No

 

7/07/2024

 

Effective 10/01/2022 contribution rate of $2.33 per hour worked.
Effective 10/01/2021 contribution rate of $2.24 per hour worked.
Effective 10/01/2020 contribution rate of $2.15 per hour worked.

 

 

Other Funds

 

2,046

 

1,887

 

1,573

$

21,663

$

24,514

$

22,952

Schedule of years in which contributions to plan that exceeded more than 5 percent of the total contributions

    

Year Contributions to Plan 

Exceeded More Than 5 % of

Total Contributions (as of

Pension Fund

 the Plan’s Year-End)

UFCW Pharmacists, Clerks and Drug Employers Pension Trust

 

12/31/2021 and 12/31/2020

Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund

 

12/31/2021 and 12/31/2020

United Food & Commercial Workers Union - Employer Pension Fund

 

9/30/2021 and 9/30/2020

United Food & Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund

9/30/2021 and 9/30/2020

XML 62 R52.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Reporting (Tables)
12 Months Ended
Mar. 04, 2023
Segment Reporting  
Schedule of balance sheet information for the Company's reportable segments

    

Retail

    

Pharmacy

    

    

Pharmacy

Services

Eliminations(1)

Consolidated

March 4, 2023:

Total Assets

$

5,487,845

$

2,049,107

$

(9,590)

$

7,527,362

Goodwill

 

43,492

464,444

 

 

507,936

February 26, 2022:

Total Assets

$

6,068,594

$

2,482,232

$

(21,823)

$

8,529,003

Goodwill

 

43,492

835,644

 

 

879,136

(1)As of March 4, 2023 and February 26, 2022, intersegment eliminations include intersegment accounts receivable of $9,590 and $21,823, respectively, that represent amounts owed from the Pharmacy Services Segment to the Retail Pharmacy Segment that are created when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products.

Schedule of reconciliation of the Company's business segments to the condensed consolidated financial statements

Retail

Pharmacy

Intersegment

    

Pharmacy

    

Services

    

Eliminations(1)

    

Consolidated

March 4, 2023:

Revenues

$

17,785,067

$

6,522,299

$

(215,467)

$

24,091,899

Gross Profit

 

4,394,850

 

409,090

 

 

4,803,940

Adjusted EBITDA(2)

 

288,077

 

141,103

 

 

429,180

Depreciation and amortization

229,380

47,203

276,583

LIFO charge

53,028

53,028

Stock-based compensation expense

10,604

933

11,537

Additions to property and equipment and intangible assets

226,563

21,122

247,685

February 26, 2022:

Revenues

$

17,494,816

$

7,323,125

$

(249,686)

$

24,568,255

Gross Profit

 

4,722,075

384,420

 

5,106,495

Adjusted EBITDA(2)

 

392,633

113,272

 

505,905

Depreciation and amortization

244,122

51,564

295,686

LIFO charge

1,314

1,314

Stock-based compensation expense

12,282

768

13,050

Additions to property and equipment and intangible assets

202,386

18,327

220,713

February 27, 2021:

 

 

Revenues

$

16,365,260

$

7,970,137

$

(292,157)

$

24,043,240

Gross Profit

 

4,255,791

448,531

 

4,704,322

Adjusted EBITDA(2)

 

279,896

157,769

 

437,665

Depreciation and amortization

269,985

57,139

327,124

LIFO credit

(51,692)

(51,692)

Stock-based compensation expense

11,594

1,409

13,003

Restructuring-related costs–SKU optimization charges

20,939

20,939

Additions to property and equipment and intangible assets

204,290

20,651

224,941

(1)Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.
(2)See the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.
Schedule of reconciliation of net loss to Adjusted EBITDA

    

March 4,

February 26,

February 27,

2023

    

2022

    

2021

(53 weeks)

(52 weeks)

(52 weeks)

Net loss from continuing operations

$

(719,188)

$

(522,372)

$

(99,381)

Interest expense

 

224,399

 

191,601

 

201,388

Income tax benefit

 

(6,467)

 

(3,780)

 

(20,157)

Depreciation and amortization

276,583

295,686

327,124

LIFO charge (credit)

 

53,028

 

1,314

 

(51,692)

Facility exit and impairment charges

 

180,637

 

164,084

 

57,714

Goodwill and intangible asset impairment charges

 

371,200

 

229,000

 

29,852

(Gain) loss on debt modifications and retirements, net

(80,142)

3,235

(5,274)

Merger and Acquisition-related costs

 

 

12,797

 

10,549

Stock-based compensation expense

11,537

13,050

13,003

Restructuring-related costs

108,626

35,121

84,552

Inventory write-downs related to store closings

14,270

5,298

3,709

Litigation and other contractual settlements

53,882

50,212

(Gain) loss on sale of assets, net

(68,586)

5,505

(69,300)

Loss (gain) on Bartell acquisition

5,346

(47,705)

Change in estimate related to manufacturer rebate receivables

15,068

Other

 

9,401

 

4,740

 

3,283

Adjusted EBITDA from continuing operations

$

429,180

$

505,905

$

437,665

XML 63 R53.htm IDEA: XBRL DOCUMENT v3.24.2
Supplementary Cash Flow Data (Tables)
12 Months Ended
Mar. 04, 2023
Supplementary Cash Flow Data  
Schedule of supplementary cash flow data

March 4,

February 26,

February 27,

2023

    

2022

    

2021

Cash paid for interest (a)

$

212,355

$

180,583

$

181,634

Cash (refunds) payments for income taxes, net(a)

$

(5,309)

$

6,233

$

7,535

Equipment financed under capital leases

$

3,334

$

1,698

$

1,849

Accrued capital expenditures

$

18,711

$

45,465

$

19,904

Gross borrowings from revolver(a)

$

3,510,000

$

5,131,000

$

7,912,000

Gross repayments to revolver(a)

$

3,019,000

$

5,272,000

$

7,712,000

(a)–Amounts are presented on a total company basis.

XML 64 R54.htm IDEA: XBRL DOCUMENT v3.24.2
Financial Instruments (Tables)
12 Months Ended
Mar. 04, 2023
Financial Instruments  
Schedule of carrying amounts and fair values of financial instruments

2023

2022

    

Carrying

    

Fair

    

Carrying

    

Fair

Amount

Value

Amount

Value

Variable rate indebtedness

$

1,581,793

$

1,600,000

$

1,038,646

$

1,059,000

Fixed rate indebtedness

$

1,343,465

$

768,328

$

1,694,340

$

1,602,122

XML 65 R55.htm IDEA: XBRL DOCUMENT v3.24.2
Revision of Previously Issued Consolidated Financial Statements (Tables)
12 Months Ended
Mar. 04, 2023
Revision of Previously Issued Consolidated Financial Statements  
Summary of revisions to the previously reported financial statements

    

Previously 

    

    

As

(In 000’s, except per share amounts )

Reported

Adjustment

 Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

724,529

$

(14,638)

$

709,891

Total current liabilities

 

2,727,875

 

(14,638)

 

2,713,237

Other noncurrent liabilities

 

130,482

 

(32,905)

 

97,577

Total liabilities

 

8,169,138

 

(47,543)

 

8,121,595

Accumulated deficit

 

(6,601,517)

 

(47,543)

 

(6,553,974)

Total stockholders’ (deficit) equity

 

(641,776)

 

(47,543)

 

(594,233)

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

211,385

$

(30,748)

$

180,637

Loss from continuing operations before income taxes

 

(756,403)

 

30,748

 

(725,655)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Net loss

 

(749,936)

 

30,748

 

(719,188)

Comprehensive loss

 

(749,351)

 

30,748

 

(718,603)

Basic and diluted loss per share from continuing operations

 

(13.71)

 

0.56

 

(13.15)

Net basic and diluted loss per share

 

(13.71)

 

0.56

 

(13.15)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(749,936)

$

30,748

$

(719,188)

Net loss from continuing operations

 

(749,936)

 

30,748

 

(719,188)

Facility exit and impairment charges

 

211,385

 

(30,748)

 

180,637

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

780,632

$

(4,073)

$

776,559

Total current liabilities

 

2,933,088

 

(4,073)

 

2,929,015

Other noncurrent liabilities

 

151,976

 

(12,722)

 

139,254

Total liabilities

 

8,429,970

 

(16,795)

 

8,413,175

Accumulated deficit

 

(5,851,581)

 

16,795

 

(5,834,786)

Total stockholders’ (deficit) equity

 

99,033

 

16,795

 

115,828

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

180,190

$

(16,106)

$

164,084

Loss from continuing operations before income taxes

 

(542,258)

 

16,106

 

(526,152)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Net loss

 

(538,478)

 

16,106

 

(522,372)

Comprehensive loss

 

(529,861)

 

16,106

 

(513,755)

Basic and diluted loss per share from continuing operations

 

(9.96)

 

0.30

 

(9.66)

Net basic and diluted loss per share

 

(9.96)

 

0.30

 

(9.66)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(538,478)

$

16,106

$

(522,372)

Net loss from continuing operations

 

(538,478)

 

16,106

 

(522,372)

Facility exit and impairment charges

 

180,190

 

(16,106)

 

164,084

    

Previously

    

    

As

(In 000’s, except per share amounts)

Reported

Adjustment

Revised

Balance Sheet:

 

  

 

  

 

  

Accrued salaries, wages, and other current liabilities

$

642,364

$

854

$

643,218

Total current liabilities

 

2,602,946

 

854

 

2,603,800

Other noncurrent liabilities

 

208,213

 

(1,543)

 

206,670

Total liabilities

 

8,720,250

 

(689)

 

8,719,561

Accumulated deficit

 

(5,313,103)

 

689

 

(5,312,414)

Total stockholders’ (deficit) equity

 

615,154

 

689

 

615,843

Statements of Operations and Comprehensive Loss:

 

  

 

  

 

  

Facility exit and impairment charges

$

58,403

$

(689)

$

57,714

Loss from continuing operations before income taxes

 

(120,227)

 

689

 

(119,538)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Net loss

 

(90,909)

 

689

 

(90,220)

Comprehensive loss

 

(66,065)

 

689

 

(65,376)

Basic and diluted loss per share from continuing operations

 

(1.87)

 

0.01

 

(1.86)

Net basic and diluted loss per share

 

(1.69)

 

0.01

 

(1.68)

Statement of Cash Flows:

 

  

 

  

 

  

Net loss

$

(90,909)

$

689

$

(90,220)

Net loss from continuing operations

 

(100,070)

 

689

 

(99,381)

Facility exit and impairment charges

 

58,403

 

(689)

 

57,714

XML 66 R56.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2018
USD ($)
store
May 29, 2021
USD ($)
Mar. 04, 2023
USD ($)
store
item
segment
Sep. 18, 2017
USD ($)
store
item
Jun. 28, 2017
item
Description of Business          
Number of reportable segments | segment     2    
Number of stores     2,309    
Assets held for sale | Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]          
Description of Business          
Number of stores       1,932  
Number of distribution centers | item       3 3
Purchase price per agreement | $       $ 4,375,000  
Discontinued Operations, Disposed of by Sale [Member] | Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]          
Description of Business          
Number of stores 1,932   1,932    
Number of distribution centers | item     3    
Proceeds from assets sold | $ $ 4,156,686 $ 94,289 $ 4,375,000    
Walgreens | Walgreens Boots Alliance WBA [Member]          
Description of Business          
Ownership interest (as a percent)       100.00%  
Rite Aid Lease Management Company          
Description of Business          
Ownership interest (as a percent)     100.00%    
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - Sales (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Product Class      
Revenues $ 24,091,899 $ 24,568,255 $ 24,043,240
Intersegment elimination      
Product Class      
Revenues (215,467) (249,686) (292,157)
Front end sales      
Product Class      
Revenues 5,078,820    
Retail Pharmacy Segment      
Product Class      
Other revenue 123,654 124,143 126,875
Revenues 17,785,067 17,494,816 16,365,260
Retail Pharmacy Segment | Pharmacy sales      
Product Class      
Revenues 12,582,593 12,152,491 10,915,442
Retail Pharmacy Segment | Front end sales      
Product Class      
Revenues $ 5,078,820 $ 5,218,182 $ 5,322,943
Retail Pharmacy Segment | Prescription drugs | Revenue from Contract with Customer, Segment Benchmark [Member] | Product Concentration Risk [Member]      
Product Class      
Percentage of sales 71.20% 70.00% 66.70%
Retail Pharmacy Segment | Over-the-counter medications and personal care | Revenue from Contract with Customer, Segment Benchmark [Member] | Product Concentration Risk [Member]      
Product Class      
Percentage of sales 10.90%    
Retail Pharmacy Segment | Health and beauty aids | Revenue from Contract with Customer, Segment Benchmark [Member] | Product Concentration Risk [Member]      
Product Class      
Percentage of sales 4.30%    
Retail Pharmacy Segment | General merchandise and other | Revenue from Contract with Customer, Segment Benchmark [Member] | Product Concentration Risk [Member]      
Product Class      
Percentage of sales 13.60%    
Pharmacy Services Segment      
Product Class      
Revenues $ 6,522,299 $ 7,323,125 $ 7,970,137
Pharmacy Services Segment | Pharmacy sales      
Product Class      
Revenues $ 12,582,593    
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - FY thru Revenues (Details)
12 Months Ended
Feb. 27, 2022
USD ($)
Point
Dec. 20, 2020
Mar. 04, 2023
USD ($)
Feb. 26, 2022
USD ($)
Feb. 27, 2021
USD ($)
Fiscal Year          
Length of reporting period     371 days 364 days 364 days
Deferred Financing Costs          
Amortization expenses of deferred financing costs     $ 9,993,000 $ 10,927,000 $ 11,201,000
Revenue Recognition          
Accrued contract liabilities     $ 2,030,000    
Noncompete agreements and other          
Intangible Assets          
Finite-lived intangible assets amortization period     3 years 3 years  
Prescription files          
Intangible Assets          
Estimated useful life, acquired intangible assets     10 years    
Amortization period of intangible assets     5 years    
Finite-lived intangible assets amortization period     5 years 6 years  
Customer relationships          
Intangible Assets          
Finite-lived intangible assets amortization period     9 years 10 years  
Customer relationships | Minimum          
Intangible Assets          
Estimated useful life, acquired intangible assets     10 years    
Customer relationships | Maximum          
Intangible Assets          
Estimated useful life, acquired intangible assets     20 years    
CMS license          
Intangible Assets          
Finite-lived intangible assets amortization period     4 years 5 years  
CMS license | Pharmacy Services Segment          
Intangible Assets          
Amortization period of intangible assets     12 years    
Finite-lived intangible assets amortization period     4 years    
Claims adjudication and other developed software          
Intangible Assets          
Finite-lived intangible assets amortization period     0 years 1 year  
Trademarks          
Intangible Assets          
Amortization period of intangible assets     10 years    
Buildings | Minimum          
Fiscal Year          
Useful life     30 years    
Buildings | Maximum          
Fiscal Year          
Useful life     45 years    
Equipment | Minimum          
Fiscal Year          
Useful life     3 years    
Equipment | Maximum          
Fiscal Year          
Useful life     15 years    
Internal-use software          
Fiscal Year          
Capitalized costs     $ 5,099,000 $ 13,388,000 $ 12,669,000
Wellness plus program          
Revenue Recognition          
Loyalty discount eligibility period   6 months      
Rite aid rewards program | Retail Pharmacy Segment          
Revenue Recognition          
Value of each reward point earned $ 0.002        
Minimum points required for conversion into rewards | Point 1,000        
Threshold period for expiry of unconverted points 90 days        
Threshold period for expiry of unredeemed rewards 30 days        
Accrued contract liabilities     $ 2,030,000 $ 0  
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details)
$ in Thousands
12 Months Ended
Mar. 04, 2023
USD ($)
item
Feb. 26, 2022
USD ($)
Feb. 27, 2021
USD ($)
Leases      
Maximum additional period for lease extension 5 years    
Number of fixed lease payment | item 1    
Advertising      
Advertising expenses, net of vendor advertising allowances $ 133,379 $ 146,085 $ 122,725
Insurance      
Self-insurance, minimum occurrence, workers' compensation 1,000    
Self-insurance, minimum occurrence, general liability $ 3,000    
Pharmacy Services Segment      
Vendor Rebates and Allowances and Purchase Discounts      
Period for rebates dispensed to manufacturers 30 days    
Rebates paid to clients, period in arrears 8 months    
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - Significant Concentrations (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Top five third party payors | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 83.40%    
Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Largest third party payor | Caremark | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 33.40% 32.10% 30.40%
Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Medicaid agencies and related managed care Medicaid payors | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 19.90%    
Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Largest Medicaid agency | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 6.60%    
Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Medicare PartD | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 38.80%    
Purchases | Suppliers | McKesson Corp. | Pharmacy sales      
Significant Concentrations      
Percentage of concentration risk 98.00%    
Pharmacy Services Segment | Medicare PartD      
Significant Concentrations      
Net revenues $ 529,025 $ 589,620 $ 630,104
Pharmacy Services Segment | Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Top Five Customers [Member]      
Significant Concentrations      
Percentage of concentration risk 65.90%    
Pharmacy Services Segment | Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Previously Disclosed Client Loss [Member]      
Significant Concentrations      
Percentage of concentration risk 6.90%    
Pharmacy Services Segment | Revenue from Contract with Customer, Segment Benchmark [Member] | Customers | Largest Payor [Member]      
Significant Concentrations      
Percentage of concentration risk 43.10% 41.10% 36.60%
Pharmacy Services Segment | Consolidated revenues | Customers | Medicare PartD      
Significant Concentrations      
Percentage of concentration risk 2.20% 2.40% 2.60%
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition (Details) - Bartell Drug Company
$ in Thousands
2 Months Ended
Dec. 18, 2020
USD ($)
store
Center
Feb. 27, 2021
USD ($)
Business Acquisition [Line Items]    
Cash consideration $ 89,724  
Number of stores acquired | store 67  
Number of distribution centers | Center 1  
Percentage of ownership in subsidiary 100.00%  
Revenues   $ 101,083
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition - Purchase price allocation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 18, 2020
Feb. 26, 2022
Feb. 27, 2021
Final purchase price allocation      
Business Combination, Bargain Purchase, Gain, Statement of Income or Comprehensive Income [Extensible Enumeration]     Gain (Loss) on Acquisition of Business
Bartell Drug Company      
Final purchase price      
Cash consideration $ 89,724    
Total purchase price 89,724    
Final purchase price allocation      
Cash and cash equivalents 3,494    
Accounts receivable 23,860    
Inventories 67,745    
Prepaid expenses and other current assets 1,857    
Total current assets 96,956    
Property and equipment 28,229    
Operating lease right-of-use assets 143,651    
Intangible assets 68,700    
Other assets 1,805    
Total assets acquired 339,341    
Accounts payable 24,166    
Accrued salaries, wages and other current liabilities 20,335    
Current portion of operating lease liabilities 24,617    
Total current liabilities 69,118    
Long-term operating lease liabilities 124,023    
Other long-term liabilities 166    
Total liabilities assumed 193,307    
Deferred tax liabilities recorded on purchase 13,951    
Net assets acquired 132,083    
Bargain purchase gain (42,359) $ (42,359) $ (47,705)
Total purchase price $ 89,724    
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition - Intangible assets acquired (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 18, 2020
Mar. 04, 2023
Prescription files    
Business Acquisition [Line Items]    
Estimated Useful Life   10 years
Bartell Drug Company    
Business Acquisition [Line Items]    
Intangible assets acquired $ 68,700  
Bartell Drug Company | Trademarks    
Business Acquisition [Line Items]    
Intangible assets acquired 14,400  
Bartell Drug Company | Prescription files    
Business Acquisition [Line Items]    
Intangible assets acquired $ 54,300  
Estimated Useful Life 10 years  
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition - Acquisition costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 18, 2020
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Business Acquisition [Line Items]        
Acquisition costs   $ 12,797 $ 10,549
Bartell Drug Company        
Business Acquisition [Line Items]        
Bargain purchase gain $ 42,359   42,359 47,705
Loss on Bartell acquisition     5,346  
Acquisition costs   $ 0 $ 12,797 $ 10,549
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisition - Proforma information (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Business Acquisition [Line Items]      
Net revenues as reported $ 24,091,899 $ 24,568,255 $ 24,043,240
Net loss (719,188) (522,372) (90,220)
Bartell Drug Company      
Business Acquisition [Line Items]      
Net revenues as reported 24,091,899 24,568,255 24,043,240
Supplemental Pro forma revenues 24,091,899 24,568,255 24,468,777
Net loss (719,188) (522,372) (90,220)
Supplemental Pro forma net loss $ (719,188) $ (522,372) $ (116,040)
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.24.2
Restructuring (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 04, 2023
Nov. 26, 2022
Aug. 27, 2022
May 28, 2022
May 30, 2020
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Restructuring related costs                
Total restructuring-related costs           $ 108,626 $ 35,121 $ 84,552
Impairment of intangible assets         $ 29,852      
Trademarks                
Restructuring related costs                
Impairment of intangible assets               29,852
Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs               63,613
Cost of revenues                
Restructuring related costs                
Total restructuring-related costs               20,939
Total restructuring-related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           108,626 35,121 84,552
Total restructuring-related costs | Accrued salaries, wages and other current liabilities                
Restructuring related costs                
Balance-beginning of period $ 18,116 $ 14,365 $ 14,408 $ 8,720   8,720    
Additions charged to expense 46,675 26,500 12,805 22,646        
Cash payments (14,979) (22,749) (12,848) (16,958)        
Balance-end of period 49,812 18,116 14,365 14,408   49,812 8,720  
Severance and related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           19,430 2,502 17,796
Severance and related costs | Accrued salaries, wages and other current liabilities                
Restructuring related costs                
Balance-beginning of period 9,409 9,061 10,930 4,257   4,257    
Additions charged to expense 1,813 4,800 913 11,904        
Cash payments (3,564) (4,452) (2,782) (5,231)        
Balance-end of period 7,658 9,409 9,061 10,930   7,658 4,257  
Non-executive retention costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs               1,012
Professional and other fees | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           89,196 32,619 44,805
Professional and other fees | Accrued salaries, wages and other current liabilities                
Restructuring related costs                
Balance-beginning of period 8,707 5,304 3,478 4,463   4,463    
Additions charged to expense 44,862 21,700 11,892 10,742        
Cash payments (11,415) (18,297) (10,066) (11,727)        
Balance-end of period $ 42,154 $ 8,707 $ 5,304 $ 3,478   42,154 4,463  
SKU Optimization Charges [Member]                
Restructuring related costs                
Total restructuring-related costs               20,939
SKU Optimization Charges [Member] | Cost of revenues                
Restructuring related costs                
Total restructuring-related costs               20,939
Retail Pharmacy Segment | Total restructuring-related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           86,484 12,237 75,571
Retail Pharmacy Segment | Severance and related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           15,342   13,443
Retail Pharmacy Segment | Non-executive retention costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs               1,136
Retail Pharmacy Segment | Professional and other fees | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           71,142 12,237 40,053
Retail Pharmacy Segment | SKU Optimization Charges [Member] | Cost of revenues                
Restructuring related costs                
Total restructuring-related costs               20,939
Pharmacy Services Segment | Total restructuring-related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           22,142 22,884 8,981
Pharmacy Services Segment | Severance and related costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           4,088 2,502 4,353
Pharmacy Services Segment | Non-executive retention costs | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs               (124)
Pharmacy Services Segment | Professional and other fees | Selling, general and administrative expenses                
Restructuring related costs                
Total restructuring-related costs           $ 18,054 $ 20,382 $ 4,752
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.24.2
Asset Sale to WBA (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2018
USD ($)
store
May 29, 2021
USD ($)
Mar. 04, 2023
USD ($)
store
item
Feb. 26, 2022
USD ($)
Feb. 27, 2021
USD ($)
Sep. 18, 2017
USD ($)
store
item
Jun. 28, 2017
item
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Number of stores | store     2,309        
Assets held for sale | Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Number of stores | store           1,932  
Number of distribution centers | item           3 3
Purchase price per agreement           $ 4,375,000  
Discontinued Operations, Disposed of by Sale [Member] | Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Number of stores | store 1,932   1,932        
Number of distribution centers | item     3        
Proceeds from assets sold $ 4,156,686 $ 94,289 $ 4,375,000        
Pre-tax gain on sale   $ 12,690          
Period of transition     3 years        
Payments for inventory and selling, general and administrative activities     $ 0 $ 0      
TSA fees     $ 0 $ 0 $ 1,467    
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.24.2
Asset Sale to WBA - Operating results of discontinued operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Costs and expenses:      
Net income from discontinued operations, net of tax     $ 9,161
Discontinued Operations, Disposed of by Sale [Member] | Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]      
Income statement disclosures      
Revenues 174
Costs and expenses:      
Cost of revenues    
Net credit to cost of revenues   8
Selling, general and administrative expenses 871
Interest expense
Gain on sale of assets, net (14,149)
Net expenses and non-operating income (13,270)
Income from discontinued operations before income taxes 13,444
Income tax (benefit) expense, discontinued operation 4,283
Net income from discontinued operations, net of tax $ 9,161
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.24.2
Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Numerator:      
Net loss from continuing operations - basic $ (719,188) $ (522,372) $ (99,381)
Loss from continuing operations attributable to common stockholders - diluted (719,188) (522,372) (99,381)
Income from discontinued operations attributable to common stockholders-basic 9,161
Income from discontinued operations attributable to common stockholders-diluted     9,161
Net loss attributable to common stockholders - basic (719,188) (522,372) (90,220)
Net loss attributable to common stockholders - diluted $ (719,188) $ (522,372) $ (90,220)
Denominator:      
Basic weighted average shares 54,680 54,055 53,653
Diluted weighted average shares 54,680 54,055 53,653
Basic loss per share:      
Continuing operations $ (13.15) $ (9.66) $ (1.86)
Discontinued operations 0.18
Net basic loss per share (13.15) (9.66) (1.68)
Diluted loss per share:      
Continuing operations (13.15) (9.66) (1.86)
Discontinued operations     0.18
Net diluted loss per share $ (13.15) $ (9.66) $ (1.68)
Incentive Stock options      
Antidilutive securities excluded from computation of income per share      
Shares excluded from the computation of diluted income (loss) per share 532 701 780
Unvested Restricted stock      
Antidilutive securities excluded from computation of income per share      
Shares excluded from the computation of diluted income (loss) per share 1,476 1,533 1,293
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges (Details)
$ in Thousands
12 Months Ended
Mar. 04, 2023
USD ($)
store
location
Feb. 26, 2022
USD ($)
store
Feb. 27, 2021
USD ($)
store
location
Lease termination and impairment charges      
Facility exit and impairment charges $ 180,637 $ 164,084 $ 57,714
Period considered for impairment of relocated stores 2 years    
Total number of impaired locations 258 354 228
Number of stores | store 2,309    
Operating lease right-of-use assets $ 2,497,206 $ 2,813,535  
Impairment charges 132,243 150,064  
Impairment charges, closed facilities $ 4,832 $ 724  
Active Stores [Member]      
Lease termination and impairment charges      
Total number of impaired locations | store 64 207 195
Number of stores | store 2,309    
Operating lease right-of-use assets $ 2,300,000    
Impairment charges 13,544 $ 56,182 $ 29,745
Carrying value of long-lived assets $ 717,200    
Retail Sites New, Relocated And Remodeled-Active Stores [Member]      
Lease termination and impairment charges      
Total number of impaired locations | store 8 1 2
ROU assets impairment $ 1,765 $ 0 $ 347
Capital asset impairment $ 2,875 538 1,172
Period considered for impairment of relocated stores 2 years    
Impairment charges $ 4,640 $ 538 $ 1,519
Retail Sites Previously Impaired-Active Stores [Member]      
Lease termination and impairment charges      
Total number of impaired locations | store 44 118 174
ROU assets impairment $ 3,087 $ 5,434 $ 15,459
Capital asset impairment 1,779 6,905 5,913
Impairment charges $ 4,866 $ 12,339 $ 21,372
Retail Sites In Closed Status [Member]      
Lease termination and impairment charges      
Total number of impaired locations | store 194 147 33
Impairment charges, closed facilities $ 123,531 $ 94,606 $ 16,542
Remaining Stores Not Meeting The Recoverability Test [Member]      
Lease termination and impairment charges      
Total number of impaired locations | store 12 88 19
ROU assets impairment $ 1,765 $ 26,130 $ 3,177
Capital asset impairment 2,273 17,175 3,677
Impairment charges $ 4,038 $ 43,305 $ 6,854
Minimum      
Lease termination and impairment charges      
Period considered for impairment of relocated stores 2 years    
Minimum | Retail Sites New, Relocated And Remodeled-Active Stores [Member]      
Lease termination and impairment charges      
Period considered for impairment of relocated stores 2 years    
Period considered for impairment of new stores 3 years    
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges - Fair value (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]            
Fair value of Long-lived assets held for use $ 65,676 $ 263,770   $ 65,676 $ 263,770  
Fair value of Long-lived assets held for sale 5,115 2,371   5,115 2,371  
Total 70,791 266,141   70,791 266,141  
Long-lived assets held, impairment charges       $ (132,243) $ (150,064)  
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]       Lease Termination And Long-Lived Asset Impairment Charges Lease Termination And Long-Lived Asset Impairment Charges  
Long-lived assets held for sale, impairment charges       $ (4,832) $ (724)  
Total (59,573) (99,416) $ (31,057) (137,075) (150,788) $ (46,287)
Nonrecurring basis | Level 1            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Fair value of Long-lived assets held for use    
Fair value of Long-lived assets held for sale    
Total    
Nonrecurring basis | Level 2            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Fair value of Long-lived assets held for use 22,959 240,176   22,959 240,176  
Fair value of Long-lived assets held for sale 5,115 2,371   5,115 2,371  
Total 28,074 242,547   28,074 242,547  
Nonrecurring basis | Level 3            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Fair value of Long-lived assets held for use 42,717 23,594   42,717 23,594  
Total $ 42,717 $ 23,594   $ 42,717 $ 23,594  
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Lease termination and impairment charges      
Facility exit charges $ 43,562 $ 13,296 $ 11,427
Facility Exit Charges      
Closed store liability      
Balance-beginning of period 1,892 2,754 2,253
Provision for facility exit charges 461 162 793
Cash payments (125) (1,024) (292)
Balance-end of period $ 2,228 $ 1,892 $ 2,754
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.24.2
Facility Exit and Impairment Charges - Results from closed stores (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Lease termination and impairment charges      
Income (loss) before income taxes $ (725,655) $ (526,152) $ (119,538)
Depreciation and amortization 276,583 295,686 327,124
Retail Sites In Closed Or Approved For Closure Status [Member]      
Lease termination and impairment charges      
Revenues 178,030 586,056 639,471
Operating expenses 192,357 640,996 699,662
Gain from sale of assets (46,125) (13,670) (7,954)
Other expenses 25,396 52,999 13,057
Income (loss) before income taxes 6,402 (94,269) (65,294)
Depreciation and amortization 934 3,499 4,535
Inventory liquidation charges $ (6,369) $ (1,646) $ (1,528)
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Other Financial Instruments    
Held to maturity investments $ 7,457 $ 7,406
Level 1    
Other Financial Instruments    
Carrying value of total long-term indebtedness 2,925,258 2,732,986
Estimated fair value of total long-term indebtedness $ 2,368,328 $ 2,661,122
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Current tax:      
Federal $ (6) $ (6) $ (6,758)
State 9,082 7,454 4,145
Total current tax expense (benefit) 9,076 7,448 (2,613)
Deferred tax and other:      
Federal   (1,301) (12,649)
State (15,543) (9,927) (4,895)
Total deferred tax expense (benefit) (15,543) (11,228) (17,544)
Total income tax (benefit) expense $ (6,467) $ (3,780) $ (20,157)
State | Minimum      
Income tax examination 3 years    
State | Maximum      
Income tax examination 5 years    
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes - Rate reconciliation (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Reconciliation of the expected statutory federal tax and the total income tax expense (benefit)      
Federal statutory rate $ (152,388) $ (110,492) $ (25,103)
Nondeductible expenses 556 398 588
State income taxes, net 271,306 (45,388) 10,042
Bargain purchase gain 1,123 (10,018)
Decrease of previously recorded liabilities (18,689) (3,798) (2,273)
Nondeductible compensation 2,045 1,551 3,764
Qualified fringe disallowance 342 224 313
Nondeductible excise tax 1,296
Stock based compensation 2,213 198 2,806
Valuation allowance (112,037) 152,785 (2,222)
Other 185 (381) 650
Total income tax (benefit) expense (6,467) $ (3,780) $ (20,157)
Income tax benefit offset amount $ 256,411    
Overall tax rate impact percent     8.40%
XML 87 R77.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Deferred tax assets:    
Accounts receivable $ 26,769 $ 22,958
Accrued expenses 143,207 95,421
Pension, retirement and other benefits 40,100 67,686
Long-lived assets 364,618 299,507
Operating lease liabilities 781,721 883,713
Credits 21,955 22,917
Net operating losses 1,200,516 1,487,639
Other 271 225
Total gross deferred tax assets 2,579,157 2,880,066
Valuation allowance (1,636,461) (1,818,069)
Total deferred tax assets 942,696 1,061,997
Deferred tax liabilities:    
Outside basis difference 5,622 5,682
Inventory 244,554 251,221
Operating lease right of use assets 680,152 785,023
Total gross deferred tax liabilities 930,328 1,041,926
Net deferred tax assets $ 12,368 $ 20,071
XML 88 R78.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes - Unrecognized Benefit (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Reconciliation of beginning and ending amount of unrecognized tax benefits      
Unrecognized tax benefits at beginning of the period $ 103,629 $ 184,414 $ 198,325
Increases to prior year tax positions 1 24 42
Decreases to tax positions in prior periods (29,432) (294) (807)
Lapse of statute of limitations (27,113) (80,515) (13,146)
Unrecognized tax benefits balance at end of the period 47,085 103,629 184,414
Unrecognized tax benefits which would impact effective tax rate, if recognized 1,498 $ 18,737 $ 20,923
Decrease in unrecognized tax benefits related to state exposures $ 4,001    
XML 89 R79.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes - Tax Contingencies (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Income Taxes      
Interest and penalties related to tax contingencies recognized as income tax expense / (benefit) $ (6,006) $ (183) $ (123)
Accrued income tax-related interest and penalties $ 490 $ 6,496  
XML 90 R80.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes - Net Operating Losses and Tax Credits (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Valuation Allowance    
Valuation allowance $ 1,636,461 $ 1,818,069
Federal    
Net Operating Losses and Tax Credits    
Net operating loss carryforwards 2,133,742  
Federal business tax credit carryforwards 11,363  
Federal | Tax Period Between Fiscal 2029 And 2031 [Member]    
Net Operating Losses and Tax Credits    
Net operating losses subject to expiration 884,668  
Federal | Tax Period Between Fiscal 2032 and 2038    
Net Operating Losses and Tax Credits    
Net operating losses subject to expiration 193,961  
State    
Net Operating Losses and Tax Credits    
Net operating loss carryforwards 12,279,752  
Net tax effect of state carryforwards $ 754,483  
XML 91 R81.htm IDEA: XBRL DOCUMENT v3.24.2
Accounts Receivable (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Accounts Receivable    
Allowance for uncollectible accounts $ 53,453 $ 28,069
XML 92 R82.htm IDEA: XBRL DOCUMENT v3.24.2
Medicare Part D (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Feb. 03, 2023
Oct. 13, 2022
Jan. 24, 2022
Aug. 12, 2021
Feb. 18, 2021
Nov. 12, 2020
Mar. 04, 2023
Nov. 26, 2022
Feb. 26, 2022
Aug. 28, 2021
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Dec. 31, 2022
Statutory Accounting Practices [Line Items]                            
Accounts receivable, net             $ 1,149,958   $ 1,343,496   $ 1,149,958 $ 1,343,496    
Medicare Part D                            
Remaining receivable for receivables sold to third party             22,362   34,898   22,362 34,898    
Loss on sale of receivable                   $ 13,713        
Loss (gain) on sale of assets, net                     (68,586) 5,505 $ (69,300)  
Goodwill, impairment charges                     371,200 229,000 $ 0  
November 2020 Receivable Purchase Agreement                            
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement           $ 464,019                
Sale price for receivables sold           444,812                
Receipts from sale of receivables           412,795                
Loss on sale of receivable           $ 19,207                
August 2021 Receivable Purchase Agreement                            
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement       $ 271,829                    
Sale price for receivables sold       258,116                    
Receipts from sale of receivables       $ 239,360                    
February 2021 Receivable Purchase Agreement                            
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement         $ 300,015                  
Sale price for receivables sold         290,613                  
Receipts from sale of receivables         269,912                  
Loss on sale of receivable         $ 9,403                  
October 2022 Receivable Purchase Agreement                            
Statutory Accounting Practices [Line Items]                            
Accounts receivable, net             13,488       13,488      
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement   $ 195,487                        
Sale price for receivables sold   180,405                        
Receipts from sale of receivables   $ 166,917                        
Loss on sale of receivable               $ 1,937            
Loss (gain) on sale of assets, net               $ 15,082            
January 2022 Receivable Purchase Agreement                            
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement     $ 400,680                      
Sale price for receivables sold     387,035                      
Receipts from sale of receivables     $ 359,388                      
Loss on sale of receivable                 13,645          
February 2023 Receivable Purchase Agreement                            
Statutory Accounting Practices [Line Items]                            
Accounts receivable, net             19,209       19,209      
Medicare Part D                            
Amount of receivables sold under Receivable Purchase Agreement $ 278,390                          
Sale price for receivables sold 261,771                          
Receipts from sale of receivables $ 242,562                          
Loss on sale of receivable             16,619              
Most Current Receivable Purchase Agreement                            
Medicare Part D                            
Loss on sale of receivable                     2,573      
EI (Elixir Insurance)                            
Statutory Accounting Practices [Line Items]                            
Minimum amount of capital and surplus required by regulatory requirements                           $ 10,693
Accounts receivable, net             $ 45,201   $ 63,203   $ 45,201 $ 63,203    
XML 93 R83.htm IDEA: XBRL DOCUMENT v3.24.2
Manufacturer Rebates Receivables (Details) - USD ($)
$ in Thousands
3 Months Ended
Feb. 26, 2022
Mar. 04, 2023
Manufacturer Rebates Receivables    
Allowance for uncollectible accounts $ 28,069 $ 53,453
Pharmacy Services Segment    
Manufacturer Rebates Receivables    
Manufacturer rebates receivables 535,620 357,699
Manufacturers Rebates Receivables | Pharmacy Services Segment    
Manufacturer Rebates Receivables    
Allowance for uncollectible accounts 18,796 $ 8,680
Increase in allowances for accounts receivable $ 15,068  
XML 94 R84.htm IDEA: XBRL DOCUMENT v3.24.2
Inventory (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Inventory      
Amount by which LIFO value is lower than FIFO value $ 539,932 $ 487,173  
LIFO charge (credit) 53,028 1,314 $ (51,692)
Amount of decrease in the cost of revenues due to the effect of LIFO inventory liquidation $ 31,857 $ 13,090 $ 26,861
XML 95 R85.htm IDEA: XBRL DOCUMENT v3.24.2
Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 3,901,622 $ 3,948,501  
Accumulated depreciation (2,993,851) (2,959,334)  
Property, plant and equipment, net 907,771 989,167  
Depreciation expense 202,559 217,639 $ 238,104
Carrying amount of assets to be disposed 3,972 1,463  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 69,588 83,485  
Buildings      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 208,681 314,143  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 1,568,983 1,566,082  
Equipment      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 1,855,083 1,794,937  
Software      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 89,597 92,139  
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 109,690 $ 97,715  
XML 96 R86.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 04, 2023
Aug. 27, 2022
May 30, 2020
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Goodwill, impairment charges       $ 371,200 $ 229,000 $ 0
Goodwill and intangible asset impairment charges       371,200 229,000 $ 29,852
Impairment of intangible assets     $ 29,852      
Pharmacy Services Segment            
Accumulated impairment losses $ 1,174,912     1,174,912 803,712  
Goodwill, impairment charges $ 119,000 $ 252,200   $ 371,200 $ 229,000  
XML 97 R87.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 04, 2023
Aug. 27, 2022
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Carrying amount of goodwill          
Beginning Balance     $ 879,136 $ 1,108,136  
Goodwill impairment     (371,200) (229,000) $ 0
Ending Balance $ 507,936   507,936 879,136 1,108,136
Retail Pharmacy Segment          
Carrying amount of goodwill          
Beginning Balance     43,492 43,492  
Goodwill impairment      
Ending Balance 43,492   43,492 43,492 43,492
Pharmacy Services Segment          
Carrying amount of goodwill          
Beginning Balance     835,644 1,064,644  
Goodwill impairment (119,000) $ (252,200) (371,200) (229,000)  
Ending Balance $ 464,444   $ 464,444 $ 835,644 $ 1,064,644
XML 98 R88.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets - Intangibles (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Feb. 25, 2022
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite $ 1,736,069 $ 1,732,305  
Total Accumulated Amortization, Finite (1,500,357) (1,455,509)  
Total Net, finite 235,712 276,796  
Gross Carrying Amount, Total 1,750,469 1,746,705  
Net, Total 250,112 291,196  
Trademarks      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Total Accumulated Amortization, Finite  
Gross Carrying Amount, Indefinite Lived 14,400 14,400  
Noncompete agreements and other      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite 201,919 197,651  
Total Accumulated Amortization, Finite (182,957) (178,958)  
Total Net, finite $ 18,962 $ 18,693  
Remaining Weighted Average Amortization Period 3 years 3 years  
Prescription files      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite $ 1,029,665 $ 1,030,169  
Total Accumulated Amortization, Finite (928,478) (918,773)  
Total Net, finite $ 101,187 $ 111,396  
Remaining Weighted Average Amortization Period 5 years 6 years  
Amortization period of intangible assets 5 years    
Customer relationships      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite $ 388,000 $ 388,000  
Total Accumulated Amortization, Finite (306,139) (286,090)  
Total Net, finite $ 81,861 $ 101,910  
Remaining Weighted Average Amortization Period 9 years 10 years  
CMS license      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite $ 57,500 $ 57,500  
Total Accumulated Amortization, Finite (23,798) (15,372)  
Total Net, finite $ 33,702 $ 42,128  
Remaining Weighted Average Amortization Period 4 years 5 years  
Claims adjudication and other developed software      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Gross Carrying Amount, Finite $ 58,985 $ 58,985  
Total Accumulated Amortization, Finite (58,985) (56,316)  
Total Net, finite $ 2,669  
Remaining Weighted Average Amortization Period 0 years 1 year  
Trademarks      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Amortization period of intangible assets 10 years    
EI (Elixir Insurance) | CMS license      
Finite Lived And Indefinite Lived Intangible Assets By Major Class      
Remaining Weighted Average Amortization Period   5 years 19 years
XML 99 R89.htm IDEA: XBRL DOCUMENT v3.24.2
Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Goodwill and Other Intangible Assets      
Amortization expense for intangible assets and liabilities $ 74,024 $ 78,047 $ 89,020
Anticipated annual amortization expense for intangible assets and liabilities      
2025 61,343    
2026 50,209    
2027 39,771    
2028 32,779    
2028 $ 25,299    
XML 100 R90.htm IDEA: XBRL DOCUMENT v3.24.2
Accrued Salaries, Wages and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Accrued Salaries, Wages and Other Current Liabilities      
Accrued wages, benefits and other personnel costs $ 190,664 $ 291,004  
Accrued interest 18,630 18,286  
Accrued sales and other taxes payable 86,920 75,068  
Accrued store expense 71,398 70,537  
Accrued litigation, legal and professional fees 41,205 43,200  
Accrued self insurance 25,760 28,402  
Other 275,314 250,062  
Accrued salaries, wages and other current liabilities $ 709,891 $ 776,559 $ 643,218
XML 101 R91.htm IDEA: XBRL DOCUMENT v3.24.2
Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Dec. 09, 2022
Nov. 30, 2022
Nov. 03, 2022
Jun. 29, 2022
Jun. 13, 2022
Feb. 26, 2022
May 28, 2021
Jul. 24, 2020
Jul. 10, 2020
Jul. 09, 2020
Jun. 25, 2020
Dec. 20, 2018
Indebtedness and credit agreements                          
Debt instrument, stated interest rate (as a percent)                   6.125%      
Lease financing obligations $ 18,912           $ 20,374            
Total debt 2,944,170           2,753,360            
Less: Current maturities of long-term debt and lease financing obligations (6,332)           (5,544)            
Long-term debt and lease financing obligations, less current maturities 2,937,838           2,747,816            
Less: Cash and cash equivalents (157,151)           (39,721)            
Senior Secured Debt                          
Indebtedness and credit agreements                          
Long-term debt $ 1,581,793           1,038,646            
6.125% senior notes due April 2023                          
Indebtedness and credit agreements                          
Debt instrument, stated interest rate (as a percent) 6.125%             6.125% 6.125%     6.125%  
Senior secured revolving credit facility due August 2026                          
Indebtedness and credit agreements                          
Long-term debt $ 1,183,883           690,990            
Principal 1,200,000           709,000            
Unamortized debt issuance costs 16,117           18,010            
FILO term loan due August 2026                          
Indebtedness and credit agreements                          
Long-term debt 397,910           347,656            
Principal 400,000           350,000            
Unamortized debt issuance costs 2,090           2,344            
Second Lien Secured Debt                          
Indebtedness and credit agreements                          
Long-term debt 1,156,132           1,428,697            
7.5% senior secured notes due July 2025                          
Indebtedness and credit agreements                          
Long-term debt $ 317,473           $ 593,176            
Debt instrument, stated interest rate (as a percent) 7.50% 7.50% 7.50% 7.50% 7.50% 7.50% 7.50%            
Principal $ 320,002           $ 600,000            
Unamortized debt issuance costs 2,529           6,824            
8.0% senior secured notes due November 2026                          
Indebtedness and credit agreements                          
Long-term debt $ 838,659           $ 835,521            
Debt instrument, stated interest rate (as a percent) 8.00%         8.00% 8.00%   8.00%   8.00% 8.00%  
Principal $ 849,918           $ 849,918   $ 849,918     $ 600,000  
Unamortized debt issuance costs 11,259           14,397            
FILO term loan due December 2023                          
Indebtedness and credit agreements                          
Principal                         $ 450,000
Unguaranteed Unsecured Debt                          
Indebtedness and credit agreements                          
Long-term debt 187,333           265,643            
7.7% notes due February 2027                          
Indebtedness and credit agreements                          
Long-term debt $ 185,293           $ 236,744            
Debt instrument, stated interest rate (as a percent) 7.70%       7.70%   7.70%            
Principal $ 185,691           $ 237,386            
Unamortized debt issuance costs 398           642            
6.875% fixed-rate senior notes due December 2028                          
Indebtedness and credit agreements                          
Long-term debt $ 2,040           $ 28,899            
Debt instrument, stated interest rate (as a percent) 6.875%       6.875%   6.875%            
Principal $ 2,046           $ 29,001            
Unamortized debt issuance costs $ 6           $ 102            
XML 102 R92.htm IDEA: XBRL DOCUMENT v3.24.2
Indebtedness and Credit Agreement - Credit Facility (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 01, 2022
Aug. 20, 2021
Mar. 04, 2023
May 28, 2021
Jul. 24, 2020
Jul. 10, 2020
Jun. 25, 2020
Dec. 20, 2018
Credit facility                
Debt instrument, stated interest rate (as a percent)           6.125%    
Rite Aid Lease Management Company                
Credit facility                
Ownership interest (as a percent)     100.00%          
Senior secured revolving credit facility due December 2023                
Credit facility                
Maximum borrowing capacity               $ 2,700,000
FILO term loan due December 2023                
Credit facility                
Maximum borrowing capacity               450,000
FILO term loan due August 2026                
Credit facility                
Maximum borrowing capacity $ 400,000 $ 350,000            
FILO term loan due August 2026 | Maximum                
Credit facility                
Threshold availability on the third consecutive business day     $ 257,500          
FILO term loan due August 2026 | LIBOR                
Credit facility                
Percentage points added to the reference rate   2.75%            
FILO term loan due August 2026 | Citibank's base rate                
Credit facility                
Percentage points added to the reference rate 2.00% 1.75%            
FILO term loan due August 2026 | SOFR                
Credit facility                
Percentage points added to the reference rate 3.00%              
Senior secured revolving credit facility due August 2026                
Credit facility                
Maximum borrowing capacity $ 2,850,000 $ 2,800,000            
Period triggering springing maturity 91 days              
Outstanding borrowings     1,600,000          
Letters of credit outstanding     208,698          
Additional borrowing capacity     1,403,996          
Maximum amount of accumulated cash on hand     200,000          
Amount of debt allowed to be outstanding     1,500,000          
Cash sweep, 3-day minimum threshold     283,250          
Cash sweep, 1-day minimum threshold     206,000          
Threshold amount of debt     $ 750,000          
Number of days relating to debt threshold     90 days          
Minimum principal balance for which non-payment causes default     $ 50,000          
Senior secured revolving credit facility due August 2026 | Minimum                
Credit facility                
Credit facility commitment fee (as a percent) 0.25%              
Additional borrowing capacity     $ 375,950          
Fixed charge coverage ratio     1.00          
Threshold availability on thirtieth consecutive day     $ 257,500          
Senior secured revolving credit facility due August 2026 | Maximum                
Credit facility                
Credit facility commitment fee (as a percent) 0.375%              
Threshold availability on revolving credit facility to trigger fixed charge coverage requirements     $ 206,000          
Senior secured revolving credit facility due August 2026 | LIBOR | Minimum                
Credit facility                
Percentage points added to the reference rate   1.25%            
Senior secured revolving credit facility due August 2026 | LIBOR | Maximum                
Credit facility                
Percentage points added to the reference rate   1.75%            
Senior secured revolving credit facility due August 2026 | Citibank's base rate | Minimum                
Credit facility                
Percentage points added to the reference rate   0.25%            
Senior secured revolving credit facility due August 2026 | Citibank's base rate | Maximum                
Credit facility                
Percentage points added to the reference rate   0.75%            
Senior secured revolving credit facility due January 2020                
Credit facility                
Maximum borrowing capacity               $ 2,700,000
6.125% senior notes due April 2023                
Credit facility                
Debt instrument, stated interest rate (as a percent)     6.125% 6.125% 6.125%   6.125%  
XML 103 R93.htm IDEA: XBRL DOCUMENT v3.24.2
Indebtedness and Credit Agreement - Transactions and Maturity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 09, 2022
Dec. 01, 2022
Jun. 13, 2022
Aug. 20, 2021
May 28, 2021
Jul. 24, 2020
Jul. 10, 2020
Jun. 25, 2020
Jun. 20, 2020
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Nov. 30, 2022
Nov. 03, 2022
Jun. 29, 2022
Jul. 09, 2020
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)             6.125%                  
Gain (loss) on debt modifications and retirements, net     $ (41,312)             $ 80,142 $ (3,235) $ 5,274        
Maturities                                
2025                   0            
2026                   0            
2027                   320,002            
2028                   2,635,609            
2028 and thereafter                   $ 2,046            
Annual weighted average rate (as a percent)                   7.20% 5.60% 5.40%        
6.125% senior notes due April 2023                                
Indebtedness and credit agreements                                
Notes redeemed and discharged             $ 1,125,000 $ 750,000 $ 750,000              
Debt instrument, stated interest rate (as a percent)         6.125% 6.125%   6.125%   6.125%            
Early redemption of debt           $ 1,062,682                    
(Gain) loss on debt retirements, net         $ 396                      
Proceeds from issuance of debt           206,373   $ 145,500                
Gain on debt modification           $ 5,274                    
Percentage of outstanding principal amount redeemed         100.00%                      
6.875% fixed-rate senior notes due December 2028                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)                   6.875% 6.875%       6.875%  
Face amount of debt repurchased                             $ 26,955  
7.7% notes due February 2027                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)                   7.70% 7.70%       7.70%  
Face amount of debt repurchased                             $ 51,695  
7.5% senior secured notes due July 2025                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent) 7.50%   7.50%             7.50% 7.50%   7.50% 7.50% 7.50%  
Debt instrument, sun cap amount     $ 100,000                          
Gain (loss) on debt modifications and retirements, net $ (38,978)                              
Face amount of debt repurchased $ 4,559   $ 150,000                   $ 160,497 $ 200,000 $ 114,942  
7.70% senior secured notes due 2027                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)     7.70%                          
6.875% senior secured notes due 2028                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)     6.875%                          
8.0% senior secured notes due November 2026                                
Indebtedness and credit agreements                                
Debt instrument, stated interest rate (as a percent)     8.00%     8.00%   8.00%   8.00% 8.00%         8.00%
Senior secured credit facility                                
Indebtedness and credit agreements                                
Gain (loss) on debt modifications and retirements, net   $ (100,000)               $ 148            
(Gain) loss on debt retirements, net       $ 2,839                        
FILO term loan due August 2026                                
Indebtedness and credit agreements                                
Maximum borrowing capacity   400,000   350,000                        
Senior secured revolving credit facility due August 2026                                
Indebtedness and credit agreements                                
Maximum borrowing capacity   $ 2,850,000   $ 2,800,000                        
XML 104 R94.htm IDEA: XBRL DOCUMENT v3.24.2
Leases (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Property, Plant and Equipment [Line Items]      
Operating lease cost $ 641,394 $ 669,421 $ 651,261
Financing lease cost:      
Amortization of right-of-use asset 3,471 3,638 4,359
Interest on long-term finance lease liabilities 1,968 2,167 2,505
Total finance lease costs 5,439 5,805 6,864
Short-term lease costs 3,126 3,180 3,214
Variable lease costs 178,263 175,697 172,088
Less: sublease income (12,871) (13,510) (14,886)
Net lease cost $ 815,351 $ 840,593 $ 818,541
Buildings | Minimum      
Property, Plant and Equipment [Line Items]      
Initial terms of noncancellable operating leases 5 years    
Initial terms of noncancellable finance leases 5 years    
Buildings | Maximum      
Property, Plant and Equipment [Line Items]      
Initial terms of noncancellable operating leases 22 years    
Initial terms of noncancellable finance leases 22 years    
Equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Initial terms of noncancellable operating leases 3 years    
Equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Initial terms of noncancellable operating leases 10 years    
XML 105 R95.htm IDEA: XBRL DOCUMENT v3.24.2
Leases - Supplemental cash flow information related to leases (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Cash paid for amounts included in the measurement of lease liabilities:      
Operating cash flows paid for operating leases $ 706,506 $ 703,326 $ 683,226
Operating cash flows paid for interest portion of finance leases 1,968 2,167 2,505
Financing cash flows paid for principal portion of finance leases 4,019 4,117 4,744
Right-of-use assets obtained in exchange for lease obligations:      
Operating leases 264,507 350,132 513,215
Finance leases
XML 106 R96.htm IDEA: XBRL DOCUMENT v3.24.2
Leases - Supplemental BS Information (Details)
$ in Thousands
12 Months Ended
Mar. 04, 2023
USD ($)
store
Feb. 26, 2022
USD ($)
Operating leases:    
Operating lease right-of-use assets $ 2,497,206 $ 2,813,535
Short-term operating lease liabilities 502,403 575,651
Long-term operating lease liabilities 2,372,943 2,597,090
Total operating lease liabilities 2,875,346 3,172,741
Finance leases:    
Property, plant and equipment, net 907,771 989,167
Current maturities of lease financing obligations $ 6,332 $ 5,544
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Long-term Debt and Capital Lease Obligations, Current Long-term Debt and Capital Lease Obligations, Current
Lease financing obligations, less current maturities $ 12,580 $ 14,830
Total finance lease liabilities $ 18,912 $ 20,374
Weighted average remaining lease term    
Operating leases (in years) 7 years 6 months 7 years 8 months 12 days
Finance leases (in years) 8 years 8 years 8 months 12 days
Weighted average discount rate    
Operating leases (as a percent) 6.50% 6.00%
Finance leases (as a percent) 9.00% 10.00%
Number of former stores with lease guarantee obligations | store 676  
Finance Leased Assets    
Finance leases:    
Property, plant and equipment, net $ 13,576 $ 13,950
XML 107 R97.htm IDEA: XBRL DOCUMENT v3.24.2
Leases - Maturity of lease liabilities under finance and operating leases (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Finance Leases    
2025 $ 3,188  
2026 7,732  
2027 2,421  
2028 1,567  
2029 1,500  
Thereafter 10,923  
Total lease payments 27,331  
Less: imputed interest (8,419)  
Total finance lease liabilities 18,912 $ 20,374
Operating Leases    
2025 677,631  
2026 593,857  
2027 507,388  
2028 426,503  
2029 351,942  
Thereafter 1,148,719  
Total lease payments 3,706,040  
Less: imputed interest (830,694)  
Total operating lease liabilities 2,875,346 $ 3,172,741
Minimum sublease rentals 24,000  
Finance and Operating Leases    
2025 680,819  
2026 601,589  
2027 509,809  
2028 428,070  
2028 353,442  
Thereafter 1,159,642  
Total lease payments 3,733,371  
Less: imputed interest (839,113)  
Total lease liabilities $ 2,894,258  
XML 108 R98.htm IDEA: XBRL DOCUMENT v3.24.2
Leases - Sale Leaseback (Details)
$ in Thousands
12 Months Ended
Mar. 04, 2023
USD ($)
item
store
Feb. 26, 2022
USD ($)
item
Feb. 27, 2021
USD ($)
item
Sale Leaseback Transaction      
Number of facilities in sale/leaseback 12 20 11
Number of stores sold     7
Number of stores | store 2,309    
Sale/leaseback proceeds | $ $ 73,344 $ 57,498 $ 177,892
Leaseback term   15 years  
Gain (loss) on sale-leaseback transactions | $ $ 38,214 $ 8,600 $ 93,841
Minimum      
Sale Leaseback Transaction      
Leaseback term     15 years
Maximum      
Sale Leaseback Transaction      
Leaseback term     20 years
Retail Store      
Sale Leaseback Transaction      
Number of stores 10    
Leaseback term 15 years    
Distribution Center      
Sale Leaseback Transaction      
Leaseback term 3 years    
XML 109 R99.htm IDEA: XBRL DOCUMENT v3.24.2
Stock Option and Stock Awards Plans (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2020
Jun. 30, 2014
Jun. 30, 2012
Jun. 30, 2010
Stock Options and Stock Awards                  
Stock-based compensation costs (benefit) $ 11,537 $ 13,050 $ 13,003            
Shares of common stock available for grant 3,628     3,250          
Maximum                  
Stock Options and Stock Awards                  
Term of options 10 years                
Performance based awards                  
Stock Options and Stock Awards                  
Stock-based compensation costs (benefit) $ (3,080) $ 2,143 $ 3,278            
2010 Omnibus Equity Plan                  
Stock Options and Stock Awards                  
Shares of common stock authorized under stock-based compensation plans                 1,750
2012 Omnibus Equity Plan                  
Stock Options and Stock Awards                  
Shares of common stock authorized under stock-based compensation plans               1,425  
2014 Omnibus Equity Plan                  
Stock Options and Stock Awards                  
Shares of common stock authorized under stock-based compensation plans             2,900    
2014 Omnibus Equity Plan | Incentive Stock options | Maximum                  
Stock Options and Stock Awards                  
Shares of common stock authorized under stock-based compensation plans             1,250    
Amended And Restated 2020 Omnibus Equity Plan                  
Stock Options and Stock Awards                  
Shares of common stock available for grant         4,562        
Omnibus Equity Plan 2020                  
Stock Options and Stock Awards                  
Shares of common stock available for grant           3,350      
XML 110 R100.htm IDEA: XBRL DOCUMENT v3.24.2
Stock Option and Stock Award Plans - Options (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Stock Options and Stock Awards      
Weighted average fair value of options granted (in dollars per share) $ 0.00 $ 0.00 $ 0.00
Options, Shares      
Outstanding at the beginning of the period (in shares) 701 780 1,295
Granted (in shares)
Exercised (in shares) (2)
Canceled (in shares) (169) (79) (513)
Outstanding at the end of the period (in shares) 532 701 780
Vested or expected to vest at the end of the period (in shares) 532    
Exercisable at the end of the period (in shares) 532    
Options, Weighted Average Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 15.50 $ 18.56 $ 30.29
Granted (in dollars per share)
Exercised (in dollars per share) 25.08
Canceled (in dollars per share) 23.85 45.78 48.16
Outstanding at the end of the period (in dollars per share) 12.85 $ 15.50 $ 18.56
Vested or expected to vest at the end of the period (in dollars per share) 12.85    
Exercisable at the end of the period (in dollars per share) $ 12.85    
Options, Additional Disclosures      
Contractual term, Outstanding at the end of the period 1 month 24 days    
Contractual term, Vested or expected to vest at the end of the period 1 month 24 days    
Contractual term, Exercisable at the end of the period 1 month 24 days    
Intrinsic value, Outstanding at the end of the period $ 0    
Intrinsic value, Vested or expected to vest at the end of the period 0    
Intrinsic value, Exercisable at the end of the period 0    
Additional General Disclosures      
Total intrinsic value of options exercised 0 $ 0 $ 10
Incentive Stock options      
Unrecognized pre-tax compensation costs related to unvested stock options, restricted stock grants and performance shares      
Unrecognized pre-tax costs $ 0    
Weighted average amortization period 0 years    
Additional General Disclosures      
Cash received from stock option exercises $ 0 0 53
Income tax benefit from stock options $ 0 $ 0 $ 1
Vesting period 4 years    
XML 111 R101.htm IDEA: XBRL DOCUMENT v3.24.2
Stock Option and Stock Award Plans - Restricted Stock (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Additional General Disclosures      
Stock-based compensation costs (benefit) $ 11,537 $ 13,050 $ 13,003
Unvested Restricted stock      
Stock Options and Stock Awards      
Vesting period 3 years    
Restricted stock, Shares      
Outstanding at the beginning of the period (in shares) 1,533 1,293 1,253
Granted (in shares) 1,662 973 780
Vested (in shares) (1,349) (546) (574)
Canceled (in shares) (370) (187) (166)
Outstanding at the end of the period (in shares) 1,476 1,533 1,293
Restricted stock, Weighted Average Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 14.42 $ 13.23 $ 10.32
Granted (in dollars per share) 6.50 15.00 17.79
Vested (in dollars per share) 12.40 12.25 13.37
Canceled (in dollars per share) 10.83 15.51 12.23
Outstanding at the end of the period (in dollars per share) $ 8.25 $ 14.42 $ 13.23
Unrecognized pre-tax compensation costs related to unvested stock options, restricted stock grants and performance shares      
Unrecognized pre-tax costs $ 9,719    
Weighted average amortization period 1 year 8 months 12 days    
Restricted stock, Additional disclosures      
Total fair value of awards vested during the period $ 16,746 $ 6,677 $ 7,670
Performance based awards      
Additional General Disclosures      
Stock-based compensation costs (benefit) $ (3,080) $ 2,143 $ 3,278
XML 112 R102.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Defined Benefit Pension Plan      
Retirement Plans      
Employer match of employee contributions up to 3% of pretax annual compensation to 401 (k) defined contribution plan (as a percent) 100.00%    
Percentage of participant's pretax annual compensation matched 100% by employer 3.00%    
Employer match of employee contributions of additional 2% of pretax annual compensation to 401 (k) defined contribution plan (as a percent) 50.00%    
Percentage of participant's pretax annual compensation matched 50% by employer 2.00%    
Total expense recognized $ 44,504 $ 41,528 $ 36,270
Employer contributions $ 0 $ 1,700 $ 6,305
Discount rate (as a percent) 5.00% 3.25% 3.00%
Supplemental Retirement Plan      
Retirement Plans      
Total expense recognized $ 0 $ 0 $ 0
Vesting period 5 years    
XML 113 R103.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Net periodic cost (Details) - Defined Benefit Pension Plan - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Net periodic pension expense      
Service cost $ 336 $ 425 $ 486
Interest cost 5,036 4,861 4,753
Expected return on plan assets (4,998) (5,194) (4,614)
Amortization of unrecognized net loss (344) (3,749)
Net periodic pension expense (income) 374 436 4,374
Employer contributions 0 1,700 6,305
Expected employer contribution during the remainder of fiscal year 0    
Other changes recognized in other comprehensive loss:      
Unrecognized net gain arising during period (585) (8,246) (20,633)
Amortization of unrecognized net (loss) gain (344) (3,749)
Net amount recognized in other comprehensive loss (585) (8,590) (24,382)
Net amount recognized in pension expense and other comprehensive loss $ (211) $ (8,154) $ (20,008)
XML 114 R104.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Benefit obligation and funded status (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Estimated amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense      
Net actuarial loss $ 0    
Prior service cost 0    
Defined Benefit Pension Plan      
Change in benefit obligations:      
Benefit obligation at end of prior year 160,133 $ 168,872  
Service cost 336 425 $ 486
Interest cost 5,036 4,861 4,753
Distributions (8,328) (8,582)  
Actuarial gain (26,014) (5,443)  
Benefit obligation at end of year 131,163 160,133 168,872
Change in plan assets:      
Fair value of plan assets at beginning of year 149,527 148,412  
Employer contributions 0 1,700 6,305
Actual return on plan assets (20,430) 7,997  
Distributions (including expenses paid by the plan) (8,328) (8,582)  
Fair value of plan assets at end of year 120,769 149,527 $ 148,412
Funded status (10,394) (10,606)  
Amounts recognized in consolidated balance sheets consisted of:      
Accrued pension liability (10,394) (10,606)  
Net amount recognized in balance sheet (10,394) (10,606)  
Amounts recognized in accumulated other comprehensive loss consist of:      
Net actuarial loss 11,202 (11,787)  
Amount recognized in other comprehensive income 11,202 (11,787)  
Estimated amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense      
Accumulated benefit obligation $ 131,163 $ 160,133  
XML 115 R105.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details) - Defined Benefit Pension Plan - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Defined Benefit Plan with Accumulated Benefit Obligation in Excess of Plan Assets    
Accumulated Benefit Obligations $ 131,163 $ 160,133
Fair Value of Plan Assets $ 120,769 $ 149,527
XML 116 R106.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Projected benefit obligation and fair value of plan assets (Details) - Defined Benefit Pension Plan - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Pension Plan with Project Benefit Obligation in Excess of Plan Assets    
Projected Benefit Obligations $ 131,163 $ 160,133
Fair Value of Plan Assets $ 120,769 $ 149,527
XML 117 R107.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Assumptions and assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation      
Expected long-term rate of return on plan assets 5.00% 5.50% 6.00%
Asset allocations      
Actual allocation (as a percent) 100.00% 100.00%  
Target allocation of plan assets      
Target allocation (as a percent) 100.00%    
Equity Securities      
Asset allocations      
Actual allocation (as a percent) 30.00% 30.00%  
U.S. equities      
Target allocation of plan assets      
Target allocation (as a percent) 30.00%    
Fixed Income      
Asset allocations      
Actual allocation (as a percent) 59.00% 57.00%  
Target allocation of plan assets      
Target allocation (as a percent) 62.00%    
Other      
Asset allocations      
Actual allocation (as a percent) 11.00% 13.00%  
Target allocation of plan assets      
Target allocation (as a percent) 8.00%    
Defined Benefit Pension Plan      
Significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation      
Discount rate (as a percent) 5.00% 3.25% 3.00%
Rate of increase in future compensation levels (as a percent)
Expected long-term rate of return on plan assets 6.50% 5.00% 5.50%
Weighted average assumptions used to determine net cost      
Discount rate (as a percent) 3.25% 3.00% 2.75%
Rate of increase in future compensation levels (as a percent)
Expected long-term rate of return on plan assets (as a percent) 5.00% 5.50% 6.00%
Defined benefit plans estimated future employer contributions      
Expected employer contribution during next fiscal year $ 0    
XML 118 R108.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Fair Value (Details) - Recurring - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Retirement Plans    
Total assets at fair value $ 120,764 $ 149,525
International equity    
Retirement Plans    
Total assets at fair value 13,901 17,783
Large Cap    
Retirement Plans    
Total assets at fair value 18,556 23,027
Small-Mid Cap    
Retirement Plans    
Total assets at fair value 3,309 4,213
Aon High Yield Plus Bond    
Retirement Plans    
Total assets at fair value 72 75
Aon Multi-Asset Credit    
Retirement Plans    
Total assets at fair value 4,775 7,386
Long Term Credit Bond Index    
Retirement Plans    
Total assets at fair value 41,360 47,976
Long Term US Government Bonds    
Retirement Plans    
Total assets at fair value 1,588 19,763
20+ Year Treasury STRIPS    
Retirement Plans    
Total assets at fair value 12,821 483
Intermediate Fixed Income    
Retirement Plans    
Total assets at fair value 9,781 8,554
AGT High Yield Bond    
Retirement Plans    
Total assets at fair value
Aon Global Real Estate    
Retirement Plans    
Total assets at fair value 11 13
Aon Core Real Estate Fund    
Retirement Plans    
Total assets at fair value 13,479 18,720
Short Term Investments    
Retirement Plans    
Total assets at fair value 1,111 1,532
Level 1    
Retirement Plans    
Total assets at fair value
Level 1 | International equity    
Retirement Plans    
Total assets at fair value
Level 1 | Large Cap    
Retirement Plans    
Total assets at fair value
Level 1 | Small-Mid Cap    
Retirement Plans    
Total assets at fair value
Level 1 | Fixed Income    
Retirement Plans    
Total assets at fair value  
Level 1 | Aon High Yield Plus Bond    
Retirement Plans    
Total assets at fair value
Level 1 | Aon Multi-Asset Credit    
Retirement Plans    
Total assets at fair value
Level 1 | Long Term Credit Bond Index    
Retirement Plans    
Total assets at fair value
Level 1 | Long Term US Government Bonds    
Retirement Plans    
Total assets at fair value
Level 1 | 20+ Year Treasury STRIPS    
Retirement Plans    
Total assets at fair value
Level 1 | Intermediate Fixed Income    
Retirement Plans    
Total assets at fair value
Level 1 | AGT High Yield Bond    
Retirement Plans    
Total assets at fair value
Level 1 | Aon Global Real Estate    
Retirement Plans    
Total assets at fair value
Level 1 | Aon Core Real Estate Fund    
Retirement Plans    
Total assets at fair value
Level 1 | Short Term Investments    
Retirement Plans    
Total assets at fair value
Level 2    
Retirement Plans    
Total assets at fair value 1,111 1,532
Level 2 | International equity    
Retirement Plans    
Total assets at fair value
Level 2 | Large Cap    
Retirement Plans    
Total assets at fair value
Level 2 | Small-Mid Cap    
Retirement Plans    
Total assets at fair value
Level 2 | Fixed Income    
Retirement Plans    
Total assets at fair value  
Level 2 | Aon High Yield Plus Bond    
Retirement Plans    
Total assets at fair value
Level 2 | Aon Multi-Asset Credit    
Retirement Plans    
Total assets at fair value
Level 2 | Long Term Credit Bond Index    
Retirement Plans    
Total assets at fair value
Level 2 | Long Term US Government Bonds    
Retirement Plans    
Total assets at fair value
Level 2 | 20+ Year Treasury STRIPS    
Retirement Plans    
Total assets at fair value
Level 2 | Intermediate Fixed Income    
Retirement Plans    
Total assets at fair value
Level 2 | AGT High Yield Bond    
Retirement Plans    
Total assets at fair value
Level 2 | Aon Global Real Estate    
Retirement Plans    
Total assets at fair value
Level 2 | Aon Core Real Estate Fund    
Retirement Plans    
Total assets at fair value
Level 2 | Short Term Investments    
Retirement Plans    
Total assets at fair value 1,111 1,532
Level 3    
Retirement Plans    
Total assets at fair value
Level 3 | International equity    
Retirement Plans    
Total assets at fair value
Level 3 | Large Cap    
Retirement Plans    
Total assets at fair value
Level 3 | Small-Mid Cap    
Retirement Plans    
Total assets at fair value
Level 3 | Fixed Income    
Retirement Plans    
Total assets at fair value  
Level 3 | Aon High Yield Plus Bond    
Retirement Plans    
Total assets at fair value
Level 3 | Aon Multi-Asset Credit    
Retirement Plans    
Total assets at fair value
Level 3 | Long Term Credit Bond Index    
Retirement Plans    
Total assets at fair value
Level 3 | Long Term US Government Bonds    
Retirement Plans    
Total assets at fair value
Level 3 | 20+ Year Treasury STRIPS    
Retirement Plans    
Total assets at fair value
Level 3 | Intermediate Fixed Income    
Retirement Plans    
Total assets at fair value
Level 3 | AGT High Yield Bond    
Retirement Plans    
Total assets at fair value
Level 3 | Aon Global Real Estate    
Retirement Plans    
Total assets at fair value
Level 3 | Aon Core Real Estate Fund    
Retirement Plans    
Total assets at fair value
Level 3 | Short Term Investments    
Retirement Plans    
Total assets at fair value
XML 119 R109.htm IDEA: XBRL DOCUMENT v3.24.2
Retirement Plans - Future Benefit Payments (Details) - Defined Benefit Pension Plan
$ in Thousands
Mar. 04, 2023
USD ($)
Future benefit payments expected to be paid in Fiscal Year  
2024 $ 9,497
2025 9,379
2026 9,373
2027 9,410
2028 9,252
2029 - 2033 44,769
Total $ 91,680
XML 120 R110.htm IDEA: XBRL DOCUMENT v3.24.2
Multiemployer Plans that Provide Pension Benefits (Details)
$ in Thousands
12 Months Ended
Feb. 06, 2022
$ / h
Feb. 01, 2022
$ / h
Oct. 01, 2021
$ / h
Feb. 07, 2021
$ / h
Jan. 01, 2021
$ / h
Oct. 01, 2020
$ / h
Feb. 02, 2020
$ / h
Jan. 01, 2020
$ / h
Sep. 30, 2018
Sep. 01, 2014
$ / h
Mar. 04, 2023
USD ($)
Feb. 26, 2022
USD ($)
Feb. 27, 2021
USD ($)
Dec. 31, 2020
$ / h
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     $ 21,663 $ 24,514 $ 22,952  
Minimum                            
Multiemployer Plans that Provide Pension Benefits                            
Funded percentage, green zone                     80.00%      
Maximum                            
Multiemployer Plans that Provide Pension Benefits                            
Funded percentage, red zone                     65.00%      
Funded percentage, yellow zone                     80.00%      
1199 SEIU Health Care Employees Pension Fund                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     $ 7,493 9,242 9,613  
Minimum funding requirements (as a percent)     11.30%           12.60%          
Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     8,131 8,989 8,239  
Minimum funding requirements for pharmacists (in dollars per hour) | $ / h         1.844                 1.758
Minimum funding requirements for clerks (in dollars per hour) | $ / h         0.836                 0.797
UFCW Pharmacists, Clerks and Drug Employers Pension Trust                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     2,605 3,224 2,319  
Minimum funding requirements for pharmacists (in dollars per hour) | $ / h               1.239            
Minimum funding requirements for clerks (in dollars per hour) | $ / h               0.855            
Minimum funding requirements for associates (in dollars per hour) | $ / h                   0.55        
United Food and Commercial Workers Union-Employer Pension Fund                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     954 802 809  
Minimum funding requirements for associates (in dollars per hour) | $ / h 2.57     2.43     2.30              
United Food and Commercial Workers Union Local 880 - Mercantile Employers Joint Pension Fund                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     434 370 399  
Minimum funding requirements for associates (in dollars per hour) | $ / h   2.33 2.24     2.15                
Other Funds                            
Multiemployer Plans that Provide Pension Benefits                            
Contributions by employer | $                     $ 2,046 $ 1,887 $ 1,573  
XML 121 R111.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Reporting - Balance Sheet information (Details)
$ in Thousands
12 Months Ended
Mar. 04, 2023
USD ($)
segment
Feb. 26, 2022
USD ($)
Feb. 27, 2021
USD ($)
Segment Reporting      
Number of reportable segments | segment 2    
Total Assets $ 7,527,362 $ 8,529,003  
Goodwill 507,936 879,136 $ 1,108,136
Accounts receivable 1,149,958 1,343,496  
Retail Pharmacy Segment      
Segment Reporting      
Goodwill 43,492 43,492 43,492
Pharmacy Services Segment      
Segment Reporting      
Goodwill 464,444 835,644 $ 1,064,644
Operating Segments | Retail Pharmacy Segment      
Segment Reporting      
Total Assets 5,487,845 6,068,594  
Goodwill 43,492 43,492  
Operating Segments | Pharmacy Services Segment      
Segment Reporting      
Total Assets 2,049,107 2,482,232  
Goodwill 464,444 835,644  
Intersegment elimination      
Segment Reporting      
Total Assets (9,590) (21,823)  
Goodwill  
Accounts receivable $ 9,590 $ 21,823  
XML 122 R112.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Reporting - Revenues (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Segment Reporting      
Revenues $ 24,091,899 $ 24,568,255 $ 24,043,240
Gross Profit 4,803,940 5,106,495 4,704,322
Adjusted EBITDA 429,180 505,905 437,665
Depreciation and amortization 276,583 295,686 327,124
LIFO charge (credit) 53,028 1,314 (51,692)
Stock-based compensation expense 11,537 13,050 13,003
Restructuring-related costs 108,626 35,121 84,552
Additions to property and equipment and intangible assets 247,685 220,713 224,941
SKU Optimization Charges [Member]      
Segment Reporting      
Restructuring-related costs     20,939
Retail Pharmacy Segment      
Segment Reporting      
Revenues 17,785,067 17,494,816 16,365,260
Operating Segments | Retail Pharmacy Segment      
Segment Reporting      
Revenues 17,785,067 17,494,816 16,365,260
Gross Profit 4,394,850 4,722,075 4,255,791
Adjusted EBITDA 288,077 392,633 279,896
Depreciation and amortization 229,380 244,122 269,985
LIFO charge (credit) 53,028 1,314 (51,692)
Stock-based compensation expense 10,604 12,282 11,594
Additions to property and equipment and intangible assets 226,563 202,386 204,290
Operating Segments | Retail Pharmacy Segment | SKU Optimization Charges [Member]      
Segment Reporting      
Restructuring-related costs     20,939
Operating Segments | Pharmacy Services Segment      
Segment Reporting      
Revenues 6,522,299 7,323,125 7,970,137
Gross Profit 409,090 384,420 448,531
Adjusted EBITDA 141,103 113,272 157,769
Depreciation and amortization 47,203 51,564 57,139
LIFO charge (credit)
Stock-based compensation expense 933 768 1,409
Additions to property and equipment and intangible assets 21,122 18,327 20,651
Operating Segments | Pharmacy Services Segment | SKU Optimization Charges [Member]      
Segment Reporting      
Restructuring-related costs    
Intersegment elimination      
Segment Reporting      
Revenues (215,467) (249,686) (292,157)
Gross Profit
Adjusted EBITDA
Depreciation and amortization
LIFO charge (credit)
Stock-based compensation expense
Additions to property and equipment and intangible assets
Intersegment elimination | SKU Optimization Charges [Member]      
Segment Reporting      
Restructuring-related costs    
XML 123 R113.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Reporting - Adjusted EBITDA (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 13, 2022
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Segment Reporting        
Net loss from continuing operations   $ (719,188) $ (522,372) $ (99,381)
Interest expense   224,399 191,601 201,388
Income tax expense   (6,467) (3,780) (20,157)
Depreciation and amortization   276,583 295,686 327,124
LIFO charge (credit)   53,028 1,314 (51,692)
Facility exit and impairment charges   180,637 164,084 57,714
Goodwill and intangible asset impairment charges   371,200 229,000 29,852
(Gain) loss on debt modifications and retirements, net $ 41,312 (80,142) 3,235 (5,274)
Merger and Acquisition-related costs   12,797 10,549
Stock-based compensation expense   11,537 13,050 13,003
Restructuring-related costs   108,626 35,121 84,552
Inventory write-downs related to store closings   14,270 5,298 3,709
Litigation and other contractual settlements   53,882 50,212
(Gain) loss on sale of assets, net   (68,586) 5,505 (69,300)
Loss (gain) on Bartell acquisition   5,346 (47,705)
Change in estimate related to manufacturer rebate receivables   15,068
Other   9,401 4,740 3,283
Adjusted EBITDA   $ 429,180 $ 505,905 $ 437,665
XML 124 R114.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments, Contingencies and Guarantees (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Apr. 22, 2022
USD ($)
Dec. 31, 2022
USD ($)
Aug. 31, 2022
USD ($)
Mar. 04, 2023
lawsuit
state
California Employment Litigation Claims Related To Reimbursement For Cell phone and Mileage Expenses        
Commitments, Contingencies and Guarantees        
Amount awarded to other party     $ 1,290  
California Employment Litigation Claims Related To Wages And Hour Class Action        
Commitments, Contingencies and Guarantees        
Amount awarded to other party     $ 800  
New York Employment Litigation Claims Related To Wages And Hour Class Action        
Commitments, Contingencies and Guarantees        
Amount awarded to other party   $ 6,450    
Blue Cross Blue Shield Litigation        
Commitments, Contingencies and Guarantees        
Number of claims | lawsuit       2
Number of states in which operated | state       8
Humana Litigation        
Commitments, Contingencies and Guarantees        
Amount awarded to other party $ 122,600      
Prejudgment interest awarded $ 40,700      
XML 125 R115.htm IDEA: XBRL DOCUMENT v3.24.2
Supplementary Cash Flow Data (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Supplementary Cash Flow Data      
Cash paid for interest $ 212,355 $ 180,583 $ 181,634
Cash payments (refunds) for income taxes, net (5,309) 6,233 7,535
Equipment financed under capital leases 3,334 1,698 1,849
Accrued capital expenditures 18,711 45,465 19,904
Gross borrowings from revolver 3,510,000 5,131,000 7,912,000
Gross repayments to revolver 3,019,000 5,272,000 7,712,000
Significant components of cash provided by (used in) Other Liabilities (Other Assets)      
Other Liabilities (111,021) 68,558 (50,947)
Other Assets 36,478 $ 33,737 $ 80,975
Accruals related to compensation and benefit 100,340    
Changes in accrued store expenses $ 11,426    
XML 126 R116.htm IDEA: XBRL DOCUMENT v3.24.2
Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 04, 2023
Feb. 26, 2022
Financial instruments    
Investment at amortized cost $ 7,457 $ 7,406
Carrying Amount    
Financial instruments    
Variable rate indebtedness 1,581,793 1,038,646
Fixed rate indebtedness 1,343,465 1,694,340
Fair Value    
Financial instruments    
Variable rate indebtedness 1,600,000 1,059,000
Fixed rate indebtedness $ 768,328 $ 1,602,122
XML 127 R117.htm IDEA: XBRL DOCUMENT v3.24.2
Revision of Previously Issued Consolidated Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Feb. 29, 2020
Revision of Previously Issued Consolidated Financial Statements        
Accrued salaries, wages and other current liabilities $ 709,891 $ 776,559 $ 643,218  
Total current liabilities 2,713,237 2,929,015 2,603,800  
Other noncurrent liabilities 97,577 139,254 206,670  
Total liabilities 8,121,595 8,413,175 8,719,561  
Accumulated deficit (6,553,974) (5,834,786) (5,312,414)  
Total stockholders' (deficit) equity (594,233) 115,828 615,843 $ 674,527
Facility exit and impairment charges 180,637 164,084 57,714  
Loss from continuing operations before income taxes (725,655) (526,152) (119,538)  
Net loss from continuing operations (719,188) (522,372) (99,381)  
Net loss (719,188) (522,372) (90,220)  
Comprehensive loss $ (718,603) $ (513,755) $ (65,376)  
Basic loss per share from continuing operations $ (13.15) $ (9.66) $ (1.86)  
Diluted loss per share from continuing operations (13.15) (9.66) (1.86)  
Net basic loss per share (13.15) (9.66) (1.68)  
Net diluted loss per share $ (13.15) $ (9.66) $ (1.68)  
As Previously Reported        
Revision of Previously Issued Consolidated Financial Statements        
Accrued salaries, wages and other current liabilities $ 724,529 $ 780,632 $ 642,364  
Total current liabilities 2,727,875 2,933,088 2,602,946  
Other noncurrent liabilities 130,482 151,976 208,213  
Total liabilities 8,169,138 8,429,970 8,720,250  
Accumulated deficit (6,601,517) (5,851,581) (5,313,103)  
Total stockholders' (deficit) equity (641,776) 99,033 615,154  
Facility exit and impairment charges 211,385 180,190 58,403  
Loss from continuing operations before income taxes (756,403) (542,258) (120,227)  
Net loss from continuing operations (749,936) (538,478) (100,070)  
Net loss (749,936) (538,478) (90,909)  
Comprehensive loss $ (749,351) $ (529,861) $ (66,065)  
Basic loss per share from continuing operations $ (13.71) $ (9.96) $ (1.87)  
Net basic loss per share $ (13.71) $ (9.96) $ (1.69)  
Adjustment        
Revision of Previously Issued Consolidated Financial Statements        
Accrued salaries, wages and other current liabilities $ (14,638) $ (4,073) $ 854  
Total current liabilities (14,638) (4,073) 854  
Other noncurrent liabilities (32,905) (12,722) (1,543)  
Total liabilities (47,543) (16,795) (689)  
Accumulated deficit (47,543) 16,795 689  
Total stockholders' (deficit) equity (47,543) 16,795 689  
Facility exit and impairment charges (30,748) (16,106) (689)  
Loss from continuing operations before income taxes 30,748 16,106 689  
Net loss from continuing operations 30,748 16,106 689  
Net loss 30,748 16,106 689  
Comprehensive loss $ 30,748 $ 16,106 $ 689  
Basic loss per share from continuing operations $ 0.56 $ 0.30 $ 0.01  
Net basic loss per share $ 0.56 $ 0.30 $ 0.01  
XML 128 R118.htm IDEA: XBRL DOCUMENT v3.24.2
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowances deducted from accounts receivable for estimated uncollectible amounts: - USD ($)
$ in Thousands
12 Months Ended
Mar. 04, 2023
Feb. 26, 2022
Feb. 27, 2021
Allowances deducted from accounts receivable for estimated uncollectible amounts:      
Balance at Beginning of Period $ 46,865 $ 24,854 $ 12,849
Additions Charged to Costs and Expenses 63,373 106,113 43,855
Deductions 48,105 84,102 31,850
Balance at End of Period $ 62,133 $ 46,865 $ 24,854
EXCEL 129 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

2LMN5HW+\(:-2=^^VS:4;M'Y^?M M6VN_O'VQANL@%+4&*%P!J_&ULI57;;MLX$/V5@;HH&H"([K*4V@;BM,4N MT )&LY=G1AK;1"E2):FX_?L=2K:B(*D?=E\DSG#F\!QR.%P>M?EF#X@.?K12 MV55P<*Z["4-;'[#E]EIWJ&AFITW+'9EF']K.(&^&I%:&21058Q/SCO"-?+CN_Q'MU?W=:0%4XHC6A1 M6:$5&-RM@MOX9I/Y^"'@;X%'.QN#5_*@]3=O_-&L@L@30HFU\PBK MM;3#%XYC["(+H.ZMT^TIF1BT0HU__N.T#[.$,OI%0G)*2 ;>XT(#RP_<\?72 MZ",8'TUH?C!(';*)G%#^4.Z=H5E!>6Z]-72^QOUDL)5<.>"J@8_?>]'1QCMX M]R=_D&BOEJ&CM7Q&6)]P-R-N\@O<.($O6KF#A8^JP>8Y0$@D)Z;)F>DFN8CX MA9MKB#(&292D%_#227DZX*7_1?EK@D>X['4X?WEN;,=K7 5T.RR:1PS6;]_$ M1?3^ MEL(IM=0E_?TV5L>HF@=]!-Q+N).)Z),Q"JEGTCU!YJW@G')4BDL@5N M+3K[FK#+2[]]4R91^A[^[]\?F_\D\-DS/KM_@Z)B>5G.'&7*LC*'32^DUV%G M$"4KRGBRTSAC<9;"9R_PH&4#HJ7=>42_$T]I,@BWB_ 5B$JP%']8[A[Y+ M6%6E)"Z^>N;+*Y:FV15L+Y>50C<[HBHBAHMX[J$MB(O%:[4>SMI3BV8_-&$+ MM>Z5&SO5Y)WZ_.W8WI["QT>"FL!>*$LEO:/4Z'J1!V#&QCL:3G=#LWO0CEKG M,#S06X7&!]#\3FMW-OP"T^NW_A=02P,$% @ -7SY6(.(4H6%!0 /AX M !D !X;"]W;W)K&UL[5EM;]LV$/XKA!L4*<#& MHM[5)@:2;.WZ(5W0=.MG6J(MKI3HD53<[-?O*-FR',E.UC8;BOF+:5)W#^]. M=[Q'X.E2JL\Z9\R@+X4H]=DH-V;Q:CS6:O+D(K7PO\SME2=_XCZ\E4 MRL]V\BX[&SG6("98:BP"A>&673(A+!"8\><*<]1N:16[_]?H;VK?P9Q2 MBD\\,_G9*!ZAC,UH)#Z@^CVE)ZI1H_-?FNSOP]]SA$M9%4:*S5?.3GDR/ZMGC^+7<=[C9YJ_, , MY0)=YQ1*++U[4+XG> .QY2EXOU[X* T5Z((*6J8,HS=LJBH;+#>JR$/@Y]?VN-.#$F7HC:%.'%@G(%1Y(9M(^X?7N/73?!CN.\V/-D MP-:PMM7M*=VS?#W&7K!E?;L>)=_N@1<1[ YZT#YI/8#J3'.TJLY.,'L1]R'> M_E:\ R?"B1?N*8^@+8]@?WE Y\HJJ%[(? ['SHR7W+"7 H[_#!;:XJ8[BWL_ M_E/7Q'\]#K_$AY/S^YT)EDW8$^S'05Z/GVH: 'GVKP&_55+KKX8]OV4*R-<3 MH:W'RW5+:@73M"HJ01\3J?-"*L/_HC6+>SK$\Z9;;CU[#ZSXFBDNLX<>OY?E MRU06"V;@7)DKQNP9JVM2(6M2<4PW!^@1U _!"4DZ*\L!"S/P21,.AA@411Y QB$8"\)4;C"N*P),$1/,5&' M7.=\H;=BV7H5Q[:;#C0I)X0>F/0U8H+C2&O\/Z7; DP%[D]F%]%Q,WWJBO M+1>4%Y#.V1]5QM,F^S>YG;%;^+I;0.5I.3-+J@;<@ZR,!]*I6>_;8<"?NX+F3U)A/)"K7AC U/Z!8.CCQXQ^%VG=J 8J];J2TXT+"(/-P8 M&V07>TZPC>P' : G6R=%%$("A#NQ/BJ:05>#;_A^'@+%&GCW]T.[0_Q=RYQV M[OW=-VC>PU:8 @?[#[X "!/(D<>&WH>0/B;T"9QH>T)OCZ%5/X#4KRL"T31E M IJ@;4-3JKE&RYP#FX(_&?0&!9_PS9-&PWZOJ9:45)K-*H%8*DM9\!19QJK; MK[SAL]#DU"!;<>S+@J5V6R,1 !C%IQ6$-N,*E@5\+"I+AMOQDP ?>_7T0#[S[P+L/ MO/O N[N%<^#=!][]/^?=X\Z='NP^KV\N->P W;"YWFM7V\O1\^9.<"/>W*P" MKYSS4B/!9J#JG$3!"*GFMK*9&+FH;PBGTH"K]=^<07HK*P#/9U*:]<1NT%X9 M3_X&4$L#!!0 ( #5\^5@MFBH;^@( $X' 9 >&PO=V]R:W-H965T M32 M6G/L8#OK^/>]Y[IYS?9YOM;FW&P!''FNI["+8.-><1Y$M M-E!S>Z8;4+A3:5-SAZ991[8QP,L.5,N(49I%-1<2O6&^<=T7+>\#7<@?O>W!BTHH&E%#4H*[0B!JI%8!KD-(381F_=IS!D-(# MQ^L]^X=..VI9<0O76OX4I=LL@CP@)52\E>Y6;S_"3L_$\Q5:VNZ7;/O8+ M( MT5JGZQT8*ZB%ZK_\<=>'$2"GSP#8#L"ZNOM$797ON./+N=%;8GPTLOE%)[5# M8W%"^4.Y+<\K(H3 LEN>.2&P$V)#_Q+"SAJB1?W08,N6Z- >7(9\%7 M0@J'0>3U-[Z28-_,(X*:HV.6[ZO.Q9_+%C'S1RFTL>:]**/\FB+#X00'; M*[AB)QF_<'-&:!H21EER@B\9.I)T?,G_[,A3C>C3I$^G\9?MW#:\@$6 M\F" M>8!@^>I%G-&+$R+2041ZBGUYAY>W;"407>$?OQ=D!T';09#N!!4[0?*TH-,I M7[W(&4TNR+]^_3'Z'T;V)]&5&Y(5**B$&Q?>@+%:*9"DT!9W]APO23RC89:E M(P^;Q2&EZ< JE -LO!M"XCS,$CHV69X-X=B]OWKF^"/:#?_M;\( RK-PQ@X< MTTE(L_S X;0! H\X4>T!,XW#9)8?3!I.DNF \<>QYGZ"A43"FLNNAL;H"JR? MC.BH .Q1&],X9'1R[$[030\5@:S>"F5;PU4!QV3V=[SU 6(1C.N!K/N)KG% MB\M^1A["^Y<&)\8:-6,[*X32L^DD(*:?WKWA=---S)5V.'^[Y08?/# ^ /\ F&)W3Y!U!+ P04 " U?/E8M345%T\$ #V"P &0 'AL+W=O M1=G)?OV.DFPKL^.AR;Y(XLL]]]P]1^I&:Z5_5 L 0Q[+ M0E9C9V',\FPXK+(%E+P:J"5(7)DI77*#0ST?5DL-/&^,RF+H4QH-2RZD,QDU M<[=Z,E*U*82$6TVJNBRY?KJ 0JW'CN=L)KZ+^<+8B>%DM.1SN /SL+S5.!IN M47)1@JR$DD3#;.R<>V<7@=W?;/A#P+KJ?1,;R52I'W9PG8\=:@E! 9FQ"!Q? M*[B$HK! 2..O#M/9NK2&_>\-^E43.\8RY15&P;/6OPV&NC/Q1T"QD U4EF0G*9"3DG:EJ(.;>U M7QT*X[BC#^\2G[+/Y/]ZHW+9@J!RFXDKF.K:AN)'NTDKJWWXY ZR&K4@7S#& MLY_V=@=2*+QZ.A -*U6L;$ZR5M\9ST0AS!/):R#G]1S/F74;D=,3S\7[S*64 M-CD]B6G:#- "R(H7N+^P":\E+Y4VXF^$MSH0454U)AY(IBI368%.O,CUO+C% M\1*7>O3C'E//]1+F)@G;6XE2ZJ8I)5?7-[^3>] EN5%<'F <]/FRD+Z:K^_2 MM(/Q718$^VQ9&KNI1_?G@]B-PNA =&'BN7'*>C.4)6X41%9AA:YN!,@WJAT/ MPO>H]3/)I3)0-;*I"3!7S;7;\-L:(OB55H9]V,&[B]U+%O-@-XEW M8XJ-F^D(D5 3?MSX<8 MF?=BJK%<0ZQJYA]8"7S$3&/R(.=XL+DT@"0?9/5&;>/WO3SM;@WJQ_:T)B'Z M]+JB9;'+DNA526-ITLD9^+MT67B_5[T^B]PX"$@T2&*LN9EXA/R3Y@8VRNZ8 M?H%LJVB"3/%P8=&W/.V5XKV*9H?@T1Y)B[P[DBA"DNX+ZR68&]:+),+$!8S< MO/S3Z-EB+>X4QS/$XH#<*\.+ENB.21H$6.T]-FX<,I=%E%S66MMV ANI6@LC MH FH4'+^R=C+K0'ZC]_8%O8TPF!Z*3C%JK7WU MEV=S,=YWB1<=^J$/>[U8"7K>=)SH1-72M&W9=G;;U)ZWO=QN>]L1XS]S+C#J M F9H2@=QZ!#==IGMP*AET]E-E<$^L?E<8&,.VF[ ]9G">,=[X3UWE$]O5?FI6DFIT=LTR>5UB:HZRT1Y=RY3=7LVHJ,-X5VR7&E#&$]."[&4-U+_65R7,!NW4N9) M)O,J43DJY>)L](J>G'.SWB[XD,C;RADC8\E4J4]F\F9^-B)&(9G*F382!#R^ MR N9ID80J/%Y+7/4;FD8W?%&^J6U'6R9BDI>J/1C,M>KLQ$?H;EU;O9 MR&KYJ]!B2/ VR. >NBMRO6J0J_SN9QO"QB#-JU*WD:E+DT:Q]E:E2)W\+BR40I=*D^PNU>%'# M5J*J(&B;I3YF$>T)\''H\QZ583^(T9M<2SAB&H'L5.7+%S#-T,(:)-?FI(F8 M)FFB$TC7#3?%<=B7Z6$:1CNH 0G0>Z5%>D^R<50%C@PP\V/'L0'FP.$X&O.0 MH9L5.*)1T&7OS*1>N,-XRLD.JD<9^B#*Q*#/3G$TXA!#S4Z6&OC4W7ZJ6W0,SD8D1#R-+0C'_N>&84<$@5&P\*2#884 M!J@:D-K*\WVPL0T7#4QT6+IKJZ($CR8%G+IO[\4PH;$SHS1R9A%CZ%T/2:$, M3C4TE$W$Y-?92N1+:;=N8J6F:;*T)_Q)8G7/!"]DX)1.;3\@F/I>.P^H ;*- MTWH>,$_JO?S6? !PU2D5K.FS_]A@!C>]:D HFJ;2B&)'7Y[T,)C9GO4 (PF,1=_6Z:B&&]3(&%PLA<-T$7 +(CUF^. M'OK<3KF'1_ZZ--;H.XP*R!2-1#Y'\G.=%":!L&W)#Y )<>3: X0XZ+ MU&5I2A*D9ETV?C35J0W?7$X;S1I_+UJ,=N#0MFF^ TZFC0M8UT%?[>?%(+BJ MX-;94Z,M'' 6G#[.]$3^_6.QOVL%AW$<4U8&MN7E)C'0(&*V@(5?7>!RB"N6;VY1!3BSJ0:G,'%]C5N9T$:WN6I M"M+> F5KT3YHZH>AO[*:0>+I M;0X)%)_8+' .,8[<_B3V,0^Z#8<3+% ME'$<.9TE4((8AX;;.FS[6'5F@EU^9Z>/3<--&'$I/C3><(%OKI!)5M3:-J+K M]GJS\)!C1N,C9^X3N)*R+4H,_:Y_M*723D1TZZ4=QPQ[ 1](.=ZF'/_7*7?_ M'K(KY89W^9ER/U/N_Y%R]@!M=F M6/OAJ;07,-O('7@,RFB6I*FY>,UKN?D#]7^&PO=V]R:W-H965TDK!=G MMNH@Q8!]L\ZR0$VNKU.[&<62\93F5-M^Q E;6 M7.14P51L'+D3C"9&*<\<@O'0R6E:6-.QD2W$=,Q+E:4%6P@DRSRGXN\YR_A^ M8KE6+;A/-UNE!8$$6T^LF7LS#_1^L^$A M97O9&2-MR8KS1SWYDDPLK FQC,5*(U#X>V*W+,LT$-#XZX!I-4=JQ>ZX1K\S MMH,M*RK9+<]^I(G:3JS(0@E;TS)3]WS_.SO88PC&/)/F%^VKO;YOH;B4BN<' M96"0IT7U3Y\/?N@H1/B, CDH$,.[.LBP_$@5G8X%WR.A=P.:'AA3C3:02PM] M*4LE8#4%/35=*AX_HF^[RD5%@BK!;$]%@A89+22Z^DY7&9/78T?!@5K-B0_@ M\PJ1>8+U_:+T]97.'YI_%T"MW('8W9Q((F8B3F4+<,]T04N+37O$9B/8AJJ?'[(0:=SNNH4$$' U)T.+P;I(M.G0L%'BDZRJBL;'M M=E,3VQBC!R:U5[A ['D''S P5AP]@?1-L =/Z7[^%IR>5A8TK2RXN)5!Q8-Z M:(RLNMK/VED_]"]O4Z_M1KVQCCZ>ZB$OZOX=3<6ANL]II@.SK[('7O?2L V7 M6*=5MY"YH1V.ZLBZ"D*_#7+7L[WP* .&G45B0VB=3%R!X%WQ,.W_=8?[F X;$-\J"M53<0= M>/[HB(J/.U2\$'<6L1V]=,EQ)KD#/QQV:$1@V*FT<3J?[CD3&_- D2CF9:&J MK_A&VKR!9M6G?[N]>D !@0U\5:",K4$5VR&DB:@>)=5$\9UY"*RX@F>%&6[A M'<>$W@#K:\Y5/=$'-"_#Z3]02P,$% @ -7SY6&B880D="0 Y"X !D M !X;"]W;W)K&UL[5I;<]LV%OXK&'6W:\TR%N^7 MU/:,[,2I9^+&:SG=Z2-$0A(V)*&"H"_]]7L 4A2H4)226DYG-R\D 1#G?CX< M@#QY8/Q3L2!$H,O1J(@7),/%,5N2'$9FC&=80)//1\62$YRH M25DZLDW3'V68YH.S$]5WP\].6"E2FI,;CHHRRS!_.BS@=6(-5QRV=+X3L M&)V=+/&<3(CXN+SAT!HU5!*:D;R@+$>J-7REY*+1G)%69 M,O9)-JZ2TX$I)2(IB84D@>%V3RY(FDI*(,?O-=%!PU-.U)]7U"^5\J#,%!?D M@J7_IHE8G [" 4K(#)>IN&4//Y-:(4_2BUE:J"MZJ-\U!R@N"\&R>C)(D-&\ MNN/'VA#[3+#K"D:R#9MIX>>TRCK*'K.GLIVZ5A1<+LIR!QY M72QQ3$X'D 0%X?=D(()VY3J9_OC#Z%M.C^A[_?N^YO:S.>UF6]J M=\@8:EZ2(2HOMKQ8: *A06."8E:(YIV_(WHK]-%5+@C$E6C/\PQ3 MF^<:H6]IKKC MO@7M<<:XH']@!9P0C67.2W1MI4A1S] V',4+W ^)P72A*(@9S7&,LC,A>1Q3Y2VS1\Q]G#[D=2H6'%=YOYC\#^ MFDN5!X;*!3AC)6#??F;3@D27'Z3W(E-KV^"9T.YAL.EOG">[F4JC6-:&V2S/ MW32;:8;#'N3U&N3U^I$7JIVD3(DTNI0^CVE**S=(L)V"O W*LFE*Y]685$7/ M,YC=BH/20]UDIET=4""S*0I&HS+89SU,,4P%"U.+>A>K]*AT:!3?' M=Z#BA".9:=,":;%B.T^H)C3"PN[%9 M1V:)R_LC\1M:"$ZGI=)$SQ/'#MMY(]-D'(L2$ .G[20^LGW#M-P6-+LN0$*O MXILJ.Y9A^4Z'$=;6U\+URX'Q$E..[G%:JD31(Q]DFI(YS7,)@1V2N9'AV4&K M)S1<*!G?9LN4/2DPR#O,N ENEA&89F7$=-=B!_#@.AI4!;#X!1ON.J)YG):) ME+K&IP(M,87\?5(EEB0\W.G47KML\15(%_A1AXTN6_B@P9UE&D[41D#H\DU_ M&_CN-W?0=PS+_=^0<0RDF;ZIU*T? @+!FI)U*A)U&A_1*VMNF:+<)JRN%(.]ODQR06>DTX [6?S9P/C M&O-X ?L/=$FFO)1GAK!_V,/S;W\O9:%5D+CD5%# (T>EF;Q=O\NY>P'>2_ MU.1WE0@7$)5SQM?%ZG@MTQ;K;C.L;W]FT[!MS3X[:B?\UKZGRJL=S3\*$.<> M=K?R++Q &20Q)&\B=RMZE0#6E05HR=7!UA1##=QIZ'[^AP+'?>_:FG]=*5II MC=5BW&12*UE6]W^53(+2#:T_3]3%GGW=N%;J"XJ/W$N>1-417^;)<=]B;'?]&.&_7HLQXA,"[V7R # L&QQU5_= MU;9"P_-\-,D X%Y=T^1/$7,,QXQJT+FJ0.?0UAT#5/Q,YPOT&R4II$M:%NB< MY4GGA$W9OZ8_L!7/ZS(5])4*0W0! +:E1'H.CJX10.WS7E8G=[(ZJ=DI+:_R MA#Q^M;]PA8]:U2\NC.D.=0S#*\, 3T^R?Z39Y0W7&% MD9"<=[=7-Y/#L;4-&*CR,@-3RF)O9\P^!^/("$(+C=_=Z1%[T&!=]5=+O7A: M5MM ?05^B01]E[(I8-\MD0 L3Q\]U=#K>U$:Z^XNG^O MB'J%_G^OB ) 5^<9*B+;,4P[>*:*R#5LV*?^CU=$WDM71('AA/YA*J+ B +_ MVU5$4"+XSLN71"YDSLO70W+KX7ZOAPY;#SG?HAX*C< VO[P>\AQ[Q^@^]9!. MI?,-]6W%ZSOALM)X7U.73S^PU^JO0EJP-FP6!0?>/O/,OJY_2U\;9Y MD'])"UEV*'AI'=Y#S:7_ Q<9;A3(SO6/@I'A0)4+77ZK2WU2";0NUS)E5ZAU MV9[ZYA*A5W#3?HUQ7?7A:].MD67XH;GJZ/+42/OQ.".PYLO?J^7G\C(7U3_( M36_S"_>X^G%Y_7KU_S?4>7.:%R@E,YAJ'@?> /'JE^JJ(=A2_<8\94*P3#TN M"$X(ER_ ^(Q!85HW)(/FQ_:S_P)02P,$% @ -7SY6/@)>*:Q!0 N!8 M !D !X;"]W;W)K&UL[1AK;]LV\*\0;EJT@&V) MU,-2DQA(4F?-,'=&'BNV;[1$6T(ET26I./GW.U*R+">.YW3M@@+[(O).QWOQ M[GCDT9*++S)A3*&[/"OD<2=1:O'>LF24L)S*/E^P O[,N,BI E#,+;D0C,9F M49Y9Q+9]*Z=IT1D>&=Q$#(]XJ;*T8!.!9)GG5-R?LHPOCSNXLT)V@RU3*MD9SSZG ML4J..T$'Q6Q&RTQ=\N5'5MMC%(QX)LT7+6M:NX.B4BJ>UXM!@SPMJI'>U7[8 M9P&I%Q"C=R7(:/F!*CH\$GR)A*8&;GIB3#6K0;FTT)MRI03\36&=&HY!^Y3E MBXS?,X$F&2TD4@E5:"+X;1HS-*DWX)05;)8JB=Y>TVG&Y+LC2X%\S<6*:EFG ME2SRA"Q,T)@7*I%H5,0LWF1@@>*-]F2E_2G9R7%,11_9;A<1FS@[^#F--QS# MS_E>WMCFA$J$NUV$3K+W+VI*%-G*;&;L%O7D5$-LY1/^/_\TXNEND@II" M]KU9GU],+'0Y^>$F0'TRYH\=?O')6DE>X4XBA?[B!7LH%^CBM)A;+4&%$NFTU,I*;;-*&"#S!2WN MU\J7(DJHF+,&@"\AR!D>E@@1? M8^&#]2\N 7TR%\R0H$OVM4R%F4N$<1BBJ]'%#?K(:*82=$8%0Z.J:C#9R-5Z M-$IAI^?XMAOXI&?;N$'_ A(*#6!RN!OYB3?3 S3HNJ'3@L,N<78P T'_1>O(-\Z7D$KES!10&1D*72!14K139'J4#OG/$84 M @-".V<"K,_09VC"F)":1,>^_OM!E/-52(D'(>7AGF^3,"2>":6-:+ED\6K: MVO6@BQW<@L(@;$'$"37Q )RN=]&%D[K9#+S:VBZ*'B;H >X'KFLV,N&E,+TD M6 CVH@4D:4ZC5*K*G .['SC^5M*"%[T6>1^="YZO!=M0!P0OYPE$D>74J&VJ M#+Q@7U4&X6 _55XZCIX[WIR??4:3M05==)8QN*KL"JEK 1TS"MT>\7#@8/(X MIC: 5E21KF^OZXC3)1 ZZW\.KJ,*.Y8IK:/9K#I(6IN[&55-P7AI/S[;[WOF M=F_4],GMA';ST/G]ROYG E3VZ7X_S\V_6[/B^-8_=O3?]I)%W;]1L(=X-@ MT(*\@?/B5A\@.%A]O]W)$;?K8;>-(-W0(]\J8L?]V&ONQ][>]^-[1B$;T@(M MDS1*'IS#BIN;<77[9W<18S%D8,ZA.094@3P=II%NI^ON7G$%J;?!9-NM>K=Z M^SKD3U#]P24#%#9W@X>DHY7N8ZW[=:7[ZVT'T[6Q8)/K6VI:DJVW &VU%FEJ MP^!0&JUZHR)^]R_.[J8QPH:VU2?]V#[T:;EM&6]HOCA\NOSVT/8SL;X%U+Q7 MT+-8?VME;T[7[2IL2RFK]9H(RLS-FZF$T"X+53TL-MCF6?:D>HUO 2V@>:P> M_@U02P,$% @ -7SY6$T#*5-3"0 )"$ !D !X;"]W;W)K&ULQ5K;XTN5[<19U^;BLC,[SS0) M2=Q0A(: HGB_?@] BJ)$29$GLY,7BP2!1G>CS^ENTF=+67U14R$T^38K2G4^ MF&H]?ST:J70J9HEZ)>>BQ).QK&:)QFTU&:EY)9+,+IH5(\Y8,)HE>3FX.+-C M=]7%F5SH(B_%74748C9+JJ9WIZ/H@&)!/C M9%'H>[G\IVCL\8V\5!;*_B7+9BX;D'2AM)PUBZ'!+"_KW^1;XX=C%O!F ;=Z MUQM9+=\D.KDXJ^225&8VI)D+:ZI=#>7RTAS*@Z[P-,*O*VS$2V*6 $Q5KM^$J[ M*WY0XH>D>D681PEGW#T@SVVM=:T\]UAK=QE9B_!VBS @>:WF22K.!T"!$M57 M,;CX]1 +IL40@BQPBV(BE306IPYF6-0!/*N")Z*LBU MG,V3\ND?"O P!IF#(ZJV4>TR[?#FO_X2<>:>DK_[]U[H)"_(W32!@>G3T>MZ M"QYP&GDJ5#OPMLB!&>LT18;.2?O@&@.RR+-$BXP@RM(I::+L]?_=W,]2)P6Y M5$KHM:8OB$^]**21YW?&.&5>3!T6=L:&,?5C=M(9":G/0^H&G+R3,EOF1=$^ M]%SJQ;RG@A=XU/.\C7&'KY_[+*2Q&Y ;\5@MP-6$!]8[_*=Y)Z LB&"XM^$= M+^*4N[SK'>[0B+M=]V 9CREC[M'NB5R?!@?<$X4X%+C'1-2E,EC=""&2E%G? M=100UJ)JX$E$-S3S,BT6F=B+VEA",47- MA4UPQ1,%-R3:4(+A)R-H5LN12P3[N)(S2QXM>EK4K-A12SMA&Y;M8R,]J01) M4048_"RGHCP@KLYBL(LLU'ZIF -US=[S!7R)1$M2^554D#^O9+9(47NL#N MT?HMT?I'$RW\*\LT+_*:73&R2:Z/"X752K74NO(0EF6H3Z!BVN63,SF4MCCY'+[#\ %'ST]NKV\YM+[+_>F4<19>%:8\=SD#W<_5)!C$[$ MR!O#%6D3_X990!FHC_Y;#VQ[BV.5&['>N!=2OK79KDU;,2'<&;GD_>W-)P+$ M5Q/1F^.[E/'H:)'[QALQ#UJF7UZ:(MX@=H;&1M46BF_FNK^]PVC O-YP[!YO MI>-0WPUQ:EE>Q[IAN I-5:6?K*O%'XM\7A,^[I !DG*2&ZY/-G/@VOMP6]!7 M +G X?U!^!%_1C=V\\Q+[QZT$T.M1UCI>X%Q%6RO.Q".*-^F:&P?'T@'-@ M/OLKL<@XF##H;Q0A=,/C?<\9#1VW@\708M'Y,2QN;V7N=V$O0._@4QZPSB#J M_Y"AR-WH/#@"W/%[F0Y5-$=BVH,]P)*&L=//%AX*<[<_WLM1-&3(EXCP@YD/ M)7D4[S@)'WD\B+^_BPLZ#)Z-O2"F<=3G%6SJN-_?M"4.G+?#O09[*'GS?D4U M!)Z#N&/QGX5?*^CY"'0V&K UGE&\/ N#*!+NA=(5BOI%E9>3EY4H;-F72J65 M7>F6V^[]I&[YK MX]Z6.Q#DBT+;*7B@\W)A7/\)(56?6G/D6[Q&UT3W46B<.< IR/ ]V/7DT#," MN="R6)BG#U/3H1LE/L'.BGR4Y1B06;>K M5P=:[*!ML8,?:+%+J%^8A($(V7+ KE[Y\%8_DB6/^6W;T=7 1M7<'PSI#M1S MU];7-K'O8&67+(7XHDXZ0_S T,>5_^P+G70=7K(-KV[J#AW3Z47=U#TTO:P; M\HVQV+1V*Z8!1_>2@:$CM], .^AS ^9T[$1]%T6KT-3)-_(H2M&M"8;!9K\\ M=-%J=]YH#L&0MLQX9C)N^LG>>%/9'LZZ=<4[K+/O6I>M!G2S FY3Z4UB8AMY M0GS+F_0PFR=Y5?/E5MY"PXTVH=.D!ZBAHK544[%@D_9EY:YL^LD='(!FU,?!W);(7\B>3V19Y5J\S.2R- FN MW@ET:5,K27%R4&''KB@[PK[^<'S<;Y4 /11O[^']R1IFTJ8,PRE5 DO-BTRA MD1[K5-L3[-)H1V/F,XI#VUOF;(6?2NI$4==2>T+-? 'HMOYKT] Z[Y@.+F/@ M%9,=R7!B]\-65TFEA<'5.NZ.+L9\ZGK]\QQZ@"SS3\CU%"@U11A!E.0S'%CW MW&9)N1@;AU;P;B4>Z\>K=_M]Q^XMHJAG955*,.E^N9X82S/=Y1>R'C_HC=CO:_@O M9?WE>SV]_O\!Y.A)#AT+,<92]BKT!Z2JO\G7-UK.[7=PE)BH7^WE5"29J,P$ M/!]+J5&ULM97?;YPX$,?_E1&MJD2R AC8'\GN M2DG:].ZA4M3TVFHZ,M&FUHXFIIM:!N#HNB9/Z]=V"[Q)W=C0&G\E:ZY]^\G>Q#"(O""O,G2<( M>CWB+5:5!Y&,7WMF,(3TCN/Q@7[7Y4ZYK(7%6UW]D(4KE\$L@ (WHJW<5[W[ M"_?Y9)Z7Z\IV3]CU:U.*F+?6Z7KO3/-:JOXMGO;[,'*816\X\+T#[W3W@3J5 M'X43JX71.S!^-='\H$NU\R9Q4OFB/#A#7R7YN=5#VS05TBX[*@G<"EO"'14* M/ S.OHEUA?9\$3H*Y1W"?(^]Z;'\#6S,X8M6KK3P2158' -"TC@(Y0>A-_PD M\8LP%Q"E#'C$DQ.\9$@\Z7C)_TC\M7Q[6OHZS1^=2]N(')>-W%&[I/DS^\F_$HN8(__:;J MY250]0Z&.UR;UF? )Z\9I^PWA*^[?W#_B/N*-4(60)T)I')(^^[@3)P/'N^! MQYPE63:RQ+.(9;/DR!*S29+VP#/J":TJ[#FAG_TFVST^US6"$T]H&2A\&>Q([^$):1M MI)9-YK.C^2R=PW6>FY9@!PP^4=,NI&O-$2R>L6D(/# M'CO]-CPB32_A?,I_@T_W M?5N7]N*U@QJ..FN-9MO='Y8<"=PWV<$Z7%'7?6?^;WE_O]$1V$IEJ<0;GU]I1U^^&)5VS:/P"^K[1VATF/L!P<:_^!5!+ P04 M" U?/E8PWAMI(\" "/!@ &0 'AL+W=O]8-_Y[KOO._ QVTKUJ!L @YY;+O0\:(S9G$>1+AMHJ3Z5&Q#VI):J MI<:::AWIC0):^:261P3C+&HI$T$Q\[Y;5S _-K?*6M& 4K$6A&92( 7U/+B,SQ>IB_<.R-+XM<,,AI(N\7"_1U]Z[5;+BFJX MDOPGJTPS#_( 55#3CIL[N?T&.ST3AU=*KOT3;?O8*0Y0V6DCVUVR9= RT:_T M>=>'@X3\O02R2R">=U_(L_Q"#2UF2FZ1ILOXU&G[[3%0?]>1896\-%1N4.;]'CD7?P8H)NI#"-1E]% M!=4Q0&3)#0S)GN&"C"+>4'6*$]C#IVS#NLISK M#2UA'MC;H$$]05"@C\B.)PDL?A]"PY\F48AQCC(Q]. M\C!+LV/?Y,S'+=DS5'^IDZ1)F&:3 ]\TR\.$Y,>5SU(;B5^Q(6%,R%M?8'0P M)%I0:S\*-2I=._IY,7B':7O9#YD_X?VHME=R;;\SQ*&VJ?AT.@F0ZL=?;QBY M\2-G)8T=8'[;V#\&*!=@SVLIS=YP!89_4/$;4$L#!!0 ( #5\^5A7#HH( M!P8 /<: 9 >&PO=V]R:W-H965TVLUNFX42J+(2,D'I9I7O5&A\W863TZ-'-7Y)4^JY&=EV5:WYWHPMP< M]6CO?N \OYHZ/S <'<[2*WVAW9^SLQK>ABN4<5[JRN:F0K6>'/6.Z<%)Y.4; M@;]R?6.#W\A[L7P M]SWZQ\9W\.4RM?K4%'_G8S<]ZJD>&NM).B_+N,0*"BR18$M%5BS[H6A9I6_I"X='=;F!M5>&M#\ MC\;51AL6EU<^*1>NAMD<]-SH7%_G38#-!)W5\&+FMKA#GZR=ZS$Z-94U13Y. M';Q\S*NTRO*T0!<.!B SSJ*]K^EEH>W^X=#!:CSF,%M:/EE89ELL4X8^F\I- M+?JU&NMQ&V (;JQ\8?>^G+!.Q,]I/4 DPH@1QCOP^"HVO,'CKQ.;32%9&(PV M&_0->&!G:::/>M!A5M?7NC=Z_X[&Y$.'.]'*G:@+?72QZ#OO3;WTS")GD)MJ M-%N[5^N9J;U/DY5/MM.G;JOOWRE&^ ?T6L\@,0^GCJ$\/U6($.)'J/Q@,=*W MF9XY--.P,4W36J.T-'-?R/LKM?/[ *QPQO] (WK_ QD(((BW0X&0$!PG,MI?K@FVVNS;U!1C7=MEO:"])?8^TM_G MN;L+U".*I8R[+(@D@O@%(R_U#+9?Z.4O4,NI:YK95].I*:&9IYXVKS7ZW5B[ MO2P_IIG/PAUT!<3/:^?E+,WKIM0S:(^K5A$R2C%7(BQ"R+J,6D5(%8%"DHUE M-*E-B3+8Y?-JGE=7R*S7>JGA1*%17F6FU,BEMX&I/2EB')$@= L[@0 3.!90 M7G_ N:5XPM1:*TIPPN,.6 H5J%0 ^P.Z[0P\1N&"=J$HJ%[P_"2U>=;D9)P7 MK=U_NIZF=HH]PENRHZT?9 MZV_(7_]A[/N;\O^R9;53PSULMT?-=M]J_Q&*?>,,VP23A=4082)YBV"E9XWD M602;<(Z)"LFLC082+,&$BF?RJZ! 5F&O>0YG03'P!#,1=1)L!!8320*0&,M$ MA 0; >E3^03!"JQ@.4(%&\$"J27"(RQ5_$/TFD!D.-\&3BF@,[5S';]57O5] M3!,2EAYX3$EKLZ(Q%)"*?HY71<2@2%0K;6 G$& P(-B.&Z#@4#BR$Y9A+MDF M7GV^;A>OPMD8JYAVH$!=2W]@>!%>309)')(@)^%<'._*JD_CO4E.?92[_L.X M]S?E_F5+:J=F>]AJCQKMOLW^Y]07X-08MAL>1\&($E%K'KXPJ7H6G\8$&#-: M%T"(Y&]4<^$=.G M>)1[N@T_= "F/<^ DG_L&S4&FJ1!E$)H/ZBE=B%GH"JF0@10_5BVN6Q8LSL^9JX](X9\KFYU2GL#MZ 9B?&./N7[R! MU5W7Z%]02P,$% @ -7SY6)Y,%BRJ!0 FB@ !D !X;"]W;W)K&ULM9IK;]LV%(;_"N$%0PMDL2ZV8W>. 3N2L W+$M3M M^F'8!UJB;:*2J)%TW #]\2,E6;)LF8VVTR^Q;N7HS><[AG_++:$2/0E MB5-QU]M*F;WK]T6X)0D6-RPCJ;JS9CS!4IWR35]DG. H#TKBOF-9HWZ":=J; M3?-K3WPV93L9TY0\<21V28+YRX+$;'_7LWN'"^_I9BOUA?YLFN$-61+Y,7OB MZJQ?42*:D%10EB).UG>]N?TNU59>K X^,#/Y)P.!2P* ,&)P$N.Z%@&$9,#P)L"<7 D9EP"AO^Z*Q\I;V ML,2S*6=[Q/73BJ8/(INC#ENT$3B,Q[4M575UH/RRKMBBJYERHFHT>6"JW OEI1**6^'MSO/NM M>.\;Y3L&0%^U<]78SJ&Q%XZ1^(#Y#7+M:^18]AA]7'KHS=5;I#3FI.WUO@5[ M0J%/MW77 C1H!^DEX)W(<$CN>FJ.%X0_ MD][LQQ_LD?5SF[B0, \2YD/" B!80]I!)>W 1)_]L4M6A&M5.R M/POTU="U%T9P5ZDA85X!&^4PG38\SYQI__E8/\CB B!80[]AI=_PE?KELT;K MF#02N@H%"?.&YT*YUN1$*\@2 R!80ZM1I=7(J%6> 0BT)7&$5+Z+A,X%OA8I MP>,:E;<_,/0)QQM.5&J*%HRI2_,XIC@-"?JTF*-Y&JD9^$6)_M<#T>+_W::Y ML29=-8>$>9 P'Q(6 ,$:?>.VZANW4$OL+:2TD# /$N9#P@(@6$/:<27M^']/ MT49"5TTA81XDS!^?S??VQ#U9FP.@$AM:32JM)J_4*J)"Z5'YKIV[AZ0- ^4YH/2 M BA:LP\Y=1]RH+*DD@2E,"3- Z7YH+0 BM94N'::;*/;\:IDJ428TXA[: T'Y060-&:VM=.C@UF MY=B@7@XHS0.E^:"T (K65+@V=&RSH_.X3]4*N*49HGHM)$*B-U@@K#]-]?+8 M]C_&A9G966M0DP>4YI>TR7&N=/HM^CU,'KMV>6RSS?->I2YH3B/T.]&^P@-. M\::P$^Y9DN'TI55 4(\'E.:!TGQ06@!%:VXGJ-TCQX*:CAU0TPB4YH'2?%!: M $5K*EP[2X[96?I/T[&9V5EK4 >HI!DF4!^TP "*5@C8/]IJE1"^R3?%"93O MEBIV7557JXUW\WR[6;]^O-BU]X#YAJK,.29K%6K=W*JTGA<;X8H3R;)\X]:* M2 M%0\7 SQX/'&3+I9E=6(X.5^S!;_EY9?UM5!'PQ9EEJYX+M,B1X+/+P;O\%E, MH\JAMO@SY0]RYS>J0KDKBJ_5P:?9Q<"K[HAG/"DK"*:^[OF49UF%I.[CWP9T MT%ZS!7/'))\6V5_IK%Q>#*(!FO$YVV3E3?'PD34F2R M_D0/C:TW0,E&EL6J<59WL$KS[3?[UA"QXX##'@?2.)"N@]_C0!L'^EP'OW'P M:V:VH=0\Q*QDDW-1/"!162NTZD=-9NVMPD_SZKG?ED+]FRJ_8G>)4FQR?Y;1#Q"+3GB(2U.[&XQ\]Q']7NV!$-;1\3 MK?%H#]ZU*&:;I$33C$DKO5MWW^Y>%8\SN68)OQBHZB"YN.>#R:^_X-#[S48- M)%@,!&;0YK>T^2[TR0V_Y_F&6QG;>@:U9U4=[R?$]\8X&H_/A_>[;-@,@S B M06 :QE9$GZJ/UM"((FBC")Q1?,I++B1?J');(IZEJ@RPJFC:HG(B'3H.(,%B M(#"#P;!E,#PN?4)(VB#!8B P@[912]OHQ>FS]0QW!OL)P8$?CCK98[/SQV$4 M=I+'9C=6B"-[[D1M")$SA/>BJ)(FGR%935ZV2)P ASY[2+ 8",P@;MP2-SXN M9<:0M$&"Q4!@!FW8TX+*>W'2-*Z[HSSP1E%$O$[6N*]Q*"%0:"8C.Q(3[V&D MTHOH>LF44$^^H]OM5&8ER(ETZ*@"18NAT$P6B6:1')>0C3\4=Y!H,12:R9U6 MS]BI,B>?RR47JDVM,]/*'7V2F)C0,/"[>6FS\[%/.[.9U2Z,1H%]-L-:T.*7 M*]K&U;CH:!0%WI-)V6KIC_T(=Z=EFV6HB"%ACZC%6M5BMZSM*0OH/WVJ=\YV M0Q\\UD&%+A2:2:N6NOA(K8M!Q2XH6@R%9G*G]2Y^N>#%3Q4J)H%J \>TFUTV M2QPHV8N[V66Q5#UHX/ND)[NT[L5NX=N?7<^0Q&[L@X<(J"B&0C-YU;(8'ZF+ M,:@P!D6+H=#,%3DMCR8V"ZE.-F&CN2A6:*J23S U@![2 M)\L5$U_1WU=\=445$V#HL50:.8CU&J:'*FF M":B:!D6+H=!,[K2:)FXU?O#7HGD0:E:C[;!/1.1YAT$WIK-S;- MNLEL!0O#GN4AH@4UV2>H^W+Y\ST7)ZIQ.*E?A:C^8<5G:5*GGD1,39]K+F21 MLPPE3/"?FN?.$ \>JY!H,12:^7AUDT&"(_,Z4R#[.H6^LO&1LTQE?%4@[CC;E-\12V<_5P8X0SEX MB$.BQ5!HYF/471*)CBP/H)T0*%H,A69RISLAXNP6GET>QK;RX'67S*;NJQW, MS8_H=*CN=.B^3J>O/'S@.1=*,ZAL3Y:J2*22U[6BJ)C7FQCIXC,'N\?D1FWRH[N&H?V1^@C9(H&@Q%)K) MG6Z0Z+ZW,/UKZF:%[FE6 M^G+I6>^3W. '#Q#03@<*S216=SIT=&1R@;87H&@Q%)K)G6XOZ+Z7,([DBIZD M0L_[)/=%#J8$M&L8[FP]5M)T46_AEJA>,MMNUFW/MMO$W]6;HSOG+_%9O-WL MK6&V>\^OF%BDN409GRM([W2D*!/;[=S;@[)8UQN<[XI2Z>/ZYY*S&1>5@?I_ M7A3EXT%U@793_>1_4$L#!!0 ( #5\^5AJP;.LO0H +!U 9 >&PO M=V]R:W-H965T78[ZBCBGR M[+XHOU1+I6KVL,KRZGRTK.OUN_&X2I9J):NWQ5KEYI-Y4:YD;=Z6BW&U+I5, MVT2K;!QXWG2\DCH?79RUQZ[+B[-B4V$])]4KEE2YR5JKY^>B]_TY,PR9!>\;O6MU7 M!Z]94Y7;HOC2O/F0GH^\ID0J4TG=(*3Y=Z>N5)8U)%..KSOH:)]GD_#P]1-= MM)4WE;F5E;HJLC]T6B_/1ZM'*UJ4T#Z[SY9MW4 MI?E4FW3UQY$BLL]Q-5=EJ5(F="[SI-'HJJCJKD)=1DB)D#". MA,5(F #!'&VG>VVGY-?D_:KI=7_)=LRE'LSHL3(76=,?TR?1YWO1DV.BDUD, M%1T)XUM8U,*:$>_=Q6PV"SW/7%_O#O5\?I[OS8*39R>*CA/]P/,/3W1T.-GK M<$+VL=WXQHQSDL*,B1HYNEKZ!-G22!A'PF(D3(!@CJRG>UE/Z>Z5).7&=*+$ MC#M+V=<5DGK*B7JK.T2<)'*H>$L:1L!@)$R"8(['OV5M1 MCPR['_):Y@M]FRGVOJI4]^5MQP#I"J5Q*"V&T@2*YFI[8#/X9 9 MOC,!6%NA92LTDX M4W_?(Z(QLB "17.%MF:13_H5KJ.PO:XV?L++](7:1U :[ZEV1,@+=8M0-%=> MZQ?YM&$$&E5!+2,HC?:33YH@%U?MKWZJ9*7*6NFJ MI5YW]U"H P6E<2@MAM($BN8*;&TH_Q0PLH*Z3U :A])B*$V@:*ZVUJ?R::,* M%)&AYA64QGL:8$9$9#HE,2@3J"JX$PNL,Q60[LB1D,R^L8]&[M5FU:4AC1RJ M(93&H;082A,HFBNU-:H"__7!.8#Z4% :A])B*$V@:*ZVUJ\*:+\*ZB=U5-_ZK876A"!HKE"6^\J(/T3(E[+AZ/Q&FIE06D<2HNA-(&BN5);*RN8 M .(UU*J"TCB4%D-I D5SM;7N54#;.)AX#;6QH#3>4_^ BM=0'PM%170#LQ! C MY>NE+%60W)B-SM#(O%LW$JTXEH8X5E,:AM!A*$RB:^_R&-;9"P)2K$.ID M06D<2HNA-(&BN=I:)RNDYPV]YK=?&CU8F:$%$2B:JZ]ULT+: MS<%<@NE,!BL-M;-Z&H"X!$/+(5 T5^B#I^QZW*Q,ZI41-/W?)M7)5M#]U&>6 MJCN5%6OS':B*>7TOR\Y;*#J+P3)CG\;#/HZ'?1[O1[A;H76W0H"[%4+=+2B- M0VDQE"90-%=;ZVZ%M+L#BM]0>PM*XST-0+A;/2G]-F6GIC_"R JMD1721M9O MI4S52I9?NCLJU,>"TCB4%D-I D5S1;4^5@CPL4*HCP6E<2@MAM($BN9J:WVL ML.>9P-?<)$'=*RB-]U2;^B486A"!HKGZ6DLKI"VMRXW.4ITO>B;KT)3!4D+M M*R@MAM($BN:N5V'MJPEM7_4L0#*!&E=0&H?28BA-H&BNJM:XFM .SF?[8V^G MJE!O"DKC/34+B; ++8A T5P)K3GW-#4P9+"36?H+082A,HFJNN M-:0FKUKW:0+UFJ T#J7%4)I T5Q5#U9_(OV.WK +=9F@--Y3LPGQF!"T( )% M-S_1TJ-=FC)82JAG!*7%4)I T5QUK;DTF;XJ[$+=)2B- M0VDQE"90-%=5ZRY-Z,?]^L(NU%>"TGA/S8@E+Z#E$"B:JZ#UD":TF>)$76*P M"[6+H#0.I<50FD#17'6M@S29O2KJ0ITC*(U#:3&4)E T=Q%-ZQQ%]!-]/5&7 M3CU452B-]]3,)P:[T(((%,V5T-I$$6VF?,AK5>8R>[.I%#GW@>8,%A-J&$%I M,90F4#177^LA1<%K F\$]8Z@- ZEQ5":0-%<5:UW%/5,9I)K7TZ,YA.9T<7LHVLJ1/1ULBIQ/]6CS*K'YDJ;D4-OMQ,)7IA6[7+'XDYH31 MU,%J]RVDM&KW\>B4%FK[0&D"17.EM;9/1)LCGW2SEK%.6:G,N#7=QV;VS?3E M9E.5P^=OCCYV0VO?;-WL0V2.E/GWFQWMM-XR??]@$.B]];S M'2M>T7D/5A'J$$%I D5SM^*P#M&4]E%VOY]MA:N,C+M%!^9%V>P@<*?*=GUWNZ%MLFW$C=K3VR_ )V:TGG,O&/;!5W1*0?K##61H#2!HKDZ M6Q-I2D]$ZM79=.EF.XG].*Q39SJ/D- 9:BM!:3&4)E T5V=K*TUI6VGHWBXT M;NC0"DKCT^=V4/?V+ATG/MLB"3JG:'RPT>1*E8MV2]"*M?>FVXT:]T?WVXZ^ M;S?;_.XX]]^)[>:A%K/=R_2C+!&ULM9AM;]LV$,>_ M"J$56PNDT8,?D]D&XJC%"JR#$:_=:UHZ6T0ETB,I.P;VX7>D9-E*9+7&M#>V M*/%^XOU%'N\XV0OY324 FCQG*5=3)]%Z>^^Z*DH@H^I6;('CD[60&=78E!M7 M;270V!IEJ1MXWM#-*./.;&+O+>1L(G*=,@X+252>950>YI"*_=3QG>.-)[9) MM+GASB9;NH$EZ"_;A<266U%BE@%73' B83UU'OS[T.\; ]OC*X.].KLFQI65 M$-],XU,\=3PS(D@AT@9!\6\'CY"FAH3C^+N$.M4[C>'Y]9'^T3J/SJRH@D>1 M_L5BG4R=L4-B6-,\U4]B_QN4#@T,+Q*ILK]D7_;U'!+E2HNL-,819(P7__2Y M%.+,(!A=, A*@^"E07#!H%<:]'[4H%\:6*G=PA6K0T@UG4VDV!-I>B/-7%@Q MK36ZS[CY[DLM\2E#.SU;%M^;B#59L@UG:Q91KLE#%(F<:\8W9"%2%C%0Y#UY M%$J;GD^P YX#T8G,R0>E&>J/'=Z&H"E+U3ORAC!._DQ$KBB/U<35.%+S/C$&/?%F& MY.V;=X1IR!I&]]C.^@BK6Q(,+2LXLAHPX8]@1A;C-V-JKO:J3]JSW-X%[N^ MZZ!1],*NWVQG(LR]VM((I@Z&$ 5R!\[LYY_\H?=KDT9=PL*.8#6]^I5>_38Z M3HUGEN49H7',3"RB*=F"9"(F&%9):M0D\*R+6-&PUO%;" MCF U"0>5A(-6'__(LQ5($QK6[!GB4K0M/> .H%@=R'<@V)R;Y!*E^(9'(S#2B^D(LOWL=D3S/>S%# M6L=SK70=P6K2^=XI_?/^LW@;X"!Q5TP97;&4Z4-C0N>]6@^]U\JUC^9:Z;JB MU;4[2YW]5NT6"<7*(SJ0):(9!AV\V)@=KU&?5M:UB[=36M@5K:YC<-(Q:(UY M7XM _@0K6T9@R4 >JD!NFXM<1HE)*4*F;&'27%,$G4K<)2WLBE:7^%02^*T9 M]&QQ2FAE*7/,E-U08Z(%5I0\7V,-GDMH3%7GW^'W/!+30V.2VVYYM8[_1Z7@ MGTH%OSV9/\[1+656MRAEN-XQ)RDK!BQ[*8;-YGQ__AWXF&2VZ&U4L=-:H2M: MH:)[=OR0@=S88QQ%[$(M*O3J;G54]& /2%[\BQ$EJ+S%XF0&.0I@,^7PNACPWS@NI@;?8O4$L# M!!0 ( #5\^5C[J@M-, 8 /TO 9 >&PO=V]R:W-H965T'%F^^T1^ISOQ$V]RS\6MS"E5Z.NZ*.5E+U=J M<]'ORS2GZT2>\0TM]2]++M:)TE_%JB\W@B:9<5H7?1P$<7^=L+(WG9ASIV(ARM:\/O+7MC;G_C$5KFJ3O2GDTVRH@NJOFSF0G_K-R@9 M6]-2,EXB09>7O7?A!8F&E8.Q^(/1>WEPC*JIW'!^6WWY-;OL!=6(:$%354$D M^M\=G=&BJ)#T./ZI07O--2O'P^,]^GLS>3V9FT32&2_^9)G*+WNC'LKH,MD6 MZA.__T#K"9D!IKR0YA/=U[9!#Z5;J?BZ=M8C6+-R]S_Y6A-QX!#&1QQP[8#; M#H,C#E'M$#W585 [# PSNZD8'DBBDNE$\'LD*FN-5AT8,HVWGCXKJ[@OE-"_ M,NVGIHM=O!%?H@5;E6S)TJ14Z%V:\FVI6+E"$JH05\HTV^[(@Z/6K-^@58B7ZG/.M3,I,3OI*C[>Z:C^MQW:U&QL^,K80 MHVM>JERB7\J,9BY 7T^TF2W>S_8*>Q&O$W&&@L%;A ,<=0QHYG=_3V_.$(Z- M.^YP)T]Q/S?NH6TW%*T%'Q=Q4,'(U7Z_E$YFID[AXJW M:$%7.DT5NJ)EFNM0WZ*_KNGZAHJ_T;^-F=3'G_D&+74.(I4SD:%-(M2#_GS@ MYM=YGN@L2Q^03 K:&4OO6*OR=2$W24HO>[H^22KN:&_ZXP]A'/S<%0=(, ($ MYL1HT,1H8-"C8_EU-&6Z.!Q <@@)1H# ' Z'#8=#[WT^IZ+B33^&JC*5'K*( M!).W74SN$,/ 0%8/O[MI<#:*!I/^W2%'W@N?RA$0F,-1W' 4OV M^)B(%97J MVU)0V26"&M^G% 7OH$^]H2'!"!"8$ZSS)ECG@$7A'))#2# "!.9P.&HX'($7 MA5%748B^*0K=9M4C^]",=)L%%LV9U[B9U_@%$_F:9OHV8QG2/)5F%:>78GJ] M7B2*9GH=6>KS&4IU2EO3$Y[YWJF<>FM"@A$@,">$86 7U0%@@M=@0#2"HA$H M-)?( W42@F=Y#=E*S' \;J6Y_](G$P6$YA*%+5'X?WC^N^7CX4DUP3_0D^]F M2#0"A>8&R>JU,((L"Z"*"A2-0*&Y1%I1%7KUQO/*PJ"K+ 1QW"X+H+H)"LTE MRBJGT"^=OL=J0J\5YEH1D*=5 TB%-0-%(U!H;FRL8@MCR&H *J5 T0@4FDND M55.A5V@\KQJ<=Z[>1Z-V-0 53%!H+E%6,H6/:*:M2/-$TBJ7%]O-IF!U7J>_ M42DU6S,N-F=/RVOOE4Z^'2'1"!2:R[(5<.$8,J]!-10H&H%"<]_56Q6%O>+B M67E=0XZ=M!ZWL]I_X5-I@D)S:;(:"3^BD?;)NM#0+-79O7^@MY_8G81!JJ 9 M*!J!0G.)M9H*8\!$QJ"Z!Q2-0*&Y1%K=@_T;5;]3A<1N)=I-W)"T0SP. M\+"=MAUVHW&,@]:;N0Z[. K"8Z_FL-4=^!'=X4DU^-VX]]5NG#VYM^QD$'3G M"!2-0*&Y,;,2" \ALQA4KX"B$2@TETBK5[!_B^E9C^.X:YD=#]OOXOR7/IFH M[Z%'L-4C^!$]\F)58JZK*N-;63P@PF1:<$DS--/+>NW\D0=8,4"T$BD:@T%PBK1;"_MVL9]6,+NG%P^!>V*PBH\H%"<_MZ MK/*)'E$^+U9!]F_ZYV9WWU^P815:Y19!]>!&HG )%(U!H+I%63D7PS7A1 M9S>>Z:%U4_2(W:"=HD?LVBG:/^B+UDFT,OWE$IG6YEW3<'.VZ6%_9SJW6^>O MP@NRZT2W,+O&^&O]_&2E1 5=:LC@[%P/3>QZS7=?%-^8[NL;KG0FF\.<)AD5 ME8'^?H7;>':0\.7()5L*EMDE;:A]_9)"QM"=JJO8!]^/YWOP/[&&V$ MO%,I@"8/><;5V$FU+LY<5\4IY%1U1 $8&; M4\:=:&1M@;XNY MQ)E;JR0L!ZZ8X$3"0V]PP,'?.OC/''S_ M@$-OZ]"SH%5F%FM&-8U&4FR(-*M1S0QL;:PWTC!NWN*-EOB4H9^.SN/[DBEF M2WH\ TU9ID[(>S*A4F-MR4R6*S(5>4'Y(SDBC).OJ2@5Y8D:N1H3,#)NO TV MK8+Y!X+YY$IPG2KRD2>0//5W,?$Z>W^7_<1O%9Q!W"'=\!WQ/=\CMST/=K^GZ; M>C2E*B6QP-V?@*2&O0FWTAA8#7/^K*/P=.CW1^YZGZ,UTBLY!C7'H)7C2YDO M0!*QK+XRA><0ODT)"?E569JP*LE@#RL8/F-JC?I*IJ!F"OZ2*6%*2[8H[;<9 MVPVD$.S@5IH$+\BZS\!:0[\2;%B##5O!YB -!'8C R_'ACAB^W8];I>V*MK4:7O M[K6?'.3*=F6%N[WDNNI$M;5N_.>VW[E_EE=_#5=4KAA7)(,ENGJ=(0:752>N M)EH4MIDMA,;6:(&PO=V]R:W-H965T;//P,M\3^I-M,>;@.8X2=CO:C,?,W^(8L6N2XD1L61,: M(RX6Z6;,4HI1D!>*HS$T#&<;YND>ZF).,1V&"'RE@61PC^G*/([*_ M'9FCPXIOX6;+Y8KQ8IZB#7["_$?Z2,72N$H)PA@G+"0)H'A].[HS;SS+D 7R M/?X.\9X=_0;R4%:$_)0+#\'MR) MPA'VN8Q XM\.+W$4R231CE]EZ*BJ4Q8\ M_GU(_Y@?O#B8%6)X2:)_PH!O;T>S$0CP&F41_T;V?^+R@"8RSR<1R_^"?;FO M,0)^QCB)R\*B!7&8%/_14+FW2),_/)P]%G7#$W6;$'PA"=\R\"$)<- ,&(L#J8X&'H[F'BH3/>Q? W-V M": !C;X&J8M_Q*MK )V\..PI[KVF^#0O;BJ.QJK.C97G6:?RP@1%(#UU3GH: M>%\$VOV!<@ZY82GR\>U(3!(,TQT>+7[_S72,/_I@Z0SS-(4U0-H52%N5OKC/ MF%C#&%B2>"6@2GJ7X![1C9@8JTY_"3Z)Q4OPQ!''8FKC@*S!0^*3& -"95G1 MM*V<\G;XL/[?#\](" #R:;7+<*'GI ZE,&0I29YBG*:Q!SZGH M.8-GBSYZCDYZ.L,\36$->M.*WE39]Y:(;8%/Q% .RC'9K"&B!-H[9/X_RP$_8(?/D#BRO+#D7BTMMGD_=EUG$_LVRWW?(SDTEGSO?)YG (6ZQ?"S8",_H)6-VR$!KYAAM-,K*!J/1E-9$ M VLT4(GF(=F)CD)HB/L["^P@<:93>])&HJQD,!)-:4TD]?V"J;3HQ2/%*0H# M@)]3(:68Y2.+\"VFXE:24JFTB#%\8G19'6#F;#)M\])Z4Z KK@<;NH'$==^*TV6B5K6NM":2VJQ-I6^6,W*!!"#YI(&V'PR6;-RN"UJN M97=&DE99UI76?+A9VS)4VW)E@REZ.:6"L"O)T#:=]K5*7=-0+KK2FEQJ2X9G M+9EF. ,14CZX"78HTVO_D0A6H51R$]((^SQ:,.RVD-.W9S!\-["HV'MT5#M MT:5W=SE'KJC:T';.MCNIV#*;V%JH-:]6&:M5NJN,Y0%VU=ES3 MG+4!:75K76E-0+5;0[5;?R;)YHIC&@_N35W9-J%M0*M-2ZMMZTIKTJIM&ZIM MNU"!J&)VCE%7N7NF>*W"K2NM":@6;J@6[F*\'6&1DI#%_7( >S3;M2RC,R-I MU6Q=:4U"M69#M69[>(W%;!0 CIX;H"CV"0W$!C&Y'QY:]E+K*KAIN9U[$W4S M!D-["P6'M8)#M8+_A?EK;!/VF+@%C5EG3M+JXKK2FFQJ%X=J%S^\'ZT>=,NE M7CI=%[^RH35I/P$H]YN+(]ARG:\>84<T',S/AJP M5$:$PHPCD<8QYB]CB-AZ:+G69N*&+)8RF[!'@P0OX!;D?3+C:F27*B&)@0K" M*.(P'UKG[MG$[60&>L5W FNQO-^I?-;R">< ")BSZ04*Y'%I]"X4PQVDD;]CZ&Q1 VL& M14)_HG6^MM>U4) *R>+"6'D0$YI_X^X[/1((#&%KJ M017 5V"-/GYPN\Z7.D!#8A5@',10-> MM\3K-DJ-,9?J;8NF/%V@"8L33%_JZ!I5#J4S)%8![I7 /?/9W#-);TBL0M\O MZ?N-Q[W_IZ ..]?J:*VLH][ JUV>QAW?R'-:\IP>G+[H-[KC.%2% MD2J:ZK :)0\]34-B%7K7V?[..^:SN= T% !3:M4([%0ZKL&,+L2Z.RGM^OZK ME&[>\ZU,WI;)>TM6_U_=T:Q]\.D:4JM&8EMIN>UWR&^CI9EN8#R1+=V3TPJ?I$ M?;E4K3SP;(&Z/V=,;@;9!N6? Z,_4$L#!!0 ( #5\^5C@RCE$20, '0. M 9 >&PO=V]R:W-H965TR[X;X$URR-,G1#0&TS#)(7F8HQ9NI-M2V';?)*F:B0_8 4S7'Z,XE8/-5& M&HC0$I8IN\6;;ZB.QQ%\(4ZI_ 6;RM;U-!"6E.&L!O,99$E>_J\'NP;8[P4X-4"&KE>Q2^$"R* _(7@#B+#F;.)#JB_1 M7*\D%^ODCA$^FG <\\_#IS*AB4S:%[#;"C%E%)P&B,$DI9_XZ/U= $Y//H$3 MD.3@>XQ+"O.(3G3&YR'8]+#V.:]\F@=\#DUPC7,64[#((Q2U"70>0!.%N8UB M9G8R!B@<@.'H,S -TU!-J!M^#T@"&::OPT MHHBLD>9__#!TC:\JM?LD"_HD6_1$ULJ+W>3%[F+W]S:7*@^=%,?FX1_(@"H% M%8\C><3%L^9;V!M[$WV]JZW"RG#L<6/5$LUI1',Z19M!PO@M @)2KL <9P7, M7U2Z=;(R%JI<)M4N/V?*VZ?>>F3+.B3;-$362LO7I,7[V]; M9,4?A* H21CS-Q,0+54NO+T-:IN6,VYOXWFGLV-%KLC<;I<+A97G&8[ZY!@U MLHPZ9;G"?*GR%;H]0>#KJE6)TTEV[$+MDRP8[:GC6+;[1L*>/+:4'C=*C___ M8NND.%;?\=Y*-MIZ!/L6JBM+8:6XLO2=YW6&R$K6-92'6N:L>J,VO4WI="XK MAC?]$D@/V-> M%B(B#/CX$F.V;0@'3:'I_P%02P,$% @ -7SY6-R8#\E@ P 30T !D M !X;"]W;W)K&ULK5==;]HP%/TK5E9-G;0U'X0$ M.HA4FE6KM$Y5NX^':0\N7""J8Z>V ^V_G^V$#*C)NBHO8#OG'/M<.S?7HS7C M]V()(-%C3J@8.TLIBU/7%=,EY%BC)G/,=2=?G"%04'/#.DG+B!YT5N MCC/J)",S=LV3$2LER2A<.[VP&;K+%4NH!-QD5> &W(+\7 MUUSUW$9EEN5 1<8HXC ?.V?^:>H;@D'\R& MMMI(6[EC[%YW+F=CQ],K @)3 MJ26P^EO!.1"BE=0Z'FI1IYE3$[?;&_4+8UZ9N<,"SAGYFD]4*\HQ6__BQ#L06P8\.$(*:$.P3 MP@.$7DWHO900UH301*:R8N*08HF3$6=KQ#5:J>F&":9A*_L9U?M^*[EZFBF> M3,ZF#V4F,K,''] U9^8HH8Q61TH/'Z<@<4;$.P7X?INBXZ-WZ$@AT+]9EMZ1J]W0&]2"C4B!-K> MGU]?U!BZE)"+W[:05Y*A75(GD%-1X"F,'94A!/ 5.,G;-W[D?;2%JTNQM".Q MG5"&32C#-O7DJTJ>'%9 2Q ("]4N&)?[9ZZ*8*74-THZ8ZZ2(/2&_F X'+FK M[>C8@/UH$/3[N\#4JACVU$\#W''5;USU_^F*,&%]]2IFM#7GA]A7+@9[)BRX M?A#TXF#/@P4W5&_) 0=1XR!J=3#!:A<(02DO%^BZJ[%$L[ M$MN)7MQ$+^X^0<1=AK)+L;0CL9U0#II0#CI+$(-GK\*!!&$#6A.$5;$E00P; M5\-65[=E41!0%9K$1'_74?5AWQBUF1N^U)P-:#5G X;1((YCNSG?^UNV>*_. M?S7UWPG0!K1F0!NP)07Z6]67_YI=HFWN_&>?E /N+$"[.PO05R_7LR/H;M69 M.?"%J=<%FK*2RJI2:T:;.\&9J83WQB?ZKF#JU[\RU45#E7&+C I$8*XDO9-8 MK8I7M7O5D:PPU>P=DZHV-LVENN\ UP#U?,Z8W'3T!,T-*OD#4$L#!!0 ( M #5\^5BZP#J>Y0X #_/ 9 >&PO=V]R:W-H965TF]V;67F(6E]$D?SDJ/3NZK^O;E2JO6^;-;;YNWLJFVO MWYR<-(LKM2F:U]6UVG;_SL+9M\>^%2NKMK^@9.ST^MBI3ZK M]K?KCW7WV\F#LBPW:MN4U=:KU>7;V;O@C4S3OL.NQ3]+==<<_.SUAW)15;_W MO\CEVYG?[Y%:JT7;$T7WOUMUKM;K7NKVX[][=/:PS;[CX<_?=+8[^.Y@+HI& MG5?K?Y7+]NKM+)MY2W59W*S;3]6=4/L#BGMO4:V;W7^]NWU;?^8M;IJVVNP[ M=WNP*;?W_R^^[/\0!QTZQ]XAW'<(AQW(D0[1OD/TU YDWX$,.T1'.L3[#O%3 M.R3[#LFP0W*D0[KOD#[U&+)]A^RI'>;[#O-=.=P_?[LG/R_:XNRTKNZ\NF_= M:?T/NPK:]>Z>\W+;%_OGMN[^M>SZM6>?5-/6-XOVIBZW*^_'7+5%N6Y^\EYY MOWW.O1]_^,G[P2NWWJ]7U4U3;)?-Z4G;;;7O>[+8;^']_1;"(UN(O _5MKUJ M/+I=JJ6E/W?W#T('<-(=[L,QA]^.^7WH%#\4]6O/)S][H1]&EATZ=W?_I;I] M[87)KGMHZ9Z[N[^[677=TZ/=Z6,[_]4+LZ.]V>.](W_7V[<]%=_WAQ/N[DQ= M./]P\BG=[_]P@:,,HH?2CW9>]*32K]6Z:-726U1-:ZWR>XS8L?Z<]*:Y+A;J M[:P[Z32JOE6SL[_^)4C\O]DJ#(GE2(PB,8;$.!(32$R",*.*R4,5$Y=^]FO5 M%NNN>@]J^=6CM>PDI]8R$LN1&$5B#(GQ>RS>8?UX]/8L\+,D3$Y/;@^K=-PL MBH/^S>^PE1RWRD@4$IU85$LN1&$5B+!X]=^$\.WCN[LL%N4F!Q"0(,THT>2C1Q/W65Q?+ M[J-?]['05HW.OE.K$8GE2(PB,8;$.!(32$R",*-HTX>B39&CSA19Q4@L1V(4 MB3$DQI&80&(2A!E5G#U4<88>'3C!J96,Q'(D1I$80V(^G*MMHVRUJM3 MGUJO2"Q'8A2),23&D9A 8A*$&64=^'K&UD>.(/8:J)"A6@[5*%1C4(U#-0'5 M)$HSZ_D@@0CP,UANM@+W F+L\<@T #/JB60S4* MU1A4XWOM\#QOO1['TLYV08ZEF>.*G$"';H$[=7O*L.'=8E'?=+\WQ;JH2]7\ M[-T5*]7L1@]5>Z5J;W%3UWUPMRZ+BW)=MN61\0,TL(-J.52C4(U!-0[5!%23 M*,U\->A\+YA#QP_00 ^JY5"-0C4&U3A4$U!-HC3SI@2=ZX7.G.7L??>.O5VH M5Q=J56ZW?4U7E]ZUJLO*=M?$^[UF7$.:!<'@E'5N:T:B)#:;Y=9FQ,_,9M32 M+$O[6PD.6S'W@4XMF;V6.+Y([-UR6?;W@C7>XJJH5]W; M6EM]^[!OK85QUD&2)(V'M3!N%B:Q[P]K8=PL"#,_'M:"10L3D@R+ 9HX034! MU21*,XM&!U/A(\%4T5QYU\77_JHLZQEPW__P"7L5D'DZ'Y:)I5T8IF0^K!.; M%V9D]*9A:Y?,XVQ8*=#T!ZH)J"91FEDI.OT)G;/Q#V<:U7\F<)YCHO'[RCP+ MPF'!C)M93D6YK=GX5$2MS4:G(N8^QLG5\J0C%99FXW.11.V:^?3J,"1TAR&? MU:VJ^R=X]Z$//:_LWOC4<314RZ$:A6H,JG&H)J":1&EF^>MP)8R1GPM#:$X" MU7*H1J$:@VHC"@N6IO/$/JL3*Q*:=$ U"M48 M5.-034 UB=+,UX%.5\(,.FZ YB-0+8=J%*HQJ,:AFH!J$J69]:SSD=!] ]34 M^>3YZ/0R)_YH;LC2RD^"X2?]<:O GP_/>]32C(1Q.OR@#PT@GK1- =VF1&GF M,C1H/.$>9 <7SM]7@J45R49SR996\R%%;1L,YCX9%(+[,*<6 M E034$VB-+-@=/P0N>.'1V>2H_'4_ZLH3LBP1"S-"!FN;I';FH5I%@ZKQ-(L M#J-@6"70O &J":@F49I9)3IOB-QYPY-GD:/Q_'^:#&?_SRVMQN>?W-9J=/ZA MEE:6\P]S'^#D4GG*80I+J_'Y1Z+VS'QJ#U9&<&*M:F@R M5RJ$:A&H-J'*H)J";WFCG."HY< MYQSIQ"-R)QX?Z^I2-?UZVONAQ?U$\Z52D,$'-!J!:CE4HU"-034.U014DRC- M+'\=R$30)>(B:+ "U7*H1J$:@VH&FV;![,A_=%69I%81+,A[,:XV:$'%Y8;!:83CHB=]+A'B_ $FSW M7DPN2>@=)%"-0C4&U3A4$U!-HC1S)7@=]!#HRG $NC(<5,NA&H5J#*IQJ":@ MFD1I9CWK'(JX)HF#7FEE8128=W-EA:$9(,XDWF M/LK)]?*4;0KH-B5*,^M )TW$G31-#;"))6,A63*\;<'2+ S2481M:18$V7P8 M3]J:^2D)A\4 S9R@FH!J$J691:,S+.+.L!X-L^?P[E<2 M!O'PL@=+L_%Y*+>T&I^'J*75^#S$W '::P-1N=B"1JU\SG5@T U"M485.-034 U2<;K<#F6[R0ZT"#N0./1087WA_>49<+=FYE MQVYTL2D67[W/:K7[RKT_O#]C 7'WSDVN>^A7[$ U"M485.-034 UB=+,EX>. MA>(0.3J)H5_* ]5RJ$:A&H-J'*H)J"91FEG/.K&*W8G5\T8GT%NIH%H.U2A4 M8U"-QY9UX1*2#2,32[,@#*/AW7^69FDM\,'Z!)>/&Q9Y2V.AI>1">A&I6VC$2%'OBLUUKE> M[,[UC@\X7GJ% ?>.32YF:#@(U2A48U"-0S4!U21*,U\:.D.,H:O-Q="H$*KE M4(U"-0;5.%034$VB-+.>=508N^_!>MZ0 QH80K4=NT!]VY-+7BHED,U"M485.-034 UB=+,%X:.'), M.2Q)H!DA5,NA&H5J#*IQJ":@FD1I9CWKC#!QWSKVK&&)VYQK>@9+0,>*"8&.&:!I(%3+H1J%:@RJ<:@FH)I$:68]ZS0P>8'% M$MWFY*J&9H)0C4(U!M4X5!-032;CQ1(=5XDF.NQ+'EDM40\]ZMMRT0TP_MSK M1-V[-[GRH;DA5*-0C4$U#M4$5),HS7R!Z!0R@:ZGF$"C0ZB60S4*U1A4XU!- M0#6)TLQZUM%A\@+K*;K-R54-#1"A&H5J#*KQ9+P"8AA:YC1LS;+AY:32TBR; M9T*NG=LM ^MGPZZ8LK2Q?+6RSHF/92*K#M]0=OKD&$B]] :A[UR87*33#@VH4 MJC&HQJ&:@&H2I9DO#AT J3.5 M>>90 IH%0K4@\,84N+II"XS^HED,U"M485.-034 UB=+, M>M;Q7_H"BXNZS_Q$\V>GU\5*?2CJ5;EMO+6Z[#;EO^Y/!'6YNGKXI:VNW\Z" MF7=1M6VUV?UXI8JEJOL&W;]?5E7[[9=^ W=5_?ON<,[^#U!+ P04 " U M?/E8*U<6$!0& #P+0 &0 'AL+W=O2G^1ASPA;FF3\OK$68G/7;/+%FJ28 MW](-R>0O2\I2+.0M6S7YAA$<::,T:3J6U6FF.,X:PX$NF[+A@.8BB3,R98CG M:8K9=DP2^GS?L!N[@@_Q:BU407,XV. 5F1'Q:3-E\JZYIT1Q2C(>TPPQLKQO MC.R[T.XI UWCKY@\\Z-KI+HRI_2KNGD7W3SO?N: MO?=*^XX!T)0/:O^TG-W3&CM&XB-FM\BU;Y!CV3WT:>:AMV]^0?(E,5+7O==@ M6^3T%+U'Y\T<9B^!DQ8B,DM&84EDT2I)8 M#Z@J2!G)X72<;Z4LOSP2)<_:,=#HR;5JA(1YD+ )),R'A 60L! (5E%M9Z_: MSH\UO7<@I0T)\R!A$TB8#PD+(&$A$*PB[>Y>VEVPZ=U(NE9UD# /$C:!A/F0 ML*#[(HJQ^ZY3C6)"H!8K:NKMU=2[4$U1S 6+Y[G>HEK(,9,PI:TS:[:Q$7NM MM"!A'B1L @GS(6%![X6TW!-=F6I4Q-+?BZ5O%,LT9XLUY@1M6"RG4CG[(:QB M/C7#UFG$2+M6(Y P#Q(V@83YD+"@@+6/%-!RNVW+LDZ4 M1H152V==C2M(RR M.A-3W91QF"R4PY,,R_2:8[=^^+_6(&9?KQ4M*,T#I4U :3XH+0"EA5"TJKZ/ MMNSM'VLQ4OH+I7%(F@=*FX#2?%!: $H+H6A5C3L'C3M@JY(298Z*'\P-7BVK M2]J<@+;I@]("4%H(1:O*Y9!]L8T[X/]]V6'F7CUT@29*2IHA))^ -NB#T@)0 M6@A%JPKLD .QS4F0*:,+0B*.EHRF"!<1(J=)75IZ7+(J<;+=[G1ZG=,QZ67% M?LOIG:0EO#I>7=P],7?B:CF 9C! :2$4K2J'0Q+#-F/RC->Z6++MH2S.J.$DU _?!!:0$H+82B565VV.ZWS?O] M4[Q5BT:NLZ]Q]B2O*=OJ12,GB:R]ND$KDLG%7Z(+<93&F0JJL#IE6!PVE-HD M]0?"0#,$H#2OI!V/GB_FSU>K^* ^!:"T$(I65=9AZ]\V[_U_G(W0DIP1!NC^ M/BC-*VE&8;Q:Q:^I8K61_JP[DFY9]_YQ>'C Z8X"_V(V2K..$K(4B*MVZY\7*PX7ES<"+K1AU7G M5 B:ZLLUP1%AJH+\?4FIV-VH!O:'O(?_ E!+ P04 " U?/E84ZB*,)X$ M "[%@ &0 'AL+W=OX $S>U>'WJMVMW;A],]&#) M$G,V09:Z3[\C9T0PLIQ"_(+ MQ([G;_OGL3/CP9;Q'V()(,EKEN9BZ"VE7-VV6F*VA(R**[:"'-_,&<^HQ")? MM,2* XVU49:V@G:[V\IHDGNC@:Y[XJ,!6\LTR>&)$['.,LK?)I"R[=#SO5W% M<[)82E71&@U6= $O(+^MGCB66I5*G&20BX3EA,-\Z(W]V\CO*0/=XJ\$MJ+V M3-14IHS]4(7[>.BUU8@@A9E4$A3_-G '::J4U:-D MIE3 '4N_)[%<#KV^1V*8TW4JG]GV#R@G=*WT9BP5^I=LR[9MC\S60K*L-,81 M9$E>_-/7$D3-P.\V& 2E0?"S0=A@T"D-.A\U"$N#4),IIJ(Y1%32T8"S+>&J M-:JI!PU36^/TDURM^XOD^#9!.SD:"X'.]4)3()*1[Y,QN22/*^!4)OD"%U8@ M/T'8G,2)F+$<:]<0$U:T8+D@9Q%(FJ3B' V_O43D[-,Y^422G'Q=LK6@>2P& M+8D#5=VU9N6@)L6@@H9!^0%YP+Z6@OR>QQ ?"K1PAM4T@]TT)X%5\8'R*](. M+TC0#CJ& =W9S3_#](H$76T>&,RCCYCWM+EOF4VG6K2.UNLTZ-TQ@8N"; F\ MX@$@0-R:(![W0O,^[U?3[[OXLO1=^HY+LC=5W M%#QU#G*+#UD5CO"A$W2:H3D2.X#FM_<1:/O=#_*,0YQ(%8+./@#1+GBL_YVB M9MR/I5!]0_;-V]&OA>>^%3XU4WUWJ0Q9@*)D.HKO(%JJQI1 M6>6/<#A70E$I=$"IUQ">^,&>4V#E=)]+P'[E#H:1A57B&!:.A"('0H>\]AF$ M;XVQ1U\HIFB8=PL5H.%VHSI TT&O$=T)$;L9G2.AJ!2JN]&E'_KA38,G[=,# M__W\8+>C]&[+67[)JI2X2!V,C$Z(XLV,' E%I= AHT[0:S;[SM(L&C$9B)\3'9F*.A*)2J$XL#/J=!F#[4-RWQ^*.,G5[+\?P!GRA;T<%!DCK7!8W7U5M=0,[UO>./]5/U,VLOBW*FM"A(MM)WAU,F)&ULQ5EA^3JS*I0PBBA MJ8A8BCA=WPQN\;5/7.V06_P>T8,X.D8ZE"5C+_KD6W@SL/6,:$Q74D,$ZF]/ M[VD<:R0UCS]+T$%U3^UX?/R&_B4/7@6S# 2]9_$?42BW-P-O@$*Z#K)8/K'# M5UH&--9X*Q:+_!<=2EM[@%:9D"PIG=4,DB@M_H/7DH@C!^QV.)#2@;0=1AT. M3NG@G.HP*AU&.3-%*#D/?B"#^8RS ^+:6J'I@YS,W%N%'Z5ZW1>2JZN1\I/S M[TP(]$@Y6FP#3M&E3V40Q>(3ND+/"Q]=7GQ"%\A"0E\5*$K1C7-*1A$\!2D57AD;?P M[H@1\2'@0V2//B-B$P>8T+W9_0M=#A%Q2 9OX:X+7Q'L*_N']=B%ZSHS4 U"$'YG@[F/_^$7?L7B)<^P?R>P!J< MC2K.1B;T^0_5.V.=Y&O.$K12Z16E691ND&J=BDO5>X3*==4ZHA5$:@$^SL%U M#]W/KR9XBCUO9NV/^0+LQH0X$]*T\P&[Z=3Q<&76"')+%=JV@;.-3V:4[KVB^7VA-:D[ M$I_8F"QW.M?1(1?GJL,$>]5A-K04ER"7^%W2CD>N9[=2 C2SQ^-61D!FCCMV M.C*"U&$18UA^D=1G!49."PPR P(#S R!U?H3FP5HL5YY>:N'01$.G/.]BM%> MT?R^T)HNV\X)"&[HN1TY44M/ M;-:>/JP1P(B,2&?HI[Z _!+(.R+%'F*O@Y-:AV*S$-4/P250*R I[KLIP,L, MV$'+#,$-W:Z0:E6()^:G7-G33BG^7O5=KVA^7VA-%FLIB,U:\/3B]T[,"L . MR@H(KKOX:[&'S6KOG.(W(IV=%7VB^27::6V U,J0&.53W@9"L&X@@DJP#_L] M9 @JXY&,J$#T=15GHT3?-;R99T7^K2_?0!ZPX@N$F[<-\; M36S<+EO R.MX1R6UZ"1FT?F<[JG0,3VI/QZM]&'^)@X&8\0Z.X7Z1//[0FOR M6(M=,OZ?RO8?*%H#YWVB^7VA-3FOQ30QB^E_LVS??T#%HXG;KEO :NPX[<(% MK,BT_&PO=V]R:W-H965T M)@<1JL0!+&R3I]C#L M0;&96*@D>A(=-\!^_*A+3(NB&"NEUX?&L@\_\GPDS_ET))YN6/ZM6%+*P?5IQ,5E_C@N5CF-%E6C-!DCQ_'&:11G MH^EI]=UU/CUE:Y[$&;W.0;%.TRA_OJ )VYR-X.CEBYOX<(NRB%.:%3'+0$X?SD;G\"0D?MF@LO@CIIMBYS,H7;EG[%MY<;DX M&SGEB&A"Y[R$B,2?)SJC25(BB7'\TX".MGV6#7<_OZ!_JIP7SMQ'!9VQY,]X MP9=GHV $%O0A6B?\AFU^HXU#;HDW9TE1_0\VM:WOCL!\77"6-HW%"-(XJ_]& MWQLB=AI@OZAK@I@'>MP?2-" 5,[4K%0]AQ*/I:Q4GQ"W@'X@S<+=FZ$*;%Z9B+(91 XWG3W47='>KI#B)PQ3*^+,#' M;$$7;8"Q&/O6 ?3BP 4R(EY%^3%PR > '(3!U]L0O'_W"Q"\Y10D;!Z5JTLS MSID9]1.]/P;(JU!1&U4#%NX#YE=@<*\AMIC VZG$53>XIYO?J5C_@--<+).H MWE1B.F,YG?-Z.G6S5B,3/7(9>TZ*532G9R,17 J:/]'1].>?H.?\JJ/6)EAH M":S%*-DR2DSH-F4><@+3-PJZ9 MZ_M06K5<<[>NN4;7KFD>LP68,Q'!%S2G"R!RR*Y[[$&$]6IUBM^JM:IUU=P+ M L\TRG4-9\:&0Q>)); 6D]Z62<_HXQWC40*R=7I/\Y*UFD-!VLO6UO)68WH[ MDXK<0%D?71OLJHM#@X,"_=+PMP[Y1H<^;UVIIQW\VQOX+OQN]]B9*'X8NQLZ MU9; 6LP$6V8"(S-?5C074YH]@J2*M7DI*H[8P]%:7$1%0;EVKH/.!D9DXB/' M4WC2V 40N]A5YMPXR#=2,-E2,#%2<+E7 )QTE@7$"!&L.*PQ5=>X<41O M]!>'6$]"@[L[GR3 2.% 8^4CE0'S$-]*P8Y&A$8* MSBMQ#F[K39PVT+5IMHH6VT-JT M2M$+C0IPC_1KRE\-^&X(4L//3&.#'%_=H5TC.''UB1A*_0G- G1(*FZ@7LG% MY@X'S[TEM#8]4L-"L[Q\8SYN4-TV4^4_E2RK(M466ILL*5.A6:?NE[EA5U * M"4(Z>\+KWI1X,$#JKNB:H8E/^O:%5*C0+%%G49X_E_/^%"5K6NZ/A&6/1XG( M4@O3Q/O=7 N%$.O,NU7%:@NMS974K- L6F^JV@VXC;F('Y_IY@.XV=[7G8L, M=$-3MJ )71P-2/.6)&A#MTVTT!9:FVZIC^'D<&G>DM)M:+6)%MI":Q?YI I' M9A7^8VF^ =^-:NK-ML8$*M%,8X+TD0Q):8W,TOKFR]=$TP\7O\D.H6&66>B,BKN)RARI?77$&:&UV_XPKJL.WB0'6F:P1% M1._Q1HI*9!:5MJICKW1C*(^96P[=O+;0VG1*&8O,,G8_Z8&ZA4[B$34W:ZPT MRT)36G7AI&=92+V)S'JSE4JO<_H4LW61/#>/3 9E4'-/0T.]5;30%EJ;92E4 MD7>P#(J,&G@PK3;10EMH;5JE9D9FS?R#&;1;Z>W<%&AL(.QL38V1W_,P TF1 MBUX1N7NGT6Z1%3N!^F1&8^42K%;E-%;0)6Y?F)$2$IEKK(-RJ::&ZOOJ7;_& MRILX:EU98^5.(-:[@Z5TPT,+J-HGD+IJJ:>6R#56$&&L^!MJS!#$?;H 2[6& M7U%KNPG@,@.SN@Y\RR.^-L=[,_#@)ZQ6"Z.VT-JD2NF(#U<8Q58+HU;10EMH M;5IWW@8X9&$4Z^J9:L#7&1&U,JHQPGTQ12I*/%11[OE0!FN4(<(NAJIK7;L) M\=1'=J$.SG-)7Z"12A._IC3+=[;*"E>C)3\S#JXHK8J==TL*;NBA-;U9M6T4);:&U:I=[$A]2;6",3U4>G M&IM E9LZG!Z!AJ7:Q);4)M8HQ&[11F.%/(C5PHW&# NMU^.,5)O8GMK$786( MD*\^UM=801^J!9Y08X:]/G^(E)O$AMPD&KGIJ'6$F+-UYL]0L8)N]+5+@(9[/F3L?O(ZMOC-@"ZU-O%36Q#U< M>+ JHJVBA;;0VK1*$4W,;Q=8"P_F;DSAP:IXMH76IE.*9V(6S_O0F=&-B4AS M!]A I-6W'VRAU42.=TZZI%3LT_+$4"%X6F>\/C.R_79[*NF\.HNC?'\!3\+Z M;)&$J8\Z78GM'XN;DX0^"$CGN#P;E->GA^H+SE;5>9I[QCE+JX]+&HE9*@W$ M[P^,\9>+LH/M&:[I?U!+ P04 " V?/E8B:;>'8@^,3=M"=?%$VFF!??A1ETB63!.R<[:^Q!;-\^-?/,?DT3$S M>4ZS;VQ-*4??XRAA-X,UYYOKX9#-US0F["K=T$1\LDRSF'!QF:V&;)-1LBB, MXFB(-QB1,!M-)T?8QFT[2+8_"A'[,$-O&,#&[UZP";N4'1XX^0/K.]]RB_ ME:,S?(O>J[Z:@,TWS*>QI6Q M4!"'2?E*OE<3L6<@.'(#7!G@KH%YQ,"H#(R^!F9E8'8,K-$1 ZLRL/H:V)6! MW5>24QDXA;/*V2U%?PMKX9$PR4/QD6?BTU#8\:E/ MYF$4\A_(^QYR1)(%NH\W),Q$M'$T6Y-L11FZ1+YH0CL2;2EZZU).PHB]$\U? M'EWT]LT[] :%"?J\3K=,$-ADR(6RG#^<5RKN2A7XB H#?4@3OF;(2Q9T(;'W MU/8Z5@"&8DKJ><$O\W*'E<0/)+M"FGF!L(8-B:"9VMRG3U<(VX4YEIB[?,4<[0UP?!0?>#,02 MSVBVHX/IK[_HMO:;+!H@82XDS(.$^9"P C6BBFSCBE319_NK6?IL@R>J @> M4@;/FD8+)#9ZM&54%CPEW2KH^6Z_F]J6[=B3X6X_*@Y[8=MP'*W=S55*/=7? MO93Y_90%0,I:+K)J%UDP+F(DDOJHQ-M[]VCINM5QT6$G;#AZQT%*H:1;-;M ^6.YHP[TF>'O;!MZV9WXI4:3IWX7LK\ M?LH"(&6MN7?JN7>4)W.1(B&Q2,[26 A;Y\^0._K2_C5/ID3+4T1%XKP5R13)GP^EZ9)2 MX:EA PES(6&>VA$/5#SUHL\T$T]BQ52A6TGN*7F$DB53_]]0 = 4M8)W7 ?O M^(S5JMZY^RY;RD%.C3](F L)\\:'RY$Y,G!GT9+TV\ M!*&RV]]A+ZVQY706YIFLWWALZIU4UJWZM2;#T#7+:??S9#S=$"E -_>2=K0T M9S3J3+!L9-/&HV;D]MSMU61TY=S]GB89G6^S+$Q6>:$M9.@?]" >@R,DJP;< MJ7&G?CE :2XHS0.E^:"T (K6#AK+9Y2YY)$ !'+/ 2DB 4B6 M#P4*H.ZO'0E-95%7EQ85V:_LUZ@[->[D# 62YH+2/%":#TH+H&CMH&E*HKKS M4[)?T&HI*,T%I7F@-!^4%D#1VK'55%]U=2GNU=GOZ/ W!3RVQMV"AZ2;J>G= MW^Y:;_3KUU=TN[IUT%YMK_!E_]J\(%DJS!A M**)+,91VY8@[S\K3^^4%3S?%X?&GE(LEOGB[IF1!L[R#^'R9IOSE(A^@_A^* MZ;]02P,$% @ -GSY6#@:)2F! P ?0P !D !X;"]W;W)K&ULK5=MCZ,V$/XK%CU5=U)W ?.29)M$NH1;]:2>M+KMM9\= MF 3K#*:VD^S^^]J&L(00M)7R)<%FGL?SC&?L87[DXJ?, 11Z*5@I%TZN5/7@ MNC+-H2#RGE=0ZC=;+@JB]%#L7%D)()D%%[!:&ELYS;N2>QG/.]8K2$ M)X'DOBB(>%T!X\>%XSNGB>]TERLSX2[G%=G!,Z@?U9/0([=ER6@!I:2\1 *V M"^>S_Y#XG@%8B[\I'&7G&1DI&\Y_FL'7;.%XQB-@D"I#0?3? =; F&'2?OS; MD#KMF@;8?3ZQ/UKQ6LR&2%AS]@_-5+YPI@[*8$OV3'WGQS^@$109OI0S:7_1 ML;'U')3NI>)% ]8>%+2L_\E+$X@.P(^O ' #P'U > 40-(#@O8"P 80V,K44 M&X>$*+*<"WY$PEAK-O-@@VG16CXMS;X_*Z'?4HU3RT>24D;5*_KR0A4B98:^ M%A6A0F^M0NNW)Q5[R-#V9 [&/&W>"\X8TCEX)")#'Q-0A#+Y2<-^ M/"?HXX=/Z .B)?HKYWNI5Y!S5VG/S?INVGBYJKW$5[ST,?K&2Y5+]*7,(#LG M<+7D5C<^Z5[A4<9O1-PC+_P-80\' PZMQ^&/L+E'.+9P/ !/W@.?6+@_HB9H M=S&P?,$5OC]!ISY2('2&D+J>]$[2MYUL=FHH\C5S.,QLCIT'69$4%HX^5R2( M SC+7W_Q8^_WH:C=DBRY$=E91,,VHN$8^UM==!-]*'PU361IS"%[6(9!%.N< M.'3CMU9F2J%42O4^)K?#U=26C-/\W$6Y)EMR(["Q\ M<1N^>+2TUHQ+??#I@U@ 8I1L;#"'XA??,GZW)$MN1'86OTD;O\EH^JT((V4* M=QO8T;*DY0[Q+:I 4)X-!;$FB[LE,)WUJ^G2"$^BL%=, T8X"H9K:=J*F8Z* M>1+\0&W+HV^[XVM@O'I6I9UM>^C/MG/LS:],;VW[ MO3>:NC'7?8RN*XD8;#6E=S_1+HFZUZT'BE>V^]MPI7M)^YCK[P,0QD"_WW*N M3@.S0/O%L?P/4$L#!!0 ( #9\^5A/\8(^300 ! 0 9 >&PO=V]R M:W-H965TS7[_02V99HM06\+[%$/??HGCOR=)?Q3L@O:LV8 M1B]9FJN)M=:ZN+9ME:Q91M65*%@.3Y9"9E3#K5S9JI",+BJC++6)XP1V1GEN M3HE#(7XDMY<[^86$[I$4M9 MHDL*"C];-F-I6C*!'U\;4JM]9VEX>/W&?E>)!S%SJMA,I'_QA5Y/K)&%%FQ) M-ZE^$KO?6"/(+_D2D:KJ+]HU6,="R49ID37&X$'&\_J7OC2!.## P0D#TAB0 MKH%WPL!M#-SO-? :@RK4=BVEBD-,-9V.I=@A6:*!K;RH@EE9@WR>EWE_UA*> M4L&&1^HO$*.]PLB#G$-#LV&S>_8_ J1 MH#(G!O/X>\S#RAP/J'';K+D5GWN"[W<&6QUI)F%'T/K\0.;X/G-)G3E3Y&MF MS\QPHHEX;46^(?7J?)R)C MZ *V-NSD.8.*RF 35XN:OIA#65/Z%6598+?3RY#X@>^/[>UAE PXGP38)\>X MV(##./+=48L[TN:WVOQ!;3&#@"5\OU%H)J3F_U8+)ETU77#@!PD#?^1V9!E@ MD1^,@HZJ/LPE(2:>6530B@H&13U550<]6S9G\QZ1Z\'T_>C#.21:?B>PHSF$;Y_!_*S7A.2-Z3K+X M3&1'$1VU$1U]8^=N6;XQ1VS4.RLX'#FNTSEY?9@_"AR_>_+ZL,"-O!";3U[4 M^A\-^O^I8!)V0KY"[ 7:3V56$O651,3UPXZ2/BSPG"CJ*C' !00LQ+L[+L? M9U#+1^B,ZZ9&T90AL414*:;-+8O3<^+2"S#I5GL3#KM!V$EB;,*%D7^B+N*# MC@X/YT>OF1S,34-P5+E]MQOTF0'FDRB*NCKZ,.PZ!YD^UD'V.LCY/\D-9V=# MD:ZR/NHR\DC0DV; !1"#4SG:]V]XL)GY\4]RPW?H2>1Z75E]D.OU\]5'>;[K MGY"T;Z#PMSHH*&LP$KRBE'_=\$6M;>#K@ WM3N!V:3;NMD M'XQ*&0/7RI%3H41L5,-<9_VV''>K$6Q/4\_*,&JL>*Y0RI9 MZ5R%X).LQ\_Z1HNB&LCF0L-X5UVN861GL@3 \Z40^NVF?$'[3X#I?U!+ P04 M " V?/E8K.V%I[T" !L" &0 'AL+W=OH'L09H,%F\,#X./B3MM>V+CDO 1IN))$PVP8?.EAT=PCH6D#_5A"O!;$'K3/S6%<,63;0:D6TB[9NKN&_C5=; M&B[=+#Z@MF^YU6$V9ER3)R8J(+? 3*7!3A$:.C$W)$ MN"0_"E49)G,S"-&.[US"Z7JLRWHLNF.L6Z;/2-3]1&A$XQ;Y:+]\#),S0E,O MI]ORT%(WZ+1!I]XOWN'W'0O09,PEDU/.!+F1!G7E\=O8:K-NNYE;;!=FP:8P M#.QJ,J"7$&0?/W32Z',;Z8',MKCCACO>YYY=@\@)*EM%6&F.KW96EV!P)WCM MEG@WMRDLLUXWZ0W"Y2906U"4-D%;B7:;1+M[$_T&2Q"DTY;37N&_3L:!S+88 MDX8Q.601)H?D/I#9%G?:<*=[YW;$M'[E7]'@*\&N5U!D).9VT+_ M&Z/WQ\*A<=J/Z7N,EK@T[73<3KB%$6ZX<^74.@[,RYR MIO10S%VY%, 2 \HSEWA>Z.8L+9S1P,P]B]& KU26%O LD%SE.1,_'R'CZZ&# MG=W$EW2^4.6$.QHLV1Q>0'U=/@L]<_RL'G9.AXI4>0P525%$S_O<$8LJQDTG[\LR5UZC5+X.'UCOV3 M$:_%3)B$,<^^IXE:#)V>@Q*8L56FOO#UW[ 59!R<\DR:7[2N;*DVGJZDXOD6 MK#W(TZ+Z9YMM( X .#P#(%L :0+H&8"_!?B7 N@60$UD*BDF#C%3;#00?(U$ M::W9R@L33(/6\M.B?.XO2NB[J<:IT>=BRG- KVP#$MW$H%B:R5MTA[Z^Q.CF MPRWZ@-("O2[X2K(BD0-7Z45+J#O=+O!8+4#.+( )>N*%6DCT5Y% ,2W.#1NAW^"R3TBH8$3"SR^!!X9.&Y1X]1W4 M7@>M7K\HIL#FSW2\/K4**(!;?A]:D0Q#>QNA[7;8:O;KURQ3&]& M=:(BV.CWC@1T,X$"9JFZM8D*+:*BYJ,X-8HH[35$G1K=D1#[=E51K2IJ+;P8 M9J 5)4:0WML05PL0UAJ,NJS!+LGBCLB. MBK ]C[U1IL!5X;L-[IT\>^AQLY M8K,B(>W;DZ1?:^S_6L7V+UQ1G,2,>#J(SXLA>''D_]="_Z"DMTGR56Y6T,EQ;9YVRQ5VQ'4=O MWU7AUO9CU]=6.<]TX\S*8X8UB.U$/OH)3-@:WW$[\NJ _1_]%-XW5+B]HZK3 MC6W.IELKP]7IUB5;W!7;L([8J8.[!"30' M,38FF?%6HZF17S]9?"SZ:,W)C_K'\BF!.MGN:ZA.$/O;-TT*B#&::TKN/ MM !1G>JK@>)+<\Z=<*5/S>9R 4SW**6!OC_C7.T&Y0+UMY71?U!+ P04 M" V?/E8@?]Z^ML$ "'$@ &0 'AL+W=OK,-M#$*YH/7;,D[3[3$FT3D42/I.WDWX^D M9-F6*+49D@^Q*-T]O.?N>#QRLF?\6:P)D>"ER$LQ==92;JY=5Z1K4F!QQ3:D M5%^6C!=8JB%?N6+#"SR9L*W-:DGL.Q+8H,'^] M(3G;3QWH'%X\T-5:ZA?N;++!*_)(Y/?-/5@YC MK6 D?E"R%R?/0%-9,/:L!W?9U/&T120GJ=006/WLR"W)J:%"'QEI5P+\&>9D>P,%'@#SD6PRZ'5;_3!97 M $5&'5G4Y[^B'AMU.,#&;\+B&SR_!^_A/ 1L">2: /*R42\5>P M)!GA. <2OP 5"B,FF51O:!59_4'KE8* BP4IR9+*2UO *H,"NT&Z_%R+#4[) MU%'U11"^(\[L]]]@Y/UA<_9[@LW?">PL$$$3B& (706V\N_1XUPM$9O_*IS0 MX.AJNYN-8(C\))FXNU/7V.2@%XS1N=S<(H="Z/F-V!F?L.$3#O+YB^GUME75 M=I&30V)8%W"%$YW,'X91BTM7QA^W^,XM."<^.2,1-22B01*/4I>I8X(3\1&4 M1-I81)W940Q]KTVD*S8*PD[LYETQZ'D!LK.)&S;Q()L;S%=J@P:;+4_7:@L# M>F3C,@AC7P? MCCC+@N(_!;5KM!(<84]D4L:KLD@USE)57>B.*J*IJS<4;6# MY*]FQ^$J+X$J> M5]22UYV1B,2J)DG$KFA8Q/^XDID4*H;AG?8T;@N,WK"^5 MH'J!F2)NXS/N9J<7A"TV72$8AK!%IBODQU%@YP*]8W/@#;+Y>XMSNJ0J,$M. MRQ4!&14X5[TB+E-K$:SQSNP(6I7MUB*$4- B9$."/<&!)]T.?%/Y2ZDP%<3* M91#J#>OMO8#F-=!9*J!QU.,4='0*^DDY9>FSZ9ZSGV9L#74>.^BW(]R5@IWU M9X-*O#XVQ\X)#O8#LQ\XWU9=TW"F^I9: I'GQVTN74&UK\=)V*9C 40(]6P. M\-B P.$.Y)MJZ;B50= UK&W5K45HY"?MZF&1BD*OQ_)CJP&'>XVG=A_:])^' MQL-*J]LPC*(@ZH0E[/9'?IQX;686,>3!,.XA=VQ!X' /D5;-2>]I2J),Z M+MBVM#8C->2I,2B, @C;W :G?FO[_%YHYXXZ=C=PN+WYMM,-='5"X:9O*]1L M$FP(3TF/G_Y'I]-_%GE7M'F-IK>G)HC>E9<$WND?;*67>W)"+PA?F9L.H:JM MRI3JC-N\;6Y3/ID[A-;[&WW+8D[^1YCJBD8=@%>T%" G2P7I7<4JS7AUZU$- M)-N8>X %DY(5YG%-L#K>: 'U?&PO=V]R:W-H965TM[9#TCY3%/S4["OE#;1G3Z*G(2S5WMEKOKEQ795M64'4I=JR$7]9"%E3# MK=RX:B<9755.1>X2SXO<@O+26.]?XZ@:GQJ&R^,[9 M476ND4EE*<0/(6(YR[0)0>'?@=VP/#>1@.._4U"G>:=Q[%X_1_]8 M)0_)+*EB-R+_EZ_T=NXD#EJQ-=WG^JLX?F*GA$(3+Q.YJOZBX\G6KM[=,4YZK=V#_[>$6O7WS#KU!O$2/6[%78*UFK@8T\P(W.V%\J#'( M",;?5%XB+WB/B$=\B_O-M/M'MKQ$)*K M(I1[6!'V!!U,,>LW5D>(.B_&@4^\N,P\5U%PR MZ'2ZVCE";QET&E:R-==6ZG" $WC8\WK00RNH?!+9H:,&.IJ$_BS*S44.?71U M^LIM?-'@S7X41#CI 0[-2)J&G>*?$<8-83Q)^&7')-6\W*"<0;=&>=N(;*SQ M ").<-Q9VYIU:)8D?HQ].VO2L":3K#?0,4;6.!D6!Z=AV,.R6)$4CU0P;:C2 M2:I_8!80;16%&MD\Z7#SP"P0XJ@':;$+DCCR4SLF]EHE\J:7VNP4JW1XP[K$ M_26U&9%PA*FCCGB2Z5%HFJ.-A*J9X: O"E9:/ 0)XQ2'_39D,TP2&+]&-C5N MU0M/:L7B.\WWM)Z2N M\&MKZP];=T"BM/^-6NRP%^$T'=E+N%4A'+Q^,N@T(^MX@"%FXLL?2E:4>#@< MU-2F@&$U5%NY6VW#T^(VV@E?4&0\%+74]WS2'Q\L=M@+<$K&NF&K?_AE 7QM M?TD'HRLF?C1@'9J!5,;];\/M',O,F1@..1M>*ECX-?AYES$$D/4QL[[18E>= MU)9"P[FONMS"T9Q)8P"_KX70SS?F\-<<]A?_ U!+ P04 " V?/E8T%1* MFLX# "E# &0 'AL+W=O$4+K$"0--MK6CI91"52(ZG8W:5N2- M34EW?][OJ"-/\QWCWT4%(-&^J:E8.)64[;7KBKR"!HLKU@)53TK&&RS5)=^Z MHN6 "^/4U&[@>;';8$*=Y=SMD32C<7JRAU4"M( %811Q*%<.!_]Z[7O:0=C\2>!G1B-D4;9 M,/9=7WPI%HZG(X(:CFKA?E%N]XVR1R4=T*RYN"L(F@([?_Q M_I"(D8,?GW$(#@[!U"$ZXQ >',*7.D0'A\ADID5ACB9=SSG:(:VNEI@")9!1<5OV)^A;SH/0J\(+0$='/9_1-LKE 0&_? XKY^B7MB MW/T+-.&P+J'1"\_HW:EEH#FI"3;EP4JT@2VAE- M4AE'0 LS;%A'I7[8L=+!KSD(MX?N!6@WSPAL>RD&=:D(1*?7:C$$FOB^^$$R6*6 M>C-_-H&RF/FA'\5VK'3 2G^RXC:XQC0'77EJJ_OOFDM/WZC$2R<4-Z=6MLI< M6\R.*_,(-AM@LY^$W54DKU2#U-4%(HW:WQ1T68)IB8PEQQ+>(U*B9P5;$K+3 MN*,LG>0@LVP[29A,4G!J%7A9$-HSX'O/W8;WHC+517GVQ%*4M0(N="GK]QT0 M[%4Y=VK'MS8:WDFLD>=-=Z7+@?W?8^JUU/HTNJ/^K0&^-7VP0+D^V_L&:+@[ M]-H?38=4?J_!*HAE))>E>)2A?O>^+^0K+6=(D;)E7/ M:8:5^HX K@W4\Y(Q^72A)QB^3);_ E!+ P04 " V?/E8V#91X,4" #8 M!P &0 'AL+W=O\ MD5M0QITHM&MW,@I%I7/&X4X2514%E2\3R,5J[/2=S<(]6V3:++A16-(%/(!^ M*N\DSMR6)64%<,4$)Q+F8^>J?QD/3;P-^,5@I;;&Q"B9"?%L)C?IV/%,0I!# MH@T#Q=\2II#GA@C3^--P.NV1!K@]WK!?6^VH94853$7^FZ4Z&SOG#DEA3JM< MWXO53VCTV 03D2O[):LFUG-(4BDMB@:,&12,UW^Z;GS8 O1'[P#\!N#O X)W M (,&,/@H(&@ @76FEF)]B*FF42C%BD@3C6QF8,VT:)3/N+GV!RUQER%.1S<\ M$0601[H&14[-GTP%UXPO@"<,UXYCT)3EZ@1WGQYB?P1^9N'] VH&[:4,+-_@ Y?2Y6Z-#KK1IE!< MJI(F,':P$BB02W"BKU_Z(^][ES.?219_$MF.:T'K6G"('5W3@*R:X*,D6!9I MKLT#EI!3#2G1@FA\WPK?QHR"BST;XH.Y_N_C<+=J7@%R87N'PNNMN*[K M1KO:MJ[PP%R+J/U!,M2EM99T)C MG;;##%LO2!. ^W,A]&9B#FB;>?0/4$L#!!0 ( #9\^5A(2O6NS , %<2 M 9 >&PO=V]R:W-H965T0] MO.?P4CKB8,7%-SD'4.2Q+"HY=.9*+2Y=5Z9S*)F\X NHL&?*1'ZGA>Y)_74/#5T*'.TXT/^6RN M] UW-%BP&=R#^K2X$]AR:Y0L+Z&2.:^(@.G0N:*78QKK #/BR4R8A#$O M_LHS-1\ZB4,RF+)EH3[PU6^P(=33>"DOI/DEJ\U8SR'I4BI>;H(Q@S*OUO_L M<2/$3@ -GPGP-P'^L0'!)B P1->9&5HW3+'10/ 5$7HTHND+HXV)1C9YI9?Q M7@GLS3%.C=Y5*2^!?&2/(,DOY \LG#\7()C*JQGYG4N)MUF5Z0%D+"#+E21O M;D"QO)!O,>#3_0UY\^HM>47RBGR<\Z7$T7+@*LQ-S^"FFSRNUWGXS^3QGHD+ MXH4_$]_S@Y;PL3W\%B87Q(],N-\,=U&16A:_EL4W>,$S>)]9L62FSJX*K'16 MI=#&:0T2MH/H'7@I%RR%H8-;3()X &?T^B<:>;^V,>P(K,$WJ/D&-O0=OLS& M=PW2,R#Z ?$PHE$0A1$=N ^[5%K&)33QHGX]KI%E6&<96K.\A0Q+LVC+S!IX MZDIT!-;@V*LY]JR5=\P.;!.@UZ4 '8$U!(AJ 2+K(FL!>"U @0*0E GQ'5]9 M*R;:GRUKQ&BGWGP:!''H[]6E=>8S><4UK_B8XB63I<0>9*5P05.SH/]/,#X@ M2&D0!7OTK F<22^IZ25'T?O7%.H=B)QGY!K4"J BM[E,L0\?SGURA;7L>P$E M7]Y#.0'Q=QM?ZURG5G-'8 U9^K4L_1?9SOTN!>@(K"$ ];8.PSMQ0Z,$0>DG21A%R5[MVY,XE^2.C:(=E'_@F[7'BZ25JW6. M4U>]*[2F(EL'1>T6ZMS*IYV:JJ[0FB)L;16U^ZH?K/W@\+'?#_H'=LN>Q+DD MMZZ,VFW9O6*JU2[:XTY>RI>P973KR^C+&#/:J3/K"JTIPM:;T>[-&3UT9]3W MXW[K71R[X"3W+*TD*F"*\=Q%C/F)]BK%N*+XP!P$3KA0OS>4<&+ZW] #L MGW*NGAKZ;*$^2QK]!U!+ P04 " V?/E8$5P)K2," &!0 &0 'AL M+W=OLR@I0F MJK:'25&R;L\.7()58S/;A.[?[VP(2K6TZL->P&??]]U]9]^EK=*/I@2PY*D2 MTLQI:6T]"P*3EU Q,U(U2#S9*UTQBZ8^!*;6P H/JD00A>$TJ!B7-$O]WEIG MJ6JLX!+6FIBFJIC^-#3^4UFT$65JS VS!/M1KC58PL!2\ FFX MDD3#?DX7X]DR=O[>X2>'UIRMB5.R4^K1&=^*.0U=0B @MXZ!X>\(2Q#"$6$: MOWM..H1TP//UB?W>:T5*&/\E M;>>;))3DC;&JZL&80<5E]V=/?1W. ./)"X"H!T1O!<0]P%2.;6_C:>#2JX=+=XM9J/.6(L]DBSU4CK2$;R($?V4X N5Z!95R8&_*1 M/&Q7Y/KJAEP1+LF/4C6&R<*D@<78CB'(^SAW79SHA3C?F1Z19$>#[,CSQ6^7?4E31S*Y3.(:;&9JEL.<8@<9T$>@ MV?MWXVGXY9+"_T3V3&\\Z(U?8\\6 MN5R1P(-CYI)#X;WTCNNEE?BTL%Z%@3 MS^H&PC%+XDF"%W@\5_:O5W0;3C\/7EW*P=DK=1,"G\2!2T,$[!$7CCXA@>ZZ MKC.LJOW#W2F+;>"7)0XJT,X!S_=*V9/A>F$8?=E?4$L#!!0 ( #9\^5@F M<]E@4@\ K^ 9 >&PO=V]R:W-H965TW7%^>7&;7>=?\OK7VT]E\]/Y MH[)8KO--M2PV2IE?O3M[K[Y-S?%NP/X1_UKF=]63V\KNJ7PMBM]V/_B+=V>C MW1;EJWQ>[XBL^=^W_&.^6NVD9CM^;]&SQSEW Y_>?M"=_9-OGLS7K,H_%JM_ M+Q?US;NSZ9FRR*^R[:K^7-QY>?N$S)TW+U;5_K_*W?UC)\:9,M]6=;%N!S=; ML%YN[O^?_=&^$$\&J,\-T-H!VJD#]': ?NH HQU@G#K ; >8IPX8MP/&IPZ8 MM ,F_0'F,P.F[8#IJ3/,V@&S4P>HHX=W;G3RD,3W7'UXT^__PI_?_XW?[RY65F>7%V5QIY2[QS?>[L9^G]N/ M;_:2Y687#U_JLOG393.NOHSSQ7*>E;GR*2MKQ5)^M/(Z6ZZJGY1?E%^_-#__ M\)/R@[+<*/^\*;95MEE4%^=U,^]N]/F\G<.[GT-[9@Y=B8M-?5,I]F:1+XZ, MC^3C54T"G#=/^/%9:P_/^H,F%9W\ZQMEI/^L:"--/[)!'^7#TWG]1E'OAVM' MAEORX4&V>:-HQK/#;?GP]]OK9G9M/UP],MPYX;FKTV>'N_+A2?'M][KG'K]OXY)3ADVT]_QOM29_6V+LKOROOYO-ANZN7F6OE4[@X7 MYGFE_"=J'J_X=;ZN_GMD8S_;YN[/FH*G*RV_YV>7?_Z:. M1_\XMK>3F$5B-HDY).:2F$=B/HD%)!:26$1B,8DE))9"F)!1QF-&&3+]LDVF MJOD<-,^7W[*OJ_QG99/7QP))*@T-)!*S2,PF,8?$7!+S[C%SC^T^87^[5%5C M-C.G%^??GF8-.6EP9%+=T(W96)PT)">-3GRF\8D;EY ;ET*8L/.;CSN_*3U MZ7TR.K;/F^0^3V(6B=DDYI"82V(>B?DD%I!82&(1B<4DEI!8"F%"#HT?76D-W>Q*S2,PF,8?$7!+S M2,PGL8#$PLF1#QP351?WZ(B<,B:QA,12"!.R9OJ8-=,_SYH?KYN#D)^>1DY6 M57E=/7L^1&H.S1P2LTC,)C&'Q%P2\TC,)[& Q$(2BZ8'AR2_C*?FM'?")#Y\ MF&F.S-Z!R_0@#'\9S_312'Q8"FV_$!.SQYB826/"+8K%W7*U^EE9KF^S9;G. M-[4RO\G*Z_S8->,/4FUH0)"816(VB3DDYI*81V(^B04D%I)8-#O\S#)1M?Y. M'1\^3--FH_[#DME!1/33 =IX(1W4T6,\[)HYDGQ(BF_Y^FM>[HL#RN?N7,:G M;=G$1)4K[Z_+/-_%QK&XD.M#\P+5+%2S4T+I3%EO>NEB"=^VXM V\VB.<8:?G@EG7!PC)&:A6HVJCFHYK;:TX-X M8VR,U)EX).^AL_JH%J!:B&H1JL6HEJ!:2FEB0'7E7E7:R[O\LCM)?%LNY\[H^ ;NM*N2J+]9'KY$?/2[K6L"JO#;_?7F^K>O_+ MGB\X&X06A5'-0C4;U1Q4O7W*Q#6U?HYJ%:K9ZI#YK3E5UW$\@M%N-:AZJ^:@6H%J(:A&JQ:B6H%I* M:>)J>EVW6Y-WNU]TL4UN#LT@5+-0S6XUX2A(G^GC7D'?06=U4-ZK9J.:@FHMJ M'JKYJ!:@6HAJ$:K%J):@6DII8F9I769IKSWEK:'%;%2S4,U&-0?57%3S4,U' MM0#50E2+4"U&M0354DH3 80]O=J&:CFM-J3S\ZZJ/1 M2.UU(5UT5@_5?%0+4"U$M0C58E1+4"VE-#&@NG9WU -5"5(M0+4:U!-522A,3J.MV:_)N]\M.>:,5 M;U2S4,U&-:?5A P:SV;]WTIST5D]5/-1+4"U$-4B5(M1+4&UE-+$#.HZWIJ\ MXSWL]TODV.#P04O=J&:CFM-J3S^"S8S1P>$/6M9&-1_5 E0+42U"M1C5$E1+ M*4V,GJZLK;'OE-PYJ:&D;U2Q4LU'-0347U3Q4\U$M0+40U2)4 MBU$M0;64TL3,ZJK=FKS:/>0;".74X(!".]VH9J.:@VHNJGG:87M=U8UI_VL( MT4D#5 M1+3KM!8G121-42RE-_-KEKJNMCU[;.=+19C:J6:AFHYJ#:BZJ>:CF MHUJ :B&J1:@6HUJ":BFEB;G4];=U>7^;[QS))QP<8^K!:6!U9AK3WLI %CJK MC6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ64)@:4U@64?-'M%W2.Y.+@!-(.CWVG M(Z/_95$6.JN-:@ZJN:CFH9J/:@&JA:@6H5J,:@FJI90F)E!7R];EM>P7=8[D MYN ,.NPCJ^/Q3#TX"D([U:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I*:6(&='9A"J6<;A M2MBZ.=/[_7T;G=5!-1?5/%3S42U M1#5(E2+42U!M932Q SJ>MF&O)<][(*_ M'!L:CFHUK0:N+O@XV-WC%MB$X:H5J,:@FJI90F9H_6 M98^\:CFHUJ :B&J1:@6HUJ":BFE MB9G5E;J;F])+<0.6&9%3@P.*U"Q4LU'-0347U;Q6$SY%S;11[UMZ?732 -5" M5(M.>T%B=-($U5)*$R.E*VL;YFM;1P;:S$8U"]5L5'-0S44U#]5\5 M0+42U M"-5B5$M0+:4T,9>Z KS7]8Z.NPW:X9FCK5^ M!J&M:E2S4&O'L]L'6$UJY1 MS4(U&]4<5'-1S3..K/0\'JL'YZ31UC6JA:@6H5J,:@FJI90F9(_9M:Y->>LZ M+JI:^;@MRWQ3#S\=),>'9A&J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFE MB9'5E;1-];57VTRTF8UJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DII8BYI M72[)"]S#/L;)L<$1A?:U4;Y7J[5K+'"N4\NUW6 MV4K)-@NE.<2Z76UWOT+R^W99Y@OEZ_?F]O5VE>UCKKU[=];\:'] /O?@1$/+ MX*AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":JEY9.GUT7C6?9M_TO(> M\ MMT^!,ZKFSROK:S.+B_6>7F=?\Q7JTK9[^B[#UI/[FUV^ZLF M)-2W[[6S\X/[/?5MJ!ZY/U+?)OO[SSO^\N(VN\[CK+Q>;BIEE5\U4XW>3)K7 ML5Q>WSS^4!>W[\[4,^5K4=?%>G_S)L\6>;E[0//G5T51/_RPF^"N*'_;/YW+ M_P%02P,$% @ -GSY6/,1!;@B P !@P !D !X;"]W;W)K&ULM59=;],P%/TK5I@02+!\-6D[VDA;!V(/DZ:5P;.;WC81 MB5ULIQT2/YYK)\V2+404A9?&3NXY/N?ZVKVS Q??90*@R&.>,3FW$J5V%[8M MXP1R*L_Y#AA^V7"14X53L;7E3@!=&U">V9[CA'9.4V9%,_/N3D0S7J@L97 G MB"SRG(J?5Y#QP]QRK>.+^W2;*/W"CF8[NH4EJ(?=G<"97;.LTQR83#DC C9S MZ]*]6+@&8"*^IG"0C3'15E:3F_7<B6LF*#N2P$"'(/*ZI XC.&=$]7&8[? M7(.B:2;?DO?D87E-WIR])61+P@M)V5K.;(5"-)T=5XM>E8MZ?UC4)[>< MJ422CVP-ZS;>1@.U"^_HXLKK)?P$JW/BA>^(YWA>AYY%/_R6BG/BC S<[Y'C MUTGU#9__CTGMREC)..IFU(?Y0NYH#',+3ZL$L0OW*#9T/778'(FN9']7F M1WWLT66&5P-E,1"\9$C!L$+-F47C>&AC7C#5F8"2-3"L^O+91][$":]]T M]C(J\$>!7T>U) >UY*!7\EU"\4:(?Y(EYB*-<;.6L,6[2G7I[*4Z=:,&(FNY M#FO7X>!5&@YI?B"REOEQ;7[E>C+,#\8A]-I M=XU.:L&3OQ8L.V_J7^2D.NY=[M2M'(BLE9EIG9GIX'4\'=+\0&0M\Z[S] ?N M_)?[MJ)MUJD[&4_#9]5?%;DD9=Y*!7;N1R4!4NF <;B11 M55E2^3R"0JR&CN^\+-RR>:[-@IL,%G0.=Z#O%S<29V[+DK$2N&*"$PFSH7/A MGX]C$V\#?C-8J;4Q,4JF0CR8R54V=#R3$!20:L- \;&$2R@*0X1I/#:<3GND M :Z/7]@G5CMJF5(%EZ+XPS*=#YV>0S*8T:K0MV+U'1H]'<.7BD+97[)J8CV' MI)72HFS F$')>/VD3XT/:P _?@,0-(!@&Q"] 0@;0/A>0-0 (NM,+<7Z,*:: M)@,I5D2::&0S VNF1:-\QLVUWVF)NPQQ.KGB2^!:R&=R/ 9-6:%.R"FYOQN3 MXZ,3^#C]\"[%NX?4!.V[H>6 M+_R7^_NLK:'1?J@I!^=J05,8.OB^*Y!+<)+/G_S8^[K/EH\D&W\0V89E46M9 M=(@]N2A%Q369/I-5SM*<_+B:_"1+6E1 F")8Q4 2G5-.)NW&/G/K0SKV$%,: METDG[/=#_$\LUVW;#8MZ7;\;;H:-#Z;\GX9T6D,Z!PVQ!J0YE7,@QZF$C.F3 M?8IKEGA#L1?TM@3O1OFA'VW)[>RX1M"XE9(_)Z;%3.LVZ@#B[FI M/CH'D@IEUR7@ZU*!(AG>MA9V#V8S;"%FUQK!VGI6L,>*9=1TEWUVQ#L:0K_7 MZ6[9L1OEAU[?V_)C-RJ(>[&_98>[5J5+P.LRW4ZA.%1=%\!VM6VH%[:/;*V/ ML-'6??&5IN[26!WGC.-K #.D],ZZF).L.U\]T6)A>\%4:.PL=ICCQP)($X#[ M,R'TR\0&PO M=V]R:W-H965TT (RL%]8EO(B17SI4%G^GY,"/KD%)Y8'2[^7-EV1A MV65$)",K44)@^?-(KDF6E4@RCA\-J-6V63H>7[^@?Z[(2S(/F)-KFOV3)F*[ ML$(+)&2-]YGX2@]_DH:05^*M:,:KO^!0V_J>!59[+FC>.,L(\K2H?_%3(\21 M _1?<4"- QHZN*\X.(V#\[,.;N/@5LK45"H=8BSPD MGQ9EO]\+)M^FTD\L[Y@<0DP\GX&[#!<"X"(!GW[LTYWL6P'>QT3@-.,?P$?P M[3X&[]]] .] 6H"_MG3/I2V?SX2,HL2:K9H6K^H6T2LM0@1N:2&V''PJ$I+T M 68R_)8#>N%PA;2(MYB= ]L] \A&CB*@:[W[9_)P#I!?N2.%>_PS[D'E#C5L MG+9'G K/F=0C_]Y(<_!%D)S_I]*^QG;5V.4D$46EIPE.&&/Q%K^_AOT M[3]4NID$BPV!]31U6TU='?J1IKM64_*BZ1G8,,J5([E&]2K4<@9]7#J1#?UR MF#P>"Z6R)RZE7QKI'\ M(SX?410YH3<@=*TT]"+'<0?,M;%-9.ZWS/U?Z?V"")4&_HA:9 =!,%1 819& MT \&_+413N0?M/P#+?_XJ+9(E R" @2?F.\N%GI>87 MC@)WHF"8RF,CZ/K.@)LVQHF]&;4*1%H%;N3P5;'3>KUUYC<)%AL"ZZD%[:[ ML4_X/6W #$RBQ:;0^KIU12X\994+C9:Y1M%B4VA]8;M* M%YZFU&U@^U__T ^']8["SH$N=(>?2'V84V7HBEVHKW9O".9D2[,$I/F.T4=2 MTE<3-U2:-O*81(M-H?5%[.IFZ)\R20W5O(VP)M%B4VA]8;N"'.HK\LE).JZ] MH>>'4>@,LU1IZ-LA&J:I-M"I0G35/-27\^UH4K(U5&8WDIA$BTVA]77KU@ P M.F5F&ETK&$6+3:'U=Q*[U0+2%LV3,[.![25Z:O[>[H6!\R4&P5ZU[>.'Z-HL2FTOFS=>@"A$R8F,KI@,(H6FT+K"]LM M&)"V;IZ>F,YX&1EY43!,R[%9A.!H4TL?Y%01NN(>Z8O[:UIPP?;UD5E: %G9 M;F0[:N*&"O!&'Y-HL2FTOHS=X@!YITQ2HPL&HVBQ*;2^L-V" ?W23OOK2>J/ M-HNA'?F1/K_@^16\B.OS[ ZF/EZ_Q6R3%AQD9"TA[?- ,F3UB75](^BN.L-]H$+0O+K< M$IP05AK(]VM*QG P 1A$ M !D !X;"]W;W)K&ULK5AM<^(V$/XK&O>F]8IE M>8/=]!1@]3PS9>%KZ172K4@CF;[/$. M'D%\WS\P.3-;EH3D4'!""\1@.S7F]G@]4O:5P=\$#OQHC-1.-I3^4)/[9&I8 M*B#((!:* W .P4$9P!^ _ O#2EH ,&E@+ !A)58]>E6TD18 MX-F$T0-BREJRJ4&E;X66BI!"9>*C8/(ID3@Q6U.:'$B6(5PDZ$^1 D/WA<#% MCFPR0'/.07#T&_H#,X95TJ"/$0A,,OY)KGY_C-#'#Y_0!T0*]%=*2RY9^,04 M,C!%;\9-$'=U$,Z9(%STE18BY6A9))!H\,M^O.WT$)CR1-IC<5Z.Y<[I9?R* MV0VRO,_(L1Q7$]"B'SXO=S?("2NXHX%'[WE_1JY5H2W=:?R_V%?]\!5L9.S! MV=C7E\#KK=L]2KAM@KH5G_=.@GY&)-]CPF05%"A.,=N!-M-ZV51='_,]CF%J MR,+-@3V!,?OU%SNP?M>I/"19-"39LB;S*S)UVSS-W-"6U\_$?#J6NFOF.+?6 MJ=FZ:_9J\48UKU7-NTBUJJR0UX*"54&Y4,E>#]=-N14RM>+^&UX@U)%OGOG%"MRI N5T.2K0Y,(09L(06\B/,BW-Z%.BENC8%AB2+AB1;#DFV&I)L M/1#9FTP)VTP)>S-E'L=E7F980')<[C,J*X:V8(2=U]*V0^_6/GDQ%[UNKTV$ M(PZMJ-+%7R3RKY0+&]46_4JC<:]$?72"->]W):=,TJTO6IO5XUH>FNUX%"JT4QC]JV'.39JHZK;=,_KWK=D_4[ M>QS9FO6E/5[7/?TK??T/@^P1=J3@*(.M=&7=A'+GK.[:ZXF@^ZIIW% A6]!J MF ).@"D#^7Q+J7B9* ?M7R>S_P!02P,$% @ -GSY6";U*^]Q! #!P M !D !X;"]W;W)K&ULK9GQ&I[2]8;+!GLV MV:(U?L;\V_:1BCN[H21IC@N6D@)0O)I:]_ N@H%T*"W^2?&!G5P#.9470K[+ MFZ_)U'+DB'"&8RX12'SM\0)GF22)OU&C\K)B\F\((87)/LW M3?AF:HTLD. 5VF7\B1S^Q/6$!I(7DXR5G^!0VSH6B'>,D[QV%B/(TZ+Z1C_J M0)PX"([:P:T=W*Z#?\;!JQV\KD-PQL&O'?Q+>QC4#H-+'8+:H133KH)51CI$ M',TFE!P E=:")B]*N4IO$>"TD)GUS*GX-15^?/8'(8@J\% M1\4Z?ENZN:S\=Z7^K=(_PB>@_.]AY=XEX-'FIBZ349 MYI4\[PQO@2A]38LU0#G9%1R0%5C7V:1*E0KFJV%RG;UC6Q3CJ2464H;I'ENS M7W^!@?.[2B:3L- D;&D2%AF"M>3U&WE]'7TVQ^NT**2^/QSE19:R+5:F(2%%2PX"?*--X3B':DCAL+.=<=.URX:]$0[6K0B'#01#K01 M%H^7=Q(]Z'4Y<(;C;IHLM-U<&[:@%PY5G\N^F2K3H[Y9-]-;H1LVH1MJ0_=4 MOC: QPT2KX/Q*WC&ZW,)J@5=FZ F8:%)V-(D+#($:TD[:J0=F7S CTS*:Q(6 MFH0M3<(B0["6O.-&WO'''_!:Q+6BFH2%X]YZYGO^V.TLCA=9188&UI(!.L>= MFF/B^:ZG7*N%45KX,S2@^G>9 D6FYM?6]&3W#3_X1E$#WDG-A;Z?JW6ZJ-/E M96;1NV;MX+G'X+G:X)V\3-!]&F.F>ZO0LZ[^6YBDA49I2Z.TR!2MK?&Q> "- M5@^@T?*!45IHE+8T2HM,T=HJ'VL(T$ 10<^X6ENC982:UMI=>8/ ][LK9M\. M.H'?,XQ,#:\MR+&4 (W4$J!B*PYA?RN^@/V]^(T[<'M[^U!%5!8!5(;**H!^ MIC\;R6/) 'ZT9@#[10.9$-V46.@[NCIC+^MUJ;!397:DL.MF=A5!^^2P(L=T M71XK,1#+Y;VJ*C>MS='5?7E@TVF?P[L%5+2'\JBK/!PYXJMSL@=$Q3K#0(97 MHBOG=BA&2ZNCI^J&DVUY5/)"."=Y>;G!*,%4&HC?5X3PMQO907, ./L?4$L# M!!0 ( #9\^5A.(C**>@< X[ 9 >&PO=V]R:W-H965T92R_3M-?/"@AP:RQ. M-J&YN1]_LG$1MH4 5PQ?$FQV'^\^%MI':_EJQ<6W;,98#K[/DS2[[LWR?/&F MW\]&,S:GV25?L%1^,^%B3G-Y**;];"$8'9=.\Z2/',?OSVF<]@97Y;E[,;CB MRSR)4W8O0+:TX1$4O8*"\@ MJ/SWQ(8L20HD&<<_%6AO<\W":L2%/OL3C?';="WM@S"9T MF>0?^>H/5B7D%7@CGF3E7["J;)T>&"VSG,\K9QG!/$[7_^GWBH@M!^CN<$"5 M SK4 5<.^% 'MW)P2V;6J90\$)K3P97@*R *:XE6?"C)++UE^G%:W/>'7,AO M8^F7#]YS/E[%20)H.@9_Y3,FP&V:TW0:/R8,W&09RS-PL74N R\)RVF<9*_D M^<\/!+Q\\0J\ '$*/LWX,I,XV54_EZ$5%^B/JC#>KL- .\*XH^(2..YK@!R$ M->Y#L_L[]G@)D%^Z(XT[.<3=T[GW)9\;4M&&5%3BX5UX<1KG#/PI1_08W$AB M;U,Y%+=/MCE^^PSNZ%%-MJ C=MV3$T#&Q!/K#7[] M!?K.;SH^;8(12V UKO&&:VQ"'[P7/,O D KQ'*=3<#/GRS1_#=:W0$?C&LXK MX8I9\6D ^P[?G35?]IF2&N'L./5[8@QO([)NYOD76/RGWA.$W S&BWGRX3F MQ6B;V[K'&+(*P=8^-D73,,]SD M&9J'M*!C*?&D_-/E:?0]MA;8!".6P&J<11O.HC/4W<@FUS;!B"6P&M?04)1FRAU0E7:AR:Y?C1:Q'85M?(@1%L"C.-'8P"WX/-G^\I1#A4 M*AP>(L,[582VZKZ (8I:RQ&M81!&7MBDXA0"'2J%#LT2_: 528516V.&D=]4 MJUHS/\+-C$\ARZ'2Y= LS#^RHLU8C/LO9;.MN/M/3- IJXT"<,]$S/6ES'P! M#)X9%;HY:=C9DY@]NY*F1#XTJ_Q["3H2\:)D9A(G3#_E6I7[5M&(+;0Z@4KQ MPW-(?FA5\UM%([;0ZIU-I?J16?4?7>,JO-KLY:#(]QM=A:'6$#NPV:8@Y@B[ M,J#$.C*+]>Y5#K5%^$6$0C<(FU3H#&$8!,TYWQQJ5RJV^MQFO7Y0E:LPZO<5 MRFR:26OL(,2MKHPYIJXY*U6-S WGGZ]S>R[@[:YS>SS]W77.[-F5-*6,D5D9 MUYA9E,P /@&QFIMI.3=KZ3)#F^BR)(+@2M M*H##T&DUM ZT(^;XNN:O!#[:T\;O+A;"M@; CB\+8I,)C2$*?2=J47$*J8Z4 M5$=&97J@6(A:MS64BUW8S+EM!HO&22OE4XAEK,0R-HOEG]<*>RX0[2Y^>SRA MLULLF%V[LJ8$-C8+[.'= TCB$4LS_0-\2YJWHLDF&K&%5F=.Z7%\CHTGV&J+ MW2H:L856)WQK\XGMW2?M;25>X+6JVV%FQ!Q=U^R5JL>GVGZ"-=M*$ ZBYD)8 M9P<]'* F$:?0YEAIE56AN'YZA^5IOO5M&(+;0ZX4K18[.B/[[Z MM66[%T9ALQ-\F!DQ1]=UZZ42]^ZI]K]4P+6JIN-!:^=CV.R(F@/M2H32Z^XA M#?$]U<^,<<2>GPIH>W @O_6,H,OE]E.BA+AK;HS_?'G<NIF M$[-C5\Z4EG;-6MJ\X]'L?.PT;!6-V$*K$[>U"=P]0]US;3;/AU;1B"VT.N%* M[KMFN?\S3S/V0!O:,D.SZ]$_)_'WN'CA*%L*FH[8 M*_ ?V-/\,:,>/2JMMMIMH=495:L+-SC'-&!UO6$5C=A"JQ.NUANNN;=OHP+M[C";5MYC5K_:UW#XLW1>^HF,9I!A(VD5C.92"G&;%^^7)]D/-% M^3KB(\]S/B\_SIBL_*(PD-]/.,]_'!1O.&Y>@1W\#U!+ P04 " V?/E8 M!\!S554# "?#0 &0 'AL+W=ON*Q\C4P?6?)18&5'HJ5 M*]<"<&9%!74#SXO= A/FI&,[=R72,=\H2AA<"20W18'%SW.@?#=Q?.=AXIJL M.9%0&%A3(66/]LX0(H-4YZ'3\J4Z=^IA'N7S^X7]KD=3)S+.&" MT^\D4_G$&3HH@R7>4'7-=Q^A2FA@_!:<2OL7[:I8ST&+C52\J,1Z!05AY2^^ MKT#L"?SX"4%0"8)#0?2$(*P$X=\*HDH063)E*I;##"N;8CE"+,,O1%Y2#0)Z8P6Y$Y!325$I1$;]$M6^(M M%]A,4M"<$:FCI-7B@@M%?F&[FW"OZU('GY9!UC1P=?HU@^"!P7G0Z?@9 MBU/D16]0X 5ARX(NNN67,#]%06SE08M\]C?RQ,K]CFS">D=#ZQ?^QXZV42]= MHW97\_DYDVN\@(FCOR\2Q!:<]-4+/_;>M1'KTVS6DUF#9E33C+KO/ M[5[](UR^)88W)7A.*%$$6AF7SQK89YDO\C9-(B^(QNYV'UY+U-"+DF;4[''4 M<.0%7AW52'=0ISOH+)XI4V1!UEB!?J,9VV#:_F+_,X%!GU76I]FL)[,&]KC& M'G=6F7[U!VVT2E6\M\>Q'T;A0;UT>A^+H2>S!H:DQI \AR%NPY \PC#0E3XZ MP-#I?2R&GLP:&(8UAN%S&)(V#,-'&,)1DO@'&#J]C\70DUD#PZC&,'H.P[ - MP^@QAB!)#JNAT_M8##V9-3#XWI\6S?LG$)5L_U] , A&AR2ZW8]%T9=;R<+= MZUP+$"M[ I!HP3=,E0UG#]L1_[$ICRZZNUL1)G7;NM26 MWFFB>8GR-% .%%_;_GC.E>ZV[66N3U @3("^O^1&PO=V]R:W-H965TJI9(Y?>0:GVSO=E>8":R%O> M0J.?5%S41.FAV/NR%4!V5E0S/\0X]6M"&V^UL/?NQ6K!CXK1!NX%DL>Z)N+[ M!V#\M/0"[_G&9[H_*'/#7RU:LH<'4%_:>Z%'_I!E1VMH).4-$E MO??!W2; M1F C_J5PDF?7R%C9[&NH*9-]TV>>A!G@B#^B2#L!>%<0=0+HKF"N!?$EDQGQ7+8$$56"\%/ M2)AHGW3QJS[@Q+Z*=4ZM7I?EN((._1 &!$4Y WZJI=;(M+LT-_J M *MCT) H]"?E&PIHTH'H;<;4(0R^0[]AKX\;-#;-^_0&T0;],^!'Z76RH6O M='5F#K_L*_G051+^I)*_B+A%.+Y!(0XCAWP]+?\(VUL4IE8>.N2;.?+,RH.7 MDZL+6C=-[)[&G IWLB4E+#V][26(1_!6O_X2I/AW%\+7 M3+9YI60O\$8#WF@J^X#W9*#>H"TT4%'5X>46;PM"\J8!ADHNE1-M-T5BIS#G MX^,J*'":Q@O_\1S:95A8!!B/PC:3!5^)(QYPQ+-PT$:!SJY<;KL,Z;G;/(WP MR*PK*LS3D=?):J[TF@Q>DUE>)6%PON"*/.EQ2[Z3+0,7@.3"6IX6X1C 9526 MX#0? 9@L\4H Z0 @G0= <0$(GG0+()V&TTLK052,K*P=43B)LI'AR9*N-)P- MAK-9ALTAN2>F7;A!#/:$V=5O!:] FCY$WZC ?8IF%R;C(,3)"(4C*M(-U C% M9+%7HL@'%/F\M0=6Z=TNCX(TI7/Q\PLO89*EXU^[(RJ/<3AR/%G3E8Z+P7$Q MZ=C^6;H,%I>E9TD4C$]O1UBB>^*QQR[ M!3;=+?3S)"]V&ULM=UK^RZK2XS_?-;ZZ+\BZKFV_+F[/JOLRSJV.CN]V9MEA89W?9 M=G]R_NGXL]_*\T_%0[W;[O/?2J5ZN+O+RK]^S7?%U\\GZLGS#_ZYO;FM#S\X M._]TG]WD7_+Z]_O?RN:[LQ?E:GN7[ZMML5?*_/KSR2_JSZEI'QHO6U[@]3LQ[];].2EST/# MUU\_Z^[QCV_^F,NLRB^*W?]NK^K;SR?+$^4JO\X>=O4_BZ]^WOY!YL';%+OJ M^%_E:[OMXD39/%1U<=MM G]K M:!L84QN8;0-S:@.K;6!-;6"W#>RI#99M@V6_@?Y&@U7;8#6U!W7Q/'*+R4U> M!GOR:*O/PZU.'F_U><#5R2.N/@^Y>ASSLZ>G[_&YO\[J[/Q367Q5RL/VC7?X MXCB!CNV;I_QV?YCK7^JR^>VV:5>?!_NK_++.K_9Y52G9_DJY*/.K;:W\3.G:^4G9;#-+F]FEW*]W6?[S79_HQ27N^U-=IB[E?+].J^S[:[ZH6GX^Y>U M\OT_?E#^H6SWRK]NBX>J:5U].JN;'3]T?[9I=_+7IYW4WMC))"M/E87QHZ(M M-'VD^86\^3K?-,U7Q^;:2/.UO'E:/)XJ^N+-YLZ$Y@O]S>:NO'GXL#]5M+=W MWIO07'V[=U_>W,TOF]ZM-YL'[PW<7XJV/+961UJ'[^W[KNG\:=@7(\VC"/.JTNQ^5DSQ5_FN?8RS[6CIT^=YYNG M>9X]S_/1:?ED&N/FX6W(S]5]MLD_GS3O,ZJ\?,Q/SO_S/U1K\5]CDY3$UB3F MD)A+8AZ)^206D%A(8A&)Q226D%@*84(UT5^JB2[3F^IT63>OZ55=/AQJQX]* M56=-<6E^5.=-;[52-M\JWV=-J5'N\W+3;//#6'V1]C*WOI#8FL0<$G-)S",Q MG\0"$@M)+'K"U*=7[L.Q]./YXG1AJ9KYZ>SQ=>T@>TU(+(4PH788+[7#D-:. M^.V#A[$2\829KQYL=;E2-?&AOI!V.7?NDYA#8BZ)>23F#X=)6^BV(0Y30'89 MDEA$8C&))2260I@P\OT$6AF&:B]Z,UW: MQ]R93F(.B;DDYI&8/S)0MJGK5F^@ K+3D,0B$HM)+"&Q%,*$N6Z]S'7KG1?Y MJOI9N7@HR\,IQ+NL?BBW]3:OE.):V17[FY^:XX2[8RUX[X3B6*VP!D_!GRQ= M[[\GD.[AW$I!8@Z)N23FD9@_,DRF:?3?$Y!=AB06D5A,8@F)I1 FU G[I4[8 M\CHQJQ;\V/RRJI3-H*R,%0E[Y V%;B_U9:],2'=P;ID@,8?$7!+S2,P?&2C; ML)>JU2L49*W3U8O#%_F_'[:/V>ZM MBQ?+X\>?'/KY3U&V<1I,C<"PHDMB8QA\1<$O-( MS">Q@,1"$HM(+":QA,12"!/*A[IXJ1^'E!<>@&A1J*"@VAK5'%1S49M<(4G-0 MS44U#]7\5GM]3*(N]*5E]$]*H-V&J!:A6HQJ":JEE"9._RY;J4K#5N?6J:J9 MWRG5TS'*OJCS2KEZR)5?[LOM[JW0\J]R=/9["S1>B6H.JKFHYJ&:CVH!JH6H M%J%:C&H)JJ64)A:7+FJIZA]QX()&*U%MC6H.JKFHYJ&:CVH!JH6H%J%:C&H) MJJ64)A:7+HNI2A-?6)"[[>;]4.R%?(=FEQ)2[Q$*IHWT-<9YOM;EO_]72T M\G#ST,SXYG#%&IWB9#CM M76J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DII8LGI M@I^J]1&'*V2B[0+5UJCFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I*:6)QZ=*BZIRX MZ&@AL8?76=2EOEP.KK.@N4]4C$'Z8(56UQ^->?^&C>$]4<5'-1S4,U M?V2X[,5J,%H!VFN(:A&JQ:B6H%I*:>+$[[*?JCS\^?L^NRO*>OM_^=73YT2V M5?60[3>YLBFJ-PXH5L-R8*FJW2\&:,83U1Q4:CFCXR6;@Y'*T![#5$M0K48U1)42RE-G/== MN%*3IKN^Y;1E*PJ+H2SZ5\,NY/W.K@6DYJ":BVH>JOEC8Z4/EK="^PQ1+4*U M&-425$LI3:P$70Y3>R^'N2GV5TJ\S??O+F$AIV:?44!SEJCFH)J+:AZJ^:@6 MH%J(:A&JQ:B6H%I*:6))Z7*6VD?D+#4T9XEJ:U1S4,U%-0_5?%0+4"U$M0C5 M8E1+4"VE-+&X=#E+[>_F++5A<$]534L=K,(K[VEVC4!SEJCFHIJ':O[8+T[X*6FCQH:9]VJUD\?W:L6]4B?-C]=0A; MF*-U@JK5'-0347U3Q4\U$M0+40U2)4BU$M0;64TL1[$W8145T>$7W_Z*4%7G]* M3%=MP^Y_2$S>T=P2@6H.JKFHYJ&:/S):YJH9KW[8 NTU1+4(U6)42U MI31Q M\GG"[J]G,W&[]<3MG(G;N1.W\R9NYT_<+I _ M_+,G&1IG1+48U1)42RE-G&1=G%&7QQFEB::VK?#B>O@D9O_,H+R/V2^N:)(1 MU5Q4\U#-'QDM:R1_%J"]AJ@6H5J,:@FJI90FSOM7M_V6)QF_(=&D#Q-SFJFM M^K6 O7DW>_=N]O;=[/V[V1MX#\?*6FK]1!/:9XAJ$:K%J):@6DII8B7HLHVZ M-#%UOCQ=2"X1I,5C?G>9EV]^)E.NSSV3AVIK5'-0S44U#]5\5 M0+42U"-5B M5$M0+:4TLM,V:O MOKC.-R_G^D?OLO&NCZBZBV1C4'U5Q4\U#-1[4 U4)4BU M1K4$U5)*$XM+%U@T_D9@ M4=YV=@U!8XVHYJ":BVH>JOFH%J!:B&H1JL6HEJ!::@RCJH:X^)Y8';I8H_%> MK/'F(2NS?9WG5\KO^^J=%9KDVNQZ@48?4O]SSC+.YI=(M!\(ZJYJ.:AFC\R6IIE6D9OM *T MUQ#5(E2+42U!M932Q,G?)1<->7+1/K6_>_5I"S>_+)OCE^.B3/9H*4!7?42U M-:HYJ.:BFH=J/JH%J!:B6H1J,:HEJ)92FEA6NDRD87_$ 0N9<;M M36J.:CF MHIJ':CZJ!:@6HEJ$:C&J):B64II87+K$IR%/?$XX8!G&X=2EJ:T&!RQH[!/5 M'%1S4K?UEN^.[-+!!HL135WXB/BH;WZ$WL-T%Y#5(M0+4:U!-522A,FO]EE1DUY M9E2:O3"':_LU+_K6JO>AO0MY'W-G-*HYJ.:BFH=J_LAH:;JM+_LK,:*]AJ@6 MH5J,:@FJI90FSOLNT&G*5V+\AL^-M*)X$]S^Q[[DW$* M1@L(A\<+HW_W;GDWLPL$J3FHYJ*:AVK^V%@MEZM5_PB&[#1$M0C58E1+4"VE M-''F=V%+4QZVI"Y?M-VHFGC:W&J.CQ;=O\&I3S2@B6H.JKG?]/AXZ#[XW[0/ M ;H/(:I%J!:C6H)J*:6)9:*+99KR6*;\0L=P=<+FO8'5G^MHMA+5'%1S4U^NLSLX_W69*5 M-\W[?V677S?\XM1NGA+E]N;VY9NZN&_>,YXHET5=%W?'+V_S["HO#QLTO[\N MBOKYF[/&_UJ4?QS[./]_4$L#!!0 ( #9\^5BUM%HT, X ,+" 9 M>&PO=V]R:W-H965TV_;UAW&\;=">-W6 FDL41?; MF6/ ,7DN1;($2;?]34O'%E&)5$G*3H"]^)$28^I(U+$Y?5.@C2\Z'U+U8^8G M/2)U^9AF?^0S8PKOZV*>Y&]/9D6Q?'-ZFD]F9A'EK].E2S(V9SRNI MW(\_:_3D:9O5PNV/O^MB?>?+.W,;Y>8FG?\GGA:SMR?G)][4W$6K>?$Y?52F MOD.CRIND\WS]7^^QOFWOQ)NL\B)=U(O+/5C$R>;/Z&O]/V)K07]X8(%?+_!? MNF!0+QCL+A@?6#"L%PQW%PP.+!C5"T8OW:5QO6#\T@5G]8*SERXXKQ>3F6E<>-?WF3%EJ OOU^]?$M$DGL?%-^_GP!11/,]_ M*;_WKR^!]_-/OW@_>7'B_3Y+5WF)Y)>G1;EOU19.)_5^!)O]\ _L1]_W/J1) M, MWF^[/^[E'Z*LW/IPO7S0LCQ\;ODWSS\_N''A7OW;:E[N^V;CO9;E\@7+^[V# MR]5SRY-RZZ.#R_4+?FZ;__']_]HBQ6)!206DI@@,4EBBL0TA%G)'3XE M=^C2R]^$VZ(\K.9%MJJ.Q*^\O(C*0W7YI<*46RN\K/S4^SDJ#]S>TF23\C:_ MM,7;N96N\2:Q@,1"$A,D)C=8?W/$J\;/AZO>Z]ZX[X\N3Q^VHTMN54.8%=W1 M4W1'SNA^CLMD7L=3[[TI)U'O0Y24D_-ZG+A)%\LH:3T,.\FN.26Q@,1"$A,D M)DE,D9B&,"O+XZ^<#0+&Y-=N@A]3OGMKHF ME\0"$@M)3)"8)#%%8AK"K)!?/(7\XMCYX8),+HD%)!:2F" Q26**Q#2$6HR^,ZE"O__HE4/NPING4?*R@<%-=LXKJ06H%J*: M0#6):@K5-*79H?:;4/O'C@ZU0&68U )4"U%-H)I$-85JFM+L##?U6]_9D70= M(= N#M4"5 M13:":1#6%:KK6QELCQ'#DF"":MJWOKMM:)HCKU?TJ+ZKY8=P: M5K190[4 U4)4$Z@F44VAFJ8T.])-"]7=5#W;S<8[=\N<.]S+P_NO5&6T-)-JGH5J :B&J"523J*9035.:'>ZF@NN?'STCH,T: MJ@6H%J*:0#6):@K5-*79&6X:MKZS!KGZ?5:JLW0^]:*'*)Y'MYO6.$V\8F;* M?^-LZDW2I.J9JW,KO-M5'J]?\3Z-V@./%G*H%M2:]13ZZ&RT.[F$Z%8%JDE4 M4ZBF*O_OXN2VT;KAK:%$M0+40U02J2513J*8IS8YV M4]'Y_6,G#1]MY% M0+40U02J2513J*8ISEZU,C,GK%UJD%_MG.F04!NMD0U02J M2513J*8IS0YO4\7Y[BKNV=GB)B[BVRCYX^_Y^@SBPR%&6SI4"U M1#6!:A+5 M%*II2K.3WG1Y_O#H40,M[U M0+40U02J2513J*8IS79=:8]:*%\Y;76]ZTWK#E!9R!>_M3NENYCZLB+Z)D6H7VZ6C:%KYW;JCS M4,!>J7+_M*SRIOL'[A#=K$ UB6H*U32EV2EM&K6!L^VX>F^*PF2YE]Y]?TB6 M-KEM#2O:KZ%:4&O;8?5[Y^.+\]VLHLT9JDE44ZBF*< M)M'\I>,I>A(' [1)0[6@UJP#[J@UMVA) MAFH2U12J:4JS<]N49 -W2793'5+S1V.6K[S!K^4#_>I]-=:'X.+[:42MD45/ M@D.UH-:L(^WYP!_M)18MQU!-HII"-4UI=F*;V$]OOD%BT!T.UH-;L MV6#< MM=06(;I5@6H2U12J:4JS8]J46$-WB?7/U?KZD%4XHV^YEYGR05?U7$$YPZYG M6N?AU6UWSBUZKMHS]_NB=ZC@"-']$*@F44VAFJ8T.\E-$S9T5U8?ZH&@JK\F M\;)ZYBN:1]5+O>[2S'NJ(:J@6U MMGU8;CTJHX48JDE44ZBF*K>WX;&O"ANBG1JJ!:@6HII -8EJ"M4TI=D9;IJWH;MY MV\FP-TD7B[A83QQWYD7O5=A^-EIO]ZWR;MP[TCF\Z+EMJ"903:*:0C5-:79X MFR9NZ&[B.M?&;J_SX1@MWX8M%[@\&UWL/26,;E6@FD0UA6J:TNRL-N7;\)E+ M4L9?JW9X%F7WICS*/IBL.NDGB\K\MB85[=M0+1BV]&V[(46;-E23J*9035.: M'=*F:1NZFS;79?GBK(A-,;,NRW?@:GSNK70.+]J\U=JS5^-#MRI03:*:0C5- M:7:"F^9M^&-.2W-?$]B]TR-UQ'?U41.U7;Y]D/14QV+TRSHU[3SJG M%SVS#=4$JDE44ZBF*7^3>I\['=+3R&^U7?JTO&$*W*E!-HII"-4UI=MZ;SF_TPSJ_]06QW=V? M>^.=@XUV?Z@6HII -8EJ"M4TI=GQ;[J_T='=WPCM_E M0+40U02J2513J*8I MS$G[?/'WO7U48W&Z*:0#6):@K5-*79X6V*QM$/ M*QK;WK3CF:=#T/X1U0)4"U%-H)I$-85JFM*LWX9QTS^.C^X?QVC_B&H!JH6H M)E!-HII"-4UI=H:;_G'L[A^/'D?$]UO'D;T75@?H9D-4$Z@F44VAFJ8T M.[Q-_3AVUX\_8!PY_.R(>U\Z!QVM'5$M1#6!:A+5%*II2K-_&YIRAQ! M&T94"U M1#6!:A+5%*II2K,SW#2,8V?[ XPC:/]8:WOCR-ZS(^AF0U03J"91 M3:&:IC0[O$VU.'97BYW&D=^B9!5EWZIYI-<:9+1F1+4 U4)4$Z@F44VAFJ8T M.^U-%SD>'SUNH(4BJ@6H%J*:0#6):@K5-*79&6X*Q;'[_,1N;P_BQCK'&>T6 M42U$-8%J$M44JNE:LU[^>V9?E-5.:E,;CMVUX?AUWQ_]M9PMUB-&DA;599&J M9S6663ROAHA!:V+1KA#5 E0+44V@FD0UA6J:TNQ8-X7B^.+H(0*M 5$M0+40 MU02J2513J*8IS%_7B[6IJNYM@G>8S8XH@ M*J*KRX7)[LV-F<]S;U)=>;;/BG29466@VU1I(OUAS,334U6W:#\_EU:3A#U M)]4&'M/LC_7N7?T/4$L#!!0 ( #9\^5A1LHOHEA %<3 0 9 >&PO M=V]R:W-H965T+<[R4QK"]#%SCJ> M2[_5Z4W=VN-\5BODJC3,HWRV62_?@U7:R_?[Z0+UZ^ M\8_YPV-1?>/J[O8I>4A_2XM_/459^=757IG-E^DJGZ]74I;>?[[X(G^*1\-J MP':)?\_3[_FKQU+U5+ZMU[]77]BSSQ>#:HW213HM*B(I__>?IUO?C/?%8\?KZXOI!FZ7VR613_6'^WTOH) MC2IONE[DV_]*W^ME!Q?2=),7ZV4]N%R#Y7RU^W_R1_V#>#5 'IX8H-0#E+X# MU'J VG? L!XP[#M@5 \8'0Y03PP8UP/&?6>8U ,F?0=WO++!I=[;W'Y99/+O;>Y_++1Y:.M?G+( MRV:7>V]W^67#R]LM?[5[76U?E%I2)'>WV?J[E%7+EU[U8/O*WHXO7XOS515" MOQ59^;?S2U4SZFJ6S>2%]>6K/)D M&QJ[9?RDV&3SXH?T04N+9+[(/Y9+_>LW3?KPUX_27Z7Y2OKGXWJ3EXOFMU=% MN9;57%?3>HWG*X+A[^9?-P60[=#I<[AAOBX7[R M0U*N3XXVWUKW13GY<#M\T#'^YJQW!//-Q(OY6SCT]N=K_/\,G)#1>(AP?KYTM)'9RPQ?'#Z=S;J\Y,_ M_8*+>_S:U*_7@>#UK^XS3MUZ:M^,F^XR+GG)N*Z4^G5G#KO-:M_P4_Z43-// M%^7.7YYFS^G%W=_^(H\'?^]*&!+32$PG,8/$3!*S2,PF,8?$7!+S2,PGL8#$ M0A*+2"R&L%9H#O>A.13IY5[/MZ+/;^.2')6A\1<$O-(S">Q@,1"$HM(+(:P5D2.]A$Y$D:DF91'NA\6Z[P\ M_EVOI&HG4UJN9_/[^31I#I:SM)AGN]W,GZ556G2%I'">O]E M**NRTGZYZ^2B /#[:YU_&KH2KJP3\$_O%2(V4R M;"\4D&L?DEA$8C&$M<)JO ^KL? @N#YG-T\[#W;'9 "1F$9B.HD9)&:2F$5B M-HDY).:2F$=B/HD%)!:26$1B,82UPG&R#\>)<$].&50',,>Q*!QU;BR2F$9B M.HD9)&:2F$5B-HDY).;NL/'K0_2#/3=R.I_$ A(+22PBL1C"6EEWO<^ZZ[>R M;MR5=<)1YV8=B6DDII.806(FB5DD9I.80V+N]9M91T[GDUA 8B&)12060U@K MZV[V67?S5M9-NK)...K,U=%X<'.0?NBT/JH%J!:B6H1J,:6U,_#5-^U M>$RS-+DOTJPS$H7*V9%(:AJJZ:AFH)J):A:JV:CFH)I;:Z_?654&P_%A'I)S M^J@6H%J(:A&JQ936SD.ER4-%F(=?5JM-LI"^;QM9Z4Q*GM,L>4C[7L(GUL_. M25+34$U'-0/53%2S4,U&-0?5W%JK=DF*5]-3K(5__4*CFHUJ :B&J1:@64UH[T)H6 MB2R\#ANK!8NG.3OGT,H)JNFH9M3:VPU2%KJ&=N]Y'71>M_>\'CJOCVH! MJH6H%J%:3&GM(&L:'[*X\J$GV>+'=L]L^;2]'=[Z?MO@[0PKM >":AJJZ:AF MH)I9:ZW=J,%8&5\KAWF&%CU0S4$U%]4\5/-1+4"U$-4B5(LIK9V+33M$%M=# M/E1W-?@H57IYIZ,S[:CFHUJ :B&J1:@64UH['YM&B2RNE$39>IJFLURZS]9+:9[GFV0U385[ MCVC;!-4T5--1S4 U4SZN3RB#L3I1#W<>T39)K;7V68>CT?$9/;0I@FH>JOFH M%J!:B&H1JL64UKZ#&+KW,1#-0W5=%0S4,VL-?&M MERQT3AO5'%1S4X KC=% M7B2KV7SU(#UE\]5T_I0LI&2YWJR*_7O G7F)%E%034,U'=6,6KMYO7=U<.2, M3FBAFHUJ#JJYJ.:AFH]J :J%J!:A6DQI[;!4FK 4MU#&E]>3T4_2_?R/=/;+ M]FWBHXNTM72:+K^EF72JQ2R>XNRD1*LHJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C M6H!J(:I%J!936CM4F[J+\AZ?;:*@=1=4TU!-1S4#U4Q4LU#-1C4'U5Q4\U#- M1[4 U4)4BU MIK1VC#9UE_*A:-^4NJQ1/,W9P4IJ&JKIJ&:@FHEJ%JK9J.:@ MFEMK1Y=07N^N+J__')QB\?[4*!]=\P#50E2+_M3/)Z;6H1V(37%%$1=7C))^ M.759O[G3)IL^)OF)LYAH=075-%334G564LC_99MDNR'=.IVLV+N M[&1$RRZHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E-:.T";\HTR>8^S MEF@-!]4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LIK1VC35='$7=U ML+.6:'<'U314TU'-0#43U2Q4LU'-036WUHYN\#@Y/$_9;SD?7;L U4)4BWK^ M1&)JUG;,-94;15RY^3/G(M'.#:IIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J M(:I%RG%W:R2/;X[.1;Y',4=MBCFJN)@SN6SN=INGTTUY(/WJU*2S66Q/2W9^ MNJE8/CP?5-%334^!?Q:MS=F3VFU5'9S50S40U"]5L5'-0S>VY[;V>R_GH MV@4]9PU[+A?U7"ZFGD4[3IJ*BRK^1)?C.-FLI&GR5)\2[$P.M-^":EJMM6]C M>'SS9AV=U4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LIK9V.37.E?"A*Q^V- M>3Y4MVO\V'E_GMV!;)\[.-83O0ZF7]3KF\GUX>Z6<(7.CD-2TU'-0#43U2Q4 MLU'-0347U3Q4\U$M0+40U2)4BRFM'9I-NT7%VRWJ\97IP]'HYC ;T=9*QYQR MQ^=\Z.BL!JJ9J&:AFHUJ#JJYJ.:AFH]J0==O^7@PO)D<'M9V=$,Z#IRB+D\> MW@R5P\/:]RB1J$V)1'VS1#(0O'-[JDLB5L\^M$6[)*BFHYJ!:B:J6:AFHYJ# M:BZJ>:CFHUJ :B&J1:@64UH[1YLNB?H>71(5[9*@FH9J.JH9J&:BFH5J-JHY MJ.:BFH=J/JH%J!:B6H1J,:6U8[3IDJC_GRZ)>)JS@Q7MDJC]KG?7T5D-5#-1 MS4(U&]4<5'-1S4,U']4"5 M1+4*UF-+:D=GT4E1Q+Z6^H:WH$+[S)K9B]NR( M1,LIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!936BM(ATV'93AXAT/X M(5I?034-U714,U#-1#4+U6Q4T 59H %1=7KB]%[\@'Z^?]A].,.W,3_7 :5--034U -5"5(M0+::T=IXVS9WA>WPXS1 M[Z":AFHZJAFH9J*:A6HVJCFH MYJ*:AVH^J@6H%J):A&HQI;5CM*GXE __+\?UPFG.#E92TVKM]4>YEH?UUX?' M\>2=T>\WI]5K*1]JOFH M%J!:B&H1JL64UH[1IM0S%%[M#M[50CS1V=&ZTUKWR.BZ>X^&3JNCFH%J)JI9 MJ&:CFH-J;L>ODCP\.HQ&JSFH%J!:B&H1JL64U@[#IIHS%%=S/E1I^%&JTG ? MAKVB#ZWBH)J&:GJMM6X-<*T>W)S#0.MX*":AFHZJAFH M9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQI;4B=-14<$;O4<$9H14<5--034U -5"5(M0+::T=HPV%9R1N(+C)W_,EYNE]&V= ME6/GJX?J1N7)],2[YV+L[/C<:>-7!\'#KE.3Z*QZQZQJQSTJ#716$]4L5+-1 MS4$U%]4\5/-1+4"U$-4B5(LIK1UY2A-YXM+,P45#6?J\7CQODZ]]^5"?PW+Q M5&<'(MJ@034=U0Q4,U'-0C4;U1Q4%@NQ,Z.SV''>],=1\@:.JW>.6W'Z0 #G=9$-0O5;%1S4,U%-0_5?%0+4"U$ MM0C58DK;A=Y5_IBFA984R=WM,LT>TJ_I8I%+T^I#;#Y?5(?K^^^6!^'W92C* MG[XH%U='WW?E3[YYNGY*'U$^RA_DJEQ;I?4D.+B=E>F3SA\?]%\7Z MZ?.%?%'F:%&LE]N'CVDR2[-J@?+O[]?KXN6+:H+OZ^SW[6K?_0]02P,$% M @ -GSY6&#&ULM5E=;]LV%/TKA%8,+=!$(O5AV;,--%:#!4BVH&F[AV$/M$W;1"72%>DX M&?;C1TF.9,DT$R/,BZV/>P]Y#B\O+\7AEN<_Q(H0"1ZRE(F1LY)R/7!=,5N1 M#(MSOB9,O5GP/,-2W>9+5ZQS@N>E4Y:ZR/,B-\.4.>-A^>PV'P_Y1J:4D=L< MB$V6X?SQ@J1\.W*@\_3@"UVN9/' '0_7>$GNB/RVOLW5G5NCS&E&F*"<@9PL M1LXG.$A05#B4%M\IV8J]:U!0F7+^H[BYFH\ 1O 5?VL.XN>.GN!C(@W.#\'7O 1( _YF@Y-S.Z79'H.4%2Z(XU[ M\A+W7ND.#6S\6GJ_Q/./X-WF:O;F\O$CN$TQDT"I##[_W-"UFE82_'VMS,&5 M))GX1Z=]A1WHL8ML,1!K/",C1Z4#0?)[XHQ__05&WF\ZW6R")9; 6IH&M::! M"7W\IU(42\J6("T"&\RXD#KU*I2P1"E2X_TX"J#?#X;N_;XN&K.H'Q2COV^6 M:,Q"B*+&K,4EK+F$QOBXI RS69O+0$;$"G/'%V49IB84@VL"H,*.]H?2#7F>\)QJCR(\[07%H%/AA7Q\2 MO9I3S\CIBDFBE)) 44HY6YZIVPPLRD ANS!)*9[2E$I*M#F[=] MV(\Z?9\< M&B$8]3H$-4:A%^H)QC7!V$CP*Y!GDJ_IM(W4KE;J?BK!N@9'OW#<%+9H\-#9Q1['1X:(P2/\(!>4R)X1B;? M<:YB*GUV/'8PK=CJQ2CR.U2T=F'4[P:8U@YY<7R$T%[- XV$KHD0 U7J3BM" ME,UX1K2,X$$/SB"*#Q*"ULX/87=\M'9!'$='&*&&$3(R^D/M$,PKW@Y@?Y&* M8:CZV*6BL0N\L.]WJ>CPXC XLNC!IBJ"Q@)A?+&AZ5RM>@+\!VXHH]DFT_*Q M6@!914MLH;45;&H@&+QA80F-%=;)PMI$2VRAM85M"C)H+%C4\JN65;4^%4E= M%#4%XVQ6K%1I6N9'WJX^]4G2W$0('@G.=9X3L^?)4KY%;0:;X@R:J[/GI&R5 M 'HAS0V8A#1ZGBRD);2VD$U%",TE82M=XH>CZ=*(&KJ<&1N09_ M?;Y\I@&3DF;74Y6TA=96LBG^D;GX;Z:VL;XTHYPZKZVB);;0V@HVFPV$WC!A M(N-.YF1A;:(EMM#:PC9;'V3>^MA(F,\TX1MFN=4]D"VTMI3-'@B9/P2W9OGQ MLLB,MW6YT6SW-P$ M] S3W.KNQQ9:I:6[=Y"9D7Q9'@@+,.,;)JMCPOII?>C\J3QJ[3R_@(.D.CIN M8*J3[!N<+RD32MN%@O3.>RH8\NIPN+J1?%T>ETZYE#PK+U<$STE>&*CW"\[E MTTW10'U$/_X?4$L#!!0 ( #9\^5C$9\*%B@, #@, 9 >&PO=V]R M:W-H965T>S].M5-]U#6#(4\.% MG@6U,>U-&.JRAH;J:]F"P#=KJ1IJ\%9M0MTJH)4#-3Q,HJ@(&\I$,)^Z9_=J M/I6=X4S O2*Z:QJJ_KT%+K>S( Z>'WQEF]K8!^%\VM(-/(#YUMXKO M[EHHU M(#23@BA8SX)/\I9, Y(!6O:UB2]^\^D'>( M(7_6LM-45'H:&LS2KA66NXQN?4;)B8SBA'R1PM2:_"HJJ%X3A"BOUY@\:[Q- MSC)^H>J:1-E'DD1).I#0XCS\#E;7)"DA*Y]O4BG-$5X\PPT#=#A?$+ M9\,+VP9THUM:PBS #J-!/4(P__FGN(A^&3+UDF3+"Y&],CSK#<_.L<__:$'A M 1";EV.A7PH@^[?^3 SYZOESQV_[\.-\%!5Y5$S#QWW'AL+2-#D(6QZ'%>,T MV0M[I3+O5>8_H)() ^BL(:U4KA?@GEHS044)9W3[%8N]3.-),3Y0?1R4Q,7H M0/- 4![EPXJ+7G%Q5O&=R_^4XE;AD6(M-L/_);DX2C2+XLF!Y(&@.#Z4/! T MRK)AR:->\NAL[W"_ZE=R?=5A-Z!: W8.N<(6+GSG@*>RIF(#S@'?,^2*LXWK M_\,]8W3)GG%)LN6%R%X9/>Z-'K_Q-)W>*N/C/5UD>72P#Q;'86D>Q6ERL%V. MPW(,BD^ZRQM$>E W ]VLIS?.-7:#_LS#_#U!+ P04 " V?/E8(.7 M#U_(8BG4!V<\*M$"3[#X5CXP^>:T*"G)<<$)+0##\XO!I7=^#7TU0%O\2?"* MKST#Y>G,%'%\3;/O)!7+B\%P %(\1U4FOM#5[[AQ*%1X,YIQ_1>L&EMW &85%S1O M!DL&.2GJ_^BI"<3:@##8,0 V ^!;!_C- !TYIV:FW;I! HU'C*X 4]8233WH MV.C1TAM2J&6<""9_)7*<&-]A&0,.3L&D*LL,RP42* -7$_"IJ'-$Q?KH!@M$ M,GX,/@!2@*]+6G%4I'SD"$E! 3FS9KJK>CJX8SH/@GM:B"4''XL4IYL CN3> M.@!?'+B"5L1[Q,Z &YP Z$(??)O<@*,/QT#&C6$#O6L[V"V>G@$8:3#X F8A MZ;=1]C6NOP/W\M8&HKG=+Y:25?$.=8&#.G!@TUJ*H^CV,8)#%T MHY'SN.Z:P6[H^:$?MG8;K,.6=6AE/5E2)DX%9CF@/0;X-9'$:A9Z8=M;0C*^T[6BS>Q3K:H@/]&"9!G[;!+DQB-W'-O..6 M=VSE_96J0K,GYWB;RS ._:"?(MMVOA?#.-@1ZV'+>6C=QK>D0,4,VS;Q\)"; M^$!@&[XFK:^)=7T>F%H;\7P"R@P5 LAZ#_#/BI2J19R @N3^\E6X!,WCF.O MMSX&LV'B1;%Y>3RW:V:NE?1UQ9BD)QNDJ)C.(D#G36K-]>*I5*/3C"QT9S-W M,'>KP$2^#WLN&*S", AV>+#6CCVK!R\IIOOR";AK]H-A;!F:,OG_GV)CWQ)[*+3-*'2:P[.+CKXP!$=27S]CQ/BQ MT7<[6EP/!1'(M<@V.OPVB&$# :1B3]$SMWG;217/KE4V^^=KOMJQAO50HXMO M&KF7BYVJ\>+]TCHE?$8K63_D.IM.)%>>52?MG<\'0MMTOQ-(GE63&/(9<8" M_#J3-=2\SC6BZJ=MA7'/W"CL%Z+:+NF9[:A#G;V7@GYTGXJMF MRG4Q%L5]06WG](+8C<>QF>RZ'N62SG9O6M8OTB:*DOYJ94")KKQR5& M*6;*0/X^IU2\O*@)VKO=\;]02P,$% @ -GSY6%=[*?O;! OQL !D M !X;"]W;W)K&ULM9G9;MLX%$!_A= 4@Q:81ERT M9FP#TP1%!V@P0=-VGFF;CHEJ\8ATW/S]4$LD6V1H@[5?$FNYE^=2R[F2)KNR M^B'6C$GP,\\*,?764FZN?5\LUBRGXJK>9C M"",_I[SP9I-FW7TUFY1;F?&"W5= ;/.<5L\?6%;NIA[R7E9\X8]K6:_P9Y,- M?60/3'[;W%=JR>^S+'G."L'+ E1L-?7^0MEC_J MA;^74P_61"QC"UFGH.K?$[MA659G4AS_=4F]?LPZ6;$6WF?Q2[CZQKJ"PSK<<8-43\V:__X8B^*>IN#,E.RB5 M]*426_:9FK'05& ;%391]2WB:490DDS\IWUP:VI'\* '#XZ!1R;P-BK: X]C M@D?@UM2.X&$/'AX#CTW@H0:. XQ&X-;4CN!1#QX= T],X)$&CL(H'H%;4SN" MQSUX? P\-8''!G (1^#6U([@20^>6,&_KIE2]DJRRH2?Z/@PK6^?!_S6$1SY MTYX_M?.7DF:=93;T674%TG@W3?53/R9D?.Y;QW*L!,'!G]!:RV% S%7\0-'(S--(5':8D"P M-QKTC<[C;Z0+G,0P@L&XF;*/YU@/'AR.S^5P;'(X@5$:C"JRC^A:T6!Q?(K% M1\_HQSR.=8_C) Y)$(V+TTU.4(SC )E=CO<>L*WJG-WQ@N?;'(CMO$6NU+E% M,S,N-CP90:U1MX_H>B0&66-RTCN#^IW)*9T*/I.%7]0/3ZJ>F.G@G751Q"%B89_"=7C0?7XJ.J-G0K651_"-($: M_B54CP?5XZ.J-W8J6%=]@!,8:Q?^)52/!]5CN^I?Q=/SO9QW.M9_ ZL7O] M]$Z%Z#)7G4J*T+BAMX_H6M%@?&(W_OX1.M*?=)D.7B DJL4/M??/9U6^O_=U MI?ZT=4>K1UX(Q;Q2Z>%5K("J]FM1NR#+3?/!95Y*6>;-SS6C2U;5.ZCMJ[*4 M+POU-YS^F]WL?U!+ P04 " V?/E8!66HB7P$ "%&P &0 'AL+W=O MN*]9:D6-RQ'O!$G[5$#ZJ@!(O# ,KD5X)O MX7X'O-%+7SC.!-8SJ*UC"E;0SLI7E'NQPVLR==22(0A_)<[LQQ_@T/NY34&; ML,@2K*9A4&H8F.BS/_?IBG# -F"#US2ADJH)H,:X4-JZR4G;-CT+[E!S\P7U M50WNB?MZKM)E$>35BT0M%%@6J64T*#,:7)F1'O\"");$;0D8,7T'A$U8-+@0 M)6S79%AJ,NRGR;^=B\-\>-EIOC=N]*RQNK[I6H+5E E+94*C,LO:. <[SM:$ MQ+E -VWB%+#!><_X?A TU+DL-0B#\:@Q]"]+P3 MMF+/C?%]Q[VY,7 OA',V_XH(TO-J(DT+D4:&]OUJ_* X#9A0OVELV*Q^U@- M EG]D70.A/%%Y_DC!)L#X;+4:.@UE\#+0F-_%'2L@M"KO(QGS/&!9C3=MXX MY M;!C:G*U&S]Y;2)NTR!:M+F3E[J'943=W%U:8 F3<%$162T]5>OV9>D$SIU2:7F=)W M EJE1;9H=06K#0*RN4% 5C<(5FF1+5I=R&J#@+YW@_ .P.^>L^;(WD)9HA5" MN6?G$RGAS_J<1X UVV>R>.U?/BW/DC[I$Y3&\SF\CXH3H0I3'% ]8/Y,,P$2 MLE%([RY4)HD79S[%C60[?0JR8E*R5%]N"8X)SPNHWS>,R=--7D%Y\C;[#U!+ M P04 " V?/E80V88&U0' #;60 &0 'AL+W=O7F MHM_/%RL1A_E9NA&)>N8QS>)0JLWLJ9]O,A$NRZ!XW:>6->['893T9I?EOKML M=IENY3I*Q%U&\FT1%0'O%7)%[RO<>D.)6'-/U2;+#E5<\J7I%8 MBX4LB%#]>!9SL5X7DGH=_]1H;S=F$;C_^%7WRI-7)_,0YF*>KO^.EG)UU9OV MR%(\AMNU_)B^!*(^H5'A+=)U7OY+7JIC)VK$Q3:7:5P'J^TX2JJ?X=?Z/V(O MP!X?":!U #T,&!X)&-0!@ZX!PSI@V#5@5 >,N@:,ZX!QUX!)'3#I&C"M Z9= M \[K@/.N ;;U^INSR@RJ?N5EOCBA#&>76?I"LN)XY14/RJ0KXU6:1$E1'_=[A[Q] M\XZ\(5%"/JW2;:Z"\LN^5*^E$/N+>MR;:EQZ9%R;DMLTD:N'>^+AC-!Q&4Y;PITNX9,RW&X)=\WA M?+L^(P/[Z.A>]_"VT?WNX59+>/"C\$2%6T6X/6P)9]W#V\Z==P^W#'DTV%7$ MH/0&'2HB_ZXDVC*]\H;M7G&!N\@WX4)<]=05+!?9L^C-?O_-'EM_MF4I$G.0 MF(O$/"3F([$ B3$DQD&85A7#754,37I5%>^+FS287/:?]Q._Y:B!-;+THYS6HZR!?I1K/)=3 M4Q6)^4@L0&(,B7$0IJ7J:)>J(W.JKD*%DO2Q2-18I6A>OG^'SVH.$SZL!5%_ M59"G+$QD6[)6]G@OP09C.CW(5>,+./5-&HFY+2^?'A:1AQS11V(!$F-(C(,P M+:/'NXP>&S/Z-OP:Q=NX+5V-@:?./9"8@\1<).8A,1^)!4B,(3$.PK3TG^S2 M?P*>D4^058'$'"3F(C$/B?E(+$!B#(EQ$*95Q717%5/C1>&3R.)BDI-6==%6 M!F; ML@W$69MD7-CY*DYC\1<).8A,1^)!4B,(3$.PK2]$5K8$ MDH4@U=^BX=%K@%$Z]1J Q!PDYB(Q#XGY2"Q 8@R)<1"FU8-M-;?O+?#O]NX_N!-3VXG3)O.8S: MPX-[DD[+40,Z.;BSY)K/YN2<16H^5 N@&H-J'*7I.4N;G*7&G"TZ6>1#G$0/ MVYRX_VPC^:ULQ;;FJ)$Z^>TIEX@37?8 M-K>'BT\9=9Y<(5N(SH_J>5#-AVH!5&-0 MC:,TO32:UK5]CIY<05O84,V!:BY4\Z":#]4"J,:@&D=I^M>WFE8V-78"?^'D MRCSPJ84$U1RHYD(U#ZKY4"VHM?WI$#VW#EJS##HF1VEZ@32M;&IN91^;7)'_ M"$L6(BF^:5Q?5.H/!:IG#)\=-P]WJN5#-@VH^5 N@&H-J'*7IY=-T MU2D%3\ HM+<.U1RHYD(U#ZKY4"V :@RJ<92F%TC36Z?&UN2OG(!!>_!0S8%J M+E3SH)H/U8):T^Y'??=50P8=DZ,TO4":WCHU]]:O8U$L5D&NU;7CH\AE*-5& ML69"UUM>9O_D.H"VT*&:"]4\J.9#M0"J,:C&49I>+TVKG8[0,RYHPQVJ.5#- MA6H>5/.A6@#5&%3C*$TOD*;A3LU?[/ZYI0K,^,G% FV^0S47JGFUMC]S&8[& M5)^Y^- Q ZC&H!I':7H1-$UU:FZJM]W1.K(0U8V9.CGEH6URJ.9"-0^J^5 M M@&H,JG&4II=&TTZG4_0$"MI4AVH.5'.AF@?5?*@60#4&U3A*TPND::I3\Q?" M?W("!6VP0S4'JKE0S8-J?JUI:U8-#F\D!= Q&53C**TJ@O[>:JZQR)[*U8-S ME>#;1%;+H>[V[E8HOB[7Y3W8?V-?.-4ZPPU3+7M\&V9/D;JBK,6C(JVSB?HS M**M6$JXV9+HIUXQ]2*5,X_+A2H1+D14'J.&PO=V]R:W-H965T1RE^($" MMDT21'_=X9CL;WIV[^7!UVBUYO+!8#;=H!5^Q/QI\T#%W:!$":,$IRPB*:!X M>=.[M:]]9RP;9!;?([QGM6L@75D0\E/>? IO>I8<$8YQP"4$$O]V>([C6"*) MD_A'%/+U3<_K@1 OT3;F7\G^7UPXY$J\ M@,0L^POVA:W5 \&6<9(4C<4(DBC-_Z/G@HA: WMTI $L&L##!L,C#9RB@=.U MP;!H,,R8R5W)>/ 11[,I)7M I;5 DQ<9F5EKX7Z4RGE_Y%3\&HEV?/;(2? 3 M?-GDDY"&(']PNT&:D/PF:1\S<"' M-,1A$V @_"Z=AR_.WT$MXF=$^\ :7@%H04] $<9,-U7@RXURS#0KP34^D%(;I#O=F?_]ECZQ_ M5%R9!/,-@35X')8\#G7HLQ]9KL A0#M,1>X#2Q11L$/Q%@.R!*0@>$51*JW> MBJ@.21PCRL &TSSVWZGHSKMULVYE/M[-K.E@5^?PI(6OLVAXZY;>NMJH*>+E M"CQF[ZQJW*[),#$)YAL":Q W*HD;:(Y"&2IT1E7.3]C&IS.K;L@\A0V'B'L=&VL>'$58?'N/1RK/7R8RW* M-2YH0=03 53180C'_W.R9:G9>O#,Z9!Q$[SI84Y@R]#.+[7"IWW4!TX MDY**B9:*.4H#H>Y.,C%I]VR/)@?1KS :']CX"AO7=M1.V%8ECZQSWW(L5M:S MWN^BB_K07 <>N*@P:F4!7V7D'5D [)H$M+4^?L=,ON*$ OR\$7I<7',"=N+I MY2[;75S6#NO2*:/2U2B:;PJM26FE7FV]?#U3EW23KD6?X[JV!S?D3$=RQNVA.'VO]=*T MS89N?^P=OC0*,Z]OCXXX5BE66R]9.PNE 1R"$/U23=-XWM;E@5"%!?(+2(,_7BM_>M6SQ> M4!YH>#2$UN2Q*B6@OI1H\7CQBST^3=P%&^$:X@RA-8FK2A7H:15231A]Q"FF M'032!?OC&H%D$LTWA=8DLZJ!H+X&^D:XX"]JQF+]^R9^V0]0$MO>;6^%WN3D MQTR%B7UD-]NI2A%'7XI\$H5Z*@^3%)^_"W^4W[]-U@]SHVB^*;0FBU4UXNBK MD:>4XH"LTNBWR.JBA_<00?7UE/P%K@%T94*97U+<^F M[S5J$*>J09RAX077,5DIS(VB^:;0FF16=8>CKSOFB*U%+@RP6)I"L*0D:23* M3 M)K["Q#[B4J70';U"EX6-K 8U"4(/,-0D"*.*W!1:3M2@=HXTP725G<=E8CG9 MICP_55D^+<_\WF8G70^>W]G7?GYRMX+)#Q)_1G0E!">(\5) 6OVQF#B:G\W- M;SC99*=5%X1SDF27:XQ"3*6!^'U)"'^YD1V4)Z1G_P-02P,$% @ -GSY M6!['0J$2!@ HA\ !H !X;"]W;W)K=23 2&'#6\4QB-NT^=)IIFO99,;+-%)!7DNVVOWXE('Q9 M*&&6E\2(>X]TCJXN5]+B1-D/OB-$@)]IDO&;R4Z(_?5TRM<[DF)NT3W)Y)L- M92D6\I%MIWS/"(YRIS29(MOVIBF.L\ERD;<]L.6"'D029^2! 7Y(4\Q^W9&$ MGFXF[H1JF"X7>[PECT0\[1^8?)I6*%&3$&[^!HO),Z0_U\$]T,['5B$A"UD)!8/GO2%8D2122',>_)>BDZE,Y M-G^_H-_GY"699\S)BB;?XTCL;B;!!$1D@P^)^$)/'TE):*;PUC3A^5]P*FWM M"5@?N*!IZ2Q'D,99\1__+(5H.""WQP&5#JCC /L:N#6SJXN3(%E5R' M$ N\7#!Z DQ92S3U(Q$IQQ< 6^$"Y8O!;DY?5%2 2.$_Y>OGQZ#,'%N_?@'9@"OL.,PF0C1S-@%9F]WOR; 'DY>Y(XQZ^Q=W/W:&!C5/- MJ9/C.3UXMU$4J_G$"?A ,L+D_S#FZX3R@YP,G=X%GJO'4ZGGFN_QFMQ,9&[A MA!W)9/GG']"S_])I-298.!)82T>WTM$UH1=KXTIEE0BL:2I3+);B;F+Q7J=H@3S+D57N/2XAG#G^8GIL2J6QU9-98W%P1UK$Q0@V-CS'!PI' 6A)ZE82><9TU9:J";O*&(0' AZY.BT:(S3O&(4ZHUE/8H=V7=+9 M1J8?&,Y4H+Q"HT1I]>YYJ,-#8S7WNSPT1GY@]_!HE*;PU;SP!AKPK.\KZ+CS M+@^-V9T+.N_>\>TN%8T5#/PN%9V5Y_50 MJ6M+:"RY=,N(R"_?H 54=M&*/-?WNC0U5F?K+-19-1=:FV9=^D%W8+[]GF\A MY?/M49;46P+N<>T%QZ#LS$$4T2^7E7 M3450Z6.JZ--OQ93EGJ4SC9ECH;.HTIC9EH-ZPJJN&*&QD&JEYC?R*@"#QD@\ M:]9EY6F62I?2.1#T+7_>0ZDNWN#KU=LP1O[Y0)#E=BEIK= 9*XV98S4V6FU6 M=;D%C;5(.V._D5=P/A3;"KJ%@D02K M6!84'%ZVQWGV![38Y%U*D_9W 6S5BBYV?U*I_"!61D[Y]=,IAHS%V] /PZAH MX5AH[7FJ"SYD+OAZYDE.C59(>'8N,O=AM^XS=SE8H)'0V@+5=20RUY%5#8++ M&@2GE(GX=Q'$_?OG5V!AOH$& 4B+8U6(0(1_:3?49J3!\A$<8-7M587 MS;?Y]6JG_0Y>A\5U<0U3W%Y_PDQN+SE(R$9"VI8OA\2*"^'B0=!]?D7Z3(6@ M:?YS1W!$F#*0[S>4BI<'U4%U+;_\#U!+ P04 " V?/E8I3\;&S $ "+ M$P &@ 'AL+W=O&ULO5AM;^,V#/XK@G>W MM/BLVDPBU+4]2FO9^_239=6+7T34X;U\:2R8? MD0\IFN5TQ_B#V !(])1GA9@Y&RG+*]<5R09R(BY8"85ZLV(\)U(M^=H5)0>2 M&J4\=3MI49+6#!D=CF.>'/UY"QW-.[K>2+WA MSJ6C#WH MQ=_IS,':(L@@D1J"J)]'N($LTTC*CG]J4*/K^@?S+.*V>61, -R[[1 M5&YFSL1!*:S(-I-W;/<7U X9 Q.6"?,7[6I9[*!D*R3+:V5E04Z+ZI<\U40< M*'BC(PI^K>!W%<(C"D&M$+Q5(:P50L-,Y8KA(2:2S*><[1#7T@I-/Q@RC;9R MGQ8Z[O>2J[=4ZH=H@3YO MV%:0(A535ZJ#M;J;U(=<5X?X1P[Q?'3+"KD1Z&.10MH&<)7%C=G^B]G7OA7Q MEO +A,/?D8_]H,>@&[OZ)UA>(']DU/T>]?@MZF.C[EF\"9H@! 8O/((7PTKM MI.@:"O6D(E'?*QV1/K:M:+I27(F2)#!S5"D0P!_!F?_ZBS?"?_8Q-218/!!8 MB\6P83$TZ,$;4[F/N7!(YH8$BP<":S$7-P:N"HM,-HBM$%0[ M@!)U;SE=;G61%FA;(LE0\%Z+*#LD>4*D*+8D4W*Y^A0)8HJYD@FQA\X>SG4) M-JE]B(-*%1YT1@0BJ 2>J(B=]P6K,OK2&*V_7X]S==D>#R-@=>O4" P$UHK MJ(G R!J!146#^M(::@F7-*$E*>1OPD:TB9=BU\/X/5H^OX2-][$Y>L4FOL!! MAU"KE:<2.A!8B]!Q0^AXF)16;TB:4KU0[/K_4VJ/>X(1=6)A=?#46 P$UHK% MI(G%Y+],[NC'N3WIRVV_PZ?5R%/Y' BLQ>=EP^>EE<_/3"JNX$E3!:KY3MBZ MH-^[?57%3(44'3 3AA$..]3T2'F1/VE+Q:^E@I$_QHU4RQD/[SM0_+:KVKJ8 MO5TF?F4![GC2(^*-<4^5;O;K?EF5F^BJ5=9TFJ]]8N^*3"5T-9:\4/16*K2-N+?;/M MV;OMKR D+=:Z,E#6;[L=($+/0'A?\MS8-4\.]Z ML7LPIM)DIA][F&I,=4OXFJJF+H.5@L078^4 KR8_U4*RTLQ" MEDQ*EIO'#9 4N!90[U>,R9>%/J"9O\W_!5!+ P04 " V?/E8-7D^+FP$ M !1$0 &@ 'AL+W=O&ULK5AM;]LV$/XK MA%8,";!$[[*"R$U94O%R P7?3AW?>7UQQY8K MI5^XL\F:+N$>U,/Z5N"3VZ+DK(1*,EX1 8NI<^U?S?U8.QB+OQELY5Z;:"F/ MG'_7#U_SJ>-I1E! IC0$Q;\G^ A%H9&0Q[\-J-..J1WWVZ_HGXUX%/-()7SD MQ3\L5ZNIDSHDAP7=%.J.;[] (\@0S'@AS2_9-K:>0[*-5+QLG)%!R:KZGSXW M@=AS\),C#D'C$'0=HB,.8>,0OMV/WP_V2' "Z*;)4&KTIO@D'$;U1<$B_ZC01>$%H(?1QV M_PR/ER1(C'M@<9^_QWUDW/T!-6$[;Z'!"X_@'4S2NID#>-8ML$6[1HOL:'IS MN9)KFL'4P=U#@G@"9_;K+W[B_6Z+U"G!YB<".XABU$8Q&D*?W2,>R\!DN2UJ MM7=LO/4.^C0+PV3B/NT'HV\3!?&AS=QBD^YP#JC'+?5XD/K72@$&1!WE7KLG M>V/&7H]\WPB)^1WV%J-1'-KI)RW]9)#^)TS53.$^(D!M1$4P>]=Z!Z%2@K+N M%TF/Q44T'J<=01:KV!]''44VK,2/[))&K:31H*3KD@O%?E!3S_B";"H!&5]6 M[ ?*K'"]%EQ:E0W"VE< L2W+45]5&'6EVXQ&T=@N/6VEIX/2AW8C]M@@F;!?A>[L"[[UOI8%-#\DW@E5+HE: 2U$?%'.TP.Q= M,)G1@KP %=;J[;VI>9C7SY:)4Z$=1G'OF.0/UML_,4 8N16MEB#)WL+&8PZO M^WB)(Z]T\C^!6>M7UL#YIZS$)T6;GPKM,,;!+L;!8*8^=#?,):8CH8))G:%- MHM;;C#6R@67O3^-N5EJLTB#J;B@VL\!+PB-ES]^=V_S! \W;5>),I\ZYT6Y5 M^3_.2]9JT0"]42ZL5D?KA;\[>/G#)R]=,6C)-WCO>-]BLL8B>M>,6ZS2>-S= M?6UF012FP1&INX.:/WQ2.RJU6RCQIO1S\N/>L?(B\/VN?(M5ZL>]B;:!>9Z7 M=N2[>W?-$L32W-DE,D9]]66L?=M^%[@VM^'.^QO]O<#<87N#'J#]BC+[#U!+ M P04 " V?/E8Y^-SY"\& #"( &@ 'AL+W=O&ULS5IM;]LV$/XKA%<,+;#$(B5+0=_?HV/,'(?]6.\8T^I&EN;J8[+3> MGTVG:K5C&56G8L]R\\M&R(QJ>%TXSR?+(XM\]NY>)< M%#KE.;N52!591N7C%4O%P\4$3YX>?./;G2X?3!?G>[IE=TQ_W]]*Z1%+V4J7)JCY M<\^N69J6EHP?_]1&)\T[2\7#ZR?K-S9X$\R2*G8MTK_X6N\N)O$$K=F&%JG^ M)AY^8W5 L]+>2J3*_HL>:EEO@E:%TB*KE8T'&<^KO_1'#<2! @Z/*)!:@?05 M@B,*?JW@OU0AJ!4"BTP5BL4AH9HNSJ5X0+*4-M;*"PNFU3;A\[Q<]SLMS:_< MZ.G%-Z:Y9&8A-;I-::[0";IB.=MPC<0RY5M:K4Z^1ILB7[,U4IKJ0J&/"=.4 MI^J34?A^EZ"/'SZA#XCGZ(^=*)215^=3;?PKWS)=U;Y<5;Z0([Y@@KZ*7.\4 M^ER^JFM@:@)KHB-/T5T1I\6O5)XB+_@%$8_X@$/7;O4;MCQ%)+3J!%!/7J(> M677LB,9OULJW]OPC]CXKS2)&9 MC%H569%:>:%W3**5R$QMV)5)>\]0*I0R"Z8%RDUYV3/)Q9JOS$65T^Q'><6@ M5:R\#& ORT)UIO9TQ2XFYFV*R7LV6?S\$PZ]7Z$5&--8,I*QSNH$S>H$+NN+ MWPV*IHH55'*:6G0A["H;,VNCK,GW"^]\>G\(B/,MKP5D)&,=0&8-(#,G(+=F M1YD.8ZSR%3.;3VD(D,I&Z #$^9;7 C*2L0X@80-(Z 0D,64U-]GX5&!OZU0K M"R\$C=/::_-L3&/)2,8Z*$8-BI&S"E[O:+YE9:M9#AJ5.H-PC,;$<4QCR4C& M.CCZQ,3]OU>XL:#6H?#.(Y(5RQQ MNOE&$.8-"',G"'?/5*?Y(%+?#WMA#F4",NO%.!] $<2MG8[KV&NIF^=T_DNN MF8%$'_6^UC]T;>8-_ >DC'.X%P$D%, 8\>.]) M[).X'P0D-HO[>\WMS1LW&R9MM,09[67##[;FDPP,EPSC(":Y@GZ\@-PL"/Q^ MO$Y_WAIO2UBQDW&Y:\RQZE+;[)07'^.P7UX@.: ,):!V(GV MIH,CJA33< ?"8Y*ZZU&M)6-9ZX+8DD3L9HDWE$MT3]."V;[3 EGNE"7;\CSG M^=:Y7X84$@?S&8GZ^P62BP,\J!'OP1%Q2Q*QFR5^SO:I>+2?:_DSI3%\ECL# M(CCRO'[$0ZG0]V9'\J,E:MC)7ZIJER+)="%S)#II L83 ;7/"_Q!4$.Y:#Z/ M^D&]![G"+;O";GK5:6SH(\]7:;$N=W+]8:W0GO(U6CZ:CWAFD?D$8C+D6F#[ M@\2 ]O<>7 NW9 N[V98SUY_K"D.:A8D7A?,^$H <4 T2/*1DO6K0G3BUK(RX M6=G-X9P,BH0,F=0)]OQYO\7# )(([#90#=MI[L$G2LDGB9I-VPF9W6V^S M=?87",20 L) @'( $.\Q:"0M\21NX@FGW(L&OG7N'B-R,## M @(P4 B0H1@,R'N,'DE+:8E[^/A_.8(AH\XT1[66C&6MNT0M\29NXGUY /IP M0@R""0PJH8$#) <-'-P.OA: Z<'A;L;DUAZ2EX7<;+_J)+1YVAS$7]KCY][S M*WR65,?IK9GJ=/\KE>8[6Z&4;8Q)[S0R(-A1-GMM/ O]^UDX860K>'O33^N.?DG./X=MH(^:!R M $T>"UZJF9-K75VZKDIR**@:B0I*W,F$+*C&J=RXJI) 4PLJN!MXWM@M*"N= M>&K7EC*>BEIS5L)2$E47!95/U\!%,W-\9[>P8IM@[ZJEQ)G; MLZ2L@%(Q41()V%+!%?VES1=K>>0I%9:%!T8%12L;)_TLR[ [?O BW[VX7Y/3DC)P05I*?N:@54JNIJ]&6$>$ _#Y$U#*9&I15S;3H41:"=&P!'/S+U5%$Y@Y>+45R"TX\?MW_MC[ M/)3/?R([2"OLTPJ/L6T+3I+:Q'_K^&(]^N^]JH&SL^>%SV8'> MJ-<;'=5[8[[\^]V7_Y=3BEY+"+S)^.*%TH&RZ.(\F+Q0ZN[=J,),LBV:[43+2I[\=="8QNQPQP;/4A3@/N9$'HW,;VD_^N(_P!02P,$ M% @ -GSY6+;AN?Z" @ -@8 !H !X;"]W;W)KFM"2>:1,R\,"0:6EY5NQU+"I+1E+B M\O>L9,=-6K?PP$NLRYZC/4?:S:21ZEZ7 (8\5%SHJ5<:4U_XOLY*J*@>R1H$ M[A125=3@5*U]72N@N0-5W(^"8.Q7E DOG;BUI4HGSQ,:[@#L& MC=X;$ZMD)>6]G7S)IUY@$P(.F;$,%#];F 'GE@C3^-5Q>OV1%K@_WK$OG';4 MLJ(:9I+_8+DII]X'C^10T TWU[+Y#)V>4\N72:[=+VFZV, CV48;675@S*!B MHOW2A\Z'/4"8O "(.D#TKX"X \1.:)N9DS6GAJ83)1NB;#2RV8'SQJ%1#1/V M%F^,PEV&.)->@V$*\%H,67(J-'E/EDK^1),A)RL04#!#Y(JS-6UM%SDI*%-D M2_D&B"Q(C3!"M0:CR?$<#&5X=#X.N= >FPP? M:VO]0M_KXO)X[,JB\I3MU M=+8I;=,P#L,Q7O9V7]- V#@(X\>P@VR3/MODU6P7]JW?[=[Z7^XH>9Y"%)R- MSY]D.A"6G)]&9T\R]?>JVG94?.EKAA7*H4!@,#I#!M5VJ79B9.T*?24-M@TW M++&Q@[(!N%](:783VSOZOXKT#U!+ P04 " V?/E87&ULQ5K;;MLX$/T5PELL6F!K M6Y0O2=8QD(0-M@_%!DF[?:9EVB8JB2Y)Y?+W2\J*9"HT?>DL]B6Q),XAYW X M.B-R\B3D#[5B3*/G+,W596>E]?JBUU/)BF54=<6:Y>;)0LB,:G,IESVUEHS. M2Z,L[>%^?]3+*,\[TTEY[TY.)Z+0*<_9G42JR#(J7ZY9*IXN.U'G]<8]7ZZT MO=&;3M9TR1Z8_K:^D^:J5Z/,><9RQ46.)%M<=JZB"Q(/K4'9XA_.GM36;V1= MF0GQPUY\GE]V^G9$+&6)MA#4_'MD-RQ-+9(9Q\\*M%/W:0VW?[^BWY;.&V=F M5+$;D7[G<[VZ[)QUT)PM:)'J>_'T%ZL<*@>8B%25?]%3U;;?04FAM,@J8S." MC.>;__2Y(F++(!KM,,"5 6X;#'88Q)5!?*C!H#(8E,QL7"EY(%33Z42*)R1M M:X-F?Y1DEM;&?9[;>7_0TCSEQDY/[YGFDIF)U.@NI;E"']&5,D&PMK.B$,WG MB"K%M$+O"=.4I^J#:?+M@:#W[SZ@=XCGZ.M*%,HT5).>-B.RN+VDZOUZTSO> MT7N$T1>1ZY5"G_(YF[L />-*[0]^]><:!Q&_4-E%_<$?"/=Q[!G03=C\ELVZ M"(]*<^PQ)X>8CTOS*.!-7,].7.+%._ >^#+G"YY0,SUFA114&\[,'FY<=IO]L?3GJ/VXQM M&D7]5JM6,^+%&M6-'!^'M8_#8-1=V9';@!))&1U>)X:0X0$)1H# '.I&-76C M8'A%B0XJA-]'M<^CX/A\I7* MI1,O=C'L60)CR.B!!"- 8 Z39S639\'H>AS0BX<&=ZCQNG,=!Y[]U'[J(V>6W8]6%[8\.'$@T M H7F6L4?0X^O5$CX&$=\4?)!J!0G/Y:XH"'"X*3DGT%:2[-*/V%PM_JW9-%![> MJ>XWNA[#ZWH,JNM!T0@4FDMGH^LQO*['WJ_?9^UH A7V4&@N38VPQV%A3ZHM MGNMJ#^>NVH*UFW=>BD"%/B@:@4)SJ6R$/@X+_?]S9Y(1A6S&^>+0A>2(5.CK\TJWB2]E#VR5!WB]@FZ''F#!PB( "YY#9% MZS M,0"P*5MUT0Z0T9M \A47[7 C.]"VMF_=\P"-T(_#G_&_EP=9C*OTD4FZ9&_S ME9.1;V/>QO]]6MCO@ M\'A7^#2:/0YK=O T%.[OB#0$!40 @%QRMP[K!"7RT6GH$'KC0UYN5:N]AT7\ M:#M.B\2-=(\'P9Q$O,J(*2SXJ=17<,J=AO0-$( M%)K+=:/_X[#^KV/,RR::%Y+G2Y/VGS5:F"1F!.T+H]XO0U5'P^U@:,<5J-R' M0MLPU]LZ\Y@Q4SO:LZ,*E6E[&PO=V]R:W-H965T M+.K+&[TNZN?EK=ZTW_E:5NNB:3^MKA?U;:6+J^U)Z]4B M\/UDL2Z6FY.ST^W7/E1GI^5=LUIN](?*J^_6ZZ+Z^Y5>E0\O3M3)]R]\7%[? M--T7%F>GM\6UOM#-Y]L/5?O98H]RM5SK3;TL-UZEO[XX>:E^/E=IVIVQ/>3W MI7ZHR<=>Q^5+6?[9??+NZL6)WUV27NG+IL,HVO_N];E>K3JH]D+^VJ&>[']H M=R+]^#OZFRW[ELV7HM;GY>J_RZOFYL5)=N)=Z:_%W:KY6#[\JG>,X@[OLES5 MVW^]A\=CV^OV+N_JIESO3FZO8+W$.Y."+=$ M'Z]L2^MUT11GIU7YX%7=T2U:]\'VWFS/;MDL-UT=+YJJ_>ZR/:\Y^ZB;9:7; MPC3>AU6QJ;UGWIMB67F_%ZL[[?WX6C?%-/#P[\]/=%]=SSHW][@1^$ M/:>?\Z>_T5^>>T&R/3VP3U^T]V%_,X+]S0BV>.'(F]%'Z!$AZD?H?NM^KF^+ M2_WBI/VUJG5UKT_._OD/E?C_Z:,' K/(AGNR(8=^]JELBI57U+5N:J]HO*]= MV>^[LO?1?L2*MUC=:\/]F0K\-(E.%_>44,]A41X'\?XPZU*C_:5&[*6^VS2Z MVA3=[WU[R?JONV7S=]]%LBC2VH# +,+QGG \68@QDBP(S"*;[,DF0"$^8B54 M86'N*T>'/4>E:1;VRS#=7VC*7NAO176MO?/BMN^ZV%.EY0"!62RS/KU;/WRZM# M"N3/EU8%A6:S);9$35;A#@)%&(1F$S;60[%_[(5*W(%1D86AGSM*[#DJ"M2! M5T%EC(/BGXXYX Z5,1"*=Q"=(-^WSVW+9R^[2_7. M*WVU;'HOD0425P>$9M,V=D2ET^4(]24H-)NP<2:*]0)2.69/7_U2(K8=I:=' MI6&6')"D\16*-Q:_E>V#\B==K7=BW+Y >N\V5_I;[[6R:.(R@=#LAVCC5 )_ M^F,TU*R@T&S"QJP$K#<0ZG('9NE2A8GO"+/OL#1/#R@S(#T.WF@897Z^\-Z6 M]^V3];94G4#[2X5M>A84FDW8>): [YT(M1D]?<2)L\R5 M9L]1K3(/&,O V(V MQN!_R_O#UU4WJ=*%_5=];=W\>GCNP\7O5<*[7^@T&SB MQL $R7150JT+"LTF;*Q+P+=2A*I,G^HMR *WZ=-S6'2HYQ,8TQ'PIF/;?%RW M?\.+1GMOEM]T]V?\LESW7RFT,X)"LYD;#Q/DTU4)-2XH-+LA;HQ+R+=8A"UQ M_XG<\C1S1=ES5!;'4;\J0V,Y0MYRO'S[B3Z#'WK\YE&DY4&AV9R- MLM V"PK-IFU\3S@][@FA?@>%9A,V?B=$1CYA3YKSY&6V+Q<'H(%$*]#@K-)FR\3H@,@L*>)"ALG\Y= M4?8%1FG@'TC#C4^)!J*@F[)J'I_AWVWN==UTA>JM$0\DCL3G:+-$QO-$TS.A M"&IX4&@V86-X(F0F%#U->Y1Z\D+9=U0%9A,V5B="ADH\F$3@TX%LPL;J1 /1U%[@[((F'D5< MY#DZ.[%Q3/'T2"J&>B44FDW8>*48&4GQ8 )5 X!LPL8KQ0.QUE[5@PNE>"1Q MH>?H$<7&>,73 ZT8ZL!0:#9AX\!B9*#%@TF4/1W()DS6 O,.S"A[*'W@@<1U MGJ-'%!L?%D_/Q&*H\T*AV82-\XJ1F1@/)J9^!!JK;F._8MY^&75+EA7RH&+V M<_2>8F/(XNDY6PQU8R@T>[V_<6,),F?CP00OX0 @F[!Q8PGOQFR1CUNJR$-* M*XY"LV^ <6?)].@N@=HR%)I-V-BR!!G=\6 2B8.CN\38LH2W9>2I4K;TD<<5 MEWV.;EEBO%HR//2DH$W@?7H?.1" M2AY97/@YVF:)\6W)](0P@;HT%)I-V+BT!)D0\F 2I4\'LM_L:%Q:RKLTHW3) MNDP>5/Q&R#FZ:*GQ;>GTQ#&%^C04FDW8^+04F3CR8 *1 X!LPL:GI:-RR^]I MS]AUGCRJN.AS=-128]W2Z9EF"G5I*#2;L'%I*3+3Y,$D*@=GFJEQ:>G83'/D MNE$>3USN.1IK*7G;_O1(,\6^?W\.;Y8:;Y8B(TT>3*)O<*29&F^6CHTTQZ\@ MY2'%%9^CHY89KY9-SSU9K]QUU<+5V;MQ3/B:/# 1K7'E M::50:#9]XZ7RZ6ED#C5.*#2;L#%..3*-Y,$$+[( ()NP,4[YF#0R&%KCRJ.( MBSQ'5RLWWBF?GCWF4*^$0K,)&Z^4([-''DRB:G#VF!NOE(_)'H,Q:UQY)'&A MY^AGY<8RY=.SQASJG5!H-F$RE1(ZEA*5-0* G.&6=+KEF+0Q&+'*=0!)6FH8 MG$.=C+KT ;,N?>RP2Q2<0SH@I*'S+GDT.7UPX*A\,CW3'Q,Y!L(5KP.H\CLP MRRA-G\S2]*>GCM\Q8*3G<&C*)_,T?>A 31Y-\,J.0')(D^F<_ICT,1"M?AW ME%=^EE&=/IG5Z0.&=?K8:9TH.(6SS2WG XN1R:3 V@2S0.0'-+$S0U,+^_3_,A5 ML0/0<@',T6I3=#JZFIY2*O!<]'D&H]/)Z/PD+M/,VX5[0"FO/*S=.C("'H53$]1%7;X/ S.(4T<'#_N72QW5)2*0')( M$PEOOH%;4#L/+BS]*D(_/M53 ]7578P?8P.(=G!UH@KI!H-C(M*^':%?#9PJ+\TLG3,R\EZ%@!P4.^X>!N>0)BZ+'S O MUB,L!P4@.:2)RQJ8>K]3M6#5[0"BO.ZS=,W(0'T5 E)0["1]&)Q#FA@L?G:] M6.RP%!2 Y) F!FM@H+X1.[L"=P!&7NQ9NF1D-+^* )DG=BP_#,XA33P5/PA? MJO!CQNKW*QR Y) FGFI@.K]1^/#6W#R4O."S],?(M'\5 3).[.!_&)Q#FN[^ M#,TXCQG,^&?J3P*SKD)Q,7%@'@3 MNV, #,XA3>P;/Z-?+'=8O E GV:'[LN%[O# S.N1?$W\6 MG!.[L0 ,SB%-W!P_RE^L>EC."4"R29/M!=3 _@)&]:)UN78=N2[WF"T#N++/ MTJ@C^Q"H!!"E8K<<@,$YI(F'XX?\B[4.BU(!2 YIXN$&=AZP^S0CU^4>LV\ M5_E9.G1D,P*5 G)5[.8#,#B'-'%P_+A_J=R/V3R@7^X )(Q#88302XXL_2I",[$Z@4D+%B-R* P3FDB8/C1_^+%0_+6 %(#FGBX ;V(R K M"<:ORSUF-P&N\K/TY\@6!2H%I*W8?0E@< YI8N+XG0#$]BQ2 ]$AZ4=]H MW;PNFN+L]+:XUN^+ZGJYJ;V5_MHB^\\[756M/=]_TI2W[3TZ\;Z435.NMQ_> MZ.)*5]T![?>_EF7S_9-%B_]05G]N?\;9_P%02P,$% @ -GSY6&C3";&/ M @ [P8 !H !X;"]W;W)K1U\DNV$?%%K $U>*UZKB;/6NKEQ756LH:+J6C10X\Y2R(IJG,J5JQH)M&R3 M*N[ZGA>[%66UDV?MVESFF=AHSFJ82Z(V547EVQ2XV$V&"KM38+;IXU M= 6/H)^;N<29.ZB4K():,5$3"M=_2RH IN!?_)2KV>.&.' ME+"D&ZX?Q.X>>C^1T2L$5^TOV?6QGD.*C=*BZI.Q@HK5W9.^]N=PD.#[)Q+\ M/L%OZ^Y ;94SJFF>2;$CTD2CFAFT5MML+([5YJ4\:HF[#/-T_@":2SK4V\\!/Q/3\@SX\S_@$J;AXX5VEGF+MVH MAA8P#"6TU=5E1FV6NXS9/PS3)W*V% M%0ZL\!PKLK&ZK/B0%22IG14-K.@<*[:Q(ALKL+/B@16?8R4V5GS,"D>>G94, MK.0<:VQC)<TL'9OHN\TEHRFVT M]/@/.8K'_Y^F>]"_S*< &\"*82_BL,0\[SI! =FUUVZB1=.VM(70V"#;X1J_ M2"!- .XOA=#[B>F2PS+6 M+7+ZD*2?LY40N?379AUG9X-5GM^]&PZSJY78A-E)7$SO1UF M=ZD(KQ\G;=9#932:#3=A% _.3Q_ONTS/3Y/[?!W%XC*5LOO-)DR_OA?KY.%L M( ^>[_@MNEWEY1W#\].[\%9\$/G'N\NTN#7<*M?11L19E,12*F[.!K_*[X+Q MO)SP..*_D7C(=GZ7REWYE"2?RQO6]=E@5&Z16(NKO"3"XL<7<2'6ZU(JMN// M"AULURPG[O[^K.N/.U_LS*!C+C\?]*/N1I\6A4S,O/O>)E%(G- MW3KY*E+I"]B<1/EF?2C*O(P6F<_23](42S] MODKNLS"^SDZ'>;$]I3J\JM9VG]96]JPM*Y*7Q/DJD[3X6EPW@6&Q(]N]49[W MYKW2*^KBTXDTFOTL*2-%*;9O**TZ-NOB$$1^!5'[D> JWR+R7D0[9$OFKR!Z M/V*'\0%;8AR^.Z.]B'G([BBO(-;AN[,?L?N1#^+N1!J/2D1>=$QW#IC^M WR M9.\VN/V(%Z8%,GGXY.XV4]WH;4^%$=4R'5L>'OGY:8="]1O@M[E]V%5^)L4+S-RD3Z10S. M__TO>3;Z3U>"D)A*8AJ)Z21FD)A)8A:)V23FD)A+8AZ)^2060%@CJ2;;I)KT MZ><7Q?N9-/IT7Y[Z9-*GK](VM?XG_="52KW;KBCHG7AL%)"82F(:B>DD9I"826(6B=DDYI"82V(>B?DD M%D!8(W]FV_R9O?VIU(Q,*A)324PC,9W$#!(S2JX$[.T MN+WOM*Q?.S:64$U%-0W5=%0S4,U$-0O5;%1S4,VMM.89VFS:.D5#U_11+:"T M9O;L="O*QV;/5[%>%\S>^.D%CXX?4E-134,U'=4,5#-1S4(U&]4<5',KK;] MA"[IHUI :KT47K31Y:72^F#9GV43!&N\Y5T$:9"TIY.VT2V/4DK4ZHS MBWKYH[.(U%14TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[6 TIJA5?=.R]^A>5I& MNZ=1344U#=5T5#-0S40U"]5L5'-0S44U#]5\5 LHK9E<=2]U^?VWGK=;1S=3 M]WM'IQ2IJ:BFH9J.:@:JF:AFH9J-:@ZJN96VVPL]GRS;;=75J-G.J*4R:35, M^UVC9G++"JCM;Z9%W5@M']19+=T4)U]1?"NEXL_[*!4;$9=?6@TS*7PN&W5] MK^U]OWYT=J#]UY56UMYV3MSE]A'0T%5U5#-0S40U"]7L/4=+F36/EH.NZJ*: MAVH^J@64ULR9NH%:[NUZ//^0W.2?A9I5@XIW\64CZKI_>USU2@]H&J$MENCFHIJ&JKIJ&:@ MFHEJ%JK9J.:@FHMJ'JKYJ!906C/EZN9K>?X=JD9H2S:JJ:BFH9J.:@:JF:AF MH9J-:@ZJN:CFH9J/:@&E-9.K[N26^UNYCZ\:H1W>J*:BFH9J.JH9J&:BFH5J M-JHYJ.96VFZE9R&/Y7;5J&/4>._+)8M*ZWH.!KFJBFH5J-JHYJ.:BFH=J/JH%W<_+^;3NH6I> MMK#NJ5;Z>ZI?C:&KM4@__X,$ZE_WV 1"-175-%33*ZUQI$(J>G M8OU[>I_EG:F#-EVCFHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!906C/!E#K! ME+ALI MCR]9]WM'IQ3:CHUJ&JKIJ&:@FHEJ%JK9J.:@FEMINV5F939J?Z>V8]184=K7 MC^VRQG*[9$UM?S,MZK9HI;>1\HU+UOV+'QTMI*:BFH9J.JH9J&:BFE5IK2+H MBT]V;'15!]5<5/-0S4>U@-*:855W92O?T)7]385MM%\;U514TU!-1S4#U4Q4 MLRJM7<*?3MLYA5X0&]5<5/-0S4>U@-*:.55W=2O]7=VOYE289S!I7=5$1]:CFHUI :]#9AO7"(B6TDO M*JU5[&A5.]3.4>U.>PW=,AW5C,X]D%L-+R:ZIH5J-JHYJ.:BFH=J/JH%E-9, MEKKU>MS?>AV4EZE]K.ATGQBA#=2HIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^ MJ@64ULRDNLUZ//L.)1VTG1K55%334$U'-0/53%2S4,U&-0?57%3S4,U'M8#2 MFLE5MUV/^]NNCR_IH%W5J*:BFH9J.JH9J&:BFH5J-JHYJ.96VNY_1J2,)K-V M3>?E*'FQF+>+.AVCIO/V?T9$;?]36@RSE1"Y&N;A^>E&I+?B0JS7F725W,<% M7WZ@M;U72L5->=G9=[\J@^&+^UWY72"7]P]KYOST+KP57IC>1D6RK,5-08Y. MYL4.IM'M:GLC3^[.!O) ^I3D>;)Y_'4EPFN1E@.*QV^2)'^^42[PD*2?'S?[ M_/]02P,$% @ -GSY6!8DJ2KF! H1X !H !X;"]W;W)K^E'F()?G[CG@.^9''Y/1(V5>^)42 ;VF2\=ED*\3N MWC!XM"4IYG=T1S+YS9JR% MYRS8&WS&"5T52FAC(-%TCQ7$VF4^+9\]L/J5[ MD<09>6: [],4L^^/)*''V01.3@]>XLU6Y ^,^72'-V1!Q)?=,Y-W1HVRBE.2 M\9AF@)'U;/( [T/DY@E%Q-\Q.?+6-)^(%WK\ M@U2$G!POH@DO_H-C&>O)-T9[+FA:)]$K[X4(/-%,;#GX+5N151? D"1J)NC$Y!$I$9\P MNP.F_0M )K+ ET4(WKYY!WC);Z2!']1P'\GR#B"W@$,GN!&8\!(8KX"!XS = MME;=;U:!:UW:;V-=4$+8XQ#YC'+/=S@BLXF<,CAA!S*9__P3=,U?Q^32"19J M NM(9]?2V2KT^9_[=$D8H&LY;^7BX65"3N.$@_\40^:Q!'8+X'Q&/ ABN@^'[V,1"0^Y"-ZC(LW:"2$=A X?H_,2)QE6W;09Z-LU(U] MYM>4?27EEV(E L];+!>GZ#M8O%ZU2J!KIT&=8*$FL(Z 02U@\.,K2*!3.IU@ MH2:PCG30;%R3>?.,4:6VRR%E8>#:LRZ#E^Z"20:MPV"&."%=5D!KK MVG&@%2W4A=;5$34ZHA\OHPI#EWXZT4)=:%W]&A\+E5Y/74G6<.R[MOSKE](P MSK<'32N6Y=UVJ-M:*% MNM"ZXC;N&&JPQU"K/]:*%NI"ZV[&-0X9J1WRN6D'#7TM,NT FEZO%L<";1\A MJU^-Z@;=2K@QU$AMJ%733I5ZULB,Q(T:&753;J7:>%ZD](3S3YD@K-HF R2) MTS@K]H='J6NUOEK10EUH71D;ZXLT[.$BK9NX6M%"76A=_1K3C=2F^^P4,]RN M?1\X@=DONI$P!'W4WZ%4M^96MHT/1NH-6>7\ O0>;$:TXO4 MIO?"#5$TW(\=&R##J-'QH=7V&JTSO92P37$VRD%!JSS>JY_6YZ\/Q:FCT827 MA[=/F&WBC(.$K&6J>>=))JP\#RUO!-T5)X1+*@1-B\LMP2O"\@#Y_9I2<;K) M7U"?2L__!U!+ P04 " V?/E8(!"/X#8( C.P &@ 'AL+W=O)DF]RH2Z6_;B]*GL[?T32QYW:"Q^"U5=]71,:FI M7!7%M_KDP^ITYM4]4ANUU#5$8O[=JG.UV=1(IA]_M*"SPSWKAL?']^CO&_*& MS%52J?-B\WNZTNO363@C*W6=[#;ZLMA4S5]RU]IZ,[+<5;K( MVL:F!UF:[_\GWUM''#6@_D@#UC9@_09BI %O&_#'-A!M ]%X9D^E\4.IYXNHSP/ "VH>#*;A'VCX3AIO5_\WLY=:D7=G'[[$;R$F M_O#.S#R2/I&AF?1DY/5Y &@\\'T)TP@.- (GC5B9@;I,D_TBE:](DM5A^6=S M 2(5#+K! E^&O$<*,(O,,/-[I(9FG 64"9A4>" 5.DG]^N'])[)<)^6-(B^6 MI5JE^B7$)1QZGGLL[%$96E%.18_(T.B5I'XT,LBB Y'(2>12%\MOK^IU?T66 M16;$4+5_4NI[?:P@4M&PNU3RH$<*L.*>[ W-&+3R.$R*>G9-]AZ8R"I=[I9Z M5YKY_U6I-HEN"%8:7G"]83>\T&>]P70.V'%)ZU6K0PHP"X64(X^*'BD-^L", M8,:9>3@5T079ED:ZEOI'$U/JCUVZ;5:]^BS-=9+?I%<;19*J4B.0'F?-&0G(D%'6#/+FKF'Z"]?R:>M3K-VSB#G3=Q5Y+\?57:ERO^! M[)R84Q=X5+08"ZWK3RN/*((^HJ@""14MQD+K^L]J)/J02)HVMSC1)GL2$RUN MT3HQZT4\&@E9*\"H6X%];K(>@%@VN%N\@1%^%-KE;;HT >S(+-PWF/PF#1,MQD+K M.M?*24X17D0Z)>ED_V&BQ5AH7?]9"1@&' &:>L M+\4APRCPZ-&+C2Z/H_?1;OGZ4%K!A^I2>)$7]=4J8,=#(5C_G0J$9Y(4/I)3 M<*M6N5NM/B*GX( "%91Z?6T#V5'.@KZ@@^QD$/AC,Y_5JMRM52?G%!QZSK)ZC[OUWC0Q\]2$Q=V)R0LVJDS$0NMN'K)J4GC/%SP"53"BHL58 M:%W_6<$HW/7'B0F+&VVR)U&EXU/07+.YL*I1N%7CAURKLFI'HMJ8X,Y'UW0W MU&0/HNX2P$+KNM&*5H&P2T"@[A) 18NQT+K^.]I)^8RME$ !EE$I!F]%0$,1 M#7>Y@8:1P1Q)7H35R>)YFRG=S2<(22R@& &HZRLKOL6S=VRZ$::X"TMW(P!U MW65UMT#>&>K&F^(\)* 8 :CK/*OO!+47-*][TF.!8+*$8 ZCK6"G_I%OYCFO6I.:K[=E-U M&2I:C(76=;5-#R1[OJZ5J'D!*EJ,A=;UG\T+I+N8/3%'=:--]B1JAO 4-##> MYT=?#V;*1&?]%69EG+++]?XKO,/5PY>>;YOO&WO7S^B;>/^]IH79?S[ZT01] M:B;>C;HVD-[KP(C<6^FU/S]8%!G,U;2^E3,6057)D*65,&AG [JN60T;Y+*8D \+QJ4E%>]X5ES M[K,NMWTAWY4&(;_K@)C_O>?J.6,$R MI24H_'MD5ZPHM!+5:&_=ID[<_OVL?MUT'CKS0&MV)8J_>:YFY[VDAW(V MH8M"W8GE[VS5H5#K9:*HF[]HV<;&T&*VJ)4H5\EP7/*J_4^?5B"V$G"P)X&L M$HB9$.U)\%<)_DM;"%8)P4L3PE5"T_5!V_<&W(@J.CR38HFDC@8U_:.AWV0# M+U[I@7*O)%SED*>&]VP*CUVA.S874O%JBOKH(O\'&F8Y&E_>?!E=H),14Y07 M]5NX]O5^A$[>O$5O$*_0EYE8U+3*Z[.!@GO1BH-LU>Y5VR[9TRXFZ%94:E:C M<96S?%=@ )U8]X0\]^22.!7_6%2G"/OO$/$(L=V0._V6RE/D!4VZ;TD?N=.O MV<,I(M'>UL;S:ZQQ0;'5-L?"2QG><0K)]#X%(?_@FEOA!UC292E"B#$<^K MA9YE4.DEU:72-GV MQ*6IG^!UV ZI<$TJ=)*ZJ12#SBC$GF 1K)D-BU/A4"RM6+35#4("/TT-*MTP M8!=YV(!B4?.PO\5X!TJTAA+]!$HF2H84?7)A<6HMT:AR1$M=X_YM3MCX..4.Y1-W'W0Y)OSRQ(6!5YB@NJ&A7&,]XP>[&T\H>1LW=Q*'85FH[$P7FB6=4G)$ECI#4,^/&MK@T"?>, M,+SEIK&3W,D'V)N];9=\J$XY>U"H%#F?\*Q=[1NDDBDNF298OT,54U9^N+/, M!C!5C,7X:A6V,U<2#P?$!-.-\XD?FE@L:B&)]PTHLL%"G%AN&0P3V?3](ON^ MX#77,/J2%53O,S)1*_L@/(A>H89L]G0EM#,]29S&)DU+F!<&Z1Z:&V^/ MG99U>*]$]JVOM\<:7:E]0;L8.CR"6_)@DGZW9SCL5#%;F.^%GJ>T^_"0BD'F)C^TA*6!.'>@K5Q MW?AGMOL1RI"0/]!2_LFX,:58[YME[^25HN)GM42IKAD#^WEC/%'"H[8/KN/NF%XC9H=LV5/$7I1IV3^__9V M7]]N=AW$O>OXI,NH#:@[[U"@I&O]T\!\GS.R1 5Q8#H72Y1/DCW&A6QV$<2] MBS!>P%N9.!4.9F+9;) 4FR]T1I8XJ'III_#9]/PXBLS).MCZ<%'J/8+^8E3# M4KJH5/OF?WUV_57JHOD68YR_PN_'[;>EC4S[J>L6=J@<+$W!)B#IG<9P4[+] M>M0>*#%O/H\\"*5$V?R<,9HSJ0/@^D0(]7R@&UA_PQO^!U!+ P04 " V M?/E8 *(S,+4$ S( &@ 'AL+W=O&UL MM9IK;]LV%(;_"J$50PL4T<67.)EM(+&T9L!2!$F[8A\9Z=CB*HD:2<4)T!\_ MDE8D*U&4&COY$HLRST/Q?:EC'3'S+1??90J@R'V>%7+AI$J5IZXKXQ1R*H]X M"87^9LU%3I5NBHTK2P$TL4%YY@:>-W5SR@IG.;?GKL1RSBN5L0*N!)%5GE/Q M< X9WRX" CJ@.!G T9UP.AG \9UP/AIP.R%@$D= M8*?N[N9NA0NIHLNYX%LB3&]-,P=6?1NM]6*%62@W2NAOF8Y3RQ7/*%9LH(@92$*+A'RJJ*"% MU\'X*B+),?R#O""O(EY9747>3<5?HZ#,V- MZS%7NS&#%\;TR:4>*)4D*A)(>N*C5^*# 8"K!6A4"!Y5. \&B6>E.")!\)$$ M7A"0KS?_N0]_$AC$AQ$=DY+^*"5^YFFKS4YAH&'-)]:2\L<6,2$:WLF** M2$45#$@V:A;.R-+'+RT:5O(+JE0J<_HCCA*@5!2BK40Y\G@[A#/<&$A3O8 MQ,+,,\V=3NXGWMR]V]<::<2.UM-&ZREVFONF4Y@D9_I.N>"5,!VD;MKGHCYS M!L<_U!Q,6(@)BY!@'1./&Q./WRZA'6/Z@PD+,6$1$JSCSZSQ9X:;T 9QAWJ" M"0MGSQ+:S'N:SY &[$A]TDA],BCU9UVZ_:U+M[?*9H.C'^H,)BS$A$5(L(Z% MOM?6;-[;Y;.:C601*BU$I458M*Y+>Y6UCYO5AGD'.^,_2T73\>1)+@I1QXRP M:%W%@U;Q8%#Q\ZP"LA)<9RA[>),RR)*]_-:K^B#S8-4Q:2$J+<*B==UI7QCX MHS?,6JAU/RHM1*5%6+2N2VWM[P^6KLO/57ZKDQ1?DWCW+/#C\=51KRVHY3XJ M+42E135MNI=.@R:7=K5NZWA_N)!OM;9OY:1YK[I-69P27H*P3V _^E[8U=JC MEO6HM!"5%M6T?>UG+VC?UO7^<&%_4>6TH*_]-J 6YZBT$)468=&Z;K0%NO^& M%;J/6J*CTD)46H1%Z[K4END^*HM34J+<*B[11W]S9')^=7_FFXV[]N,;OM]$LJ-JR0)(.U1GI'QUI] ML=NAWC44+^T6["U7BN?V, 6:@# =]/=KSM5CPPS0_)_ \C]02P,$% @ M-GSY6.#(TOMR! 1A !H !X;"]W;W)KT3-M$)5(E*3OY]CM* MBF)+M)8.7E[$$GWW)W]'\LCS="_D-[6E5*.G(N=JYFRU+J]=5V5;6A!U)4K* MX9NUD 71\"HWKBHE):O:JJOY8/$M[<3F7%"LH5$QQ)NIXY-_AZ@4/C M4%O\Q>A>'3PC@[(4XIMY^6TUD?SW"C!.+ZWHD[7IW$\ M?'Y1OZ_A 69)%+T3^=]LI;L,(R@8;S[)4QN( P<_[Q">< A:A^"M#F'K4(?:;5#J."R( M)O.I%'LDC36HF8/U9EF5.82 VSCNZ(VJ)[6 O( MB*&+!=6$Y>H2?4!?'Q?HXMTE>H<81W]N1:4(7ZFIJV$01LK-V@YOFP[]$QUB M'WT67&\5^LA7='4LX,+H.P3_!>'6'U7\3.05\L+WR/?\P#*@NW'W>[J\0GY< MN_L6]\5;W)/:'8_0!-V$!+5>\!\FQ!;M1BVTJYFL<:U*DM&9 VE!4;FCSOSG MGW#L_6*+U#G%%F<2.XIBV$4Q'%.?UW$K"5LA2(VP8C6%/K0M?HU.5.N8)+F; M^]@/HFCJ[@XC,S3#$R^:!,=F"YL9CH.P,SNBB3J:Z"TTSV95*'0!F;&"O7?9 MLF6BH$B3)ZK>(TZMD(U\?#"L#U'@I3W&H57L!WW"H5$2!9&=+^[XXE&^C]\K M5AHXM&:<\(RN$ !2B3)2,DURE%-([=9D$P^&$P0'X6[ AD8X3B<],(O1)$SM M8$D'EHR"W629K(#FA8,^P7F]8KJ2=IK$,H8$XQ[.T"J,PKBW8A<6K33U3JS$ M20U- NP@$>V"V& M=DF*_4.[(["T TO? "9IM\NT&,5*AU@>3H=80[O(3_PAUM N24:PL/=ZOGOC MYPG;<+9F&8'=!9FB%+S&$VM8E":K2+%C< ZCY3.ZJ!0\,'Z)_M!;V'V_,[)D M.=.,0M)IFFZ4HEI=6H]][YPGT5G5%N=2.YZ#@SL6'EU<@W!:XX>'21IC7-\J MCI:4Q3">1%$_G]GT(B\-DQ,KRG^E\=] TZP$*X@_W!MQF$SZ&/[@K R")$CZ M&$.SB9PX0#9@IV)JC#2H429N#[<01 MC2V7(ASZ<3]0HUW_<*#.I-8$RCTHL HJ-W6AJF"]5%PWA4K7VA7#-W4)V&N_ M-45R7;B]RC05-E0Q&\857'76(.E=)1 OV12MS8L695W&+86&HK!^W$*A3Z4Q M@._70NB7%]-!]]/!_!]02P,$% @ -GSY6/-)5?;Y @ ;0L !H !X M;"]W;W)K9/%Y"QP]RPC><+-V2SE?J"&<]V> .W(.]VUUR- MS,8E)3E001A%'-9SX]P^6]BEH*RX)W 0K7.D45:,/>C!53HW+)T(,DBDML#J ML(<%9)EV4CG^U*9&,Z<6ML^?W9,99P?$=;5RTR?E=U.J%0VA^C'>2J[N$J63\9)03!.",W1%A>2% M>D)2H--+D)ADX@OZANYN+]'IR1=T@@A%O[:L$)BF8F9*-;OV,)-ZIHMJ)N>- MF7YB/D&6]Q4YEN/VR!?#\B6L)L@)2KG3E9N*N0%W&G"G]'/_"TY>P/NH*ANO MWT;OLC.QPPG,#;6-!/ ]&/'G3W9@?>]C',FL0^PVQ.Z0>WQ%]R"DYD18O7/& M)?D+*4J8D'W@E9M?NNE?@WT<>GXX,_=MH+XB*VB*.D&])J@W&'2!.7\B=(/. M&\LQ; )&PZ&79)'M4/>E31\G<#U M7"_PCY+VU 5356CU)XV:I-%P4DPXNL=9 7WA!K4?73TCF74PIPWF=)S],AV3 M>"2S#K%MO?Q%6R/NF-JLN\ L_3I:B'V%EC]M%W8#MWH*>ZQ=4SMU_D""R'6B MX["OZQ258^M>H!/6;/5"NA%5;<=&+164P5HIK4FH+'C5VU4#R79E>[1B4C5; MY>E6]&PO=V]R:W-H965T1J@L9S# M*][#A\ZYDJZ>BO)KM5&J1M^V65Y=3S9U_?!V-JM6&[5-JFGQH'+]E[NBW":U M/BSO9]5#J9)UVVB;S2C&8K9-TGPROVJ_^UC.KXI=G:6Y^EBB:K?=)N7W&Y45 M3]<3,OGQQ:?T?E,W7\SF5P_)O?JLZB\/'TM]-#M$6:=;E5=ID:-2W5U/WI&W M2QXV#5K$OU/U5!U]1DTJMT7QM3GX=7T]P4V/5*96=1,BT;\>U4)E61-)]^// M+NCD<,ZFX?'G']'?M\GK9&Z32BV*[#_INMY<3\()6JN[9)?5GXJG7U274-#$ M6Q59U?Z/GCHLGJ#5KJJ+;==8]V";YOO?R;>.B*,&1#S3@'8-J-V /]. =0U8 MWP:\:\#[-@BZ!FWJLWWN+7%Q4B?SJ[)X0F6#UM&:#RW[;6O-5YHW$^5S7>J_ MIKI=/?^D'M-VT(L[]+'4!\6NRKZC7ZMJI]9H4>15D:7KI-8'[],\R5=IDJ'/ MM?Y"SY:Z0J]B52=I5KU&;]"7SS%Z]=-K]!.:H6J3E*I":8Z^Y&E=_:R_U)__ MV.CP2;ZNKF:U[GS3A=FJZ^C-OJ/TF8X2BCX4>;VIT#)?J_5I@)G.^I Z_9'Z M#?5&_)"44X3YSXABRH .+?S-WZO;*:*B;4Z!YG&?YK)M3H#FRS[-H[8Y]I#! M#O. M?'89>8!-)[[$W+XA,T&^+9Z2%;J>J)WN$J5CVHR__O?B,#_A,9BS&#Q MF,&6(P4[&35^NBSY_MUJ5S?A429:4J=++[$GO[A722PP5]4:5>@LI2SU M*$N3VS1+:PV"QFI_FJ ]37-M>9Q+'(61GIB/QZ, P*0(@N@4%KLPP1DEX2EL MZ04R4#:#+DHPB(:<(L@%T:Q$-+FQYO!0'[D M@1_98P*=(44Z>82$DB"R)L0"P''"B+0G#H"3) J$M4Z7WJX/)"8\$!.>VY-V MVUW67BJT8DM7:0U1$SJIO-$["8ND-1<6 # (&9>AL,B!@(Q03JR(2V__![(3 M'=B)>DP;+>M67S=%ME9E]0_TJJ/I-5)_[M+Z.T17!"07< ^OIR[L27HA%LY&#.$$QZ&]SP XO6=S1X M#*B>(-2F#P 2O1\Q^TKO3W H@=002+T$_J8-=^8G$22, H21B(2A31@ #*C6 M!PYA #"*6&COW_Y\AO)EO #QBM8#7R IK"\I ! F!0!&VE/95WM_IX>28J0V M\6OM1;'5<3=-C>11/4^/JWTU/:&6=S8] # @3-JK,8: (F!2V/1<0DX3HZ>) M7U#?)%6ZVJ\RO:CV_O^EZVU_!GFRG;"I+9\7$"Z:"EL/@.&FMFQ8^O,:RIN1 MV<2OL^,TVS52Z?]C;G^.\"QS YB#@H','<)_4V, "=^!=[L4K? K ,)DCT) M G 005"XJ7 N>Y?0X<0(<>)7X@U!:W!Z@12%/56L4:/%HT9;CA7MM"AKO '%?W4EDHZDW[NR M\)C1XE&C+<>*=CIVQJE0OU,9K1[9G>>DTDBU\[0JC0L(UQA"6V,".*'=L["= MGC^_H?P9HT+]1N5%54GJF@DJJ0SMJM$" D:,85NRQQ!08!IQ^\KO3V,H3<:? M4+\_>6EMDKH.@S#,0VH3!> "$ME2.P9P%(>4V.43?QI#:3*.A?H=2Z\291?C MM$8I(F)[^ 4$Y#2*[*IL# $EQ32P#9V_^T/I,8Z%^AU+ST(E=:OU;X3 >F+8 M52<(&80!"6Q_'X-(1ABQ;>+2G\-0CHP[H7YW,K1<2=T*_AO!B;27T@( 1A&V MRYHQ !-Z!.P;!TM_.D/I,I:$^BW)T+HF=0O[E.@EZ.SD+HZ$F$3.$G1Q0+SM]1Z%NKZT*=9PO G64+BCT5SHJ\A'!G1KBS,X_UK/^[J^I&-(#\C"2; M.Q;'C!:/&FTY5K3383 &@05_=26*C23GN[$;,UH\:K3E6-%.Q\X8%^8W+J-5 MHKKSG%RE"!>./89P'$O;R "PT'$Q_MR&< M7'XNX5N8\2W,[UM>6GYB@)U@-,*VNX-PA$IJ%S-!7. \O.//8BA+QIRP/D\Z MG:,&, Y<.KDL(!P1TGZ0+H9P(G0N[Y=P(=RX$.YW(3T+3QRP#Q W ZB!H"Y MS/A[/I098T6XWXH,+3=QX$$DD"H7!U+EP@"J+F%+N+$EW&]+AI::./ ($L.2 MV_LUA"."8+L6#N$ LBYA/[BQ']QO/T:J-'&W[@]2!]Q&@)AS80!Q%WF]X.C] M K\3&5AAXNXM ) H%P82Y<( HB[A%;CQ"MQ_,\%76>)NM1]DPX6!;+@P@(U+ MJ&]NU#?WJ^]^)27N:F&0%Q<&\N+" %XNH:RY4=;"["-K;Q!D!UJZ4]P*(%&>O/SCS3UK2-Q]PFD\TQ!;1RF()#+U*CR>W;T MBN=6Z8M[\VYMI:?-+J_WKSP>OCV\O_NN?6O5^OZ&O(WW;^&:,/N7@C]HS9#J MBV&F[G1(/)5Z*97[]VSW!W7QT+Y(>EO4=;%M/VY4HE5: ]!_ORN*^L=!\G9UV9AM_&S8+GC$XV3*3IFD) MW=E'80OPU):H)"#[[_=*=ES #I.'O( EGW-\S[U7'Z,#%S_DAE(%3U7)Y-C: M*+6]MFV9;6A%Y!7?4H9O5EQ41.%0K&VY%93DAE25MN>);\5ZH_2$'8^V9$WG5"VV#P)'=JN2%Q5E MLN ,!%V-K<2]3@<:;P#?"WJ01\^@G2PY_Z$'LWQL.3H@6M),:06"?WLZI66I MA3",GXVFU7Y2$X^?G]5OC7?TLB223GGY3Y&KS=@:6I#3%=F5ZAL_?**-GU#K M9;R4YA<.#=:Q(-M)Q:N&C!%4!:O_R5.3AR."&[U \!J"=TX(7B#X#<%_+2%H M"(')3&W%Y"$EBL0CP0\@-!K5](-)IF&C_8+ILL^5P+<%\E0\GWZZ21=W-S"; M??R>W"V2Q]F7>TCN4_BZ2.YFM__.[O^&9#K]LKA_G,/[E"I2E/(#?(2DQ)8A M+*,2\YSO,D5S6 E>82DSOF-*8E=DM-B394D!^Q.H5 46"F$[AF&;RNMWI#+P M:]1.&[R1AN1S9"IWJ>.VL<36I77DON'(]^,R9VDBX81C< MJ8"-*6KSY#WG:>)=5/Q,Q!4XP1_@.9[?$]#T,OV6+J_ BPS=ZZ&GKZ$/#-V] MX,9OJ^X;/?\%O3>O75^)ZA""_A#T=G8MMR2C8POW*TG%GEKQ[[^YD?-77WK? M4BQ]([&3U =MZH-+ZO&$E#KQ0!1,Z+I@K&!KX"MXH*+@>5\>:[W0Z.E=?!\' MT3 *1_;^.$%=E!<,P^ 4E791KC<,_FQ1)Y;"UE)XT5*2YX7>Q"5,-T2LL4D4 MARF7V$:X?.'F"<\H27N7<2T<'<43^?[ /_/61;E.Y+IGL+0+"_QA&/:;BUIS MT45SJ5D?VEU?_%'WDT/7.:]-%S4,7,<["[^+\MUAZ/2'/VC#'[RVW7 KO-QH M@TYS1)[KGQ>CB^IIQ[2+.FW'VHQ]='!5%%M'7P DF#VHWIO;V?:.D9BC]6Q^ M@G>/^JKP2Z:^N.#&C:M,0DE7*.E<#3 F45\&ZH'B6W,\+KG"P]8\;O#^1(4& MX/L5Y^IYH#_0WLCB_P%02P,$% @ -GSY6)H=5JM)"H($^&P+^;%3:&K M8"+G0@_";A,*W.U;-@C;R648.+F1S.@@?#C[^'LN]?6'P-U//IVFLFR9D('(_=>-YV]\T$G ME/J=;5M#O75;"'V+;-+ M%^Y 8"*Y5($V!6G2M2%2/3FX[7I0J[5.P814-K?+X'Z/Z^$[P*H'!AGGC<%. MZ +#?DFTIDKY%_YEO8BW]@WNVNB M:1I#==/)N [H;ZHY[4W9RS?I!B5[E/KKW$Q'V#Y4*KU5-&<+VU_DC0%,O8VK MD[+DRR^<345!W>1?G7#8)RM>,).*/9EL4"H3$Z J#!ZITFRR&?FC2'E/%WI5 M3HL<]]PY0L__=IVG5%!%^*9I4_N'O,IO=ER_^=[#L_U:V77L-1EW#]]C_;8_ M;)-Q>O@>Z[/-H9L\BI+L'8/)8ZC)[KM]L^\U&=4GH8WCUM9AJXD&<*@=A#_A MB,S728/QG''-1-V;L2RCXL69R\AK,C9_DFWIF_$9SOV=YA>.VE.U"87$QE=T&Q4=]5T;)N!:9BL]06$7>3&7GX$XSC, MCP"&Y<$<8!S'PO+\3_/IH?-Q&.:MYT5Z**>',X M2; 5'8V\#D;8NB4)_/C5,&_ P/) IK];:WRW\0K97P?8GNZK$&RF>"5B,\77 M&A#_N@$C3?V[C>4!!K8+6.U ?G\>J"D_)XYA5S%OV!.,(VF*(5"+_AI-$F1U M$OCX]P=[2N(X3?T(8'X'<8PA\#3B".8 /&!('-OWX,[[*%J]IZ+U_RF'SU!+ M P04 " V?/E8EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P M#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TX MI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606 MIW.D5XA-/E M_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU M@LD/['X 4$L#!!0 ( #9\^5@E.8[0;P@ #5- / >&PO=V]R:V)O M;VLN>&ULQ9QO<]HZ%H>_BH97V9EF8_[:=)K.$""WS)# XK3WY1UA1/"M;;&R MG33]]"N;I#T"[V_WS0FO$HPQ#P+IT3DZ\J=G;;ZOM?XN?J1)EE^W=D6Q_WAU ME4<[E;S*]T;)3;Y3JDB3JX[G#:Y2&6>MSY_>KK4T M5_2!+E14Q#JS!ZL#WV+UG/]^OGHHGN(\7L=)7+QE86^C9-"F8DLU!]&E_LX>ZPN8S_%%?D8=3N\ M_3TTXD?S_S2CWF[C2$UT5*8J*P[M:%12 6;Y+M[G+9')5%VWWDX1,MN(:5;8 M1A*S[' I>V[U2>U;SS:'3UU87-*&YF-LGS"S30W.!SE>W(>+^6PR>IA.Q,UH M/KH?3T7X93I]" E@!P!VS@8H+I:20'8!9/<=(<,'^^=N>F\!%[=BL9RN"&0/ M0/;.!CE>W"T)9!] ]L\(^5>'0 X Y.!LD.'#8DP@?0#IGQ'2:5R@M31D5IK(0I%!)*F]DHHSRW5PYEHD2AQ9\W(PJ&)-)FMLA< MY[E8*B/"G32*4B%KM)FU<2NC>H(GIC_BPUQFENYE;.JIS7A',9$WVLSBN+5( MXIM,2B7NE,Q+HZH7Y!0/&:/-K(Q9%NE4B0?Y0SE,2!!M9D.\#F"Y6*E(Q4^R M?O??:$@+;68OW*F-'62-$DMI"C&A6$@$;683W,FLW,IJ/+.]=*76%N._M%X' MF:##;()9]F1/T.:% B$/=)@]8&/)O8WT7CZ(92+?(B)KJWWU.@H) PUF+_RA M]>8Y3I*:;E'L[%<\LR%K]EAQ"&J)#K)$A]D2MM>:4FTJ@4D3J_R#^%,^VI_A M*S7%1-KH,&MCEFW4NE";3.4'MK&Q?=K.FAZ-LD,SQ43:Z#!K8VY=X8S('62) M#K,EPD)'W\5B7SU1-]KAP.A9FHWM.A03B:/#+(Z5*N*#7^O^[#0?LD:'VQIE M4L0JW2?ZQ7;>&DT4.VDIC7Z*-Q036:3#'4^HQ[KM5FJO3>'.C+O(&UUF;XQU MFL9%/6_Z(,8ZJ]A4%L6OHPO%1#;I,MLD+/?[I/[Y55'96.8[<9OH9S&1A9,/ M0C+I,LOD-LZD;3F96(=4,=#Q9+0+LU7,"EFIZCWM$&,CVJ6Q#W29)R]BEN>5 M6&C^HHL4TF562#C^,IU\G4_%;';Y;33_.GJ8+>[%Z'XB_O5U-)]13*20+K-" M8'K 2;1TD5NZW&Z!F%V*B=S290]*?F4QQ,5#-:O._T'9D%^ZS'YQTAF-=$@K M76:MG.0UF@A[R"\]9K^X"8Y&/.25'K-78*;#Z<@]I)8>LUIH*J&Q#9%:>LQJ M@9&>N*"8<"F$62TPUG._:J26'K-:8*SG8B*U]-B36R#6HU= M!EFEQVP5&/2YK8?TTF/6RW'0U]2.?627/K-=8/3GM&,?6:;/';T<1W^-#8D$ MTV<6#(JO+"S%1*KI,ZNF,<1J;$QDFCZS:6"LY?XJX;+[68.8'L5$INF?-8CI M4TQDFCZS:3#F@&(B\_2YS0,Q?8J)S-,_Y_K[7P&M"4'^&;S?^KNXF*A"QHDS M# V0=0;,UJ%PEV)9FFAG)T-B;^S+A:29Y0%2SX![;=[!),LOL@IN:0)M@-0S M8%^#H9CT4:1S%Q.Y9\#LGJ,OW>CZ*B)^+4*DF,@] V;W'*55FKH.+/9B=DY# M7J4)$?EFP)TT.T&\M &%,K*>7QJ*B7PS8/;-TTUS?]-:)*"92CL^^ M[$^3DPT=W$>F\9E-X]!=BI7%$$9%.JM^ HX0?60<_QV+Q2SF1&V5,6I3'1!V MJ*>8L,"8V3I'F%^SJBGM_/RG1;U1M C51];QF:USA%DU(EW;IIA(/CZS?(XP M[^W;_%;X7!/, ,DG8(]R3HH&&_MY@-03,*OGJ'RP&1!))V"6#BPD=(OSD70" M9NG\*B1L;D$DFH!9-'"AR6U!9)R V3AXH8E.*0-DG(#9.!B33BD#9)R V3@8 MDTXI [BIA=DX&)-.*0-DG("[8 "N+M+?YA 99\A>S8Q6%QU,Y)PALW,P)NU" M0V2>(7OU ,*D76B(S#/DW@OSNE;;H)TATLZ063NO7)>"+)(E(JK6R+:)?J:8 M2#O#=REK/L:\"5\W(%-,I)TALW9^8=[)*OM7U#G^I#HH;#RVIIA(.\/W*1RX M/&38ZD=K&7UOB+V'2#O#,Q82Y()N\!W"W93EQ[[-\K@THV'8;'MPTZ7'[)T3QD.(:^?PL;;!F@,*-V%Z[,71)Z W*E-; MZTB]3MS=OG!?IL=>67 ":F=T95K:V0F+QQPIX4W^W+O\3\O'[/AD [@L4B+<.9WI?VS]?_[X!",W'?#Z )=+3YN\RKX6EZXX!",W'?'P!NSW)27FU\QP#N6P;@ M D+WJX=F8K]I0',)8=/L"=\]@/OV ;B*T!V>H)FX[RD ]VP=_4:AF0YW&+BJ M3\\_?]K8"5BF-O?V37)[/)))M#2B^E-?J]/K5S<&V)9),K;'%ME M[ECV^3]02P,$% @ -GSY6$E$#<= P 044 !H !X;"]?3B.^_,K#X?3;CV?+T^/PW&]>5D_CD-PK@RGKV>L;JZ^GGEQ M]W8<_^?$P\/#\V;\>=C\WHW[^1\'#W\.IY?I:1SGU<7=^O0XSM>KX77[^?0T MO#_XR_/)JXO;^^O5Z?;>KX:E!P49%)8?%&507'Y0DD%I^4%9!N7E!Q495)8? M5&5077Y0DT%M^4%=!O7E!WFG,CK )(,U0&NO7'N UU[!]@"QO9+M 69[1=L# MU/;*M@>X[15N#Y#;*]T>8+=7O#U [Z!Z!X#>0?4. +V#^;(-T#NHW@&@=U"] M T#OH'H'@-Y!]0X O8/J'0!Z!]4[ /0.JG< Z!U5[PC0.ZK>$:!W5+TC0.]H M?BP!Z!U5[PC0.ZK>$:!W5+TC0.^H>D> WE'UC@"]H^H= 7HGU3L!]$ZJ=P+H MG53O!- [J=X)H'6?7. M +VSZIT!>F?5.P/TSJIW!NB=5>\,T#N;/RL!>F?5.P/TSJIW!NB=5>\,T#NK MWAF@=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NJG%:!W5;TK0.^J>E> WE7UK@"]J^I= 7I7U;L" M]*[F9D& WE7UK@"]J^I= 7HWU;L!]&ZJ=P/HW53O!M"[J=X-H'=3O1M [Z9Z M-X#>3?5N +V;ZMT >C=SLS= [Z9Z-X#>7?7N +V[ZMT!>G?5NP/T[JIW!^C= M5>\.T+NKWAV@=U>].T#OKGIW@-Y=]>X O;N)=0!Z>V=S'8#?WIE@QP$$]\XD M.PY@N'_7WX\:63\2"Z'KS.FF[]02P,$% M @ -GSY6&:]5%&2 @ =T( !, !;0V]N=&5N=%]4>7!E&ULS=S? M;ILP%,?Q5XFXK0*V 1NFIC?M;K=>[ 48. T*_X3=+GW[.:2MM*F+5F72OC=! M"?;Y';#TN3NY_O8\6;-DAW!G.\Y]YAR\'?S:'VM$-]=W=EL]=G[U^1!^=NTX;*+9=BY:W9X6'K,V M435-75M7/MQ/GH;FMY3U2T(<=BYKW*Z=W%58$"7O)ASO_#G@9=_7)SO/;6-7 M]]7LOU1]6)43^/DPLG-MN/Q[T>R7'W>@J%[.S;\X_XEAA*7_Q\ M]GC:C6W^,CN\WA_CO%_.PR7+Y?)W_.L9O]7_8!\*TD<*Z2.#])%#^M"0/@RD MCP+21PGI0PI*(Q11)85423%54E"5%%4EA55)<5528)44615%5D6155%D5119 M%45619%54615%%D5159%D36ER)I29$TILJ8465.*K"E%UI0B:TJ1-:7(FE)D MS2BR9A19,XJL&476C")K1I$UH\B:463-*+)F%%ESBJPY1=:<(FM.D36GR)I3 M9,TILN8467.*K#E%5DV155-DU119-45639%54V35%%DU159-D5539#4460U% M5D.1U5!D-119#4560Y'54&0U%%D-1=:"(FM!D;6@R%I09"THLA8460N*K 5% MUH(B:T&1M:3(6E)D+2FREA192XJL)476DB)K29&UI,A:4F25@D*K%!1;I:#@ M*@5%5RDHO$I!\54*"K!24(25@D*L%!AC0>-8&&,Y UF&UL4$L! M A0#% @ -7SY6,>Q5Q[O *P( !$ ( !KP &1O M8U!R;W!S+V-O&UL4$L! A0#% @ -7SY6)E&PO=V]R:W-H M965T&UL4$L! A0#% @ -7SY6!6KOHBE!@ %AL !@ M ("!@A4 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ -7SY6+W^-UB5 P K L !@ ("!728 M 'AL+W=ODQ>8DP* !6P & M@($*+0 >&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY M6!8X_0Z9 @ W08 !@ ("!C#< 'AL+W=O&PO=V]R:W-H M965T 9 M " @:IN !X;"]W;W)K&UL4$L! M A0#% @ -7SY6#3_"ARU"@ (2( !D ("!^WD 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY M6$;JO"#;$P &4, !D ("!,I( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6&HQT?8Y P 4P< M !D ("!9+@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6*D9('NI P % @ !D M ("!;\L 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ -7SY6(4?QZP3 P [P< !D ("!R. 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6!G^ MI_8F"@ *BD !D ("!+P$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6'D; M>@"P !2< !D M ("!VB8! 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ -7SY6+C$1L^*! =0P !D ("! M_DT! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ -7SY6/3/LPB1+P @*8 !D ("!Q5\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6->;5&EZ" $2 !D M ("!5J@! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ -7SY6(.(4H6%!0 /AX !D ("!.;L! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M-7SY6,3E-(?'!@ 7QH !D ("!K,@! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6/@)>*:Q!0 MN!8 !D ("!)MT! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6,-X;:2/ @ CP8 !D M ("!!O ! 'AL+W=O&PO=V]R:W-H M965T3!8LJ@4 )HH 9 M " @0KY 0!X;"]W;W)K&UL4$L! M A0#% @ -7SY6%5:V.J7!@ 8"\ !D ("!Z_X! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY M6/NJ"TTP!@ _2\ !D ("!3Q4" 'AL+W=O&PO=V]R:W-H965TX> @!X;"]W;W)K M&UL4$L! A0#% @ -7SY6 >8/.-> P *! M !D ("!524" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -7SY6+K .I[E#@ /\\ !D M ("! 3 " 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ -7SY6$^%9:1J!0 D!X !D ("!/4H" 'AL+W=O M3P( >&PO=V]R:W-H965T&UL4$L! A0#% @ -GSY6#@: M)2F! P ?0P !D ("!=%X" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -GSY6&=L- ': P 9Q$ !D M ("!I&D" 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ -GSY6-!42IK. P I0P !D ("! M5W<" 'AL+W=OP( >&PO=V]R:W-H965T&UL4$L! A0#% M @ -GSY6!%<":TC @ !@4 !D ("!6X(" 'AL+W=O&PO=V]R:W-H965T@ @!X;"]W;W)K&UL4$L! A0#% @ -GSY6";U*^]Q! #!P !D M ("!]:," 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ -GSY6,??],M_ P % T !D ("!VK," M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M-GSY6%&RB^B6$ 5Q,! !D ("!K-4" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -GSY6'-'6P T!0 MYQ4 !D ("!O>\" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -GSY6$-F&!M4!P VUD !D M ("![?X" 'AL+W=O&PO=V]R:W-H M965T&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H965TH," !&!@ &@ @(%C(P, >&PO=V]R:W-H M965T)@, >&PO=V]R:W-H965T&PO=V]R:W-H965TJ &@ @(%)+P, >&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H M965T&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H965T&PO=V]R:W-H M965T&PO=V]R:W-H965T&PO=V]R:W-H965T0, >&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " V M?/E89KU449(" !W0@ $P @ %-B@, 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 ?@!^ +PB 0C0, ! end XML 130 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 131 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 133 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 587 650 1 false 157 0 false 13 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.riteaid.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.riteaid.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 00305 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLossParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY Statements 7 false false R8.htm 00405 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical) Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquityParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical) Statements 8 false false R9.htm 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 9 false false R10.htm 10101 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 10201 - Disclosure - Acquisition Sheet http://www.riteaid.com/role/DisclosureAcquisition Acquisition Notes 11 false false R12.htm 10301 - Disclosure - Restructuring Sheet http://www.riteaid.com/role/DisclosureRestructuring Restructuring Notes 12 false false R13.htm 10401 - Disclosure - Asset Sale to WBA Sheet http://www.riteaid.com/role/DisclosureAssetSaleToWba Asset Sale to WBA Notes 13 false false R14.htm 10501 - Disclosure - Loss Per Share Sheet http://www.riteaid.com/role/DisclosureLossPerShare Loss Per Share Notes 14 false false R15.htm 10601 - Disclosure - Facility Exit and Impairment Charges Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentCharges Facility Exit and Impairment Charges Notes 15 false false R16.htm 10701 - Disclosure - Fair Value Measurements Sheet http://www.riteaid.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 10801 - Disclosure - Income Taxes Sheet http://www.riteaid.com/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 10901 - Disclosure - Accounts Receivable Sheet http://www.riteaid.com/role/DisclosureAccountsReceivable Accounts Receivable Notes 18 false false R19.htm 11001 - Disclosure - Medicare Part D Sheet http://www.riteaid.com/role/DisclosureMedicarePartD Medicare Part D Notes 19 false false R20.htm 11101 - Disclosure - Manufacturer Rebates Receivables Sheet http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivables Manufacturer Rebates Receivables Notes 20 false false R21.htm 11201 - Disclosure - Inventory Sheet http://www.riteaid.com/role/DisclosureInventory Inventory Notes 21 false false R22.htm 11301 - Disclosure - Property, Plant and Equipment Sheet http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipment Property, Plant and Equipment Notes 22 false false R23.htm 11401 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 23 false false R24.htm 11501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities Sheet http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilities Accrued Salaries, Wages and Other Current Liabilities Notes 24 false false R25.htm 11601 - Disclosure - Indebtedness and Credit Agreement Sheet http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreement Indebtedness and Credit Agreement Notes 25 false false R26.htm 11701 - Disclosure - Leases Sheet http://www.riteaid.com/role/DisclosureLeases Leases Notes 26 false false R27.htm 11801 - Disclosure - Stock Option and Stock Award Plans Sheet http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlans Stock Option and Stock Award Plans Notes 27 false false R28.htm 11901 - Disclosure - Retirement Plans Sheet http://www.riteaid.com/role/DisclosureRetirementPlans Retirement Plans Notes 28 false false R29.htm 12001 - Disclosure - Multiemployer Plans that Provide Pension Benefits Sheet http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefits Multiemployer Plans that Provide Pension Benefits Notes 29 false false R30.htm 12101 - Disclosure - Segment Reporting Sheet http://www.riteaid.com/role/DisclosureSegmentReporting Segment Reporting Notes 30 false false R31.htm 12201 - Disclosure - Commitments, Contingencies and Guarantees Sheet http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuarantees Commitments, Contingencies and Guarantees Notes 31 false false R32.htm 12301 - Disclosure - Supplementary Cash Flow Data Sheet http://www.riteaid.com/role/DisclosureSupplementaryCashFlowData Supplementary Cash Flow Data Notes 32 false false R33.htm 12401 - Disclosure - Financial Instruments Sheet http://www.riteaid.com/role/DisclosureFinancialInstruments Financial Instruments Notes 33 false false R34.htm 12501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements Sheet http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatements Revision of Previously Issued Consolidated Financial Statements Notes 34 false false R35.htm 12601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS Notes 35 false false R36.htm 20102 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPolicies 36 false false R37.htm 30103 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPolicies 37 false false R38.htm 30203 - Disclosure - Acquisition (Tables) Sheet http://www.riteaid.com/role/DisclosureAcquisitionTables Acquisition (Tables) Tables http://www.riteaid.com/role/DisclosureAcquisition 38 false false R39.htm 30303 - Disclosure - Restructuring (Tables) Sheet http://www.riteaid.com/role/DisclosureRestructuringTables Restructuring (Tables) Tables http://www.riteaid.com/role/DisclosureRestructuring 39 false false R40.htm 30403 - Disclosure - Asset Sale to WBA (Tables) Sheet http://www.riteaid.com/role/DisclosureAssetSaleToWbaTables Asset Sale to WBA (Tables) Tables http://www.riteaid.com/role/DisclosureAssetSaleToWba 40 false false R41.htm 30503 - Disclosure - Loss Per Share (Tables) Sheet http://www.riteaid.com/role/DisclosureLossPerShareTables Loss Per Share (Tables) Tables http://www.riteaid.com/role/DisclosureLossPerShare 41 false false R42.htm 30603 - Disclosure - Facility Exit and Impairment Charges (Tables) Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables Facility Exit and Impairment Charges (Tables) Tables http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentCharges 42 false false R43.htm 30803 - Disclosure - Income Taxes (Tables) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.riteaid.com/role/DisclosureIncomeTaxes 43 false false R44.htm 31303 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipment 44 false false R45.htm 31403 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Tables http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssets 45 false false R46.htm 31503 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Tables) Sheet http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesTables Accrued Salaries, Wages and Other Current Liabilities (Tables) Tables http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilities 46 false false R47.htm 31603 - Disclosure - Indebtedness and Credit Agreement (Tables) Sheet http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTables Indebtedness and Credit Agreement (Tables) Tables http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreement 47 false false R48.htm 31703 - Disclosure - Leases (Tables) Sheet http://www.riteaid.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.riteaid.com/role/DisclosureLeases 48 false false R49.htm 31803 - Disclosure - Stock Option and Stock Award Plans (Tables) Sheet http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansTables Stock Option and Stock Award Plans (Tables) Tables http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlans 49 false false R50.htm 31903 - Disclosure - Retirement Plans (Tables) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansTables Retirement Plans (Tables) Tables http://www.riteaid.com/role/DisclosureRetirementPlans 50 false false R51.htm 32003 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Tables) Sheet http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsTables Multiemployer Plans that Provide Pension Benefits (Tables) Tables http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefits 51 false false R52.htm 32103 - Disclosure - Segment Reporting (Tables) Sheet http://www.riteaid.com/role/DisclosureSegmentReportingTables Segment Reporting (Tables) Tables http://www.riteaid.com/role/DisclosureSegmentReporting 52 false false R53.htm 32303 - Disclosure - Supplementary Cash Flow Data (Tables) Sheet http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataTables Supplementary Cash Flow Data (Tables) Tables http://www.riteaid.com/role/DisclosureSupplementaryCashFlowData 53 false false R54.htm 32403 - Disclosure - Financial Instruments (Tables) Sheet http://www.riteaid.com/role/DisclosureFinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.riteaid.com/role/DisclosureFinancialInstruments 54 false false R55.htm 32503 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Tables) Sheet http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsTables Revision of Previously Issued Consolidated Financial Statements (Tables) Tables http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatements 55 false false R56.htm 40101 - Disclosure - Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details) Details 56 false false R57.htm 40102 - Disclosure - Summary of Significant Accounting Policies - Sales (Details) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails Summary of Significant Accounting Policies - Sales (Details) Details http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 57 false false R58.htm 40103 - Disclosure - Summary of Significant Accounting Policies - FY thru Revenues (Details) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails Summary of Significant Accounting Policies - FY thru Revenues (Details) Details 58 false false R59.htm 40104 - Disclosure - Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details) Details 59 false false R60.htm 40105 - Disclosure - Summary of Significant Accounting Policies - Significant Concentrations (Details) Sheet http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails Summary of Significant Accounting Policies - Significant Concentrations (Details) Details 60 false false R61.htm 40201 - Disclosure - Acquisition (Details) Sheet http://www.riteaid.com/role/DisclosureAcquisitionDetails Acquisition (Details) Details http://www.riteaid.com/role/DisclosureAcquisitionTables 61 false false R62.htm 40202 - Disclosure - Acquisition - Purchase price allocation (Details) Sheet http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails Acquisition - Purchase price allocation (Details) Details 62 false false R63.htm 40203 - Disclosure - Acquisition - Intangible assets acquired (Details) Sheet http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails Acquisition - Intangible assets acquired (Details) Details 63 false false R64.htm 40204 - Disclosure - Acquisition - Acquisition costs (Details) Sheet http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails Acquisition - Acquisition costs (Details) Details 64 false false R65.htm 40205 - Disclosure - Acquisition - Proforma information (Details) Sheet http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails Acquisition - Proforma information (Details) Details 65 false false R66.htm 40301 - Disclosure - Restructuring (Details) Sheet http://www.riteaid.com/role/DisclosureRestructuringDetails Restructuring (Details) Details http://www.riteaid.com/role/DisclosureRestructuringTables 66 false false R67.htm 40401 - Disclosure - Asset Sale to WBA (Details) Sheet http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails Asset Sale to WBA (Details) Details http://www.riteaid.com/role/DisclosureAssetSaleToWbaTables 67 false false R68.htm 40402 - Disclosure - Asset Sale to WBA - Operating results of discontinued operations (Details) Sheet http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails Asset Sale to WBA - Operating results of discontinued operations (Details) Details 68 false false R69.htm 40501 - Disclosure - Loss Per Share (Details) Sheet http://www.riteaid.com/role/DisclosureLossPerShareDetails Loss Per Share (Details) Details http://www.riteaid.com/role/DisclosureLossPerShareTables 69 false false R70.htm 40601 - Disclosure - Facility Exit and Impairment Charges (Details) Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails Facility Exit and Impairment Charges (Details) Details http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables 70 false false R71.htm 40602 - Disclosure - Facility Exit and Impairment Charges - Fair value (Details) Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails Facility Exit and Impairment Charges - Fair value (Details) Details 71 false false R72.htm 40603 - Disclosure - Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details) Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details) Details 72 false false R73.htm 40604 - Disclosure - Facility Exit and Impairment Charges - Results from closed stores (Details) Sheet http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails Facility Exit and Impairment Charges - Results from closed stores (Details) Details 73 false false R74.htm 40701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.riteaid.com/role/DisclosureFairValueMeasurements 74 false false R75.htm 40801 - Disclosure - Income Taxes (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.riteaid.com/role/DisclosureIncomeTaxesTables 75 false false R76.htm 40802 - Disclosure - Income Taxes - Rate reconciliation (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails Income Taxes - Rate reconciliation (Details) Details 76 false false R77.htm 40803 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 77 false false R78.htm 40804 - Disclosure - Income Taxes - Unrecognized Benefit (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails Income Taxes - Unrecognized Benefit (Details) Details 78 false false R79.htm 40805 - Disclosure - Income Taxes - Tax Contingencies (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesTaxContingenciesDetails Income Taxes - Tax Contingencies (Details) Details 79 false false R80.htm 40806 - Disclosure - Income Taxes - Net Operating Losses and Tax Credits (Details) Sheet http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails Income Taxes - Net Operating Losses and Tax Credits (Details) Details 80 false false R81.htm 40901 - Disclosure - Accounts Receivable (Details) Sheet http://www.riteaid.com/role/DisclosureAccountsReceivableDetails Accounts Receivable (Details) Details http://www.riteaid.com/role/DisclosureAccountsReceivable 81 false false R82.htm 41001 - Disclosure - Medicare Part D (Details) Sheet http://www.riteaid.com/role/DisclosureMedicarePartDDetails Medicare Part D (Details) Details http://www.riteaid.com/role/DisclosureMedicarePartD 82 false false R83.htm 41101 - Disclosure - Manufacturer Rebates Receivables (Details) Sheet http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails Manufacturer Rebates Receivables (Details) Details http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivables 83 false false R84.htm 41201 - Disclosure - Inventory (Details) Sheet http://www.riteaid.com/role/DisclosureInventoryDetails Inventory (Details) Details http://www.riteaid.com/role/DisclosureInventory 84 false false R85.htm 41301 - Disclosure - Property, Plant and Equipment (Details) Sheet http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails Property, Plant and Equipment (Details) Details http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentTables 85 false false R86.htm 41401 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details) Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails Goodwill and Other Intangible Assets - Narrative (Details) Details 86 false false R87.htm 41402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails Goodwill and Other Intangible Assets - Goodwill (Details) Details 87 false false R88.htm 41403 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details) Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails Goodwill and Other Intangible Assets - Intangibles (Details) Details 88 false false R89.htm 41404 - Disclosure - Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details) Sheet http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details) Details 89 false false R90.htm 41501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Details) Sheet http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails Accrued Salaries, Wages and Other Current Liabilities (Details) Details http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesTables 90 false false R91.htm 41601 - Disclosure - Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details) Sheet http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details) Details 91 false false R92.htm 41602 - Disclosure - Indebtedness and Credit Agreement - Credit Facility (Details) Sheet http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails Indebtedness and Credit Agreement - Credit Facility (Details) Details 92 false false R93.htm 41603 - Disclosure - Indebtedness and Credit Agreement - Transactions and Maturity (Details) Sheet http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails Indebtedness and Credit Agreement - Transactions and Maturity (Details) Details 93 false false R94.htm 41701 - Disclosure - Leases (Details) Sheet http://www.riteaid.com/role/DisclosureLeasesDetails Leases (Details) Details http://www.riteaid.com/role/DisclosureLeasesTables 94 false false R95.htm 41702 - Disclosure - Leases - Supplemental cash flow information related to leases (Details) Sheet http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails Leases - Supplemental cash flow information related to leases (Details) Details 95 false false R96.htm 41703 - Disclosure - Leases - Supplemental BS Information (Details) Sheet http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails Leases - Supplemental BS Information (Details) Details 96 false false R97.htm 41704 - Disclosure - Leases - Maturity of lease liabilities under finance and operating leases (Details) Sheet http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails Leases - Maturity of lease liabilities under finance and operating leases (Details) Details 97 false false R98.htm 41705 - Disclosure - Leases - Sale Leaseback (Details) Sheet http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails Leases - Sale Leaseback (Details) Details 98 false false R99.htm 41801 - Disclosure - Stock Option and Stock Awards Plans (Details) Sheet http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails Stock Option and Stock Awards Plans (Details) Details http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansTables 99 false false R100.htm 41802 - Disclosure - Stock Option and Stock Award Plans - Options (Details) Sheet http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails Stock Option and Stock Award Plans - Options (Details) Details 100 false false R101.htm 41803 - Disclosure - Stock Option and Stock Award Plans - Restricted Stock (Details) Sheet http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails Stock Option and Stock Award Plans - Restricted Stock (Details) Details 101 false false R102.htm 41901 - Disclosure - Retirement Plans (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansDetails Retirement Plans (Details) Details http://www.riteaid.com/role/DisclosureRetirementPlansTables 102 false false R103.htm 41902 - Disclosure - Retirement Plans - Net periodic cost (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails Retirement Plans - Net periodic cost (Details) Details 103 false false R104.htm 41903 - Disclosure - Retirement Plans - Benefit obligation and funded status (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails Retirement Plans - Benefit obligation and funded status (Details) Details 104 false false R105.htm 41904 - Disclosure - Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details) Details 105 false false R106.htm 41905 - Disclosure - Retirement Plans - Projected benefit obligation and fair value of plan assets (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails Retirement Plans - Projected benefit obligation and fair value of plan assets (Details) Details 106 false false R107.htm 41906 - Disclosure - Retirement Plans - Assumptions and assets (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails Retirement Plans - Assumptions and assets (Details) Details 107 false false R108.htm 41907 - Disclosure - Retirement Plans - Fair Value (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails Retirement Plans - Fair Value (Details) Details 108 false false R109.htm 41908 - Disclosure - Retirement Plans - Future Benefit Payments (Details) Sheet http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails Retirement Plans - Future Benefit Payments (Details) Details 109 false false R110.htm 42001 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Details) Sheet http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails Multiemployer Plans that Provide Pension Benefits (Details) Details http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsTables 110 false false R111.htm 42101 - Disclosure - Segment Reporting - Balance Sheet information (Details) Sheet http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails Segment Reporting - Balance Sheet information (Details) Details 111 false false R112.htm 42102 - Disclosure - Segment Reporting - Revenues (Details) Sheet http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails Segment Reporting - Revenues (Details) Details 112 false false R113.htm 42103 - Disclosure - Segment Reporting - Adjusted EBITDA (Details) Sheet http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails Segment Reporting - Adjusted EBITDA (Details) Details 113 false false R114.htm 42201 - Disclosure - Commitments, Contingencies and Guarantees (Details) Sheet http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails Commitments, Contingencies and Guarantees (Details) Details http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuarantees 114 false false R115.htm 42301 - Disclosure - Supplementary Cash Flow Data (Details) Sheet http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails Supplementary Cash Flow Data (Details) Details http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataTables 115 false false R116.htm 42401 - Disclosure - Financial Instruments (Details) Sheet http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails Financial Instruments (Details) Details http://www.riteaid.com/role/DisclosureFinancialInstrumentsTables 116 false false R117.htm 42501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Details) Sheet http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails Revision of Previously Issued Consolidated Financial Statements (Details) Details http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsTables 117 false false R118.htm 42601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) Details http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts 118 false false All Reports Book All Reports rad-20230304.xsd rad-20230304_cal.xml rad-20230304_def.xml rad-20230304_lab.xml rad-20230304_pre.xml rad-20230304x10ka.htm http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 136 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "rad-20230304x10ka.htm": { "nsprefix": "rad", "nsuri": "http://www.riteaid.com/20230304", "dts": { "schema": { "local": [ "rad-20230304.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "rad-20230304_cal.xml" ] }, "definitionLink": { "local": [ "rad-20230304_def.xml" ] }, "labelLink": { "local": [ "rad-20230304_lab.xml" ] }, "presentationLink": { "local": [ "rad-20230304_pre.xml" ] }, "inline": { "local": [ "rad-20230304x10ka.htm" ] } }, "keyStandard": 544, "keyCustom": 106, "axisStandard": 40, "axisCustom": 0, "memberStandard": 59, "memberCustom": 93, "hidden": { "total": 220, "http://fasb.org/us-gaap/2023": 197, "http://www.riteaid.com/20230304": 18, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 587, "entityCount": 1, "segmentCount": 157, "elementCount": 1061, "unitCount": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1980, "http://xbrl.sec.gov/dei/2023": 36, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets", "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:InventoryNet", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R3": { "role": "http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical", "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_xg3DvcBifkWBu-vmBsrCzA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_xg3DvcBifkWBu-vmBsrCzA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CostOfRevenue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R5": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss", "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R6": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLossParenthetical", "longName": "00305 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": null }, "R7": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "As_Of_2_29_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_aSEP9asZL0-PuN8pvvvj7Q", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_2_29_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_aSEP9asZL0-PuN8pvvvj7Q", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquityParenthetical", "longName": "00405 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GainLossOnSaleOfOtherAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R10": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "longName": "10101 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.riteaid.com/role/DisclosureAcquisition", "longName": "10201 - Disclosure - Acquisition", "shortName": "Acquisition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.riteaid.com/role/DisclosureRestructuring", "longName": "10301 - Disclosure - Restructuring", "shortName": "Restructuring", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.riteaid.com/role/DisclosureAssetSaleToWba", "longName": "10401 - Disclosure - Asset Sale to WBA", "shortName": "Asset Sale to WBA", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.riteaid.com/role/DisclosureLossPerShare", "longName": "10501 - Disclosure - Loss Per Share", "shortName": "Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentCharges", "longName": "10601 - Disclosure - Facility Exit and Impairment Charges", "shortName": "Facility Exit and Impairment Charges", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.riteaid.com/role/DisclosureFairValueMeasurements", "longName": "10701 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxes", "longName": "10801 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.riteaid.com/role/DisclosureAccountsReceivable", "longName": "10901 - Disclosure - Accounts Receivable", "shortName": "Accounts Receivable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.riteaid.com/role/DisclosureMedicarePartD", "longName": "11001 - Disclosure - Medicare Part D", "shortName": "Medicare Part D", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivables", "longName": "11101 - Disclosure - Manufacturer Rebates Receivables", "shortName": "Manufacturer Rebates Receivables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:ManufacturerRebatesReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:ManufacturerRebatesReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.riteaid.com/role/DisclosureInventory", "longName": "11201 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipment", "longName": "11301 - Disclosure - Property, Plant and Equipment", "shortName": "Property, Plant and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssets", "longName": "11401 - Disclosure - Goodwill and Other Intangible Assets", "shortName": "Goodwill and Other Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilities", "longName": "11501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities", "shortName": "Accrued Salaries, Wages and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreement", "longName": "11601 - Disclosure - Indebtedness and Credit Agreement", "shortName": "Indebtedness and Credit Agreement", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.riteaid.com/role/DisclosureLeases", "longName": "11701 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlans", "longName": "11801 - Disclosure - Stock Option and Stock Award Plans", "shortName": "Stock Option and Stock Award Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlans", "longName": "11901 - Disclosure - Retirement Plans", "shortName": "Retirement Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefits", "longName": "12001 - Disclosure - Multiemployer Plans that Provide Pension Benefits", "shortName": "Multiemployer Plans that Provide Pension Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:MultiemployerPensionPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:MultiemployerPensionPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.riteaid.com/role/DisclosureSegmentReporting", "longName": "12101 - Disclosure - Segment Reporting", "shortName": "Segment Reporting", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuarantees", "longName": "12201 - Disclosure - Commitments, Contingencies and Guarantees", "shortName": "Commitments, Contingencies and Guarantees", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowData", "longName": "12301 - Disclosure - Supplementary Cash Flow Data", "shortName": "Supplementary Cash Flow Data", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.riteaid.com/role/DisclosureFinancialInstruments", "longName": "12401 - Disclosure - Financial Instruments", "shortName": "Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatements", "longName": "12501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements", "shortName": "Revision of Previously Issued Consolidated Financial Statements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ErrorCorrectionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ErrorCorrectionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts", "longName": "12601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS", "shortName": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "20102 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "36", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ComparabilityOfPriorYearFinancialData", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ComparabilityOfPriorYearFinancialData", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "30103 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionTables", "longName": "30203 - Disclosure - Acquisition (Tables)", "shortName": "Acquisition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.riteaid.com/role/DisclosureRestructuringTables", "longName": "30303 - Disclosure - Restructuring (Tables)", "shortName": "Restructuring (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.riteaid.com/role/DisclosureAssetSaleToWbaTables", "longName": "30403 - Disclosure - Asset Sale to WBA (Tables)", "shortName": "Asset Sale to WBA (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.riteaid.com/role/DisclosureLossPerShareTables", "longName": "30503 - Disclosure - Loss Per Share (Tables)", "shortName": "Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables", "longName": "30603 - Disclosure - Facility Exit and Impairment Charges (Tables)", "shortName": "Facility Exit and Impairment Charges (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:ScheduleOfLeaseTerminationAndImpairmentChargesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:ScheduleOfLeaseTerminationAndImpairmentChargesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesTables", "longName": "30803 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentTables", "longName": "31303 - Disclosure - Property, Plant and Equipment (Tables)", "shortName": "Property, Plant and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables", "longName": "31403 - Disclosure - Goodwill and Other Intangible Assets (Tables)", "shortName": "Goodwill and Other Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesTables", "longName": "31503 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Tables)", "shortName": "Accrued Salaries, Wages and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTables", "longName": "31603 - Disclosure - Indebtedness and Credit Agreement (Tables)", "shortName": "Indebtedness and Credit Agreement (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.riteaid.com/role/DisclosureLeasesTables", "longName": "31703 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "rad:LeaseDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "rad:LeaseDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansTables", "longName": "31803 - Disclosure - Stock Option and Stock Award Plans (Tables)", "shortName": "Stock Option and Stock Award Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansTables", "longName": "31903 - Disclosure - Retirement Plans (Tables)", "shortName": "Retirement Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsTables", "longName": "32003 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Tables)", "shortName": "Multiemployer Plans that Provide Pension Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfMultiemployerPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfMultiemployerPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.riteaid.com/role/DisclosureSegmentReportingTables", "longName": "32103 - Disclosure - Segment Reporting (Tables)", "shortName": "Segment Reporting (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataTables", "longName": "32303 - Disclosure - Supplementary Cash Flow Data (Tables)", "shortName": "Supplementary Cash Flow Data (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.riteaid.com/role/DisclosureFinancialInstrumentsTables", "longName": "32403 - Disclosure - Financial Instruments (Tables)", "shortName": "Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsTables", "longName": "32503 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Tables)", "shortName": "Revision of Previously Issued Consolidated Financial Statements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails", "longName": "40101 - Disclosure - Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details)", "shortName": "Summary of Significant Accounting Policies - Description of Business, Asset Sale (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_segment_1B5Q7Y8eZEmIq9uJD7Mj7Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_18_2017_dei_LegalEntityAxis_rad_WalgreensBootsAllianceWbaMember_srt_OwnershipAxis_rad_WalgreensMember_CHKI_n2APESDzQEJbO49Dg", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ComparabilityOfPriorYearFinancialData", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R57": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "longName": "40102 - Disclosure - Summary of Significant Accounting Policies - Sales (Details)", "shortName": "Summary of Significant Accounting Policies - Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_StatementBusinessSegmentsAxis_rad_FrontEndSalesMember_9UR_crRGBkCKhJYlKHOcPQ", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R58": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "longName": "40103 - Disclosure - Summary of Significant Accounting Policies - FY thru Revenues (Details)", "shortName": "Summary of Significant Accounting Policies - FY thru Revenues (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FiscalPeriodDuration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:FiscalPeriod", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:FiscalPeriodDuration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:FiscalPeriod", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails", "longName": "40104 - Disclosure - Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details)", "shortName": "Summary of Significant Accounting Policies - Cost of Revenue thru Estimates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails", "longName": "40105 - Disclosure - Summary of Significant Accounting Policies - Significant Concentrations (Details)", "shortName": "Summary of Significant Accounting Policies - Significant Concentrations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_srt_MajorCustomersAxis_rad_TopFiveThirdPartyPayorsMember_srt_ProductOrServiceAxis_rad_PharmacySalesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerSegmentBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_VYBGorCxzk25RoeQUJl5cQ", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "us-gaap:MajorCustomersPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_srt_MajorCustomersAxis_rad_TopFiveThirdPartyPayorsMember_srt_ProductOrServiceAxis_rad_PharmacySalesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerSegmentBenchmarkMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_VYBGorCxzk25RoeQUJl5cQ", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "us-gaap:MajorCustomersPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "longName": "40201 - Disclosure - Acquisition (Details)", "shortName": "Acquisition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "Duration_12_18_2020_To_12_18_2020_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_k0AUbDPC8kSJzYmiZF8HCg", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_18_2020_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_0RJ-wPQPOkujyHlKsbbGJg", "name": "rad:NumberOfStoresAcquired", "unitRef": "Unit_Standard_store_99FQaMr2vUO7nM_TLPMTBg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R62": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails", "longName": "40202 - Disclosure - Acquisition - Purchase price allocation (Details)", "shortName": "Acquisition - Purchase price allocation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "Duration_12_18_2020_To_12_18_2020_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_k0AUbDPC8kSJzYmiZF8HCg", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_18_2020_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_0RJ-wPQPOkujyHlKsbbGJg", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R63": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "longName": "40203 - Disclosure - Acquisition - Intangible assets acquired (Details)", "shortName": "Acquisition - Intangible assets acquired (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_rad_PrescriptionFilesMember_eevz95X-dEWxsY16CtYaYw", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_18_2020_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_UqYLPSsyq0ipVeQonS1ZLw", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R64": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "longName": "40204 - Disclosure - Acquisition - Acquisition costs (Details)", "shortName": "Acquisition - Acquisition costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "Duration_2_28_2021_To_2_26_2022_zF43n4pvBEmdcsuo0rBD4w", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_28_2021_To_2_26_2022_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_tyEMY7Q2W0m7JWGDSA4Smw", "name": "rad:LossOnBartellAcquisition", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R65": { "role": "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "longName": "40205 - Disclosure - Acquisition - Proforma information (Details)", "shortName": "Acquisition - Proforma information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_BusinessAcquisitionAxis_rad_BartellDrugCompanyMember_u-YXyXjKl0mRGHAVk-zJig", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R66": { "role": "http://www.riteaid.com/role/DisclosureRestructuringDetails", "longName": "40301 - Disclosure - Restructuring (Details)", "shortName": "Restructuring (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:RestructuringCharges", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_3_1_2020_To_2_27_2021_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_ZMt7UdBV8UOIaSqp7ClTLA", "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R67": { "role": "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "longName": "40401 - Disclosure - Asset Sale to WBA (Details)", "shortName": "Asset Sale to WBA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:NumberOfStores", "unitRef": "Unit_Standard_store_99FQaMr2vUO7nM_TLPMTBg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_28_2021_To_5_29_2021_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_rad_SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember_O3cl6ydlYkCpa6tVAFDuNw", "name": "us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R68": { "role": "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "longName": "40402 - Disclosure - Asset Sale to WBA - Operating results of discontinued operations (Details)", "shortName": "Asset Sale to WBA - Operating results of discontinued operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "Duration_3_1_2020_To_2_27_2021_2GnRQ_fIZkCxogTsQ-_bhw", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_3_1_2020_To_2_27_2021_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_rad_SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember_gs_qYVZ82Em1HR0OGYecmg", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R69": { "role": "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "longName": "40501 - Disclosure - Loss Per Share (Details)", "shortName": "Loss Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Unit_Standard_shares_ZPvR-ciP-02dkOeaxl9m6w", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R70": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "longName": "40601 - Disclosure - Facility Exit and Impairment Charges (Details)", "shortName": "Facility Exit and Impairment Charges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:LeaseTerminationAndLongLivedAssetImpairmentCharges", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:PeriodConsideredForRecordingImpairmentChargesOnOperatingLossBasis", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "rad:ScheduleOfLeaseTerminationAndImpairmentChargesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R71": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "longName": "40602 - Disclosure - Facility Exit and Impairment Charges - Fair value (Details)", "shortName": "Facility Exit and Impairment Charges - Fair value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "rad:AssetsHeldForUseLongLivedFairValueDisclosure", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_27_2022_To_3_4_2023_EQ5B8LkIx0GeU_0GOvTbrQ", "name": "us-gaap:TangibleAssetImpairmentCharges", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R72": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "longName": "40603 - Disclosure - Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details)", "shortName": "Facility Exit and Impairment Charges - accrued facility exit charges roll forward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GainLossOnContractTermination", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GainLossOnContractTermination", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "longName": "40604 - Disclosure - Facility Exit and Impairment Charges - Results from closed stores (Details)", "shortName": "Facility Exit and Impairment Charges - Results from closed stores (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_rad_RetailSitesInClosedOrApprovedForClosureStatusMember_sj_49CHHakWoiAnZKhlvBg", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "rad:ScheduleOfRevenueAndIncomeLossBeforeIncomeTaxesOfClosedStoresOrStoresApprovedForClosureTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R74": { "role": "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails", "longName": "40701 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "longName": "40801 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails", "longName": "40802 - Disclosure - Income Taxes - Rate reconciliation (Details)", "shortName": "Income Taxes - Rate reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails", "longName": "40803 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)", "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails", "longName": "40804 - Disclosure - Income Taxes - Unrecognized Benefit (Details)", "shortName": "Income Taxes - Unrecognized Benefit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_2_26_2022_ifBHvbiUn0SNbjdQ8c-KaA", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_2_29_2020_JrTzyIbH60OIlQGBOf4Iwg", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R79": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesTaxContingenciesDetails", "longName": "40805 - Disclosure - Income Taxes - Tax Contingencies (Details)", "shortName": "Income Taxes - Tax Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails", "longName": "40806 - Disclosure - Income Taxes - Net Operating Losses and Tax Credits (Details)", "shortName": "Income Taxes - Net Operating Losses and Tax Credits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_InternalRevenueServiceIRSMember_NAVp03C8IUO6EOcBHKEBYw", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R81": { "role": "http://www.riteaid.com/role/DisclosureAccountsReceivableDetails", "longName": "40901 - Disclosure - Accounts Receivable (Details)", "shortName": "Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": null }, "R82": { "role": "http://www.riteaid.com/role/DisclosureMedicarePartDDetails", "longName": "41001 - Disclosure - Medicare Part D (Details)", "shortName": "Medicare Part D (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_30_2021_To_8_28_2021_z3rMyPE2bECOlbfesC08SQ", "name": "us-gaap:GainLossOnSaleOfAccountsReceivable", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R83": { "role": "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "longName": "41101 - Disclosure - Manufacturer Rebates Receivables (Details)", "shortName": "Manufacturer Rebates Receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "As_Of_2_26_2022_ifBHvbiUn0SNbjdQ8c-KaA", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_2_26_2022_us-gaap_StatementBusinessSegmentsAxis_rad_PharmacyServicesMember_IqOGDNZ-mUqETIlsnXClQg", "name": "rad:RebateReceivables", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "rad:ManufacturerRebatesReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R84": { "role": "http://www.riteaid.com/role/DisclosureInventoryDetails", "longName": "41201 - Disclosure - Inventory (Details)", "shortName": "Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R85": { "role": "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "longName": "41301 - Disclosure - Property, Plant and Equipment (Details)", "shortName": "Property, Plant and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "longName": "41401 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)", "shortName": "Goodwill and Other Intangible Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_2_26_2022_us-gaap_StatementBusinessSegmentsAxis_rad_PharmacyServicesMember_IqOGDNZ-mUqETIlsnXClQg", "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R87": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "longName": "41402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)", "shortName": "Goodwill and Other Intangible Assets - Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "As_Of_2_26_2022_ifBHvbiUn0SNbjdQ8c-KaA", "name": "us-gaap:Goodwill", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": null }, "R88": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "longName": "41403 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details)", "shortName": "Goodwill and Other Intangible Assets - Intangibles (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails", "longName": "41404 - Disclosure - Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details)", "shortName": "Goodwill and Other Intangible Assets - Unfavorable lease intangibles and amortization expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails", "longName": "41501 - Disclosure - Accrued Salaries, Wages and Other Current Liabilities (Details)", "shortName": "Accrued Salaries, Wages and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R91": { "role": "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "longName": "41601 - Disclosure - Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details)", "shortName": "Indebtedness and Credit Agreement - Indebtedness and lease financing obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "As_Of_7_10_2020_979NcHYxDEmfmCTU3eaQRg", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DebtAndCapitalLeaseObligations", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R92": { "role": "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "longName": "41602 - Disclosure - Indebtedness and Credit Agreement - Credit Facility (Details)", "shortName": "Indebtedness and Credit Agreement - Credit Facility (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "As_Of_7_10_2020_979NcHYxDEmfmCTU3eaQRg", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_20_2018_us-gaap_LongtermDebtTypeAxis_rad_SeniorSecuredRevolvingCreditFacilityDueDecember2023Member_hWfrfDwSjEGrC7PvY-u__w", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R93": { "role": "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails", "longName": "41603 - Disclosure - Indebtedness and Credit Agreement - Transactions and Maturity (Details)", "shortName": "Indebtedness and Credit Agreement - Transactions and Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "As_Of_7_10_2020_979NcHYxDEmfmCTU3eaQRg", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R94": { "role": "http://www.riteaid.com/role/DisclosureLeasesDetails", "longName": "41701 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "rad:LeaseDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "rad:LeaseDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R95": { "role": "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails", "longName": "41702 - Disclosure - Leases - Supplemental cash flow information related to leases (Details)", "shortName": "Leases - Supplemental cash flow information related to leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OperatingLeasePayments", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "rad:DisclosureOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:OperatingLeasePayments", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "rad:DisclosureOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R96": { "role": "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "longName": "41703 - Disclosure - Leases - Supplemental BS Information (Details)", "shortName": "Leases - Supplemental BS Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:FinanceLeaseLiabilityCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "rad:DisclosureOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R97": { "role": "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails", "longName": "41704 - Disclosure - Leases - Maturity of lease liabilities under finance and operating leases (Details)", "shortName": "Leases - Maturity of lease liabilities under finance and operating leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R98": { "role": "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "longName": "41705 - Disclosure - Leases - Sale Leaseback (Details)", "shortName": "Leases - Sale Leaseback (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:SaleAndLeasebackNumberOfFacilities", "unitRef": "Unit_Standard_item_8ShlGwZAREWQG3-24dQucA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:SaleAndLeasebackNumberOfFacilities", "unitRef": "Unit_Standard_item_8ShlGwZAREWQG3-24dQucA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails", "longName": "41801 - Disclosure - Stock Option and Stock Awards Plans (Details)", "shortName": "Stock Option and Stock Awards Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "unitRef": "Unit_Standard_shares_ZPvR-ciP-02dkOeaxl9m6w", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R100": { "role": "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "longName": "41802 - Disclosure - Stock Option and Stock Award Plans - Options (Details)", "shortName": "Stock Option and Stock Award Plans - Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "Unit_Divide_USD_shares_xg3DvcBifkWBu-vmBsrCzA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "Unit_Divide_USD_shares_xg3DvcBifkWBu-vmBsrCzA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R101": { "role": "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "longName": "41803 - Disclosure - Stock Option and Stock Award Plans - Restricted Stock (Details)", "shortName": "Stock Option and Stock Award Plans - Restricted Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_8edkFhI8y0uf8yKSWbtxVQ", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R102": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "longName": "41901 - Disclosure - Retirement Plans (Details)", "shortName": "Retirement Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_jVkeM6Vn90iUYL8XiblgBQ", "name": "rad:DefinedContributionPlanEmployerMatchLevelOne", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_jVkeM6Vn90iUYL8XiblgBQ", "name": "rad:DefinedContributionPlanEmployerMatchLevelOne", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R103": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "longName": "41902 - Disclosure - Retirement Plans - Net periodic cost (Details)", "shortName": "Retirement Plans - Net periodic cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_jVkeM6Vn90iUYL8XiblgBQ", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_jVkeM6Vn90iUYL8XiblgBQ", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R104": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "longName": "41903 - Disclosure - Retirement Plans - Benefit obligation and funded status (Details)", "shortName": "Retirement Plans - Benefit obligation and funded status (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R105": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "longName": "41904 - Disclosure - Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details)", "shortName": "Retirement Plans - Accumulated benefit obligation and fair value of plan assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R106": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails", "longName": "41905 - Disclosure - Retirement Plans - Projected benefit obligation and fair value of plan assets (Details)", "shortName": "Retirement Plans - Projected benefit obligation and fair value of plan assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R107": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "longName": "41906 - Disclosure - Retirement Plans - Assumptions and assets (Details)", "shortName": "Retirement Plans - Assumptions and assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitObligationExpectedLongTermReturnOnAssets", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "rad:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitObligationExpectedLongTermReturnOnAssets", "unitRef": "Unit_Standard_pure_yc4K4T4Y50SI97FedVhoJg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R108": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails", "longName": "41907 - Disclosure - Retirement Plans - Fair Value (Details)", "shortName": "Retirement Plans - Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_i4QdGm_yYk2oudCgq9X6jQ", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_i4QdGm_yYk2oudCgq9X6jQ", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R109": { "role": "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "longName": "41908 - Disclosure - Retirement Plans - Future Benefit Payments (Details)", "shortName": "Retirement Plans - Future Benefit Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_XAdlcwXtQUKTCU3TRKEgvQ", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R110": { "role": "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails", "longName": "42001 - Disclosure - Multiemployer Plans that Provide Pension Benefits (Details)", "shortName": "Multiemployer Plans that Provide Pension Benefits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:MultiemployerPlanEmployerContributionCost", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMultiemployerPlansTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:MultiemployerPlanEmployerContributionCost", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMultiemployerPlansTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R111": { "role": "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "longName": "42101 - Disclosure - Segment Reporting - Balance Sheet information (Details)", "shortName": "Segment Reporting - Balance Sheet information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_segment_1B5Q7Y8eZEmIq9uJD7Mj7Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_rad_RetailPharmacyMember_LfW3NvFqOU2uHNHaHQZBUQ", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R112": { "role": "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "longName": "42102 - Disclosure - Segment Reporting - Revenues (Details)", "shortName": "Segment Reporting - Revenues (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:GrossProfit", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R113": { "role": "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "longName": "42103 - Disclosure - Segment Reporting - Adjusted EBITDA (Details)", "shortName": "Segment Reporting - Adjusted EBITDA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:InventoryWriteDown", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R114": { "role": "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails", "longName": "42201 - Disclosure - Commitments, Contingencies and Guarantees (Details)", "shortName": "Commitments, Contingencies and Guarantees (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "Duration_8_1_2022_To_8_31_2022_srt_LitigationCaseAxis_rad_CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember_3G_PlZ2_1Ui4KV4GiNtwLQ", "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_8_1_2022_To_8_31_2022_srt_LitigationCaseAxis_rad_CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember_3G_PlZ2_1Ui4KV4GiNtwLQ", "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R115": { "role": "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails", "longName": "42301 - Disclosure - Supplementary Cash Flow Data (Details)", "shortName": "Supplementary Cash Flow Data (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:InterestPaidNet", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_27_2022_To_3_4_2023_d8Sr6jYAhEqEVVdRwxFQbA", "name": "us-gaap:InterestPaidNet", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R116": { "role": "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails", "longName": "42401 - Disclosure - Financial Instruments (Details)", "shortName": "Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true, "unique": true } }, "R117": { "role": "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "longName": "42501 - Disclosure - Revision of Previously Issued Consolidated Financial Statements (Details)", "shortName": "Revision of Previously Issued Consolidated Financial Statements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "As_Of_3_4_2023_K3igykNQRkyGDn2Ph1liHg", "name": "rad:EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_2_27_2021_37ydn3YDMki-wdNZBJfEaQ", "name": "us-gaap:LiabilitiesCurrent", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } }, "R118": { "role": "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails", "longName": "42601 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details)", "shortName": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "As_Of_2_26_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_M_j-7iUCCUed12j4uuCAJw", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_2_29_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_2kUXtg7aoEu_q733ksyX9w", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "Unit_Standard_USD_VGjzSQJmSUqPnnChK-nsHA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "rad-20230304x10ka.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Manufacturer Rebates Receivables", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Receivable Type [Axis]", "documentation": "Information by type of receivable." } } }, "auth_ref": [ "r59" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48", "r997" ] }, "us-gaap_AccountsReceivableFromSecuritization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableFromSecuritization", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable from Securitization", "terseLabel": "Remaining receivable for receivables sold to third party", "documentation": "The amount owed to the reporting entity by counterparties in securitized loan transactions." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, net", "verboseLabel": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r436", "r437" ] }, "us-gaap_AccountsReceivableSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableSale", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Sale", "terseLabel": "Amount of receivables sold under Receivable Purchase Agreement", "documentation": "Amount of decrease from sale of accounts receivable." } } }, "auth_ref": [ "r449" ] }, "rad_AccountsReceivableSoldSalePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AccountsReceivableSoldSalePrice", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount to be received for accounts receivable sold to a third party.", "label": "Accounts Receivable Sold, Sale Price", "terseLabel": "Sale price for receivables sold" } } }, "auth_ref": [] }, "us-gaap_AccruedInsuranceCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedInsuranceCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Insurance, Current", "terseLabel": "Accrued self insurance", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r52" ] }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrentAbstract", "lang": { "en-us": { "role": { "label": "Accrued Salaries, Wages and Other Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued litigation, legal and professional fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r52" ] }, "rad_AccruedSalariesWagesAndOtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AccruedSalariesWagesAndOtherCurrentLiabilitiesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "documentation": "Selling, general and administrative expenses. Rollforward of the restructuring liability.", "label": "Accrued salaries, wages and other current liabilities" } } }, "auth_ref": [] }, "rad_AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AccruedSalariesWagesAndOtherCurrentLiabilitiesTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "documentation": "Description and amounts for obligations incurred through the end of the reporting period that relate to salaries, benefits, sales and personal property taxes, occupancy and other stores expenses.", "label": "Accrued Salaries, Wages and Other Current Liabilities [Text Block]", "terseLabel": "Accrued Salaries, Wages and Other Current Liabilities" } } }, "auth_ref": [] }, "rad_AccruedStoreExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AccruedStoreExpenseCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for expense related to store.", "label": "Accrued Store Expense Current", "terseLabel": "Accrued store expense" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r60", "r61", "r205", "r326", "r827", "r860", "r864" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Loss", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r6", "r30", "r61", "r747", "r750", "r801", "r855", "r856", "r1044", "r1045", "r1046", "r1059", "r1060", "r1061" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Estimated useful life, acquired intangible assets", "verboseLabel": "Estimated Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r229" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r200", "r997", "r1228" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-In Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r691", "r692", "r693", "r873", "r1059", "r1060", "r1061", "r1203", "r1230" ] }, "rad_AdditionsToRestructuringExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AdditionsToRestructuringExpense", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "documentation": "Additions charged to restructuring expense.", "label": "Additions To Restructuring Expense", "terseLabel": "Additions charged to expense" } } }, "auth_ref": [] }, "rad_AdjustedEarningsBeforeInterestIncomeTaxesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AdjustedEarningsBeforeInterestIncomeTaxesDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents adjusted earnings before interest expense, income taxes, depreciation and amortization, LIFO adjustments, facility closing and impairment, inventory write-downs related to store closings, debt retirements and other items.", "label": "Adjusted Earnings Before Interest Income Taxes Depreciation and Amortization", "verboseLabel": "Adjusted EBITDA" } } }, "auth_ref": [] }, "rad_AdjustmentOfChangesInEstimatesToProfitAndLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AdjustmentOfChangesInEstimatesToProfitAndLoss", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of adjustment of changes to estimates.", "label": "Adjustment of Changes in Estimates to Profit and Loss", "verboseLabel": "Change in estimate related to manufacturer rebate receivables" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Exchange of restricted shares for taxes", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition", "terseLabel": "Amortization of restricted stock balance", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Other Long-term Incentive Plans, Requisite Service Period Recognition", "terseLabel": "Amortization of performance-based incentive plans", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r126", "r127", "r654" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile to net cash (used in) provided by operating activities of continuing operations:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Cost, Policy, Expensed Advertising Cost [Policy Text Block]", "terseLabel": "Advertising", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r278" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising Expense", "terseLabel": "Advertising expenses, net of vendor advertising allowances", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r699" ] }, "rad_AgtHighYieldBondMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AgtHighYieldBondMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to AGT High Yield Bond.", "label": "AGT High Yield Bond" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Allocated Share-based Compensation Expense", "terseLabel": "Stock-based compensation costs (benefit)", "verboseLabel": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r686", "r698" ] }, "us-gaap_AllowanceForCreditLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForCreditLossMember", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Allowances deducted from accounts receivable for estimated uncollectible amounts:", "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r1054", "r1055", "r1056", "r1057", "r1058" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAccountsReceivableDetails", "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for Doubtful Accounts Receivable", "terseLabel": "Allowance for uncollectible accounts", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r327", "r438", "r448", "r450", "r451", "r1222" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Increase in allowances for accounts receivable", "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r1073" ] }, "rad_AmendedAndRestated2020OmnibusEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AmendedAndRestated2020OmnibusEquityPlanMember", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2020 Omnibus Equity Plan.", "label": "Amended And Restated 2020 Omnibus Equity Plan" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Financing Costs", "terseLabel": "Amortization expenses of deferred financing costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r211", "r540", "r774", "r1050" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense for intangible assets and liabilities", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r17", "r98", "r103" ] }, "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax", "terseLabel": "Net amount recognized in pension expense and other comprehensive loss", "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss." } } }, "auth_ref": [ "r983" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from the computation of diluted income (loss) per share", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r397" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r78" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Income Per Share", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r78" ] }, "rad_AonCoreRealEstateFunMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AonCoreRealEstateFunMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Aon Core Real Estate Fun.", "label": "Aon Core Real Estate Fund" } } }, "auth_ref": [] }, "rad_AonGlobalRealEstateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AonGlobalRealEstateMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Aon Global Real Estate.", "label": "Aon Global Real Estate" } } }, "auth_ref": [] }, "rad_AonHighYieldPlusBondMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AonHighYieldPlusBondMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Aon High Yield Plus Bond.", "label": "Aon High Yield Plus Bond" } } }, "auth_ref": [] }, "rad_AonMultiAssetCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AonMultiAssetCreditMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Aon Multi-Asset Credit.", "label": "Aon Multi-Asset Credit" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r262", "r324", "r354", "r406", "r421", "r427", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r741", "r743", "r766", "r823", "r897", "r997", "r1009", "r1099", "r1100", "r1212" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r317", "r331", "r354", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r741", "r743", "r766", "r997", "r1099", "r1100", "r1212" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "totalLabel": "Total", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r155" ] }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Assets Held-for-sale, Long Lived, Fair Value Disclosure", "terseLabel": "Fair value of Long-lived assets held for sale", "documentation": "Fair value portion of assets classified as held for sale." } } }, "auth_ref": [ "r995" ] }, "rad_AssetsHeldForUseLongLivedFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "AssetsHeldForUseLongLivedFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Long-lived assets that are held for use in normal operations and not anticipated to be sold in less than one year.", "label": "Assets Held for Use, Long Lived Fair Value Disclosure", "verboseLabel": "Fair value of Long-lived assets held for use" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1013", "r1014", "r1015" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r1013", "r1014", "r1015" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r1013", "r1014", "r1015" ] }, "rad_August2021ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "August2021ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the August 2021 Receivable Purchase Agreement.", "label": "August 2021 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r657", "r658", "r659", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685" ] }, "rad_BartellDrugCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BartellDrugCompanyMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the Bartell Drug Company.", "label": "Bartell Drug Company" } } }, "auth_ref": [] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Citibank's base rate", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "rad_BlueCrossBlueShieldLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BlueCrossBlueShieldLitigationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Blue Cross/Blue Shield litigation.", "label": "Blue Cross Blue Shield Litigation" } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Buildings", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r235" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r737", "r985", "r988" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r133", "r136", "r737", "r985", "r988" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r737" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Percentage of Voting Interests Acquired", "verboseLabel": "Percentage of ownership in subsidiary", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r134" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionTables" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of unaudited pro forma combined financial data", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r1026", "r1027" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Net Income (Loss)", "verboseLabel": "Supplemental Pro forma net loss", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r735", "r736" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Supplemental Pro forma revenues", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r735", "r736" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Merger and Acquisition-related costs", "verboseLabel": "Acquisition costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r132" ] }, "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationBargainPurchaseGainRecognizedAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Bargain Purchase, Gain Recognized, Amount", "negatedTerseLabel": "Bargain purchase gain", "verboseLabel": "Bargain purchase gain", "documentation": "In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity." } } }, "auth_ref": [ "r143", "r144", "r145", "r146", "r147", "r148" ] }, "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationBargainPurchaseGainRecognizedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Bargain Purchase, Gain, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain from bargain purchase in business combination." } } }, "auth_ref": [ "r740" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "verboseLabel": "Total purchase price", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r2", "r3", "r25" ] }, "us-gaap_BusinessCombinationConsiderationTransferredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred [Abstract]", "verboseLabel": "Final purchase price" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisition" ], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisition", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r256", "r738" ] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Revenues", "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r135" ] }, "rad_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedSalariesWagesAndOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedSalariesWagesAndOtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of accrued salaries, wages and other current liabilities, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued salaries, Wages and Other Current Liabilities", "terseLabel": "Accrued salaries, wages and other current liabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "totalLabel": "Total current assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable", "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "totalLabel": "Total current liabilities", "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities recorded on purchase", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets", "verboseLabel": "Intangible assets acquired", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r137", "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Other long-term liabilities", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "rad_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating lease liability due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability, Current", "terseLabel": "Current portion of operating lease liabilities" } } }, "auth_ref": [] }, "rad_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of non-current operating lease liability assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability, Noncurrent", "terseLabel": "Long-term operating lease liabilities" } } }, "auth_ref": [] }, "rad_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of operating lease right-of-use assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use assets", "terseLabel": "Operating lease right-of-use assets" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r137", "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r138" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]", "verboseLabel": "Final purchase price allocation" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Acquisition" } } }, "auth_ref": [] }, "rad_CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to California Employment Litigation, claims related to reimbursement for cell phone and mileage expenses.", "label": "California Employment Litigation Claims Related To Reimbursement For Cell phone and Mileage Expenses [Member]", "terseLabel": "California Employment Litigation Claims Related To Reimbursement For Cell phone and Mileage Expenses" } } }, "auth_ref": [] }, "rad_CaliforniaEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CaliforniaEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to California Employment Litigation, claims related to wages and hour class action.", "label": "California Employment Litigation Claims Related To Wages And Hour Class Action [Member]", "terseLabel": "California Employment Litigation Claims Related To Wages And Hour Class Action" } } }, "auth_ref": [] }, "rad_CaliforniaEmploymentLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CaliforniaEmploymentLitigationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to California Employment Litigation.", "label": "California Employment Litigation" } } }, "auth_ref": [] }, "rad_CapitalAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CapitalAssetImpairment", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of capital asset impairment during the period.", "label": "Capital Asset Impairment", "terseLabel": "Capital asset impairment" } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Accrued capital expenditures", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r72", "r73", "r74" ] }, "us-gaap_CapitalLeaseObligationsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalLeaseObligationsIncurred", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Capital Lease Obligations Incurred", "terseLabel": "Equipment financed under capital leases", "documentation": "Amount of increase in lease obligation from new lease." } } }, "auth_ref": [ "r72", "r73" ] }, "rad_CaremarkMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CaremarkMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Caremark.", "label": "Caremark" } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Amount", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r156", "r157" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "negatedTerseLabel": "Less: Cash and cash equivalents", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r69", "r320", "r956" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r70" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r69", "r219", "r352" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r219" ] }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowSupplementalDisclosuresTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowData" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Supplementary Cash Flow Data", "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r217" ] }, "rad_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Cash Paid for Amounts Included in the Measurement of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "auth_ref": [] }, "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations", "terseLabel": "Financing activities of discontinued operations", "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r219" ] }, "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations", "terseLabel": "Investing activities of discontinued operations", "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r189", "r219" ] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Operating activities of discontinued operations", "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r189", "r219" ] }, "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Net Funded Status and Amounts Recognized [Table Text Block]", "terseLabel": "Schedule of reconciliation for both benefit obligation and plan assets of defined benefit plans, as well as funded status and amounts recognized in balance sheet", "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans." } } }, "auth_ref": [ "r41" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r57", "r164", "r825", "r884" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments, Contingencies and Guarantees" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuarantees" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments, Contingencies and Guarantees", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r240", "r493", "r494", "r937", "r1092" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1000", "r1001", "r1002", "r1004", "r1005", "r1006", "r1007", "r1059", "r1060", "r1203", "r1227", "r1230" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r199" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r199", "r885" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r199" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r31", "r199", "r885", "r903", "r1230", "r1231" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $1 per share; 75,000 shares authorized; shares issued and outstanding 56,629 and 55,752", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r199", "r826", "r997" ] }, "us-gaap_ComparabilityOfPriorYearFinancialData": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComparabilityOfPriorYearFinancialData", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]", "terseLabel": "Comparability", "documentation": "Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets and Liabilities [Abstract]", "terseLabel": "Significant components of deferred tax assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Provision for income tax expense (benefit)" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss", "verboseLabel": "Comprehensive loss", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r62", "r336", "r338", "r345", "r819", "r834" ] }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerSoftwareIntangibleAssetMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Claims adjudication and other developed software", "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks." } } }, "auth_ref": [ "r952", "r1085", "r1086" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r80", "r83", "r158", "r159", "r435", "r936" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r80", "r83", "r158", "r159", "r435", "r865", "r936" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r80", "r83", "r158", "r159", "r435", "r936", "r1025" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "terseLabel": "Significant Concentrations", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r936" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of concentration risk", "verboseLabel": "Percentage of sales", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r80", "r83", "r158", "r159", "r435" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r79", "r80", "r83", "r84", "r158", "r261", "r936" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r80", "r83", "r158", "r159", "r435", "r936" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r292", "r359", "r741", "r742", "r743", "r744", "r803", "r947", "r1037", "r1040", "r1041", "r1098", "r1101", "r1102" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r292", "r359", "r741", "r742", "r743", "r744", "r803", "r947", "r1037", "r1040", "r1041", "r1098", "r1101", "r1102" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r359", "r408", "r419", "r420", "r421", "r422", "r423", "r425", "r429", "r505", "r506", "r507", "r508", "r510", "r511", "r513", "r515", "r516", "r1038", "r1039", "r1099", "r1100" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r359", "r408", "r419", "r420", "r421", "r422", "r423", "r425", "r429", "r505", "r506", "r507", "r508", "r510", "r511", "r513", "r515", "r516", "r1038", "r1039", "r1099", "r1100" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r150", "r961" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Construction in progress", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "rad_ContraCostOfGoodsSoldDisposalGroupIncludingDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ContraCostOfGoodsSoldDisposalGroupIncludingDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Net credit attributable to cost of goods sold for disposal group during the period.", "label": "Contra Cost Of Goods Sold, Disposal Group Including Discontinued Operations", "negatedLabel": "Net credit to cost of revenues" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Asset and Liability [Abstract]", "terseLabel": "Revenue Recognition" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue", "verboseLabel": "Accrued contract liabilities", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r549", "r550", "r561" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Sales Revenue, Services, Net", "terseLabel": "Net revenues", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r562" ] }, "us-gaap_CostOfGoodsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsTotalMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Purchases", "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r1024" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Cost of revenues", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r214", "r354", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r766", "r1099" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Cost of revenues", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Sales, Policy [Policy Text Block]", "terseLabel": "Cost of Revenues", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r1036" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total costs and expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r212" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r311", "r356", "r357", "r522", "r547", "r802", "r958", "r960" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "rad_CreditFacilityCashSweepProvisionMinimumDepositsAndCapacityAnyOneDay": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CreditFacilityCashSweepProvisionMinimumDepositsAndCapacityAnyOneDay", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum amount of deposits and capacity on any one day to avoid the cash sweep provision under the credit agreement.", "label": "Credit Facility Cash Sweep Provision Minimum Deposits And Capacity Any One Day", "terseLabel": "Cash sweep, 1-day minimum threshold" } } }, "auth_ref": [] }, "rad_CreditFacilityCashSweepProvisionMinimumDepositsAndCapacityOverThreeDayPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "CreditFacilityCashSweepProvisionMinimumDepositsAndCapacityOverThreeDayPeriod", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum amount of deposits and capacity for three consecutive business days to avoid the cash sweep provision under the credit agreement.", "label": "Credit Facility Cash Sweep Provision Minimum Deposits And Capacity Over Three Day Period", "terseLabel": "Cash sweep, 3-day minimum threshold" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1034", "r1053", "r1198" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current tax expense (benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r255", "r723", "r729", "r1053" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current tax:" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1034", "r1053", "r1198" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Customers", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r81", "r435" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Customer relationships", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r141" ] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Debt and Lease Obligation", "terseLabel": "Total debt", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r266" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Indebtedness and Credit Agreement" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreement" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Indebtedness and Credit Agreement", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r241", "r353", "r518", "r524", "r525", "r526", "r527", "r528", "r529", "r534", "r541", "r542", "r544" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Percentage points added to the reference rate", "verboseLabel": "Interest rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Carrying value of total long-term indebtedness", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r42", "r264", "r545" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Principal", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r161", "r163", "r519", "r775", "r974", "r975" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument, stated interest rate (as a percent)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r54", "r520" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Indebtedness and credit agreements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r359", "r519", "r520", "r521", "r522", "r523", "r525", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r543", "r775", "r973", "r974", "r975", "r976", "r977", "r1051" ] }, "rad_DebtInstrumentMinimumPrincipalAmountForWhichNonPaymentCausesDefault": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DebtInstrumentMinimumPrincipalAmountForWhichNonPaymentCausesDefault", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum principal balance of the debt instrument for which non-payment is an event of default under the credit agreement.", "label": "Debt Instrument Minimum Principal Amount For Which Non-payment Causes Default", "terseLabel": "Minimum principal balance for which non-payment causes default" } } }, "auth_ref": [] }, "rad_DebtInstrumentPeriodBeforeMaturityDateWhenUnpaidAmountTriggersChangeInDueDate": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DebtInstrumentPeriodBeforeMaturityDateWhenUnpaidAmountTriggersChangeInDueDate", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The period before maturity date when unpaid amount of debt triggers a change in maturity date.", "label": "Debt Instrument Period Before Maturity Date When Unpaid Amount Triggers Change In Due Date", "terseLabel": "Period triggering springing maturity" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed", "terseLabel": "Percentage of outstanding principal amount redeemed", "documentation": "Percentage of principal amount of debt redeemed." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRepurchasedFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRepurchasedFaceAmount", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Repurchased Face Amount", "terseLabel": "Face amount of debt repurchased", "documentation": "Face (par) amount of the original debt instrument that was repurchased." } } }, "auth_ref": [] }, "rad_DebtInstrumentSunCapAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DebtInstrumentSunCapAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of sun cap limit for debt instrument.", "label": "Debt Instrument, Sun Cap Amount", "terseLabel": "Debt instrument, sun cap amount" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r55", "r114", "r115", "r160", "r161", "r163", "r165", "r242", "r243", "r359", "r519", "r520", "r521", "r522", "r523", "r525", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r543", "r775", "r973", "r974", "r975", "r976", "r977", "r1051" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Held-to-maturity Securities", "terseLabel": "Investment at amortized cost", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r439", "r440", "r441", "r818" ] }, "us-gaap_DebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtWeightedAverageInterestRate", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Annual weighted average rate (as a percent)", "documentation": "Weighted average interest rate of debt outstanding." } } }, "auth_ref": [] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations in Next Twelve Months", "terseLabel": "Decrease in unrecognized tax benefits related to state exposures", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r128" ] }, "us-gaap_DeferredChargesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredChargesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Financing Costs", "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges." } } }, "auth_ref": [ "r323" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1053", "r1197", "r1198" ] }, "us-gaap_DeferredFinanceCostsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNetAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Finance Costs [Abstract]", "terseLabel": "Deferred Financing Costs" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net, Noncurrent", "terseLabel": "Deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r705", "r706" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred tax expense (benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r17", "r255", "r287", "r728", "r729", "r1053" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred tax and other:" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Total gross deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r196", "r197", "r263", "r717" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1053", "r1197", "r1198" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total gross deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r718" ] }, "rad_DeferredTaxAssetsLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DeferredTaxAssetsLeasingArrangements", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to temporary differences from leasing arrangements.", "label": "Deferred Tax Assets Leasing Arrangements", "terseLabel": "Operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1195" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1195" ] }, "us-gaap_DeferredTaxAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNetAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating losses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Operating Loss carryforwards, Amount", "terseLabel": "Net tax effect of state carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Net operating losses subject to expiration", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Other", "terseLabel": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Credits", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r130", "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits", "terseLabel": "Pension, retirement and other benefits", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued expenses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Accounts Receivable", "terseLabel": "Accounts receivable", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Long lived Assets", "terseLabel": "Long-lived assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "verboseLabel": "Valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r719" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Inventory", "terseLabel": "Inventory", "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory." } } }, "auth_ref": [ "r131", "r1196" ] }, "rad_DeferredTaxLiabilitiesDeferredExpenseCapitalizedOutsideBasisDifference": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedOutsideBasisDifference", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to outside basis difference.", "label": "Deferred Tax Liabilities Deferred Expense Capitalized Outside Basis Difference", "terseLabel": "Outside basis difference" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesLeasingArrangements", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Leasing Arrangements", "terseLabel": "Operating lease right of use assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements." } } }, "auth_ref": [ "r131", "r1196" ] }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation", "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level." } } }, "auth_ref": [ "r597" ] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax", "negatedTotalLabel": "Amount recognized in other comprehensive income", "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r8", "r61", "r1147" ] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax [Abstract]", "terseLabel": "Amounts recognized in accumulated other comprehensive loss consist of:" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Gains (Losses), before Tax", "terseLabel": "Net actuarial loss", "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r61", "r609" ] }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Actual Return on Plan Assets", "terseLabel": "Actual return on plan assets", "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses." } } }, "auth_ref": [ "r579", "r983" ] }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActuarialGainLoss", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Actuarial Gain (Loss)", "negatedLabel": "Actuarial gain", "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan." } } }, "auth_ref": [ "r572" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amortization of Gains (Losses)", "verboseLabel": "Amortization of unrecognized net loss", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r566", "r604", "r629", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Balance Sheet", "totalLabel": "Net amount recognized in balance sheet", "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans." } } }, "auth_ref": [ "r116", "r117" ] }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]", "terseLabel": "Amounts recognized in consolidated balance sheets consisted of:" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetGainLossBeforeTaxAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss), Net Actuarial Gain (Loss), before Tax [Abstract]", "terseLabel": "Other changes recognized in other comprehensive loss:" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]", "terseLabel": "Estimated amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssetsTargetAllocationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssetsTargetAllocationsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assets, Target Allocations [Abstract]", "terseLabel": "Target allocation of plan assets" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate (as a percent)", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r611" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Rate of increase in future compensation levels (as a percent)", "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r612" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate (as a percent)", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r611" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets", "terseLabel": "Expected long-term rate of return on plan assets (as a percent)", "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r613", "r634" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Rate of increase in future compensation levels (as a percent)", "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r612" ] }, "rad_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitObligationExpectedLongTermReturnOnAssets": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitObligationExpectedLongTermReturnOnAssets", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "An assumption as to the expected long-term rate of return on plan assets to determine the benefit obligation.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Obligation, Expected Long-term Return on Assets", "terseLabel": "Expected long-term rate of return on plan assets" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligation", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Benefit obligation at end of year", "periodStartLabel": "Benefit obligation at end of prior year", "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r567" ] }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Benefits Paid", "negatedLabel": "Distributions", "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services." } } }, "auth_ref": [ "r574", "r637" ] }, "rad_DefinedBenefitPlanBenefitsPaidIncludingExpensesPaidByPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedBenefitPlanBenefitsPaidIncludingExpensesPaidByPlan", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payments made for which participants are entitled under a pension plan, including pension benefits, death benefits, and benefits due on termination of employment. Also includes payments made under a postretirement benefit plan, including prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services. This item represents a periodic decrease to the plan obligations and a decrease to plan assets. This also includes expenses paid by the plan.", "label": "Defined Benefit Plan Benefits Paid Including Expenses Paid by Plan", "negatedLabel": "Distributions (including expenses paid by the plan)" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Asset Categories [Axis]", "documentation": "Information by defined benefit plan asset investment." } } }, "auth_ref": [ "r588", "r589", "r591", "r592", "r593", "r594", "r595", "r596", "r616", "r981", "r982", "r983" ] }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in benefit obligations:", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in plan assets:", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Contributions by Employer", "terseLabel": "Employer contributions", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r581", "r591", "r633", "r981", "r982", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Retirement Plans", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities", "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r981", "r983" ] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "International equity", "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r981", "r982", "r983" ] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesUsLargeCapMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Large Cap", "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r983", "r1129" ] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesUsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "U.S. equities", "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r981", "r982", "r983" ] }, "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]", "terseLabel": "Future benefit payments expected to be paid in Fiscal Year" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Estimated Future Employer Contributions [Abstract]", "terseLabel": "Defined benefit plans estimated future employer contributions" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Future Amortization of Gain (Loss)", "negatedLabel": "Net actuarial loss", "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position." } } }, "auth_ref": [ "r1106" ] }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Future Amortization of Prior Service Cost (Credit)", "terseLabel": "Prior service cost", "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position." } } }, "auth_ref": [ "r1106" ] }, "rad_DefinedBenefitPlanExpectedFutureBenefitPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedBenefitPlanExpectedFutureBenefitPayments", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the total amount of the benefits expected to be paid.", "label": "Defined Benefit Plan, Expected Future Benefit Payments", "totalLabel": "Total" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter", "terseLabel": "2029 - 2033", "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months", "terseLabel": "2024", "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Year Five", "terseLabel": "2028", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Year Four", "terseLabel": "2027", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Year Three", "terseLabel": "2026", "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails": { "parentTag": "rad_DefinedBenefitPlanExpectedFutureBenefitPayments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payments, Year Two", "terseLabel": "2025", "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year." } } }, "auth_ref": [ "r598" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plans, Estimated Future Employer Contributions in Next Fiscal Year", "terseLabel": "Expected employer contribution during the remainder of fiscal year", "verboseLabel": "Expected employer contribution during next fiscal year", "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year." } } }, "auth_ref": [ "r599", "r984" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Return on Plan Assets", "negatedLabel": "Expected return on plan assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r566", "r603", "r628", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Fair Value of Plan Assets", "periodEndLabel": "Fair value of plan assets at end of year", "periodStartLabel": "Fair value of plan assets at beginning of year", "terseLabel": "Total assets at fair value", "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee." } } }, "auth_ref": [ "r578", "r589", "r591", "r592", "r981", "r982", "r983" ] }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFundedStatusOfPlan", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funded Status of Plan", "totalLabel": "Funded status", "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status." } } }, "auth_ref": [ "r564", "r587", "r983" ] }, "us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInformationAboutPlanAssetsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Information about Plan Assets [Abstract]", "terseLabel": "Asset allocations" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r566", "r570", "r602", "r627", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost", "totalLabel": "Net periodic pension expense (income)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r600", "r625", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]", "terseLabel": "Net periodic pension expense" } } }, "auth_ref": [] }, "rad_DefinedBenefitPlanOtherInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedBenefitPlanOtherInvestmentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to other investment.", "label": "Defined Benefit Plan, Other Investment [Member]", "terseLabel": "Other" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair Value of Plan Assets", "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r623", "r983" ] }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation", "terseLabel": "Projected Benefit Obligations", "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r623", "r983" ] }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]", "terseLabel": "Defined Benefit Plan with Accumulated Benefit Obligation in Excess of Plan Assets" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Accumulated Benefit Obligations", "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r623", "r624", "r983" ] }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair Value of Plan Assets", "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r623", "r624", "r983" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsAllocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsAllocationTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Actual Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of pension plan asset allocation percentages", "documentation": "Tabular disclosure of investment allocation of defined benefit plan assets. Includes, but is not limited to, investment allocation percentage or range of percentages." } } }, "auth_ref": [ "r1128" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan Assets, Category [Table Text Block]", "terseLabel": "Summary of the plan's investments measured at fair value on a recurring basis", "documentation": "Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy." } } }, "auth_ref": [ "r1129", "r1130" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Target Plan Asset Allocations", "terseLabel": "Target allocation (as a percent)", "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan." } } }, "auth_ref": [ "r588", "r983" ] }, "us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract]", "terseLabel": "Pension Plan with Project Benefit Obligation in Excess of Plan Assets" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r568", "r601", "r626", "r983", "r984" ] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Actual Plan Asset Allocations", "terseLabel": "Actual allocation (as a percent)", "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan." } } }, "auth_ref": [ "r1128" ] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]", "terseLabel": "Significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]", "terseLabel": "Weighted average assumptions used to determine net cost" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Retirement Plans" } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan, Cost Recognized", "terseLabel": "Total expense recognized", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r638" ] }, "rad_DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the first level of employee contributions (percentage of pretax annual compensation) which are matched by the employer.", "label": "Defined Contribution Plan Employer Match Employee Contribution Level One", "terseLabel": "Percentage of participant's pretax annual compensation matched 100% by employer" } } }, "auth_ref": [] }, "rad_DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the second level of employee contributions (percentage of pretax annual compensation) which are matched by the employer.", "label": "Defined Contribution Plan Employer Match Employee Contribution Level Two", "terseLabel": "Percentage of participant's pretax annual compensation matched 50% by employer" } } }, "auth_ref": [] }, "rad_DefinedContributionPlanEmployerMatchLevelOne": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedContributionPlanEmployerMatchLevelOne", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the employer matching contribution of the first level of employee contributions.", "label": "Defined Contribution Plan Employer Match Level One", "terseLabel": "Employer match of employee contributions up to 3% of pretax annual compensation to 401 (k) defined contribution plan (as a percent)" } } }, "auth_ref": [] }, "rad_DefinedContributionPlanEmployerMatchLevelTwo": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DefinedContributionPlanEmployerMatchLevelTwo", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the employer matching contribution of the second level of employee contributions.", "label": "Defined Contribution Plan Employer Match Level Two", "terseLabel": "Employer match of employee contributions of additional 2% of pretax annual compensation to 401 (k) defined contribution plan (as a percent)" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "terseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r17", "r105" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r17", "r411" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r32", "r151", "r152", "r153", "r154", "r358" ] }, "rad_DescriptionOfBusinessAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DescriptionOfBusinessAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Description of Business [Abstract]", "terseLabel": "Description of Business" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1104" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlans" ], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "terseLabel": "Stock Options and Stock Awards", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r652", "r656", "r687", "r688", "r690", "r992" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Stock Options and Stock Awards" } } }, "auth_ref": [] }, "rad_DisclosureOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DisclosureOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of supplemental balance sheet information related to leases .", "label": "Disclosure of Supplemental Balance Sheet Information Related to Leases [Table Text Block]", "terseLabel": "Schedule of supplemental balance sheet information related to leases" } } }, "auth_ref": [] }, "rad_DisclosureOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DisclosureOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of supplemental cash flow information related to leases.", "label": "Disclosure of Supplemental Cash Flow Information Related to Leases [Table Text Block]", "terseLabel": "Schedule of supplemental cash flow information related to leases" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) On Disposition Of Assets, Pretax", "terseLabel": "Pre-tax gain on sale", "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r175", "r177", "r179" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "totalLabel": "Income from discontinued operations before income taxes", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r175", "r176", "r177", "r178", "r179", "r187", "r209", "r1223" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Discontinued operations", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "verboseLabel": "Discontinued operations", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalExpense", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Intra-Entity Amounts, Discontinued Operation after Disposal, Expense", "terseLabel": "Payments for inventory and selling, general and administrative activities", "documentation": "Amount of expense in continuing operations related to continuing involvement in a discontinued operation after the disposal that before the disposal was eliminated as intra-entity transactions." } } }, "auth_ref": [ "r184" ] }, "us-gaap_DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIntraEntityAmountsDiscontinuedOperationAfterDisposalRevenue", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Intra-Entity Amounts, Discontinued Operation after Disposal, Revenue", "terseLabel": "TSA fees", "documentation": "Amount of revenue in continuing operations related to continuing involvement in a discontinued operation after disposal that before the disposal was eliminated as intra-entity transactions." } } }, "auth_ref": [ "r184" ] }, "us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Period of Continuing Involvement after Disposal", "terseLabel": "Period of transition", "documentation": "Period of expected continuing involvement with a discontinued operation after the disposal date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r183" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "verboseLabel": "Income tax (benefit) expense, discontinued operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r176", "r177", "r178", "r179", "r187", "r192", "r707", "r727", "r731" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Asset Sale to WBA" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operations, Disposed of by Sale [Member]", "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results." } } }, "auth_ref": [ "r12" ] }, "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]", "documentation": "Component or group of components classified as held-for-sale or disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale." } } }, "auth_ref": [ "r11", "r12", "r13" ] }, "us-gaap_DiscontinuedOperationsHeldforsaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsHeldforsaleMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Assets held for sale", "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale." } } }, "auth_ref": [ "r11", "r13", "r315" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r315" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Purchase price per agreement", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "rad_DisposalGroupIncludingDiscontinuedOperationCostAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DisposalGroupIncludingDiscontinuedOperationCostAndExpensesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Disposal Group Including Discontinued Operation Cost and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "auth_ref": [] }, "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The net amount of cost of revenue, operating and non-operating income and expense, combined, attributable to disposal group including discontinued operation.", "label": "Disposal Group Including Discontinued Operation Costs Expenses Gains And Losses, Net", "totalLabel": "Net expenses and non-operating income" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of revenues", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r188", "r316" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Including Discontinued Operation Selling General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r188" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Interest Expense", "terseLabel": "Interest expense", "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r44", "r45", "r47", "r188" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Carrying amount of assets to be disposed", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r5", "r174", "r190", "r237" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Revenues", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r188", "r316" ] }, "rad_DisposalGroupIncludingDiscontinuedOperationsGainLossOnSaleOfAssetsOtherThanStores": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DisposalGroupIncludingDiscontinuedOperationsGainLossOnSaleOfAssetsOtherThanStores", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": "rad_DisposalGroupIncludingDiscontinuedOperationCostsExpensesGainsAndLossesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of gain (loss) on sale of assets other than stores attributable to disposal group including discontinued operations.", "label": "Disposal Group Including Discontinued Operations Gain Loss On Sale Of Assets Other Than Stores", "negatedLabel": "Gain on sale of assets, net" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]", "terseLabel": "Income statement disclosures" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWba" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Asset Sale to WBA", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r173", "r233" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r985", "r988" ] }, "rad_DistributionCenterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "DistributionCenterMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to distribution center.", "label": "Distribution Center [Member]", "terseLabel": "Distribution Center" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1013", "r1014", "r1015" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1013", "r1014", "r1015", "r1017" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1016" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarlyRepaymentOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarlyRepaymentOfSeniorDebt", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Early Repayment of Senior Debt", "terseLabel": "Early redemption of debt", "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity." } } }, "auth_ref": [ "r68" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Loss Per Share" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Net basic loss per share", "totalLabel": "Net basic loss per share", "verboseLabel": "Net basic loss per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r346", "r372", "r373", "r375", "r376", "r378", "r384", "r387", "r394", "r395", "r396", "r400", "r754", "r755", "r820", "r835", "r964" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "verboseLabel": "Basic loss per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Net diluted loss per share", "totalLabel": "Net diluted loss per share", "verboseLabel": "Net diluted loss per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r346", "r372", "r373", "r375", "r376", "r378", "r387", "r394", "r395", "r396", "r400", "r754", "r755", "r820", "r835", "r964" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted loss per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]", "terseLabel": "Antidilutive securities excluded from computation of income per share" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Loss Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r383", "r397", "r398", "r399" ] }, "us-gaap_EffectOfLIFOInventoryLiquidationOnIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfLIFOInventoryLiquidationOnIncome", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Effect of LIFO Inventory Liquidation on Income", "terseLabel": "Amount of decrease in the cost of revenues due to the effect of LIFO inventory liquidation", "documentation": "The effect of liquidating LIFO (last in first out) inventory layers on income." } } }, "auth_ref": [ "r456" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Overall tax rate impact percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r708" ] }, "rad_EffectiveIncomeTaxRateReconciliationDecreaseOfPreviouslyRecordedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "EffectiveIncomeTaxRateReconciliationDecreaseOfPreviouslyRecordedLiabilities", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in previously recorded liabilities.", "label": "Effective Income Tax Rate Reconciliation, Decrease of Previously Recorded Liabilities", "terseLabel": "Decrease of previously recorded liabilities" } } }, "auth_ref": [] }, "rad_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationCostAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationCostAmount", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to non deductible compensation costs.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Cost, Amount", "terseLabel": "Nondeductible compensation" } } }, "auth_ref": [] }, "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Represents current obligations for wages, benefits, sales and other taxes, rent and other store expenses, and other costs incurred as of the balance sheet date. All items are expected to be paid within one year of the balance sheet date.", "label": "Employee Related Liabilities and Other Liabilities, Current", "terseLabel": "Accrued salaries, wages and other current liabilities", "totalLabel": "Accrued salaries, wages and other current liabilities" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued wages, benefits and other personnel costs", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r52" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized pre-tax costs", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r689" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]", "terseLabel": "Unrecognized pre-tax compensation costs related to unvested stock options, restricted stock grants and performance shares" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average amortization period", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r689" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options", "terseLabel": "Income tax benefit from stock options", "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r284" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Severance and related costs", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Incentive Stock options", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1018" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1012" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1012" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1019" ] }, "rad_EnvisionInsuranceCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "EnvisionInsuranceCompanyMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Envision Insurance Company (EIC).", "label": "EI (Elixir Insurance)" } } }, "auth_ref": [] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Equipment", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r31", "r312", "r340", "r341", "r342", "r367", "r368", "r369", "r371", "r379", "r381", "r401", "r444", "r447", "r548", "r691", "r692", "r693", "r724", "r725", "r746", "r747", "r748", "r749", "r750", "r751", "r753", "r767", "r768", "r769", "r770", "r771", "r772", "r801", "r855", "r856", "r857", "r873", "r924" ] }, "us-gaap_ErrorCorrectionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ErrorCorrectionTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatements" ], "lang": { "en-us": { "role": { "label": "Error Correction [Text Block]", "terseLabel": "Revision of Previously Issued Consolidated Financial Statements", "documentation": "The entire disclosure for reporting error correction." } } }, "auth_ref": [ "r377" ] }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "terseLabel": "Revision of Previously Issued Consolidated Financial Statements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r372", "r373", "r374", "r378", "r379", "r380", "r381", "r400" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r532", "r765", "r974", "r975" ] }, "us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureInventoryDetails" ], "lang": { "en-us": { "role": { "label": "LIFO Inventory Amount", "terseLabel": "Amount by which LIFO value is lower than FIFO value", "documentation": "The excess of replacement or current cost over the stated LIFO (last in first out) inventory value when the LIFO inventory method is utilized." } } }, "auth_ref": [ "r329" ] }, "us-gaap_ExtinguishmentOfDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtAmount", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Extinguishment of Debt, Amount", "terseLabel": "Notes redeemed and discharged", "documentation": "Gross amount of debt extinguished." } } }, "auth_ref": [] }, "rad_FacilityAndEquipmentLeaseExitChargesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FacilityAndEquipmentLeaseExitChargesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails" ], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan and equipment lease exit charges.", "label": "Facility And Equipment Lease Exit Charges [Member]", "terseLabel": "Facility Exit Charges" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "verboseLabel": "Other Financial Instruments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r757", "r758", "r762" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r757", "r758", "r762" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value of long-lived assets measured on non-recurring basis", "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2." } } }, "auth_ref": [ "r155", "r260" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Financial instruments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r155", "r156", "r157" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Schedule of carrying amounts and fair values of financial instruments", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r155", "r156" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Hierarchy [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r532", "r591", "r592", "r593", "r594", "r595", "r596", "r758", "r804", "r805", "r806", "r974", "r975", "r981", "r982", "r983" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r40", "r155", "r532", "r974", "r975" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r757", "r758", "r759", "r760", "r763" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r756" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Level 1", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r532", "r591", "r596", "r758", "r804", "r981", "r982", "r983" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Level 2", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r532", "r591", "r596", "r758", "r805", "r974", "r975", "r981", "r982", "r983" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Level 3", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r532", "r591", "r592", "r593", "r594", "r595", "r596", "r758", "r806", "r974", "r975", "r981", "r982", "r983" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails", "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r532", "r591", "r592", "r593", "r594", "r595", "r596", "r804", "r805", "r806", "r974", "r975", "r981", "r982", "r983" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Nonrecurring basis", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r757", "r758", "r759", "r760", "r761", "r763" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Recurring", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r756", "r763" ] }, "rad_February2021ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "February2021ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the February 2021 Receivable Purchase Agreement.", "label": "February 2021 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "rad_February2023ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "February2023ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the February 2023 Receivable Purchase Agreement.", "label": "February 2023 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Federal, State, and Local, Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "Income tax benefit offset amount", "documentation": "Amount of current and deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1198" ] }, "rad_FiloTermLoanDueAugust2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FiloTermLoanDueAugust2026Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the senior secured term loan facility, which is due in August 2026.", "label": "FILO term loan due August 2026" } } }, "auth_ref": [] }, "rad_FinanceLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FinanceLeaseCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of finance lease costs.", "label": "Finance Lease Cost", "totalLabel": "Total finance lease costs" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "rad_FinanceLeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on long-term finance lease liabilities", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r780", "r787", "r996" ] }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestPaymentOnLiability", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows paid for interest portion of finance leases", "documentation": "Amount of interest paid on finance lease liability." } } }, "auth_ref": [ "r782", "r793" ] }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease Liabilities, Payments, Due [Abstract]", "terseLabel": "Finance Leases" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability", "terseLabel": "Lease financing obligations", "totalLabel": "Total finance lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r778", "r797" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current", "terseLabel": "Current maturities of lease financing obligations", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r778" ] }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current finance lease liability." } } }, "auth_ref": [ "r779" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of minimum lease payments, financing leases", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1209" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Lease financing obligations, less current maturities", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r778" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due", "totalLabel": "Total lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due Year Five", "terseLabel": "2029", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due Year Four", "terseLabel": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due Year Three", "terseLabel": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payments, Due Year Two", "terseLabel": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r797" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash flows paid for principal portion of finance leases", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r781", "r793" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "rad_FinanceLeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use asset", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r780", "r787", "r996" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance leases (as a percent)", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r796", "r996" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance leases (in years)", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r795", "r996" ] }, "rad_FinanceLeasedAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FinanceLeasedAssetsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to finance leased assets.", "label": "Finance Leased Assets" } } }, "auth_ref": [] }, "rad_FinanceLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FinanceLeasesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Finance Leases [Abstract]", "terseLabel": "Finance leases:" } } }, "auth_ref": [] }, "rad_FinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Disclosure [Text Block]", "terseLabel": "Financial Instruments", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionTables" ], "lang": { "en-us": { "role": { "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation", "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination." } } }, "auth_ref": [] }, "rad_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Finite Lived And Indefinite Lived Intangible Assets By Major Class" } } }, "auth_ref": [] }, "rad_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about finite lived and indefinite lived intangible assets.", "label": "Finite Lived and Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Amortization period of intangible assets", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Total Accumulated Amortization, Finite", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r322", "r474" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r231" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r231" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r231" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r231" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r231" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r471", "r473", "r474", "r476", "r815", "r816" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsUnfavorableLeaseIntangiblesAndAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Anticipated annual amortization expense for intangible assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetailsCalc2": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount, Finite", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r230", "r816" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r99", "r102" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetailsCalc2": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total Net, finite", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r230", "r815" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Remaining Weighted Average Amortization Period", "verboseLabel": "Finite-lived intangible assets amortization period", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r815" ] }, "us-gaap_FiscalPeriod": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiscalPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fiscal Period, Policy [Policy Text Block]", "terseLabel": "Fiscal Year", "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed." } } }, "auth_ref": [ "r149" ] }, "us-gaap_FiscalPeriodDuration": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiscalPeriodDuration", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Fiscal Period Duration", "terseLabel": "Length of reporting period", "documentation": "Duration of a fiscal period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but not limited to, weeks in a year or quarter." } } }, "auth_ref": [] }, "rad_FiscalYearAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FiscalYearAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Fiscal Year [Abstract]", "terseLabel": "Fiscal Year" } } }, "auth_ref": [] }, "rad_FixedChargeCoverageRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FixedChargeCoverageRatio", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the fixed charge coverage ratio relating to the debt agreement.", "label": "Fixed Charge Coverage Ratio", "terseLabel": "Fixed charge coverage ratio" } } }, "auth_ref": [] }, "us-gaap_FixedIncomeFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FixedIncomeFundsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Intermediate Fixed Income", "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments." } } }, "auth_ref": [ "r1129" ] }, "us-gaap_FixedIncomeSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FixedIncomeSecuritiesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fixed Income", "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity." } } }, "auth_ref": [ "r983", "r1000", "r1001", "r1129" ] }, "rad_FixedRate6.875PercentSeniorNotesDueDecember2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FixedRate6.875PercentSeniorNotesDueDecember2028Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the fixed-rate senior notes bearing an interest rate of 6.875 percent, due in December 2028.", "label": "6.875% fixed-rate senior notes due December 2028" } } }, "auth_ref": [] }, "rad_FrontEndSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "FrontEndSalesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Front end sales revenue under the Retail Pharmacy segment", "label": "Front end sales" } } }, "auth_ref": [] }, "rad_GainLossOnAcquisitionOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "GainLossOnAcquisitionOfBusiness", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0, "order": 8.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized from acquisition of business.", "label": "Gain (Loss) on Acquisition of Business", "negatedLabel": "Loss (gain) on Bartell acquisition" } } }, "auth_ref": [] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnContractTermination", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Contract Termination", "terseLabel": "Facility exit charges", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r221" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0, "order": 7.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "(Gain) loss on sale of assets, net", "negatedNetLabel": "Loss (gain) on sale of assets, net", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r1050" ] }, "us-gaap_GainLossOnSaleOfAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Sale of Accounts Receivable", "negatedLabel": "Loss on sale of receivable", "documentation": "Amount of gain (loss) on sale of accounts receivable." } } }, "auth_ref": [ "r808" ] }, "us-gaap_GainLossOnSaleOfOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfOtherAssets", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Other Assets", "negatedLabel": "(Gain) loss on sale of assets, net", "documentation": "Amount of gain (loss) on sale or disposal of other assets." } } }, "auth_ref": [ "r1050" ] }, "rad_GainLossOnUnamortizedDebtExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "GainLossOnUnamortizedDebtExtinguishment", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments\n made and the carrying amount of debt which\n is extinguished prior to maturity.", "label": "Gain Loss On Unamortized Debt Extinguishment", "terseLabel": "(Gain) loss on debt retirements, net" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0, "order": 6.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 7.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gains (Losses) on Extinguishment of Debt", "negatedLabel": "(Gain) loss on debt modifications and retirements, net", "negatedTerseLabel": "(Gain) loss on debt modifications and retirements, net", "terseLabel": "Gain (loss) on debt modifications and retirements, net", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r17", "r112", "r113" ] }, "us-gaap_GainsLossesOnRestructuringOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnRestructuringOfDebt", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Gains (Losses) on Restructuring of Debt", "terseLabel": "Gain on debt modification", "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete." } } }, "auth_ref": [ "r26" ] }, "us-gaap_GainsLossesOnSalesOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfAssets", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Assets for Financial Service Operations", "negatedLabel": "Gain from sale of assets", "documentation": "Amount of gain (loss) on sale or disposal of assets utilized in financial service operations." } } }, "auth_ref": [] }, "rad_GeneralMerchandiseAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "GeneralMerchandiseAndOtherMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the general merchandise and other, a product class of the entity.", "label": "General merchandise and other" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r321", "r458", "r817", "r968", "r997", "r1075", "r1082" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Asset Impairment", "terseLabel": "Goodwill and intangible asset impairment charges", "verboseLabel": "Goodwill and intangible asset impairment charges", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Other Intangible Assets" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Other Intangible Assets", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r228" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r457", "r470", "r968" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Indefinite Lived Assets [Policy Text Block]", "terseLabel": "Indefinite lived assets", "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r232" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated impairment losses", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r461", "r468", "r968" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impairment Loss", "negatedLabel": "Goodwill impairment", "terseLabel": "Goodwill, impairment charges", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r17", "r459", "r465", "r470", "r968" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill [Line Items]", "terseLabel": "Goodwill", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r968" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill [Roll Forward]", "terseLabel": "Carrying amount of goodwill", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "verboseLabel": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r213", "r354", "r406", "r420", "r426", "r429", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r766", "r966", "r1099" ] }, "us-gaap_GuaranteeObligationsByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsByNatureAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Guarantor Obligations, Nature [Axis]", "documentation": "Information by nature of guarantee." } } }, "auth_ref": [ "r501", "r502", "r503", "r504" ] }, "us-gaap_GuaranteeObligationsNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsNatureDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Guarantor Obligations, Nature [Domain]", "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees." } } }, "auth_ref": [ "r501", "r502", "r503", "r504" ] }, "rad_GuaranteedUnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "GuaranteedUnsecuredDebtMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to guaranteed unsecured debt.", "label": "Guaranteed Unsecured Debt" } } }, "auth_ref": [] }, "rad_HealthAndBeautyAidsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "HealthAndBeautyAidsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the health and beauty aids, a product class of the entity.", "label": "Health and beauty aids" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Fair Value", "terseLabel": "Held to maturity investments", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r273", "r442", "r818", "r822" ] }, "rad_HumanaLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "HumanaLitigationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Blue Cross/Blue Shield litigation.", "label": "Humana Litigation" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1013", "r1014", "r1015" ] }, "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use." } } }, "auth_ref": [ "r477" ] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r17", "r38" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": "us-gaap_TangibleAssetImpairmentCharges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets Held-for-use", "negatedLabel": "Long-lived assets held, impairment charges", "verboseLabel": "Impairment charges", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r17", "r104", "r236" ] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": "us-gaap_TangibleAssetImpairmentCharges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets to be Disposed of", "negatedLabel": "Long-lived assets held for sale, impairment charges", "terseLabel": "Impairment charges, closed facilities", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r17", "r234" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r239" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest", "terseLabel": "Loss from continuing operations before income taxes", "totalLabel": "Loss before income taxes", "verboseLabel": "Income (loss) before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r208", "r268", "r406", "r420", "r426", "r429", "r821", "r831", "r966" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss from continuing operations", "totalLabel": "Net loss from continuing operations", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r259", "r354", "r370", "r406", "r420", "r426", "r429", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r755", "r766", "r831", "r966", "r1099" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Continuing operations", "verboseLabel": "Basic loss per share from continuing operations", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r206", "r267", "r269", "r346", "r370", "r372", "r373", "r375", "r376", "r387", "r394", "r395", "r755", "r820", "r1224" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Continuing operations", "verboseLabel": "Diluted loss per share from continuing operations", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r206", "r346", "r370", "r372", "r373", "r375", "r376", "r387", "r394", "r395", "r396", "r755", "r820", "r1224" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "netLabel": "Net income from discontinued operations, net of tax", "terseLabel": "Net income from discontinued operations, net of tax", "totalLabel": "Net income from discontinued operations, net of tax", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r175", "r176", "r177", "r178", "r179", "r192", "r316", "r732", "r832" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r985", "r988" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Asset Sale to WBA", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r20", "r37", "r46", "r174", "r180", "r181", "r182", "r185", "r186", "r191", "r193", "r194", "r238" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r478", "r484", "r908" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r484", "r908" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r27" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r27" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Domain]", "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r355", "r701", "r709", "r715", "r721", "r726", "r730", "r733", "r734", "r872" ] }, "rad_IncomeTaxExaminationYear": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncomeTaxExaminationYear", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of tax examination.", "label": "Income Tax Examination, Year", "terseLabel": "Income tax examination" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "netLabel": "Income tax benefit", "totalLabel": "Total income tax (benefit) expense", "verboseLabel": "Income tax expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r276", "r288", "r380", "r381", "r414", "r707", "r727", "r836" ] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]", "terseLabel": "Reconciliation of the expected statutory federal tax and the total income tax expense (benefit)" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r339", "r703", "r704", "r715", "r716", "r720", "r722", "r868" ] }, "rad_IncomeTaxRateReconciliationAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncomeTaxRateReconciliationAcquisitionCosts", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to acquisition cost.", "label": "Income Tax Rate Reconciliation Acquisition Costs", "terseLabel": "Nondeductible excise tax" } } }, "auth_ref": [] }, "rad_IncomeTaxReconciliationBargainPurchaseGain": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncomeTaxReconciliationBargainPurchaseGain", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to gain on bargain purchase.", "label": "Income Tax Reconciliation Bargain Purchase Gain", "terseLabel": "Bargain purchase gain" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1194" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Federal statutory rate", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r708" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount", "terseLabel": "Qualified fringe disallowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense." } } }, "auth_ref": [ "r1194" ] }, "rad_IncomeTaxReconciliationNondeductibleExpenseOtherThanCompensationAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncomeTaxReconciliationNondeductibleExpenseOtherThanCompensationAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses other than compensation and share-based compensation.", "label": "Income Tax Reconciliation Nondeductible Expense Other Than Compensation And Share-Based Compensation", "terseLabel": "Nondeductible expenses" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount", "terseLabel": "Stock based compensation", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1194" ] }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherReconcilingItems", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Other", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments." } } }, "auth_ref": [ "r1194" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State income taxes, net", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r1194" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net", "terseLabel": "Cash payments (refunds) for income taxes, net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r71" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r16" ] }, "rad_IncreaseDecreaseInAccruedStoreExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncreaseDecreaseInAccruedStoreExpenses", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash inflow (outflow) during the reporting period due to changes in the amount of obligations related to accrued store expenses.", "label": "Increase Decrease In Accrued Store Expenses", "terseLabel": "Changes in accrued store expenses" } } }, "auth_ref": [] }, "rad_IncreaseDecreaseInAllowanceForAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncreaseDecreaseInAllowanceForAccountsReceivable", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for accounts receivable.", "label": "Increase (Decrease) in Allowance for Accounts Receivable", "terseLabel": "Change in allowances for uncollectible accounts receivable" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Changes in deferred taxes", "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Accruals Related to Changes in Compensation and Benefits", "terseLabel": "Accruals related to compensation and benefit", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "rad_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in Operating lease right-of-use assets and operating lease liabilities.", "label": "Increase (Decrease) in Operating Lease Right-of-use Assets and Operating Lease Liabilities", "negatedTerseLabel": "Operating lease right-of-use assets and operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets", "negatedTerseLabel": "Other Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities", "verboseLabel": "Other Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Deficit", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r472", "r475" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetailsCalc2": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Gross Carrying Amount, Indefinite Lived", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r232" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r100", "r232" ] }, "us-gaap_IndemnificationGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndemnificationGuaranteeMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Indemnification Agreement [Member]", "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor." } } }, "auth_ref": [ "r1097" ] }, "rad_IndividuallyInsignificantMultiemployerPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "IndividuallyInsignificantMultiemployerPlanMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to individually insignificant multiemployer plan.", "label": "Other Funds" } } }, "auth_ref": [] }, "us-gaap_InsuranceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance [Abstract]", "terseLabel": "Insurance" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible Assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r102", "r811", "r812", "r813", "r815", "r962" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetailsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Gross Carrying Amount, Total", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r321" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetailsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangibles, net", "totalLabel": "Net, Total", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r97", "r101" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 1.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "terseLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r162", "r271", "r343", "r410", "r773", "r909", "r1008", "r1229" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Net", "terseLabel": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r349", "r350", "r351" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Interest Payable, Current", "terseLabel": "Accrued interest", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r52" ] }, "us-gaap_InternalRevenueServiceIRSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalRevenueServiceIRSMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Federal", "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Intersegment elimination", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r408", "r419", "r420", "r421", "r422", "r423", "r425", "r429" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureInventory" ], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r452" ] }, "us-gaap_InventoryLIFOReservePeriodCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLIFOReservePeriodCharge", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 4.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureInventoryDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Inventory, LIFO Reserve, Period Charge", "terseLabel": "LIFO charge (credit)", "verboseLabel": "LIFO charge (credit)", "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period." } } }, "auth_ref": [ "r227" ] }, "rad_InventoryLiquidationCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "InventoryLiquidationCharges", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "documentation": "Charge resulting from the reduction in the valuation of excess inventory from the carrying amount to net realizable value, plus any costs of holding and disposing of those inventories.", "label": "Inventory Liquidation Charges", "terseLabel": "Inventory liquidation charges" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "verboseLabel": "Inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r330", "r957", "r997" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r277", "r319", "r328", "r452", "r453", "r455", "r810", "r963" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Inventory Write-down", "terseLabel": "Inventory write-downs related to store closings", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r454" ] }, "rad_January2022ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "January2022ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the January 2022 Receivable Purchase Agreement.", "label": "January 2022 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Land", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r1105" ] }, "rad_LargestCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LargestCustomerMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the largest single customer.", "label": "Largest Payor [Member]" } } }, "auth_ref": [] }, "rad_LargestMedicaidAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LargestMedicaidAgenciesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the largest Medicaid agencies.", "label": "Largest Medicaid agency" } } }, "auth_ref": [] }, "rad_LargestThirdPartyPayorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LargestThirdPartyPayorsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the largest third party payors.", "label": "Largest third party payor" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease, Cost", "totalLabel": "Net lease cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r786", "r996" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Cost [Abstract]", "terseLabel": "Financing lease cost:" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of components of net lease cost", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1208" ] }, "rad_LeaseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LeaseDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information about leases.", "label": "Lease Disclosure [Text Block]", "terseLabel": "Leases" } } }, "auth_ref": [] }, "rad_LeaseGuaranteeAssetsSoldNumberOfProperties": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LeaseGuaranteeAssetsSoldNumberOfProperties", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of properties no longer owned by the entity but for which they are obligated to pay for lease guarantees in the event that the current owner fails to perform.", "label": "Lease Guarantee Assets Sold, Number of Properties", "terseLabel": "Number of former stores with lease guarantee obligations" } } }, "auth_ref": [] }, "rad_LeaseTerminationAndImpairmentChargesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LeaseTerminationAndImpairmentChargesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Facility Exit and Impairment Charges" } } }, "auth_ref": [] }, "rad_LeaseTerminationAndLongLivedAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LeaseTerminationAndLongLivedAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 }, "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from early termination of leases and from the aggregate write-down of tangible assets from their carrying value to their fair value.", "label": "Lease Termination And Long-Lived Asset Impairment Charges", "terseLabel": "Facility exit and impairment charges" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r235" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeaseTermOfContract1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeaseTermOfContract1", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Finance Lease, Term of Contract", "terseLabel": "Initial terms of noncancellable finance leases", "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1207" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r785" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r785" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lease, Policy [Policy Text Block]", "terseLabel": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r784" ] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease.", "label": "Lessee Operating and Finance Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in the next twelve months following latest fiscal year.", "label": "Lessee Operating And Finance Lease Liability Payments Due Next Twelve Months", "terseLabel": "2025" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearAfterYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee Operating and Finance Lease Liability Payments Due Year After Year Five", "terseLabel": "Thereafter" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee Operating and Finance Lease Liability Payments Due Year Five", "terseLabel": "2028" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee Operating and Finance Lease Liability Payments Due Year Four", "terseLabel": "2028" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in third fiscal year following latest fiscal year.", "label": "Lessee Operating and Finance Lease Liability Payments Due Year Three", "terseLabel": "2027" } } }, "auth_ref": [] }, "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "rad_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in second fiscal year following latest fiscal year.", "label": "Lessee Operating and Finance Lease Liability Payments Due Year Two", "terseLabel": "2026" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDescriptionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescriptionAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Description [Abstract]", "terseLabel": "Leases" } } }, "auth_ref": [] }, "rad_LesseeOperatingLeaseFutureMinimumSubleaseRentalsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LesseeOperatingLeaseFutureMinimumSubleaseRentalsDue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of lessee's future minimum sublease rentals due for operating lease.", "label": "Lessee Operating Lease Future Minimum Sublease Rentals Due", "terseLabel": "Minimum sublease rentals" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of minimum lease payments, operating leases", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1209" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2029", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Maximum additional period for lease extension", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1207" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee Leasing Arrangements, Operating Leases, Term of Contract", "terseLabel": "Initial terms of noncancellable operating leases", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1207" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "verboseLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r51", "r354", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r742", "r743", "r744", "r766", "r883", "r965", "r1009", "r1099", "r1212", "r1213" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' (deficit) equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r204", "r265", "r829", "r997", "r1052", "r1070", "r1205" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "terseLabel": "Total current liabilities", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r53", "r318", "r354", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r742", "r743", "r744", "r766", "r997", "r1099", "r1212", "r1213" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilityReserveEstimatePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityReserveEstimatePolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liability Reserve Estimate, Policy [Policy Text Block]", "terseLabel": "Litigation Reserves", "documentation": "Disclosure of accounting policy for estimating its liability as of the balance sheet date for the ultimate cost of settling reported and unreported claims incurred and claims adjustment expenses (including effects of inflation and other societal and economic factors)." } } }, "auth_ref": [ "r166" ] }, "us-gaap_LicensingAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicensingAgreementsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "CMS license", "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)." } } }, "auth_ref": [ "r142", "r700", "r1193" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Line of Credit", "terseLabel": "Outstanding borrowings", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r42", "r264", "r1220" ] }, "us-gaap_LineOfCreditFacilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]", "terseLabel": "Credit facility" } } }, "auth_ref": [] }, "rad_LineOfCreditFacilityMaximumAmountAllowedForAccumulatingCashOnHand": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityMaximumAmountAllowedForAccumulatingCashOnHand", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount represents maximum amount allowed for accumulating cash on hand.", "label": "Line of Credit Facility, Maximum Amount Allowed for Accumulating Cash on Hand", "terseLabel": "Maximum amount of accumulated cash on hand" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r49" ] }, "rad_LineOfCreditFacilityNumberOfDaysThresholdRelatingToDebtThreshold": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityNumberOfDaysThresholdRelatingToDebtThreshold", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of days threshold relating to the debt threshold per the debt agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Line Of Credit Facility Number of Days Threshold Relating To Debt Threshold", "terseLabel": "Number of days relating to debt threshold" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Additional borrowing capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r49" ] }, "rad_LineOfCreditFacilityThresholdAmountAllowedOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityThresholdAmountAllowedOutstanding", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold amount allowed to be outstanding per the debt agreement.", "label": "Line Of Credit Facility Threshold Amount Allowed Outstanding", "terseLabel": "Amount of debt allowed to be outstanding" } } }, "auth_ref": [] }, "rad_LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirements", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold amount of availability on the revolving credit facility, below which the entity is required to maintain a specified minimum fixed charge coverage ratio per the covenant terms.", "label": "Line of Credit Facility, Threshold Amount of Availability for Fixed Charge Coverage Requirements", "terseLabel": "Threshold availability on revolving credit facility to trigger fixed charge coverage requirements" } } }, "auth_ref": [] }, "rad_LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirementsOnThirdConsecutiveBusinessDay": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirementsOnThirdConsecutiveBusinessDay", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold amount of availability on the revolving credit facility, below which the entity is required to maintain a specified minimum fixed charge coverage ratio on the third consecutive business day per the covenant terms.", "label": "Line Of Credit Facility Threshold Amount Of Availability For Fixed Charge Coverage Requirements On Third Consecutive Business Day", "terseLabel": "Threshold availability on the third consecutive business day" } } }, "auth_ref": [] }, "rad_LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirementsThirtiethConsecutiveCalendarDay": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityThresholdAmountOfAvailabilityForFixedChargeCoverageRequirementsThirtiethConsecutiveCalendarDay", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold availability under the debt instrument for the 30th consecutive calendar day related to the fixed charge coverage ratio.", "label": "Line Of Credit Facility Threshold Amount Of Availability For Fixed Charge Coverage Requirements Thirtieth Consecutive Calendar Day", "terseLabel": "Threshold availability on thirtieth consecutive day" } } }, "auth_ref": [] }, "rad_LineOfCreditFacilityThresholdAmountOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LineOfCreditFacilityThresholdAmountOfDebt", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold amount of debt per the agreement.", "label": "Line Of Credit Facility Threshold Amount Of Debt", "terseLabel": "Threshold amount of debt" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Credit facility commitment fee (as a percent)", "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility." } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information." } } }, "auth_ref": [] }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementAmountAwardedToOtherParty", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Amount awarded to other party", "documentation": "Amount awarded to other party in judgment or settlement of litigation." } } }, "auth_ref": [] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, Expense", "terseLabel": "Litigation and other contractual settlements", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [] }, "us-gaap_LitigationSettlementInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementInterest", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement Interest", "verboseLabel": "Prejudgment interest awarded", "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation." } } }, "auth_ref": [] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAccountsReceivable" ], "lang": { "en-us": { "role": { "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Accounts Receivable", "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r1065" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.riteaid.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "rad_LondonInterbankOfferedRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LondonInterbankOfferedRateMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "LIBOR" } } }, "auth_ref": [] }, "rad_LongTermCreditBondIndexMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LongTermCreditBondIndexMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about long term credit bond index.", "label": "Long Term Credit Bond Index" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt", "terseLabel": "Long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r42", "r264", "r531", "r546", "r974", "r975", "r1220" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt and Capital Lease Obligations", "terseLabel": "Long-term debt and lease financing obligations, less current maturities", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r42", "r824" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt and Capital Lease Obligations, Current", "negatedLabel": "Less: Current maturities of long-term debt and lease financing obligations", "terseLabel": "Current maturities of long-term debt and lease financing obligations", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r52" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Fair Value", "terseLabel": "Estimated fair value of total long-term indebtedness", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months", "verboseLabel": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r19", "r359", "r536" ] }, "rad_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in and after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Year Five And Thereafter", "terseLabel": "2028 and thereafter" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four", "terseLabel": "2028", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r19", "r359", "r536" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r19", "r359", "r536" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "terseLabel": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r19", "r359", "r536" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, less current maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r325" ] }, "rad_LongTermUsGovernmentBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LongTermUsGovernmentBondsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about long term US government bonds.", "label": "Long Term US Government Bonds" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtPercentageBearingFixedInterestAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtPercentageBearingFixedInterestAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Percentage Bearing Fixed Interest, Amount", "terseLabel": "Fixed rate indebtedness", "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtPercentageBearingVariableInterestAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtPercentageBearingVariableInterestAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Percentage Bearing Variable Interest, Amount", "terseLabel": "Variable rate indebtedness", "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r55" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r55", "r111" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "verboseLabel": "Commitments, Contingencies and Guarantees", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r495", "r496", "r497", "r500", "r1093", "r1094" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r495", "r496", "r497", "r500", "r1093", "r1094" ] }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNewClaimsFiledNumber", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Number of claims", "documentation": "The total number of new claims filed pertaining to a loss contingency during the period." } } }, "auth_ref": [ "r1093", "r1094" ] }, "rad_LossOnBartellAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "LossOnBartellAcquisition", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails" ], "lang": { "en-us": { "role": { "documentation": "Business combination bargain purchase loss recognized amount.", "label": "Loss on Bartell acquisition", "negatedLabel": "Loss on Bartell acquisition" } } }, "auth_ref": [] }, "us-gaap_MaintenanceCostPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaintenanceCostPolicyPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Maintenance Cost, Policy [Policy Text Block]", "terseLabel": "Repairs and Maintenance", "documentation": "Disclosure of the accounting policy for maintenance costs. Does not include planned major maintenance activities." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r435", "r980", "r1104", "r1225", "r1226" ] }, "us-gaap_MajorCustomersPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorCustomersPolicyPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Major Customers, Policy [Policy Text Block]", "terseLabel": "Significant Concentrations", "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity." } } }, "auth_ref": [ "r79", "r80", "r83", "r225" ] }, "rad_ManufacturerRebatesReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ManufacturerRebatesReceivablesAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Manufacturer Rebates Receivables" } } }, "auth_ref": [] }, "rad_ManufacturerRebatesReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ManufacturerRebatesReceivablesTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivables" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for manufacturer rebates receivable.", "label": "Manufacturer Rebates Receivables [Text block]", "terseLabel": "Manufacturer Rebates Receivables" } } }, "auth_ref": [] }, "rad_ManufacturersRebatesReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ManufacturersRebatesReceivablesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to manufacturers rebates receivables.", "label": "Manufacturers Rebates Receivables" } } }, "auth_ref": [] }, "us-gaap_MarketingAndAdvertisingExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingAndAdvertisingExpenseAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Marketing and Advertising Expense [Abstract]", "terseLabel": "Advertising" } } }, "auth_ref": [] }, "us-gaap_MaturitiesOfLongTermDebtAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaturitiesOfLongTermDebtAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Maturities of Long-term Debt [Abstract]", "terseLabel": "Maturities" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r496", "r497", "r498", "r499", "r644", "r809", "r854", "r875", "r876", "r927", "r928", "r929", "r930", "r931", "r948", "r949", "r967", "r978", "r991", "r999", "r1103", "r1214", "r1215", "r1216", "r1217", "r1218", "r1219" ] }, "rad_McKessonCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "McKessonCorporationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents McKesson Corp.", "label": "McKesson Corp." } } }, "auth_ref": [] }, "rad_MedicaidAgenciesAndRelatedManagedCareMedicaidPayorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MedicaidAgenciesAndRelatedManagedCareMedicaidPayorsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the Medicaid agencies and related managed care Medicaid payors.", "label": "Medicaid agencies and related managed care Medicaid payors" } } }, "auth_ref": [] }, "rad_MedicarePartDMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MedicarePartDMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the Medicare Part D.", "label": "Medicare PartD" } } }, "auth_ref": [] }, "rad_MedicarePrescriptionDrugPlanDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MedicarePrescriptionDrugPlanDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "N/A.", "label": "Medicare Prescription Drug Plan, Disclosures [Abstract]", "terseLabel": "Medicare Part D" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r496", "r497", "r498", "r499", "r644", "r809", "r854", "r875", "r876", "r927", "r928", "r929", "r930", "r931", "r948", "r949", "r967", "r978", "r991", "r999", "r1103", "r1214", "r1215", "r1216", "r1217", "r1218", "r1219" ] }, "rad_MinimumPointsRequiredForConversion": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MinimumPointsRequiredForConversion", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Minimum points required for conversion into rewards.", "label": "Minimum Points Required for Conversion", "terseLabel": "Minimum points required for conversion into rewards" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership interest (as a percent)", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "label": "Real Estate, Type of Property [Axis]", "documentation": "Information by type of real estate property." } } }, "auth_ref": [ "r291", "r301", "r935", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946" ] }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "label": "Real Estate [Domain]", "documentation": "Land and any structures permanently fixed to it." } } }, "auth_ref": [ "r291", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946" ] }, "rad_MostCurrentReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MostCurrentReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Most Current Receivable Purchase Agreement Member", "label": "Most Current Receivable Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInValuationAllowancesAndReservesRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "Allowances deducted from accounts receivable for estimated uncollectible amounts:", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "rad_MultiemployerPensionPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPensionPlansTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefits" ], "lang": { "en-us": { "role": { "documentation": "Represents the disclosure of certain information related to the company's multiemployer defined benefit pension plans.", "label": "Multiemployer Pension Plans [Text Block]", "terseLabel": "Multiemployer Plans that Provide Pension Benefits" } } }, "auth_ref": [] }, "us-gaap_MultiemployerPlanEmployerContributionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MultiemployerPlanEmployerContributionCost", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Multiemployer Plan, Period Contributions", "terseLabel": "Contributions by employer", "documentation": "Amount of cost for employer contribution to multiemployer plan. Multiemployer plan includes, but is not limited to, pension plan determined to be individually significant and insignificant and other postretirement benefit plan." } } }, "auth_ref": [ "r639", "r640", "r651", "r991" ] }, "us-gaap_MultiemployerPlanEmployerContributionCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MultiemployerPlanEmployerContributionCostAbstract", "lang": { "en-us": { "role": { "label": "Multiemployer Plans that Provide Pension Benefits" } } }, "auth_ref": [] }, "rad_MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusGreen": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusGreen", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the funded percentage of the plan based on Pension Protection Act zone status: Green.", "label": "Multiemployer Plans Funded Percentage Based On Pension Protection Act Zone Status Green", "terseLabel": "Funded percentage, green zone" } } }, "auth_ref": [] }, "rad_MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusRed": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusRed", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the funded percentage of the plan based on Pension Protection Act zone status: Red.", "label": "Multiemployer Plans Funded Percentage Based On Pension Protection Act Zone Status Red", "terseLabel": "Funded percentage, red zone" } } }, "auth_ref": [] }, "rad_MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusYellow": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansFundedPercentageBasedOnPensionProtectionActZoneStatusYellow", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the funded percentage of the plan based on Pension Protection Act zone status: Yellow.", "label": "Multiemployer Plans Funded Percentage Based On Pension Protection Act Zone Status Yellow", "terseLabel": "Funded percentage, yellow zone" } } }, "auth_ref": [] }, "us-gaap_MultiemployerPlansLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MultiemployerPlansLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Multiemployer Plans [Line Items]", "terseLabel": "Multiemployer Plans that Provide Pension Benefits", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r651", "r985", "r986", "r987", "r988", "r989", "r990", "r991" ] }, "rad_MultiemployerPlansMinimumContributionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansMinimumContributionPercentage", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum contribution(s) as a percentage of gross wages earned per associate, required for future periods relating to a multiemployer plan by collective bargaining arrangements, statutory obligations, or other contractual obligations.", "label": "Multiemployer Plans Minimum Contribution Percentage", "terseLabel": "Minimum funding requirements (as a percent)" } } }, "auth_ref": [] }, "rad_MultiemployerPlansMinimumContributionRate": { "xbrltype": "perUnitItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansMinimumContributionRate", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum contribution(s) per hour worked per associate, required for future periods relating to a multiemployer plan by collective bargaining arrangements, statutory obligations, or other contractual obligations.", "label": "Multiemployer Plans Minimum Contribution Rate", "terseLabel": "Minimum funding requirements for associates (in dollars per hour)" } } }, "auth_ref": [] }, "rad_MultiemployerPlansMinimumContributionRateForNonPharmacists": { "xbrltype": "perUnitItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansMinimumContributionRateForNonPharmacists", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum contribution(s) per hour worked for non pharmacists associate, required for future periods relating to a multiemployer plan by collective bargaining arrangements, statutory obligations, or other contractual obligations.", "label": "Multiemployer Plans Minimum Contribution Rate for Non Pharmacists", "terseLabel": "Minimum funding requirements for clerks (in dollars per hour)" } } }, "auth_ref": [] }, "rad_MultiemployerPlansMinimumContributionRateForPharmacists": { "xbrltype": "perUnitItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "MultiemployerPlansMinimumContributionRateForPharmacists", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum contribution(s) per hour worked for pharmacists associate, required for future periods relating to a multiemployer plan by collective bargaining arrangements, statutory obligations, or other contractual obligations.", "label": "Multiemployer Plans, Minimum Contribution Rate for Pharmacists", "terseLabel": "Minimum funding requirements for pharmacists (in dollars per hour)" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r435", "r980", "r1104", "r1225", "r1226" ] }, "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Discontinued Operations", "totalLabel": "Net cash provided by discontinued operations", "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations." } } }, "auth_ref": [ "r219" ] }, "us-gaap_NetCashProvidedByUsedInDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInDiscontinuedOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Discontinued Operations [Abstract]", "terseLabel": "Cash flows from discontinued operations:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations", "totalLabel": "Net cash provided by (used in) financing activities of continuing operations:", "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r1049" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "verboseLabel": "Financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations", "totalLabel": "Net cash used in investing activities of continuing operations:", "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r1049" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "verboseLabel": "Investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlowsCal2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash (used in) provided by operating activities of continuing operations:", "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r219", "r220", "r221" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "verboseLabel": "Operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r210", "r221", "r270", "r316", "r334", "r337", "r342", "r354", "r370", "r372", "r373", "r375", "r376", "r380", "r381", "r392", "r406", "r420", "r426", "r429", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r755", "r766", "r833", "r905", "r922", "r923", "r966", "r1008", "r1099" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders - basic", "verboseLabel": "Net loss attributable to common stockholders - basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r347", "r372", "r373", "r375", "r376", "r384", "r385", "r393", "r396", "r406", "r420", "r426", "r429", "r966" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Computation of loss attributable to common stockholders:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss attributable to common stockholders - diluted", "terseLabel": "Net loss attributable to common stockholders - diluted", "totalLabel": "Net loss attributable to common stockholders - diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r347", "r386", "r388", "r389", "r390", "r391", "r393", "r396" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic", "terseLabel": "Loss from continuing operations attributable to common stockholders - basic", "verboseLabel": "Net loss from continuing operations - basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders." } } }, "auth_ref": [ "r385", "r396" ] }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted", "terseLabel": "Loss from continuing operations attributable to common stockholders - diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders." } } }, "auth_ref": [ "r386", "r389", "r390", "r391", "r396" ] }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Income from discontinued operations attributable to common stockholders-basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted", "terseLabel": "Income from discontinued operations attributable to common stockholders-diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recently Adopted Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "rad_NewYorkEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NewYorkEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to New York Employment Litigation.", "label": "New York Employment Litigation Claims Related To Wages And Hour Class Action" } } }, "auth_ref": [] }, "rad_NewYorkEmploymentLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NewYorkEmploymentLitigationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to New York Employment Litigation.", "label": "New York Employment Litigation" } } }, "auth_ref": [] }, "us-gaap_NoncompeteAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncompeteAgreementsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Noncompete agreements and other", "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party." } } }, "auth_ref": [ "r140" ] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Assets", "terseLabel": "Carrying value of long-lived assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r434" ] }, "rad_Notes7.7PercentDueFeb2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "Notes7.7PercentDueFeb2027Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the notes bearing an interest rate of 7.7 percent, due in February 2027.", "label": "7.7% notes due February 2027" } } }, "auth_ref": [] }, "rad_November2020ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "November2020ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the November 2020 Receivable Purchase Agreement.", "label": "November 2020 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "rad_NumberOfDistributionCenters": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NumberOfDistributionCenters", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of distribution centers.", "label": "Number Of Distribution Centers", "terseLabel": "Number of distribution centers" } } }, "auth_ref": [] }, "rad_NumberOfFixedLeasePayment": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NumberOfFixedLeasePayment", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of fixed lease payments.", "label": "Number of Fixed Lease Payment", "terseLabel": "Number of fixed lease payment" } } }, "auth_ref": [] }, "rad_NumberOfLocationsImpaired": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NumberOfLocationsImpaired", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of locations for which impairment charges have been recognized.", "label": "Number Of Locations Impaired", "terseLabel": "Total number of impaired locations" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1064" ] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://www.riteaid.com/role/DisclosureCommitmentsContingenciesAndGuaranteesDetails" ], "lang": { "en-us": { "role": { "label": "Number of States in which Entity Operates", "terseLabel": "Number of states in which operated", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_NumberOfStores": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStores", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Number of Stores", "terseLabel": "Number of stores", "verboseLabel": "Number of stores", "documentation": "Represents the number of stores." } } }, "auth_ref": [] }, "rad_NumberOfStoresAcquired": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NumberOfStoresAcquired", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of stores in acquisition.", "label": "Number of stores acquired" } } }, "auth_ref": [] }, "rad_NumberOfStoresSold": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "NumberOfStoresSold", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of stores sold or disposed.", "label": "Number of stores sold" } } }, "auth_ref": [] }, "rad_October2022ReceivablePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "October2022ReceivablePurchaseAgreementMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the October 2022 Receivable Purchase Agreement.", "label": "October 2022 Receivable Purchase Agreement [Member]", "terseLabel": "October 2022 Receivable Purchase Agreement" } } }, "auth_ref": [] }, "rad_OmnibusEquityPlan2010Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OmnibusEquityPlan2010Member", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2010 Omnibus Equity Plan.", "label": "2010 Omnibus Equity Plan" } } }, "auth_ref": [] }, "rad_OmnibusEquityPlan2012Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OmnibusEquityPlan2012Member", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2012 Omnibus Equity Plan.", "label": "2012 Omnibus Equity Plan" } } }, "auth_ref": [] }, "rad_OmnibusEquityPlan2014Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OmnibusEquityPlan2014Member", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2014 Omnibus Equity Plan.", "label": "2014 Omnibus Equity Plan" } } }, "auth_ref": [] }, "rad_OmnibusEquityPlan2020Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OmnibusEquityPlan2020Member", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2020 Plan.", "label": "Omnibus Equity Plan 2020" } } }, "auth_ref": [] }, "rad_OperatingAndFinanceLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OperatingAndFinanceLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Operating and Finance Lease Liabilities Payments Due [Abstract]", "verboseLabel": "Finance and Operating Leases" } } }, "auth_ref": [] }, "rad_OperatingAndFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OperatingAndFinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating and finance lease.", "label": "Operating and Finance Lease Liability", "terseLabel": "Total lease liabilities" } } }, "auth_ref": [] }, "rad_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating and finance lease liabilities undiscounted excess amount.", "label": "Operating and Finance Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "terseLabel": "Operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r788", "r996" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Impairment Loss", "verboseLabel": "ROU assets impairment", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1206" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities, Payments Due [Abstract]", "terseLabel": "Operating Leases" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesUnderFinanceAndOperatingLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "totalLabel": "Total operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r778" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease liabilities", "verboseLabel": "Short-term operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r778" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r778" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows paid for operating leases", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r783", "r793" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "verboseLabel": "Operating lease right-of-use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r777" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases (as a percent)", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r796", "r996" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating leases (in years)", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r795", "r996" ] }, "rad_OperatingLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OperatingLeasesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Operating Leases [Abstract]", "terseLabel": "Operating leases:" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r130" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Net Operating Losses and Tax Credits", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r129" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Segments", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r419", "r420", "r421", "r422", "r423", "r429" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r222", "r223", "r224", "r258" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r323" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax, Portion Attributable to Parent", "negatedNetLabel": "Amortization of net actuarial losses included in net periodic pension cost, net of $0, $0 and $0 income tax expense", "negatedTerseLabel": "Changes in Defined Benefit Plans, net of $0 tax expense", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent." } } }, "auth_ref": [ "r8", "r29", "r205", "r259" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Defined benefit pension plans:" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLossParenthetical", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax, Portion Attributable to Parent", "negatedLabel": "Amortization of net actuarial losses included in net periodic pension cost, net of income tax expense", "negatedTerseLabel": "Changes in defined benefit plans, tax expense", "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent." } } }, "auth_ref": [ "r14", "r29", "r259" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent", "terseLabel": "Change in fair value of interest rate cap", "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge, attributable to parent. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r332", "r745" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Total other comprehensive income", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r14", "r29", "r259", "r335", "r338" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income:", "verboseLabel": "Other comprehensive loss:" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax", "terseLabel": "Net amount recognized in other comprehensive loss", "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r8", "r205", "r983", "r1146" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax", "negatedLabel": "Unrecognized net gain arising during period", "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r7", "r205", "r245" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax", "verboseLabel": "Amortization of unrecognized net (loss) gain", "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r10", "r205", "r333", "r608" ] }, "us-gaap_OtherInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestmentsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Other types of investments", "documentation": "Primary financial statement caption encompassing other investments." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "terseLabel": "Other", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52", "r997" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r56" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails" ], "lang": { "en-us": { "role": { "label": "Other Expenses", "negatedLabel": "Other", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r216" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other expenses", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestructuringMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Professional and other fees", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r969", "r970", "r971", "r972" ] }, "rad_OtherRetailSitesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OtherRetailSitesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites not otherwise specified.", "label": "Remaining Stores Not Meeting The Recoverability Test [Member]" } } }, "auth_ref": [] }, "rad_OverTheCounterMedicationsAndPersonalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "OverTheCounterMedicationsAndPersonalCareMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the over-the-counter medications and personal care, a product class of the entity.", "label": "Over-the-counter medications and personal care" } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Restructuring", "negatedLabel": "Cash payments", "negatedTerseLabel": "Cash payments", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r483", "r1048" ] }, "rad_PaymentsForRestructuringNetOfSubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PaymentsForRestructuringNetOfSubleaseIncome", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash payments made as the result of exit or disposal activities, net of sublease income on the related facilities.", "label": "Payments For Restructuring Net Of Sublease Income", "negatedLabel": "Cash payments" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtRestructuringCosts", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Debt Restructuring Costs", "negatedLabel": "Financing fees paid for early debt redemption", "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage." } } }, "auth_ref": [ "r67" ] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Financing Costs", "negatedLabel": "Deferred financing costs paid", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r67" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments Related to Tax Withholding for Share-based Compensation", "negatedLabel": "Payments for taxes related to net share settlement of equity awards", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r348" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "verboseLabel": "Cash consideration", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r65", "r739" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition of business, net of cash acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r65" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Intangible assets acquired", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r218" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Productive Assets", "terseLabel": "Additions to property and equipment and intangible assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r275", "r1199", "r1200", "r1201" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for property, plant and equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r218" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlans" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "Retirement Plans", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r563", "r588", "r590", "r596", "r615", "r617", "r618", "r619", "r620", "r621", "r635", "r636", "r638", "r983" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Defined Benefit Plans, Current Liabilities", "negatedLabel": "Accrued pension liability", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current." } } }, "auth_ref": [ "r195", "r564", "r565", "r587", "r983" ] }, "us-gaap_PensionAndOtherPostretirementPlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementPlansPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]", "terseLabel": "Benefit Plan Accruals", "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived." } } }, "auth_ref": [ "r21", "r22", "r23", "r33", "r122" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Pension Plan", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r564", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r613", "r614", "r616", "r619", "r622", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r638", "r639", "r651", "r983", "r984", "r988", "r989", "r990" ] }, "rad_PerformanceObligationPeriodOfMeasurement": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PerformanceObligationPeriodOfMeasurement", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "The period over which the points accumulated under the loyalty program are measured to determine award level. Also, the subsequent period during which members receive the discounted prices to which they are entitled per their status.", "label": "Performance Obligation, Period Of Measurement", "verboseLabel": "Loyalty discount eligibility period" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Performance based awards", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "rad_PeriodConsideredForImpairmentOfNewStores": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PeriodConsideredForImpairmentOfNewStores", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period considered for impairment of new stores.", "label": "Period Considered for Impairment of New Stores", "terseLabel": "Period considered for impairment of new stores" } } }, "auth_ref": [] }, "rad_PeriodConsideredForImpairmentOfRelocatedStores": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PeriodConsideredForImpairmentOfRelocatedStores", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period considered for impairment of relocated stores.", "label": "Period Considered for Impairment of Relocated Stores", "terseLabel": "Period considered for impairment of relocated stores" } } }, "auth_ref": [] }, "rad_PeriodConsideredForRecordingImpairmentChargesOnOperatingLossBasis": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PeriodConsideredForRecordingImpairmentChargesOnOperatingLossBasis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period considered for recording impairment charges on the basis of operating loss for that period.", "label": "Period Considered for Recording Impairment Charges on Operating Loss Basis", "terseLabel": "Period considered for impairment of relocated stores" } } }, "auth_ref": [] }, "rad_PharmacySalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PharmacySalesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Pharmacy Sales under Retail Pharmacy segment", "label": "Pharmacy sales" } } }, "auth_ref": [] }, "rad_PharmacyServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PharmacyServicesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to pharmacy services.", "label": "Pharmacy Services Segment" } } }, "auth_ref": [] }, "us-gaap_PlanAssetCategoriesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanAssetCategoriesDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Plan Asset Categories [Domain]", "documentation": "Defined benefit plan asset investment." } } }, "auth_ref": [ "r588", "r589", "r591", "r592", "r593", "r594", "r595", "r596", "r616", "r981", "r982", "r983" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r764" ] }, "us-gaap_PostretirementMedicalPlansWithPrescriptionDrugBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PostretirementMedicalPlansWithPrescriptionDrugBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Medicare Part D" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1043" ] }, "rad_PrescriptionDrugsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PrescriptionDrugsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents prescription drugs, a product class of the entity.", "label": "Prescription drugs" } } }, "auth_ref": [] }, "rad_PrescriptionFilesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PrescriptionFilesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to prescription files.", "label": "Prescription files" } } }, "auth_ref": [] }, "rad_PreviouslyDisclosedClientLossMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "PreviouslyDisclosedClientLossMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to previously disclosed client loss.", "label": "Previously Disclosed Client Loss [Member]" } } }, "auth_ref": [] }, "us-gaap_PriorPeriodAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodAdjustmentAbstract", "lang": { "en-us": { "role": { "label": "Revision of Previously Issued Consolidated Financial Statements" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromAccountsReceivableSecuritization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromAccountsReceivableSecuritization", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Accounts Receivable Securitization", "terseLabel": "Receipts from sale of receivables", "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Divestiture of Businesses", "verboseLabel": "Proceeds from assets sold", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r64" ] }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Insurance Settlement, Investing Activities", "terseLabel": "Proceeds from insured loss", "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities." } } }, "auth_ref": [ "r15", "r63" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Net proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from issuance of debt", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r1047" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from issuance of long-term debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r66", "r869" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Lines of Credit", "terseLabel": "Gross borrowings from revolver", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r66", "r1051" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Lines of Credit", "verboseLabel": "Net proceeds from (payments to) revolver", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "rad_ProceedsFromRepaymentsOfZeroBalanceCashAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ProceedsFromRepaymentsOfZeroBalanceCashAccounts", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The net cash inflow (outflow) from Zero Balance Cash Accounts.", "label": "Proceeds from Repayments of Zero Balance Cash Accounts", "terseLabel": "Change in zero balance cash accounts" } } }, "auth_ref": [] }, "rad_ProceedsFromSaleLeasebackTransactionsInvesting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ProceedsFromSaleLeasebackTransactionsInvesting", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow received in a sale-leaseback transaction during the period recognized in investing activities.", "label": "Proceeds From Sale Leaseback Transactions Investing", "terseLabel": "Proceeds from sale-leaseback transactions" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSalesOfAssetsInvestingActivities", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sales of Assets, Investing Activities", "terseLabel": "Proceeds from dispositions of assets and investments", "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities." } } }, "auth_ref": [ "r1021" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options", "terseLabel": "Cash received from stock option exercises", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r9", "r36" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "terseLabel": "Product Class", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Products and Services [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r431", "r814", "r848", "r849", "r850", "r851", "r852", "r853", "r951", "r979", "r998", "r1030", "r1095", "r1096", "r1104", "r1225" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Products and Services [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r431", "r814", "r848", "r849", "r850", "r851", "r852", "r853", "r951", "r979", "r998", "r1030", "r1095", "r1096", "r1104", "r1225" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAdditions", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Additions", "terseLabel": "Capitalized costs", "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation", "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease." } } }, "auth_ref": [ "r1022", "r1029", "r1089" ] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net", "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r1029", "r1087" ] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, gross", "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r1020", "r1042", "r1088" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r18" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r233", "r281", "r285", "r286" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r18", "r281", "r285", "r830" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property, plant and equipment, including capital lease assets", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r18" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r235" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r496", "r497", "r498", "r499", "r588", "r644", "r682", "r683", "r684", "r807", "r809", "r854", "r875", "r876", "r927", "r928", "r929", "r930", "r931", "r948", "r949", "r967", "r978", "r991", "r999", "r1002", "r1090", "r1103", "r1215", "r1216", "r1217", "r1218", "r1219" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails", "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Range [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r496", "r497", "r498", "r499", "r588", "r644", "r682", "r683", "r684", "r807", "r809", "r854", "r875", "r876", "r927", "r928", "r929", "r930", "r931", "r948", "r949", "r967", "r978", "r991", "r999", "r1002", "r1090", "r1103", "r1215", "r1216", "r1217", "r1218", "r1219" ] }, "rad_RebateReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RebateReceivables", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of rebate receivables.", "label": "Rebate Receivables", "terseLabel": "Manufacturer rebates receivables" } } }, "auth_ref": [] }, "rad_RebatesDispensedToClientsPeriodInArrears": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RebatesDispensedToClientsPeriodInArrears", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "The period in arrears during which rebates are dispensed to clients.", "label": "Rebates Dispensed To Clients, Period In Arrears", "terseLabel": "Rebates paid to clients, period in arrears" } } }, "auth_ref": [] }, "rad_RebatesDispensedToManufacturersPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RebatesDispensedToManufacturersPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents period after end of quarter during which rebates are dispensed to manufacturers, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Rebates Dispensed To manufacturers Period", "terseLabel": "Period for rebates dispensed to manufacturers" } } }, "auth_ref": [] }, "rad_ReceivablePurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ReceivablePurchaseAgreementsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Receivable Purchase Agreements.", "label": "Receivable Purchase Agreements" } } }, "auth_ref": [] }, "us-gaap_ReceivableTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivableTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Receivable [Domain]", "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Accounts Receivable" } } }, "auth_ref": [] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Receivables, Policy [Policy Text Block]", "terseLabel": "Allowance for Uncollectible Receivables", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r1066", "r1067", "r1068", "r1069" ] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Schedule of balance sheet information for the Company's reportable segments", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r92", "r93" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Schedule of reconciliation of net loss to Adjusted EBITDA", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r91", "r93" ] }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of beginning and ending amount of unrecognized tax benefits", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "rad_ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to restructuring actions that include a reorganization of executive management team, restructuring that resulted in a reduction of managerial layers and consolidated roles across the organization, and other transformation initiatives.", "label": "Reorganization Of Executive Management Team, Ongoing Workforce Reduction And Consolidation, And Transformation Initiatives [Member]", "terseLabel": "Total restructuring-related costs" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Repayments of Lines of Credit", "verboseLabel": "Gross repayments to revolver", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r68", "r1051" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-term Debt", "negatedLabel": "Principal payments on long-term debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r68", "r870" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r356", "r357", "r522", "r547", "r802", "r959", "r960" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r313", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r400", "r445", "r446", "r725", "r752", "r753", "r754", "r755", "r776", "r800", "r801", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r866" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r313", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r400", "r445", "r446", "r725", "r752", "r753", "r754", "r755", "r776", "r800", "r801", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r866" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Unvested Restricted stock", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r78" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuring" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r480", "r481", "r483", "r486", "r492" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingAdjustedEbitdaDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Charges", "netLabel": "Restructuring-related costs", "verboseLabel": "Total restructuring-related costs", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r17", "r487", "r489", "r1091" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r482", "r483", "r489", "r490" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Lease termination and impairment charges", "verboseLabel": "Restructuring", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r489", "r490", "r491" ] }, "us-gaap_RestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCosts", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Costs", "terseLabel": "Provision for facility exit charges", "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r17" ] }, "us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentCharges" ], "lang": { "en-us": { "role": { "label": "Restructuring, Impairment, and Other Activities Disclosure [Text Block]", "terseLabel": "Facility Exit and Impairment Charges", "documentation": "The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Reserve", "periodEndLabel": "Balance-end of period", "periodStartLabel": "Balance-beginning of period", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r483", "r488" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Closed store liability", "verboseLabel": "Restructuring related costs", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "rad_RetailPharmacyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailPharmacyMember", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to retail pharmacy.", "label": "Retail Pharmacy Segment" } } }, "auth_ref": [] }, "srt_RetailSiteMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RetailSiteMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "label": "Retail Site [Member]", "documentation": "Locations where products are offered for sale to consumers." } } }, "auth_ref": [ "r954", "r955", "r1010", "r1011" ] }, "rad_RetailSitesInActiveStatusMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailSitesInActiveStatusMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites in active status.", "label": "Active Stores [Member]" } } }, "auth_ref": [] }, "rad_RetailSitesInClosedOrApprovedForClosureStatusMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailSitesInClosedOrApprovedForClosureStatusMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites that are closed or have been approved for closure.", "label": "Retail Sites In Closed Or Approved For Closure Status [Member]" } } }, "auth_ref": [] }, "rad_RetailSitesInClosedStatusMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailSitesInClosedStatusMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites in closed status.", "label": "Retail Sites In Closed Status [Member]" } } }, "auth_ref": [] }, "rad_RetailSitesNewRelocatedAndRemodeledMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailSitesNewRelocatedAndRemodeledMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites that are new (past three years), relocated (past two years) or remodeled (last year).", "label": "Retail Sites New, Relocated And Remodeled-Active Stores [Member]" } } }, "auth_ref": [] }, "rad_RetailSitesPreviouslyImpairedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailSitesPreviouslyImpairedMember", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail sites that were impaired for the first time in prior periods.", "label": "Retail Sites Previously Impaired-Active Stores [Member]" } } }, "auth_ref": [] }, "rad_RetailStoreMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetailStoreMember", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to retail store.", "label": "Retail Store [Member]", "terseLabel": "Retail Store" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r201", "r244", "r828", "r859", "r864", "r871", "r886", "r997" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r312", "r367", "r368", "r369", "r371", "r379", "r381", "r444", "r447", "r691", "r692", "r693", "r724", "r725", "r746", "r748", "r749", "r751", "r753", "r855", "r857", "r873", "r1230" ] }, "rad_RetentionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RetentionMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "documentation": "Retention of key associates associated with the exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Non-executive retention costs" } } }, "auth_ref": [] }, "us-gaap_RetirementPlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Retirement Plan Name [Axis]", "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r991", "r1023", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130", "r1131", "r1132", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1143", "r1144", "r1145", "r1146", "r1147", "r1148", "r1149", "r1150", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166" ] }, "us-gaap_RetirementPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Multiemployer Plan Name [Domain] (Deprecated 2020-01-31)", "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r991", "r1023", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130", "r1131", "r1132", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1143", "r1144", "r1145", "r1146", "r1147", "r1148", "r1149", "r1150", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r564", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r613", "r614", "r616", "r619", "r622", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r638", "r639", "r640", "r651", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan and Other Postretirement Benefit Plan [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r564", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r613", "r614", "r616", "r619", "r622", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r638", "r639", "r640", "r651", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Net", "terseLabel": "Revenues", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r407", "r408", "r419", "r424", "r425", "r431", "r433", "r435", "r559", "r560", "r814" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r289", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r950" ] }, "us-gaap_RevenueFromContractWithCustomerSegmentBenchmarkMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerSegmentBenchmarkMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Segment Benchmark [Member]", "documentation": "Revenue from specified business segment for satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r1024" ] }, "us-gaap_RevenueNotFromContractWithCustomer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueNotFromContractWithCustomer", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Not from Contract with Customer", "terseLabel": "Other revenue", "documentation": "Amount of revenue that is not accounted for under Topic 606." } } }, "auth_ref": [ "r1035" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Net revenues as reported", "verboseLabel": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r344", "r354", "r407", "r408", "r419", "r424", "r425", "r431", "r433", "r435", "r443", "r505", "r506", "r508", "r509", "r510", "r512", "r514", "r516", "r517", "r766", "r821", "r1099" ] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Adjustment", "documentation": "Cumulative increase (decrease) to previously issued financial statements for correction of error." } } }, "auth_ref": [ "r372", "r373", "r374", "r378", "r379", "r380", "r381" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Finance leases", "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability." } } }, "auth_ref": [ "r794", "r996" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r794", "r996" ] }, "rad_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Right-of-use Assets Obtained in Exchange for Lease Obligations [Abstract]", "terseLabel": "Right-of-use assets obtained in exchange for lease obligations:" } } }, "auth_ref": [] }, "rad_RiteAidRewardsProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RiteAidRewardsProgramMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Rite aid rewards program.", "label": "Rite aid rewards program" } } }, "auth_ref": [] }, "rad_RiteAidSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "RiteAidSubsidiariesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Rite Aid's subsidiaries, as a group.", "label": "Rite Aid Lease Management Company" } } }, "auth_ref": [] }, "rad_SEIUHealthCareEmployeesPensionFund1199Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SEIUHealthCareEmployeesPensionFund1199Member", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about SEIU Health Care Employees Pension Fund 1199.", "label": "1199 SEIU Health Care Employees Pension Fund" } } }, "auth_ref": [] }, "rad_SaleAndLeasebackNumberOfFacilities": { "xbrltype": "integerItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SaleAndLeasebackNumberOfFacilities", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of facilities involved in the sale and leaseback transaction.", "label": "Sale And Leaseback Number Of Facilities", "terseLabel": "Number of facilities in sale/leaseback" } } }, "auth_ref": [] }, "us-gaap_SaleAndLeasebackTransactionGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleAndLeasebackTransactionGainLossNet", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "label": "Sale and Leaseback Transaction, Gain (Loss), Net", "terseLabel": "Gain (loss) on sale-leaseback transactions", "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale." } } }, "auth_ref": [ "r792", "r799", "r996" ] }, "rad_SaleLeasebackTransactionLeasebackMinimumLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SaleLeasebackTransactionLeasebackMinimumLeaseTerm", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum lease term for the leaseback of assets under the sale/leaseback transaction.", "label": "Sale Leaseback Transaction Leaseback Minimum Lease Term", "terseLabel": "Leaseback term" } } }, "auth_ref": [] }, "us-gaap_SaleLeasebackTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleLeasebackTransactionLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "label": "Sale Leaseback Transaction", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274", "r798" ] }, "rad_SaleLeasebackTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SaleLeasebackTransactionPrice", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "documentation": "The net proceeds from the sale of assets in the sale/leaseback transaction.", "label": "Sale Leaseback Transaction Price", "terseLabel": "Sale/leaseback proceeds" } } }, "auth_ref": [] }, "us-gaap_SaleLeasebackTransactionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleLeasebackTransactionTable", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSaleLeasebackDetails" ], "lang": { "en-us": { "role": { "label": "Sale Leaseback Transaction [Table]", "documentation": "A summary of the elements of a transaction involving the entity's sale of property to another party and the lease of the property back to the entity." } } }, "auth_ref": [ "r274", "r798" ] }, "rad_SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaDetails", "http://www.riteaid.com/role/DisclosureAssetSaleToWbaOperatingResultsOfDiscontinuedOperationsDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to assets sold to Walgreens Boots Alliance (WBA) and Buyer under the Asset Purchase Agreement.", "label": "Sale Of Assets To Walgreens Boots Alliance WBA And Buyer [Member]" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated revenues", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r435", "r1024" ] }, "rad_SalesTaxCollectedPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SalesTaxCollectedPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Describes an entity's accounting policy related to sales tax collected.", "label": "Sales Tax Collected [Policy Text Block]", "terseLabel": "Sales Tax Collected" } } }, "auth_ref": [] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "As Previously Reported", "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r313", "r367", "r369", "r370", "r371", "r372", "r373", "r381", "r400", "r725", "r752", "r753", "r754", "r776", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r866", "r1028", "r1031", "r1032", "r1033", "r1062", "r1071", "r1072", "r1204", "r1210", "r1211" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued salaries, wages and other current liabilities", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Schedule of accumulated benefit obligation and fair value of plan assets", "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r983", "r1155", "r1156" ] }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of target allocation of plan assets", "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall." } } }, "auth_ref": [ "r246" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r78" ] }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Schedules of assumptions used for benefit obligation and cost", "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate." } } }, "auth_ref": [ "r610" ] }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Schedule of projected benefit obligation and fair value of plan assets", "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets." } } }, "auth_ref": [ "r983", "r1155" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionAcquisitionCostsDetails", "http://www.riteaid.com/role/DisclosureAcquisitionDetails", "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureAcquisitionProformaInformationDetails", "http://www.riteaid.com/role/DisclosureAcquisitionPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r133", "r136", "r737" ] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of supplementary cash flow data", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "rad_ScheduleOfClosedStoreAndDistributionCenterChargesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ScheduleOfClosedStoreAndDistributionCenterChargesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the closed store and distribution center charges related to new closures, changes in assumptions and interest accretion.", "label": "Schedule of Closed Store and Distribution Center Charges [Table Text Block]", "verboseLabel": "Schedule of accrued facility exit charges" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of provision for income tax expense (benefit) from continuing operations", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r252" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of indebtedness and lease financing obligations", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of significant components of deferred tax assets and liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r251" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansAccumulatedBenefitObligationAndFairValueOfPlanAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansAssumptionsAndAssetsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansBenefitObligationAndFundedStatusDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansFutureBenefitPaymentsDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansNetPeriodicCostDetails", "http://www.riteaid.com/role/DisclosureRetirementPlansProjectedBenefitObligationAndFairValueOfPlanAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r21", "r118", "r119", "r120", "r121" ] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAssetSaleToWbaTables" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of assets and operating results of discontinued operations", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r20", "r37", "r46", "r174", "r180", "r181", "r182", "r185", "r186", "r191", "r193", "r194", "r238" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of calculation of basic and diluted loss per share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1063" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the expected statutory federal tax and the total income tax expense (benefit) from continuing operations", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r250" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Schedule of revenues", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]", "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments." } } }, "auth_ref": [ "r372", "r373", "r374", "r378", "r379", "r380", "r381", "r400" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Summary of revisions to the previously reported financial statements", "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of future benefit payments expected to be paid", "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter." } } }, "auth_ref": [ "r247" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "verboseLabel": "Schedule of finite-lived intangible assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r99", "r102" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r968" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Summary of the changes in the carrying amount of goodwill", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r968", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of indefinite-lived intangible assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r39", "r232" ] }, "rad_ScheduleOfLeaseTerminationAndImpairmentChargesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ScheduleOfLeaseTerminationAndImpairmentChargesTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lease termination and impairment charges consist of charges incurred to terminate store and equipment leases and charges incurred to impair assets whose carrying values are determined not to be fully recoverable.", "label": "Schedule of Lease Termination and Impairment Charges [Table Text Block]", "verboseLabel": "Schedule of amounts relating to facility exit and impairment charges" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMultiemployerPlansTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMultiemployerPlansTable", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Multiemployer Plans [Table]", "documentation": "Disclosure of information about multiemployer plan." } } }, "auth_ref": [ "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r651", "r985", "r986", "r987", "r988", "r989", "r990", "r991" ] }, "us-gaap_ScheduleOfMultiemployerPlansTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMultiemployerPlansTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Multiemployer Plans [Table Text Block]", "terseLabel": "Schedule of multiemployer defined benefit pension plans", "documentation": "Tabular disclosure of information about multiemployer plan." } } }, "auth_ref": [ "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r650", "r651", "r991" ] }, "rad_ScheduleOfMultiemployerPlansYearContributionsExceededMoreThan5PercentOfTotalContributionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ScheduleOfMultiemployerPlansYearContributionsExceededMoreThan5PercentOfTotalContributionsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of years in which contributions to plan exceeded more than 5 percent of the total contributions for the multiemployer plans.", "label": "Schedule of Multiemployer Plans Year Contributions Exceeded More than 5 Percent of Total Contributions [Table Text Block]", "terseLabel": "Schedule of years in which contributions to plan that exceeded more than 5 percent of the total contributions" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Summary of net periodic pension expense for the defined benefit plans", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r248" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock transactions", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r125" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table Text Block]", "terseLabel": "Schedule of principal classes of products", "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails", "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of purchase price allocation", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r257" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesDetails", "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesResultsFromClosedStoresDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r489", "r490", "r491" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringTables" ], "lang": { "en-us": { "role": { "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of restructuring-related costs", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r106", "r108", "r109" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of restructuring-related liabilities", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r107", "r110" ] }, "rad_ScheduleOfRevenueAndIncomeLossBeforeIncomeTaxesOfClosedStoresOrStoresApprovedForClosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ScheduleOfRevenueAndIncomeLossBeforeIncomeTaxesOfClosedStoresOrStoresApprovedForClosureTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue and income (loss) before income tax of closed stores or stores that are approved for closure.", "label": "Schedule of Revenue and Income (Loss) before Income Taxes of Closed Stores or Stores Approved for Closure [Table Text Block]", "terseLabel": "Schedule of revenue, operating expenses, and income before income taxes of stores" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r95", "r207" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r88", "r89", "r90", "r96" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of reconciliation of the Company's business segments to the condensed consolidated financial statements", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r88", "r89", "r90", "r96" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r653", "r655", "r657", "r658", "r659", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Schedule of stock option transactions", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r34", "r35", "r124" ] }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts" ], "lang": { "en-us": { "role": { "label": "Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS", "documentation": "The entire disclosure for valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r290", "r366" ] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "SOFR", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r1202" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r403", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r429", "r435", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r485", "r491", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r968", "r1030", "r1225" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReporting" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r402", "r403", "r404", "r405", "r406", "r418", "r423", "r427", "r428", "r429", "r430", "r431", "r432", "r435" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SelfInsuranceReservePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SelfInsuranceReservePolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Self Insurance Reserve [Policy Text Block]", "terseLabel": "Insurance", "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR)." } } }, "auth_ref": [] }, "rad_SelfInsuranceStopLossCoverageMinimumOccurrenceGeneralLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SelfInsuranceStopLossCoverageMinimumOccurrenceGeneralLiability", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum occurrence for which stop-loss coverage is maintained under the self-insurance arrangement for general liability.", "label": "Self-Insurance Stop Loss Coverage Minimum Occurrence General Liability", "terseLabel": "Self-insurance, minimum occurrence, general liability" } } }, "auth_ref": [] }, "rad_SelfInsuranceStopLossCoverageMinimumOccurrenceWorkersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SelfInsuranceStopLossCoverageMinimumOccurrenceWorkersCompensation", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum occurrence for which stop-loss coverage is maintained under the self-insurance arrangement for workers' compensation.", "label": "Self-Insurance Stop Loss Coverage Minimum Occurrence, Workers' Compensation", "terseLabel": "Self-insurance, minimum occurrence, workers' compensation" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r215" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Selling, General and Administrative Expenses", "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption." } } }, "auth_ref": [ "r24" ] }, "rad_SeniorNotes6.125Percent2023DueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes6.125Percent2023DueMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the senior notes bearing an interest rate of 6.125 percent, due in 2023.", "label": "6.125% senior notes due April 2023" } } }, "auth_ref": [] }, "rad_SeniorNotes6.75PercentAnd6.125PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes6.75PercentAnd6.125PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the senior notes bearing an interest rate of 6.75 percent, due in 2021 and senior notes bearing an interest rate of 6.125% senior notes due 2023", "label": "6.75% and 6.125% senior notes" } } }, "auth_ref": [] }, "rad_SeniorNotes6.875PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes6.875PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior notes bearing an interest rate of 6.875%, due in 2025.", "label": "Senior Notes 6.875 Percent [Member]", "terseLabel": "6.875% senior secured notes due 2028" } } }, "auth_ref": [] }, "rad_SeniorNotes7.5PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes7.5PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior notes bearing an interest rate of 7.5%, due in 2025.", "label": "7.5% senior secured notes due July 2025" } } }, "auth_ref": [] }, "rad_SeniorNotes7.70PercentAnd6.875PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes7.70PercentAnd6.875PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior notes bearing interest rates of 7.70% and 6.875%, due in February 2027 and December 2028, respectively.", "label": "Senior Notes 7.70 Percent And 6.875 Percent" } } }, "auth_ref": [] }, "rad_SeniorNotes7.70PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorNotes7.70PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior notes bearing an interest rate of 7.70%, due in 2025.", "label": "Senior Notes 7.70 Percent [Member]", "terseLabel": "7.70% senior secured notes due 2027" } } }, "auth_ref": [] }, "rad_SeniorSecuredCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredCreditFacilityMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior secured credit facility.", "label": "Senior secured credit facility" } } }, "auth_ref": [] }, "rad_SeniorSecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredDebtMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior secured debt.", "label": "Senior Secured Debt" } } }, "auth_ref": [] }, "rad_SeniorSecuredNotes8.0PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredNotes8.0PercentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to senior secured notes, bearing an interest rate of 8.0%, due in 2026.", "label": "8.0% senior secured notes due November 2026" } } }, "auth_ref": [] }, "rad_SeniorSecuredRevolvingCreditFacilityDueAugust2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredRevolvingCreditFacilityDueAugust2026Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior secured credit facility, which is due in August 2026.", "label": "Senior secured revolving credit facility due August 2026" } } }, "auth_ref": [] }, "rad_SeniorSecuredRevolvingCreditFacilityDueDecember2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredRevolvingCreditFacilityDueDecember2023Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior secured credit facility, which is due in December 2023.", "label": "Senior secured revolving credit facility due December 2023" } } }, "auth_ref": [] }, "rad_SeniorSecuredRevolvingCreditFacilityDueJanuary2020Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredRevolvingCreditFacilityDueJanuary2020Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior secured credit facility, which is due in January 2020.", "label": "Senior secured revolving credit facility due January 2020" } } }, "auth_ref": [] }, "rad_SeniorSecuredTermLoanDueDecember2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SeniorSecuredTermLoanDueDecember2023Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the senior secured term loan facility, which is due in December 2023.", "label": "FILO term loan due December 2023" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r16" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]", "verboseLabel": "Additional General Disclosures" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r992" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Restricted stock, Additional disclosures" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Canceled (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r674" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Canceled (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r674" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r672" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r672" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at the end of the period (in shares)", "periodStartLabel": "Outstanding at the beginning of the period (in shares)", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r669", "r670" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Restricted stock, Shares", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at the end of the period (in dollars per share)", "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r669", "r670" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Restricted stock, Weighted Average Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r673" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of awards vested during the period", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r676" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r673" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stock Options and Stock Awards", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r653", "r655", "r657", "r658", "r659", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Shares of common stock authorized under stock-based compensation plans", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r994" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares of common stock available for grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r123" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share based Compensation Arrangement by Share based Payment Award, Options Outstanding, Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Options, Additional Disclosures" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable at the end of the period (in shares)", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r663" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable at the end of the period (in dollars per share)", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r663" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Total intrinsic value of options exercised", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r676" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Canceled (in shares)", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r1173" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Canceled (in dollars per share)", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r1173" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r665" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Weighted average fair value of options granted (in dollars per share)", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r675" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Intrinsic value, Outstanding at the end of the period", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r123" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at the end of the period (in shares)", "periodStartLabel": "Outstanding at the beginning of the period (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r661", "r662" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Options, Shares", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at the end of the period (in dollars per share)", "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r661", "r662" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Options, Weighted Average Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Intrinsic value, Vested or expected to vest at the end of the period", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r677" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested or expected to vest at the end of the period (in shares)", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r677" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested or expected to vest at the end of the period (in dollars per share)", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r677" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansRestrictedStockDetails", "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Equity Award [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r657", "r658", "r659", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r666" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r665" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r652", "r660", "r679", "r680", "r681", "r682", "r685", "r694", "r695", "r696", "r697" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardsPlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Term of options", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r993" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Intrinsic value, Exercisable at the end of the period", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r123" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Contractual term, Exercisable at the end of the period", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r123" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Contractual term, Outstanding at the end of the period", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r249" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Contractual term, Vested or expected to vest at the end of the period", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r677" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Shares, Issued", "periodEndLabel": "BALANCE (in shares)", "periodStartLabel": "BALANCE (in shares)", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r31" ] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedLabel": "Exchange of restricted shares for taxes (in shares)", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceAndDepositContractsTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartD" ], "lang": { "en-us": { "role": { "label": "Compensation and Employee Benefit Plans, Other than Share-based Compensation [Text Block]", "terseLabel": "Medicare Part D", "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred." } } }, "auth_ref": [ "r272" ] }, "us-gaap_ShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestmentsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Short Term Investments", "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet." } } }, "auth_ref": [ "r932", "r933", "r934", "r953" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease costs", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r789", "r996" ] }, "rad_SignificantComponentsOfCashUsedByOtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SignificantComponentsOfCashUsedByOtherLiabilitiesAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Significant Components of Cash Used by Other Liabilities [Abstract]", "verboseLabel": "Significant components of cash provided by (used in) Other Liabilities (Other Assets)" } } }, "auth_ref": [] }, "rad_SkuOptimizationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SkuOptimizationMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to SKU Optimization.", "label": "SKU Optimization Charges [Member]" } } }, "auth_ref": [] }, "rad_SmallMidCapMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SmallMidCapMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information about small-mid cap equity securities.", "label": "Small-Mid Cap" } } }, "auth_ref": [] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.riteaid.com/role/DisclosurePropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Software", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Internal-use software", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "rad_SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund.", "label": "Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund" } } }, "auth_ref": [] }, "us-gaap_StartUpActivitiesCostPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StartUpActivitiesCostPolicy", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Start-up Activities, Cost Policy [Policy Text Block]", "terseLabel": "Store Pre-opening Expenses", "documentation": "Disclosure of accounting policy for start-up costs. Start-up activities include those one-time activities related to opening a new facility, introducing a new product or service, conducting business in a new territory, conducting business with a new class of customer or beneficiary, initiating a new process in an existing facility, or commencing some new operation. Start-up activities include activities related to organizing a new entity (commonly referred to as organization costs)." } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "State", "terseLabel": "State", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsGoodwillDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureManufacturerRebatesReceivablesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingBalanceSheetInformationDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSalesDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r314", "r403", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r429", "r435", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r479", "r485", "r491", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r968", "r1030", "r1225" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r31", "r58", "r312", "r340", "r341", "r342", "r367", "r368", "r369", "r371", "r379", "r381", "r401", "r444", "r447", "r548", "r691", "r692", "r693", "r724", "r725", "r746", "r747", "r748", "r749", "r750", "r751", "r753", "r767", "r768", "r769", "r770", "r771", "r772", "r801", "r855", "r856", "r857", "r873", "r924" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r367", "r368", "r369", "r401", "r814", "r867", "r874", "r877", "r878", "r879", "r880", "r881", "r882", "r885", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r898", "r899", "r900", "r901", "r902", "r904", "r906", "r907", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r924", "r1003" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsNarrativeDetails", "http://www.riteaid.com/role/DisclosureIncomeTaxesDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r367", "r368", "r369", "r401", "r814", "r867", "r874", "r877", "r878", "r879", "r880", "r881", "r882", "r885", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r898", "r899", "r900", "r901", "r902", "r904", "r906", "r907", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r924", "r1003" ] }, "us-gaap_StatutoryAccountingPracticesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Statutory Accounting Practices [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1221" ] }, "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required", "terseLabel": "Minimum amount of capital and surplus required by regulatory requirements", "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices." } } }, "auth_ref": [ "r168" ] }, "us-gaap_StatutoryAccountingPracticesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesTable", "presentation": [ "http://www.riteaid.com/role/DisclosureMedicarePartDDetails" ], "lang": { "en-us": { "role": { "label": "Statutory Accounting Practices [Table]", "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices." } } }, "auth_ref": [ "r167", "r169", "r170", "r171", "r172", "r1221" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "negatedLabel": "Cancellation of restricted stock (in shares)", "documentation": "Number of shares related to Restricted Stock Award forfeited during the period." } } }, "auth_ref": [ "r31", "r198", "r199", "r244" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock (in shares)", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r31", "r244" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.riteaid.com/role/DisclosureStockOptionAndStockAwardPlansOptionsDetails", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Stock options exercised (in shares)", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r31", "r198", "r199", "r244", "r666" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures", "negatedLabel": "Cancellation of restricted stock", "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period." } } }, "auth_ref": [ "r31", "r198", "r199", "r244" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r31", "r198", "r199", "r244" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Stock options exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r31", "r58", "r244" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureRevisionOfPreviouslyIssuedConsolidatedFinancialStatementsDetails", "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets", "http://www.riteaid.com/role/StatementConsolidatedStatementsOfStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "BALANCE - end of period", "periodStartLabel": "BALANCE - beginning of period", "terseLabel": "Total stockholders' (deficit) equity", "totalLabel": "Total stockholders' (deficit) equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r199", "r202", "r203", "r226", "r887", "r903", "r925", "r926", "r997", "r1009", "r1052", "r1070", "r1205", "r1230" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.riteaid.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' (deficit) equity:" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Sublease Income", "negatedLabel": "Less: sublease income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r791", "r996" ] }, "us-gaap_SubordinatedDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubordinatedDebtMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Second Lien Secured Debt", "documentation": "This element represents domestic or foreign subordinated debt. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets." } } }, "auth_ref": [] }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits from continuing operations", "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months." } } }, "auth_ref": [ "r28", "r253", "r254" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "lang": { "en-us": { "role": { "label": "Supplementary Cash Flow Data" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSupplementaryCashFlowDataDetails" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplementary Cash Flow Data" } } }, "auth_ref": [] }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansDetails" ], "lang": { "en-us": { "role": { "label": "Supplemental Retirement Plan", "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "label": "Suppliers", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r81" ] }, "us-gaap_TangibleAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TangibleAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Tangible Asset Impairment Charges", "negatedTotalLabel": "Total", "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value." } } }, "auth_ref": [ "r179", "r236" ] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Amount", "terseLabel": "Federal business tax credit carryforwards", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r130" ] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]", "documentation": "Information about the period subject to enacted tax laws." } } }, "auth_ref": [] }, "rad_TaxPeriodBetweenFiscal2029And2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "TaxPeriodBetweenFiscal2029And2031Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to tax periods from fiscal 2029 through fiscal 2031.", "label": "Tax Period Between Fiscal 2029 And 2031 [Member]" } } }, "auth_ref": [] }, "rad_TaxPeriodBetweenFiscal2032And2037Member": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "TaxPeriodBetweenFiscal2032And2037Member", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to tax periods from fiscal 2032 through fiscal 2038.", "label": "Tax Period Between Fiscal 2032 and 2038" } } }, "auth_ref": [] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails": { "parentTag": "rad_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureAccruedSalariesWagesAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Taxes Payable, Current", "terseLabel": "Accrued sales and other taxes payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r50" ] }, "rad_ThresholdPeriodForExpiryOfUnconvertedPoints": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ThresholdPeriodForExpiryOfUnconvertedPoints", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period before which the points needs to be converted.", "label": "Threshold Period for Expiry of Unconverted Points", "terseLabel": "Threshold period for expiry of unconverted points" } } }, "auth_ref": [] }, "rad_ThresholdPeriodForExpiryOfUnredeemedRewards": { "xbrltype": "durationItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ThresholdPeriodForExpiryOfUnredeemedRewards", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period before which the rewards needs to be redeemed.", "label": "Threshold Period for Expiry of Unredeemed Rewards", "terseLabel": "Threshold period for expiry of unredeemed rewards" } } }, "auth_ref": [] }, "rad_TopFiveCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "TopFiveCustomersMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the top five customers.", "label": "Top Five Customers [Member]" } } }, "auth_ref": [] }, "rad_TopFiveThirdPartyPayorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "TopFiveThirdPartyPayorsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantConcentrationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the top five third party payors.", "label": "Top five third party payors" } } }, "auth_ref": [] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.riteaid.com/role/DisclosureAcquisitionIntangibleAssetsAcquiredDetails", "http://www.riteaid.com/role/DisclosureGoodwillAndOtherIntangibleAssetsIntangiblesDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r139" ] }, "rad_TwentyPlusYearTreasuryStripsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "TwentyPlusYearTreasuryStripsMember", "presentation": [ "http://www.riteaid.com/role/DisclosureRetirementPlansFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information related to treasury STRIPS.", "label": "20+ Year Treasury STRIPS" } } }, "auth_ref": [] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureFacilityExitAndImpairmentChargesAccruedFacilityExitChargesRollForwardDetails", "http://www.riteaid.com/role/DisclosureRestructuringDetails", "http://www.riteaid.com/role/DisclosureSegmentReportingRevenuesDetails" ], "lang": { "en-us": { "role": { "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r482", "r483", "r489", "r490" ] }, "rad_UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about the UFCW Pharmacists, Clerks and Drug Employers Pension Trust.", "label": "UFCW Pharmacists, Clerks and Drug Employers Pension Trust" } } }, "auth_ref": [] }, "us-gaap_UnamortizedDebtIssuanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnamortizedDebtIssuanceExpense", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance costs", "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset." } } }, "auth_ref": [] }, "rad_UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about United Food and Commercial Workers Union-Employer Pension Fund.", "label": "United Food and Commercial Workers Union-Employer Pension Fund" } } }, "auth_ref": [] }, "rad_UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember", "presentation": [ "http://www.riteaid.com/role/DisclosureMultiemployerPlansThatProvidePensionBenefitsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to United Food and Commercial Workers Union Local 880 - Mercantile Employers Joint Pension Fund.", "label": "United Food and Commercial Workers Union Local 880 - Mercantile Employers Joint Pension Fund" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits balance at end of the period", "periodStartLabel": "Unrecognized tax benefits at beginning of the period", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r702", "r711" ] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decreases to tax positions in prior periods", "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r712" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTaxContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued income tax-related interest and penalties", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r710" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesTaxContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Interest and penalties related to tax contingencies recognized as income tax expense / (benefit)", "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r710" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases to prior year tax positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r712" ] }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Lapse of statute of limitations", "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations." } } }, "auth_ref": [ "r713" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesUnrecognizedBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "verboseLabel": "Unrecognized tax benefits which would impact effective tax rate, if recognized", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r714" ] }, "rad_UnsecuredUnguaranteedDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "UnsecuredUnguaranteedDebtMember", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementIndebtednessAndLeaseFinancingObligationsDetails", "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementTransactionsAndMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to unguaranteed unsecured debt.", "label": "Unguaranteed Unsecured Debt" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r85", "r86", "r87", "r279", "r280", "r282", "r283" ] }, "us-gaap_ValuationAllowanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureIncomeTaxesNetOperatingLossesAndTaxCreditsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowance [Abstract]", "terseLabel": "Valuation Allowance" } } }, "auth_ref": [] }, "us-gaap_ValuationAllowancesAndReservesBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesBalance", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowances and Reserves, Balance", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "documentation": "Amount of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r360", "r365" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowances and Reserves, Charged to Cost and Expense", "terseLabel": "Additions Charged to Costs and Expenses", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense." } } }, "auth_ref": [ "r363" ] }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDeductions", "crdr": "debit", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowances and Reserves, Deductions", "terseLabel": "Deductions", "documentation": "Amount of decrease in valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ValuationAllowancesAndReservesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowances and Reserves [Domain]", "documentation": "Valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r360", "r361", "r362", "r364", "r365" ] }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesTypeAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowances and Reserves Type [Axis]", "documentation": "Information by valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r360", "r361", "r362", "r364", "r365" ] }, "srt_ValuationAndQualifyingAccountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsAbstract", "lang": { "en-us": { "role": { "label": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS" } } }, "auth_ref": [] }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "VALUATION AND QUALIFYING ACCOUNTS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r290", "r360", "r361", "r362", "r364", "r365" ] }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureTable", "presentation": [ "http://www.riteaid.com/role/DisclosureScheduleIiValuationAndQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Valuation and Qualifying Accounts Disclosure [Table]", "documentation": "Disclosure of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r290", "r360", "r361", "r362", "r364", "r365" ] }, "rad_ValueOfEachRewardPoint": { "xbrltype": "monetaryItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "ValueOfEachRewardPoint", "crdr": "credit", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Value of each reward point earned.", "label": "Value of Each Reward Point", "terseLabel": "Value of each reward point earned" } } }, "auth_ref": [] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://www.riteaid.com/role/DisclosureLeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Lease, Cost", "terseLabel": "Variable lease costs", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r790", "r996" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.riteaid.com/role/DisclosureIndebtednessAndCreditAgreementCreditFacilityDetails", "http://www.riteaid.com/role/DisclosureIndebtednessDipTermLoanCreditAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "rad_VendorRebatesAndAllowancesAndPurchaseDiscountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "VendorRebatesAndAllowancesAndPurchaseDiscountsAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCostOfRevenueThruEstimatesDetails" ], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Vendor Rebates and Allowances and Purchase Discounts" } } }, "auth_ref": [] }, "rad_WalgreensBootsAllianceWbaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "WalgreensBootsAllianceWbaMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Walgreens Boots Alliance WBA.", "label": "Walgreens Boots Alliance WBA [Member]" } } }, "auth_ref": [] }, "rad_WalgreensMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "WalgreensMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDescriptionOfBusinessAssetSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Walgreens Boots Alliance, Inc. (\"WBA\").", "label": "Walgreens" } } }, "auth_ref": [] }, "rad_WeightedAverageDiscountRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "WeightedAverageDiscountRateAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted average discount rate" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average shares", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r386", "r396" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.riteaid.com/role/DisclosureLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r384", "r396" ] }, "rad_WeightedAverageRemainingLeaseTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "WeightedAverageRemainingLeaseTermAbstract", "presentation": [ "http://www.riteaid.com/role/DisclosureLeasesSupplementalBsInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted average remaining lease term" } } }, "auth_ref": [] }, "rad_WellnessPlusProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.riteaid.com/20230304", "localname": "WellnessPlusProgramMember", "presentation": [ "http://www.riteaid.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFyThruRevenuesDetails" ], "lang": { "en-us": { "role": { "documentation": "Wellness membership plus program.", "label": "Wellness plus program" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1D" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21B", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21B" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481097/715-30-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "60", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "60", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481408/470-60-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "80", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(a)(b)(c)", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "10", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483478/205-10-45-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-6" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-7" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "S99", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480781/205-20-S99-3" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "70", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-3" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-4" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "30", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-5" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "30", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-6" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-12" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//944-40/tableOfContent" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-3" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-6" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479956/944-505-55-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479956/944-505-55-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//230/tableOfContent" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-1" }, "r228": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r229": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r230": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r231": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r232": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r233": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r234": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15" }, "r235": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r236": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r237": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r238": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r239": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r240": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r241": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r242": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r243": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r244": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r245": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r246": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(d)(5)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r247": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(f)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r248": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r249": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r250": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r251": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r252": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r253": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r254": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r255": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r256": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r257": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r258": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r259": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r260": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r261": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r262": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r263": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r264": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r265": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r266": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r267": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r268": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r269": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r270": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r271": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r272": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//944/tableOfContent" }, "r273": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r274": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481295/840-40-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Publisher": "SEC" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SAB Topic 11.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-3" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-5" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r951": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r952": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r953": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "SubTopic": "320", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r954": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r955": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r956": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r957": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r958": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r959": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r960": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r961": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r962": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r963": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r964": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r965": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r966": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r967": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r968": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r969": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r970": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r971": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r972": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r973": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r974": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r975": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r976": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r977": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r978": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r979": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r980": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r981": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r982": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r983": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r984": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r985": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r986": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r987": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r988": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r989": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r990": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r991": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1012": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1013": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1014": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1015": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1016": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1017": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1018": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1019": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1130": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 137 0001558370-24-010167-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-010167-xbrl.zip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

P=0)I M*X=SW/5J5DPFC85P3RG=(IM?&S_\W]^(W.&D,X =90]5(N<;+WEJ7X9-=(<# MCG3+"ULWT DLJ+JN-W75P&F9 [2MW[UH+8YW7E 16M]>>8Q"=;^O:-WI+:1& M?7ON&W77F>4H[KI#U%%A=B/9V+V@UK&L?[0S/@B%AJRYIU]IQ);OD(?ES-^R M29%Y>7PWZ_)U1Z.TY01'MPW\MP5Y$OWQA8!7 MZY$M\T67IE8%PUZZ;%TT:#:#TPK&XE(L.73:P+TB&:71%&;Q/;F/PY M<%Z\ MQ(?=+]@:JY_0E:^$3+J\<8+<5._*CIZ!(>3I=LW Z9EEF\KAY)!>S>39\J@0 MWAFQ753MEQE9BV"I+N\G=,3?W001O6;>JD:8I5P5]R@=HK]BP&59#^]8'B2] MF=!+/MA%<#'OAWR#G@CO:MJ0@$E!$(\^P3L7Q85[P"#8[KP@X>O E=B6&%>YH$L3^ M9=28M,:JBI_94IT-F8\TXML70A![*CYD7I(Y4W))GX*(GSZWJ:J_K^G[XBKM M8UQ3(=^R;=JAZ:V!DT<&:%MN3'871[X'J2B\]J99T7Z^*/&/KPWDNXW3;B!. MIO9C?'#M*N]B\HAU)U^:-BKK8!=*K(B55JQE49P,I:)?^ZZ2*#<33^=06D.[ M1A9V1\KD?.K3OQ7E4"3>LJ(FRMLK=]X;3*XI6RS6E&X!IJ,X;J[ITU/FF[:R M>#FG5V+M..2\84@-4_<")LX,:EW3NLMW6IQH.$V48+F_#Z\GU--. M7[["95N(KK>Q7<(25+"(Q^)<,,9%D#(KRH)H3_W;7?XL";QO OG/KI@I7>07 MVV[7C44_4S9OY8^R/'JO+3";[P4WZUA"5>8EPUW@92Y;BNH:,7]X3N0O)+<1 M$;T'15:#XJV%NX1FWJL33L,&&(/B([PZS-/],Y18STXV>QJ5O>-[X+?K<_$7 MQO;7T7,,X!K+[&-Z&-F3&="4]/4QV7Z*(3*GPAFWEESZ0,:7#@YAD.+ M<&VC,HB>V;_CY(V'E:8*]T6J7"BS9M7N1S(L=/-.6+7C^0W3?;P#5C7UL(45 M5G7Y&@@ZA!\?SG1SSI@@1:[+KTF\WWV-LQ9P:M?3H4P8IWOV=405'\)S(WL8% 7XKCB?:&? @KX(D%OE6".8F-A\+ MJCE&:8F17W7BG._*3]R(3J^;-[RA&;'8(&Q:"4NIE9EPTS!=IJ,AQ[[4U #= MZ]]8;HQ9'Z!"?DFQ2$#2XOP8:Q0G6YC%K B.']\B[OAY@_KI9VT:0GC2 MASALNW,]KD6<9&T0+4T?[["YDW#V6I6:SNL39ABO>?!<2D *[!Z@<=0,)+%I M= GAJ#GQ1-*=4MH!BA[>'S+5)DZ.,8I8X0^.;A"W.VA./6UOD&9DE5 _8,Y- MEB7!/VD 2F/.93ZR >KWY"8=/U?V=X!S,K"'I:;_V=/Z M2;BCJCI.M63.27Z50D+IDKL-JL"!K.?GPE)1X'3'@:9H9H\#C!D^&\EJP MTJ2X@]9.@M+:=)KR=%=(,!>J,HU8J;]^;HZQYRUI<6/E-H+(L46VQ\/2^+JVS M_"X5_"PND!:O%+/.1>;$]&A]?["0#THJ]&4JC$L=L9X0303^T-4\X;<#02ZX M&PB259<""1>.@'1$B.=@[8\/XE^E:X'54%Z0B&:.COG3XMP,1(,W P $FGZE M!D[[.]L^B6E'-L__VAD]F6E%4<\QTPDQ+FE(.MM\6!?LSEH,5:11''ZM? M A'3)QT!+U@#VV4047\Q=K;!.ME8_B0Z40EI%9+ !2),(B)$6I"O1]1I9L4" MZ;4,12=8A!,VEXM]D]81C.@2$H@C7N8B)[!>6XNY2BY MJAN@KDMB(1^6-*+K(/NN6B0TLY*3QV=7&^KO^88&D\77@*I\],[FCQLO(01-UOFM'P"XYW@IBP[F-;>MS7: M UZ2LZ2G]B%U+@YPG"P0J20BA4C"_9"$@DJ%6)"$B'#!R#]KM$3JSMQLHD%RPP-[0: /\DWTXF2 7VYW8?Q&Z4,6KWZ_W8'1 M=[[OW%4>]Y#NU50>RZV%\0[B?I%'+-1H)(8NM,U68TV1Z-,]P!.L,NIS43J' M:EM9W,.T4\.C-W@."^(=GMWBZ@[-WZ)GUB[U2=4\1+*L?L?C+"B[5C<][Y@; M;!ZW"9C&T:#/?X/_S73C&IKVY@(P9!-LXXMR^B4.?87H!D%&_)^W;F/9PT]AHI&3>TFX,+U&-5VE,Q$?]Z+CL M'J*0A !$E@#N:7(97.=J"E%6Q-=HR@Z)'F/1'0)GHSHE$B] MHB&1R6&ZH%&\#2+T[/'92X/52-"*-DZ#-VJ(Z) &;V#^C%%78R*ZX)VB9@@S ML/!6R$L!CI>#D_+>$/%%3M]'* P#L:.567)&'RH*K-'6Q.QXHU>1:1T-3-QA M#9K"J4+$'X=;0+F(_"KW&CMR:%L^7V-GV+MO& M34I&$31XTB0:QDM@9M5S?,:TR!\EFN/QDB$DU%Z&]U3+[SD#X=;N^2^#V0/;6$',[JB&&^ P_5;P$98!7?2?G_!"(CI:$&@?#*CHP714 MJZ[!0 AB(1/(V!C8JM?"#$VD&XU>VVBN/C.CZ%'"@#68#WGM&?WW-/."\"'( M:&/(8$L1O..W39]B@![^'><(;)52?XA!@P1:)-]$FSI#K#$I4"5L>AV=K;BW MQL;R/FT<46HU< ZP =H6:7EZBN-.MJ,JO'[8UCI.ML*#!E)EQ,>SH<,U MA:Z91RT>/18OX.VG3:5F&P/19)['S*9M?J4O]Y37I/Y9Y-_3;>S3D/HJ5MI; M=Q;VJH9 @^5V5YR-#2NJ8=F:LXV7$0A?C>@+^;#STHS]E%!*WJB7I-\M6.E< MQN*O+W'^-Q(G[*^YU&R%#7^%OWSGBA$L(RK-VBEA?<$SA04VD*:J[._C9"QR ME]#G(-ZGX=OU=N<%B1I_=-2:!7/T:=W &6U59L,6O0I,P1,O%!+MY/WS!U1@ MYVT=), +P1:2\)!=$K#?Q?,ISGP#:VC5.*#JA13=3&?ZU]%Y&*=P34G=N6^L M,0N3[]*VT;D_+CX;4^\4WKYSO^*=.W?N+6!0,][KB(@NB.C#N*WR4V!)I583 M;2V(US*[=2L,LKD4;COLD=FR^45Q)I*=OP0I6U_OZ"I8!W3:9\@L(<"\XUSI M?&[\RG3]0BE/7@K9>^_I*H:(J&40!MD;>81W&DS;Y!UW2\[C* U\YLOX5W$" MW280X"6F:+I;71;9%>%6RP0_=GT,(.)-O%:NC'$"E(8W2!N_C"G MGKZA[9ABK)-4>LB0K$J)N-^>%#+E[CP(159"*LA:#S67( X[A%1*0\SJ>I1"DDH*<5WB6@HA'%+@HD[^TC0:\@\$H#4&>K[W8 M5$F;7I/0YOXBP/<&:D!BD&+-UH!45UF\7-VK8<'!K05Q#R@CU<.B M?3XZ7S;!:M-$DQN/+?27E$:<39^BX-\3>VKV\,BC]F_7I&R[W.*8G+8L?G;( M@RU]^')KJQP!+H)E*]ZE3,J*F(&&#^!1K(*3LH;H*T>L=I7'%T P2&K=@2RY M%]#Z0O9"H -'"9NMZGQ_^UOQ/EA%SJ:JEN)3L38D_T"QZ_'V]$];U:\]2;1RN1>@&7]#K^FQ1VG M2OK;]5?ZTOKBYX"J>,EFJ/X=VT2-]7 3TF MK&[ZU-?9$/ A5MBN=W#L0-*\ M47-=PX#U9N/-2LW-&*LX*(Z%B7BOC)S19;_C!F;+@2U8*#+A0>U9\V&;+A.R MXN'N(R9N- V/"D-6(6XX>=(2)K9WJ$=O$LD8W,1LA1T\4U^\9/S?- 24?DO; M'O%1K8N34;40D/>/E"KBW4@:)KYVP$)MQ$,_'WE'Q:/?T-5'9AH?]^GA9=IQ M"/2_]STM$%SUD*N>[S9M6..+A@,!1YMLDX^'9G5=L]YC_)F*QWJI?[L>CM51 M_=FR7S,2B@Q8KSQ+%FQ1P1839C%94E)TR,K@HT/#B#13(G>44B^D4W%C;\8* M)V,D5WA1Q-&NO14$M 5N"/,K8Y)]DC#!A-XM2#44PTU_;7K5KQ"W#ZBSR#UE(Z:55S49Q&[ 9S)I?4M5I$2\Y&-)+.^&2]%)J(8#(NE2( M0$H9B!?Y#1Z2PX=1K]BT_'<@B\]O7Z@'V?A@DKY*Z+_V-%HU)5L:5A.WD0W0 M7K8DA6IXS66(\+HV(35,RI8=/O]9ZMRD<><+H&HU9S+*^[5O'.7MU68PRA6$ MUQWET ?AG2Q(RXAW^")H$P(I\S@32$T(@3B=CRZJUY[?V.] H6_\-U2=EPUT M*: =#"TU*2[%./9DRG_^=T 3-E@V;S?,,0O5G)GNRC,9[4H8M+@T'35G,-;5 MY#=!^67SR!R;]!B P2Y.5QLS,8$AB/32?EL#,S"(06J,MPO9+#!X/]?1;I^E MG %^5/-X&FO,9-"W:]LXQ(^+SV! =PBMO1T,C9$?L0S43X,'ZJ<9#]1/PP;J MISD.U$.AQPW43U@&ZD^#!^I/,QZH/PT;J#_-<: >"CUNH/[D8J ./ 6X.7QF M_@"E$(UCM$;Z,=EZ9T@@ >$B&,L&=!@D5^I<,D?UB-,! MC!K5<5J++@[%[80A=7'?3=#2Q%P(59F(MXREVJ<\H68$B/P[6D>A)/!>/#"(=RKVP9. AZ%2.TAMR$- MX'5,]-0P0![\-H.(7ZW88S$=??0_P#8I,LH, I"YHY"A=#%?:AA$ S,T>7OF M/:410T:I?B.VH2M/9N7V4DY]T5BY.I!AF8HX_&O^'N-M F]%)G1#HY25%S_" M6I#]YS*DEQ'SU),F1WVJ/G$3PB2(-U\8LM A7F*:1NWQETX61QLFB\JEX>NA M4DZ8S(50\'Q+3=;B]V^5N$22U\DYYR.#!@0Y2/N3YRAM^6R]E7!;MYK.LGEV MU\!K7XIR:\^(>?-'R:N*S+P6;^H]]CD"MG77] 8:-TJOQ!VVM[/(O_S7/MAQ M1H24?I>O02%QZ_,&@RKCM$P]#(HM4O6:N#=(-?30ONC%?&*(MF23E5?\"OAVYTN0;0AE_8IC!#:5^?PV)VR4KLERSVK#%BA_J% \MCYJ8NL.8&B=?(#VOX/'!XHNB-2'DQU,NUJ79BLSMIL(#6F> M.8_3UFOWC05Q&VB[;O5XB<-2>$VQ0U;]& >I2<+;=&)O%E2[2^+G((5GK&#O M?VW(Y)I32'IO(JH;GBF1%/E*L]OUPW[)W3.Q9]'@+PRKC=/H-%$H,T>J5\6] M\M!1Q%2R[W1#=GGW9.OY[(\BF233V]1 MWDC(ES-5DIAI\TU.B&O1%[GBSR7)!,FZ@Z=&B@[S?Y/+(LO@][ MFYSM=HRT>>;,M1 M35,YG$32JUGC$T5%(;S+GW91=4=K]1A1T:23Q8]-Q6BS8I-M"J:PBP)O-$(8 M6'J[[DSNUUD!M['UZWJX%]A<&J_Y*T4@2+<&YA:XXV M8NNKA-NFU72NS::=-?#:MJ+O>'M MY)N 8'Q\0A%;>OY^Q2?90.SQ00R]5\RZ]'4%<0E!(5I5;U7DMLTW']FJ&/8. M$^J%P;\A?Z8(QE^07;B'*V!O9 4;^M#H)@[YT^,0O2 V(?/8B6P3\RU'T=G4 MNXLV\2_;)E+C5L*Z5&(3IM$TE#1U>+I9QJX+?PSN"@?>,M^^SK/Q^+?1?9$R MC160,ZA]A@1J78F/3;:/DX"M(=F8LF%LXWC]*_,J&L@/)>>C6I"R;T[.M4R" M&+(BCP#NIB>OA.D^3M^4CQ U;H1"K,W8<=E@YC MYX)U);$P@JS":U&X !9+N&K_Z3J"4U?=(]'1O AW9A[C+QZ<^F9O#Z TQZ4$ MK054E7JX^4M9BOAY1EUT76']@5=9J1J.+^0E<4?MWFG\JU4)P$WFC"^X6T#JJ8+;JE7TE0VZJSQ>6U:2>E2B M'F9*6P+=+,BO29RZ.<^TJN;QRTK\)KMX7XFK'T0^$X#Z<*_&A>W"AX!H<8"A M;SYN*XO;6CLUE,VTL2!>^^P6UY1A.IY,[2AYF6;!-H\0E=.Q8#-.<;;SZ+V> M[;--#%-]QV,$K85QFV>WCK5L"8TE\1IHC[SZ.]?\/)*U2\J&';XE<*QEY[,! M'<7G-D[;'P-H*SNGL6HHQ7_S:'68XI^G[."96%=>^#]L_93Z 3]8[$Q*W5\+ M]^A5U+KV\&-W%;QC655PW2'-VW?B#;G0;$3$1TXIEZ]><1GUG]1KNAG1412G M6:GH5P5Z-)?#'N71([7VA26:!+'/O6TV)]"J]8F#*"RI)\UW4M,+ HT["*"P MJ^7!%W0QG4.JK3B"G<\B51A7EP>O?:8170<97(H/HGT0/57QMV?+E%^4;R': M\:WBY"W#J,GNPL@F\;H3IA33WD,L^Y>2S E^X3*0#[D4WRU()8@4:\X6A[DL MTZ:7P0)@_6Y](%-7#N R!] )@>V3A&%CD+O&-(BP<>.X+R# M9L-W:=;6-,\;=FBVM0VA@<;;6W<6)JR&0(,A=U=$;\Z*XH\U:MY-_G;8"J-Q M6\9!=T?4\K) RX^9BTGWZ*SNPJ,WXCZY;;KB3I[IL*PWS\Y-5I5+C6.)?T'7 ME(GDFUOCCVL1-PL80*L>?*G='%[^,*&4?@2VZ'N."WT4N $O@4<5PRT-)XO^ M0I1\ 3/,R5"N/ ^:4<.@B5&Z:^(G#T7Y1X_W8F-@!P*P$M'4P"B[.-A1X72,]QFHWA:]CZ M;,W;ND6CVUZPK;G87_!E1Q[%!L. Y4Q9])Z"V01AP'_OV6\PV@%NIC"/9>/- M@-&MX^4?"SIJ7_1:KRF\&D!EKKH'/Z3>X8*("Y^N]R<005=O5J0]HYSN5G!Q M+H5DV"+56KZ\*[8UH)BX2(!&$YK(?Q,P1^0\;+Z&?F:R^_(<#;&WWA9/Q)D'XZ,J0Z8YF M_@%AY49TGV MI]T>2BW?X&V6D"<1X7VS.FD6K$JWJR(3J4'@E112!.W@"9C7XD\?0IZUGB?' M757G1R _F(+ =_4IB+^)'+6/NCNXMFZ.#^VCB $:T^ MFG>;6U_V&=X*SOET)"H*:X2V)F:W"NA5Q/[N2/O9#:3@P^?@6X-, %'-M/E; ME)9]^,]>\N0%T1V#;\/$^/4XOYH>8L_> N/?[CV YT; %) M2"Z\%*"278XJ!B_5QH=N=SOSWDC1'8'^L'B0-J#X?/#)^5@PQ>#EG%K;.JHK M=4%7"3QY>[N^2^AS$._3\ U*),Q3E=)&-Z!DMG6\\SC-&K.&6^E@WK/?<"R'3(#JK<]_#M30]3_3X/!C M!")MP];.#/A[>^@FOPE'A?K\UWA"L*B?"X!@3K;D$");QVO5?D+B\@"@"8\O MU OA$:'+B,&=L>4ID-RP+= AS>*<"DWCIG!FH-SF[ X1AFOFC,ZX6'R2JPF& M\9QA.E3_O[T7!NL GBR !\/ >TB],(Q?/&8_YH\?CEC[;/6O?2">N0>";GZT M>4AMG)RCB<+Q"41O5=R.LXXB__&*!WK%7H4D]X(=G3W8_\(]8:12?]Q]=?'2 M]'1@'$:DK(*4CROD+FES? Y ,G[*[&P;YT1A!4%-#[6]X9-P4Q74<^:K/DC! MCCB6X;@ ?LCBU>_D.!@4$=F=;YAJ]#HJ+H^R N(17WAK3$P!A9\]#.IA#<^2 MYC2P4^"X :W.CN!T=+//;D(J.*0L+W=#V?QQ[E(T4LJ&D=JFA+:"9,PBW!:E M\1CK\J?HB;\J/@S,MB9F25.=>"@04F/]V5%/MQ;V24;<9) $(%P"C%1B!RK> MJ@N:D*XU]B6V:;IJWH+=^%9QDXDAU&1^&=DD7LHQI=C(J[7Y385%=55AH9.F MT@D5N8;PNMKAS'=*2;Q>,_^)>$W\/ EQ-9\G#^"H00W@IJ/A6,C,HUX;+\EH MZ&#?J[FC3$-'WLN$@-P^ SF%Y0$(";8[;Y617:/ZDS_]=[3F P:MHAP'//>G MWA)NNAB!3MNS?HK-X"60,;ZO:7N%^RI5SZYS4+D Z2%XBH)UL/*BC&\3 M5X#5DNUY%6#C0IA'<\\1,%]IIIBSOZ4*;C91T;693>;S\H"3UZ+29E>DO M".O M;U/HW1EODXSWI=*LG\4O^5KJWN:TN29 L6=K5;)'J*XBKW=JSBYB/?+ M;+T/V=]@-=2VX+#2T$Z]@]DSW4 L M!W*=8NNS9KNA.D[ =[7@1>"\0H@%*<0J?\+*>%/!>L$U@:-\?/-+OAGII$#V=)0F$9H(*31<'%:OA MI(VA>A=7!57JX+XC.$B#\9<#CT^"CB[4972[BQ,O>9-N$:;B1EXH9".>)-RD M]^TF0:N1^G+-Y8XFOV WB?9YN ,P/<]^A.V,D/WCG/UWD)VS4?BVCI,7+_&' M>%O-M7'RHB8*??Y20]5Y.41="AA?YXG.2*TW-)Z/#21$FSC,O:0C<-NT3+ZS MA9F9?3\:G:;?7GU&YJ^@A%$*J"9$Z! C#5A$!$(KXLHCX$LG'+P VT3* .6% MYV;MLH[=A@TEYV3#-7G-FFO#_2!7=FE$2V<7GH[T^35A]J^J?%%X9C97T['3 MYGC)&=E<75ZC-L>;=OI8M6$MQ1O53]!64_ L"FM4SJQP"JD3-',CS#KYP117 M\!O-N2%5@5'C_JO0/:)/7D;]0>;M) N!D2_]3)-E/-"!.-V<"TWQTJJHB*(S MXRM)O[X0_QDQDBRM\9#^>&V=B;3=#!.*"R<#GWNA?N6OM])LC%3Q(E]WC5D8 MKHV;9S43ECK(5P:(+N=8U1XL6#HNT[FCTQ<1(,E_&+?E[0+&)\&_J7^[S]+ MAV1T07I1GN%V'RB.:QBGG9O'KB'N8$2KLXE,,*&CX=@%]ME3^J^]"$XX#&&( MA2B0,C%(I3 &5[$*+O%KX^:C\%4BR4)R80B7AE3BN(QY<(GB;K4GR.-] 2J#JX\-W*P'H19XP'GH9C3@W$8DYD$3QON$N_9?[C?,RH39ZE? M=FZI,@_K[]*WR>";RN.W\4ZI+>T4.=WD!9S%'M>9AP3U: M=Y[0U*O@M^,^P4V?V^ XH#&L+)Q'(3FI*6E*I*A\HM'J[1%VOEJ@Z2J/VUI[ M-6W,.G]8&*^%]HL\,@TQO[U0M4V^\=8/#V&YKMDRB]C\/P2D3NMV ]0;>XC6HJW&6[M-TG7M.> M3'-==CAX S->$UE$SAI2"I9"S/RME)14@L*I82&J2%,NA"7?0%R2R^LF?&&& M7V%)GX*(X\H?E(TXZEYYDKN7/U)6O97@Q)]N@;/E8[27QDVQH$L3^9=09#SV)IK)!DJ470M0E\3(PX^)]:2&L/1@>,B_) M< '! *A8K0L&EZ3%O.4$3@C2>YKN0_"6KQ@+W#$IDSLN*RM[%XN'F @=F='M'K:&6=E_DH5%X24@HB\-5P4(F3A54IIG#AT*& L>P/7 M=\J->PDEOUP*/2VJ[H-:H;6C3LZ0V+?P4J&U0N[.C-CWM+%!;(8@C:E._ MLH<"R+(WGM!,9C1XGEFPG7#>,%'##,=W,CAZ-*&N!+4NY#NF22P;+MTHVD@L' MOTKBX:)/IT"7H*454F$K4BX9]''C9?^(]Z%_S1]6+)]V?!2/.@[#O+^Q6?*@ M(D8*5-?3TNS83%4?XX1%,M8SX5T3T3>IWDY]S!]-=924 -6M8VXETVPVI 7 M#E;^?BHMP>QJF#TYV"===7^IJ1QQ<:,D/]$D?9QE7(BQ;P=FB\"10G.X3-T'"[1N5(N+GCD9>R._21_YUQ("G:99?A1J\ M]:G2(FXZ,X"6VE%";W-XJA>>*/)

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ⅅ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

K65!"MC+U=:S4XYD;1E$XL,VWUSHF3D *Q,O5XY+-#-IZH6ZD';J MJ3%&-11;A[/!L);PTS1::$UTRKNDS1,16VP3S:9VVZJJ^X6ALH89$NFZO$ MV1YN)D7JQ(FPP7# *XWZN-68CCD!R_?49EV,'Z^LVZINNZER2<@U>Z5)86C$ MC?I"3!ROI"RR72;27&<6 @,O M8*6X1:8'HY0VGL"51V^/56J5&.%>28PRGCGE^ M-AN3+@M7'NV3+(T%/E6;=(06Y126A7%;UH=PY=$^^4%?SR\U/C9>63W-*7#Q M0C./PA/'&TV9HM2OF *6EAU>,?-2L2DFH4EPM+0@VMUB@9Y$L=PJ-QNJ?7HL MQNIPZ=%6F],J9DN2VV#8GE7+-><3;$R@IQ[M=1:CQ.HDQM:QR31JMJCTC""A M34(>/[608HK+<3MI"R69,V81PZ$Z1A(N/7KJHC&L)Z02.1%:U8:&YP7:RD"G MQPDR);J#KI,M4RRCKFJ3A96(5S.014](G7AD15JR4UHSN9[3+&2SJ0RW2,*E MQR1M5F;&(!O3L8D^X.4(K1")$EIZM-X67HEHJ71(W)I38M2FZF/&373KVF5V3U<@*SDM3ZO,A4U#@+A!]QO '!F0C1:"3/,9%,M;.FV+J".PNX]&@#$6J1 M9".3$HZUEBU5K'>BA7$3+=UL %B1LJ<4>B-9T!=[8EM.-OG2?) 1V*@B]/F) MT,XP21$NQ3TO %(CD\Y;JXG+6I>OFM"<.YWJZ@3\4=)#LF0/0WW=7(0TPW,P MP*,AI0CHDX[IA?MLZ'Q VF9?@RZ%T HIG>H7E$YO(."!97Z)2,JN/T4&[%0W M;==2V?[^D=/@Q%EPX,+NO WON+R)/"$&0TV;K,_!\<;*IZ]+45I\W/^QO M [[5MZZA\BQ[!NJA/;_GJ_.-^6./B6-MWNH_#??.\+[(-X4]D6<+//?4_;WG MF^"9D*PW(-G\'H&NRF?/_;$ 0'C3Z^![@M"+-TNEGFWJKJ->V=WP$M%["\$? MW^O\VGF-ONS$ILXF/0>(N!DBL( C'@$1]!-^MH%$@(A -/UIB"#.9J4&B+@5 M(O"G6"+ Q -@ GN*!9?$(R BD$V/@HA -ET6$Q],)G_3I+[=J1/@CT>1OQNE M9)U7&;\7#&13AQ_^[Z_$KT_"@TP\8?>M)DN\$3M^*UP, ^%>''P7$ ZXXT&Y M(W$$@G.H]>HSCO][B.A]/B ^RPU?QP:"H!#,!HI9\=!CNEZ"Z,4VH& MBF!.5 D&!6$P$.9='DV;?;Z8N+PW/.Y1YX ] !W<_MQ>(" H=/F#"9]X@#+F M.YS;<^4$E.]K0W\@!024_S,H_]'=)-NJ*%@^ %[ 3E68(68,=CEL]D[[,[=_ M]1/8OH,1?-7&%.=S1AZTFO2M#(L?4QAZDWX16Y9!>8XU:06-(/M$E>BT4F_) M_8ZF,[FS,6]Y,X[ 9M M&-[-8NMJAG*$:(D=L_5IO61%>YPZABQ&018CP^1UYEE=W6D7L-B?RV(WZ6[P M;@Z;JT2AH/2K+#:;E%H8;54F,QP6G\'IDPDR3)SEL&_H OV8AJQ!E[%J.Z&I M:2$J,/N'0^LOJ#/_@>;A0WA"+R9Z']'!^:-4\_UIN@6?,WW9QAIE/SJQ.B'E MY,X =X4Y[V!J+3VTTTYAQ<1AP33L.QVFJ7-M[P.N_I;.KLLI5(_HP_I9]L"G M^7J6KJSFV4R-$G)QTHZO9K&<0"X 7P/[@ CCU%6&V01.[("OOSM?W\0(^31; M6X-5<4:.2JUQ3N@9L7J]/.UG(5O3D*UC6.SB)LG][ \/2*_9'U-+ W^<2OHM M#) ?+[]N[MV_L&GQ!PBFF]L1M0V'G7&2"/F!.\:KXE0 FQB/IARSUI*PBQ(P M'Z)A#*=_B)__7CK%]^3)/\=E>7LKX#UL&Q]X\030#/;$#T1\Q^Q+75D&3;JF.'S)XC:8:73JTNY:%D#%2DSWN)U&8/ MG 8A,4BD_O;A@R"1.DBD_B,]<4$Z:9!('5!^0/E_6")UX'4-O*X_S92\B=<5 M&4IL7[#5)+226-]&*AB,;R%E3>LP;^U&DV$"OWQ"QD/EB&>#C.\?Y;+]DS*^#W I".%W!ZJJO/&4"[)ACG3E?U^GR^&;6U&(I:.B^>^S]6NL33U@P".<1$($_X0%'/ (BZ"NQN\%@XO,8(E=?]S( M)6:L7&B4QM4)X'%':3P\JO>=:9="]T,?^!2N Z'^F#S]4:S>:H16['N/Q[G@ MY*P_7K1_;S*XU+"L/T3DWSLZ?/:4+PM=GB_*XG<_^AT2 O!'0/D=BI3)^R1" M/%JI9D#X?]:Y \+?W>;?%ON/;\J]N*=#UE$;DDODJ=_!Z7;!20A( !UHUB30 MK!73A?DC-U"MKS7N!PF8>Y_K?K4T25MD^[LDJA*I#5;C:KTQ7N4R!E$;XKJ6 M'UQH=,*+2II38X#2_9X[E.W&..>,$NVBNDI&B+HW!H@(1^EXF+C.(*![.\1O MJ472*DGY$A)NM04K[>Y.,.H.,ZU\X0P MF^H-;<9FV%2C[DT:(L()G S'R'-5;@_J\[BW2O1M%<# W O,O<#<"P@_(/R M\ ,_QQW]'-S0M)P(*K]Y,:XXI/L]"[3+U.1_?U_'-[6"?KJ11@7)<9UZ?C"484M=2H7A8F*N?/,8AA1#B*D8&C(N# G\>!-W(SO(,% MY6*M5FS0T86PFJ9RXYA3T=24/[0@%H^%J1@>>!F^FY>A;!J#&ZHH]S[N ]E8 M=\R;NFI;H5=,JWL?]]YR_,::5-4TY%<)Y@U/%(*$E&3UD+23'N MQ7W(.!&FHU=4IP(A\#!<$0B!'ZW,G9<"%6(QS38L1=#Z1KS)X;F*RB^ %$!Q MHQ@=#V,T=B6-[MN*@ ?W.KUL_\B;L.=,X'T*@O1_9I#^QEK7"2D[+HH-JSYF M%@+5:5F]]22Y,IBDW^P]G !V,QD-V4CP:^+V^G=\K2#*XN^W[P\\=)!D$A!\0_A]-^-\8^P_N MY_CGK:8>!V,O+EL(_#T0^)VR >XEH_XX@130[P\YY!]*O]\%K]_2)*Y9,$[@ MK,*AJ2X9#FH9K\Y<;0K;MH=#QB7+;LIME,%W M+XH;5JI!1DH:"K-AH]2*7TW5Y%*S14M21%]-14Y(!=7WV15UTE,MT:"JR42F M))7'$2/:'M0M,5^W/A^O>'5#X.?]3;RH-DSV'=5*RK([<=%PAHPZM< +T+P& M\,WDQ 04M$:_GG"=TD,MFVK)4F<\$;6R.&&6.7=0%W$TN8 M!_(WW)T_ U%TAXC)Y611MMV>KB*K)B_DEE(F4=08CE ^/^'S+K(H:4X75K10 M);&256YIK3'-M*I)*(LH)(OH6)#J\OU<0($%'5C0@04=T&] OW\*_7X7O'Y+ M#] [QE%&!7[1*:0%2R#2(VQ1PA.5-C9X^=TO;3FO?:19PAQ8LP?@C_1$F/WJX^UG!;NO[][Z.2;C3[<( MKY4"NV^JO:-ZM%9+8&/!:HRP-+N*EF?1UJ(.#3 2.H.H,$D2@2_HI^6>!'S[ MB+FO'V3SD:L%A&DHCZM.N7Y&)\CQH5UW^%8-!HX3KZ;XZ3\NDH4!OJ2 M;8?D8^TJ,#\_7Y/PPRH[__ RSINJ5&=K.)UIG)MX8]S)"6PQE9''8ZN=)Q$CP_A4 M-)P@KQ6?^AY<_/W\::=+L?O[BC:>Y<4%-[): MF6@+,3WLC8.%R7C@]/IV3J^S!6,M])NJA"2P:VF@ABQU(FG&KF<.C"G",K+ M#19D8?SQ61@!_?Z00_ZA]/M=\/K]O![_'(]A_CF>C0Z)[XU3BKQFIU9 MU=-%(2>P-6U4PBP.JXLX:M\;BC]M9[WY9PC<$0'__2#^>]LY<&T&M&,4G6XU M#%6@NGJQ+G.1;MU.0@:D$ /&K\& ]Z?"'^P:.&P7$YCXCVLB75@4?B.Y=RF] M8]\'^@&A-\E*8GJI%'F,&FM6A,CSI$L H8<:V8823]C5M(Z B0(F>CCEX9-< MU)OP2FO!1A+CUHRMSNW)B'?$.N0B"G'1E52'[\%"W]+;$?33_+-LL:"?9D#X M >$'A'_C>,6WQ?[C&_\?RPM0-%L&:'!"EN2H04+ 8QLZ04 U2 @(Z#>@W\!$ M#A("'@J/W]P6^),"DN]-<9ZZEBJNY&@IRD<[,8PKT/&LJC2'9G'PQ;J&SP^V M>N&9S/BZ:P.HKC75DO=+T2+$UDFIYT>9X:+0H81<68O6VASCUOMUD4!]6ZE= M?L'/JW?X*^#0@$,_4X5P:Q9-IG1[7"(S.D85*A6_0I!4\%W,K!\;#_U>NLN9F.H[Q:);S2ET!',T0:5XPXJ)V6216(A A /- MA;Z26+P]4UY.30G8[('9[%H*R-?YC!>C7&\16T89JI*E)J64&!]'DI#/8+<* M[&KZQUV5C?\X4D]7_SW*T+@@M6D&N%2=9Y*ZQ#5\]7UMNUOX;)"T0U+(4FU7 M=V K5F>HACA .2''#+522=2+%7YFJ:A_?R@Y4<%C%?1Y0[4=[T/8ZC]4BDN L:M1)#ID9TVPJ MC<4R6^\=L&JAFGT'LUJ2\HPX-+3@3-U!9!>3[78OC])05/M+9-B'H]6 M)]#6[)!IZ*L- MA#VX3J45_ Y"RPM4V"'-0)^K<]A"SAE*#B* OJ3I-OJN:L'7 5PHZOX3I VV M[7 (8!A^![P;_GUJ =A8_A9,Z\EC37 &B!G-<"5?R"C:_-__@O]L2%\&#[:@ M9!GZ=+NMJH0=!VT;__3_[N]^9 M6Q'9U$WK>=, 8.]80R]<22"1.% C/4N5QA$)#LMXEO2%M+(W%A#]%,4W/9^> MMTT$2,3$V!-!_Q7:^QD"Y B:$VD9V8.9+X(CNMIWGOVO;3Y#-^;V0]/6((*> M$5]J"Y"#6..7TF\" ":WLIFZ>+R^12]G1#09R/=C0+/A)*%3"C- M-FIL(\D7V&HH6)NN+U0Y@#LZ$'&1^.7QZG8EB@!6QEZNK!0(4UQ:69.9&5P?'^!956<&0)W 7JXLBXMF3U2G M<8%PHO:\J:RB.2D)5AZ]O:A&]6&R2:I,VBIJDX+@C+ER':P\>CMEI%BQ$%4Q MAJH/&NYJ3E:$R@*L3+Q_*7$3+C1Q!H@6AUIFM>EPF"92>HWU2,9DM]0I. M3&@QPUE$+[;-6*C>S72X5PR2V-TOFA%&UL!J(L>-]F0TB8Z667XCQXY6X.XDF8N:LPK14 ME<[HO0'3' [$Q/'*4F+2Q3&RC#%NW33Z4R&K)G(#D3Y>V>]W5=>5JT6,:U+M M?**;SY4G@#ZQXZ4\GG+72W.%C].)>F7=J9$-*C& 0ZZ.EJ::45 M9M(B)#9!+42<.%ZJI$:E26>:+PFM\=2,3=-38E$:P*5'&*WUJP+)B]8*4SMQ MJM1AJME5M0Z7'J%T-LRZT<2Z5AR7MPJ"--K#!Z0OMSOMB3VS+R29? MF@\R AM5A#X_$=H9)BG"I<1EM;A7K3&H'/=-73<7,*B-S,*0[4[ &O 3V'U M^R:OT$R*HUY_GN*[Z04(1;?Y,D8NH7$6!V+_&8G"UTL+-"YR@I--GM[8^5P0)]'B9"F.8O1=A_TDWH@=O14N.O"" M[F)"'V.0U\!S(YYYZ_RO4U# -)]G&N*S3)-XBN%7A<=7><+WX#"Z$O,(_0BWC^BTO^!1XS6I!6J<,FX:A5L@U^H^ERM@#T-[1.#")=Q M=AWKB*R%M5+,8+GHJI%XLBZB\>YD&$\DKE%H%W#H@W+H#^K%\1@<>C;9]6.< M.HT-9XUY>F*/2YIE9RNM84]9#D0TOYV*Q\,4B0>\&O!JP*L?Y56O$/: 3Y.& M(S (LQ+Z#\?D8 M76?.9Y \LM!\*U4UD"M?T=)A%2:_,$\(D(H@]J4465/&N=RBLLRJY>IT#6O- M@'(>#\=)XGH7?L"-#\N-W[4YS6-PXWLU\M>YDDIDQ[6\A<6P2"8O38?)/-;) M0:X$BGB,)L.)6#S@RX O [Z\HO;].G:U;KP.N!,J MW1@>CB4NKW3?VYP$^*!^C*E_+Z%S[W-?6%L/' .W5>"'EJJ>$$<\.8I2>*%5 M$B)"VE%M4HC/EP.1@BH\$8X2/]AG%S!RX.%[+$;^D.[_"D.W24T4)NV!*VB# M3*:8JU%]8@(9&FK_6#Q,_N206<#2 4L_!DM_P6QXA;&3Q4@RMVZ69UBKH,AR M/)KOU3#(V#1D;#J^"%^OA\B\-9?6]G/FJYU0H)8+2K=E5ANB'%K MK9RJ%F>IV0"V<0.Z/AZ.48%;\$]DQ\ M>"N5_16VC,M-@RTWEOEQNI"2^7R] M.B^W!X M@<8>):AP#",#Q@P8,V#,*RO>K[!G@UXR\R+.9QE";67;8VI0S,\@ M>]*0/1-A+'YNV,.W==@G J= X!0('/;WT^&U^2DOP+IO]1EVJIJ-73**[-V4''!UP]&-P]!>LAM-\;===ER=(Q1U+(WM%C+OIAB!" MOJ8A7Y/AZ%F^_@;>>GZH6BJ:LG2)P:Y_D#/BCI71UJ37+Y>FJTD/3E*"HVC#>#01CI\MY OX.^#O@+\?P99XB]-5 MU^:;_*!MCG,1AIR:5B%>(NJ TVG$Z3$Z3%W!K+BKM;P=& LG*_[C-Q/R!XI- M?>A=S@"YMV,@<(@$H8K'$&+OM3Q.2*ET3^_WB.ZI17SDSZ:UPAK M"N)A\B F0-F?DB;X@1+@_N8-5VR)F&ENN'6:[&YJ'-UR-(T8FF2#)/Q M<_?S-PA-0$ ]A[3)U'54):3!=J6J[01ABL#C\?AA"BB1?G\+D7360A ,1;-E M(/(!!S)+&3!D<@)_.Q4I;6G\PF[EZMBD';-*Z8$ZQ%4TLQV8"XEP](3O\N^ ME0-6?GCGY?=CY;.FP@=8>HK'''?2Y5ELXB1FY)SJ.+$&8FE@-R1(+$S1T8"I M Z8.F/K*)L.;QL('F#I?7Q42LJRW!%456XOUA)&3!<34-&1J.HSCQUD$?__8 MX(/N@U!3?U#\X?IMC ]9FP2LK9AN3U?O([>N.C7@[D?]:4Z0LQ;'"8E%E,:K MF#G@)\?U-@XU=2HOK"P MKMNH,5(A:B3BNE#FVDG(U33B:CH:)F+G&I8AJ^(_C@20]^]F6=6= *#+__Y7 MT>9?Q];3CC0W!+/WR68"W@3\O)F,]X33ZN2?J6EK<+//EJH#L,S5[4 W["]( M2'N;VU%H1#9UTWK>D.'FB=/EB<>A5S]1ZL9B(F)/V,9VAF!0MT05DES'#&$A M#+[W/^#%F_\BN&UWX3$%V($N36WU>?/#/Q=@ZC.00WN(Z-+*=)WGOK94E7U M^_0?/S2OEZ.+(0,"><6OBXW$T?" $TX/)10+Z3%OG/H2]OU?H4/ KL" MS*@?3&?T/_KU;]9U7$L-F1M6?)DI-Y3F:L@PG5!/58V0I2JNK"JAWBH$Z%>; MN).0#<4@_(H%U@/^#YG]T,9U=>O#_-^[B[[8YT*S2.QYJ*AX<.5\L#8\J.[' M9BE/&%8ERQ*Y[-!Q4A2>&K.U:C^BDS-G8@R )(P^G4JSN ]: *WH.D2'XJHA MS0@Y0S74]^@.2##5 O1ER%#ZZTBZH'/;3UO_YYM2^T&\Z#4 %L-Y)JFC M?6D'+_%@KP$*T63P5P[01P31$KP@0KPE&;:'>_L90.V&VSPBL8.=/A! ,ZX% MI1XD23CV.J2"A4JH(EGR,!0-AR#?AT,'Q]G7#OOH_\!CX/?3Y@0L6VVDGVWJ MRGMU,7"#3,0$-]1SBVZRP;3J.?+_L_>ES:DJ7=O?GU]![>>YJ\ZI"KF91-WG MO+L*%><99N]C%-0FP,P>] G8VTAS&^.\K$1QS =((O8@R9C,>GA2 MY2L$KA7T=3DSK'5P#DP1NEOJ )0P9V6#&0<3$2U"X)>Y"W^$;[@#>*%8@;J3 M41/,A2$K=UBMA+Y2!;S&G3N.=8?5!YAJ>+YKC (TU>&ULQYJ=FHQ/%L8(N=4 M:H;]WC0MV?;!U/&+P)C#=32SZ6SF&K2P>V*8/10@\)]7#QJXS0Z+S M0 <\;*4!U#_U.OUAJWBSRP)MXL$@]O"U"1:B@^HI-,ND:@T)+]&6>6/-U!*\ MDN_1Q=6/7TGZCF8.DYKW $9L)7 AF\)6AC^!<^=%LW>'[>,,TN^P7LG!9-W5 MM)"R@=]"1@8;/YH2AM:$!W', P!QH!6P$ ?8$"8_,+KHRYH[0USNR6+[)]/^ M<:M0B>RXD!GQ(Z(@NMYBH8J#LJH?FH$:N+_!KV.R>O@LHEKH]PX8[I[4U(6- M]X7RU!*#:4HL]$:CO#H'MD$FT#+A/><@L$MH6I_:"4*UZYC=W!XV9I'J1)-< MPR=BVLDW1D2E:KG#]2)5K[2YSYCDK3&P$^UVI4$4MMFIR+/%SM"& 0/-'YE MGH]!_3W6V3,/68G2E+OO>#MJB@<.#@BJX,\8#\(L,R+D?2D]Q@"EZ<\=& M2]#S;^WG] "QA:]T55'$4"I:!3=Q1Y MB)<8<+\!53.\B"B$\P@G_B\XE7]C%G@7!N8/ BB0=DSZ, M$]\J_?J3>3__PIY/:.4I2HM9<>8$RGQD%=_5[]A0OW!>WKA.LW.IB0^4\6;H/UJ ++=\WM%@GT421 MG[E8TQ()-9B(U#D9ZC95L-LM:5P:FMFUHW>\%BZ-)I^Z5FOI!6FNY[F42(DT M7TO@68&Q 7AIEK8\%AEY>:U^'L"*YA:J 9G\Q\.:FNMN@'SOL%KN#NLYC@K\ M./4.RW)W88 +@)+L@=4 ?G34Z[D[^MP2@+*LJ\DS##F&9XR"/\W+K7;)[&KX2@"(>E15;MD;I<:=0,^6M531)(.N166$X%X83N* GDW>I]&%1W,5HU"&) M_0 M ,W6[#=1J>-S[[F^U)9M/8RFP-\B\A.%4%+\F.ISV51.##C*;^?<94TECC,M MB+ZGHEFDFJ.UFBQY8F.,IV:C>E#H42A(=1 VV3/_TXQ?7N^-/[>JYM>\-F[Q MLE$=+5:+OB%U/B5.-T[7J,5B7,1Y5IYNY'FR6QFN.7@>?0Z8EK^)DOP&,!%T M0X%#13;L0 X+'2X4J4/?A*5"!_)YGC0FB O6$/Q)QX]O1T.U8'OU: H0CPNK M*R?/RK=H^,JG96PGKX<,>?!NC!2SMPTG'#!))O>ZC?[]GS=5T^T-*RJLHU!) MEZ[A(\"M31P=9_Q3ME;RQMOM[DC?,^1C&=JN6S3:%43<4^G_8'L_/];7[?5G M)J_QO3F+*L2 "8S]G]'7=I^Y8;E?].%!Q=^/9\]]J*,#2,4^+4)DR'OF3+)Z MMC^*?I3,OS(V<>':\[^=1O;WP>^7BHLZJ&8(H'86+F4 2!X453ZY21W3M_T= M7[M1C9Z\,NKQ"#@QX(_M4H?'N%(.RS;:S4:;ZY0:=8RKYS!!S BE7(EKEWCA MW_^.KK+S]4:'%[!. W2^+C2JI1S7X7-8OE3GZMD25\6$#OB@QM<[ O97-D1D M3?W[=*-)GW(P^6AIA^AA_K/#G()*$"-_!JG^MXOJK!'F.$WB@UX#/:&M% M U\$!!7S)C)P866T==-[%-#+P/X4E8Z!S;NSV;_+/S[EC#G#4P!9"URM,8:D M0P-$ #ZT#;N@J5G'\ST!CBP#R(*Z.]>F _J0L1S%C(K(1](DM5E4IQG/.[]/$UU-<70;/,4+U1 ?06F!R7\4*%!5 M^+-VS&/BA"R6)%-W&"0F%/'/OB*@\!?U3SCP_3_[#WV(^H1B,L MWU@$@ /Y&@:&O#3 .X&U&(X*%QCX=QE.9N@90$5'R&;HW$=@\X N$E)VOW?KF9T.+]D Q!P^<"0.EDP>8'C0$U/PN^E:H'(!RSB>@L3-[^M>18P.%0$MI5"()-,'% MM%!#0J/9_=7?5?LIKK:O\EI]T6+\;-_L-E9PAWGZ6"W3:R8ZMZ UP9*:AX9/_NYJ,]FPH<4>,>0H M?_+'- O9[1\C/\I\ANKX:'@J]' ?S94)6_X%5=E0D3(#%+ =;.:X,&$OVY^@ MBZ\EI7>ZBH3_L!5B]RD_FUO.1M-0J"",F3S[WA_I>+)&#]7D MR<9Y?2<;*-RN*-ZE,LI:X MK*S@@>ST>[R\BZQ/=^]9G%Y9TH[;ZU_P9)+05*U-^-HH>-QT#3 ,%!R/(L1? M ;:.V^5O8,O:A+"50A%H ECOW+&?H@!<_N]^IQMP00!+O^4 -7?ATF!X7@ W M<0>N%T#UB$)D>U-]>60D3X&,4!]G82$0%"G4#!03O'*T)'^/EEPX',Y6V]%@ M8+0F@K4@"IGRJ$@FJ 3_-#SV?-/Z%2%H2YRSJ1%=-$1VJWDS MJVYVV7'KQR_F+L$>%K1^&H+N6-R-(@&NN_ERNZ!TID<4*(-993+E MP;2F2Z3$/&]9Y(4>ZXXW/3X[R[:3O87/,5T.M$P^;TF5LXXA%;F 8+ER#F\: MJ\2@LI*HPVU6\ MT0(M#][>\LM>U5YD% )ONMGMM&$OUC7XS(.WMRF.9D:^FC=EW)[;0JK$5'A. M2DC4\Y;9B4Q0=BTO\Y5JO]*=KQKX>**#E@?]I$H!.Y2'V0:/]W,2:3:*8K:T M BT/^EEGZSB=R:9G/#5UEXN%E^BI/GSF03^70M7**>Z4$2NC\:))BQ//TEL2 M*Q'/6P[-G%H2]'2*,"1?\+/]57]!P)8'_=0F%*Z.G.I0W%0-7:^R2[E7U $] M/WAF-56;MK2\CIM9KLAQ(Y;HD5I+2AVVS"^SFXRIC#A"2QBY_MPN#CH#>$7\ M0(O E>V_%*#98;L ZZ!_9@ M3 153Q1[;35ERKU:JL_.IZNUQ<%;8@Z>ZOH%TYV5J;8YJVR[U;Q6,"M]=#W# M05,%'V5L*R.-B*RIE=ODQAAVLRN)I ^;"IIN)C>\;/&4[BURJEA(B4!)2>:P MJ<03 R'5'WIF0"G9D:Q;E"ZO8-.#8:W;M-^7O35.],S!LB(+Q;J1!L-*'#ZU MWFFUV7[)Q0E\)0@,G[#7;AL\]8BJ3 >$1@_&2L9<>'*-:A1[LQP\T_Z(!@0- M-KEDFH)L:DYZWJWK/=:T0=,C*C#2I(G0%'5.[#FC56%8R%&$J,.F!\.J2MU" M3VTL37.SVBQ:?;NUK<$;,E*'!N!J\[Y,3IL+D769CL;BVCS7 QTXHEG5A39* M3\?UGEA)3!;;')FV)U8+-CWHP$8?&_F![]%FX'-%MNE)F[Z+FAYTH%#PE)3, MMK=B4'#]_B(QDNL>P-,C^NITRG5YW?,*1-"?6&.ME6:7#1TV/>B [$F%(3%W M>@1P)W&.]+[GH?%=,_@>EY]1I'9BW14 XR]KY>'/DJ4:Y MWX>ZYT,/$?L+_ EXE'#CGX;"[X[]N/?[H2(2_#(S?%_3_H:18E6#F[8-6\/@ M@H^M)EH8]#=L\#-X&!B6#;A#Y/'NLI':6G,5 SBR_V 39Z4MX7$)AA^%IN'9 MU8>9Z7=L4G@MXSS;+FHKH37N 2BEMF;+&DI,[_5MX$]B(:/78R&CY[$0?CTW MPHXW4;'Z7LBCPE3+K?ID[!& #;44#G"5Z1#F>(GG#G7H]L0;4_.%;\:M.0EJ-0K%:85XEL;;8F&:$UF*]T&%%CJ( :\1KFNO#>!YZ! YM%K:;.:IF/3T\03549,+AX^ G#Z^U7]C87$9P8XV'8_M91/^31JEJ MH-8\:2$**I\ST\HJ&*JM2]PJ 27^,,_H?^$))*^/H90O5JGEI$:9AM"L-]K: ML&2;JPN-@7PVAA4 L%?VS>0,N""B73/1BK#6Z=Q2R1ACLY<)\.4LXP$']]2; MLJC/6"$B\$/+@5>*R$8O4FTNU&STQQQ FCS0\"Y4\*,+1S[%LP7!3Q;-;+XT M*;KS!.#S8.$@[H^45]YC><>RG!6T"; @ T(0S&8P]O4,\)X>FO)X<@>RHI#9 M'#W>_XT1MI\(,LZ\Q17 L*8&EA:MPP=BVJM7]#B8- $0A\+/A[M<^W:!Z]45 M@C2%7DJ;Y MS3YRVSK1O]?3'XOW!54-A-^!;HT0"C!,J82Q^EPQ"F0MXK='N M@S!M@3YYDMT@'F_MB=HQAPN7PNN&WG93+7'/)%ZZ=7HO^+GW?+A) M=0S,8#=KN]]Q>.?0SS 9!(]7>C4'LW>UTD-3>>0Y5N _OW/JW"?9?.#XD>C? M#UYMER1C05R!()+W=#(6Q!4((K:(JQ$$0<>"N )! &B*%^MK$$0,35SF,U=(03C%'C#EBS!%C8(@YXK?3C&_ $?EH(UE, M&;X-26SO=H;%,O^>-L_MM@L^58"8"7UWW8^94*P9WQ85T67P\9+X;6@0/"H+ M;K@+9"N6^OAH[BQ6AQ@TCND&.A'C%/3J\;SH MG_^K*)HV'G^NFC0"WX-'7Z'CS=&Q3H_G9:3#FT1.IO^7'NNNRO)4C.CSA[.G MLNA(B_V3L>@GYY2?[;@S2J+2X5U-9;>SW91&199HE*Q6(=,8,Z65_NZKH#]Z MG,V>)H='H#V_-1H>]TN9WG*+&Y-+C_K^358KM#4;L!5VG_,'IYB7D*W4^3070?A6?)AP<7^$><-G0I!8/RAS=X__UEU/N[AF).S-*ORZP_(RS_81L_:93>>R5,OS/] MW]TT\5JP?A+D)UF-UA@S:_ 3K<&R>GT,X2$!X"%Q3QS>3Q0C1!RLC^5_PRM$ M'*S_9L'Z++RRSXJC]9>NM/X>3LL'ZP[RCCO6##^ MRO:>Y=V/A"<(SZ.6JW4 MY�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end XML 138 rad-20230304x10ka_htm.xml IDEA: XBRL DOCUMENT 0000084129 us-gaap:AllowanceForCreditLossMember 2022-02-27 2023-03-04 0000084129 us-gaap:AllowanceForCreditLossMember 2021-02-28 2022-02-26 0000084129 us-gaap:AllowanceForCreditLossMember 2020-03-01 2021-02-27 0000084129 us-gaap:AllowanceForCreditLossMember 2023-03-04 0000084129 us-gaap:AllowanceForCreditLossMember 2022-02-26 0000084129 us-gaap:AllowanceForCreditLossMember 2021-02-27 0000084129 us-gaap:AllowanceForCreditLossMember 2020-02-29 0000084129 2022-11-27 2023-03-04 0000084129 2021-11-28 2022-02-26 0000084129 2020-11-29 2021-02-27 0000084129 us-gaap:RetainedEarningsMember 2023-03-04 0000084129 us-gaap:AdditionalPaidInCapitalMember 2023-03-04 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-04 0000084129 us-gaap:RetainedEarningsMember 2022-02-26 0000084129 us-gaap:AdditionalPaidInCapitalMember 2022-02-26 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-02-26 0000084129 us-gaap:RetainedEarningsMember 2021-02-27 0000084129 us-gaap:AdditionalPaidInCapitalMember 2021-02-27 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-27 0000084129 us-gaap:RetainedEarningsMember 2020-02-29 0000084129 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-29 0000084129 rad:EnvisionInsuranceCompanyMember 2022-12-31 0000084129 us-gaap:CommonStockMember 2023-03-04 0000084129 us-gaap:CommonStockMember 2022-02-26 0000084129 us-gaap:CommonStockMember 2021-02-27 0000084129 us-gaap:CommonStockMember 2020-02-29 0000084129 2022-07-31 0000084129 rad:AmendedAndRestated2020OmnibusEquityPlanMember 2021-07-31 0000084129 rad:OmnibusEquityPlan2020Member 2020-07-31 0000084129 srt:MaximumMember us-gaap:EmployeeStockOptionMember rad:OmnibusEquityPlan2014Member 2014-06-30 0000084129 rad:OmnibusEquityPlan2014Member 2014-06-30 0000084129 rad:OmnibusEquityPlan2012Member 2012-06-30 0000084129 rad:OmnibusEquityPlan2010Member 2010-06-30 0000084129 us-gaap:RestrictedStockMember 2022-02-26 0000084129 us-gaap:RestrictedStockMember 2021-02-27 0000084129 us-gaap:RestrictedStockMember 2020-02-29 0000084129 us-gaap:RestrictedStockMember 2021-02-28 2022-02-26 0000084129 us-gaap:RestrictedStockMember 2020-03-01 2021-02-27 0000084129 rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 rad:PharmacySalesMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:PharmacySalesMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:FrontEndSalesMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:FrontEndSalesMember 2022-02-27 2023-03-04 0000084129 rad:PharmacySalesMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 rad:FrontEndSalesMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 rad:PharmacySalesMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 rad:FrontEndSalesMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2023-03-04 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-05-28 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-05-28 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-05-28 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-02-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-02-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-02-26 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2022-02-26 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2021-02-27 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2020-02-29 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-02-27 2023-03-04 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2021-02-28 2022-02-26 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:RetentionMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:RetentionMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:OperatingSegmentsMember rad:SkuOptimizationMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:OperatingSegmentsMember rad:SkuOptimizationMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:CostOfSalesMember rad:SkuOptimizationMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:OtherRestructuringMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:RetentionMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2020-03-01 2021-02-27 0000084129 us-gaap:IntersegmentEliminationMember rad:SkuOptimizationMember 2020-03-01 2021-02-27 0000084129 us-gaap:CostOfSalesMember rad:SkuOptimizationMember 2020-03-01 2021-02-27 0000084129 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-03-01 2021-02-27 0000084129 us-gaap:CostOfSalesMember 2020-03-01 2021-02-27 0000084129 rad:SkuOptimizationMember 2020-03-01 2021-02-27 0000084129 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-03-04 0000084129 us-gaap:LeaseholdImprovementsMember 2023-03-04 0000084129 us-gaap:LandMember 2023-03-04 0000084129 us-gaap:EquipmentMember 2023-03-04 0000084129 us-gaap:ConstructionInProgressMember 2023-03-04 0000084129 us-gaap:BuildingMember 2023-03-04 0000084129 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-02-26 0000084129 us-gaap:LeaseholdImprovementsMember 2022-02-26 0000084129 us-gaap:LandMember 2022-02-26 0000084129 us-gaap:EquipmentMember 2022-02-26 0000084129 us-gaap:ConstructionInProgressMember 2022-02-26 0000084129 us-gaap:BuildingMember 2022-02-26 0000084129 rad:FinanceLeasedAssetsMember 2023-03-04 0000084129 rad:FinanceLeasedAssetsMember 2022-02-26 0000084129 us-gaap:SoftwareDevelopmentMember 2022-02-27 2023-03-04 0000084129 us-gaap:SoftwareDevelopmentMember 2021-02-28 2022-02-26 0000084129 us-gaap:SoftwareDevelopmentMember 2020-03-01 2021-02-27 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2018-03-01 2018-03-31 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-02-27 2023-03-04 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-28 2022-02-26 0000084129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-01 2021-02-27 0000084129 us-gaap:InternalRevenueServiceIRSMember 2023-03-04 0000084129 rad:RetailStoreMember 2023-03-04 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2018-03-31 0000084129 rad:BlueCrossBlueShieldLitigationMember 2023-03-04 0000084129 rad:RetailSitesInActiveStatusMember 2023-03-04 0000084129 us-gaap:RetainedEarningsMember 2022-02-27 2023-03-04 0000084129 us-gaap:RetainedEarningsMember 2021-02-28 2022-02-26 0000084129 us-gaap:RetainedEarningsMember 2020-03-01 2021-02-27 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2022-02-27 2023-03-04 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2022-02-27 2023-03-04 0000084129 rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember 2022-02-27 2023-03-04 0000084129 rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember 2022-02-27 2023-03-04 0000084129 rad:SEIUHealthCareEmployeesPensionFund1199Member 2022-02-27 2023-03-04 0000084129 rad:IndividuallyInsignificantMultiemployerPlanMember 2022-02-27 2023-03-04 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2021-02-28 2022-02-26 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2021-02-28 2022-02-26 0000084129 rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember 2021-02-28 2022-02-26 0000084129 rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember 2021-02-28 2022-02-26 0000084129 rad:SEIUHealthCareEmployeesPensionFund1199Member 2021-02-28 2022-02-26 0000084129 rad:IndividuallyInsignificantMultiemployerPlanMember 2021-02-28 2022-02-26 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2020-03-01 2021-02-27 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2020-03-01 2021-02-27 0000084129 rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember 2020-03-01 2021-02-27 0000084129 rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember 2020-03-01 2021-02-27 0000084129 rad:SEIUHealthCareEmployeesPensionFund1199Member 2020-03-01 2021-02-27 0000084129 rad:IndividuallyInsignificantMultiemployerPlanMember 2020-03-01 2021-02-27 0000084129 rad:RiteAidSubsidiariesMember 2023-03-04 0000084129 rad:WalgreensMember rad:WalgreensBootsAllianceWbaMember 2017-09-18 0000084129 rad:BlueCrossBlueShieldLitigationMember 2022-02-27 2023-03-04 0000084129 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-04 0000084129 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-03-04 0000084129 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-02-26 0000084129 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-02-26 0000084129 us-gaap:SubordinatedDebtMember 2023-03-04 0000084129 rad:UnsecuredUnguaranteedDebtMember 2023-03-04 0000084129 rad:SeniorSecuredDebtMember 2023-03-04 0000084129 us-gaap:SubordinatedDebtMember 2022-02-26 0000084129 rad:UnsecuredUnguaranteedDebtMember 2022-02-26 0000084129 rad:SeniorSecuredDebtMember 2022-02-26 0000084129 rad:NewYorkEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember 2022-12-01 2022-12-31 0000084129 rad:CaliforniaEmploymentLitigationClaimsRelatedToWagesAndHourClassActionMember 2022-08-01 2022-08-31 0000084129 rad:CaliforniaEmploymentLitigationClaimsRelatedToReimbursementForCellPhoneAndMileageExpensesMember 2022-08-01 2022-08-31 0000084129 rad:HumanaLitigationMember 2022-04-22 2022-04-22 0000084129 srt:MinimumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-12-01 2022-12-01 0000084129 srt:MaximumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-12-01 2022-12-01 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-12-01 0000084129 rad:FiloTermLoanDueAugust2026Member 2022-12-01 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2021-08-20 0000084129 rad:FiloTermLoanDueAugust2026Member 2021-08-20 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueJanuary2020Member 2018-12-20 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueDecember2023Member 2018-12-20 0000084129 srt:MinimumMember us-gaap:EquipmentMember 2023-03-04 0000084129 srt:MaximumMember us-gaap:EquipmentMember 2023-03-04 0000084129 srt:MinimumMember us-gaap:BuildingMember 2023-03-04 0000084129 srt:MaximumMember us-gaap:BuildingMember 2023-03-04 0000084129 us-gaap:TrademarksMember 2020-03-01 2021-02-27 0000084129 2020-03-01 2020-05-30 0000084129 rad:PharmacyServicesMember 2022-11-27 2023-03-04 0000084129 rad:PharmacyServicesMember 2022-05-29 2022-08-27 0000084129 rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 rad:RetailPharmacyMember 2023-03-04 0000084129 rad:RetailPharmacyMember 2022-02-26 0000084129 rad:RetailPharmacyMember 2021-02-27 0000084129 rad:PharmacyServicesMember 2021-02-27 0000084129 rad:SeniorNotes7.5PercentMember 2022-12-09 2022-12-09 0000084129 rad:SeniorSecuredCreditFacilityMember 2022-12-01 2022-12-01 0000084129 2022-06-13 2022-06-13 0000084129 rad:SeniorSecuredCreditFacilityMember 2022-02-27 2023-03-04 0000084129 rad:February2023ReceivablePurchaseAgreementMember 2022-11-27 2023-03-04 0000084129 rad:MostCurrentReceivablePurchaseAgreementMember 2022-02-27 2023-03-04 0000084129 rad:January2022ReceivablePurchaseAgreementMember 2021-11-28 2022-02-26 0000084129 2021-05-30 2021-08-28 0000084129 rad:October2022ReceivablePurchaseAgreementMember 2022-08-28 2022-11-26 0000084129 us-gaap:TrademarksMember 2023-03-04 0000084129 us-gaap:LicensingAgreementsMember rad:PharmacyServicesMember 2023-03-04 0000084129 rad:EnvisionInsuranceCompanyMember us-gaap:LicensingAgreementsMember 2022-02-26 0000084129 rad:EnvisionInsuranceCompanyMember us-gaap:LicensingAgreementsMember 2022-02-25 0000084129 us-gaap:TrademarksMember 2023-03-04 0000084129 us-gaap:NoncompeteAgreementsMember 2023-03-04 0000084129 us-gaap:LicensingAgreementsMember 2023-03-04 0000084129 us-gaap:CustomerRelationshipsMember 2023-03-04 0000084129 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-03-04 0000084129 rad:PrescriptionFilesMember 2023-03-04 0000084129 us-gaap:TrademarksMember 2022-02-26 0000084129 us-gaap:NoncompeteAgreementsMember 2022-02-26 0000084129 us-gaap:LicensingAgreementsMember 2022-02-26 0000084129 us-gaap:CustomerRelationshipsMember 2022-02-26 0000084129 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-02-26 0000084129 rad:PrescriptionFilesMember 2022-02-26 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-07-10 2020-07-10 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-06-25 2020-06-25 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-06-20 2020-06-20 0000084129 us-gaap:EmployeeStockOptionMember 2021-02-28 2022-02-26 0000084129 us-gaap:EmployeeStockOptionMember 2020-03-01 2021-02-27 0000084129 us-gaap:RestrictedStockMember 2022-02-27 2023-03-04 0000084129 us-gaap:EmployeeStockOptionMember 2022-02-27 2023-03-04 0000084129 us-gaap:RestrictedStockMember 2023-03-04 0000084129 us-gaap:EmployeeStockOptionMember 2023-03-04 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-07-24 2020-07-24 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2021-02-28 2021-05-29 0000084129 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2022-02-27 2023-03-04 0000084129 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-02-28 2022-02-26 0000084129 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-03-01 2021-02-27 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2023-03-04 0000084129 us-gaap:FixedIncomeSecuritiesMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2022-02-26 0000084129 rad:DefinedBenefitPlanOtherInvestmentMember 2022-02-26 0000084129 us-gaap:FixedIncomeSecuritiesMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember 2023-03-04 0000084129 rad:DefinedBenefitPlanOtherInvestmentMember 2023-03-04 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:SmallMidCapMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:FairValueMeasurementsRecurringMember 2023-03-04 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:SmallMidCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:TwentyPlusYearTreasuryStripsMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:SmallMidCapMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermUsGovernmentBondsMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:LongTermCreditBondIndexMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonMultiAssetCreditMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonHighYieldPlusBondMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonGlobalRealEstateMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AonCoreRealEstateFunMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 rad:AgtHighYieldBondMember us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:FairValueMeasurementsRecurringMember 2022-02-26 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2021-02-27 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2022-02-26 0000084129 us-gaap:InternalRevenueServiceIRSMember rad:TaxPeriodBetweenFiscal2032And2037Member 2023-03-04 0000084129 us-gaap:InternalRevenueServiceIRSMember rad:TaxPeriodBetweenFiscal2029And2031Member 2023-03-04 0000084129 us-gaap:StateAndLocalJurisdictionMember 2023-03-04 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2023-03-04 0000084129 rad:SeniorNotes7.5PercentMember 2022-12-09 0000084129 rad:SeniorNotes7.5PercentMember 2022-11-30 0000084129 rad:SeniorNotes7.5PercentMember 2022-11-03 0000084129 rad:SeniorNotes7.5PercentMember 2022-06-29 0000084129 rad:Notes7.7PercentDueFeb2027Member 2022-06-29 0000084129 rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member 2022-06-29 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2022-06-13 0000084129 rad:SeniorNotes7.70PercentMember 2022-06-13 0000084129 rad:SeniorNotes7.5PercentMember 2022-06-13 0000084129 rad:SeniorNotes6.875PercentMember 2022-06-13 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2021-05-28 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-07-24 0000084129 2020-07-10 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2020-07-09 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2020-06-25 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2023-03-04 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2023-03-04 0000084129 rad:SeniorNotes7.5PercentMember 2023-03-04 0000084129 rad:Notes7.7PercentDueFeb2027Member 2023-03-04 0000084129 rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member 2023-03-04 0000084129 rad:FiloTermLoanDueAugust2026Member 2023-03-04 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-02-26 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2022-02-26 0000084129 rad:SeniorNotes7.5PercentMember 2022-02-26 0000084129 rad:Notes7.7PercentDueFeb2027Member 2022-02-26 0000084129 rad:FixedRate6.875PercentSeniorNotesDueDecember2028Member 2022-02-26 0000084129 rad:FiloTermLoanDueAugust2026Member 2022-02-26 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2020-07-24 0000084129 rad:SeniorSecuredNotes8.0PercentMember 2020-06-25 0000084129 rad:SeniorSecuredTermLoanDueDecember2023Member 2018-12-20 0000084129 us-gaap:FairValueInputsLevel1Member 2023-03-04 0000084129 us-gaap:FairValueInputsLevel1Member 2022-02-26 0000084129 rad:FiloTermLoanDueAugust2026Member us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-01 2022-12-01 0000084129 rad:FiloTermLoanDueAugust2026Member us-gaap:BaseRateMember 2022-12-01 2022-12-01 0000084129 srt:MinimumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member us-gaap:BaseRateMember 2021-08-20 2021-08-20 0000084129 srt:MinimumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member rad:LondonInterbankOfferedRateMember 2021-08-20 2021-08-20 0000084129 srt:MaximumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member us-gaap:BaseRateMember 2021-08-20 2021-08-20 0000084129 srt:MaximumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member rad:LondonInterbankOfferedRateMember 2021-08-20 2021-08-20 0000084129 rad:FiloTermLoanDueAugust2026Member us-gaap:BaseRateMember 2021-08-20 2021-08-20 0000084129 rad:FiloTermLoanDueAugust2026Member rad:LondonInterbankOfferedRateMember 2021-08-20 2021-08-20 0000084129 rad:MedicarePartDMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:MedicarePartDMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 rad:MedicarePartDMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 rad:RiteAidRewardsProgramMember rad:RetailPharmacyMember 2023-03-04 0000084129 rad:RiteAidRewardsProgramMember rad:RetailPharmacyMember 2022-02-26 0000084129 rad:CaremarkMember rad:LargestThirdPartyPayorsMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:TopFiveThirdPartyPayorsMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:PreviouslyDisclosedClientLossMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:PrescriptionDrugsMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:OverTheCounterMedicationsAndPersonalCareMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:MedicarePartDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:MedicarePartDMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:MedicaidAgenciesAndRelatedManagedCareMedicaidPayorsMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:McKessonCorporationMember rad:PharmacySalesMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:LargestMedicaidAgenciesMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2022-02-27 2023-03-04 0000084129 rad:LargestCustomerMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:HealthAndBeautyAidsMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:GeneralMerchandiseAndOtherMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 rad:CaremarkMember rad:LargestThirdPartyPayorsMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2021-02-28 2022-02-26 0000084129 rad:PrescriptionDrugsMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 rad:MedicarePartDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 rad:LargestCustomerMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 rad:CaremarkMember rad:LargestThirdPartyPayorsMember rad:PharmacySalesMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember 2020-03-01 2021-02-27 0000084129 rad:PrescriptionDrugsMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:ProductConcentrationRiskMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 rad:MedicarePartDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 rad:LargestCustomerMember us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember us-gaap:CustomerConcentrationRiskMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 2020-02-29 0000084129 rad:BartellDrugCompanyMember us-gaap:TrademarksMember 2020-12-18 0000084129 rad:BartellDrugCompanyMember rad:PrescriptionFilesMember 2020-12-18 0000084129 rad:BartellDrugCompanyMember 2020-12-18 2021-02-27 0000084129 rad:BartellDrugCompanyMember 2020-12-18 2020-12-18 0000084129 rad:BartellDrugCompanyMember 2022-02-27 2023-03-04 0000084129 rad:BartellDrugCompanyMember 2020-03-01 2021-02-27 0000084129 us-gaap:OperatingSegmentsMember rad:RetailPharmacyMember 2023-03-04 0000084129 us-gaap:OperatingSegmentsMember rad:PharmacyServicesMember 2023-03-04 0000084129 us-gaap:OperatingSegmentsMember rad:RetailPharmacyMember 2022-02-26 0000084129 us-gaap:OperatingSegmentsMember rad:PharmacyServicesMember 2022-02-26 0000084129 us-gaap:RestrictedStockMember 2022-02-27 2023-03-04 0000084129 us-gaap:EmployeeStockOptionMember 2022-02-27 2023-03-04 0000084129 us-gaap:RestrictedStockMember 2021-02-28 2022-02-26 0000084129 us-gaap:EmployeeStockOptionMember 2021-02-28 2022-02-26 0000084129 us-gaap:RestrictedStockMember 2020-03-01 2021-02-27 0000084129 us-gaap:EmployeeStockOptionMember 2020-03-01 2021-02-27 0000084129 rad:ManufacturersRebatesReceivablesMember rad:PharmacyServicesMember 2021-11-28 2022-02-26 0000084129 rad:ManufacturersRebatesReceivablesMember rad:PharmacyServicesMember 2023-03-04 0000084129 rad:ManufacturersRebatesReceivablesMember rad:PharmacyServicesMember 2022-02-26 0000084129 us-gaap:PerformanceSharesMember 2022-02-27 2023-03-04 0000084129 us-gaap:PerformanceSharesMember 2021-02-28 2022-02-26 0000084129 us-gaap:PerformanceSharesMember 2020-03-01 2021-02-27 0000084129 us-gaap:CommonStockMember 2022-02-27 2023-03-04 0000084129 us-gaap:AdditionalPaidInCapitalMember 2022-02-27 2023-03-04 0000084129 us-gaap:CommonStockMember 2021-02-28 2022-02-26 0000084129 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 2022-02-26 0000084129 us-gaap:CommonStockMember 2020-03-01 2021-02-27 0000084129 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2021-02-27 0000084129 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2022-02-27 2023-03-04 0000084129 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2022-02-27 2023-03-04 0000084129 rad:PrescriptionFilesMember 2022-02-27 2023-03-04 0000084129 rad:BartellDrugCompanyMember rad:PrescriptionFilesMember 2020-12-18 2020-12-18 0000084129 us-gaap:IntersegmentEliminationMember 2023-03-04 0000084129 rad:October2022ReceivablePurchaseAgreementMember 2023-03-04 0000084129 rad:February2023ReceivablePurchaseAgreementMember 2023-03-04 0000084129 rad:EnvisionInsuranceCompanyMember 2023-03-04 0000084129 us-gaap:IntersegmentEliminationMember 2022-02-26 0000084129 rad:EnvisionInsuranceCompanyMember 2022-02-26 0000084129 rad:RiteAidRewardsProgramMember rad:RetailPharmacyMember 2022-02-27 2022-02-27 0000084129 rad:RetailStoreMember 2022-02-27 2023-03-04 0000084129 rad:DistributionCenterMember 2022-02-27 2023-03-04 0000084129 srt:MinimumMember 2020-03-01 2021-02-27 0000084129 srt:MaximumMember 2020-03-01 2021-02-27 0000084129 rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 rad:PharmacyServicesMember 2023-03-04 0000084129 rad:PharmacyServicesMember 2022-02-26 0000084129 rad:RetailSitesNewRelocatedAndRemodeledMember srt:MinimumMember 2022-02-27 2023-03-04 0000084129 rad:WellnessPlusProgramMember 2020-12-20 2020-12-20 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2022-02-27 2023-03-04 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2021-02-28 2022-02-26 0000084129 rad:FacilityAndEquipmentLeaseExitChargesMember 2020-03-01 2021-02-27 0000084129 rad:RetailSitesInClosedStatusMember 2022-02-27 2023-03-04 0000084129 rad:RetailSitesInActiveStatusMember 2022-02-27 2023-03-04 0000084129 rad:RetailSitesInClosedStatusMember 2021-02-28 2022-02-26 0000084129 rad:RetailSitesInActiveStatusMember 2021-02-28 2022-02-26 0000084129 rad:RetailSitesInClosedStatusMember 2020-03-01 2021-02-27 0000084129 rad:RetailSitesInActiveStatusMember 2020-03-01 2021-02-27 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2023-03-04 0000084129 us-gaap:DiscontinuedOperationsHeldforsaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2017-09-18 0000084129 us-gaap:DiscontinuedOperationsHeldforsaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2017-06-28 0000084129 rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember 2021-01-01 2021-01-01 0000084129 rad:SouthernCaliforniaUnitedFoodAndCommercialWorkersUnionsAndDrugEmployersPensionFundMember 2020-01-01 2020-12-31 0000084129 rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember 2020-01-01 2020-01-01 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2022-02-06 2022-02-06 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2022-02-01 2022-02-01 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2021-10-01 2021-10-01 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2021-02-07 2021-02-07 0000084129 rad:UnitedFoodAndCommercialWorkersUnionLocal880MercantileEmployersJointPensionFundMember 2020-10-01 2020-10-01 0000084129 rad:UnitedFoodAndCommercialWorkersUnionEmployerPensionFundMember 2020-02-02 2020-02-02 0000084129 rad:UFCWPharmacistsClerksAndDrugEmployersPensionTrustMember 2014-09-01 2014-09-01 0000084129 rad:SEIUHealthCareEmployeesPensionFund1199Member 2021-10-01 2021-10-01 0000084129 rad:SEIUHealthCareEmployeesPensionFund1199Member 2018-09-30 2018-09-30 0000084129 srt:MaximumMember 2022-02-27 2023-03-04 0000084129 srt:MinimumMember 2022-02-27 2023-03-04 0000084129 rad:RiteAidRewardsProgramMember rad:RetailPharmacyMember 2022-02-27 0000084129 rad:BartellDrugCompanyMember 2021-02-28 2022-02-26 0000084129 srt:MinimumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-02-27 2023-03-04 0000084129 srt:MaximumMember rad:FiloTermLoanDueAugust2026Member 2022-02-27 2023-03-04 0000084129 srt:MaximumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-02-27 2023-03-04 0000084129 srt:ScenarioPreviouslyReportedMember 2022-02-27 2023-03-04 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-02-27 2023-03-04 0000084129 srt:ScenarioPreviouslyReportedMember 2021-02-28 2022-02-26 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-02-28 2022-02-26 0000084129 srt:ScenarioPreviouslyReportedMember 2020-03-01 2021-02-27 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2020-03-01 2021-02-27 0000084129 rad:RetailSitesInClosedOrApprovedForClosureStatusMember 2022-02-27 2023-03-04 0000084129 rad:RetailSitesInClosedOrApprovedForClosureStatusMember 2021-02-28 2022-02-26 0000084129 rad:RetailSitesInClosedOrApprovedForClosureStatusMember 2020-03-01 2021-02-27 0000084129 srt:MinimumMember us-gaap:StateAndLocalJurisdictionMember 2022-02-27 2023-03-04 0000084129 srt:MaximumMember us-gaap:StateAndLocalJurisdictionMember 2022-02-27 2023-03-04 0000084129 rad:SeniorSecuredCreditFacilityMember 2021-08-20 2021-08-20 0000084129 rad:SeniorNotes6.125Percent2023DueMember 2021-05-28 2021-05-28 0000084129 srt:MinimumMember rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2023-03-04 0000084129 srt:ScenarioPreviouslyReportedMember 2023-03-04 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2023-03-04 0000084129 srt:ScenarioPreviouslyReportedMember 2022-02-26 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-02-26 0000084129 srt:ScenarioPreviouslyReportedMember 2021-02-27 0000084129 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-02-27 0000084129 2021-02-27 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2022-02-27 2023-03-04 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2023-03-04 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2022-02-27 2023-03-04 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2021-02-28 2022-02-26 0000084129 us-gaap:PensionPlansDefinedBenefitMember 2020-03-01 2021-02-27 0000084129 rad:SeniorNotes7.5PercentMember 2022-06-13 2022-06-13 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-12-01 2022-12-01 0000084129 rad:SeniorSecuredRevolvingCreditFacilityDueAugust2026Member 2022-02-27 2023-03-04 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2021-02-28 2022-02-26 0000084129 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember rad:SaleOfAssetsToWalgreensBootsAllianceWbaAndBuyerMember 2020-03-01 2021-02-27 0000084129 rad:RetailSitesPreviouslyImpairedMember 2022-02-27 2023-03-04 0000084129 rad:RetailSitesNewRelocatedAndRemodeledMember 2022-02-27 2023-03-04 0000084129 rad:OtherRetailSitesMember 2022-02-27 2023-03-04 0000084129 rad:RetailSitesPreviouslyImpairedMember 2021-02-28 2022-02-26 0000084129 rad:RetailSitesNewRelocatedAndRemodeledMember 2021-02-28 2022-02-26 0000084129 rad:OtherRetailSitesMember 2021-02-28 2022-02-26 0000084129 rad:RetailSitesPreviouslyImpairedMember 2020-03-01 2021-02-27 0000084129 rad:RetailSitesNewRelocatedAndRemodeledMember 2020-03-01 2021-02-27 0000084129 rad:OtherRetailSitesMember 2020-03-01 2021-02-27 0000084129 rad:BartellDrugCompanyMember 2020-12-18 0000084129 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-04 0000084129 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-02-26 0000084129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-02-26 0000084129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-02-26 0000084129 us-gaap:OperatingSegmentsMember rad:RetailPharmacyMember 2022-02-27 2023-03-04 0000084129 us-gaap:OperatingSegmentsMember rad:PharmacyServicesMember 2022-02-27 2023-03-04 0000084129 us-gaap:IntersegmentEliminationMember 2022-02-27 2023-03-04 0000084129 us-gaap:OperatingSegmentsMember rad:RetailPharmacyMember 2021-02-28 2022-02-26 0000084129 us-gaap:OperatingSegmentsMember rad:PharmacyServicesMember 2021-02-28 2022-02-26 0000084129 us-gaap:IntersegmentEliminationMember 2021-02-28 2022-02-26 0000084129 2021-02-28 2022-02-26 0000084129 us-gaap:OperatingSegmentsMember rad:RetailPharmacyMember 2020-03-01 2021-02-27 0000084129 us-gaap:OperatingSegmentsMember rad:PharmacyServicesMember 2020-03-01 2021-02-27 0000084129 us-gaap:IntersegmentEliminationMember 2020-03-01 2021-02-27 0000084129 2020-03-01 2021-02-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-11-27 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-11-27 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-11-27 2023-03-04 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-08-28 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-08-28 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-08-28 2022-11-26 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-05-29 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-05-29 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-05-29 2022-08-27 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:OtherRestructuringMember 2022-02-27 2022-05-28 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember us-gaap:EmployeeSeveranceMember 2022-02-27 2022-05-28 0000084129 rad:AccruedSalariesWagesAndOtherCurrentLiabilitiesMember rad:ReorganizationOfExecutiveManagementTeamOngoingWorkforceReductionAndConsolidationAndTransformationInitiativesMember 2022-02-27 2022-05-28 0000084129 2023-03-04 0000084129 2022-02-26 0000084129 rad:February2023ReceivablePurchaseAgreementMember 2023-02-03 2023-02-03 0000084129 rad:October2022ReceivablePurchaseAgreementMember 2022-10-13 2022-10-13 0000084129 rad:January2022ReceivablePurchaseAgreementMember 2022-01-24 2022-01-24 0000084129 rad:August2021ReceivablePurchaseAgreementMember 2021-08-12 2021-08-12 0000084129 rad:February2021ReceivablePurchaseAgreementMember 2021-02-18 2021-02-18 0000084129 rad:November2020ReceivablePurchaseAgreementMember 2020-11-12 2020-11-12 0000084129 2022-08-27 0000084129 2024-07-22 0000084129 2022-02-27 2023-03-04 iso4217:USD shares rad:lawsuit rad:segment rad:state shares iso4217:USD pure rad:store rad:Point iso4217:USD utr:H rad:item rad:Center rad:location 9161000 0.18 0000084129 2023 FY true http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent Rite Aid Corporation ("Rite Aid," the "Company," "we," "us," and "our") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment" or "Form 10-K/A") to our Annual Report on Form 10-K for the fiscal year ended March 4, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on May 1, 2023 (the "Original Form 10-K") to make certain changes, as described below. Subsequent to the issuance of the Company's consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement related to the Company's historical accounting for closed store liabilities in accordance with changes in ASC 420, Exit or Disposal Cost Obligations. Based on their evaluation, management concluded the misstatement is not material to the Company's previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the "previously issued financial statements"). However, due to the discovery of this error, we reevaluated the effectiveness of our internal control over financial reporting ("ICFR") as of March 4, 2023 and identified a material weakness in our ICFR. For a more detailed description of this material weakness, refer to Part II, Item 9A,"Controls and Procedures." This Amendment therefore amends our assessment of our ICFR and our disclosure controls and procedures to indicate that they were not effective as of March 4, 2023 because of this material weakness. Our independent registered public accounting firm, Deloitte & Touche LLP, has also amended its opinion on our ICFR as of March 4, 2023. In conjunction with filing this Amendment, we determined it was appropriate to revise the consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes thereto to reflect the impact of the immaterial misstatement in the periods impacted. For additional information and a more detailed discussion, refer to Note 25 Revision of Previously Issued Consolidated Financial Statements. Item 1A, "Risk Factors," of Part I of the Original Form 10-K, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Continuing Operations;" Item 8, "Financial Statements and Supplementary Data," and Item 9A, "Controls and Procedures," of Part II of the Original Form 10-K are hereby deleted in their entireties and replaced with Item 1A, Item 7, Item 8, and Item 9A included herein, Item 15, "Exhibits and Financial Statement Schedule," of Part IV of the Original Form 10-K also has been amended to include a new consent of Deloitte & Touche LLP and, as required by Rule 12b-15 under the Securities Act of 1934, as amended, to provide new currently dated certifications by our Chief Executive Officer and Chief Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The new consent is attached to this Amendment as Exhibit 23 and the new certifications are attached to this Amendment as Exhibits 31.1, 31.2 and 32. The other Items of the Original Form 10-K have not been amended and, accordingly, have not been repeated in this Amendment. The only changes to the Original Form 10-K are related to the matters described above. Except as described above, this Amendment does not amend, update, or change any other item or disclosure in the Original Form 10-K and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Original Form 10-K was filed, and the Company has not undertaken herein to amend, update, or change any information contained in the Original Form 10-K to give effect to any event following the date of filing of the Original Form 10-K, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and any subsequent filing with the SEC. 55752000 56629000 -719188000 -522372000 -99381000 -719188000 -522372000 -90220000 -13.15 -9.66 -1.86 0.18 -13.15 -9.66 -1.68 http://www.riteaid.com/20230304#GainLossOnAcquisitionOfBusiness -13.15 -9.66 -1.86 -13.15 -9.66 -1.68 http://www.riteaid.com/20230304#LeaseTerminationAndLongLivedAssetImpairmentCharges http://www.riteaid.com/20230304#LeaseTerminationAndLongLivedAssetImpairmentCharges P3Y P90D P5Y P22Y http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent 0.00 0.00 P0Y 10-K/A true 2023-03-04 --03-04 false 1-5742 RITE AID CORP DE 23-1614034 PO Box 3165 Harrisburg PA 17105 717 761-2633 Yes No No Yes Accelerated Filer false false false true false false 447694555 55974015 Deloitte & Touche LLP 34 Philadelphia, Pennsylvania 157151000 39721000 1149958000 1343496000 1900744000 1959389000 93194000 106749000 3301047000 3449355000 907771000 989167000 2497206000 2813535000 507936000 879136000 250112000 291196000 12368000 20071000 50922000 86543000 7527362000 8529003000 6332000 5544000 1494611000 1571261000 709891000 776559000 502403000 575651000 2713237000 2929015000 2925258000 2732986000 2372943000 2597090000 12580000 14830000 97577000 139254000 8121595000 8413175000 1 1 75000000 75000000 56629000 55752000 56629000 55752000 5917964000 5910299000 -6553974000 -5834786000 -14852000 -15437000 -594233000 115828000 7527362000 8529003000 24091899000 24568255000 24043240000 19287959000 19461760000 19338918000 4902087000 5033876000 4657185000 180637000 164084000 57714000 371200000 229000000 29852000 224399000 191601000 201388000 80142000 -3235000 5274000 68586000 -5505000 69300000 -5346000 47705000 24817554000 25094407000 24162778000 -725655000 -526152000 -119538000 -6467000 -3780000 -20157000 -719188000 -522372000 -99381000 9161000 -719188000 -522372000 -90220000 -719188000 -522372000 -99381000 9161000 -719188000 -522372000 -90220000 -13.15 -9.66 -1.86 0.18 -13.15 -9.66 -1.68 -719188000 -522372000 -90220000 0 0 0 -585000 -8590000 -24382000 27000 462000 585000 8617000 24844000 -718603000 -513755000 -65376000 54716000 54716000 5890903000 -5222194000 -48898000 674527000 -90220000 -90220000 0 -24382000 -24382000 462000 462000 -65376000 189000 189000 2897000 3086000 780000 780000 -780000 166000 166000 -166000 9126000 9126000 599000 599000 2000 2000 51000 53000 55143000 55143000 5897168000 -5312414000 -24054000 615843000 -522372000 -522372000 0 -8590000 -8590000 27000 27000 -513755000 177000 177000 2411000 2588000 973000 973000 -973000 187000 187000 -187000 10308000 10308000 600000 600000 5420000 5420000 55752000 55752000 5910299000 -5834786000 -15437000 115828000 -719188000 -719188000 0 -585000 -585000 -718603000 415000 415000 2247000 2662000 1662000 1662000 -1662000 370000 370000 -370000 13897000 13897000 720000 720000 -3413000 -3413000 56629000 56629000 5917964000 -6553974000 -14852000 -594233000 -719188000 -522372000 -90220000 9161000 -719188000 -522372000 -99381000 276583000 295686000 327124000 180637000 164084000 57714000 371200000 229000000 29852000 53028000 1314000 -51692000 68586000 -5505000 69300000 15267000 22011000 -5346000 47705000 11537000 13050000 13003000 80142000 -3235000 5274000 -7703000 6709000 10633000 -151610000 -54086000 182404000 -5158000 97112000 -177263000 -96570000 139228000 -35372000 86133000 29375000 28044000 -36478000 -33737000 -80975000 -111021000 68558000 -50947000 -52439000 379272000 105179000 215285000 194090000 195141000 32400000 26623000 29800000 86230000 10436000 12500000 69582000 18706000 11444000 73344000 57498000 177892000 -104759000 -134073000 -109335000 50000000 350000000 849918000 491000000 -141000000 200000000 277941000 545036000 1058537000 18289000 -8285000 -36463000 53000 1733000 833000 2399000 2662000 2588000 3086000 2325000 18638000 14729000 274628000 -366380000 -65243000 0 0 -82189000 0 0 94310000 0 0 0 0 0 12121000 117430000 -121181000 -57278000 39721000 160902000 218180000 157151000 39721000 160902000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1. Summary of Significant Accounting Policies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Description of Business</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is a Delaware corporation and through its 100% owned subsidiaries, operates a pharmacy retail healthcare company in the United States of America. The Company operates through its two reportable segments: the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy Segment operates one of the largest retail drugstore chains in the United States, with 2,309 stores in operation as of March 4, 2023. The Retail Pharmacy Segment’s drugstores’ primary business is the sale of brand and generic prescription drugs. The Retail Pharmacy Segment also sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment provides a fully integrated suite of pharmacy benefit management (“PBM”) offerings including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication and pharmacy discount programs, through Elixir Pharmacy and Laker Software. Elixir also offers a national Medicare Part D prescription drug plan through Elixir Insurance (“EI”). See Note 21 for additional details on the Company’s reportable segments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The discussion and presentation of the operating and financial results of our business segments have been impacted by the following event.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement (the "Amended and Restated Asset Purchase Agreement"), dated as of September 18, 2017, by and among Rite Aid, WBA and Walgreen Co., an Illinois corporation and 100% owned subsidiary of WBA ("Buyer"), Buyer agreed to purchase from Rite Aid 1,932 stores (the "Acquired Stores"), three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of approximately $4,375,000, on a cash free, debt free basis (the "Asset Sale" or the "Sale"). As of March 4, 2023, the Company has sold all 1,932 Acquired Stores, three distribution centers and related assets to WBA in exchange for proceeds of $4,375,000, which were used to repay outstanding debt. Based on its magnitude and because the Company has exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Asset Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). See additional information as provided in Note 4 Asset Sale to WBA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Revenues for the Company are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:47.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retail Pharmacy Segment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,582,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,152,491</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,915,442</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Front-end sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,078,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,218,182</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,322,943</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 124,143</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,875</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total Retail Pharmacy Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,494,816</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,365,260</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy Services Segment revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,323,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,970,137</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intersegment elimination</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (249,686)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292,157)</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Sales of prescription drugs for our Retail Pharmacy Segment represented approximately 71.2%, 70.0% and 66.7% of the Company’s total drugstore sales in fiscal years 2023, 2022 and 2021, respectively. The Retail Pharmacy Segment’s principal classes of products in fiscal 2023 were the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percentage</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Product Class</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of Sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prescription drugs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Over-the-counter medications and personal care</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Health and beauty aids</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General merchandise and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Fiscal Year</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year ended March 4, 2023 included 53 weeks. The fiscal years ended February 26, 2022 and February 27, 2021 included 52 weeks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Principles of Consolidation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements include the accounts of the Company and all of its 100% owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents consist of cash on hand and highly liquid investments, which are readily convertible to known amounts of cash and which have original maturities of three months or less when purchased.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Allowance for Uncollectible Receivables</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In our Retail Pharmacy Segment, substantially all prescription sales are made to customers who are covered by third-party payors, such as insurance companies, government agencies and employers. The Company recognizes receivables that represent the amount owed to the Company for sales made to customers or employees of those payors that have not yet been paid. In our Pharmacy Services Segment, receivables are recorded for claims for prescriptions </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">issued for customers, customer administrative fees, amounts due from the Centers for Medicare and Medicaid Services (“CMS”) for Medicare Part D, and amounts due from certain drug manufacturers or rebate aggregators for rebates. The Company maintains a reserve for the expected credit losses associated with these receivables. This reserve is calculated based upon historical collection activity adjusted for current conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inventories</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are stated at the lower of cost or market. Inventory balances include the capitalization of certain costs related to purchasing, freight and handling costs associated with placing inventory in its location and condition for sale. The Company uses the last-in, first-out (“LIFO”) cost flow assumption for substantially all of its inventories. The Company calculates its inflation index based on internal product mix and utilizes the link-chain LIFO method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Asset impairments are recorded when the carrying value of assets are not recoverable. For purposes of recognizing and measuring impairment of long-lived assets, the Company categorizes assets of operating stores as “Assets to Be Held and Used” and “Assets to Be Disposed Of.” The Company evaluates assets at the store level because this is the lowest level of identifiable cash flows ascertainable to evaluate impairment. Assets being tested for recoverability at the store level include tangible long-lived assets, right-of-use assets for leased stores, and identifiable, finite-lived intangibles that arose in purchase business combinations. Corporate assets to be held and used are evaluated for impairment based on excess cash flows from the stores that support those assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Property, Plant and Equipment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment are stated at cost, net of accumulated depreciation and amortization. The Company provides for depreciation using the straight-line method over the following useful lives: buildings—30 to 45 years; equipment—3 to 15 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the term of the lease. When determining the amortization period of a leasehold improvement, the Company considers whether discretionary exercise of a lease renewal option is reasonably assured. If it is determined that the exercise of such option is reasonably assured, the Company will amortize the leasehold improvement asset over the minimum lease term, plus the option period. This determination depends on the remaining life of the minimum lease term and any economic penalties that would be incurred if the lease option is not exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized lease assets are recorded at the lesser of the present value of minimum lease payments or fair market value and amortized over the estimated useful life of the related property or term of the lease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company capitalizes direct internal and external development costs associated with internal-use software. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. For fiscal years 2023, 2022 and 2021, the Company capitalized costs of approximately $5,099, $13,388 and $12,669, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Goodwill</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes goodwill as the excess of the purchase price over the fair value of the assets acquired and liabilities assumed during business combinations. The Company accounts for goodwill under ASC Topic 350, “Intangibles—Goodwill and Other”, which does not permit amortization, but instead requires the Company to perform an annual impairment review, or more frequently if events or circumstances indicate that impairment may be more likely. See Note 14 for additional information on goodwill.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intangible Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has certain finite-lived intangible assets that are amortized over their useful lives. Prescription files acquired in business combinations are amortized over an estimated useful life of 10 years on an accelerated basis, which approximates the anticipated prescription file retention and related cash flows. Purchased prescription files acquired in other than business combinations are amortized over their estimated useful lives of five years on a straight-line basis. The value of finite-lived trade names are amortized over 10 years on a straight-line basis. The value of customer relationships, acquired in connection with the Company’s acquisition of Elixir, are amortized over a period between 10 and 20 years on a descending percentage method which matches the pattern of expected discounted cash flows. The Pharmacy Services Segment’s contract with CMS for Part D, which is required in order to act as a national provider of the Part D benefit, is amortized over 12 years on a straight line basis, of which four years remain.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Indefinite lived assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has a single indefinite-lived intangible asset consisting of a trade name. Intangible assets that are determined to have an indefinite life are not amortized, but are required to be evaluated at least annually for impairment. If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-lived intangible asset is impaired by the amount of the excess.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Deferred Financing Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Costs incurred to issue debt are deferred and amortized as a component of interest expense over the terms of the related debt agreements. Amortization expense of deferred financing costs was $9,993, $10,927 and $11,201 for fiscal 2023, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For front-end sales, the Retail Pharmacy Segment recognizes revenues upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation at the point of sale for front-end transactions. The Retail Pharmacy Segment front-end revenue is measured based on the amount of fixed consideration that it expects to </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">receive, net of an allowance for estimated future returns. Return activity is immaterial to revenues and results of operations in all periods presented. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For pharmacy sales, the Retail Pharmacy Segment recognizes revenue upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation, upon pickup by the customer, which is when the customer takes title to the product. Each prescription claim represents an individual arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims. The Company's revenue is measured based on the amount of fixed consideration that we expect to receive, reduced by refunds owed to the third-party payor for pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not highly subjective or volatile. The effect of adjustments between estimated and actual amounts has not been material to the Company's results of operations or financial position. Prescriptions are generally not returnable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Retail Pharmacy Segment offered a chain-wide loyalty card program titled wellness+. Individual customers were able to become members of the wellness+ program. Members participating in the wellness+ loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, the Company granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue. For the fifty-three week period ended March 4, 2023, the Company recognized additional contract deferrals of </span>$2,030 as a reduction of revenues. The Retail Pharmacy Segment had accrued contract liabilities of $2,030 and $0 as of March 4, 2023 and February 26, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and; (ii) under retail pharmacy network contracts where it is the principal at the contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member co-payments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services Segment’s online claims processing system. At this point the Company has performed all of its performance obligations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member-based fee, or a claims volume-based fee.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized, except the administrative fee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Drug Discounts—The Pharmacy Services Segment deducts from its revenues that are generated from prescription drugs sold by third-party pharmacies any rebates, inclusive of discounts and fees, earned by its clients based on utilization levels and other factors as negotiated with the prescription drug manufacturers, rebate aggregators or suppliers. Rebates are paid to clients in accordance with the terms of client contracts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Medicare Part D—The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a Medicare Part D Prescription Drug Plan (“PDP”). Please refer to Note 10, Medicare Part D.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Disaggregation of Revenue</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following tables disaggregate the Company’s revenue by major source in each segment for the fiscal year ended March 4, 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In thousands</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retail Pharmacy Segment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Pharmacy sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,582,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Front-end sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,078,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Retail Pharmacy Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy Services Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intersegment elimination</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See Note 21 for additional information about the revenues of the Company’s business segments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cost of Revenues</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cost of revenues for the Retail Pharmacy Segment includes the following: the cost of inventory sold during the period, including related vendor rebates and allowances, LIFO credit or charges, costs incurred to return merchandise to vendors, inventory shrink, purchasing costs and warehousing costs, which include inbound freight costs from the vendor, distribution payroll and benefit costs, distribution center occupancy costs and depreciation expense and delivery expenses to the stores.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment’s cost of revenues includes the cost of prescription drugs sold during the reporting period indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The cost of prescription drugs sold component of cost of revenues includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients’ benefit plans from the Pharmacy Services Segment’s mail service dispensing pharmacy, net of any volume-related or other discounts (see the section entitled “Vendor Rebates and Allowances and Purchase Discounts” below) and (ii) the cost of prescription drugs sold through the Pharmacy Services Segment’s retail pharmacy network under contracts where it is the principal, net of any volume-related or other discounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See Note 21 for additional information about the cost of revenues of the Company’s business segments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Vendor Rebates and Allowances and Purchase Discounts</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Retail Pharmacy Segment’s rebates and allowances received from vendors relate to either buying and merchandising or promoting the product. Buying and merchandising related rebates and allowances are recorded as a reduction of cost of revenue as product is sold. Buying and merchandising rebates and allowances include all types of vendor programs such as cash discounts from timely payment of invoices, purchase discounts or rebates, volume purchase allowances, price reduction allowances and slotting allowances. Certain product promotion related rebates and allowances, primarily related to advertising, are recorded as a reduction in selling, general and administrative expenses when the advertising commitment has been satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment receives purchase discounts on products purchased. The Pharmacy Services Segment’s contractual arrangements with vendors, including manufacturers and rebate aggregators, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized when prescriptions are dispensed and are generally billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Pharmacy Services Segment’s results of operations. The Pharmacy Services Segment accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services Segment also receives additional discounts under its wholesaler and rebate aggregator contracts and fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Rebates payable to clients for the Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment has contractual arrangements with clients, including health plans, commercial employers, labor groups, and state and local governments, which entitles such clients to a portion of certain rebates received by the Pharmacy Services Segment. Estimated rebates payable to clients are recognized when prescriptions are dispensed and are generally paid to clients up to eight months in arrears.  Historically, the effect of adjustments resulting from the reconciliation of estimated rebates payable to clients recognized and the amount actually paid has not been material to the Pharmacy Services Segment’s results of operations.  The Pharmacy Services Segment accounts for the effect of any such difference as a change in accounting estimate in the period the reconciliation is completed.  Estimated rebates payable to clients are recorded as a reduction of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company determines if an arrangement contains a lease at the inception of a contract. Operating lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized at the commencement date based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company’s leases is not readily </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest that we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses quoted interest rates obtained from financial institutions in an input to derive its incremental borrowing rate as the discount rate for the lease. The ROU asset is equal to the operating lease liability plus lease payments made before commencement, less lease incentives received from the landlord.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s real estate leases typically contain options that permit lease extensions for additional periods of up to five years each. For real estate leases, generally, the renewal periods are not included within the lease term and the associated payments are not included in the measurement of the ROU asset and operating lease liability as the options to extend are not considered reasonably certain to occur at lease commencement. The Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and will include all reasonably certain options in the measurement of its lease term. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the operating lease right-of-use asset and the operating lease liability until the renewals are i) evaluated and ii) determined to be exercised. The Company has an insignificant amount of non-real estate leases however, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. The Company rarely executes leases less than 12 months. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For real estate leases, the Company accounts for lease components and non-lease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the operating lease right-of-use assets and operating lease liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company records rent expense on operating leases on a straight-line basis over the reasonably certain lease term. The Company begins to record rent expense at the time that the Company has the right to use the property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Selling, General and Administrative Expenses</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Selling, general and administrative expenses include store and corporate administrative payroll and benefit costs, occupancy costs which include retail store and corporate rent costs, facility and leasehold improvement depreciation and utility costs, advertising, repair and maintenance, insurance, equipment depreciation and professional fees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Repairs and Maintenance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Routine repairs and maintenance are charged to operations as incurred. Improvements and major repairs, which extend the useful life of an asset, are capitalized and depreciated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Advertising</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Advertising costs, net of specific vendor advertising allowances, are expensed in the period the advertisement first takes place. Advertising expenses, net of vendor advertising allowances, for fiscal 2023, 2022 and 2021 were $133,379, $146,085 and $122,725, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Insurance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is self-insured for certain general liability and workers’ compensation claims. For claims that are self-insured, stop-loss insurance coverage is maintained for workers’ compensation occurrences exceeding $1,000 and general liability occurrences exceeding $3,000. The Company utilizes actuarial studies as the basis for developing reported claims and estimating claims incurred but not reported relating to the Company’s self-insurance. Workers’ compensation claims are discounted to present value using a risk-free interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is also self-insured for certain employee health and welfare plans. We record the related self-insurance liabilities based on claims incurred and an estimate of claims incurred but not yet reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Benefit Plan Accruals</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has several defined benefit plans, under which participants earn a retirement benefit based upon a formula set forth in the plan. The Company records expense related to these plans using actuarially determined amounts that are calculated under the provisions of ASC 715, “Compensation—Retirement Benefits.” Key assumptions used in the actuarial valuations include the discount rate, the expected rate of return on plan assets and the rate of increase in future compensation levels.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has several stock award plans, which are described in detail in Note 18. The Company accounts for stock-based compensation under ASC 718, “Compensation—Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Store Pre-opening Expenses</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Costs incurred prior to the opening of a new or relocated store, associated with a remodeled store or related to the opening of a distribution facility are charged to operations as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Litigation Reserves</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is involved in litigation on an ongoing basis. The Company accrues its best estimate of the probable loss related to legal claims. Such estimates are developed in consultation with in-house counsel, and are based upon a combination of litigation and settlement strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred income taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities. Deferred income tax expense (benefit) represents the change during the reporting period in the deferred tax assets and deferred tax liabilities, net of the effect of acquisitions and dispositions. Deferred tax assets include tax loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company has net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate a significant deferred tax asset. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes tax liabilities in accordance with ASC 740, “Income Taxes” and the Company adjusts these liabilities with changes in judgment as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the tax liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Sales Tax Collected</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sales taxes collected from customers and remitted to various governmental agencies are presented on a net basis (excluded from revenues) in the Company’s statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Significant Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s pharmacy sales were primarily to customers covered by health plan contracts, which typically contract with a third-party payor that agrees to pay for all or a portion of a customer’s eligible prescription purchases. During fiscal 2023, the top five third-party payors accounted for approximately 83.4% of the Company’s pharmacy sales. The largest third-party payor, Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. Third-party payors are entities such as an insurance company, governmental agency, health maintenance organization or other managed care provider, and typically represent several health care contracts and customers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During fiscal 2023, state sponsored Medicaid agencies and related managed care Medicaid payors accounted for approximately 19.9% of the Company’s pharmacy sales, the largest of which was approximately 6.6% of the Company’s pharmacy sales. During fiscal 2023, approximately 38.8% of the Company’s pharmacy sales were to customers covered by Medicare Part D. Any significant loss of third-party payor business could have a material adverse effect on the Company’s business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During fiscal 2023, the Company purchased brand and generic pharmaceuticals, which amounted to approximately 98% of the dollar volume of its prescription drugs from McKesson Corporation (“McKesson”) under its expanded agreement executed on February 17, 2014 and amended in fiscal 2019 for its pharmaceutical purchasing and distribution whereby McKesson assumed responsibility for purchasing essentially all of the brand and generic medications the Company dispenses as well as providing a new direct store delivery model to all of the Company’s stores. If the Company’s relationship with McKesson was disrupted, it could temporarily have difficulty filling </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">prescriptions for brand-named and generic drugs until it executed a replacement wholesaler agreement or developed and implemented self-distribution processes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s Pharmacy Services Segment revenue is currently generated from a limited number of customers. During fiscal 2023, its top five customers accounted for 65.9% of its Pharmacy Services Segment revenue, which includes 6.9% related to a client which termed on January 1, 2023. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. Pharmacy Services Segment customers are entities such as employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of health benefit plans, and individuals throughout the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a PDP. During fiscal 2023, fiscal 2022 and fiscal 2021, net revenues of $529,025 (2.2% of consolidated revenues), $589,620 (2.4% of consolidated revenues) and $630,104 (2.6% of consolidated revenues), respectively, include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derivatives</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company may enter into interest rate swap agreements to hedge the exposure to increasing rates with respect to its variable rate debt, when the Company deems it prudent to do so. Upon inception of interest rate swap or cap agreements, or modifications thereto, the Company performs a comprehensive review of the interest rate swap agreements based on the criteria as provided by ASC 815, “Derivatives and Hedging.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">In March 2020, the </span>Financial Accounting Standards Board (“FASB”)<span style="background:#ffffff;"> issued ASU 2020-04, </span><i style="font-style:italic;background:#ffffff;">Reference Rate Reform (Topic 848)</i><span style="background:#ffffff;">: </span><i style="font-style:italic;background:#ffffff;">Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i><span style="background:#ffffff;">. This ASU provides optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another rate affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of Interbank Offered Rates (“IBORs”) and, particularly, the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to the above ASU to clarify certain optional expedients and exceptions in Topic 848. The Company adopted ASU 2020-04 effective December 1, 2022 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In December 2019, the FASB issued ASU 2019-12, <i style="font-style:italic;">Simplifying the Accounting for Income Taxes (Topic 740)</i>. This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation, the recognition of deferred tax liabilities and the methodology for calculating income taxes in the interim period. The amendments also improve consistent application of and simplify </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020 (fiscal 2022). The Company adopted ASU 2019-12 effective February 28, 2021 and the adoption of this standard did not have a material impact on the Company’s financial position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In August 2018, the FASB issued ASU 2018-14, <i style="font-style:italic;">Compensation - Retirement benefits (Topic 715-20)</i>. This ASU amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. This ASU is effective for fiscal years ending after December 15, 2020 and must be applied on a retrospective basis. The Company adopted ASU 2018-14 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In August 2018, the FASB issued ASU No. 2018-15, <i style="font-style:italic;">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40)</i>, which is intended to provide entities with additional guidance to determine which software implementation costs to capitalize and which costs to expense. The ASU will allow entities to capitalize costs for implementation activities during the application development stage. ASU No. 2018-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2019 (fiscal 2021). Early adoption of ASU 2018-15 is permitted. The Company adopted ASU 2018-15 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In June 2016, the FASB issued ASU 2016-13, <i style="font-style:italic;">Measurement of Credit Losses on Financial Instruments</i>, which adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model), that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity will recognize, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses. ASU 2016-13 impacts non-banks as most non-banks have financial instruments or other assets (e.g., trade, contract and lease receivables, financial guarantees, loans and loan commitments and held-to-maturity debt securities). The Company adopted ASU 2016-13 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p> 1 2 2309 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement (the "Amended and Restated Asset Purchase Agreement"), dated as of September 18, 2017, by and among Rite Aid, WBA and Walgreen Co., an Illinois corporation and 100% owned subsidiary of WBA ("Buyer"), Buyer agreed to purchase from Rite Aid 1,932 stores (the "Acquired Stores"), three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of approximately $4,375,000, on a cash free, debt free basis (the "Asset Sale" or the "Sale"). As of March 4, 2023, the Company has sold all 1,932 Acquired Stores, three distribution centers and related assets to WBA in exchange for proceeds of $4,375,000, which were used to repay outstanding debt. Based on its magnitude and because the Company has exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Asset Sale as required by Accounting Standards Codification 210-05—Discontinued Operations (ASC 205-20). See additional information as provided in Note 4 Asset Sale to WBA.</p> 1 1932 3 4375000000 1932 3 4375000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:47.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retail Pharmacy Segment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,582,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,152,491</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,915,442</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Front-end sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,078,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,218,182</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,322,943</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 124,143</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,875</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total Retail Pharmacy Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,494,816</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,365,260</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy Services Segment revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,323,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,970,137</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intersegment elimination</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (249,686)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292,157)</p></td></tr><tr><td style="vertical-align:bottom;width:49.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr></table> 12582593000 12152491000 10915442000 5078820000 5218182000 5322943000 123654000 124143000 126875000 17785067000 17494816000 16365260000 6522299000 7323125000 7970137000 -215467000 -249686000 -292157000 24091899000 24568255000 24043240000 0.712 0.700 0.667 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percentage</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Product Class</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of Sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prescription drugs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Over-the-counter medications and personal care</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Health and beauty aids</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">General merchandise and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:middle;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 0.712 0.109 0.043 0.136 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Fiscal Year</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year ended March 4, 2023 included 53 weeks. The fiscal years ended February 26, 2022 and February 27, 2021 included 52 weeks.</p> P371D P364D P364D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Principles of Consolidation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements include the accounts of the Company and all of its 100% owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</p> 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents consist of cash on hand and highly liquid investments, which are readily convertible to known amounts of cash and which have original maturities of three months or less when purchased.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Allowance for Uncollectible Receivables</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In our Retail Pharmacy Segment, substantially all prescription sales are made to customers who are covered by third-party payors, such as insurance companies, government agencies and employers. The Company recognizes receivables that represent the amount owed to the Company for sales made to customers or employees of those payors that have not yet been paid. In our Pharmacy Services Segment, receivables are recorded for claims for prescriptions </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">issued for customers, customer administrative fees, amounts due from the Centers for Medicare and Medicaid Services (“CMS”) for Medicare Part D, and amounts due from certain drug manufacturers or rebate aggregators for rebates. The Company maintains a reserve for the expected credit losses associated with these receivables. This reserve is calculated based upon historical collection activity adjusted for current conditions.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inventories</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are stated at the lower of cost or market. Inventory balances include the capitalization of certain costs related to purchasing, freight and handling costs associated with placing inventory in its location and condition for sale. The Company uses the last-in, first-out (“LIFO”) cost flow assumption for substantially all of its inventories. The Company calculates its inflation index based on internal product mix and utilizes the link-chain LIFO method.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Asset impairments are recorded when the carrying value of assets are not recoverable. For purposes of recognizing and measuring impairment of long-lived assets, the Company categorizes assets of operating stores as “Assets to Be Held and Used” and “Assets to Be Disposed Of.” The Company evaluates assets at the store level because this is the lowest level of identifiable cash flows ascertainable to evaluate impairment. Assets being tested for recoverability at the store level include tangible long-lived assets, right-of-use assets for leased stores, and identifiable, finite-lived intangibles that arose in purchase business combinations. Corporate assets to be held and used are evaluated for impairment based on excess cash flows from the stores that support those assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of the asset exceeds the fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Property, Plant and Equipment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment are stated at cost, net of accumulated depreciation and amortization. The Company provides for depreciation using the straight-line method over the following useful lives: buildings—30 to 45 years; equipment—3 to 15 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the term of the lease. When determining the amortization period of a leasehold improvement, the Company considers whether discretionary exercise of a lease renewal option is reasonably assured. If it is determined that the exercise of such option is reasonably assured, the Company will amortize the leasehold improvement asset over the minimum lease term, plus the option period. This determination depends on the remaining life of the minimum lease term and any economic penalties that would be incurred if the lease option is not exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Capitalized lease assets are recorded at the lesser of the present value of minimum lease payments or fair market value and amortized over the estimated useful life of the related property or term of the lease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company capitalizes direct internal and external development costs associated with internal-use software. Neither preliminary evaluation costs nor costs associated with the software after implementation are capitalized. For fiscal years 2023, 2022 and 2021, the Company capitalized costs of approximately $5,099, $13,388 and $12,669, respectively.</p> P30Y P45Y P3Y P15Y 5099000 13388000 12669000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Goodwill</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes goodwill as the excess of the purchase price over the fair value of the assets acquired and liabilities assumed during business combinations. The Company accounts for goodwill under ASC Topic 350, “Intangibles—Goodwill and Other”, which does not permit amortization, but instead requires the Company to perform an annual impairment review, or more frequently if events or circumstances indicate that impairment may be more likely. See Note 14 for additional information on goodwill.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intangible Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has certain finite-lived intangible assets that are amortized over their useful lives. Prescription files acquired in business combinations are amortized over an estimated useful life of 10 years on an accelerated basis, which approximates the anticipated prescription file retention and related cash flows. Purchased prescription files acquired in other than business combinations are amortized over their estimated useful lives of five years on a straight-line basis. The value of finite-lived trade names are amortized over 10 years on a straight-line basis. The value of customer relationships, acquired in connection with the Company’s acquisition of Elixir, are amortized over a period between 10 and 20 years on a descending percentage method which matches the pattern of expected discounted cash flows. The Pharmacy Services Segment’s contract with CMS for Part D, which is required in order to act as a national provider of the Part D benefit, is amortized over 12 years on a straight line basis, of which four years remain.</p> P10Y P5Y P10Y P10Y P20Y P12Y P4Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Indefinite lived assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has a single indefinite-lived intangible asset consisting of a trade name. Intangible assets that are determined to have an indefinite life are not amortized, but are required to be evaluated at least annually for impairment. If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-lived intangible asset is impaired by the amount of the excess.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Deferred Financing Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Costs incurred to issue debt are deferred and amortized as a component of interest expense over the terms of the related debt agreements. Amortization expense of deferred financing costs was $9,993, $10,927 and $11,201 for fiscal 2023, 2022 and 2021, respectively.</p> 9993000 10927000 11201000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For front-end sales, the Retail Pharmacy Segment recognizes revenues upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation at the point of sale for front-end transactions. The Retail Pharmacy Segment front-end revenue is measured based on the amount of fixed consideration that it expects to </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">receive, net of an allowance for estimated future returns. Return activity is immaterial to revenues and results of operations in all periods presented. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For pharmacy sales, the Retail Pharmacy Segment recognizes revenue upon the transfer of control of the goods to the customer. The Company satisfies its performance obligation, upon pickup by the customer, which is when the customer takes title to the product. Each prescription claim represents an individual arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims. The Company's revenue is measured based on the amount of fixed consideration that we expect to receive, reduced by refunds owed to the third-party payor for pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not highly subjective or volatile. The effect of adjustments between estimated and actual amounts has not been material to the Company's results of operations or financial position. Prescriptions are generally not returnable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Retail Pharmacy Segment offered a chain-wide loyalty card program titled wellness+. Individual customers were able to become members of the wellness+ program. Members participating in the wellness+ loyalty card program earned points on a calendar year basis for eligible front-end merchandise purchases and qualifying prescription purchases. The wellness+ program was terminated as of July 1, 2020, with benefits earned as of that date available to be used through the end of calendar 2020. Beginning in December 2020, the Company granted temporary extensions of benefits to certain previous members that were eligible for a discount as of the end of each previous six-month period such that those prior members were eligible to continue to receive that discount on purchases made through the subsequent six months with no additional purchase requirement. New and existing customers who were not already eligible for program benefits also had the opportunity to earn additional discounts on purchases made through each six-month period. A final extension was granted on December 31, 2021 through February 26, 2022 at which point all discounts were terminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A new loyalty program, Rite Aid Rewards, was initiated on February 27, 2022. Customers that enroll in the new program earn points for each dollar spent on front of store purchases as well as for eligible pharmacy prescriptions. Points can then be converted into a “Rite Aid Rewards” coupon that can be tendered as payment in a future purchase. Each point is worth $0.002. Customers must accumulate 1,000 points and create an online account in order to convert earned points to a “Rite Aid Rewards” coupon. Unused/unconverted points expire after 90 days. Unredeemed “Rite Aid Rewards” coupons expire 30 days after conversion from points earned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;"> Points earned pursuant to the Rite Aid Rewards program represent a performance obligation. The value of unredeemed Rite Aid Rewards points is deferred as a contract liability (included in other current liabilities). As members redeem points in the form of a Rite Aid Rewards coupon or when points or unredeemed Rite Aid Rewards coupons expire, the Retail Pharmacy Segment recognizes the redeemed/expired portion of the deferred contract liability into revenue. For the fifty-three week period ended March 4, 2023, the Company recognized additional contract deferrals of </span>$2,030 as a reduction of revenues. The Retail Pharmacy Segment had accrued contract liabilities of $2,030 and $0 as of March 4, 2023 and February 26, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Pharmacy Services Segment sells prescription drugs indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The Pharmacy Services Segment recognizes revenue from prescription drugs sold by: (i) its mail service dispensing pharmacy and; (ii) under retail pharmacy network contracts where it is the principal at the contract prices negotiated with its clients, primarily employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">health benefit plans, and individuals throughout the United States. Revenues include: (i) the portion of the price the client pays directly to the Pharmacy Services Segment, net of any volume-related or other discounts paid back to the client (see “Drug Discounts” below); (ii) the price paid to the Pharmacy Services Segment by client plan members for mail order prescriptions (“Mail Co-Payments”); (iii) client plan member co-payments made directly to the retail pharmacy network and; (iv) administrative fees. Revenue is recognized when the Pharmacy Services Segment meets its performance obligations relative to each transaction type. The following revenue recognition policies have been established for the Pharmacy Services Segment:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from prescription drugs sold by third-party pharmacies in the Pharmacy Services Segment’s retail pharmacy network and associated administrative fees are recognized at the Pharmacy Services Segment’s point-of-sale, which is when the claim is adjudicated by the Pharmacy Services Segment’s online claims processing system. At this point the Company has performed all of its performance obligations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from prescription drugs sold by the Pharmacy Services Segment’s mail service dispensing pharmacy are recognized when the prescription is shipped. At the time of shipment, the Pharmacy Services Segment has performed all of its performance obligations under its client contracts, as control of and title to the product has passed to the client plan members. The Pharmacy Services Segment does not experience a significant level of returns or reshipments.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenues generated from administrative fees based on membership or claims volume are recognized monthly based on the terms within the individual contracts, either a monthly member-based fee, or a claims volume-based fee.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In the majority of its contracts, the Pharmacy Services Segment is the principal because its client contracts give clients the right to obtain access to its pharmacy contracts under which the Pharmacy Services Segment directs its pharmacy network to provide the services (drug dispensing, consultation, etc.) and goods (prescription drugs) to the clients’ members at its negotiated pricing. The Pharmacy Services Segment’s obligations under its client contracts are separate and distinct from its obligations to the third-party pharmacies included in its retail pharmacy network contracts. In the majority of these contracts, the Pharmacy Services Segment is contractually required to pay the third-party pharmacies in its retail pharmacy network for products sold after payment is received from its clients. The Pharmacy Services Segment has control over these transactions until the prescription is transferred to the member and, thus, that it is acting as a principal. As such, the Pharmacy Services Segment records the total prescription price contracted with clients in revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Amounts paid to pharmacies and amounts charged to clients are exclusive of the applicable co-payment under Pharmacy Services Segment contracts. Retail pharmacy co-payments, which we instruct retail pharmacies to collect from members, are included in our revenues and our cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For contracts under which the Pharmacy Services Segment acts as an agent or does not control the prescription drugs prior to transfer to the client, no revenue is recognized, except the administrative fee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Drug Discounts—The Pharmacy Services Segment deducts from its revenues that are generated from prescription drugs sold by third-party pharmacies any rebates, inclusive of discounts and fees, earned by its clients based on utilization levels and other factors as negotiated with the prescription drug manufacturers, rebate aggregators or suppliers. Rebates are paid to clients in accordance with the terms of client contracts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Medicare Part D—The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a Medicare Part D Prescription Drug Plan (“PDP”). Please refer to Note 10, Medicare Part D.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Disaggregation of Revenue</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following tables disaggregate the Company’s revenue by major source in each segment for the fiscal year ended March 4, 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In thousands</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retail Pharmacy Segment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Pharmacy sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,582,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Front-end sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,078,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Retail Pharmacy Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy Services Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intersegment elimination</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See Note 21 for additional information about the revenues of the Company’s business segments.</p> P6M P6M P6M 0.002 1000 P90D P30D 2030000 2030000 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">In thousands</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retail Pharmacy Segment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Pharmacy sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,582,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Front-end sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,078,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,654</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Retail Pharmacy Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pharmacy Services Segment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intersegment elimination</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:83.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 12582593000 5078820000 123654000 17785067000 6522299000 -215467000 24091899000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cost of Revenues</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cost of revenues for the Retail Pharmacy Segment includes the following: the cost of inventory sold during the period, including related vendor rebates and allowances, LIFO credit or charges, costs incurred to return merchandise to vendors, inventory shrink, purchasing costs and warehousing costs, which include inbound freight costs from the vendor, distribution payroll and benefit costs, distribution center occupancy costs and depreciation expense and delivery expenses to the stores.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment’s cost of revenues includes the cost of prescription drugs sold during the reporting period indirectly through its retail pharmacy network and directly through its mail service dispensing pharmacy. The cost of prescription drugs sold component of cost of revenues includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients’ benefit plans from the Pharmacy Services Segment’s mail service dispensing pharmacy, net of any volume-related or other discounts (see the section entitled “Vendor Rebates and Allowances and Purchase Discounts” below) and (ii) the cost of prescription drugs sold through the Pharmacy Services Segment’s retail pharmacy network under contracts where it is the principal, net of any volume-related or other discounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">See Note 21 for additional information about the cost of revenues of the Company’s business segments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Vendor Rebates and Allowances and Purchase Discounts</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Retail Pharmacy Segment’s rebates and allowances received from vendors relate to either buying and merchandising or promoting the product. Buying and merchandising related rebates and allowances are recorded as a reduction of cost of revenue as product is sold. Buying and merchandising rebates and allowances include all types of vendor programs such as cash discounts from timely payment of invoices, purchase discounts or rebates, volume purchase allowances, price reduction allowances and slotting allowances. Certain product promotion related rebates and allowances, primarily related to advertising, are recorded as a reduction in selling, general and administrative expenses when the advertising commitment has been satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment receives purchase discounts on products purchased. The Pharmacy Services Segment’s contractual arrangements with vendors, including manufacturers and rebate aggregators, wholesalers and retail pharmacies, normally provide for the Pharmacy Services Segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, or (ii) a discount (or rebate) paid subsequent to dispensing when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy). These rebates are recognized when prescriptions are dispensed and are generally billed within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Pharmacy Services Segment’s results of operations. The Pharmacy Services Segment accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services Segment also receives additional discounts under its wholesaler and rebate aggregator contracts and fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Rebates payable to clients for the Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment has contractual arrangements with clients, including health plans, commercial employers, labor groups, and state and local governments, which entitles such clients to a portion of certain rebates received by the Pharmacy Services Segment. Estimated rebates payable to clients are recognized when prescriptions are dispensed and are generally paid to clients up to eight months in arrears.  Historically, the effect of adjustments resulting from the reconciliation of estimated rebates payable to clients recognized and the amount actually paid has not been material to the Pharmacy Services Segment’s results of operations.  The Pharmacy Services Segment accounts for the effect of any such difference as a change in accounting estimate in the period the reconciliation is completed.  Estimated rebates payable to clients are recorded as a reduction of revenues.</p> P30D P8M <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company determines if an arrangement contains a lease at the inception of a contract. Operating lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized at the commencement date based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company’s leases is not readily </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest that we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. The Company uses quoted interest rates obtained from financial institutions in an input to derive its incremental borrowing rate as the discount rate for the lease. The ROU asset is equal to the operating lease liability plus lease payments made before commencement, less lease incentives received from the landlord.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s real estate leases typically contain options that permit lease extensions for additional periods of up to five years each. For real estate leases, generally, the renewal periods are not included within the lease term and the associated payments are not included in the measurement of the ROU asset and operating lease liability as the options to extend are not considered reasonably certain to occur at lease commencement. The Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and will include all reasonably certain options in the measurement of its lease term. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the operating lease right-of-use asset and the operating lease liability until the renewals are i) evaluated and ii) determined to be exercised. The Company has an insignificant amount of non-real estate leases however, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. The Company rarely executes leases less than 12 months. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For real estate leases, the Company accounts for lease components and non-lease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the operating lease right-of-use assets and operating lease liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company records rent expense on operating leases on a straight-line basis over the reasonably certain lease term. The Company begins to record rent expense at the time that the Company has the right to use the property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> P5Y 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Selling, General and Administrative Expenses</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Selling, general and administrative expenses include store and corporate administrative payroll and benefit costs, occupancy costs which include retail store and corporate rent costs, facility and leasehold improvement depreciation and utility costs, advertising, repair and maintenance, insurance, equipment depreciation and professional fees.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Repairs and Maintenance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Routine repairs and maintenance are charged to operations as incurred. Improvements and major repairs, which extend the useful life of an asset, are capitalized and depreciated.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Advertising</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Advertising costs, net of specific vendor advertising allowances, are expensed in the period the advertisement first takes place. Advertising expenses, net of vendor advertising allowances, for fiscal 2023, 2022 and 2021 were $133,379, $146,085 and $122,725, respectively.</p> 133379000 146085000 122725000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Insurance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is self-insured for certain general liability and workers’ compensation claims. For claims that are self-insured, stop-loss insurance coverage is maintained for workers’ compensation occurrences exceeding $1,000 and general liability occurrences exceeding $3,000. The Company utilizes actuarial studies as the basis for developing reported claims and estimating claims incurred but not reported relating to the Company’s self-insurance. Workers’ compensation claims are discounted to present value using a risk-free interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is also self-insured for certain employee health and welfare plans. We record the related self-insurance liabilities based on claims incurred and an estimate of claims incurred but not yet reported.</p> 1000000 3000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Benefit Plan Accruals</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has several defined benefit plans, under which participants earn a retirement benefit based upon a formula set forth in the plan. The Company records expense related to these plans using actuarially determined amounts that are calculated under the provisions of ASC 715, “Compensation—Retirement Benefits.” Key assumptions used in the actuarial valuations include the discount rate, the expected rate of return on plan assets and the rate of increase in future compensation levels.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has several stock award plans, which are described in detail in Note 18. The Company accounts for stock-based compensation under ASC 718, “Compensation—Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Store Pre-opening Expenses</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Costs incurred prior to the opening of a new or relocated store, associated with a remodeled store or related to the opening of a distribution facility are charged to operations as incurred.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Litigation Reserves</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is involved in litigation on an ongoing basis. The Company accrues its best estimate of the probable loss related to legal claims. Such estimates are developed in consultation with in-house counsel, and are based upon a combination of litigation and settlement strategies.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred income taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities. Deferred income tax expense (benefit) represents the change during the reporting period in the deferred tax assets and deferred tax liabilities, net of the effect of acquisitions and dispositions. Deferred tax assets include tax loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company has net operating loss (“NOL”) carryforwards that can be utilized to offset future income for federal and state tax purposes. These NOLs generate a significant deferred tax asset. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes tax liabilities in accordance with ASC 740, “Income Taxes” and the Company adjusts these liabilities with changes in judgment as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the tax liabilities.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Sales Tax Collected</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Sales taxes collected from customers and remitted to various governmental agencies are presented on a net basis (excluded from revenues) in the Company’s statement of operations.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Significant Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Retail Pharmacy Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s pharmacy sales were primarily to customers covered by health plan contracts, which typically contract with a third-party payor that agrees to pay for all or a portion of a customer’s eligible prescription purchases. During fiscal 2023, the top five third-party payors accounted for approximately 83.4% of the Company’s pharmacy sales. The largest third-party payor, Caremark, represented 33.4%, 32.1% and 30.4% of pharmacy sales during fiscal 2023, 2022 and 2021, respectively. Third-party payors are entities such as an insurance company, governmental agency, health maintenance organization or other managed care provider, and typically represent several health care contracts and customers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During fiscal 2023, state sponsored Medicaid agencies and related managed care Medicaid payors accounted for approximately 19.9% of the Company’s pharmacy sales, the largest of which was approximately 6.6% of the Company’s pharmacy sales. During fiscal 2023, approximately 38.8% of the Company’s pharmacy sales were to customers covered by Medicare Part D. Any significant loss of third-party payor business could have a material adverse effect on the Company’s business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During fiscal 2023, the Company purchased brand and generic pharmaceuticals, which amounted to approximately 98% of the dollar volume of its prescription drugs from McKesson Corporation (“McKesson”) under its expanded agreement executed on February 17, 2014 and amended in fiscal 2019 for its pharmaceutical purchasing and distribution whereby McKesson assumed responsibility for purchasing essentially all of the brand and generic medications the Company dispenses as well as providing a new direct store delivery model to all of the Company’s stores. If the Company’s relationship with McKesson was disrupted, it could temporarily have difficulty filling </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">prescriptions for brand-named and generic drugs until it executed a replacement wholesaler agreement or developed and implemented self-distribution processes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Pharmacy Services Segment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s Pharmacy Services Segment revenue is currently generated from a limited number of customers. During fiscal 2023, its top five customers accounted for 65.9% of its Pharmacy Services Segment revenue, which includes 6.9% related to a client which termed on January 1, 2023. The largest payor, CMS, represented 43.1%, 41.1% and 36.6% of Pharmacy Services Segment revenue during fiscal 2023, 2022 and 2021, respectively. Pharmacy Services Segment customers are entities such as employers, insurance companies, unions, government employee groups, health plans, Managed Medicaid plans, Medicare plans, and other sponsors of health benefit plans, and individuals throughout the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Pharmacy Services Segment, through its EI subsidiary, participates in the federal government’s Medicare Part D program as a PDP. During fiscal 2023, fiscal 2022 and fiscal 2021, net revenues of $529,025 (2.2% of consolidated revenues), $589,620 (2.4% of consolidated revenues) and $630,104 (2.6% of consolidated revenues), respectively, include insurance premiums earned by the PDP, which are determined based on the PDP’s annual bid and related contractual arrangements with CMS.</p> 0.834 0.334 0.321 0.304 0.199 0.066 0.388 0.98 0.659 0.069 0.431 0.411 0.366 529025000 0.022 589620000 0.024 630104000 0.026 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derivatives</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company may enter into interest rate swap agreements to hedge the exposure to increasing rates with respect to its variable rate debt, when the Company deems it prudent to do so. Upon inception of interest rate swap or cap agreements, or modifications thereto, the Company performs a comprehensive review of the interest rate swap agreements based on the criteria as provided by ASC 815, “Derivatives and Hedging.”</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">In March 2020, the </span>Financial Accounting Standards Board (“FASB”)<span style="background:#ffffff;"> issued ASU 2020-04, </span><i style="font-style:italic;background:#ffffff;">Reference Rate Reform (Topic 848)</i><span style="background:#ffffff;">: </span><i style="font-style:italic;background:#ffffff;">Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i><span style="background:#ffffff;">. This ASU provides optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another rate affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of Interbank Offered Rates (“IBORs”) and, particularly, the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to the above ASU to clarify certain optional expedients and exceptions in Topic 848. The Company adopted ASU 2020-04 effective December 1, 2022 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In December 2019, the FASB issued ASU 2019-12, <i style="font-style:italic;">Simplifying the Accounting for Income Taxes (Topic 740)</i>. This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation, the recognition of deferred tax liabilities and the methodology for calculating income taxes in the interim period. The amendments also improve consistent application of and simplify </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020 (fiscal 2022). The Company adopted ASU 2019-12 effective February 28, 2021 and the adoption of this standard did not have a material impact on the Company’s financial position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In August 2018, the FASB issued ASU 2018-14, <i style="font-style:italic;">Compensation - Retirement benefits (Topic 715-20)</i>. This ASU amends ASC 715 to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The ASU also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost and the benefit obligation for postretirement health care benefits. This ASU is effective for fiscal years ending after December 15, 2020 and must be applied on a retrospective basis. The Company adopted ASU 2018-14 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In August 2018, the FASB issued ASU No. 2018-15, <i style="font-style:italic;">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40)</i>, which is intended to provide entities with additional guidance to determine which software implementation costs to capitalize and which costs to expense. The ASU will allow entities to capitalize costs for implementation activities during the application development stage. ASU No. 2018-15 is effective for fiscal years and interim periods within those years beginning after December 15, 2019 (fiscal 2021). Early adoption of ASU 2018-15 is permitted. The Company adopted ASU 2018-15 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In June 2016, the FASB issued ASU 2016-13, <i style="font-style:italic;">Measurement of Credit Losses on Financial Instruments</i>, which adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model), that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity will recognize, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses. ASU 2016-13 impacts non-banks as most non-banks have financial instruments or other assets (e.g., trade, contract and lease receivables, financial guarantees, loans and loan commitments and held-to-maturity debt securities). The Company adopted ASU 2016-13 in fiscal 2021 and the adoption of this standard did not have a material impact on the Company’s financial position, results of operations and cash flows.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">2. Acquisition</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 18, 2020, pursuant to that certain stock purchase agreement, dated as of October 7, 2020, by and between the Company and Bartell Drug Company (“Bartell”), the Company acquired Bartell (the “Acquisition”), a Washington corporation, for approximately $89,724 in cash, subject to certain customary post-closing working capital adjustments. The Company financed the Acquisition with borrowings under its senior secured credit facilities together with cash on hand.  Bartell operated 67 retail drugstores and one distribution center in the greater Seattle Washington area.  Bartell operates as a 100 percent owned subsidiary of the Company within its Retail Pharmacy Segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s consolidated financial statements for fiscal 2023 and 2022 include Bartell’s results of operations. The Company’s consolidated financial statements for fiscal 2021 include Bartell’s results of operations from the Acquisition date of December 18, 2020 through February 27, 2021, including revenues of $101,083<span style="white-space:pre-wrap;">. The Company’s consolidated financial statements at February 26, 2022 reflect the final purchase accounting adjustments in accordance with ASC 805 “Business Combinations,” whereby the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values on the Acquisition date.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following allocation of the purchase price and the estimated transaction costs is final:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Final purchase price</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Final purchase price allocation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,494</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,860</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67,745</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,857</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,956</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,229</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 143,651</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible assets<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,700</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,805</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 339,341</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,166</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued salaries, wages and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,335</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current portion of operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,617</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 69,118</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 124,023</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 166</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total liabilities assumed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 193,307</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities recorded on purchase</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,951</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 132,083</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bargain purchase gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (42,359)</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Total purchase price</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:3pt;padding-left:20pt;text-indent:-20pt;margin:0pt;"><span style="font-size:10pt;">(1)</span>            <span style="font-size:10pt;">Intangible assets are recorded at estimated fair value, as determined by management based on available information which includes a final valuation prepared by an independent third-party. The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty and the multi-period excess earnings methods. The major assumptions used in arriving at the estimated identifiable intangible asset values included management’s final estimates of future cash flows, discounted at an appropriate rate of return which are based on the weighted average cost of capital for both the Company and other market participants, projected customer attrition rates, as well as applicable royalty rates for comparable assets. The useful lives for intangible assets were determined based upon the remaining useful economic lives of the intangible assets that are expected to contribute directly or indirectly to future cash flows. The estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation include:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Useful Life </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(In Years)</b></p></td></tr><tr><td style="vertical-align:top;width:57.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Prescription files</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 54,300</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Tradename</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">Indefinite</p></td></tr><tr><td style="vertical-align:top;width:57.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 68,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:12pt 0pt 0pt 0pt;">During fiscal 2021, the Company recorded a gain on <span style="-sec-ix-hidden:Hidden_lWibATd4YkajELWP1VOi8Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Bartell acquisition</span></span> of $47,705 primarily due to fair value adjustments related to prescription files and the tradename compared to book values. During fiscal 2022, in connection with determining its final purchase price allocation, the Company recorded a loss on Bartell acquisition of $5,346 primarily due to contract termination charges, inventory valuation adjustments and changes in deferred income taxes, resulting in a net bargain purchase gain of $42,359<span style="white-space:pre-wrap;">. The Company believes that the bargain purchase gain was primarily the result of the decision by the Bartell stockholders to sell their interests as Bartell had been experiencing increasing borrowings under its credit agreements to meet its operating needs and increasing net losses. The agreed upon purchase price reflected the fact the seller would have needed to incur further significant debt to cover the operating costs of Bartell, which would have required amendments to its credit arrangements. With the Company’s existing infrastructure, scale and expertise, the Company believe that it has access to the necessary synergies to allow necessary operational improvements to be implemented more efficiently than the seller. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20.15pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During fiscal 2023, fiscal 2022 and fiscal 2021, acquisition costs of $0, $12,797 and $10,549<span style="white-space:pre-wrap;">, respectively, were expensed as incurred. The following unaudited pro forma combined financial data gives effect to the Acquisition as if it had occurred as of March 1, 2019.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The unaudited combined pro forma results do not include any incremental cost savings that may result from the integration. The adjustments are based on information available to the Company at this time. Accordingly, the adjustments are subject to change and the impact of such changes may be material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:20pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The unaudited combined pro forma information is for informational purposes only.  The pro forma information is not necessarily indicative of what the combined company’s results actually would have been had the Acquisition been completed as of the beginning of the periods as indicated.  In addition, the unaudited pro forma information does not purport to project the future results of the combined company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net revenues as reported</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Supplemental Pro forma revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,468,777</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss as reported</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Supplemental Pro forma net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (116,040)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p> 89724000 67 1 1 101083000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Final purchase price</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:22.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Final purchase price allocation</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,494</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,860</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67,745</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,857</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,956</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,229</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 143,651</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible assets<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,700</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,805</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 339,341</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,166</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued salaries, wages and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,335</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current portion of operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,617</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 69,118</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 124,023</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 166</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total liabilities assumed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 193,307</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities recorded on purchase</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,951</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 132,083</p></td></tr><tr><td style="vertical-align:top;width:77.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bargain purchase gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (42,359)</p></td></tr><tr><td style="vertical-align:top;width:77.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Total purchase price</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,724</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:3pt;padding-left:20pt;text-indent:-20pt;margin:0pt;"><span style="font-size:10pt;">(1)</span>            <span style="font-size:10pt;">Intangible assets are recorded at estimated fair value, as determined by management based on available information which includes a final valuation prepared by an independent third-party. The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty and the multi-period excess earnings methods. The major assumptions used in arriving at the estimated identifiable intangible asset values included management’s final estimates of future cash flows, discounted at an appropriate rate of return which are based on the weighted average cost of capital for both the Company and other market participants, projected customer attrition rates, as well as applicable royalty rates for comparable assets. The useful lives for intangible assets were determined based upon the remaining useful economic lives of the intangible assets that are expected to contribute directly or indirectly to future cash flows. The estimated fair value of intangible assets and related useful lives as included in the final purchase price allocation include:</span></p> 89724000 89724000 3494000 23860000 67745000 1857000 96956000 28229000 143651000 68700000 1805000 339341000 24166000 20335000 24617000 69118000 124023000 166000 193307000 13951000 132083000 42359000 89724000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Useful Life </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(In Years)</b></p></td></tr><tr><td style="vertical-align:top;width:57.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Prescription files</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 54,300</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:top;width:57.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Tradename</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">Indefinite</p></td></tr><tr><td style="vertical-align:top;width:57.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 68,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 54300000 P10Y 14400000 68700000 47705000 -5346000 42359000 0 12797000 10549000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pro forma</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net revenues as reported</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Supplemental Pro forma revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,468,777</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss as reported</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Supplemental Pro forma net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (116,040)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p> 24091899000 24568255000 24043240000 24091899000 24568255000 24468777000 -719188000 -522372000 -90220000 -719188000 -522372000 -116040000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">3. Restructuring</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Beginning in fiscal 2019, the Company initiated a series of restructuring plans designed to reorganize its executive management team, reduce managerial layers, and consolidate roles. In March 2020, the Company announced </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">the details of its strategy, which includes building tools to work with regional health plans to improve patient health outcomes, rationalizing SKU’s in its front-end offering to free up working capital and update its merchandise assortment, assessing its pricing and promotional strategy, rebranding its retail pharmacy and pharmacy services business, launching its Store of the Future format and further reducing SG&amp;A and headcount, including integrating certain back office functions in the Pharmacy Services Segment both within the segment and across the enterprise. Other strategic initiatives include the expansion of the Company’s digital business, replacing and updating the Company’s financial systems to improve efficiency, and movement to a common client platform at Elixir. In April 2022, the Company announced further strategic initiatives to reduce costs through the closure of unprofitable stores, reduce corporate administration expenses, improve efficiencies in worked payroll and other store labor costs, engage in a comprehensive review of purchasing and other business processes in both the Retail Pharmacy and Pharmacy Services Segments in order to identify areas of opportunity, as well as expense reductions at the Pharmacy Services Segment. In December 2022, the Company announced a new multi-year performance acceleration program, which allows it to fast-track initiatives that will improve sales, script volume and operating margins, and free up cash. The Company is partnering with a leading consulting firm that has worked with several Fortune 150 firms to execute the turnaround model. This program has given the Company visibility to the profitability opportunities it can drive over the next three years by focusing on improvements and growth in its core businesses. These and future restructuring activities are expected to provide future growth and expense efficiency benefits. There can be no assurance that the Company’s current and future restructuring charges will achieve the cost savings and remerchandising benefits in the amounts or time anticipated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the year ended March 4, 2023, the Company incurred total restructuring-related costs of $108,626, which are included as a component of SG&amp;A. These costs are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,342</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,430</p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(c)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,054</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,196</p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 86,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 108,626</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the year ended February 26, 2022, the Company incurred total restructuring-related costs of $35,121, which are included as a component of SG&amp;A. These costs are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(a) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,502</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,502</p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(c) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,237</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,382</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 32,619</p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,237</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,884</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,121</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">For the year ended February 27, 2021, the Company incurred total restructuring-related costs of $84,552, of which $63,613 is included as a component of SG&amp;A and $20,939 is included as a component of cost of revenues. These costs are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,443</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,796</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:10pt;">Non-executive retention costs associated with the March 2019 reorganization</span><sup style="font-size:6pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(b) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,012</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(c) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,053</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,805</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">SKU optimization charges<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(d) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 84,552</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In addition, during the fiscal year ended February 27, 2021, the Company incurred intangible asset impairment charges of $29,852 in connection with its rebranding initiatives as described in Note 14, <i style="font-style:italic;">Goodwill and Other Intangibles</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A summary of activity for the year ended March 4, 2023 in the restructuring-related liabilities associated with the programs noted above, which is included in accrued salaries, wages and other current liabilities, is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Severance and related</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Professional and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">costs</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"> (a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">other fees </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(c)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,257</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,720</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,904</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,742</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,646</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,231)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,727)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,958)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of May 28, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,930</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,478</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,408</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 913</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,805</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,782)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,066)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,848)</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of August 27, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,304</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,365</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,500</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,452)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,297)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (22,749)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of November 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,116</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,813</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,675</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,564)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,415)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,979)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 49,812</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.</span></td></tr></table> 108626000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,342</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,430</p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(c)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,054</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,196</p></td></tr><tr><td style="vertical-align:bottom;width:62.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 86,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 108,626</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(a) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,502</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,502</p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(c) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,237</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,382</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 32,619</p></td></tr><tr><td style="vertical-align:bottom;width:64.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,237</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,884</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,121</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services Segment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restructuring-related costs </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Severance and related costs associated with ongoing reorganization efforts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,443</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,353</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,796</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-size:10pt;">Non-executive retention costs associated with the March 2019 reorganization</span><sup style="font-size:6pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(b) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,012</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Professional and other fees relating to restructuring activities<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(c) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,053</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,805</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">SKU optimization charges<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;white-space:pre-wrap;">(d) </sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td></tr><tr><td style="vertical-align:bottom;width:63.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Total restructuring-related costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 84,552</p></td></tr></table> 15342000 4088000 19430000 71142000 18054000 89196000 86484000 22142000 108626000 35121000 2502000 2502000 12237000 20382000 32619000 12237000 22884000 35121000 84552000 63613000 20939000 13443000 4353000 17796000 1136000 -124000 1012000 40053000 4752000 44805000 20939000 20939000 75571000 8981000 84552000 29852000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Severance and related</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Professional and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">costs</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"> (a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">other fees </b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(c)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,257</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,720</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,904</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,742</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,646</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,231)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,727)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,958)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of May 28, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,930</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,478</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,408</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 913</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,805</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,782)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,066)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,848)</p></td></tr><tr><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:55.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of August 27, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,304</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,365</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,500</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,452)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,297)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (22,749)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of November 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,116</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions charged to expense  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,813</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,675</p></td></tr><tr><td style="vertical-align:bottom;width:53.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="white-space:pre-wrap;">Cash payments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,564)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,415)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,979)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 49,812</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">– Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.</span></td></tr></table> 4257000 4463000 8720000 11904000 10742000 22646000 5231000 11727000 16958000 10930000 3478000 14408000 913000 11892000 12805000 2782000 10066000 12848000 9061000 5304000 14365000 4800000 21700000 26500000 4452000 18297000 22749000 9409000 8707000 18116000 1813000 44862000 46675000 3564000 11415000 14979000 7658000 42154000 49812000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">4. Asset Sale to WBA</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On September 18, 2017, the Company entered into the Amended and Restated Asset Purchase Agreement with WBA and Buyer, which amended and restated in its entirety the previously disclosed Asset Purchase Agreement, dated as of June 28, 2017, by and among the Company, WBA and Buyer. Pursuant to the terms and subject to the conditions set forth in the Amended and Restated Asset Purchase Agreement, Buyer purchased from the Company 1,932 Acquired Stores, three distribution centers, related inventory and other specified assets and liabilities related thereto for a purchase price of $4,375,000, on a cash-free, debt-free basis (the “Asset Sale” or “Sale”). The Company completed the store transfer process in March of 2018, which resulted in the transfer of all 1,932 stores and related assets to WBA, and received cash proceeds of $4,156,686.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the first quarter of fiscal 2021, the Company completed the sale of the final distribution center and related assets to WBA for proceeds of $94,289. The impact of the sale of the distribution center and related assets resulted in a pre-tax gain of $12,690, which was included in the results of operations and cash flows of discontinued operations during fiscal 2021. The transfer of the final distribution center and related assets constitutes the final closing under the Amended and Restated Asset Purchase Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company had agreed to provide transition services to Buyer for up to three years after the initial closing of the Sale. Under the terms of the TSA, the Company provided various services on behalf of WBA, including, but not limited to, the purchase and distribution of inventory and virtually all selling, general and administrative activities. The term of the TSA had been extended to October 17, 2020, unless earlier terminated. In connection with these services, the Company purchased the related inventory and incurred cash payments for the selling, general and administrative activities, which, the Company billed on a cash neutral basis to WBA in accordance with terms as outlined in the TSA. There were no billings for these items during the fifty-three week period ended March 4, 2023 and fifty-two week period ended February 26, 2022. The Company charged WBA TSA fees of $0, $0 and $1,467 during the fifty-three week period ended March 4, 2023, and fifty-two week periods ended February 26, 2022 and February 27, 2021, respectively, which are reflected as a reduction to selling, general and administrative expenses. On October 17, 2020, the Company and WBA mutually agreed to terminate the services under the TSA. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on its magnitude and because the Company exited certain markets, the Sale represented a significant strategic shift that has a material effect on the Company’s operations and financial results. Accordingly, the Company has applied discontinued operations treatment for the Sale as required by Accounting Standards Codification 210-05—<i style="font-style:italic;">Discontinued Operations </i>(ASC 205-20). In accordance with ASC 205-20, the Company reclassified the financial results of the Disposal Group in its consolidated statements of operations and consolidated statements of cash flows for fiscal 2021. The Company also revised its discussion and presentation of operating and financial results to be reflective of its continuing operations as required by ASC 205-20.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of March 4, 2023 and February 26, 2022, there were no assets and liabilities classified as held for sale relating to the Asset Sale to WBA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The operating results of the discontinued operations that are reflected on the consolidated statements of operations within net income from discontinued operations are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:90.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_AJc_dNiQMEGhkyc8VvJjEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_l7sdwv0ckUi1g5FeuWGQsg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 174</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Costs and expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenues<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_OQQSLI3qL0iWTrrn2r482w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ab2ZPHI9ekSSRLxrfCtYFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yYNRY4ZPVEetyR5R25-ETw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__bIWwvFCfUuGKbkHW8gLmw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 871</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(b)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wc7RqDavy0qnQQru0RJ39Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_1-HwHMVIMEK36mt_N7Xbiw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-fErwEJSmUOHti2BbvAG-g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gain on sale of assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_DmOEEoWP_0qHw1zAcZx47Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pg9_V6pa7UuSAkx9XK6VVQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,149)</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_MAl-Xg1wP0KLoYNV5GUXgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_K8DYHIJR40KZlhUk7CA2lg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,270)</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income from discontinued operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_bZZIygwLOEKEF2jag-RShQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pi9khgSRr0eiGmgflGU1RA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,444</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_UFUSLNN7FEaZxIBhctv2Hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ftYTKBNorUuFEEaNUIVSPA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,283</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income from discontinued operations, net of tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_htshc4erYUSdvV_5s6914A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-RU8st0aL0OanRZi5XJhrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,161</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cost of revenues and selling, general and administrative expenses for the discontinued operations excludes corporate overhead. These charges are reflected in continuing operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In accordance with ASC 205-20, the operating results for the fifty-two week period ended February 27, 2021, for the discontinued operations include interest expense relating to the outstanding indebtedness repaid with the estimated excess proceeds from the Sale.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The operating results reflected above do not fully represent the Disposal Group’s historical operating results, as the results reported within net income from discontinued operations only include expenses that are directly attributable to the Disposal Group.</p> 1932 3 4375000000 1932 4156686000 94289000 12690000 P3Y 0 0 0 0 1467000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The operating results of the discontinued operations that are reflected on the consolidated statements of operations within net income from discontinued operations are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:90.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_AJc_dNiQMEGhkyc8VvJjEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_l7sdwv0ckUi1g5FeuWGQsg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 174</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Costs and expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cost of revenues<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_OQQSLI3qL0iWTrrn2r482w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ab2ZPHI9ekSSRLxrfCtYFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yYNRY4ZPVEetyR5R25-ETw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__bIWwvFCfUuGKbkHW8gLmw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 871</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(b)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wc7RqDavy0qnQQru0RJ39Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_1-HwHMVIMEK36mt_N7Xbiw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-fErwEJSmUOHti2BbvAG-g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gain on sale of assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_DmOEEoWP_0qHw1zAcZx47Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pg9_V6pa7UuSAkx9XK6VVQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,149)</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_MAl-Xg1wP0KLoYNV5GUXgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_K8DYHIJR40KZlhUk7CA2lg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,270)</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income from discontinued operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_bZZIygwLOEKEF2jag-RShQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pi9khgSRr0eiGmgflGU1RA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,444</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_UFUSLNN7FEaZxIBhctv2Hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ftYTKBNorUuFEEaNUIVSPA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,283</p></td></tr><tr><td style="vertical-align:bottom;width:65.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income from discontinued operations, net of tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_htshc4erYUSdvV_5s6914A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-RU8st0aL0OanRZi5XJhrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,161</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cost of revenues and selling, general and administrative expenses for the discontinued operations excludes corporate overhead. These charges are reflected in continuing operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In accordance with ASC 205-20, the operating results for the fifty-two week period ended February 27, 2021, for the discontinued operations include interest expense relating to the outstanding indebtedness repaid with the estimated excess proceeds from the Sale.</span></td></tr></table><div style="margin-top:12pt;"></div> 174000 -8000 871000 14149000 -13270000 13444000 4283000 9161000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">5. Loss Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Basic loss per share is computed by dividing loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company subject to anti-dilution limitations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Basic and diluted loss per share:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income from discontinued operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wdNyLgQAS0qJas7iKn96Fg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_L7HQIjLPmUK5fbD8ejTJxg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,161</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss attributable to common stockholders — basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Denominator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Basic and diluted weighted average shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,055</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,653</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic and diluted loss per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_gml_RLJaRkWg4EDYm43SCg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_PybW99F-RkS4c94XJbaeNg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_1aXxl68OAUu_uSJVryinFQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.86)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Discontinued operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_OS4a-RBqeEelb3eOM5G0WA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5FvLPSg4KkefWAhrsuaAxQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.18</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_7EmlRvKz0EO-olVWD4P5Gw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_fe6uNSO8y0SwcnRhsziYzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_UOTMXNuEl0aMi0aFTsk-1g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.68)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Due to their anti-dilutive effect, 532, 701 and 780 potential common shares related to stock options have been excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021, respectively. Also, excluded from the computation of diluted loss per share as of March 4, 2023, February 26, 2022 and February 27, 2021 are restricted shares of 1,476, 1,533 and 1,293, respectively, which are included in shares outstanding.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Basic and diluted loss per share:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income from discontinued operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wdNyLgQAS0qJas7iKn96Fg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_L7HQIjLPmUK5fbD8ejTJxg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,161</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss attributable to common stockholders — basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Denominator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Basic and diluted weighted average shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,680</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,055</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,653</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic and diluted loss per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_gml_RLJaRkWg4EDYm43SCg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_PybW99F-RkS4c94XJbaeNg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_1aXxl68OAUu_uSJVryinFQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.86)</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Discontinued operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_OS4a-RBqeEelb3eOM5G0WA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5FvLPSg4KkefWAhrsuaAxQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.18</p></td></tr><tr><td style="vertical-align:bottom;width:56.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_7EmlRvKz0EO-olVWD4P5Gw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_fe6uNSO8y0SwcnRhsziYzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_UOTMXNuEl0aMi0aFTsk-1g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.68)</p></td></tr></table> -719188000 -719188000 -522372000 -522372000 -99381000 -99381000 9161000 9161000 -719188000 -719188000 -522372000 -522372000 -90220000 -90220000 54680000 54680000 54055000 54055000 53653000 53653000 -13.15 -9.66 -1.86 0.18 -13.15 -9.66 -1.68 532000 701000 780000 1476000 1533000 1293000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">6. Facility Exit and Impairment Charges</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment Charges</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that an asset group has a carrying value that may not be recoverable. The individual operating store is the lowest level for which cash flows are identifiable. As such, the Company evaluates individual stores for recoverability of assets. To determine if a store needs to be tested for recoverability, the Company considers items such as decreases in market prices, changes in the manner in which the store is being used or physical condition, changes in legal factors or business climate, an accumulation of losses significantly in excess of budget, a current period operating or cash flow loss combined with a history of operating or cash flow losses or a projection of continuing losses, or an expectation that the store will be closed or sold.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company monitors new and recently relocated stores against operational projections and other strategic factors such as regional economics, new competitive entries and other local market considerations to determine if an impairment evaluation is required. For other stores, it performs a recoverability analysis if it has experienced current-period and historical cash flow losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In performing the recoverability test, the Company compares the expected future cash flows of a store to the carrying amount of its assets. Significant judgment is used to estimate future cash flows. Major assumptions that contribute to its future cash flow projections include expected sales, gross profit and distribution expenses; expected costs such as payroll, occupancy costs and advertising expenses; and estimates for other significant selling, general and administrative expenses. Many long-term macroeconomic and industry factors are considered, both quantitatively and qualitatively, in the future cash flow assumptions. In addition to current and expected economic conditions such as inflation, interest and unemployment rates that affect customer shopping patterns, the Company considers that it operates in a highly competitive industry which includes the actions of other national and regional drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, dollar stores and internet pharmacies. Additionally, the Company takes into consideration that certain operating stores are executing specific improvement plans which are monitored quarterly to recoup recent capital investments, such as an acquisition of an independent pharmacy, which it has made to respond to specific competitive or local market conditions, or have specific programs tailored towards a specific geography or market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recorded impairment charges of $137,075 in fiscal 2023, $150,788 in fiscal 2022 and $46,287 in fiscal 2021. The Company recorded impairment charges of $59,573 in the fourth quarter of fiscal 2023, $99,416 in the fourth quarter of fiscal 2022 and $31,057 in the fourth quarter of fiscal 2021. The Company’s methodology for recording impairment charges has been consistently applied in the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, $717.2 million of the Company’s long-lived assets, including intangible assets, were associated with 2,309 active operating stores. Additionally, we have approximately $2.3 billion of operating lease right-of-use assets associated with the active stores.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If an operating store’s estimated future undiscounted cash flows are not sufficient to cover its carrying value, its carrying value is reduced to fair value. Fair value is its estimated future discounted cash flows. The discount rate is commensurate with the risks associated with the recovery of a similar asset. Operating lease right-of-use assets are included within the stores’ asset groups. The Company obtains fair values of these right-of-use assets based on real estate market data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">An impairment charge is recorded in the period that the store does not meet its original return on investment and/or has an operating loss for the last two years and its projected cash flows do not exceed its current asset carrying value. The amount of the impairment charge is the entire difference between the current asset carrying value and its fair value which is the estimated future discounted cash flows. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recorded impairment charges for active stores of $13,544 in fiscal 2023, $56,182 in fiscal 2022 and $29,745 in fiscal 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company reviews key performance results for active stores on a quarterly basis and approves certain stores for closure. Impairment for closed stores, if any (many stores are closed on lease expiration), are recorded in the quarter the closure decision is approved. Closure decisions are made on an individual store or regional basis considering all of the macroeconomic, industry and other factors, in addition to the active store’s individual operating results. The Company recorded impairment charges for closed facilities of $123,531 in fiscal 2023, $94,606 in fiscal 2022 and $16,542 in fiscal 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table summarizes the impairment charges and number of locations, segregated by closed facilities and active stores that have been recorded in fiscal 2023, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(in thousands, except number of stores)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Active stores:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stores previously impaired<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,866</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,339</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,372</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">New, relocated and remodeled stores<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,519</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Remaining stores not meeting the recoverability test<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,854</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—active stores</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56,182</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,745</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—closed facilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,542</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—all locations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 137,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 354</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 150,788</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 228</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,287</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, the Company will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,087</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,779</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$5,434</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$6,905</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$15,459</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$5,913</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to new stores (open at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) and relocated stores (relocated in the last </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met their original return on investment projections and have a historical loss of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,765</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$2,875</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$538</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$347</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,172</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,765</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$2,273</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$26,130</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$17,175</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,177</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,677</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The primary drivers of its impairment charges are each store’s current and historical operating performance and the assumptions that the Company makes about each store’s operating performance in future periods. Projected cash flows are updated based on the next year’s operating budget which includes the qualitative factors noted above. The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 1—Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2—Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3—Inputs to the valuation methodology are unobservable inputs based upon management’s best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Long-lived non-financial assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using Level 2 and Level 3 inputs as defined in the fair value hierarchy. The fair value of long-lived assets using Level 2 inputs is determined by evaluating the current economic conditions in the geographic area for similar use assets. The fair value of long-lived assets using Level 3 inputs is determined by estimating the amount and timing of net future cash flows (which are unobservable inputs) and discounting them using a risk-adjusted rate of interest (which is Level 1). The Company estimates future cash flows based on its experience and knowledge of the market in which the store is located. Significant increases or decreases in actual cash flows may result in valuation changes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below sets forth by level within the fair value hierarchy the long-lived assets, which include right-of-use assets, as of the impairment measurement date for which an impairment assessment was performed and total losses as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.11830902%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Values</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">as of </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charges</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Impairment Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_RcQL14VOaEOla9ljC4OzEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Long-lived assets held for use</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-olZ4BHfr0m68q-EUuQJzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,959</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65,676</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (132,243)</p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-lived assets held for sale</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_cfXmD1B5bka8S4JeKKUKyw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,832)</p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_smWu9wnMbUenRM2umTLbwA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 70,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (137,075)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.041152954%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Values</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">as of </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charges</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Impairment Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_Q8B_cjIYWE27jDC2KD2TLw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Long-lived assets held for use</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VYN8tLMIpkOioZOhviDkHw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 240,176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 263,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (150,064)</p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-lived assets held for sale</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tjyiCNoWMkWFk-XUZ9QSlg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (724)</p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_4VhoepO0nE2oQO974BEI9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 242,547</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 266,141</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (150,788)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The above assets reflected in the caption ‘Long-lived assets held for sale’ have not been reclassified to assets held for sale due to their immateriality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:12pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Lease Termination and Facility Exit Charges</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company assesses stores and distribution centers for potential closure or relocation. Decisions to close or relocate stores or distribution centers in future periods would result in inventory liquidation charges, as well as impairment of assets at these locations. When a store or distribution center is closed, the Company records executory costs for leases, as well as other store or distribution center closing and liquidation costs, when incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In fiscal 2023, 2022 and 2021, the Company recorded facility exit charges of $43,562, $13,296 and $11,427, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company calculates the liability for facility exit or disposal cost obligations to include long-term contract termination costs and costs related to the disposal of long-lived assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table reflects the accrued facility exit charges:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance—beginning of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Provision for facility exit charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 461</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 793</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Changes in assumptions and other adjustments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest accretion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (125)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,024)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292)</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance—end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,228</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,754</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s revenues and income before income taxes for fiscal 2023, 2022 and 2021 included results from stores that have been closed or are approved for closure as of March 4, 2023. The revenue, operating expenses and income before income taxes of these stores for the periods are presented as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178,030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 586,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 639,471</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 192,357</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 640,996</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 699,662</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gain from sale of assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (46,125)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,670)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,954)</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 52,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,057</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,402</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (94,269)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,294)</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Included in these stores’ income (loss) before income taxes are:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 934</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,535</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inventory liquidation charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,369)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,646)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,528)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The above results are not necessarily indicative of the impact that these closures will have on revenues and operating results of the Company in the future, as the Company often transfers the business of a closed store to another Company store, thereby retaining a portion of these revenues and operating expenses.</p> 137075000 150788000 46287000 59573000 99416000 31057000 717200000 2309 2300000000 P2Y 13544000 56182000 29745000 123531000 94606000 16542000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:18.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(in thousands, except number of stores)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charge</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Active stores:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stores previously impaired<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,866</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,339</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,372</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">New, relocated and remodeled stores<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,519</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Remaining stores not meeting the recoverability test<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,038</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,854</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—active stores</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56,182</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,745</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—closed facilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 123,531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,542</p></td></tr><tr><td style="vertical-align:bottom;width:37.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total impairment charges—all locations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 137,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 354</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 150,788</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 228</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,287</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to stores that were impaired for the first time in prior periods. In an effort to improve the operating results or to meet geographical competition, the Company will often make additional capital additions in stores that were impaired in prior periods. These additions will be impaired in future periods if they are deemed to be unrecoverable. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,087</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,779</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$5,434</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$6,905</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$15,459</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$5,913</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to new stores (open at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) and relocated stores (relocated in the last </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) and significant strategic remodels (remodeled in the last year) that did not meet their recoverability test during the current period. These stores have not met their original return on investment projections and have a historical loss of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,765</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$2,875</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$538</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$347</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,172</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">These charges are related to the remaining active stores that did not meet the recoverability test during the current period. These stores have a historical loss of at least </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Their future cash flow projections do not recover their current carrying value. The fiscal 2023 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,765</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$2,273</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2022 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$26,130</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$17,175</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions. The fiscal 2021 impairment charge includes </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,177</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of impairment relating to the ROU and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$3,677</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of capital additions.</span></td></tr></table><div style="margin-top:12pt;"></div> 44 4866000 118 12339000 174 21372000 8 4640000 1 538000 2 1519000 12 4038000 88 43305000 19 6854000 64 13544000 207 56182000 195 29745000 194 123531000 147 94606000 33 16542000 258 137075000 354 150788000 228 46287000 3087000 1779000 5434000 6905000 15459000 5913000 P3Y P2Y P2Y 1765000 2875000 0 538000 347000 1172000 P2Y 1765000 2273000 26130000 17175000 3177000 3677000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.11830902%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Values</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">as of </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charges</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Impairment Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_RcQL14VOaEOla9ljC4OzEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Long-lived assets held for use</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-olZ4BHfr0m68q-EUuQJzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,959</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65,676</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (132,243)</p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-lived assets held for sale</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_cfXmD1B5bka8S4JeKKUKyw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,115</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,832)</p></td></tr><tr><td style="vertical-align:bottom;width:43.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_smWu9wnMbUenRM2umTLbwA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.61%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 70,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (137,075)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.041152954%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Values</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">as of </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charges</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Impairment Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_Q8B_cjIYWE27jDC2KD2TLw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Long-lived assets held for use</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VYN8tLMIpkOioZOhviDkHw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 240,176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 263,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (150,064)</p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-lived assets held for sale</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tjyiCNoWMkWFk-XUZ9QSlg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (724)</p></td></tr><tr><td style="vertical-align:bottom;width:42.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_4VhoepO0nE2oQO974BEI9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 242,547</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 266,141</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (150,788)</p></td></tr></table> 22959000 42717000 65676000 132243000 5115000 5115000 4832000 28074000 42717000 70791000 137075000 240176000 23594000 263770000 150064000 2371000 2371000 724000 242547000 23594000 266141000 150788000 43562000 13296000 11427000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance—beginning of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Provision for facility exit charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 461</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 793</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Changes in assumptions and other adjustments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest accretion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (125)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,024)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292)</p></td></tr><tr><td style="vertical-align:bottom;width:60.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance—end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,228</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,892</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,754</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 1892000 2754000 2253000 461000 162000 793000 125000 1024000 292000 2228000 1892000 2754000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178,030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 586,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 639,471</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 192,357</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 640,996</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 699,662</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gain from sale of assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (46,125)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,670)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,954)</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 52,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,057</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,402</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (94,269)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,294)</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Included in these stores’ income (loss) before income taxes are:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 934</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,535</p></td></tr><tr><td style="vertical-align:bottom;width:59.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inventory liquidation charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,369)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,646)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,528)</p></td></tr></table> 178030000 586056000 639471000 192357000 640996000 699662000 46125000 13670000 7954000 -25396000 -52999000 -13057000 6402000 -94269000 -65294000 934000 3499000 4535000 -6369000 -1646000 -1528000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">7. Fair Value Measurements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company utilizes the three-level valuation hierarchy as described in Note 6 for the recognition and disclosure of fair value measurements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023 and February 26, 2022, the Company did not have any financial assets measured on a recurring basis. Please see Note 6 and Note 14 for fair value measurements of non-financial assets measured on a non-recurring basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Other Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets. The Company believes the carrying value of these investments approximates their fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair value for Secured Overnight Financing Rate (“SOFR”) based borrowings as of March 4, 2023 and LIBOR-based borrowings as of February 26, 2022 under the Company’s senior secured credit facility is estimated based on the quoted market price of the financial instrument which is considered Level 1 of the fair value hierarchy. The fair values of substantially all of the Company’s other long-term indebtedness are estimated based on quoted market prices of the financial instruments which are considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,925,258 and $2,368,328, respectively, as of March 4, 2023. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $2,732,986 and $2,661,122 respectively, as of February 26, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 7457000 7406000 2925258000 2368328000 2732986000 2661122000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">8. Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The provision for income tax benefit from continuing operations was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current tax:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,758)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,082</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,145</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,076</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,448</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,613)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax and other:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,301)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,649)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,927)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,895)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,228)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17,544)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A reconciliation of the expected statutory federal tax and the total income tax benefit from continuing operations was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal statutory rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (152,388)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (110,492)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (25,103)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 556</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 398</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 588</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income taxes, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 271,306</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (45,388)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,042</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bargain purchase gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_WIhqaI5RbEuoDQ31UZe6gQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,123</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,018)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Decrease of previously recorded liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,273)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,045</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,551</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,764</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Qualified fringe disallowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 342</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 313</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible excise tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Hmk1AjuyMU2vu6-dF2zF4Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_cHjodbDL2EOIB_7cnFrFhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,296</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 198</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,806</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (112,037)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 152,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,222)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (381)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 650</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net loss for fiscal 2023 from continuing operations included an income tax benefit of $6,467. The state income tax expense reflected in the table above primarily resulted from the re-measurement of state deferred tax assets due to a reduced statutory Pennsylvania corporate net income tax rate. This state tax expense was offset by a corresponding income tax benefit of $256,411 to reduce the valuation allowance as a result of the reduced tax rate. Overall, an income tax benefit of $112,037 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net loss for fiscal 2022 from continuing operations included an income tax benefit of $3,780, of which $152,785 of income tax expense was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net loss for fiscal 2021 from continuing operations included income tax benefit of $20,157, of which $2,222 was recorded to maintain a full valuation allowance for federal deferred tax assets as well as the majority of the Company’s state deferred tax assets. These assets may not be realized based on the Company's most recent assessment that it is more likely than not that sufficient taxable income may not be generated to realize the tax benefits of the Company’s net deferred tax assets. Additionally, the overall tax rate includes a permanent tax benefit related to the Company’s bargain purchase gain on the Bartell acquisition resulting in an impact of 8.4%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on its financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,958</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 143,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 95,421</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Pension, retirement and other benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67,686</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-lived assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 364,618</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 299,507</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 781,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 883,713</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,917</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net operating losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,200,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,487,639</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 225</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total gross deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,579,157</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,880,066</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,636,461)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,818,069)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 942,696</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,061,997</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Outside basis difference</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,682</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 244,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,221</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating lease right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 680,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 785,023</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total gross deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 930,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,041,926</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,368</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,071</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">A reconciliation of the beginning and ending amount of unrecognized tax benefits from continuing operations was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 103,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 184,414</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 198,325</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Increases to prior year tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Decreases to tax positions in prior periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (29,432)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (294)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (807)</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Increases to current year tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Settlements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Divestitures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Lapse of statute of limitations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (27,113)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (80,515)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,146)</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,085</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 103,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 184,414</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The amount of the above unrecognized tax benefits as of March 4, 2023, February 26, 2022 and February 27, 2021 which would impact the Company’s effective tax rate, if recognized, was $1,498, $18,737 and $20,923, respectively. Additionally, any impact on the effective rate may be mitigated by the valuation allowance that is remaining against the Company’s net deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company believes that it is reasonably possible that a decrease of up to $4,001 in unrecognized tax benefits related to state exposures may be necessary in the next twelve months, however, management does not expect the change to have a significant impact on the results of operations or the financial position of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes interest and penalties related to tax contingencies as income tax expense. The Company recognized an expense/(benefit) for interest and penalties in connection with tax matters of $(6,006), $(183) and $(123) for fiscal years 2023, 2022 and 2021, respectively. As of March 4, 2023 and February 26, 2022 the total amount of accrued income tax-related interest and penalties was $490 and $6,496, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company files U.S. federal income tax returns as well as income tax returns in those states where it does business. The consolidated federal income tax returns are closed for examination through fiscal year 2019. However, any net operating losses that were generated in these prior closed years may be subject to examination by the IRS upon utilization. Tax examinations by various state taxing authorities could generally be conducted for a period of <span style="-sec-ix-hidden:Hidden_4K0Xl1wthUWawSWzJTFrIQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> to five years after filing of the respective return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Net Operating Losses and Tax Credits</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, the Company had federal net operating loss carryforwards of approximately $2,133,742. Of these, $884,668 will expire, if not utilized, between fiscal 2029 and 2031. An additional $193,961 will expire, if not utilized, between fiscal 2032 and 2038. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, the Company had state net operating loss carryforwards of approximately $12,279,752, the majority of which will expire ratably through fiscal 2032; the net tax effect of these carryforwards is $754,483 and are reflected in the table above. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, the Company had federal business tax credit carryforwards of $11,363, the majority of which will expire between 2024 and 2029.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Valuation Allowances</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The valuation allowances as of March 4, 2023 and February 26, 2022 apply to the net deferred tax assets of the Company. The Company maintained a valuation allowance of $1,636,461 and $1,818,069 as of March 4, 2023 and February 26, 2022, respectively. A valuation allowance has been recorded for fiscal 2023 and fiscal 2022 to reduce certain federal and state net deferred tax assets that may not be realized based on all available evidence that currently does not support the realization of these assets.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current tax:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,758)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,082</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,145</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,076</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,448</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,613)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax and other:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,301)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,649)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,927)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,895)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,228)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17,544)</p></td></tr><tr><td style="vertical-align:bottom;width:60.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr></table> -6000 -6000 -6758000 9082000 7454000 4145000 9076000 7448000 -2613000 -1301000 -12649000 -15543000 -9927000 -4895000 -15543000 -11228000 -17544000 -6467000 -3780000 -20157000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 Weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Federal statutory rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (152,388)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (110,492)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (25,103)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 556</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 398</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 588</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income taxes, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 271,306</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (45,388)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,042</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bargain purchase gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_WIhqaI5RbEuoDQ31UZe6gQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,123</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,018)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Decrease of previously recorded liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,273)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,045</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,551</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,764</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Qualified fringe disallowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 342</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 313</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nondeductible excise tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Hmk1AjuyMU2vu6-dF2zF4Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_cHjodbDL2EOIB_7cnFrFhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,296</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 198</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,806</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (112,037)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 152,785</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,222)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 185</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (381)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 650</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr></table> -152388000 -110492000 -25103000 556000 398000 588000 271306000 -45388000 10042000 1123000 -10018000 -18689000 -3798000 -2273000 2045000 1551000 3764000 342000 224000 313000 1296000 2213000 198000 2806000 -112037000 152785000 -2222000 185000 -381000 650000 -6467000 -3780000 -20157000 -6467000 256411000 -112037000 -3780000 152785000 -20157000 -2222000 0.084 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,958</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 143,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 95,421</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Pension, retirement and other benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67,686</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-lived assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 364,618</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 299,507</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 781,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 883,713</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,955</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 22,917</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net operating losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,200,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,487,639</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 225</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total gross deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,579,157</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,880,066</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,636,461)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,818,069)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 942,696</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,061,997</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Outside basis difference</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,682</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 244,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 251,221</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating lease right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 680,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 785,023</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total gross deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 930,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,041,926</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,368</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,071</p></td></tr></table> 26769000 22958000 143207000 95421000 40100000 67686000 364618000 299507000 781721000 883713000 21955000 22917000 1200516000 1487639000 271000 225000 2579157000 2880066000 1636461000 1818069000 942696000 1061997000 5622000 5682000 244554000 251221000 680152000 785023000 930328000 1041926000 12368000 20071000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 103,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 184,414</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 198,325</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Increases to prior year tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Decreases to tax positions in prior periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (29,432)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (294)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (807)</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Increases to current year tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Settlements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Divestitures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Lapse of statute of limitations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (27,113)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (80,515)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,146)</p></td></tr><tr><td style="vertical-align:bottom;width:60.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unrecognized tax benefits balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,085</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 103,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 184,414</p></td></tr></table> 103629000 184414000 198325000 1000 24000 42000 29432000 294000 807000 27113000 80515000 13146000 47085000 103629000 184414000 1498000 18737000 20923000 4001000 -6006000 -183000 -123000 490000 6496000 P5Y 2133742000 884668000 193961000 12279752000 754483000 11363000 1636461000 1818069000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">9. Accounts Receivable </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company maintains an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable. The allowance for uncollectible accounts as of March 4, 2023 and February 26, 2022 was $53,453 and $28,069, respectively. The Company’s accounts receivable are due primarily from third-party payors (e.g., PBM companies, insurance companies or governmental agencies) and are recorded net of any allowances provided for under the respective plans. Since payments due from third-party payors are sensitive to payment criteria changes and legislative actions, the allowance is reviewed continually and adjusted for accounts deemed uncollectible by management.</p> 53453000 28069000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">10. Medicare Part D</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company offers Medicare Part D benefits through EI, which has contracted with CMS to be a PDP and, pursuant to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, must be a risk-bearing entity regulated under state insurance laws or similar statutes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">EI is a licensed domestic insurance company under the applicable laws and regulations. Pursuant to these laws and regulations, EI must file quarterly and annual reports with the National Association of Insurance Commissioners (“NAIC”) and certain state regulators, must maintain certain minimum amounts of capital and surplus under formulas established by certain states and must, in certain circumstances, request and receive the approval of certain state regulators before making dividend payments or other capital distributions to the Company. The Company does not believe these limitations on dividends and distributions materially impact its financial position. EI is subject to minimum capital and surplus requirements in certain states. The minimum amount of capital and surplus required to satisfy regulatory requirements in these states is $10,693 as of December 31, 2022. EI was in excess of the minimum required amounts in these states as of March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has recorded estimates of various assets and liabilities arising from its participation in the Medicare Part D program based on information in its claims management and enrollment systems. Significant estimates arising from its participation in this program include: (i) estimates of low-income cost subsidies, reinsurance amounts, and coverage gap discount amounts ultimately payable to CMS based on a detailed claims reconciliation that will occur in the following year; (ii) an estimate of amounts receivable from CMS under a risk-sharing feature of the Medicare Part D program design, referred to as the risk corridor and; (iii) estimates for claims that have been reported and are in the process of being paid or contested and for our estimate of claims that have been incurred but have not yet been reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On November 12, 2020, the Company entered into a receivable purchase agreement (the “November 2020 Receivable Purchase Agreement”) with Bank of America, N.A. (the “Purchaser”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the November 2020 Receivable Purchase Agreement, the Company sold $464,019, a portion of its calendar 2020 CMS receivable, for $444,812, of which $412,795 was received on November 12, 2020 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $19,207, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 28, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On November 12, 2020, concurrent with the November 2020 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “November 2020 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the November 2020 Indemnity Agreement. Based on its evaluation of the November 2020 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the November 2020 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the November 2020 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 18, 2021, the Company entered into a receivable purchase agreement (the “February 2021 Receivable Purchase Agreement”) with Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the February 2021 Receivable Purchase Agreement, the Company sold $300,015, the remaining portion of its calendar 2020 CMS receivable, for $290,613, of which $269,912 was received on February 18, 2021 and the remainder was received in fiscal 2022 upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $9,403, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 27, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 18, 2021, concurrent with the February 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2021 Indemnity Agreement. Based on its evaluation of the February 2021 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2021 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On August 12, 2021, the Company entered into a receivable purchase agreement (the “August 2021 Receivable Purchase Agreement”) with Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the August 2021 Receivable Purchase Agreement, the Company sold $271,829, a portion of its calendar 2021 CMS receivable, for $258,116, of which $239,360 was received on August 12, 2021 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,713, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended August 28, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 12, 2021, concurrent with the August 2021 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “August 2021 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the August 2021 Indemnity Agreement. Based on its evaluation of the August 2021 Indemnity Agreement, the Company has determined that it is highly unlikely </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">that the events covered under the August 2021 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the August 2021 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 24, 2022, the Company entered into a receivable purchase agreement (the “January 2022 Receivable Purchase Agreement”) with Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the January 2022 Receivable Purchase Agreement, the Company sold $400,680, a portion of its calendar 2021 CMS receivable, for $387,035, of which $359,388 was received on January 24, 2022 and the remainder was received in fiscal 2023 upon final remittance from CMS. In connection therewith, the Company recognized a loss of $13,645, which is included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended February 26, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 24, 2022, concurrent with the January 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “January 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the January 2022 Indemnity Agreement. Based on its evaluation of the January 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the January 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the January 2022 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October 13, 2022, the Company entered into a receivable purchase agreement (the “October 2022 Receivable Purchase Agreement”) with Purchaser. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the October 2022 Receivable Purchase Agreement, the Company sold $195,487, a portion of its calendar 2022 CMS receivable, for $180,405, of which $166,917 was received on October 13, 2022. The remaining $13,488, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $15,082, which was included as a component of (gain) loss on sale of assets, net during the thirteen-week period ended November 26, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October 13, 2022, concurrent with the October 2022 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “October 2022 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse, and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the October 2022 Indemnity Agreement. Based on its evaluation of the October 2022 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the October 2022 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the October 2022 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the thirteen-week period ended November 26, 2022, the Company incurred additional fees of $1,937, which were included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 3, 2023, the Company entered into a receivable purchase agreement (the “February 2023 Receivable Purchase Agreement”) with Purchaser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the terms and conditions set forth in the February 2023 Receivable Purchase Agreement, the Company sold $278,390, a portion of its calendar 2022 CMS receivable, for $261,771, of which $242,562 was received on February 3, 2023. The remaining $19,209, which is included in accounts receivable, net as of March 4, 2023, is payable to the Company, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance from CMS. In connection therewith, the Company recognized a loss of $16,619, which is included as a component of (gain) loss on sale of assets, net during the fourteen-week period ended March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 3, 2023, concurrent with the February 2023 Receivable Purchase Agreement, the Company entered into an indemnity agreement (the “February 2023 Indemnity Agreement”), whereby the Company has agreed to indemnify, reimburse and hold Purchaser harmless from certain liabilities and expenses actually suffered or incurred by the Purchaser resulting from the occurrence of certain events as specified in the February 2023 Indemnity Agreement. Based on its evaluation of the February 2023 Indemnity Agreement, the Company has determined that it is highly unlikely that the events covered under the February 2023 Indemnity Agreement would occur, and consequently, the Company has not recorded any indemnification liability associated with the February 2023 Indemnity Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the fourteen-week period ended March 4, 2023, the company incurred additional fees of $2,573, which are included as a component of (gain) loss on sale of assets, net related to the sale of the 2021 CMS receivable to Bank of America. The additional fees were incurred due to a CMS delay in settling the 2021 receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of March 4, 2023 and February 26, 2022, accounts receivable, net included $22,362 and $34,898 due from the Purchaser, subject to final CMS claim reconciliation adjustments, upon receipt of the final remittance for the respective calendar years from CMS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 4pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of March 4, 2023 and February 26, 2022, accounts receivable, net included $45,201 and $63,203 of amounts due from CMS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 4pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 4pt 0pt;"><span style="white-space:pre-wrap;">The Inflation Reduction Act of 2022 contains several provisions affecting Medicare, which will take effect over various periods of time from 2023 to 2029. Based on the Company’s current analysis of the provisions, it does not believe that this legislation will have a material impact on the financial statements.</span></p> 10693000 464019000 444812000 412795000 -19207000 300015000 290613000 269912000 -9403000 271829000 258116000 239360000 -13713000 400680000 387035000 359388000 -13645000 195487000 180405000 166917000 13488000 -15082000 -1937000 278390000 261771000 242562000 19209000 -16619000 -2573000 22362000 34898000 45201000 63203000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">11. Manufacturer Rebates Receivables</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Pharmacy Services Segment has manufacturer rebates receivables of $357,699 and $535,620 included in Accounts receivable, net of an allowance for uncollectible rebates of $8,680 and $18,796, as of March 4, 2023 and February 26, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the thirteen-week period ended February 26, 2022, the Company reassessed its historical policy for estimating its allowance for manufacturer rebate receivables and concluded that, due to changes in its business practices and other market conditions, certain amounts within the outstanding receivable had an increased risk of uncollectability. As a result, the Company increased its allowance for manufacturer rebate receivables by $15,068, which was recorded as an increase to costs of revenue during the thirteen-week period ended February 26, 2022. The Company determined that this change in estimate is a non-recurring item that should be added back to Adjusted EBITDA (see “Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non GAAP Measures” for details).</p> 357699000 535620000 8680000 18796000 15068000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">12. Inventory</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of March 4, 2023 and February 26, 2022, inventories were $539,932 and $487,173, respectively, lower than the amounts that would have been reported using the first-in, first-out (“FIFO”) cost flow assumption. The Company calculates its FIFO inventory valuation using the retail method for store inventories and the cost method for distribution facility inventories. The Company recorded a LIFO charge of $53,028 and $1,314, for fiscal year 2023 and 2022, respectively, and a LIFO credit of $51,692 for fiscal year 2021. During fiscal 2023, 2022 and 2021, a reduction in non-pharmacy inventories resulted in the liquidation of applicable LIFO inventory quantities carried at lower costs in prior years. This LIFO liquidation resulted in a $31,857, $13,090 and $26,861 cost of revenues decrease, with a corresponding reduction to the adjustment to LIFO for fiscal 2023, fiscal 2022 and fiscal 2021, respectively.</p> 539932000 487173000 53028000 1314000 -51692000 31857000 13090000 26861000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">13. Property, Plant and Equipment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Following is a summary of property, plant and equipment, including capital lease assets, as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 69,588</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 83,485</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 208,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 314,143</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,568,983</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,566,082</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,855,083</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,794,937</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,597</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 92,139</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 109,690</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 97,715</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,901,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,948,501</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,993,851)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,959,334)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 907,771</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 989,167</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Depreciation expense, which included the depreciation of assets recorded under capital leases, was $202,559, $217,639 and $238,104 in fiscal 2023, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Included in property, plant and equipment was the carrying amount, which approximates fair value, of assets to be disposed of totaling $3,972 and $1,463 as of March 4, 2023 and February 26, 2022, respectively.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 69,588</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 83,485</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 208,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 314,143</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,568,983</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,566,082</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,855,083</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,794,937</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 89,597</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 92,139</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 109,690</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 97,715</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,901,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,948,501</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,993,851)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,959,334)</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 907,771</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 989,167</p></td></tr></table> 69588000 83485000 208681000 314143000 1568983000 1566082000 1855083000 1794937000 89597000 92139000 109690000 97715000 3901622000 3948501000 2993851000 2959334000 907771000 989167000 202559000 217639000 238104000 3972000 1463000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">14. Goodwill and Other Intangibles</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Goodwill and indefinite-lived assets, such as certain trademarks acquired in connection with acquisition transactions, are not amortized, but are instead evaluated for impairment on an annual basis at the end of the fiscal year, or more frequently if events or circumstances indicate it may be more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, the Company performs a quantitative goodwill impairment test. The fair value estimates used in the quantitative impairment test are calculated using an average of the income and market approaches. The income approach is based on the present value of future cash flows of each reporting unit, while the market approach is based on certain multiples of selected guideline public companies or selected guideline transactions. The approaches, which qualify as Level 3 within the fair value hierarchy, incorporate a number of market participant assumptions including future growth rates, discount rates, income tax rates and market activity in assessing fair value and are reporting unit specific. If the carrying amount exceeds the reporting unit’s fair value, the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. In addition, the Company considers the income tax effect of any tax deductible goodwill when measuring a goodwill impairment loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the fourth quarter of fiscal 2021, the Company completed a quantitative goodwill impairment assessment and determined after evaluating the results, events and circumstances, that sufficient evidence existed to assert that it is more likely than not that the fair values of the reporting units exceeded their carrying values. Therefore, no goodwill impairment charge was recorded for the fiscal year ended February 27, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the fourth quarter of fiscal 2022, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to a decrease in Adjusted EBITDA that was driven by commercial and Medicare Part D business compression due to industry consolidation, an increase in the medical loss ratio at Elixir Insurance, and a decision to exit our rebate aggregation business. This resulted in goodwill impairment charges of $229,000 for the fiscal year ended February 26, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the second quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to an update to the Company’s preliminary fiscal 2024 and beyond forecasted revenue driven by current updates in the estimate of lives for calendar year 2023 based on the latest estimates of existing client retention for 2023, the latest selling season and EI bid results and other business factors which only became evident during the second quarter. This resulted in goodwill impairment charges of $252,200 in the second quarter of fiscal 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">In the fourth quarter of fiscal 2023, the Company completed a qualitative goodwill impairment assessment, at which time it was determined after evaluating results, events, and circumstances that a quantitative assessment was necessary for the Pharmacy Services Segment. The quantitative assessment concluded that the carrying amount of the Pharmacy Services Segment exceeded its fair value principally due to downward macroeconomic pressure during the fourth quarter of fiscal 2023 which manifested in increased interest rates, increased cost of borrowing and a decrease of industry multiples. The market factors that drove the goodwill impairment charges of $119,000 in the fourth quarter of fiscal 2023 were not known in prior quarters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The goodwill related to the Pharmacy Services Segment is at risk of future impairment if the fair value of this segment, and its associated assets, decrease in value due to further declines in its operating results or an inability to execute management’s business strategies. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company's estimates. If the Company's ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record impairment charges in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of March 4, 2023 and February 26, 2022, the accumulated impairment losses for the Pharmacy Services Segment was $1,174,912 and $803,712, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Below is a summary of the changes in the carrying amount of goodwill by segment for the fiscal years ended March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,064,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,108,136</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VrCnSX-W9UyK_dq6Tu-gQw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (229,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (229,000)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 835,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 879,136</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_uWssvQQU3ECr5sPRn7ggTA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (371,200)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (371,200)</p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 464,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,936</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s intangible assets are primarily finite-lived and amortized over their useful lives. Following is a summary of the Company’s finite-lived and indefinite-lived intangible assets as of March 4, 2023 and February 26, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Non-compete agreements and other<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 201,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (182,957)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,962</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 197,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (178,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,693</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Prescription files</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,029,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (928,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,030,169</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (918,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 111,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">6</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Customer relationships<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (306,139)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 81,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">9</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (286,090)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">10</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">CMS license</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (23,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 33,702</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">4</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (15,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 42,128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Claims adjudication and other developed software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (58,985)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_SnGtDDrWQ0OecHJzwqe5FA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">0</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (56,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">1</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total finite</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,736,069</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 235,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,732,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 276,796</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Jrxy8ZWBuUyOmPyeAn6WIw;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-JuimyuooUuPwgEGXIOulA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,750,469</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 250,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,746,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 291,196</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is continuing to reposition its approach to the Elixir Insurance Part D business including an expectation of a purposeful shrinkage of the business. As a result, at the end of fiscal 2022, the Company adjusted the remaining amortization period of the CMS License to five years. Prior to such adjustment, the remaining life was nineteen years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In connection with the restructuring initiatives previously announced on March 16, 2020, the Company rebranded its EnvisionRxOptions and MedTrak subsidiaries to its new brand name, Elixir. These trademarks qualify as Level 3 within the fair value hierarchy. Upon the implementation of the rebranding initiatives during the first quarter of fiscal 2021, the Company has determined that the carrying value exceeded the fair value and consequently the Company incurred an impairment charge of $29,852 for these trademarks, which is included within intangible asset impairment charges within the consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Amortization expense for these intangible assets and liabilities was $74,024, $78,047 and $89,020 for fiscal 2023, 2022 and 2021, respectively. The anticipated annual amortization expense for these intangible assets and liabilities is 2024—$61,343; 2025—$50,209; 2026—$39,771; 2027—$32,779 and 2028—$25,299.</p> 0 229000000 252200000 119000000 1174912000 803712000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,064,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,108,136</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VrCnSX-W9UyK_dq6Tu-gQw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (229,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (229,000)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 835,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 879,136</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill impairment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_uWssvQQU3ECr5sPRn7ggTA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (371,200)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (371,200)</p></td></tr><tr><td style="vertical-align:bottom;width:58.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance, March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 464,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,936</p></td></tr></table> 43492000 1064644000 1108136000 229000000 229000000 43492000 835644000 879136000 371200000 371200000 43492000 464444000 507936000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Non-compete agreements and other<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 201,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (182,957)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,962</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 197,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (178,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,693</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Prescription files</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,029,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (928,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,030,169</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (918,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 111,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">6</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Customer relationships<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (306,139)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 81,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">9</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (286,090)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">10</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">CMS license</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (23,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 33,702</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">4</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (15,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 42,128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Claims adjudication and other developed software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (58,985)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_SnGtDDrWQ0OecHJzwqe5FA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">0</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (56,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">1</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total finite</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,736,069</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 235,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,732,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 276,796</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Jrxy8ZWBuUyOmPyeAn6WIw;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-JuimyuooUuPwgEGXIOulA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,750,469</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 250,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,746,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 291,196</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.</span></td></tr></table><div style="margin-top:12pt;"></div> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:34.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Non-compete agreements and other<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 201,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (182,957)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,962</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 197,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (178,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 18,693</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">3</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Prescription files</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,029,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (928,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,030,169</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (918,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 111,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">6</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Customer relationships<sup style="font-size:5.25pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (306,139)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 81,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">9</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 388,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (286,090)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 101,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">10</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">CMS license</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (23,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 33,702</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">4</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 57,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (15,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 42,128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">5</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Claims adjudication and other developed software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (58,985)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_SnGtDDrWQ0OecHJzwqe5FA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">0</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 58,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (56,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="font-size:7pt;">1</span></p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total finite</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,736,069</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 235,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,732,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 276,796</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Jrxy8ZWBuUyOmPyeAn6WIw;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-JuimyuooUuPwgEGXIOulA;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 14,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Indefinite</p></td><td style="vertical-align:bottom;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:27.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,750,469</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,500,357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 250,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,746,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> (1,455,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 291,196</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.</span></td></tr></table><div style="margin-top:12pt;"></div> 201919000 182957000 18962000 P3Y 197651000 178958000 18693000 P3Y 1029665000 928478000 101187000 P5Y 1030169000 918773000 111396000 P6Y 388000000 306139000 81861000 P9Y 388000000 286090000 101910000 P10Y 57500000 23798000 33702000 P4Y 57500000 15372000 42128000 P5Y 58985000 58985000 P0Y 58985000 56316000 2669000 P1Y 1736069000 1500357000 235712000 1732305000 1455509000 276796000 14400000 14400000 14400000 14400000 1750469000 1500357000 250112000 1746705000 1455509000 291196000 P5Y P19Y 29852000 74024000 78047000 89020000 61343000 50209000 39771000 32779000 25299000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">15. Accrued Salaries, Wages and Other Current Liabilities</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Accrued salaries, wages and other current liabilities consisted of the following as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued wages, benefits and other personnel costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 190,664</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 291,004</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,286</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued sales and other taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 86,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75,068</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued store expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71,398</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 70,537</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued litigation, legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,200</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued self-insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25,760</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,402</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 275,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 250,062</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 709,891</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 776,559</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued wages, benefits and other personnel costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 190,664</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 291,004</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,286</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued sales and other taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 86,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75,068</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued store expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 71,398</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 70,537</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued litigation, legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,200</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued self-insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25,760</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,402</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 275,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 250,062</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 709,891</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 776,559</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p> 190664000 291004000 18630000 18286000 86920000 75068000 71398000 70537000 41205000 43200000 25760000 28402000 275314000 250062000 709891000 776559000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">16. Indebtedness and Credit Agreement </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Following is a summary of indebtedness and lease financing obligations as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Senior secured revolving credit facility due August 2026 ($1,200,000 and $709,000 face value less unamortized debt issuance costs of $16,117 and $18,010)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,183,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 690,990</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">FILO Term Loan due August 2026 ($400,000 and $350,000 face value less unamortized debt issuance costs of $2,090 and $2,344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 397,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 347,656</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,581,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,038,646</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Second Lien Secured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">7.5% senior secured notes due July 2025 ($320,002 and $600,000 face value less unamortized debt issuance costs of $2,529 and $6,824)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 317,473</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 593,176</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">8.0% senior secured notes due November 2026 ($849,918 face value less unamortized debt issuance costs of $11,259 and $14,397)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 838,659</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 835,521</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,156,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,428,697</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unguaranteed Unsecured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">7.7% notes due February 2027 ($185,691 and $237,386 face value less unamortized debt issuance costs of $398 and $642)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 185,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 236,744</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">6.875% fixed-rate senior notes due December 2028 ($2,046 and $29,001 face value less unamortized debt issuance costs of $6 and $102)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 28,899</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 187,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 265,643</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease financing obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20,374</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,944,170</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,753,360</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current maturities of long-term debt and lease financing obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,332)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,544)</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term debt and lease financing obligations, less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,937,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,747,816</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Credit Facilities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 20, 2018, the Company entered into a senior secured credit agreement (as amended by the First Amendment to Credit Agreement, dated as of January 6, 2020, the “Prior Credit Agreement”; and the Credit Agreement, as further amended by the Second Amendment (as defined below), the “Prior Amended Credit Agreement”), which provided for facilities consisting of a $2,700,000 senior secured asset-based revolving credit facility and a $450,000 “first-in, last-out” senior secured term loan facility, the proceeds of which were used in December 2018 to refinance its prior $2,700,000 existing credit agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 20, 2021, the Company entered into the Second Amendment to Credit Agreement (the “Second Amendment”), which, among other things, amended the Prior Credit Agreement to provide for a $2,800,000 senior secured asset-based revolving credit facility (the “Prior Senior Secured Revolving Credit Facility”) and a $350,000 “first-in, last-out” senior secured term loan facility (“Prior Senior Secured Term Loan” and together with the Prior Senior Secured Revolving Credit Facility, collectively, the “Prior Amended Facilities”). The Prior Amended Facilities extended the Company’s debt maturity profile and provided additional liquidity. Borrowings under the Prior Senior Secured Revolving Credit Facility bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of between 0.25% to 0.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of between 1.25% and 1.75%, in each case based upon the Average ABL Availability (as defined in the Prior Amended Credit Agreement). Borrowings under the Prior Senior Secured Term Loan bore interest at a rate per annum equal to, at the Company’s option, (x) a base rate (determined in a customary manner) plus a margin of 1.75% or (y) an adjusted LIBOR rate (determined in a customary manner) plus a margin of 2.75%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 1, 2022, the Company entered into the Third Amendment to Credit Agreement (the “Third Amendment”), which, among other things, amended the Prior Amended Credit Agreement (the Prior Amended Credit Agreement, as modified by the Third Amendment, the “Existing Credit Agreement”) to provide for a $2,850,000 senior secured asset-based revolving credit facility (the “Existing Senior Secured Revolving Credit Facility”) and a $400,000 “first-in, last-out” senior secured term loan facility (the “Existing Senior Secured Term Loan” and, together with the Existing Senior Secured Revolving Credit Facility, collectively, the “Existing Facilities”), replaced the LIBOR rate with a Term SOFR-based rate as the applicable benchmark for the Existing Facilities, included COVID-19 vaccines in the borrowing base under the Existing Senior Secured Revolving Credit Facility, subject to limitations and conditions as specified in the Existing Credit Agreement, and increased the interest rate applicable to loans under the Existing Senior Secured Term Loan to (x) a base rate (determined in a customary manner) plus a margin of 2.00% or (y) an adjusted Term SOFR-based rate (determined in a customary manner) plus a margin of 3.00%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is required to pay fees between 0.250% and 0.375% per annum on the daily unused amount of the commitments under the Existing Senior Secured Revolving Credit Facility, depending on Average ABL Availability (as defined in the Existing Credit Agreement). The Existing Facilities are scheduled to mature on August 20, 2026 (subject to a springing maturity if certain of the Company’s existing secured notes are not refinanced or repaid prior to the date that is 91 days prior to the stated maturity thereof).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s borrowing capacity under the Existing Senior Secured Revolving Credit Facility is based upon a specified borrowing base consisting of accounts receivable, inventory and prescription files. As of March 4, 2023, the Company had approximately $1,600,000 of borrowings outstanding under the Existing Facilities and had letters of credit outstanding under the Existing Senior Secured Revolving Credit Facility in a face amount of approximately $208,698, which resulted in remaining borrowing capacity under the Existing Senior Secured Revolving Credit Facility of $1,403,996. If at any time the total credit exposure outstanding under the Existing Senior Secured Revolving Credit Facility exceeds the borrowing base, the Company will be required to repay amounts outstanding to eliminate such shortfall.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Existing Credit Agreement restricts the Company and all of its subsidiaries including the subsidiaries that guarantee its obligations under the Existing Facilities, the secured guaranteed notes and unsecured guaranteed notes (collectively, the “Subsidiary Guarantors”) from accumulating cash on hand in excess of $200,000 at any time when revolving loans are outstanding (not including cash located in store and lockbox deposit accounts and cash necessary to cover current liabilities). The Existing Credit Agreement also states that if at any time (other than following the exercise of remedies or acceleration of any senior obligations or second priority debt and receipt of a triggering notice by the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">senior collateral agent from a representative of the senior obligations or the second priority debt) either (i) an event of default exists under the Existing Facilities or (ii) availability under the Existing Senior Secured Revolving Credit Facility is less than or equal to $283,250 for three consecutive business days or less than or equal to $206,000 on any day (a “cash sweep period”), the funds in the Company’s deposit accounts will be swept to a concentration account with the senior collateral agent and will be applied first to repay outstanding revolving loans under the Existing Facilities, and then held as collateral for the senior obligations until such cash sweep period is rescinded pursuant to the terms of the Existing Facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s obligations under the Existing Facilities and the Subsidiary Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on all of the Subsidiary Guarantors’ cash and cash equivalents, accounts receivable, inventory, prescription files (including eligible script lists), intellectual property (prior to the repayment of the Existing Senior Secured Term Loan) and certain other assets arising therefrom or related thereto (including substantially all of their deposit accounts, collectively, the “ABL priority collateral”) and (ii) a second-priority lien on all of the Subsidiary Guarantors’ equipment, fixtures, investment property (other than equity interests in subsidiaries), intellectual property (following the repayment of the Existing Senior Secured Term Loan) and all other assets that do not constitute ABL priority collateral, in each case, subject to customary exceptions and limitations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Existing Credit Agreement allows the Company to have outstanding, at any time, up to an aggregate principal amount of $1,500,000 in secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock in addition to borrowings under the Existing Facilities and existing indebtedness, provided that not in excess of $750,000 of such secured second priority debt, split-priority debt, unsecured debt and disqualified preferred stock shall mature or require scheduled payments of principal prior to <span style="-sec-ix-hidden:Hidden_TDN7LFLFZUO1580r7fMtCA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">90 days</span></span> after the latest maturity date of any Term Loan or Other Revolving Commitment (each as defined in the Existing Credit Agreement) (excluding bridge facilities allowing extensions on customary terms to at least the date that is 90 days after such date). Subject to the limitations described in the immediately preceding sentence, the Existing Credit Agreement additionally allows the Company to issue or incur an unlimited amount of unsecured debt and disqualified preferred stock so long as a Financial Covenant Effectiveness Period (as defined in the Existing Credit Agreement) is not in effect; provided, however, that certain of the Company’s other outstanding indebtedness limits the amount of unsecured debt that can be incurred if certain interest coverage levels are not met at the time of incurrence or other exemptions are not available. The Existing Credit Agreement also contains certain restrictions on the amount of secured first priority debt the Company is able to incur. The Existing Credit Agreement also allows for the voluntary repurchase of any debt or other convertible debt, so long as the Existing Facilities are not in default and the Company maintains availability under its revolver of more than $375,950.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Existing Credit Agreement has a financial covenant that requires the Company to maintain a minimum fixed charge coverage ratio of 1.00 to 1.00 (i) on any date on which availability under the Existing Senior Secured Revolving Credit Facility is less than $206,000 or (ii) on the third consecutive business day on which availability under the Existing Senior Secured Revolving Credit Facility is less than $257,500 and, in each case, ending on and excluding the first day thereafter, if any, which is the 30th consecutive calendar day on which availability under the revolver is equal to or greater than $257,500. As of March 4, 2023, the availability under the Existing Senior Secured Revolving Credit Facility was at a level that did not trigger the Existing Credit Agreement’s financial covenant. The Existing Credit Agreement also contains covenants which place restrictions on the incurrence of debt, the payments of dividends, the making of investments, sale of assets, mergers and acquisitions and the granting of liens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Existing Credit Agreement provides for customary events of default including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if the Company fails to make any </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">required payment on debt having a principal amount in excess of $50,000 or any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of such debt to accelerate the maturity or require the repayment, repurchase, redemption or defeasance of such debt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"></span><span style="font-style:italic;font-weight:bold;">Fiscal 2021, 2022 and 2023 Transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On June 25, 2020, the Company commenced an offer to exchange (the “June 25, 2020 Exchange Offer”) up to $750,000 aggregate principal amount of the outstanding 6.125% Senior Notes due 2023 (the “6.125% Notes”) for a combination of $600,000 newly issued 8.0% Senior Secured Notes due 2026 (the “8.0% Notes”) and $145,500 cash. On July 10, 2020, the Company increased the maximum amount of 6.125% Notes that may be accepted for exchange from $750,000 to $1,125,000 and, on July 24, 2020, the Company announced that it accepted for payment $1,062,682 aggregate principal amount of the 6.125% Notes in exchange for $849,918 aggregate principal amount of newly issued 8.0% Notes and $206,373 in cash. In connection therewith, the Company recorded a gain on debt modification of $5,274 which is included in the results of operations and cash flows of continuing operations. The 8.0% Notes are secured on an equal and ratable basis by the same assets that secure the 7.500% Notes. The 8.0% Notes are guaranteed on a senior secured basis by the same subsidiaries that guarantee the 7.500% Notes. In conjunction with the June 25, 2020 Exchange Offer, the Company also commenced a solicitation of consents from the holders of outstanding 6.125% Notes to certain proposed amendments to the indenture governing the 6.125% Notes. On July 9, 2020, following the receipt of the requisite number of consents, the Company entered into a supplemental indenture, which modified certain limitations in the debt covenant to allow for the creation of the 8.0% Notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On April 28, 2021, the Company issued a notice of redemption for all of the 6.125% Notes that were outstanding on May 28, 2021, pursuant to the terms of the indenture of the 6.125% Notes. On May 28, 2021, the Company redeemed 100% of the remaining outstanding 6.125% Notes at par. In connection therewith, the Company recorded a loss on debt retirement of $396 which included unamortized debt issuance costs. The debt repayment and related loss on debt retirement is included in the results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On August 20, 2021, the Company entered into the Second Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Prior Senior Secured Revolving Credit Facility from $2,700,000 to $2,800,000 and decrease the aggregate principal amount of loans outstanding under the Prior Senior Secured Term Loan from $450,000 to $350,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $2,839 which included unamortized debt issuance costs. The debt repayment and related loss on debt modification and retirement is included in the results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On June 13, 2022, the Company commenced a series of cash tender offers to purchase up to $150,000 aggregate principal amount of the Company’s 7.500% Senior Secured Notes due 2025 (the “7.500% Notes”), 8.0% Notes), 7.70% Notes due 2027 (the “7.70% Notes”) and 6.875% Notes due 2028 (the “6.875% Notes”), subject to prioritized acceptance levels, a subcap of $100,000 with respect to the 7.500% Notes and proration. On June 29, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $114,942 of its 7.500% Notes, $51,695 aggregate principal amount of its 7.70% Notes and $26,955 aggregate principal amount of its 6.875% Notes. In connection therewith, the Company recorded a gain on debt retirement of $41,312, which included unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On November 3, 2022, the Company announced the commencement of a cash tender offer to purchase up to $200,000 aggregate purchase price (not including any accrued and unpaid interest) of the Company’s 7.500% Notes, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">subject to proration. On November 30, 2022, pursuant to an early settlement, the Company purchased an aggregate principal amount of $<span style="font-family:'TimesNewRoman';">160,497</span><span style="font-family:'TimesNewRoman';"> </span>of its 7.500% Notes <span style="font-family:'TimesNewRoman';">and on December 9, 2022, </span>pursuant to the final settlement,<span style="font-family:'TimesNewRoman';"> the Company purchased an additional aggregate principal amount of </span><span style="font-family:'TimesNewRoman';">$4,559</span><span style="font-family:'TimesNewRoman';"> of its </span><span style="font-family:'TimesNewRoman';">7.500%</span><span style="font-family:'TimesNewRoman';"> Notes. In connection therewith, the Company recorded a gain on debt retirement of </span><span style="font-family:'TimesNewRoman';">$38,978</span><span style="font-family:'TimesNewRoman';">, which includes unamortized debt issuance costs. The debt repayment and related gain on debt retirement is included in the results of operations and cash flows</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 1, 2022, the Company entered into the Third Amendment in order to, among other things, increase the aggregate principal amount of commitments under the Existing Senior Secured Revolving Credit Facility from $2,800,000 to $2,850,000 and increase the aggregate principal amount of loans outstanding under the Existing Senior Secured Term Loan from $350,000 to $400,000. As a result of the Third Amendment, the Company has increased its liquidity by $100,000. In connection therewith, the Company recorded a loss on debt modification and retirement of $148, which includes unamortized debt issuance costs. The related loss on debt modification and retirement is included in the results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="font-style:italic;font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;"><span style="font-style:italic;font-weight:bold;">Interest Rates and Maturities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The annual weighted average interest rate on the Company’s indebtedness was 7.2%, 5.6% and 5.4% for fiscal 2023, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The aggregate annual principal payments of long-term debt for the five succeeding fiscal years are as follows: 2024—$0; 2025—$0; 2026—$320,002; 2027—$2,635,609 and $2,046 in 2028 and thereafter.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Senior secured revolving credit facility due August 2026 ($1,200,000 and $709,000 face value less unamortized debt issuance costs of $16,117 and $18,010)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,183,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 690,990</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">FILO Term Loan due August 2026 ($400,000 and $350,000 face value less unamortized debt issuance costs of $2,090 and $2,344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 397,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 347,656</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,581,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,038,646</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Second Lien Secured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">7.5% senior secured notes due July 2025 ($320,002 and $600,000 face value less unamortized debt issuance costs of $2,529 and $6,824)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 317,473</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 593,176</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">8.0% senior secured notes due November 2026 ($849,918 face value less unamortized debt issuance costs of $11,259 and $14,397)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 838,659</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 835,521</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,156,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,428,697</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Unguaranteed Unsecured Debt:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">7.7% notes due February 2027 ($185,691 and $237,386 face value less unamortized debt issuance costs of $398 and $642)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 185,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 236,744</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">6.875% fixed-rate senior notes due December 2028 ($2,046 and $29,001 face value less unamortized debt issuance costs of $6 and $102)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 28,899</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 187,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 265,643</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease financing obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20,374</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,944,170</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,753,360</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current maturities of long-term debt and lease financing obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,332)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,544)</p></td></tr><tr><td style="vertical-align:bottom;width:69.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term debt and lease financing obligations, less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,937,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,747,816</p></td></tr></table> 1200000000 709000000 16117000 18010000 1183883000 690990000 400000000 350000000 2090000 2344000 397910000 347656000 1581793000 1038646000 0.075 0.075 320002000 600000000 2529000 6824000 317473000 593176000 0.080 0.080 849918000 849918000 11259000 14397000 838659000 835521000 1156132000 1428697000 0.077 0.077 185691000 237386000 398000 642000 185293000 236744000 0.06875 0.06875 2046000 29001000 6000 102000 2040000 28899000 187333000 265643000 18912000 20374000 2944170000 2753360000 6332000 5544000 2937838000 2747816000 2700000000 450000000 2700000000 2800000000 350000000 0.0025 0.0075 0.0125 0.0175 0.0175 0.0275 2850000000 400000000 0.0200 0.0300 0.00250 0.00375 P91D 1600000000 208698000 1403996000 200000000 283250000 206000000 1500000000 750000000 P90D 375950000 1.00 206000000 257500000 257500000 50000000 750000000 0.06125 0.06125 600000000 0.080 0.080 145500000 0.06125 750000000 1125000000 1062682000 0.06125 849918000 0.080 206373000 5274000 0.080 0.07500 0.080 0.07500 0.06125 0.06125 0.080 0.06125 0.06125 1 0.06125 396000 2700000000 2800000000 450000000 350000000 2839000 150000000 0.07500 0.07500 0.080 0.0770 0.0770 0.06875 0.06875 100000000 0.07500 114942000 0.07500 51695000 0.0770 26955000 0.06875 -41312000 200000000 0.07500 160497000 0.07500 4559000 0.07500 -38978000 2800000000 2850000000 350000000 400000000 -100000000 148000 0.072 0.056 0.054 0 0 320002000 2635609000 2046000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">17. Leases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company leases most of its retail stores and certain distribution facilities under <span style="-sec-ix-hidden:Hidden_eJ72AOCEiket_3I50yWpNA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">noncancellable</span></span> <span style="-sec-ix-hidden:Hidden_KESTwdghVkG4LvVHjnNBZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">operating</span></span> and finance leases, most of which have initial lease terms ranging from 5 to 22 years. The Company also leases certain of its equipment and other assets under noncancellable operating leases with initial terms ranging from 3 to 10 years. In addition to minimum rental payments, certain store leases require additional payments based on sales volume, as well as reimbursements for taxes, maintenance and insurance. Most leases contain renewal options, certain of which involve rent increases. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table is a summary of the Company’s components of net lease cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:47.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 641,394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 669,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 651,261</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financing lease cost:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Amortization of right-of-use asset </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,359</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Interest on long-term finance lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,505</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total finance lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,805</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,864</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,214</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Variable lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 175,697</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 172,088</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: sublease income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,871)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,886)</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net lease cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 815,351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 818,541</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Supplemental cash flow information related to leases for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating cash flows paid for operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 706,506</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 703,326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 683,226</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating cash flows paid for interest portion of finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,505</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Financing cash flows paid for principal portion of finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,744</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Right-of-use assets obtained in exchange for lease obligations:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 264,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 350,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 513,215</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ej5zcseOnEasIONw8rnTuw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_K2RjRJc_ME-39_Zj7fd34A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rITNIyYetEKZx-6iugHZ_A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Supplemental balance sheet information related to leases as of March 4, 2023 and February 26, 2022 (in thousands, except lease term and discount rate):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating leases:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease right-of-use asset </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,497,206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,813,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 502,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 575,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,372,943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,597,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,875,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,172,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Finance leases:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4UTwYICUrU2Cj0wK18MX0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Current maturities of long-term debt and lease financing obligations </span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease financing obligations, less current maturities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total finance lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Weighted average remaining lease term</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Weighted average discount rate</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As a result of the Sale to WBA and the related Amended and Restated Asset Purchase Agreement, the Company has lease guarantee obligations related to 676 former stores. The Company is only obligated to pay for the lease guarantees in the event that WBA fails to perform under the lease agreements, as WBA is the primary obligor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table summarizes the maturity of lease liabilities under finance and operating leases as of March 4, 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:32.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Finance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fiscal year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Leases</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 677,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 680,819</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,732</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 593,857</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 601,589</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 509,809</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 426,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 428,070</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 351,942</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 353,442</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,148,719</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,159,642</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease payments </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,706,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,733,371</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: imputed interest </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,419)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (830,694)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (839,113)</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,875,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,894,258</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Future operating lease payments have not been reduced by minimum sublease rentals of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$24.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million due in the future under noncancelable leases.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Sale-Leaseback Transactions:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended March 4, 2023, <span style="background:#ffffff;">the Company </span>sold twelve owned and operated properties, including the Pontiac, MI and Liverpool, NY distribution centers and ten retail stores to independent third parties. Net proceeds from the sales were $73,344. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years for the retail stores and over a minimum lease term of three years for the distribution centers. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $38,214 which is included in the (gain) loss on sale of assets, net for fifty-three weeks ended March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended February 26, 2022, the Company sold twenty owned and operating properties to independent third parties. Net proceeds from the sale were $57,498. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over a minimum lease term of 15 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $8,600 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 26, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During the year ended February 27, 2021, the Company sold eleven owned and operating properties, including the Company’s Perryman, MD, Woodland, CA, and Lancaster, CA distribution centers, the Company’s Ice Cream Plant and seven retail stores to independent third parties. Net proceeds from the sales were $177,892. Concurrent with these sales, the Company entered into agreements to lease the properties back from the purchasers over minimum lease terms between 15 and 20 years. The Company accounted for these leases as operating lease right-of-use assets and corresponding operating lease liabilities in accordance with the Lease Standard. The transactions resulted in a gain of $93,841 which is included in the (gain) loss on sale of assets, net for the fifty-two weeks ended February 27, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company has additional capacity under its outstanding debt agreements to enter into additional sale-leaseback transactions.</p> P5Y P22Y P3Y P10Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:47.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 641,394</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 669,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 651,261</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financing lease cost:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Amortization of right-of-use asset </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,471</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,359</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Interest on long-term finance lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,505</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total finance lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,805</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,864</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,214</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Variable lease costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 178,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 175,697</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 172,088</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: sublease income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,871)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,886)</p></td></tr><tr><td style="vertical-align:bottom;width:50.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net lease cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 815,351</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,593</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 818,541</p></td></tr></table> 641394000 669421000 651261000 3471000 3638000 4359000 1968000 2167000 2505000 5439000 5805000 6864000 3126000 3180000 3214000 178263000 175697000 172088000 12871000 13510000 14886000 815351000 840593000 818541000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:38.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid for amounts included in the measurement of lease liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating cash flows paid for operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 706,506</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 703,326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 683,226</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating cash flows paid for interest portion of finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,505</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Financing cash flows paid for principal portion of finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,744</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Right-of-use assets obtained in exchange for lease obligations:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 264,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 350,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 513,215</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ej5zcseOnEasIONw8rnTuw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_K2RjRJc_ME-39_Zj7fd34A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rITNIyYetEKZx-6iugHZ_A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr></table> 706506000 703326000 683226000 1968000 2167000 2505000 4019000 4117000 4744000 264507000 350132000 513215000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating leases:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease right-of-use asset </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,497,206</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,813,535</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 502,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 575,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,372,943</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,597,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,875,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,172,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Finance leases:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_4UTwYICUrU2Cj0wK18MX0g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Current maturities of long-term debt and lease financing obligations </span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease financing obligations, less current maturities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,580</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total finance lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Weighted average remaining lease term</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Weighted average discount rate</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finance leases </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 2497206000 2813535000 502403000 575651000 2372943000 2597090000 2875346000 3172741000 13576000 13950000 6332000 5544000 12580000 14830000 18912000 20374000 P7Y6M P7Y8M12D P8Y P8Y8M12D 0.065 0.060 0.090 0.100 676 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:32.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Finance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fiscal year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Leases</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 677,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 680,819</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,732</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 593,857</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 601,589</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 509,809</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 426,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 428,070</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 351,942</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 353,442</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,148,719</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,159,642</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease payments </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,706,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,733,371</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: imputed interest </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,419)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (830,694)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (839,113)</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,875,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,894,258</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Future operating lease payments have not been reduced by minimum sublease rentals of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$24.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million due in the future under noncancelable leases.</span></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:32.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Finance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fiscal year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> Leases</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 677,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 680,819</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,732</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 593,857</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 601,589</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 509,809</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 426,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 428,070</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 351,942</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 353,442</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,148,719</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,159,642</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease payments </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,706,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,733,371</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: imputed interest </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,419)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (830,694)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (839,113)</p></td></tr><tr><td style="vertical-align:bottom;width:65.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,912</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,875,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,894,258</p></td></tr></table> 3188000 677631000 680819000 7732000 593857000 601589000 2421000 507388000 509809000 1567000 426503000 428070000 1500000 351942000 353442000 10923000 1148719000 1159642000 27331000 3706040000 3733371000 8419000 830694000 839113000 18912000 2875346000 2894258000 24000000.0 12 10 73344000 P15Y P3Y 38214000 20 57498000 P15Y 8600000 11 7 177892000 P15Y P20Y 93841000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">18. Stock Option and Stock Award Plans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes share-based compensation expense in accordance with ASC 718, “Compensation—Stock Compensation.” Expense is recognized over the requisite service period of the award, net of an estimate for the impact of forfeitures. Operating results for fiscal 2023, 2022 and 2021 include $11,537, $13,050 and $13,003 of compensation costs related to the Company’s stock-based compensation arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2010, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2010 Omnibus Equity Plan. Under the plan, 1,750 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2010 Omnibus Equity Plan became effective on June 23, 2010.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2012, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2012 Omnibus Equity Plan. Under the plan, 1,425 shares of Rite Aid common stock are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2012 Omnibus Equity Plan became effective on June 21, 2012.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2014, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2014 Omnibus Equity Plan. Under the plan, 2,900 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan and the Rite Aid Corporation 2012 Omnibus Equity Plan as of the effective date of the 2014 Plan (provided that no more than 1,250 shares may be granted as incentive stock options) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2014 Omnibus Equity Plan became effective on June 19, 2014.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2020, the stockholders of Rite Aid Corporation approved the adoption of the Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,350 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Rite Aid Corporation 2010 Omnibus Equity Plan, the Rite Aid Corporation 2012 Omnibus Equity Plan and the Rite Aid Corporation 2014 Omnibus Equity Plan (collectively, the “Prior Plans”) are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the 2020 Omnibus Equity Plan became effective on July 8, 2020. Upon the adoption date, shares of common stock may no longer be issued pursuant to the Prior Plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2021, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 4,562 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 7, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2022, the stockholders of Rite Aid Corporation approved the adoption of an amended and restated Rite Aid Corporation 2020 Omnibus Equity Plan. Under the plan, 3,250 shares of Rite Aid common stock plus any shares of common stock remaining available for grant under the Prior Plans are available for granting of restricted stock, stock options, phantom stock, stock bonus awards and other equity based awards at the discretion of the Board of Directors. The adoption of the Amended and Restated 2020 Omnibus Equity Plan became effective on July 27, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">All of the plans provide for the Board of Directors (or at its election, the Compensation Committee) to determine both when and in what manner options may be exercised; however, it may not be more than 10 years from the date of grant. All of the plans provide that stock options may be granted at prices that are not less than the fair market value of a share of common stock on the date of grant. The aggregate number of remaining shares authorized for issuance for all plans is 3,628 as of March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Options</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company determines the fair value of stock options issued on the date of grant using the Black-Scholes-Merton option-pricing model. The Company did not grant any options in fiscal 2023, 2022 and 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The weighted average fair value of options granted during fiscal 2023, <span style="-sec-ix-hidden:Hidden_b8LudMs_qUSdEDk9cwuZdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2022</span></span> and <span style="-sec-ix-hidden:Hidden_IFHL2vhM2kiSPNOReZInkw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2021</span></span> was $0.00. Following is a summary of stock option transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Per Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 29, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_zYFIVw7Nh0m7KMthcB4AZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vrN3I5c7WEqLNNqVuzVqmg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (513)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 48.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_0IdeDHorOkyM0VpRf1icVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Z8RNc4al5UCK5y79sQiROQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_8iFmNEbhCki0oVHqBN7HPw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nT-tcBZAEUaljUJRvPoE9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (79)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45.78</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 701</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_SWNDQm0rnEeQ2fot-gY0Dw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZNI3Rc2SIk6vkjceoYIUyg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_7zw1vYiE0EGMe7BxJbf81w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_x-g0rMS3c0OT9GnHbS3Lzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (169)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Vested or expected to vest as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, there was $0 of total unrecognized pre-tax compensation costs related to unvested stock options, net of forfeitures. These costs are expected to be recognized over a weighted average period of <span style="-sec-ix-hidden:Hidden_pHCNrTtgxUSuEU5gLl_5Mw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">zero</span></span> years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash received from stock option exercises for fiscal 2023, 2022 and 2021 was $0, $0 and $53, respectively. The income tax benefit from stock options for fiscal 2023, 2022 and 2021 was $0, $0 and $1, respectively. The total intrinsic value of stock options exercised for fiscal 2023, 2022 and 2021 was $0, $0 and $10, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Typically, stock options granted vest, and are subsequently exercisable in equal annual installments over a four-year period for employees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restricted Stock</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company provides restricted stock grants to associates under plans approved by the stockholders. Shares awarded under the plans typically vest in equal annual installments over a three-year period. Unvested shares are forfeited upon termination of employment. Following is a summary of restricted stock transactions for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 29, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.32</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17.79</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (574)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.37</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (166)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.23</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.23</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.00</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (546)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.25</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (187)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.51</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14.42</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.50</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,349)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.40</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (370)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.83</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.25</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of March 4, 2023, there was $9,719 of total unrecognized pre-tax compensation costs related to unvested restricted stock grants, net of forfeitures. These costs are expected to be recognized over a weighted average period of 1.7 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The total fair value of restricted stock vested during fiscal years 2023, 2022 and 2021 was $16,746, $6,677 and $7,670, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Performance Based Incentive Plan</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company provides certain of its associates with performance based incentive awards under its equity incentive plans, pursuant to which the associates will receive a certain number of shares of the Company’s common stock based on the Company meeting certain financial and performance goals. If such goals are not met, no stock-based compensation expense is recognized and any recognized stock-based compensation expense is reversed. The Company recorded a benefit of $3,080 and expense of $2,143 and $3,278 related to these performance based incentive awards under the Company’s equity incentive plans for fiscal 2023, 2022 and 2021, respectively, which is recorded as a component of stock-based compensation expense.</p> 11537000 13050000 13003000 1750 1425 2900 1250 3350 4562 3250 P10Y 3628 0.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Per Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 29, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_zYFIVw7Nh0m7KMthcB4AZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vrN3I5c7WEqLNNqVuzVqmg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (513)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 48.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_0IdeDHorOkyM0VpRf1icVw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Z8RNc4al5UCK5y79sQiROQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_8iFmNEbhCki0oVHqBN7HPw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nT-tcBZAEUaljUJRvPoE9Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (79)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45.78</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 701</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_SWNDQm0rnEeQ2fot-gY0Dw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZNI3Rc2SIk6vkjceoYIUyg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_7zw1vYiE0EGMe7BxJbf81w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_x-g0rMS3c0OT9GnHbS3Lzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (169)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Vested or expected to vest as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr><tr><td style="vertical-align:bottom;width:60.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">0.00</p></td></tr></table> 1295000 30.29 2000 25.08 513000 48.16 780000 18.56 79000 45.78 701000 15.50 169000 23.85 532000 12.85 P0Y1M24D 0.00 532000 12.85 P0Y1M24D 0.00 532000 12.85 P0Y1M24D 0.00 0 0 0 53000 0 0 1000 0 0 10000 P4Y P3Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 29, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.32</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17.79</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (574)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.37</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (166)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.23</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13.23</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 973</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.00</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (546)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.25</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (187)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15.51</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14.42</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.50</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,349)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12.40</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (370)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.83</p></td></tr><tr><td style="vertical-align:bottom;width:75.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance as of March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.25</p></td></tr></table> 1253000 10.32 780000 17.79 574000 13.37 166000 12.23 1293000 13.23 973000 15.00 546000 12.25 187000 15.51 1533000 14.42 1662000 6.50 1349000 12.40 370000 10.83 1476000 8.25 9719000 P1Y8M12D 16746000 6677000 7670000 -3080000 2143000 3278000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">19. Retirement Plans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Defined Contribution Plans</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company and its subsidiaries sponsor several retirement plans that are primarily 401(k) defined contribution plans covering nonunion associates and certain union associates. The Company does not contribute to all of the plans. In accordance with those plan provisions, the Company matches 100% of a participant’s pre-tax payroll contributions, up to a maximum of 3% of such participant’s pre-tax annual compensation. Thereafter, the Company will match 50% of the participant’s additional pre-tax payroll contributions, up to a maximum of 2% of such participant’s additional pre-tax annual compensation. Total expense recognized for the above plans was $44,504 in fiscal 2023, $41,528 in fiscal 2022 and $36,270 in fiscal 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company sponsored a Supplemental Executive Retirement Plan (“SERP”) for its officers, based on an account-based plan design, that was subject to a five-year graduated vesting schedule. On February 25, 2019, the SERP was terminated and additional allocations were discontinued and all prior benefits under the program became fully vested. During fiscal 2020, participant benefits under this program were paid in full. No expense was recognized for the SERP in fiscal 2023, 2022 or 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Defined Benefit Plans</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company and its subsidiaries also sponsor a qualified defined benefit pension plan that requires benefits to be paid to eligible associates based upon years of service and, in some cases, eligible compensation. The Company’s funding policy for The Rite Aid Pension Plan (the “Defined Benefit Pension Plan”) is to contribute the minimum amount required by the Employee Retirement Income Security Act of 1974. However, the Company may, at its sole discretion, contribute additional funds to the plan. The Company made contributions of $0 in fiscal 2023, $1,700 in fiscal 2022 and $6,305 in fiscal 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Net periodic pension expense and other changes recognized in other comprehensive income for the defined benefit pension plans included the following components:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 486</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,036</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,753</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,998)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,194)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,614)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of unrecognized net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nm49hsDJFE2n48pDjxuV-Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,749</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net periodic pension expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,374</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other changes recognized in other comprehensive loss:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrecognized net gain arising during period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,246)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,633)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Amortization of unrecognized net (loss) gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_kTiOe8q-YEukR2U3B33dJA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,749)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized in other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,590)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (24,382)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized in pension expense and other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (211)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,154)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,008)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The table below sets forth reconciliation from the beginning of the year for both the benefit obligation and plan assets of the Company’s defined benefit plans, as well as the funded status and amounts recognized in the Company’s balance sheet as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in benefit obligations:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Benefit obligation at end of prior year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 168,872</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 425</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,036</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,861</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Distributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,328)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,582)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Actuarial gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (26,014)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,443)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Benefit obligation at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in plan assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Fair value of plan assets at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 148,412</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Employer contributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,700</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Actual return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,430)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,997</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Distributions (including expenses paid by the plan)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,328)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,582)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of plan assets at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Funded status</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amounts recognized in consolidated balance sheets consisted of:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued pension liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amounts recognized in accumulated other comprehensive loss consist of:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net actuarial loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,787)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,787)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The decrease in the benefit obligation during the year ended March 4, 2023, was driven by the increase in discount rate from 3.25% as of February 26, 2022 to 5.00% as of March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The decrease in the benefit obligation during the year ended February 26, 2022, was driven by the increase in discount rate from 3.00% as of February 27, 2021 to 3.25% as of February 26, 2022. The pension plan also benefitted from favorable return on assets and favorable experience from updated census data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The estimated net actuarial loss and prior service cost amounts that will be amortized from accumulated other comprehensive loss into net periodic pension expense in fiscal 2024 are $0 and $0, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The accumulated benefit obligation for the defined benefit pension plan was $131,163 and $160,133 as of March 4, 2023 and February 26, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The accumulated benefit obligation and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated Benefit Obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair Value of Plan Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The projected benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets as of March 4, 2023 and February 26, 2022 were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Projected Benefit Obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair Value of Plan Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The significant actuarial assumptions used for all defined benefit plans to determine the benefit obligation as of March 4, 2023, February 26, 2022 and February 27, 2021 were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rate of increase in future compensation levels</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_eQlOoabYLk2I6a8_RvYCoQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_knxfNkdN70KtU3plOIa4wA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nB6um1m-m0OfOOUfP6f0Qg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected long-term rate of return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Weighted average assumptions used to determine net cost for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021 were:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%   </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%   </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rate of increase in future compensation levels</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_t7AG5xWyw02XZZ0jYHrXSg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_xaC20wobJUyw15YKCjxQrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_D7Ddf6PGOkiyNWH80RaWdw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected long-term rate of return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To develop the expected long-term rate of return on assets assumption, the Company considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio. This resulted in the selection of the 5.00% long-term rate of return on plan assets assumption for fiscal 2023, 5.50% for 2022 and 6.00% for 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s pension plan asset allocations as of March 4, 2023 and February 26, 2022 by asset category were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed income securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The investment objectives of the Defined Benefit Pension Plan, the only defined benefit plan with assets, are to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Achieve a rate of return on investments that exceeds inflation over a full market cycle and is consistent with actuarial assumptions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Balance the correlation between assets and liabilities by diversifying the portfolio among various asset classes to address return risk and interest rate risk;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Balance the allocation of assets between the investment managers to minimize concentration risk;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Maintain liquidity in the portfolio sufficient to meet plan obligations as they come due; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Control administrative and management costs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The asset allocation established for the pension investment program reflects the risk tolerance of the Company, as determined by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the current and anticipated financial strength of the Company;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the funded status of the plan; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">plan liabilities.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Investments in both the equity and fixed income markets will be maintained, recognizing that historical results indicate that equities (primarily common stocks) have higher expected returns than fixed income investments. It is also recognized that the correlation between assets and liabilities must be balanced to address higher volatility of equity investments (return risk) and interest rate risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following targets are to be applied to the allocation of plan assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:85.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Target</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Allocation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed income securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company expects to contribute $0 to the Defined Benefit Pension Plan during fiscal 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Short-Term Investments</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Short-term investments, which is a short-term investment fund, and is considered cash and cash equivalents, is classified within Level 2 of the valuation hierarchy due to the lack of an active market for trading.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Common and Collective Trusts</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Common collective trust funds are stated at fair value as determined by the issuer of the common collective trust funds based on the net asset value (“NAV”) of the underlying investments in accordance with ASC 820. There are generally no restrictions on redemptions from these funds and no unfunded commitments to invest. In accordance with ASC subtopic 820-10, certain investments that were measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. The underlying investments mainly consist of equity and fixed income securities funds that are valued based on the daily closing price as reported by the fund.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The proceeding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement as of March 4, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table sets forth by level within the fair value hierarchy a summary of the plan’s investments measured at fair value on a recurring basis as of March 4, 2023 and February 26, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements as of March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">for Identical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assets (Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 3)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity Securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">International equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_JIbJK-jBtUO0HaTq3RzKGg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_47P8ClbPYEeIDvV8TTxoeA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_MVMeCX0SsE6ipR47h3yu7w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,901</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Large Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rdPKRZBFp02pAPRhw-m5oQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ICRxp0UmE0OCSoV-6dIFzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3TtalxuyYE2RmR84SBMlZQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,556</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Small-Mid Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_I8M8KVVzIk6_PZRykwocvA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_aGx6vRkC50KLmT2JHUvLsA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_bxnaOYDquEur4n5xPtXzqA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,309</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon High Yield Plus Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_lWpn7gLkwkipW-EtaYwckw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_UzrqYB0SbkuayB8_9liRcg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__ty9-yhXIEaoY9xwaY092w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 72</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Multi-Asset Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_YEx2wog_o024PY2dz2_RUQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_1mJptztaL0OB-MgPAM9QjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_HRJxDCPakUS46oJHmdjheg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,775</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term Credit Bond Index</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_JozmSR4mjUeH1Vkw-OqI3w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Soq_1mpR9kyQEBWU8ZhiJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_HKTDJNg7Jke5y9lHfHXaaQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,360</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term U.S. Government Bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-GLpUfOtC06UWBdkuDqvPQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_NfdycTSwXESuPtgxsG0zrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_0bYLTMpA1EOCA9oNlx49wA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,588</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">20+ Year Treasury STRIPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-v2OgcmRskajgRJaMq6SGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Erhsn2sqDU2sWdj-G6axIg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_a2K1ekrAWUaNb5P6MZWpag;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,821</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intermediate Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vmVbadgg0UOUkflI-Tef2w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZE0FUP4HG0ux_dmti_Gy1w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_IDL2-_wbPUaYubGfUMch6w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,781</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">AGT High Yield Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_CeZ0UNWRC0ih9tNPjUoSZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_hyETv0nDn0qkw8FDS-IdrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3wmqw4M1dU-6g_qohA_MrQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_2Q8bUW72dkSdN0iwnowbXg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other types of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Global Real Estate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VZsKbqrhLEuBswH0z9bN3g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_fNmjRqT7GUCaOT3EPJS-HA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_93VGLgn-6ESNvtxmJdg20Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Core Real Estate Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_XY9fXuGqIk28zI7RnsWcSQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_6UoAJ6vSxE-dkmIvQ-_QWQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wTkdjr6pV0qUBXtW7iYFtA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,479</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-Term Investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ULC7a5bUH0a-ZbucVaxftA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pRbgIsLrSUOZEzHyokbnjw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3XtLDiA8_Eip3R896Uxw8A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_IC-e-9lPLEmXlmOBX9TmBw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,764</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements as of February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">for Identical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assets (Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 3)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity Securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">International equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__ZNCDpR-7UOwtqi-mqGjHQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_n1jtgI9in0-zDYJ3E-s-Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_6uLedB_mpUO0xgZsYV1x4g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,783</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Large Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wdwtRw3_XEepaFg4eQjCAQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qTBNrIshCkiffEjN6FzFKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_E-kW8wb3lE2tJmjOHbaTlQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,027</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Small-Mid Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_chMosheziUSHzMwvnTa1og;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_zUwXkI7PJkOPDuEdi9DQkw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qP8l7zCo7kWjr2AXZZh2Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,213</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon High Yield Plus Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_moHEuN9xNEmCoclZnlb-KQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rDxws8CpL0CHshoaIsgcug;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_mFXsde5oXkWyDwCdHgyQxw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Multi-Asset Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rFuM1sJVzUayZG6WtWIqOg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_QUfktcKW3keQvKNsYWRVrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_P06CpNR_6Emf5XaCiyLrfg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,386</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term Credit Bond Index</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_oMFbBIdld0OlYksqtLwbMQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3TdOeCQrKU2KHD2y-_Y52Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_huIuwXrvHU-4rL4u9LAFfw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,976</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term U.S. Government Bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yAhNW2LaSkW5exr3yrlBmQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_dzQ_K9OtAEWecoSsJWbsPg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vt0QdxdwWUu9iuMAo69bgA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,763</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">20+ Year Treasury STRIPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RzTPkdriMkqif2dMRmQolg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Q_aGAl1CnEuagPxqNugLhw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Wro4Jh3t80iic4Wyj8OIcw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 483</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intermediate Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_QWVh9jIDdkSOgBky9fWfcA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_GWsh6JepvkKUjLVNtj2HQg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Eh8hqn-ZVkO3aT2FsFFrMw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,554</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">AGT High Yield Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_gV75dioPDEiWetSAG9Po4Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_dmTp3JSaVUefV15Jz3Pf3g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_2dukwx8z-UeuUIDzM8vznw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_NTnazSwK5kiJhNR-EZp9Hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other types of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Global Real Estate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ys_J0x97ckuxyL-W-WswJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ynat-xttq021mbhfxx4-Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_KgcEM4St9Uev1x3KetdV2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Core Real Estate Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yKvNYC0uHUWL86VJfoEqnw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_htUyBE4cy0SZmhMYpQ1QRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_4r2JpdsJ6EaAWA765xgEZg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,720</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-Term Investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3GRgmQuCsUKlGZAyoL8urA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vEywJ8m0D02TKqbOmcCEaA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_01vVcCqGZUG0GSRUEK38hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-NNriFMA00KYuKNWU88xNw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,525</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Following are the future benefit payments expected to be paid for the Defined Benefit Pension Plan during the years indicated:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,497</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,379</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,373</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,410</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,252</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2029 - 2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,769</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 91,680</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 1 0.03 0.50 0.02 44504000 41528000 36270000 P5Y 0 0 0 0 1700000 6305000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 425</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 486</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,036</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,861</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,753</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,998)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,194)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,614)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of unrecognized net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nm49hsDJFE2n48pDjxuV-Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,749</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net periodic pension expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,374</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other changes recognized in other comprehensive loss:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Unrecognized net gain arising during period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,246)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,633)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Amortization of unrecognized net (loss) gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_kTiOe8q-YEukR2U3B33dJA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,749)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized in other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,590)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (24,382)</p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized in pension expense and other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (211)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,154)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,008)</p></td></tr></table> 336000 425000 486000 5036000 4861000 4753000 4998000 5194000 4614000 -344000 -3749000 374000 436000 4374000 585000 8246000 20633000 -344000 -3749000 -585000 -8590000 -24382000 -211000 -8154000 -20008000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in benefit obligations:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Benefit obligation at end of prior year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 168,872</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 425</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,036</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,861</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Distributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,328)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,582)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Actuarial gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (26,014)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,443)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Benefit obligation at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in plan assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Fair value of plan assets at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 148,412</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Employer contributions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,700</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Actual return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,430)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,997</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Distributions (including expenses paid by the plan)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,328)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,582)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of plan assets at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Funded status</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amounts recognized in consolidated balance sheets consisted of:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued pension liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,394)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,606)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amounts recognized in accumulated other comprehensive loss consist of:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net actuarial loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,787)</p></td></tr><tr><td style="vertical-align:bottom;width:73.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amount recognized</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,787)</p></td></tr></table> 160133000 168872000 336000 425000 5036000 4861000 8328000 8582000 26014000 5443000 131163000 160133000 149527000 148412000 1700000 -20430000 7997000 8328000 8582000 120769000 149527000 -10394000 -10606000 -10394000 -10606000 10394000 10606000 -10394000 -10606000 11202000 -11787000 -11202000 11787000 0.0325 0.0500 0.0300 0.0325 0 0 131163000 160133000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated Benefit Obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair Value of Plan Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr></table> 131163000 160133000 120769000 149527000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Projected Benefit Obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 160,133</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair Value of Plan Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,527</p></td></tr></table> 131163000 160133000 120769000 149527000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rate of increase in future compensation levels</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_eQlOoabYLk2I6a8_RvYCoQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_knxfNkdN70KtU3plOIa4wA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nB6um1m-m0OfOOUfP6f0Qg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected long-term rate of return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%   </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%   </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rate of increase in future compensation levels</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_t7AG5xWyw02XZZ0jYHrXSg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_xaC20wobJUyw15YKCjxQrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_D7Ddf6PGOkiyNWH80RaWdw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">N/A</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected long-term rate of return on plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 0.0500 0.0325 0.0300 0.0650 0.0500 0.0550 0.0325 0.0300 0.0275 0.0500 0.0550 0.0600 0.0500 0.0550 0.0600 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed income securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 0.30 0.30 0.59 0.57 0.11 0.13 1 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:85.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Target</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Allocation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed income securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:85.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 0.30 0.62 0.08 1 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements as of March 4, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">for Identical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assets (Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 3)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity Securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">International equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_JIbJK-jBtUO0HaTq3RzKGg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_47P8ClbPYEeIDvV8TTxoeA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_MVMeCX0SsE6ipR47h3yu7w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,901</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Large Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rdPKRZBFp02pAPRhw-m5oQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ICRxp0UmE0OCSoV-6dIFzQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3TtalxuyYE2RmR84SBMlZQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,556</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Small-Mid Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_I8M8KVVzIk6_PZRykwocvA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_aGx6vRkC50KLmT2JHUvLsA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_bxnaOYDquEur4n5xPtXzqA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,309</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon High Yield Plus Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_lWpn7gLkwkipW-EtaYwckw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_UzrqYB0SbkuayB8_9liRcg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__ty9-yhXIEaoY9xwaY092w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 72</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Multi-Asset Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_YEx2wog_o024PY2dz2_RUQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_1mJptztaL0OB-MgPAM9QjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_HRJxDCPakUS46oJHmdjheg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,775</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term Credit Bond Index</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_JozmSR4mjUeH1Vkw-OqI3w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Soq_1mpR9kyQEBWU8ZhiJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_HKTDJNg7Jke5y9lHfHXaaQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,360</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term U.S. Government Bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-GLpUfOtC06UWBdkuDqvPQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_NfdycTSwXESuPtgxsG0zrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_0bYLTMpA1EOCA9oNlx49wA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,588</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">20+ Year Treasury STRIPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-v2OgcmRskajgRJaMq6SGw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Erhsn2sqDU2sWdj-G6axIg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_a2K1ekrAWUaNb5P6MZWpag;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,821</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intermediate Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vmVbadgg0UOUkflI-Tef2w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZE0FUP4HG0ux_dmti_Gy1w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_IDL2-_wbPUaYubGfUMch6w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,781</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">AGT High Yield Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_CeZ0UNWRC0ih9tNPjUoSZw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_hyETv0nDn0qkw8FDS-IdrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3wmqw4M1dU-6g_qohA_MrQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_2Q8bUW72dkSdN0iwnowbXg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other types of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Global Real Estate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_VZsKbqrhLEuBswH0z9bN3g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_fNmjRqT7GUCaOT3EPJS-HA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_93VGLgn-6ESNvtxmJdg20Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Core Real Estate Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_XY9fXuGqIk28zI7RnsWcSQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_6UoAJ6vSxE-dkmIvQ-_QWQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wTkdjr6pV0qUBXtW7iYFtA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,479</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-Term Investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ULC7a5bUH0a-ZbucVaxftA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pRbgIsLrSUOZEzHyokbnjw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td></tr><tr><td style="vertical-align:bottom;width:50.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3XtLDiA8_Eip3R896Uxw8A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_IC-e-9lPLEmXlmOBX9TmBw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 120,764</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements as of February 26, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">for Identical</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assets (Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs (Level 3)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity Securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">International equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden__ZNCDpR-7UOwtqi-mqGjHQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_n1jtgI9in0-zDYJ3E-s-Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_6uLedB_mpUO0xgZsYV1x4g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,783</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Large Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wdwtRw3_XEepaFg4eQjCAQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qTBNrIshCkiffEjN6FzFKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_E-kW8wb3lE2tJmjOHbaTlQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 23,027</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Small-Mid Cap</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_chMosheziUSHzMwvnTa1og;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_zUwXkI7PJkOPDuEdi9DQkw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qP8l7zCo7kWjr2AXZZh2Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,213</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon High Yield Plus Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_moHEuN9xNEmCoclZnlb-KQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rDxws8CpL0CHshoaIsgcug;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_mFXsde5oXkWyDwCdHgyQxw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 75</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Multi-Asset Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_rFuM1sJVzUayZG6WtWIqOg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_QUfktcKW3keQvKNsYWRVrA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_P06CpNR_6Emf5XaCiyLrfg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,386</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term Credit Bond Index</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_oMFbBIdld0OlYksqtLwbMQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3TdOeCQrKU2KHD2y-_Y52Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_huIuwXrvHU-4rL4u9LAFfw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,976</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long-Term U.S. Government Bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yAhNW2LaSkW5exr3yrlBmQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_dzQ_K9OtAEWecoSsJWbsPg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vt0QdxdwWUu9iuMAo69bgA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,763</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">20+ Year Treasury STRIPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RzTPkdriMkqif2dMRmQolg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Q_aGAl1CnEuagPxqNugLhw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Wro4Jh3t80iic4Wyj8OIcw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 483</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intermediate Fixed Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_QWVh9jIDdkSOgBky9fWfcA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_GWsh6JepvkKUjLVNtj2HQg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Eh8hqn-ZVkO3aT2FsFFrMw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,554</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">AGT High Yield Bond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_gV75dioPDEiWetSAG9Po4Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_dmTp3JSaVUefV15Jz3Pf3g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_2dukwx8z-UeuUIDzM8vznw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_NTnazSwK5kiJhNR-EZp9Hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other types of investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Global Real Estate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ys_J0x97ckuxyL-W-WswJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ynat-xttq021mbhfxx4-Dg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_KgcEM4St9Uev1x3KetdV2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aon Core Real Estate Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_yKvNYC0uHUWL86VJfoEqnw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_htUyBE4cy0SZmhMYpQ1QRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_4r2JpdsJ6EaAWA765xgEZg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,720</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-Term Investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_3GRgmQuCsUKlGZAyoL8urA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_vEywJ8m0D02TKqbOmcCEaA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td></tr><tr><td style="vertical-align:bottom;width:50.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_01vVcCqGZUG0GSRUEK38hg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-NNriFMA00KYuKNWU88xNw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,525</p></td></tr></table> 13901000 18556000 3309000 72000 4775000 41360000 1588000 12821000 9781000 11000 13479000 1111000 1111000 1111000 120764000 17783000 23027000 4213000 75000 7386000 47976000 19763000 483000 8554000 13000 18720000 1532000 1532000 1532000 149525000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Defined Benefit</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Plan</b></p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,497</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,379</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,373</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,410</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,252</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2029 - 2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 44,769</p></td></tr><tr><td style="vertical-align:bottom;width:81.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 91,680</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 9497000 9379000 9373000 9410000 9252000 44769000 91680000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">20. Multiemployer Plans that Provide Pension Benefits</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company contributes to a number of multiemployer defined benefit pension plans under the terms of collective-bargaining agreements that cover certain of its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer plans. Assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers. If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers. Additionally, if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s participation in these plans for the annual period ended March 4, 2023 is outlined in the table below. The “EIN/Pension Plan Number” column provides the Employer Identification Number (EIN) and the three-digit plan number, if applicable. The most recent Pension Protection Act zone status available for fiscal 2023 and fiscal 2022 is for the plan year-ends as indicated below. The zone status is based on information that the Company received from the plan and is certified by the plan’s actuary. Among other factors, plans in the red zone are generally less than 65% funded, plans in the yellow zone are less than 80% funded, and plans in the green zone are at least 80% funded. The “FIP/RP Status Pending/Implemented” column indicates plans for which a financial improvement plan (“FIP”) or a rehabilitation plan (“RP”) is either pending or has been implemented. In addition to regular plan contributions, the Company may be subject to a surcharge if the plan is in the red zone. The “Surcharge Imposed” column indicates whether a surcharge has been imposed on contributions to the plan. The last two columns list the expiration date(s) of the collective-bargaining agreement(s) to which the plans are subject and any minimum funding requirements. There have been no significant changes that affect the comparability of total employer contributions of fiscal years 2023, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FIP/ RP</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Protection </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Status</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:17.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Collective-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EIN/Pension</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Act Zone Status</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pending/</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:17.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contributions of the Company</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Surcharge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bargaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Funding</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">Pension</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Plan Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Implemented</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Imposed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Agreement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Requirements</b></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">1199 SEIU Health Care Employees Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">13-3604862-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2020</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 7,493</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 9,242</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 9,613</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">4/18/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Contribution rate of 11.3% of gross wages per associate beginning 10/01/2021. Contribution rate of 12.6% of gross wages per associate beginning 09/30/2018. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">51-6029925-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,131</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,989</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,239</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/20/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Beginning 01/01/2021, contributions of $1.844 per hour worked for pharmacists and $0.836 per hour worked for non-pharmacists. From 01/01/2020 through 12/31/2020 contributions of $1.758 per hour worked for pharmacists and $0.797 per hour worked for non-pharmacists.</p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">UFCW Pharmacists, Clerks and Drug Employers Pension Trust</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">94-2518312-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,605</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 3,224</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,319</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/13/2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> Effective 01/01/2020, contribution rate of </span>$0.855 per hour worked for clerks and $1.239 per hour works for pharmacists. Effective 09/01/2014, contribution rate frozen at $0.55 per hour worked for associates.</p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">United Food and Commercial Workers Union-Employer Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">34-6665155-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>9/30/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>9/30/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Implemented</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 954</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 802</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 809</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/07/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Effective 02/06/2022, contribution rate of $2.57 per hour worked.<br/>Effective 02/07/2021 contribution rate of $2.43 per hour worked.<br/> Effective 02/02/2020 contribution rate of $2.30 per hour worked. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">United Food and Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">51-6031766-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>9/30/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>9/30/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 434</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 370</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 399</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/07/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Effective 10/01/2022 contribution rate of $2.33 per hour worked.<br/>Effective 10/01/2021 contribution rate of $2.24 per hour worked.<br/> Effective 10/01/2020 contribution rate of $2.15 per hour worked. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">Other Funds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,046</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,887</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 21,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 24,514</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 22,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company was listed in these plans’ Forms 5500 as providing more than 5% of the total contributions for the following plans and plan years:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Contributions to Plan </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exceeded More Than 5 % of</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Contributions (as of</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Pension Fund</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> the Plan’s Year-End)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">UFCW Pharmacists, Clerks and Drug Employers Pension Trust</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2021 and 12/31/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2021 and 12/31/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Food &amp; Commercial Workers Union - Employer Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9/30/2021 and 9/30/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Food &amp; Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9/30/2021 and 9/30/2020</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the date the Company’s financial statements were issued, certain Forms 5500 were not available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">During fiscal 2023, 2022 and 2021, the Company did not withdraw from any plans or incur any additional withdrawal liabilities.</p> 0.65 0.80 0.80 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expiration</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FIP/ RP</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pension Protection </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Status</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:17.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Collective-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EIN/Pension</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Act Zone Status</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pending/</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:17.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contributions of the Company</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Surcharge</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Bargaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Funding</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><b style="font-weight:bold;">Pension</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Plan Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Implemented</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:4.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Imposed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Agreement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Requirements</b></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">1199 SEIU Health Care Employees Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">13-3604862-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2020</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 7,493</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 9,242</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 9,613</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">4/18/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Contribution rate of 11.3% of gross wages per associate beginning 10/01/2021. Contribution rate of 12.6% of gross wages per associate beginning 09/30/2018. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">51-6029925-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,131</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,989</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 8,239</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/20/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Beginning 01/01/2021, contributions of $1.844 per hour worked for pharmacists and $0.836 per hour worked for non-pharmacists. From 01/01/2020 through 12/31/2020 contributions of $1.758 per hour worked for pharmacists and $0.797 per hour worked for non-pharmacists.</p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">UFCW Pharmacists, Clerks and Drug Employers Pension Trust</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">94-2518312-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>12/31/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,605</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 3,224</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,319</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/13/2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;"><span style="white-space:pre-wrap;"> Effective 01/01/2020, contribution rate of </span>$0.855 per hour worked for clerks and $1.239 per hour works for pharmacists. Effective 09/01/2014, contribution rate frozen at $0.55 per hour worked for associates.</p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">United Food and Commercial Workers Union-Employer Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">34-6665155-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>9/30/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Red—<br/>9/30/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Implemented</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 954</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 802</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 809</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/07/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Effective 02/06/2022, contribution rate of $2.57 per hour worked.<br/>Effective 02/07/2021 contribution rate of $2.43 per hour worked.<br/> Effective 02/02/2020 contribution rate of $2.30 per hour worked. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">United Food and Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">51-6031766-001</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>9/30/2022</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Green—<br/>9/30/2021</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 434</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 370</p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 399</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">No</p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">7/07/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">Effective 10/01/2022 contribution rate of $2.33 per hour worked.<br/>Effective 10/01/2021 contribution rate of $2.24 per hour worked.<br/> Effective 10/01/2020 contribution rate of $2.15 per hour worked. </p></td></tr><tr><td style="vertical-align:top;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:top;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:18.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">Other Funds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 2,046</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,887</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 1,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:18.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 21,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 24,514</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"> 22,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 7493000 9242000 9613000 0.113 0.126 8131000 8989000 8239000 1.844 0.836 1.758 0.797 2605000 3224000 2319000 0.855 1.239 0.55 954000 802000 809000 2.57 2.43 2.30 434000 370000 399000 2.33 2.24 2.15 2046000 1887000 1573000 21663000 24514000 22952000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Contributions to Plan </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exceeded More Than 5 % of</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Contributions (as of</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Pension Fund</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> the Plan’s Year-End)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">UFCW Pharmacists, Clerks and Drug Employers Pension Trust</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2021 and 12/31/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Southern California United Food and Commercial Workers Unions and Drug Employers Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12/31/2021 and 12/31/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Food &amp; Commercial Workers Union - Employer Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9/30/2021 and 9/30/2020</p></td></tr><tr><td style="vertical-align:bottom;width:72.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United Food &amp; Commercial Workers Union Local 880—Mercantile Employers Joint Pension Fund</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9/30/2021 and 9/30/2020</p></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">21. Segment Reporting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has two reportable segments, Retail Pharmacy Segment and Pharmacy Services Segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Retail Pharmacy Segment’s primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy Segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise and a large private brand product line. The Pharmacy Services Segment offers a full range of PBM services including plan design and administration, formulary management and claims processing. Additionally, the Pharmacy Services Segment offers specialty and mail order services, and drug benefits to eligible beneficiaries under the federal government’s Medicare Part D program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s chief operating decision makers are its Chief Executive Officer, Chief Financial Officer, and several other members of the Executive Leadership Team (collectively the “CODM”). The CODM has ultimate responsibility for enterprise decisions. The CODM determines, in particular, resource allocation for, and monitors performance of, the consolidated enterprise, the Retail Pharmacy Segment and the Pharmacy Services Segment. The Retail Pharmacy and Pharmacy Services Segment managers have responsibility for operating decisions, allocating resources and assessing performance within their respective segments. The CODM relies on internal management reporting that analyzes enterprise results on certain key performance indicators, namely, revenues, gross profit and Adjusted EBITDA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following is balance sheet information for the Company’s reportable segments:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Eliminations</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Consolidated</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">March 4, 2023:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,487,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,049,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,590)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,527,362</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 464,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_z7YGMw9mD0y-5xpW_JTZzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,936</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 26, 2022:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,068,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,482,232</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (21,823)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,529,003</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 835,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qGf06o0cRUG1hiLTGMnq9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 879,136</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of March 4, 2023 and February 26, 2022, intersegment eliminations include intersegment accounts receivable of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$9,590</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$21,823</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, respectively, that represent amounts owed from the Pharmacy Services Segment to the Retail Pharmacy Segment that are created when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table is a reconciliation of the Company’s business segments to the consolidated financial statements for the fiscal years ended March 4, 2023, February 26, 2022 and February 27, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intersegment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Eliminations</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Consolidated</b></p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">March 4, 2023:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,394,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 409,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tAs9TtVNfEqwS4xhrhVuvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,803,940</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 288,077</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,103</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_H5IHNar8TEyqy5Y87mHgfQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 429,180</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 229,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5nZs7gjlVkO3P33qEeKBdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,583</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO charge</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_z6XLwmKPw020Y8U8c4IJhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_sEwSZ9xUKkCUohpqcqr7VA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,604</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-wHHQPk2f06vzSKN0VSCPQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,537</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 226,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_hIJqRoA0KUuLH4RZkOOddA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 247,685</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 26, 2022:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,494,816</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,323,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (249,686)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,722,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 384,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_jVg1AuUQAUy3xA5cHo-RnQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,106,495</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 392,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 113,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ij3tZ9pJEkaSh4ALWC6YUw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 505,905</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 244,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,564</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RSBJPyLEp06NeFlPYtBDEg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 295,686</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO charge</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_aQsTV9Tnx0qiwbYxBWRumw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_D6F6GIGMfE-SLJTv52Opew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 768</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_kvaFPB3wNEeXO4JrL6abeg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,050</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 202,386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RsAfxyQL7U2uw4lM74YiOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 220,713</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 27, 2021:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,365,260</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,970,137</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292,157)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,255,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 448,531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_giOXVQ6mJES-Qg6iME1jfQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,704,322</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 279,896</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 157,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tVt1CsTShEmO6l8xn9lYAQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 437,665</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 269,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,139</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_k1ItN_j7uUWI9wuMCQ17YQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 327,124</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ReYKFZ0aNEK8tszkdzxkhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_24Fhx01m50Kpx2zvWrl8rA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ec2b730jJUWkD9qC_5xJnQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,003</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Restructuring-related costs–SKU optimization charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_keDJEbeTVUWCLsXDhIisUA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wOMG-i3CI028bE4cK0a2Uw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 204,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pdUUaJrEyUWWMlv29zbk9g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224,941</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">See the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following is a reconciliation of net loss to Adjusted EBITDA for fiscal 2023, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224,399</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 191,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 201,388</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Depreciation and amortization </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 295,686</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 327,124</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">LIFO charge (credit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill and intangible asset impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 371,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 229,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,852</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(Gain) loss on debt modifications and retirements, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (80,142)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,274)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Merger and Acquisition-related costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_T-K9q-uRzE-0ksdJ-YTPUg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,549</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,537</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,050</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,003</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restructuring-related costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 108,626</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 84,552</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory write-downs related to store closings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,709</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Litigation and other contractual settlements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5cuHvRhEqEigPnLCJTv5Fw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(Gain) loss on sale of assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (68,586)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (69,300)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss (gain) on Bartell acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Nd5ZohfVNU6jih3pG33yDQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,705)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in estimate related to manufacturer rebate receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nUAsLN6APEaYrr9XsB3tOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,068</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_V6cgooBldkueK2bwEoLBbA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,283</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjusted EBITDA from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 429,180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 505,905</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 437,665</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 2 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Eliminations</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Consolidated</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">March 4, 2023:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,487,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,049,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,590)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,527,362</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 464,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_z7YGMw9mD0y-5xpW_JTZzg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 507,936</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 26, 2022:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,068,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,482,232</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (21,823)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,529,003</p></td></tr><tr><td style="vertical-align:bottom;width:52.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,492</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 835,644</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_qGf06o0cRUG1hiLTGMnq9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 879,136</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of March 4, 2023 and February 26, 2022, intersegment eliminations include intersegment accounts receivable of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$9,590</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$21,823</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, respectively, that represent amounts owed from the Pharmacy Services Segment to the Retail Pharmacy Segment that are created when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 5487845000 2049107000 -9590000 7527362000 43492000 464444000 507936000 6068594000 2482232000 -21823000 8529003000 43492000 835644000 879136000 9590000 21823000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retail</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intersegment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pharmacy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Eliminations</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Consolidated</b></p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">March 4, 2023:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,785,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,522,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (215,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,091,899</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,394,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 409,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tAs9TtVNfEqwS4xhrhVuvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,803,940</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 288,077</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,103</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_H5IHNar8TEyqy5Y87mHgfQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 429,180</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 229,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 47,203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5nZs7gjlVkO3P33qEeKBdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,583</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO charge</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_z6XLwmKPw020Y8U8c4IJhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_sEwSZ9xUKkCUohpqcqr7VA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,604</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_-wHHQPk2f06vzSKN0VSCPQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,537</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 226,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_hIJqRoA0KUuLH4RZkOOddA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 247,685</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 26, 2022:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,494,816</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,323,125</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (249,686)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,568,255</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,722,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 384,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_jVg1AuUQAUy3xA5cHo-RnQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,106,495</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 392,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 113,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Ij3tZ9pJEkaSh4ALWC6YUw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 505,905</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 244,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,564</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RSBJPyLEp06NeFlPYtBDEg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 295,686</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO charge</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_aQsTV9Tnx0qiwbYxBWRumw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_D6F6GIGMfE-SLJTv52Opew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 768</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_kvaFPB3wNEeXO4JrL6abeg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,050</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 202,386</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_RsAfxyQL7U2uw4lM74YiOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 220,713</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">February 27, 2021:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,365,260</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,970,137</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (292,157)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,043,240</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Gross Profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,255,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 448,531</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_giOXVQ6mJES-Qg6iME1jfQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,704,322</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Adjusted EBITDA<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 279,896</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 157,769</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_tVt1CsTShEmO6l8xn9lYAQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 437,665</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 269,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,139</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_k1ItN_j7uUWI9wuMCQ17YQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 327,124</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">LIFO credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ReYKFZ0aNEK8tszkdzxkhQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_24Fhx01m50Kpx2zvWrl8rA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,594</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_ec2b730jJUWkD9qC_5xJnQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,003</p></td></tr><tr><td style="vertical-align:top;width:50.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Restructuring-related costs–SKU optimization charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_keDJEbeTVUWCLsXDhIisUA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_wOMG-i3CI028bE4cK0a2Uw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,939</p></td></tr><tr><td style="vertical-align:top;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Additions to property and equipment and intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 204,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_pdUUaJrEyUWWMlv29zbk9g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224,941</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services Segments record the revenue on a stand-alone basis.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">See the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Continuing Operations—Adjusted EBITDA, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Diluted Share and Other Non-GAAP Measures” for additional details.</span></td></tr></table><div style="margin-top:12pt;"></div> 17785067000 6522299000 -215467000 24091899000 4394850000 409090000 4803940000 288077000 141103000 429180000 229380000 47203000 276583000 53028000 53028000 10604000 933000 11537000 226563000 21122000 247685000 17494816000 7323125000 -249686000 24568255000 4722075000 384420000 5106495000 392633000 113272000 505905000 244122000 51564000 295686000 1314000 1314000 12282000 768000 13050000 202386000 18327000 220713000 16365260000 7970137000 -292157000 24043240000 4255791000 448531000 4704322000 279896000 157769000 437665000 269985000 57139000 327124000 -51692000 -51692000 11594000 1409000 13003000 20939000 20939000 204290000 20651000 224941000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(53 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(52 weeks)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 224,399</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 191,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 201,388</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (20,157)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Depreciation and amortization </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 295,686</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 327,124</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">LIFO charge (credit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,314</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (51,692)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill and intangible asset impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 371,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 229,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 29,852</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(Gain) loss on debt modifications and retirements, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (80,142)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,274)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Merger and Acquisition-related costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_T-K9q-uRzE-0ksdJ-YTPUg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,549</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,537</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,050</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,003</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restructuring-related costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 108,626</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 84,552</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory write-downs related to store closings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,709</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Litigation and other contractual settlements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 53,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_5cuHvRhEqEigPnLCJTv5Fw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(Gain) loss on sale of assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (68,586)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (69,300)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss (gain) on Bartell acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_Nd5ZohfVNU6jih3pG33yDQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,705)</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Change in estimate related to manufacturer rebate receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_nUAsLN6APEaYrr9XsB3tOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,068</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="-sec-ix-hidden:Hidden_V6cgooBldkueK2bwEoLBbA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> —</span></span></p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,283</p></td></tr><tr><td style="vertical-align:bottom;width:58.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjusted EBITDA from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 429,180</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 505,905</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 437,665</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> -719188000 -522372000 -99381000 224399000 191601000 201388000 -6467000 -3780000 -20157000 276583000 295686000 327124000 53028000 1314000 -51692000 180637000 164084000 57714000 371200000 229000000 29852000 80142000 -3235000 5274000 12797000 10549000 11537000 13050000 13003000 108626000 35121000 84552000 14270000 5298000 3709000 53882000 50212000 68586000 -5505000 69300000 -5346000 47705000 15068000 -9401000 -4740000 -3283000 429180000 505905000 437665000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">22. Commitments, Contingencies and Guarantees</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Legal Matters and Regulatory Proceedings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company is regularly involved in a variety of legal matters including arbitration, litigation (and related settlement discussions), audits by counter parties under our contracts, and other claims, and is subject to regulatory proceedings including audits, inspections, inquiries, investigations, and similar actions by health care, insurance, pharmacy, tax and other governmental authorities arising in the ordinary course of its business, including, without limitation, the matters described below. Substantial damages are sought from the Company in virtually all of these matters, even if a specific amount is not specified. The Company records accruals for outstanding legal matters and applicable regulatory proceedings when it believes it is probable that a loss has been incurred, and the amount can be reasonably estimated. The Company evaluates on a quarterly basis, developments in legal matters and regulatory proceedings that could affect the amount of any existing accrual or that warrant an accrual. If a loss contingency is not both probable and estimable, the Company typically does not establish an accrued liability. Unless specifically noted otherwise, with respect to the litigation and other legal proceedings described below, the Company is unable to estimate the amount or range of reasonably possible loss due to the inherent difficulty of predicting the outcome of and uncertainties at the current stage of such litigation and legal proceedings. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">None of the Company’s accruals for outstanding legal matters or regulatory proceedings are currently material, individually or in the aggregate, to the Company’s consolidated financial position. However, during the course of any proceeding, developments may result in the creation or an increase of an accrual that could be material. Additionally, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">unfavorable or unexpected outcomes in outstanding legal matters or regulatory proceedings could exceed any accrual and impact the Company’s financial position. Further, even if the Company is successful in its legal proceedings, the Company may incur significant costs and expenses defending itself or others that it is required to indemnify, and such costs and expenses may not be subject to or may exceed reimbursement pursuant to any applicable insurance. Such proceedings may also require significant attention of management.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s contingencies are subject to significant uncertainties, many of which are beyond the Company’s control, including, among other factors: (i) the stage of any proceeding and delays in scheduling; (ii) whether class or collective action status is sought and the likelihood of a class being certified; (iii) the outcome of pending or potential appeals, motions and settlement discussions; (iv) the range and magnitude of potential damages, fines or penalties, which are often unspecified or indeterminate; (v) the impact of discovery on the matter; (vi) whether novel or unsettled legal theories are at issue or advanced; (vii) whether there are significant factual issues to be resolved including findings made by juries; (viii) the exercise of discretion in enforcement actions including in the case of certain government agency investigations, whether a <i style="font-style:italic;">qui tam</i><span style="white-space:pre-wrap;"> lawsuit (“whistleblower” action) has been filed and whether the government agency makes a decision to intervene in the lawsuit following investigation; (ix) changes in priorities following any change in political administration at the state or federal level; and/or (x) the impact, results and settlements of similar claims made against competitors and other industry participants. Additionally, the Company may determine that a settlement is in its best interest, even if it believes that it has meritorious defenses and has not previously accrued for the matter.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment Litigation. </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company is currently a defendant in several lawsuits filed in courts in California that contain allegations regarding violations of the California Business and Professions Code, various California employment laws and regulations, industry wage orders, wage-and-hour laws, rules and regulations pertaining primarily to failure to pay overtime, failure to pay premiums for missed meals and rest periods, failure to provide accurate wage statements, and failure to reimburse business expenses (collectively, the “California Cases”). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Some of the California Cases purport or may be determined to be class actions or representative actions under the California Private Attorneys General Act and seek substantial damages and penalties. In August 2022, the Company agreed to settle a putative class action regarding reimbursement for cell phone and mileage expenses for shift supervisors and managers/assistant managers for $1.29 million, and a putative wage and hour class action brought on behalf of drivers and other ice cream plant associates for $0.8<span style="white-space:pre-wrap;"> million. These settlements are subject to court approval. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company has also reached an agreement in principle to resolve a putative employment collective and class action filed in federal court in New York, which raises similar allegations in addition to others about the payment frequency for certain employees (the “New York Case”). </span>In December 2022, the parties reached an agreement in principle to resolve the individual plaintiff’s claims as well as those of the class, resulting in the federal court issuing an order of judgment and a new matter filed in New York state court, which the parties have agreed to resolve for $6.45 million. The parties continue to work on a definitive settlement agreement, which will be subject to court approval and the Company expects that it will have the right terminate the agreement if certain participation thresholds are not met. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has aggressively defended itself and challenged the merits of these employment lawsuits and, where applicable, allegations that the lawsuits should be certified as class or representative actions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Usual and Customary Litigation.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company’s retail stores overcharged for prescription drugs by not submitting the price available to members of the Rite Aid’s Rx Savings Program as the pharmacy’s usual and customary price, and related theories. The Company is defending itself against these claims. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is a defendant in a putative consumer class action lawsuit in the United States District Court for the Southern District of California captioned <i style="font-style:italic;">Byron Stafford v. Rite Aid Corp</i>. A separate lawsuit, <i style="font-style:italic;">Robert Josten v. Rite Aid Corp</i>., was consolidated with this lawsuit for pre-trial purposes. The lawsuit contains allegations that (i) the Company was obligated to charge the plaintiffs’ insurance companies its usual and customary prices for their prescription drugs; and (ii) the Company failed to do so because the prices it reported were not equal to or adjusted to account for the prices that Rite Aid offered to uninsured and underinsured customers through its Rx Savings Program. The Company is defending itself in a second putative class action lawsuit against similar pricing allegations filed in the United States District Court for the Eastern District of Pennsylvania.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 6, 2019, Humana, Inc., filed a claim pursuant to a binding arbitration provision of the parties’ agreement alleging that the Company improperly submitted various usual and customary overcharges by failing to report its Rx Savings Program prices as its usual and customary prices to Humana. An arbitration hearing was held in this matter in November 2021.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On April 22, 2022, the arbitrator issued an Opinion and Final Award against the Company for breach of contract awarding Humana $122.6 million, which includes $40.7 million in prejudgment interest (the “Arbitration Award”). The Company continues to believe that the Arbitration Award contains a number of significant factual and legal errors. On June 20, 2022, the Company both opposed Humana’s effort to confirm the Arbitration Award and petitioned the United States District Court for Western District of Kentucky for vacatur of the Arbitration Award, as is its right under the Federal Arbitration Act (“FAA”). As such, the Company has determined that it is not probable that a loss has occurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The FAA, as interpreted and applied by federal courts, permits vacatur when, among other things, an arbitrator’s decision: (1) is irreconcilable with the terms of a contract between the parties; (2) rests on a plain legal error that manifests disregard for the law; or (3) incorporates a refusal to consider pertinent, material evidence. Similarly, the FAA, as interpreted and applied by federal courts, permits modification of an arbitrator’s decision to correct an evident material miscalculation of figures. Although the Company cannot make any assurances of success in its efforts, it is the Company’s view that the errors in the Arbitration Award support both vacatur and modification under the FAA, the effect of either of which could be to set aside the Arbitration Award or reduce or eliminate the damages provided for in the Arbitration Award.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Argument on Humana’s petition to confirm the Arbitration Award and Rite Aid’s motion for vacatur of the Arbitration Award is scheduled for May 10, 2023. Depending on the court’s determination, it is possible that one or both parties may appeal the decision, or seek other remedies. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company is a defendant in two consolidated lawsuits pending in the United States District Court for the District of Minnesota filed in 2020 by various Blue Cross/Blue Shield plans that operate in eight different states (North Carolina, North Dakota, Alabama, Utah, Minnesota, Oregon, Washington and New Jersey) alleging that the Company improperly submitted various usual and customary overcharges to several Pharmacy Benefit Managers, all but one of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">which are not owned by plaintiffs, with which Rite Aid and the insurers had independent contracts. The Company is also defending a lawsuit filed in Delaware state court in 2019 by multiple Centene entities alleging that the Company overcharged for prescriptions by improperly reporting <span style="white-space:pre-wrap;">usual and customary prices. The Delaware lawsuit is scheduled to start trial in May 2023. The Company is defending a similar lawsuit filed in 2022 by WellCare in Florida state court.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Drug Utilization Review and Code 1 Litigation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In June 2012, <i style="font-style:italic;">qui tam</i> plaintiff, Loyd F. Schmuckley (“Relator”) filed a complaint under seal against the Company alleging that it failed to comply with certain requirements of California’s Medicaid program between 2007 and 2014. In June 2013, the Company was served with a Civil Investigative Demand (“CID”) by the United States Attorney’s Office for the Eastern District of California regarding (1) the Company’s Drug Utilization Review and prescription dispensing protocol; and (2) the dispensing of drugs designated as “Code 1” by the State of California. Specifically, the Relator alleged that the Company did not perform special verification and documentation for certain medications known as “Code 1” drugs. While the complaint remained under seal, the United States Department of Justice conducted an extensive investigation and ultimately declined to intervene. Although numerous states declined to intervene, in September 2017, the State of California’s Department of Justice’s Bureau of Medical Fraud and Elder Abuse filed a complaint in intervention. The Company filed a motion to dismiss Relator’s and the State of California’s respective complaints in January 2018, and the hearing was held on March 23, 2018. <span style="white-space:pre-wrap;">On September 5, 2018, the court issued an order denying the motion to dismiss. Substantial damages are sought from the Company in this matter. No trial date has been set and as discovery continues, the parties have participated in and are expected to continue to participate in a mediation process, although there is no expected date or terms for any potential resolution of this matter. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Controlled Substances Litigation, Audits and Investigations</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company, along with various other defendants, is named in multiple opioid-related lawsuits filed by counties, cities, municipalities, Native American tribes, hospitals, third-party payers, and others across the United States. In December 2017, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) consolidated and transferred more than a thousand federal opioid-related lawsuits that name the Company as a defendant to the multi-district litigation (“MDL”) pending in the United States District Court for the Northern District of Ohio under <i style="font-style:italic;">In re National Prescription Opiate Litigation</i> (Case No. 17-MD-2804). A significant number of similar cases that are not part of the MDL and name the Company as a defendant are also pending in state courts. On June 1, 2022, the JPML ordered that newly filed cases will no longer be transferred to the MDL. The plaintiffs in these opioid-related lawsuits generally allege claims that include, without limitation, public nuisance and negligence theories of liability resulting from the impacts of widespread opioid abuse against defendants along the pharmaceutical supply chain, including manufacturers, wholesale distributors, and retail pharmacies.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> </sup>At this stage of the proceedings, the Company is not able to predict the outcome of the opioid-related lawsuits in which it remains a defendant or estimate a potential range of loss regarding the lawsuits, and is defending itself against all relevant claims. From time to time, some of these cases may be settled, dismissed or otherwise terminated, and additional such cases may be filed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company also has received warrants, subpoenas, CIDs, and other requests for documents and information from, and is being investigated by, the federal and state governments regarding opioids and other controlled substances. The Company has been cooperating with and responding to these investigatory inquiries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As previously disclosed, on December 13, 2022, a qui tam complaint filed by three former Rite Aid pharmacy personnel (Andrew White, Mark Rosenberg, and Ann Wegelin) (collectively, “<i style="font-style:italic;">qui tam</i> Relators”) was unsealed by the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">federal District Court for the Northern District of Ohio in an order that also directed the United States Department of Justice to file within 90 days a complaint intervening or partially intervening in the Second Amended Complaint (the “Complaint”). On February 23, 2023, the following states, which were listed in the Complaint, declined to intervene: Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Nevada, New Hampshire, New Jersey, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington and the District of Columbia. On February 23, 2023, California stated its intention to make an intervention decision on or before May 2, 2023. On March 13, 2023, the United States Department of Justice filed its complaint in the federal District Court for the Northern District of Ohio against Rite Aid (“DOJ’s Complaint”) alleging violations of the federal False Claims Act and Controlled Substances Act related to the dispensing of controlled substances, primarily opioids. DOJ’s Complaint seeks damages under the False Claims Act, civil penalties under the Controlled Substances Act, damages in connection with alleged payment by mistake (on behalf of Federal Healthcare Programs), and damages in connection with alleged unjust enrichment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In April 2019, the Company initiated a coverage action styled <i style="font-style:italic;">Rite Aid Corporation et al. v. ACE American Ins. Co. et al</i>. Through this action, the Company is seeking the recovery of defense costs and settlement and/or judgment costs that may be paid for the opioid-related lawsuits. The action seeks declaratory relief with respect to the obligations of the insurers under the policies at issue in the action and asserts claims for breach of contract and statutory remedies against one of these insurers. Although the trial court determined on the Company’s motion for partial summary judgment that this insurer was obligated to reimburse the Company for its defense costs, on January 10, 2022, the Delaware Supreme Court reversed the trial court’s order and ruled that the insurer had no duty to defend the first MDL suits set for trial based on the specific allegations at issue in those cases. The matter has been remanded to the lower court for further proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous Litigation and Investigations.</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Following the Company’s response to a 2020 CID from the Federal Trade Commission (“FTC”) with respect to consumer protection laws, the Company is seeking to negotiate a resolution with the FTC. The allegations relate to certain business practices that the Company has not engaged in for nearly three years, and the Company currently believes that any resolution will not likely require a monetary payment. Discussions are ongoing with the FTC and the timing and substance of any settlement cannot be determined at this time. During the course of the Company’s discussions with the FTC in connection with its response to that CID, the FTC also requested certain information from the Company related to compliance with the Company’s 2010 FTC Consent Order. The Company cooperated with the FTC's request, however, the FTC Staff informed the Company that it would recommend that the FTC file a complaint against the Company for violation of the Consent Order, including a monetary payment and other relief, unless the Company informs FTC Staff that it is willing to discuss a resolution. The Company is evaluating the matter, including potential resolution, although no assurance can be given that the matter will be resolved to the parties’ mutual satisfaction, or that the resolution will not include a monetary payment, and that the payment will not be material. It is also possible that discussions relating to the 2010 FTC Consent Order could affect the resolution of the 2020 CID.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The Company has received CIDs from the Department of Justice related to the Medicare Part D plan sponsored by a subsidiary of the Company. The Company is also defending a lawsuit asserting numerous claims based on allegations surrounding the Company’s use of a certain font including in the Company’s rebranded logo. The Company is defending a putative class action it has removed to federal court in California regarding alleged privacy breaches. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company is defending a putative shareholder class action currently captioned <i style="font-style:italic;">Page v. Rite Aid Corporation et al.</i>, filed in the United States District Court for the Eastern District of Pennsylvania<span style="white-space:pre-wrap;">. The matter names Rite Aid </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Corporation and certain executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to alleged misstatements and omissions concerning the growth of </span>Elixir’s PBM services businesses. The matter remains in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit. The Company is also defending a putative shareholder class action currently captioned <i style="font-style:italic;">Holland v. Rite Aid Corporation et al.</i>, filed in the United States District Court for the Northern District of Ohio<span style="white-space:pre-wrap;">. The matter names Rite Aid Corporation and certain former and current executives individually as defendants and raises claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 related to the DOJ’s Complaint and alleged misstatements and omissions concerning the Company’s </span>risk for regulatory action and litigation related to controlled substances practices.  This matter is also in early stages, but the Company intends to aggressively defend against the allegations and challenge their merit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 1290000 800000 6450000 122600000 40700000 2 8 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">23. Supplementary Cash Flow Data</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.13888931%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid for interest<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> (a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 212,355</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 181,634</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash (refunds) payments for income taxes, net<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,309)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,535</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment financed under capital leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,698</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,849</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued capital expenditures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,904</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross borrowings from revolver<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,131,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,912,000</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross repayments to revolver<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,019,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,272,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,712,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(a)–Amounts are presented on a total company basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Significant components of cash used in Other Liabilities of $111,021 for the fifty-three week period ended March 4, 2023 includes cash used from changes in accrued wages, benefits and other personnel costs of $100,340 and provided from changes in accrued store expenses of $11,426.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.13888931%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 4,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 26,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">February 27,</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid for interest<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> (a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 212,355</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,583</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 181,634</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash (refunds) payments for income taxes, net<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,309)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,535</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment financed under capital leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,698</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,849</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued capital expenditures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,904</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross borrowings from revolver<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,510,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,131,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,912,000</p></td></tr><tr><td style="vertical-align:bottom;width:65.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross repayments to revolver<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(a)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,019,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,272,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,712,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(a)–Amounts are presented on a total company basis.</p> 212355000 180583000 181634000 -5309000 6233000 7535000 3334000 1698000 1849000 18711000 45465000 19904000 3510000000 5131000000 7912000000 3019000000 5272000000 7712000000 -111021000 100340000 11426000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">24. Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The carrying amounts and fair values of financial instruments as of March 4, 2023 and February 26, 2022 are listed as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Variable rate indebtedness</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,581,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,038,646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,059,000</p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed rate indebtedness</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,343,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 768,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,694,340</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,602,122</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short-term nature. In addition, as of March 4, 2023, the Company has $7,457 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of prepaid expenses and other current assets. As of February 26, 2022, the Company has $7,406 of investments carried at amortized cost as these investments are being held to maturity, which are included as a component of other assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">The following methods and assumptions were used in estimating fair value disclosures for financial instruments:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;"><span style="font-style:italic;font-weight:bold;">Borrowings under credit facilities:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;">The carrying amounts for SOFR-based and LIBOR-based borrowings under the credit facilities are estimated based on the quoted market price of the financial instruments. The LIBOR-based borrowings under the credit facilities transitioned to Term SOFR on December 1, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 11pt 0pt;"><span style="font-style:italic;font-weight:bold;">Long-term indebtedness:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The fair values of long-term indebtedness are estimated based on the quoted market prices of the financial instruments. If quoted market prices were not available, the Company estimated the fair value based on the quoted market price of a financial instrument with similar characteristics.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Variable rate indebtedness</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,581,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,600,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,038,646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,059,000</p></td></tr><tr><td style="vertical-align:bottom;width:39.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed rate indebtedness</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,343,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 768,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,694,340</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,602,122</p></td></tr></table> 1581793000 1600000000 1038646000 1059000000 1343465000 768328000 1694340000 1602122000 7457000 7406000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">25. Revision of Previously Issued Consolidated Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Subsequent to the issuance of the Company’s consolidated financial statements as of and for the fiscal year ended March 4, 2023, management evaluated the materiality of a misstatement in accordance with the U.S. SEC Staff’s Accounting Bulletin Nos. 99, </span><i style="font-style:italic;">Materiality</i> (“SAB 99”) and 108, <i style="font-style:italic;">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</i><span style="white-space:pre-wrap;"> (“SAB 108”). The misstatement pertains to the Company’s historical accounting for closed store liabilities. Based on their evaluation, management concluded the misstatement is not material to the Company’s previously issued consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and each of the interim and year-to-date periods then ended, (collectively the “previously issued financial statements”). However, as prescribed by SAB 108, in conjunction with the re-issuance of the Company’s previously issued financial statements, the misstatement has been corrected as an immaterial revision of the accompanying consolidated financial statements as of and for each of the three fiscal years ended March 4, 2023 and the related notes hereto. A summary of the nature of the misstatement and its impact on the Company’s previously issued financial statements is summarized as follows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company adopted ASC 842, <i style="font-style:italic;">Leases</i>, (“ASC 842”) on the first day of fiscal year 2020 under the alternative transition method as permissible under ASC 842. As part of this adoption, the Company elected the practical expedients, as permitted under the transition guidance, which included, among other things, the ability to carry forward existing lease classifications. Based on this election, the Company appropriately eliminated the majority of its closed store and lease exit liabilities as of the date of adoption, which had been accrued in accordance with ASC 420,<i style="font-style:italic;"> Exit or Disposal Cost Obligations</i><span style="white-space:pre-wrap;">, (“ASC 420”). Moreover, due to the Company’s practical expedients election, variable costs, consisting primarily of real estate taxes and common area maintenance expenses, associated with store closures that occur subsequent to the adoption of ASC 842 may no longer be accrued under ASC 420, but rather recognized as expense as they are incurred. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">Due to an oversight in their evaluation of an amendment to ASC 420 as a result of the adoption of ASC 842, management determined that the Company incorrectly continued to accrue estimated costs associated with store closures as a liability subsequent to the date of adoption, rather than recognize the costs as they are incurred. The impact of the misstatement resulted in an overstatement of these costs, which have historically been classified within </span><i style="font-style:italic;">Facility exit and impairment charges </i>in the Company’s Consolidated Statements of Operations, and an overstatement of store closure liabilities, which have historically been classified within <i style="font-style:italic;">Accrued salaries, wages and other current liabilities</i> (current </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">portion) and <i style="font-style:italic;">Other noncurrent liabilities</i> (long-term portion) in the Company’s Consolidated Balance Sheets. The misstatement had no impact on the Company’s previously issued consolidated financial statements as of and for the fiscal year ended February 29, 2020 and each of the interim and year-to-date periods then ended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A summary of revisions to the Company’s previously reported financial statements is presented below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of and for the fiscal year ended March 4, 2023</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts )</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 724,529</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 709,891</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,727,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,713,237</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 130,482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (32,905)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 97,577</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,169,138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,121,595</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,601,517)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,553,974)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (641,776)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (594,233)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 211,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (30,748)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (756,403)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (725,655)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,351)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (718,603)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 211,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (30,748)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of and for the fiscal year ended February 26, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,073)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 776,559</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,933,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,073)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,929,015</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 151,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,722)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 139,254</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,429,970</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,795)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,413,175</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,851,581)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,795</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,834,786)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 99,033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,795</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 115,828</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (542,258)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (526,152)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (529,861)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (513,755)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.96)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.96)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of and for the fiscal year ended February 27, 2021</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 642,364</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 854</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 643,218</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,602,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 854</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,603,800</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 208,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 206,670</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,720,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,719,561</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,313,103)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,312,414)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 615,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 615,843</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 58,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (120,227)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (119,538)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,909)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (66,065)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,376)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.86)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.69)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.68)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,909)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 58,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts )</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 724,529</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 709,891</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,727,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,713,237</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 130,482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (32,905)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 97,577</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,169,138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,121,595</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,601,517)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,553,974)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (641,776)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (594,233)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 211,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (30,748)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (756,403)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (725,655)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,351)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (718,603)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.71)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13.15)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (749,936)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (719,188)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 211,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (30,748)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,637</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 780,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,073)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 776,559</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,933,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,073)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,929,015</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 151,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,722)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 139,254</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,429,970</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,795)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,413,175</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,851,581)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,795</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,834,786)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 99,033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,795</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 115,828</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (542,258)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (526,152)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (529,861)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (513,755)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.96)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.96)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9.66)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (538,478)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (522,372)</p></td></tr><tr><td style="vertical-align:bottom;width:64.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 180,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 164,084</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(In 000’s, except per share amounts)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued salaries, wages, and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 642,364</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 854</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 643,218</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,602,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 854</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,603,800</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other noncurrent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 208,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,543)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 206,670</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,720,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,719,561</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,313,103)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,312,414)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total stockholders’ (deficit) equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 615,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 615,843</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statements of Operations and Comprehensive Loss:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 58,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Loss from continuing operations before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (120,227)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (119,538)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,909)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (66,065)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,376)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic and diluted loss per share from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.86)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net basic and diluted loss per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.69)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.01</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1.68)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cash Flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,909)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (90,220)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (99,381)</p></td></tr><tr><td style="vertical-align:bottom;width:64.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility exit and impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 58,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,714</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 724529000 -14638000 709891000 2727875000 -14638000 2713237000 130482000 -32905000 97577000 8169138000 -47543000 8121595000 -6601517000 -47543000 -6553974000 -641776000 -47543000 -594233000 211385000 -30748000 180637000 -756403000 30748000 -725655000 -749936000 30748000 -719188000 -749936000 30748000 -719188000 -749351000 30748000 -718603000 -13.71 0.56 -13.15 -13.71 0.56 -13.15 -749936000 30748000 -719188000 -749936000 30748000 -719188000 211385000 -30748000 180637000 780632000 -4073000 776559000 2933088000 -4073000 2929015000 151976000 -12722000 139254000 8429970000 -16795000 8413175000 -5851581000 16795000 -5834786000 99033000 16795000 115828000 180190000 -16106000 164084000 -542258000 16106000 -526152000 -538478000 16106000 -522372000 -538478000 16106000 -522372000 -529861000 16106000 -513755000 -9.96 0.30 -9.66 -9.96 0.30 -9.66 -538478000 16106000 -522372000 -538478000 16106000 -522372000 180190000 -16106000 164084000 642364000 854000 643218000 2602946000 854000 2603800000 208213000 -1543000 206670000 8720250000 -689000 8719561000 -5313103000 689000 -5312414000 615154000 689000 615843000 58403000 -689000 57714000 -120227000 689000 -119538000 -100070000 689000 -99381000 -90909000 689000 -90220000 -66065000 689000 -65376000 -1.87 0.01 -1.86 -1.69 0.01 -1.68 -90909000 689000 -90220000 -100070000 689000 -99381000 58403000 -689000 57714000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Years Ended March 4, 2023, February 26, 2022 and February 27, 2021</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(dollars in thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Additions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Balance at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Charged to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Balance at</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Allowances deducted from accounts receivable for estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beginning</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Costs and</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">End of</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">uncollectible amounts:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Deductions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Period</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Year ended March 4, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 63,373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 48,105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 62,133</p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Year ended February 26, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,854</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 106,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 84,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 46,865</p></td></tr><tr><td style="vertical-align:bottom;width:60.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Year ended February 27, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,849</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,855</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 31,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 24,854</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 46865000 63373000 48105000 62133000 24854000 106113000 84102000 46865000 12849000 43855000 31850000 24854000

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